PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hoebe, K; Du, X; Georgel, P; Janssen, E; Tabeta, K; Kim, SO; Goode, J; Lin, P; Mann, N; Mudd, S; Crozat, K; Sovath, S; Han, J; Beutler, B				Hoebe, K; Du, X; Georgel, P; Janssen, E; Tabeta, K; Kim, SO; Goode, J; Lin, P; Mann, N; Mudd, S; Crozat, K; Sovath, S; Han, J; Beutler, B			Identification of Lps2 as a key transducer of MyD88-independent TIR signalling	NATURE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; ADAPTER MOLECULE; RECEPTOR; ACTIVATION; LIPOPOLYSACCHARIDE; MICE; RECOGNITION; ENDOTOXIN; RESPONSES	In humans, ten Toll-like receptor (TLR) paralogues sense molecular components of microbes, initiating the production of cytokine mediators that create the inflammatory response. Using N-ethyl-N-nitrosourea, we induced a germline mutation called Lps2, which abolishes cytokine responses to double-stranded RNA and severely impairs responses to the endotoxin lipopolysaccharide (LPS), indicating that TLR3 and TLR4 might share a specific, proximal transducer. Here we identify the Lps2 mutation: a distal frameshift error in a Toll/interleukin-1 receptor/resistance (TIR) adaptor protein known as Trif or Ticam-1. Trif Lps2 homozygotes are markedly resistant to the toxic effects of LPS, and are hypersusceptible to mouse cytomegalovirus, failing to produce type I interferons when infected. Compound homozygosity for mutations at Trif and MyD88 (a cytoplasmic TIR-domain-containing adaptor protein) loci ablates all responses to LPS, indicating that only two signalling pathways emanate from the LPS receptor. However, a Trif-independent cell population is detectable when Trif Lps2 mutant macrophages are stimulated with LPS. This reveals that an alternative MyD88-dependent 'adaptor X' pathway is present in some, but not all, macrophages, and implies afferent immune specialization.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA	Scripps Research Institute; La Jolla Institute for Immunology	Beutler, B (corresponding author), Scripps Res Inst, Dept Immunol, IMM-31,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bruce@scripps.edu	Han, J/G-4671-2010; TABTA, KOICHI/AAG-6481-2020; Kim, Sung Ouk/AAO-1795-2020; georgel, philippe/P-5676-2016; Crozat, Karine/L-7297-2019; KIM, Sung Ouk/A-1309-2008	TABTA, KOICHI/0000-0002-7019-1872; Kim, Sung Ouk/0000-0002-0282-6661; georgel, philippe/0000-0001-6853-7080; Crozat, Karine/0000-0003-4761-3675; Hoebe, Kasper/0000-0002-3626-8098				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Beutler B, 2002, CURR TOP MICROBIOL, V270, P1; Beutler B, 2001, BIOCHEM SOC T, V29, P853, DOI 10.1042/0300-5127:0290853; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Du X, 1999, BLOOD CELL MOL DIS, V25, P328, DOI 10.1006/bcmd.1999.0262; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HEPPNER G, 1965, J BACTERIOL, V90, P696, DOI 10.1128/JB.90.3.696-703.1965; Hoebe K, 2003, J ENDOTOXIN RES, V9, P250, DOI 10.1179/096805103225001459; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kim SO, 2001, AM J PHYSIOL-LUNG C, V281, pL1095, DOI 10.1152/ajplung.2001.281.5.L1095; Orange JS, 1996, J IMMUNOL, V156, P4746; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamaji M, 2002, PHOTOCH PHOTOBIO SCI, V1, P169, DOI 10.1039/b110092k; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	32	969	1032	0	44	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 14	2003	424	6950					743	748		10.1038/nature01889	http://dx.doi.org/10.1038/nature01889			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12872135				2022-12-24	WOS:000184733900030
J	Losos, JB; Leal, M; Glor, RE; de Queiroz, K; Hertz, PE; Schettino, LR; Lara, AC; Jackman, TR; Larson, A				Losos, JB; Leal, M; Glor, RE; de Queiroz, K; Hertz, PE; Schettino, LR; Lara, AC; Jackman, TR; Larson, A			Niche lability in the evolution of a Caribbean lizard community	NATURE			English	Article							ANOLIS LIZARDS; PHYLOGENETIC-RELATIONSHIPS; ECOLOGY; SYSTEMS; MODEL	Niche conservatism-the tendency for closely related species to be ecologically similar - is widespread(1-3). However, most studies compare closely related taxa that occur in allopatry(3); in sympatry, the stabilizing forces that promote niche conservatism(4,5), and thus inhibit niche shifts, may be countered by natural selection favouring ecological divergence to minimize the intensity of interspecific interactions(6,7). Consequently, the relative importance of niche conservatism versus niche divergence in determining community structure has received little attention(7). Here, we examine a tropical lizard community in which species have a long evolutionary history of ecological interaction. We find that evolutionary divergence overcomes niche conservatism: closely related species are no more ecologically similar than expected by random divergence and some distantly related species are ecologically similar, leading to a community in which the relationship between ecological similarity and phylogenetic relatedness is very weak. Despite this lack of niche conservatism, the ecological structuring of the community has a phylogenetic component: niche complementarity only occurs among distantly related species, which suggests that the strength of ecological interactions among species may be related to phylogeny, but it is not necessarily the most closely related species that interact most strongly.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Union Coll, Dept Biol Sci, Schenectady, NY 12308 USA; Smithsonian Inst, Natl Museum Amer Hist, Div Amphibians & Reptiles, Washington, DC 20560 USA; Columbia Univ Barnard Coll, Dept Biol, New York, NY 10027 USA; CITGMA, Inst Ecol & Sistemat, Havana 10800, Cuba; Villanova Univ, Dept Biol, Villanova, PA 19085 USA	Washington University (WUSTL); Union College; Smithsonian Institution; Smithsonian National Museum of Natural History; Columbia University; Villanova University	Losos, JB (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.		Leal, Manuel/A-7220-2010; Glor, Richard/N-4656-2013	Glor, Richard/0000-0002-3359-1631; Jackman, Todd/0000-0002-5391-8136				Butler MA, 2002, ECOL MONOGR, V72, P541, DOI 10.1890/0012-9615(2002)072[0541:MSDSSA]2.0.CO;2; Danley PD, 2001, MOL ECOL, V10, P1075, DOI 10.1046/j.1365-294X.2001.01283.x; de Queiroz Kevin, 1998, American Museum Novitates, V3249, P1; Gerber GP, 2000, OECOLOGIA, V124, P599, DOI 10.1007/s004420000414; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jackman TR, 1999, SYST BIOL, V48, P254, DOI 10.1080/106351599260283; LANGLEY CH, 1974, J MOL EVOL, V3, P161, DOI 10.1007/BF01797451; Leal M, 1998, OECOLOGIA, V117, P273, DOI 10.1007/s004420050658; LOSOS JB, 1994, ANNU REV ECOL SYST, V25, P467, DOI 10.1146/annurev.es.25.110194.002343; Losos JB, 1999, ECOLOGY, V80, P252, DOI 10.2307/176994; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Petren K, 1999, P ROY SOC B-BIOL SCI, V266, P321, DOI 10.1098/rspb.1999.0641; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; REAGAN DP, 1992, COPEIA, P392; RICHMAN AD, 1992, NATURE, V355, P817, DOI 10.1038/355817a0; SCHOENER TW, 1980, J ANIM ECOL, V49, P19, DOI 10.2307/4276; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; SHOCHAT D, 1981, COMP BIOCHEM PHYS A, V68, P67, DOI 10.1016/0300-9629(81)90319-4; Silvertown J, 2001, J ECOL, V89, P428, DOI 10.1046/j.1365-2745.2001.00553.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448	22	244	252	1	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					542	545		10.1038/nature01814	http://dx.doi.org/10.1038/nature01814			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891355				2022-12-24	WOS:000184454700040
J	Masutomi, K; Yu, EY; Khurts, S; Ben-Porath, I; Currier, JL; Metz, GB; Brooks, MW; Kaneko, S; Murakami, S; DeCaprio, JA; Weinberg, RA; Stewart, SA; Hahn, WC				Masutomi, K; Yu, EY; Khurts, S; Ben-Porath, I; Currier, JL; Metz, GB; Brooks, MW; Kaneko, S; Murakami, S; DeCaprio, JA; Weinberg, RA; Stewart, SA; Hahn, WC			Telomerase maintains telomere structure in normal human cells	CELL			English	Article							REVERSE-TRANSCRIPTASE HTERT; HUMAN-DIPLOID FIBROBLASTS; CATALYTIC SUBUNIT; LIFE-SPAN; G-STRAND; SACCHAROMYCES-CEREVISIAE; HUMAN-LYMPHOCYTES; IMMORTAL CELLS; RNA COMPONENT; MOUSE CELLS	In normal human cells, telomeres shorten with successive rounds of cell division, and immortalization correlates with stabilization of telomere length. These observations suggest that human cancer cells achieve immortalization in large part through the illegitimate activation of telomerase expression. Here, we demonstrate that the rate-limiting telomerase catalytic subunit hTERT is expressed in cycling primary presenescent human fibroblasts, previously believed to lack hTERT expression and telomerase activity. Disruption of telomerase activity in normal human cells slows cell proliferation, restricts cell lifespan, and alters the maintenance of the 3' single-stranded telomeric overhang without changing the rate of overall telomere shortening. Together, these observations support the view that telomerase and telomere structure are dynamically regulated in normal human cells and that telomere length alone is unlikely to trigger entry into replicative senescence.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Kanazawa Univ, Canc Res Inst, Dept Mol Oncol, Kanazawa, Ishikawa 9200934, Japan; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa 9208641, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Kanazawa University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Kanazawa University	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.		Stewart, Sheila A/C-5213-2012		NATIONAL CANCER INSTITUTE [F32CA093033, R01CA078461, K01CA094223] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA94223, R01 CA78461, F32 CA93033] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Cimino-Reale G, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e35; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Enomoto S, 2002, MOL BIOL CELL, V13, P2626, DOI 10.1091/mbc.02-02-0012; Etheridge KT, 2002, J BIOL CHEM, V277, P24764, DOI 10.1074/jbc.M201227200; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HARA E, 1991, BIOCHEM BIOPH RES CO, V179, P528, DOI 10.1016/0006-291X(91)91403-Y; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hiyama E, 1996, INT J ONCOL, V9, P453; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Jacob NK, 2003, MOL CELL, V11, P1021, DOI 10.1016/S1097-2765(03)00131-X; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Kolquist KA, 1998, NAT GENET, V19, P182, DOI 10.1038/554; Li GZ, 2003, P NATL ACAD SCI USA, V100, P527, DOI 10.1073/pnas.0235444100; Liu KB, 1999, P NATL ACAD SCI USA, V96, P5147, DOI 10.1073/pnas.96.9.5147; Martin-Rivera L, 1998, P NATL ACAD SCI USA, V95, P10471, DOI 10.1073/pnas.95.18.10471; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Masutomi K, 2000, J BIOL CHEM, V275, P22568, DOI 10.1074/jbc.M000622200; Matthews P, 2001, J PATHOL, V194, P183, DOI 10.1002/path.848; Nakamura TM, 1998, CELL, V92, P587, DOI 10.1016/S0092-8674(00)81123-X; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; SHAY JW, 1989, EXP CELL RES, V184, P109, DOI 10.1016/0014-4827(89)90369-8; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Son NH, 2000, J IMMUNOL, V165, P1191, DOI 10.4049/jimmunol.165.3.1191; Steinert S, 2000, BIOCHEM BIOPH RES CO, V273, P1095, DOI 10.1006/bbrc.2000.3080; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Tahara H, 1999, ONCOGENE, V18, P1561, DOI 10.1038/sj.onc.1202458; Ulaner GA, 1998, CANCER RES, V58, P4168; Vaziri H, 1999, MOL CELL BIOL, V19, P2373; Wei WY, 1999, EXP CELL RES, V253, P519, DOI 10.1006/excr.1999.4665; Wong JMY, 2002, NAT CELL BIOL, V4, P731, DOI 10.1038/ncb846; Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682; Yasumoto S, 1996, ONCOGENE, V13, P433; Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x; Zhu XL, 1996, P NATL ACAD SCI USA, V93, P6091, DOI 10.1073/pnas.93.12.6091	60	599	664	4	68	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					241	253		10.1016/S0092-8674(03)00550-6	http://dx.doi.org/10.1016/S0092-8674(03)00550-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887925	Bronze, Green Submitted			2022-12-24	WOS:000184378700013
J	Virtamo, J; Pietinen, P; Huttunen, JK; Malila, N; Virtanen, MJ; Albanes, D; Taylor, PR; Albert, P				Virtamo, J; Pietinen, P; Huttunen, JK; Malila, N; Virtanen, MJ; Albanes, D; Taylor, PR; Albert, P		ATBC Study Grp	Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation - A postintervention follow-up	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTROLLED TRIAL FINLAND; LUNG-CANCER; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKE; PROSTATE-CANCER; VITAMIN-A; PREVENTION; MICRONUTRIENTS; FERRETS; RISK	Context In the Finnish Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) study, alpha-tocopherol supplementation decreased prostate cancer incidence, whereas beta-carotene increased the risk of lung cancer and total mortality. Postintervention follow-up provides information regarding duration of the intervention effects and may reveal potential late effects of these antioxidants. Objective To analyze postintervention effects of alpha-tocopherol and beta-carotene on cancer incidence and total and cause-specific mortality. Design, Setting, and Participants Postintervention follow-up assessment of cancer incidence and cause-specific mortality (6 years [May 1, 1993-April 30, 1999]) and total mortality (8 years [May 1, 1993-April 30, 2001]) of 25563 men. In the ATBC Study, 29133 male smokers aged 50 to 69 years received a-tocopherol (50 mg), beta-carotene (20 mg), both agents, or placebo daily for 5 to 8 years. End point information was obtained from the Finnish Cancer Registry and the Register of Causes of Death. Cancer cases were, confirmed through medical record review. Main Outcome Measures Site-specific cancer incidence and total and cause-specific mortality and calendar time-specific risk for lung cancer incidence and total mortality. Results Overall posttrial relative risk (RR) for lung cancer incidence (n = 1037) was 1.06 (95% confidence interval [CI], 0.94-1.20) among recipients of beta-carotene compared with nonrecipients. For prostate cancer incidence (n=672), the RR was 0.88 (95% CI, 0.76-1.03) for participants receiving alpha-tocopherol compared with nonrecipients. No late preventive effects on other cancers were observed for either supplement. There were 7261 individuals who died by April 30, 2001, during the posttrial follow-up period; the RR was 1.01 (95% CI, 0.96-1.05) for alpha-tocopherol recipients vs nonrecipients and 1.07 (95% CI, 1.02-1.12) for beta-carotene recipients vs nonrecipients. Regarding duration of intervention effects and potential late effects, the excess risk for beta-carotene recipients was no longer evident 4 to 6 years after ending the intervention and was primarily due to cardiovascular diseases. Conclusions The beneficial and adverse effects of supplemental alpha-tocopherol and beta-carotene disappeared during postintervention follow-up. The preventive effects of alpha-tocopherol on prostate cancer require confirmation in other trials. Smokers should avoid beta-carotene supplementation.	Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FIN-00300 Helsinki, Finland; NCI, Bethesda, MD 20892 USA; Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland; Univ Turku, Cent Hosp, SF-20500 Turku, Finland; Jorvi Hosp, SF-02740 Espoo, Finland; Finnish Canc Registry, FIN-00170 Helsinki, Finland	Finland National Institute for Health & Welfare; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Helsinki; Helsinki University Central Hospital; University of Turku; Finnish Cancer Registry	Virtamo, J (corresponding author), Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Mannerheimintie 166, FIN-00300 Helsinki, Finland.		Albanes, Demetrius/B-9749-2015		NCI NIH HHS [N01-CN-45165] Funding Source: Medline; CCR NIH HHS [N01-RC-45035] Funding Source: Medline; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN045165] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CCR NIH HHS; DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albanes D, 1996, J NATL CANCER I, V88, P1560, DOI 10.1093/jnci/88.21.1560; Albanes D, 2000, CANCER CAUSE CONTROL, V11, P197, DOI 10.1023/A:1008936214087; Arora A, 2001, CARCINOGENESIS, V22, P1173, DOI 10.1093/carcin/22.8.1173; *ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Breslow NE., 1987, STAT METHODS CANC RE, P81; Chan JM, 2001, EPIDEMIOL REV, V23, P82, DOI 10.1093/oxfordjournals.epirev.a000799; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; De Flora S, 1999, MUTAGENESIS, V14, P153, DOI 10.1093/mutage/14.2.153; DORGAN JF, 1991, HEMATOL ONCOL CLIN N, V5, P43, DOI 10.1016/S0889-8588(18)30453-2; Greenberg ER, 1996, JAMA-J AM MED ASSOC, V275, P699, DOI 10.1001/jama.275.9.699; Hastie TJ., 1990, GEN ADDITIVE MODELS; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Klein EA, 2001, J UROLOGY, V166, P1311, DOI 10.1016/S0022-5347(05)65759-X; Korhonen P, 2002, ACTA ONCOL, V41, P381, DOI 10.1080/028418602760169442; Liu C, 2000, CARCINOGENESIS, V21, P2245, DOI 10.1093/carcin/21.12.2245; Malila N, 2002, CANCER CAUSE CONTROL, V13, P617, DOI 10.1023/A:1019556227014; Mayne ST, 1996, J NATL CANCER I, V88, P1513; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Paolini M, 1999, NATURE, V398, P760, DOI 10.1038/19655; Paolini M, 2001, CARCINOGENESIS, V22, P1483, DOI 10.1093/carcin/22.9.1483; PETO R, 1981, NATURE, V290, P201, DOI 10.1038/290201a0; Rautalahti MT, 1999, CANCER-AM CANCER SOC, V86, P37, DOI 10.1002/(SICI)1097-0142(19990701)86:1&lt;37::AID-CNCR7&gt;3.0.CO;2-F; Shklar G, 2000, CANCER INVEST, V18, P214, DOI 10.3109/07357900009031826; Virtamo J, 2000, CANCER CAUSE CONTROL, V11, P933, DOI 10.1023/A:1026546803917; Wang XD, 1999, J NATL CANCER I, V91, P60, DOI 10.1093/jnci/91.1.60	28	300	312	0	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2003	290	4					476	485						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703JB	12876090				2022-12-24	WOS:000184275300019
J	Albrecht, C; Blank, K; Lalic-Multhaler, M; Hirler, S; Mai, T; Gilbert, I; Schiffmann, S; Bayer, T; Clausen-Schaumann, H; Gaub, HE				Albrecht, C; Blank, K; Lalic-Multhaler, M; Hirler, S; Mai, T; Gilbert, I; Schiffmann, S; Bayer, T; Clausen-Schaumann, H; Gaub, HE			DNA: A programmable force sensor	SCIENCE			English	Article							SINGLE; SPECTROSCOPY; MECHANICS	Direct quanti. cation of biomolecular interaction by single-molecule force spectroscopy has evolved into a powerful tool for materials and life sciences. We introduce an approach in which the unbinding forces required to break intermolecular bonds are measured in a differential format by comparison with a known reference bond (here, a short DNA duplex). In addition to a marked increase in sensitivity and force resolution, which enabled us to resolve single base pair mismatches, this concept allows for highly specific parallel assays. This option was exploited to overcome cross-reactions of antibodies in a protein biochip application.	Nanotype GmbH, D-82166 Grafelfing, Germany; Lehrstuhl Angew Phys, D-80799 Munich, Germany; Ctr Nanosci, D-80799 Munich, Germany	University of Munich; University of Munich	Clausen-Schaumann, H (corresponding author), Nanotype GmbH, Lochhamer Schlag 12, D-82166 Grafelfing, Germany.	hauke.clausen-schaumann@nanotype.de	Blank, Kerstin/C-6323-2008; Clausen-Schaumann, Hauke/W-1830-2017	Blank, Kerstin/0000-0001-5410-6984; Clausen-Schaumann, Hauke/0000-0002-9413-0310; Schiffmann, Susanne/0000-0001-5035-2504				Abbott A, 2002, NATURE, V415, P112, DOI 10.1038/415112a; Bernard A, 2001, ANAL CHEM, V73, P8, DOI 10.1021/ac0008845; Bockelmann U, 1997, PHYS REV LETT, V79, P4489, DOI 10.1103/PhysRevLett.79.4489; Bustamante C, 2000, NAT REV MOL CELL BIO, V1, P130, DOI 10.1038/35040072; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Clausen-Schaumann H, 2000, CURR OPIN CHEM BIOL, V4, P524, DOI 10.1016/S1367-5931(00)00126-5; Cutler P, 2003, PROTEOMICS, V3, P3, DOI 10.1002/pmic.200390007; EKINS RP, 1994, TRENDS BIOTECHNOL, V12, P89, DOI 10.1016/0167-7799(94)90111-2; EKINS RP, 1989, J PHARMACEUT BIOMED, V7, P155, DOI 10.1016/0731-7085(89)80079-2; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Gittes F, 1998, EUR BIOPHYS J BIOPHY, V27, P75, DOI 10.1007/s002490050113; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Hugel T, 2002, SCIENCE, V296, P1103, DOI 10.1126/science.1069856; Janshoff A, 2000, ANGEW CHEM INT EDIT, V39, P3213; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Krautbauer R, 2003, NANO LETT, V3, P493, DOI 10.1021/nl034049p; KUMAR A, 1995, ACCOUNTS CHEM RES, V28, P219, DOI 10.1021/ar00053a003; Lavery R, 2002, J PHYS-CONDENS MAT, V14, pR383, DOI 10.1088/0953-8984/14/14/202; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; Mehta AD, 1999, SCIENCE, V283, P1689, DOI 10.1126/science.283.5408.1689; Mendoza LG, 1999, BIOTECHNIQUES, V27, P778, DOI 10.2144/99274rr01; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Merkel R, 2001, PHYS REP, V346, P344; Mitchell P, 2002, NAT BIOTECHNOL, V20, P225, DOI 10.1038/nbt0302-225; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Naef F, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.040902; Nollau P, 1997, J Int Fed Clin Chem, V9, P162; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; Petach H, 2002, CURR OPIN BIOTECH, V13, P309, DOI 10.1016/S0958-1669(02)00329-4; PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1999, NAT STRUCT BIOL, V6, P346; SCHILDKRAUT C, 1965, BIOPOLYMERS, V3, P195, DOI 10.1002/bip.360030207; Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Strunz T, 1999, P NATL ACAD SCI USA, V96, P11277, DOI 10.1073/pnas.96.20.11277; Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153	43	139	146	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					367	370		10.1126/science.1084713	http://dx.doi.org/10.1126/science.1084713			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869761				2022-12-24	WOS:000184207300044
J	Huang, C; Rajfur, Z; Borchers, C; Schaller, MD; Jacobson, K				Huang, C; Rajfur, Z; Borchers, C; Schaller, MD; Jacobson, K			JNK phosphorylates paxillin and regulates cell migration	NATURE			English	Article							JUN NH2-TERMINAL KINASE; FOCAL ADHESION KINASE; N-TERMINAL KINASE; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; ACTIVATION; FIBRONECTIN; SERINE; MORPHOGENESIS	The c-Jun amino-terminal kinase (JNK) is generally thought to be involved in inflammation, proliferation and apoptosis(1,2). Accordingly, its substrates are transcription factors and antiapoptotic proteins(2). However, JNK has also been shown to be required for Drosophila dorsal closure(3,4), and MAP kinase/ERK kinase kinase 1, an upstream kinase in the JNK pathway, has been shown to be essential for cell migration(5,6). Both results imply that JNK is important in cell migration. Here we show that JNK1 is required for the rapid movement of both fish keratocytes and rat bladder tumour epithelial cells (NBT-II). Moreover, JNK1 phosphorylates serine 178 on paxillin, a focal adhesion adaptor, both in vitro and in intact cells. NBT-II cells expressing the Ser 178 --> Ala mutant of paxillin (Pax(S178A)) formed focal adhesions and exhibited the limited movement associated with such contacts in both single-cell-migration and wound-healing assays. In contrast, cells expressing wild-type paxillin moved rapidly and retained close contacts as the predominant adhesion. Expression of Pax(S178A) also inhibited the migration of two other cell lines. Thus, phosphorylation of paxillin by JNK seems essential for maintaining the labile adhesions required for rapid cell migration.	Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Comprehens Ctr Inflammatory Disorders, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jacobson, K (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	frap@med.unc.edu	BORCHERS, Christoph/U-5964-2019; Rajfur, Zenon/H-2506-2013	Rajfur, Zenon/0000-0003-1265-6480				Abassi YA, 2002, EMBO J, V21, P4571, DOI 10.1093/emboj/cdf446; Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Bellis SL, 1997, BIOCHEM J, V325, P375, DOI 10.1042/bj3250375; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Brown MC, 1998, MOL BIOL CELL, V9, P1803, DOI 10.1091/mbc.9.7.1803; Christerson LB, 1999, CELL MOTIL CYTOSKEL, V43, P186, DOI 10.1002/(SICI)1097-0169(1999)43:3<186::AID-CM2>3.0.CO;2-1; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Hauck CR, 2001, CANCER RES, V61, P7079; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; ILLC D, 1995, NATURE, V377, P539; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Lee J, 1997, J CELL SCI, V110, P2833; Liu JL, 1999, ONCOGENE, V18, P6700, DOI 10.1038/sj.onc.1203050; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Oktay M, 1999, J CELL BIOL, V145, P1461, DOI 10.1083/jcb.145.7.1461; Ozanne BW, 2000, EUR J CANCER, V36, P1640, DOI 10.1016/S0959-8049(00)00175-1; Ridley AJ, 1999, BIOCHEM SOC SYMP, V65, P111; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Uyen HD, 2002, J CELL SCI, V115, P3073; Vadlamudi R, 1999, ONCOGENE, V18, P7253, DOI 10.1038/sj.onc.1203163; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697	30	398	416	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					219	223		10.1038/nature01745	http://dx.doi.org/10.1038/nature01745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853963				2022-12-24	WOS:000184032700048
J	Traversa, G; Bianchi, C; Da Cas, R; Abraha, I; Menniti-Ippolito, F; Venegoni, M				Traversa, G; Bianchi, C; Da Cas, R; Abraha, I; Menniti-Ippolito, F; Venegoni, M			Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To estimate the risk of acute hepatotoxicity associated with nimesulide compared with other non-steroidal anti-inflammatory drugs. Design Retrospective cohort and nested case-control study. Setting Umbria region, Italy. Participants 400 000 current, recent, and past users (almost 2 million prescriptions) of non-steroidal anti-inflammatory drugs between I January 1997 and 31 December 2001. Main outcome measures Admissions to hospital for acute non-viral hepatitis and incidence of all hepatopathies and liver injury among users of nimesulide and other non-steroidal anti-inflammatory drugs. Results Cur-rent use of non-steroidal anti-inflammatory drugs was associated with a 1.4 (95% confidence interval 1.0 to 2.1) increased risk of hepatopathy compared with past use. In current users of nimesulide the rate ratio for all heparopathies and more severe liver injury was 1.3 (0.7 to 2.3) and 1.9 (1.1 to 3.8), respectively. Conclusion The risk of liver injury in patients taking nimesulide and other non-steroidal anti-inflammatory drugs is small.	Natl Inst Hlth, Dept Epidemiol, I-00161 Rome, Italy; Reg Hlth Author Umbria Reg, I-06124 Perugia, Italy; Fatebenefratelli Hosp, Dept Internal Med, I-20121 Milan, Italy	Istituto Superiore di Sanita (ISS)	Traversa, G (corresponding author), Natl Inst Hlth, Dept Epidemiol, Regina Elena 299, I-00161 Rome, Italy.	giuseppe.traversa@iss.it	Abraha, Iosief/K-4327-2018; Venegoni, Mauro/H-3416-2019	Abraha, Iosief/0000-0002-5440-775X; Venegoni, Mauro/0000-0002-5462-5327				BENICHOU C, 1990, J HEPATOL, V11, P272; Conforti A, 2001, DRUG SAFETY, V24, P1081, DOI 10.2165/00002018-200124140-00006; DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; DANAN G, 1994, ADVERSE DRUG REACTIO; Hernandez-Diaz S, 2000, ARCH INTERN MED, V160, P2093, DOI 10.1001/archinte.160.14.2093; Hernandez-Diaz Sonia, 2001, American Journal of Medicine, V110, p20S; Macia MA, 2002, CLIN PHARMACOL THER, V72, P596, DOI 10.1067/mcp.2002.128869; Menniti-Ippolito F, 1998, EUR J CLIN PHARMACOL, V54, P393, DOI 10.1007/s002280050481; RODRIGUEZ LAG, 1992, BRIT MED J, V305, P865, DOI 10.1136/bmj.305.6858.865; Rodriguez LAG, 1998, ARCH INTERN MED, V158, P33, DOI 10.1001/archinte.158.1.33; RODRIQUEZ LAG, 1994, ARCH INTERN MED, V154, P311, DOI 10.1001/archinte.1994.00420030117012; TRAVERSA G, 1995, EPIDEMIOLOGY, V6, P49, DOI 10.1097/00001648-199501000-00010; Walker AM, 1997, ARTHRITIS RHEUM, V40, P201, DOI 10.1002/art.1780400204	13	130	163	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2003	327	7405					18	22		10.1136/bmj.327.7405.18	http://dx.doi.org/10.1136/bmj.327.7405.18			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699NK	12842950	Bronze, Green Published			2022-12-24	WOS:000184062700017
J	Ruthazer, ES; Akerman, CJ; Cline, HT				Ruthazer, ES; Akerman, CJ; Cline, HT			Control of axon branch dynamics by correlated activity in vivo	SCIENCE			English	Article							RECEPTOR ANTAGONISTS DISRUPT; NMDA RECEPTOR; VISUAL-CORTEX; SYNAPSE ELIMINATION; RETINOTECTAL AXONS; RANA-PIPIENS; TIME-LAPSE; PROJECTION; MAP; ZEBRAFISH	To determine how patterned visual activity regulates the development of axonal projections, we collected in vivo time-lapse images of retinal axons from albino Xenopus tadpoles in which binocular innervation of the optic tectum was induced. Axons added branch tips with nearly equal probability in all territories, but eliminated them preferentially from territory dominated by the opposite eye. This selective branch elimination was abolished by blockade of N-methyl-D-aspartate receptors. These results describe a correlation-based mechanism by which visual experience directly governs axon branch dynamics that contribute to the development of topographic maps.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Cline, HT (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Ruthazer, Edward/H-4782-2019; Ruthazer, Edward S/P-5935-2014	Ruthazer, Edward/0000-0003-0452-3151; Ruthazer, Edward S/0000-0003-0452-3151	NEI NIH HHS [F32 EY006963-03] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY006963] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Antonini A, 1996, J COMP NEUROL, V369, P64; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; BOSS VC, 1984, J NEUROSCI, V4, P2891; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; Cohen-Cory S, 1999, J NEUROSCI, V19, P9996; CONSTANTINEPATON M, 1978, SCIENCE, V202, P639, DOI 10.1126/science.309179; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Dawson AJ, 2001, J COMP NEUROL, V434, P40, DOI 10.1002/cne.1163; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GAZE RM, 1979, J EMBRYOL EXP MORPH, V53, P103; Gnuegge L, 2001, J NEUROSCI, V21, P3542, DOI 10.1523/JNEUROSCI.21-10-03542.2001; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; KAETHNER RJ, 1992, J NEUROSCI, V12, P3257, DOI 10.1523/JNEUROSCI.12-08-03257.1992; KATZ LC, 1996, SCIENCE, V274, P1132; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; MEYER RL, 1982, SCIENCE, V218, P589, DOI 10.1126/science.7123262; OLSON MD, 1991, J COMP NEUROL, V303, P412, DOI 10.1002/cne.903030307; OROURKE NA, 1994, NEURON, V12, P921, DOI 10.1016/0896-6273(94)90343-3; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; REH TA, 1984, J NEUROSCI, V4, P442; REH TA, 1985, J NEUROSCI, V5, P1132; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Schmidt JT, 2000, J NEUROBIOL, V42, P303, DOI 10.1002/(SICI)1097-4695(20000215)42:3<303::AID-NEU2>3.3.CO;2-1; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; STRAZNICKY C, 1979, J EMBRYOL EXP MORPH, V50, P111; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Witte S, 1996, J NEUROBIOL, V31, P219, DOI 10.1002/(SICI)1097-4695(199610)31:2<219::AID-NEU7>3.0.CO;2-E; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001	33	188	191	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2003	301	5629					66	70		10.1126/science.1082545	http://dx.doi.org/10.1126/science.1082545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843386				2022-12-24	WOS:000183914700032
J	Whitehouse, PJ				Whitehouse, PJ			Lessons and responses in Alzheimer disease research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNIZATION; TRIAL		Case Western Reserve Univ, Cleveland, OH 44106 USA	Case Western Reserve University	Whitehouse, PJ (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.							Bishop GM, 2002, NATURE, V416, P677, DOI 10.1038/416677d; BRETELER MMB, 1992, EPIDEMIOL REV, V14, P59, DOI 10.1093/oxfordjournals.epirev.a036092; Check E, 2002, NATURE, V415, P462, DOI 10.1038/415462a; Ernst RL, 1997, ALZ DIS ASSOC DIS, V11, P135; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Kodish E, 1996, ACAD MED, V71, P1287, DOI 10.1097/00001888-199612000-00009; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SUMMERS WK, 1986, NEW ENGL J MED, V315, P1241, DOI 10.1056/NEJM198611133152001; Whitehouse P. J., 1999, J AM GERIATR SOC, V47, P1; Whitehouse PJ, 2000, CONCEPTS ALZHEIMER D; PARKINSON STUDY GROU	12	2	2	1	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2003	290	1					115	115		10.1001/jama.290.1.115	http://dx.doi.org/10.1001/jama.290.1.115			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696CR	12837723	Bronze			2022-12-24	WOS:000183868600031
J	Graf, P				Graf, P			Hive beetle causes a buzz in Europe	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					793	793		10.1038/423793b	http://dx.doi.org/10.1038/423793b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815395	Bronze			2022-12-24	WOS:000183585300012
J	Cinatl, J; Morgenstern, B; Bauer, G; Chandra, P; Rabenau, H; Doerr, HW				Cinatl, J; Morgenstern, B; Bauer, G; Chandra, P; Rabenau, H; Doerr, HW			Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus	LANCET			English	Article							NITRIC-OXIDE	The outbreak of SARS warrants the search for antiviral compounds to treat the disease. At present, no specific treatment has been identified for SARS-associated coronavirus Infection. We assessed the antiviral potential of ribavirin, 6-azauridine, pyrazofurin, mycophenolic acid, and glycyrrhizin against two clinical Isolates of coronavirus (FFM-1 and FFM-2) from patients with SARS admitted to the clinical centre of Frankfurt University, Germany. Of all the compounds, glycyrrhizin was the most active in inhibiting replication of the SARS-associated virus. Our findings suggest that glycyrrhizin should be assessed for treatment of SARS.	Goethe Univ Frankfurt, Sch Med, Inst Med Virol, D-60596 Frankfurt, Germany	Goethe University Frankfurt	Cinatl, J (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Med Virol, Paul Ehrlich Str 40, D-60596 Frankfurt, Germany.	cinatl@em.uni-frankfurt.de						Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Jeong HG, 2002, FEBS LETT, V513, P208, DOI 10.1016/S0014-5793(02)02311-6; Lin YL, 1997, J VIROL, V71, P5227, DOI 10.1128/JVI.71.7.5227-5235.1997	5	759	873	3	84	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2003	361	9374					2045	2046		10.1016/S0140-6736(03)13615-X	http://dx.doi.org/10.1016/S0140-6736(03)13615-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814717	Bronze, Green Published			2022-12-24	WOS:000183488900013
J	Szostak, JW				Szostak, JW			Molecular messages	NATURE			English	Editorial Material									Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.							Adami C, 2000, PHYSICA D, V137, P62, DOI 10.1016/S0167-2789(99)00179-7; HAMMING RW, 1987, CODING INFORMATION T; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; ZUREK WH, 1991, STUDIES SCI COMPLEXI, V8	4	57	61	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2003	423	6941					689	689		10.1038/423689a	http://dx.doi.org/10.1038/423689a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802312	Bronze			2022-12-24	WOS:000183443400022
J	Kulasingam, SL; Myers, ER				Kulasingam, SL; Myers, ER			Potential health and economic impact of adding a human papillomavirus vaccine to screening programs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATYPICAL SQUAMOUS CELLS; CERVICAL-CANCER; COST-EFFECTIVENESS; NATURAL-HISTORY; FOLLOW-UP; STRATEGIES; NEOPLASIA; BENEFITS; WOMEN; ABNORMALITIES	Context Recently published results suggest that effective vaccines against cervical cancer-associated human papillomavirus (HPV) may become available within the next decade. Objective To examine the potential health and economic effects of an HPV vaccine in a setting of existing screening. Design, Setting, and Population A Markov model was used to estimate the lifetime (age 12-85 years) costs and life expectancy of a hypothetical cohort of women screened for cervical cancer in the United States. Three strategies were compared: (1) vaccination only; (2) conventional cytological screening only; and (3) vaccination followed by screening. Two of the strategies incorporated a vaccine targeted against a defined proportion of high-risk (oncogenic) HPV types. Screening intervals of 1, 2, 3, and 5 years and starting ages for screening of 18, 22, 24, 26, and 30 years were chosen for 2 of the strategies (conventional cytological screening only and vaccination followed by screening). Main Outcome Measures Incremental cost per life-year gained. Results Vaccination only or adding vaccination to screening conducted every 3 and 5 years was not cost-effective. However, at more frequent screening intervals, strategies combining vaccination and screening were preferred. Vaccination plus biennial screening delayed until age 24 years had the most attractive cost-effectiveness ratio ($44889) compared with screening only beginning at age 18 years and conducted every 3 years. However, the strategy of vaccination with annual screening beginning at age 18 years had the largest overall reduction in cancer incidence and mortality at a cost of $236250 per life-year gained compared with vaccination and annual screening beginning at age 22 years. The cost-effectiveness of vaccination plus delayed screening was highly sensitive to age of vaccination, duration of vaccine efficacy, and cost of vaccination. Conclusions Vaccination for HPV in combination with screening can be a cost-effective health intervention, but it depends on maintaining effectiveness during the ages of peak oncogenic HPV incidence. Identifying the optimal age for vaccination should be a top research priority.	Duke Univ, Ctr Clin Hlth Policy Res, Durham, NC 27705 USA; Duke Univ, Dept Obstet & Gynecol, Durham, NC 27705 USA	Duke University; Duke University	Kulasingam, SL (corresponding author), Duke Univ, Ctr Clin Hlth Policy Res, 1st Union Tower,Suite 220,2200 W Main St, Durham, NC 27705 USA.	kulas002@mc.duke.edu		Kulasingam, Shalini/0000-0002-0932-9166				ANDERSON RM, 1995, P ROY SOC B-BIOL SCI, V261, P147, DOI 10.1098/rspb.1995.0129; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Brown AD, 1999, JAMA-J AM MED ASSOC, V281, P347, DOI 10.1001/jama.281.4.347; Conaglen HM, 2001, INT J STD AIDS, V12, P651, DOI 10.1258/0956462011923877; Coste J, 2003, BMJ-BRIT MED J, V326, P733, DOI 10.1136/bmj.326.7392.733; Crum CP, 2002, NEW ENGL J MED, V347, P1702; CUZICK J, 1995, LANCET, V345, P1533, DOI 10.1016/S0140-6736(95)91086-7; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; FAHS MC, 1992, ANN INTERN MED, V117, P520, DOI 10.7326/0003-4819-117-6-520; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Gustafsson L, 1997, CANCER CAUSE CONTROL, V8, P755, DOI 10.1023/A:1018435522475; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Hueston WJ, 2000, J COMMUN HEALTH, V25, P23, DOI 10.1023/A:1005136817158; Hughes JP, 2002, EPIDEMIOLOGY, V13, P631, DOI 10.1097/00001648-200211000-00006; Jacobs MV, 2000, INT J CANCER, V87, P221, DOI 10.1002/1097-0215(20000715)87:2&lt;221::AID-IJC11&gt;3.0.CO;2-2; Jones MH, 1996, J ROY SOC MED, V89, P257, DOI 10.1177/014107689608900506; Kim JJ, 2002, JAMA-J AM MED ASSOC, V287, P2382, DOI 10.1001/jama.287.18.2382; Klee M, 2000, GYNECOL ONCOL, V76, P5, DOI 10.1006/gyno.1999.5644; Koutsky LA, 2000, J NATL CANCER I, V92, P397, DOI 10.1093/jnci/92.5.397; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; KULASINGAM S, 2002, 20 INT PAP C OCT 5 9; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; LEIGH BC, 1994, J ADOLESCENT HEALTH, V15, P117, DOI 10.1016/1054-139X(94)90538-X; Li CR, 1999, MATURITAS, V32, P95, DOI 10.1016/S0378-5122(99)00020-1; Liaw KL, 1999, J NATL CANCER I, V91, P954, DOI 10.1093/jnci/91.11.954; Mandelblatt JS, 2002, JAMA-J AM MED ASSOC, V287, P2372, DOI 10.1001/jama.287.18.2372; Maxwell GL, 2002, OBSTET GYNECOL, V100, P740, DOI 10.1016/S0029-7844(02)02195-6; MCCRORY DC, 1999, PUBLICATION AG HLTH; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Myers ER, 2000, OBSTET GYNECOL, V96, P645, DOI 10.1016/S0029-7844(00)00979-0; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; *NAT CANC I, 2000, SURV EP END RES; Obwegeser JH, 2001, ACTA CYTOL, V45, P709, DOI 10.1159/000328292; PHELPS CE, 1988, MED DECIS MAKING, V8, P279, DOI 10.1177/0272989X8800800409; Ratnam S, 2000, CANCER EPIDEM BIOMAR, V9, P945; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; SherlawJohnson C, 1997, INT J CANCER, V72, P210, DOI 10.1002/(SICI)1097-0215(19970717)72:2&lt;210::AID-IJC2&gt;3.0.CO;2-U; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stratton KR, 2001, VACCINES 21 CENTURY; Thomas KK, 2000, J INFECT DIS, V182, P1097, DOI 10.1086/315805; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Winkelmayer WC, 2002, MED DECIS MAKING, V22, P417, DOI 10.1177/027298902236927	46	248	254	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2003	290	6					781	789		10.1001/jama.290.6.781	http://dx.doi.org/10.1001/jama.290.6.781			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709VU	12915431	Bronze			2022-12-24	WOS:000184647700029
J	Celeste, A; Difilippantonio, S; Difilippantonio, MJ; Fernandez-Capetillo, O; Pilch, DR; Sedelnikova, OA; Eckhaus, M; Ried, T; Bonner, WM; Nussenzweig, A				Celeste, A; Difilippantonio, S; Difilippantonio, MJ; Fernandez-Capetillo, O; Pilch, DR; Sedelnikova, OA; Eckhaus, M; Ried, T; Bonner, WM; Nussenzweig, A			H2AX haploinsufficiency modifies genomic stability and tumor susceptibility	CELL			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX; CHROMOSOMAL-ABERRATIONS; HAPLO-INSUFFICIENCY; V(D)J RECOMBINATION; GENE AMPLIFICATION; DNA; MICE; P53; REPAIR	Histone H2AX becomes phosphorylated in chromatin domains flanking sites of DNA double-strand breakage associated with gamma-irradiation, meiotic recombination, DNA replication, and antigen receptor rearrangements. Here, we show that loss of a single H2AX allele compromises genomic integrity and enhances the susceptibility to cancer in the absence of p53. In comparison with heterozygotes, tumors arise earlier in the H2AX homozygous null background, and H2AX(-/-) p53(-/-) lymphomas harbor an increased frequency of clonal nonreciprocal translocations and amplifications. These include complex rearrangements that juxtapose the c-myc oncogene to antigen receptor loci. Restoration of the H2AX null allele with wild-type H2AX restores genomic stability and radiation resistance, but this effect is abolished by substitution of the conserved serine phosphorylation sites in H2AX with alanine or glutamic acid residues. Our results establish H2AX as genomic caretaker that requires the function of both gene alleles for optimal protection against tumorigenesis.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; NIH, Vet Resources Program, Off Res Serv, Bethesda, MD 20892 USA; NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Fernandez-Capetillo, Oscar/H-3508-2015; Difilippantonio, Michael/AAF-2839-2021	Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Difilippantonio, Michael/0000-0002-4676-7034; Martin (nee Sedelnikova), Olga/0000-0003-3470-2935	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133; Bai F, 2003, MOL CELL BIOL, V23, P1269, DOI 10.1128/MCB.23.4.1269-1277.2003; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Cook WD, 2000, ONCOGENE, V19, P3434, DOI 10.1038/sj.onc.1203653; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; Desiderio S, 1996, CURR TOP MICROBIOL, V217, P45; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Gladdy RA, 2003, CANCER CELL, V3, P37, DOI 10.1016/S1535-6108(02)00236-2; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Goss KH, 2002, SCIENCE, V297, P2051, DOI 10.1126/science.1074340; Gruber SB, 2002, SCIENCE, V297, P2013, DOI 10.1126/science.1074399; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Inoue K, 2001, GENE DEV, V15, P2934, DOI 10.1101/gad.929901; Karanjawala ZE, 1999, CURR BIOL, V9, P1501, DOI 10.1016/S0960-9822(00)80123-2; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; KNUDSON AG, 1985, CANCER RES, V45, P1437; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Mak TW, 2000, NAT IMMUNOL, V1, P77, DOI 10.1038/76950; Monni O, 2001, LEUKEMIA LYMPHOMA, V40, P259, DOI 10.3109/10428190109057924; Nacht M, 1996, GENE DEV, V10, P2055, DOI 10.1101/gad.10.16.2055; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Quon KC, 2001, GENE DEV, V15, P2917, DOI 10.1101/gad.949001; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sharpless NE, 2001, MOL CELL, V8, P1187, DOI 10.1016/S1097-2765(01)00425-7; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Stankovic T, 2002, LEUKEMIA LYMPHOMA, V43, P1563, DOI 10.1080/1042819021000002884; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Vanasse GJ, 1999, J CLIN INVEST, V103, P1669, DOI 10.1172/JCI6658; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Weaver ZA, 1999, GENE CHROMOSOME CANC, V25, P251, DOI 10.1002/(SICI)1098-2264(199907)25:3<251::AID-GCC7>3.0.CO;2-3; Xu Y, 1998, MOL CELL BIOL, V18, P4385, DOI 10.1128/MCB.18.7.4385; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	62	456	476	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2003	114	3					371	383		10.1016/S0092-8674(03)00567-1	http://dx.doi.org/10.1016/S0092-8674(03)00567-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914701	Green Accepted, Bronze			2022-12-24	WOS:000184679200013
J	Pasterkamp, RJ; Peschon, JJ; Spriggs, MK; Kolodkin, AL				Pasterkamp, RJ; Peschon, JJ; Spriggs, MK; Kolodkin, AL			Semaphorin 7A promotes axon outgrowth through integrins and MAPKs	NATURE			English	Article								Striking parallels exist between immune and nervous system cellular signalling mechanisms. Molecules originally shown to be critical for immune responses also serve neuronal functions, and similarly neural guidance cues can modulate immune function. We show here that semaphorin 7A (Sema7A), a membrane-anchored member of the semaphorin family of guidance proteins previously known for its immunomodulatory effects, can also mediate neuronal functions. Unlike many other semaphorins, which act as repulsive guidance cues, Sema7A enhances central and peripheral axon growth and is required for proper axon tract formation during embryonic development. Unexpectedly, Sema7A enhancement of axon outgrowth requires integrin receptors and activation of MAPK signalling pathways. These findings define a previously unknown biological function for semaphorins, identify an unexpected role for integrins and integrin-dependent intracellular signalling in mediating semaphorin responses, and provide a framework for understanding and interfering with Sema7A function in both immune and nervous systems.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Amgen Corp, Dept Mol Biol, Seattle, WA 98119 USA; Amgen Corp, Dept Funct Genom, Seattle, WA 98119 USA	Johns Hopkins University	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu		Pasterkamp, Jeroen/0000-0003-1631-6440				Angelisova P, 1999, IMMUNOBIOLOGY, V200, P234, DOI 10.1016/S0171-2985(99)80073-4; Bagnard D, 1998, DEVELOPMENT, V125, P5043; BISMUTH G, 2002, SCI STKE, pRE4; BOBOLIS KA, 1992, BLOOD, V79, P1574; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; de Castro F, 1999, J NEUROSCI, V19, P4428; de Fougerolles AR, 2002, IMMUNOL REV, V186, P208, DOI 10.1034/j.1600-065X.2002.18617.x; Doherty P, 2000, MOL CELL NEUROSCI, V16, P283, DOI 10.1006/mcne.2000.0907; Frank I, 1996, AIDS, V10, P1611, DOI 10.1097/00002030-199612000-00004; Fujioka S, 2003, BIOCHEM BIOPH RES CO, V301, P304, DOI 10.1016/S0006-291X(02)03023-1; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; He Zhigang, 2002, Sci STKE, V2002, pre1, DOI 10.1126/stke.2002.119.re1; Hirata T, 1997, J NEUROBIOL, V32, P415, DOI 10.1002/(SICI)1097-4695(199704)32:4<415::AID-NEU5>3.0.CO;2-9; Holmes S, 2002, SCAND J IMMUNOL, V56, P270, DOI 10.1046/j.1365-3083.2002.01129.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Lange C, 1998, GENOMICS, V51, P340, DOI 10.1006/geno.1998.5256; Milner R, 2002, J NEUROSCI RES, V69, P286, DOI 10.1002/jnr.10321; Mine T, 2000, TISSUE ANTIGENS, V55, P429, DOI 10.1034/j.1399-0039.2000.550505.x; Nguyen-Ba-Charvet KT, 2002, J NEUROSCI, V22, P5473; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; PFAFF M, 1994, CELL ADHES COMMUN, V2, P491, DOI 10.3109/15419069409014213; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sakai T, 1999, J BIOL CHEM, V274, P29666, DOI 10.1074/jbc.274.42.29666; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SCHWOB JE, 1984, J COMP NEUROL, V223, P177, DOI 10.1002/cne.902230204; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Soussi-Yanicostas N, 2002, CELL, V109, P217, DOI 10.1016/S0092-8674(02)00713-4; Sugisaki N, 1996, J NEUROBIOL, V29, P127, DOI 10.1002/(SICI)1097-4695(199602)29:2<127::AID-NEU1>3.0.CO;2-C; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Xu XM, 1998, J BIOL CHEM, V273, P22428, DOI 10.1074/jbc.273.35.22428; Yamada A, 1999, J IMMUNOL, V162, P4094; Yip PM, 1998, MOL BIOL CELL, V9, P277, DOI 10.1091/mbc.9.2.277; Zhou XF, 2001, J NEUROSCI RES, V66, P1054, DOI 10.1002/jnr.10029.abs; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	46	376	388	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					398	405		10.1038/nature01790	http://dx.doi.org/10.1038/nature01790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879062				2022-12-24	WOS:000184318400035
J	Muller, MM; Malinowski, P; Gruber, T; Hillyard, SA				Muller, MM; Malinowski, P; Gruber, T; Hillyard, SA			Sustained division of the attentional spotlight	NATURE			English	Article							SPATIAL SELECTIVE ATTENTION; VISUAL-EVOKED POTENTIALS; FOCAL ATTENTION; EXTRASTRIATE; ALLOCATION; LOCATIONS; STRIATE; BRAIN; SPACE; TASKS	By voluntarily directing attention to a specific region of a visual scene, we can improve our perception of stimuli at that location(1). This ability to focus attention upon specific zones of the visual field has been described metaphorically as a moveable spotlight or zoom lens that facilitates the processing of stimuli within its 'beam'(2,3). A long-standing controversy has centred on the question of whether the spotlight of spatial attention has a unitary beam or whether it can be divided flexibly to disparate locations(2,4-6). Evidence supporting the unitary spotlight view has come from numerous behavioural(3,7-10) and electrophysiological(11,12) studies. Recent experiments, however, indicate that the spotlight of spatial attention may be divided between noncontiguous zones of the visual field for very brief stimulus exposures (<100 ms)(13,14). Here we use an electrophysiological measure of attentional allocation (the steady-state visual evoked potential) to show that the spotlight may be divided between spatially separated locations (excluding interposed locations) over more extended time periods. This spotlight division appears to be accomplished at an early stage of visual-cortical processing.	Univ Leipzig, Inst Allgemeine Psychol, D-04103 Leipzig, Germany; Liverpool John Moores Univ, Sch Psychol, Liverpool L3 2ET, Merseyside, England; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Leipzig University; Liverpool John Moores University; University of Liverpool; University of California System; University of California San Diego	Muller, MM (corresponding author), Univ Leipzig, Inst Allgemeine Psychol, Seeburgstr 14-20, D-04103 Leipzig, Germany.	m.mueller@rz.uni-leipzig.de	Malinowski, Peter/A-4394-2009	Malinowski, Peter/0000-0001-5074-4508				Awh E, 2000, J EXP PSYCHOL HUMAN, V26, P834, DOI 10.1037/0096-1523.26.2.834; CASTIELLO U, 1992, J EXP PSYCHOL HUMAN, V18, P837, DOI 10.1037/0096-1523.18.3.837; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [DOI 10.1002/HBM.460020306, 10.1002/hbm.460020306]; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; Di Russo F, 1999, NEUROREPORT, V10, P2755; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; Eimer M, 1999, PSYCHOPHYSIOLOGY, V36, P491, DOI 10.1017/S0048577299980915; ERIKSEN CW, 1985, J EXP PSYCHOL HUMAN, V11, P583, DOI 10.1037/0096-1523.11.5.583; Hahn S, 1998, VIS COGN, V5, P217, DOI 10.1080/713756781; HEINZE HJ, 1994, PERCEPT PSYCHOPHYS, V56, P42, DOI 10.3758/BF03211689; Hillyard SA, 1997, HUM BRAIN MAPP, V5, P287, DOI 10.1002/(SICI)1097-0193(1997)5:4<287::AID-HBM14>3.0.CO;2-B; KIEFER RJ, 1987, CAN J PSYCHOL, V41, P474, DOI 10.1037/h0084168; LABERGE D, 1989, PSYCHOL REV, V96, P101, DOI 10.1037/0033-295X.96.1.101; LaBerge D., 1995, ATTENTIONAL PROCESSI; Martinez A, 2001, VISION RES, V41, P1437, DOI 10.1016/S0042-6989(00)00267-4; McCormick PA, 1998, J EXP PSYCHOL HUMAN, V24, P350, DOI 10.1037/0096-1523.24.1.350; Moore CM, 1996, PSYCHON B REV, V3, P360, DOI 10.3758/BF03210761; MULLER M, 1994, NATO ADV SCI INST SE, V271, P325; Muller MM, 1997, BRAIN TOPOGR, V9, P163, DOI 10.1007/BF01190385; Muller MM, 1998, COGNITIVE BRAIN RES, V6, P249, DOI 10.1016/S0926-6410(97)00036-0; Muller MM, 2002, PSYCHOL SCI, V13, P119, DOI 10.1111/1467-9280.00422; Muller MM, 1998, NAT NEUROSCI, V1, P631, DOI 10.1038/2865; PAN KY, 1993, PERCEPT PSYCHOPHYS, V53, P134, DOI 10.3758/BF03211723; Peterson MS, 2000, J GEN PSYCHOL, V127, P6, DOI 10.1080/00221300009598568; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.neuro.13.1.25; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; Regan D., 1989, HUMAN BRAIN ELECTROP; SHAW ML, 1977, J EXP PSYCHOL HUMAN, V3, P201, DOI 10.1037/0096-1523.3.2.201; WEICHSELGARTNER E, 1987, SCIENCE, V238, P778, DOI 10.1126/science.3672124	30	307	309	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					309	312		10.1038/nature01812	http://dx.doi.org/10.1038/nature01812			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867981				2022-12-24	WOS:000184183900041
J	Murphy, CT; McCarroll, SA; Bargmann, CI; Fraser, A; Kamath, RS; Ahringer, J; Li, H; Kenyon, C				Murphy, CT; McCarroll, SA; Bargmann, CI; Fraser, A; Kamath, RS; Ahringer, J; Li, H; Kenyon, C			Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans	NATURE			English	Article							SUPEROXIDE-DISMUTASE; INSULIN-RECEPTOR; COMPUTATIONAL ANALYSIS; REGULATES LONGEVITY; STRESS RESISTANCE; OXIDATIVE STRESS; EXPRESSION; MEMBER; IDENTIFICATION; FAMILY	Ageing is a fundamental, unsolved mystery in biology. DAF-16, a FOXO-family transcription factor, influences the rate of ageing of Caenorhabditis elegans in response to insulin/insulin-like growth factor 1 (IGF-I) signalling. Using DNA microarray analysis, we have found that DAF-16 affects expression of a set of genes during early adulthood, the time at which this pathway is known to control ageing. Here we find that many of these genes influence the ageing process. The insulin/IGF-I pathway functions cell non-autonomously to regulate lifespan, and our findings suggest that it signals other cells, at least in part, by feedback regulation of an insulin/IGF-I homologue. Furthermore, our findings suggest that the insulin/IGF-I pathway ultimately exerts its effect on lifespan by upregulating a wide variety of genes, including cellular stress-response, antimicrobial and metabolic genes, and by downregulating specific life-shortening genes.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Cambridge; University of Cambridge	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	ckenyon@biochem.ucsf.edu	McCarroll, Steven A/A-8433-2009	McCarroll, Steven/0000-0002-6954-8184; Kenyon, Cynthia/0000-0003-3446-2636; Ahringer, Julie/0000-0002-7074-4051; Bargmann, Cornelia/0000-0002-8484-0618; Fraser, Andrew/0000-0001-9939-6014; Murphy, Coleen/0000-0002-8257-984X	Wellcome Trust [054523] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Banyai L, 1998, BBA-PROTEIN STRUCT M, V1429, P259, DOI 10.1016/S0167-4838(98)00237-4; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bussemaker HJ, 2000, P NATL ACAD SCI USA, V97, P10096, DOI 10.1073/pnas.180265397; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; DAVIS WL, 1990, BIOCHIM BIOPHYS ACTA, V1051, P276, DOI 10.1016/0167-4889(90)90133-X; DeRisi J, 2000, FEBS LETT, V470, P156, DOI 10.1016/S0014-5793(00)01294-1; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 2001, CURR OPIN GENET DEV, V11, P287, DOI 10.1016/S0959-437X(00)00192-1; Gems D, 1998, GENETICS, V150, P129; Gregoire FM, 1998, BIOCHEM BIOPH RES CO, V249, P385, DOI 10.1006/bbrc.1998.9164; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Herndon LA, 2000, RES PRO CEL, V29, P113; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1994, J GERONTOL, V49, pB270, DOI 10.1093/geronj/49.6.B270; Longo VD, 1999, ARCH BIOCHEM BIOPHYS, V365, P131, DOI 10.1006/abbi.1999.1158; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ookuma S, 2003, CURR BIOL, V13, P427, DOI 10.1016/S0960-9822(03)00108-8; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Riddle DL, 1997, C ELEGANS, P739; Ried K, 1998, HUM MOL GENET, V7, P1771, DOI 10.1093/hmg/7.11.1771; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sun JT, 2002, GENETICS, V161, P661; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Taub J, 2003, NATURE, V421, P764, DOI 10.1038/nature01425; Tissenbaum HA, 1998, GENETICS, V148, P703; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Van Helden J, 2000, YEAST, V16, P177, DOI 10.1002/(SICI)1097-0061(20000130)16:2<177::AID-YEA516>3.0.CO;2-9; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Wolkow Catherine A., 2000, Science (Washington D C), V290, P147, DOI 10.1126/science.290.5489.147; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	52	1597	1719	10	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					277	284		10.1038/nature01789	http://dx.doi.org/10.1038/nature01789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12845331				2022-12-24	WOS:000184183900032
J	Castrillon, DH; Miao, LL; Kollipara, R; Horner, JW; DePinho, RA				Castrillon, DH; Miao, LL; Kollipara, R; Horner, JW; DePinho, RA			Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; MOUSE; GROWTH; FAILURE; IDENTIFICATION; OOCYTES; PATHWAY; AGE-1; GENES; FKHR	Foxo transcription factors have been implicated in diverse biological processes, including metabolism, cellular stress responses, and aging. Here, we show that Foxo3a(-/-) female mice exhibit a distinctive ovarian phenotype of global follicular activation leading to oocyte death, early depletion of functional ovarian follicles, and secondary infertility. Foxo3a thus functions at the earliest stages of follicular growth as a suppressor of follicular activation. In addition to providing a molecular entry point for studying the regulation of follicular growth, these results raise the possibility that accelerated follicular initiation plays a role in premature ovarian failure, a common cause of infertility and premature aging in women.	Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol,Womens & Perinatal Pathol Div, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	DePinho, RA (corresponding author), Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA.			DePinho, Ronald/0000-0002-5625-577X	PHS HHS [K08] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Anasti JN, 1998, FERTIL STERIL, V70, P1, DOI 10.1016/S0015-0282(98)00099-5; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; DORMAN JB, 1995, GENETICS, V141, P1399; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1018, DOI 10.1210/me.13.6.1018; Elvin JA, 1998, REV REPROD, V3, P183, DOI 10.1530/ror.0.0030183; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Fortune JE, 2000, MOL CELL ENDOCRINOL, V163, P53, DOI 10.1016/S0303-7207(99)00240-3; FRASER IS, 1988, FERTIL STERIL, V50, P747; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gems D, 1998, GENETICS, V150, P129; Kaestner KH, 2000, GENE DEV, V14, P142; LINTERNMOORE S, 1979, BIOL REPROD, V20, P773, DOI 10.1095/biolreprod20.4.773; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; PETERS H, 1975, J REPROD FERTIL, V45, P559, DOI 10.1530/jrf.0.0450559; Prueitt RL, 2001, NAT GENET, V27, P132, DOI 10.1038/84735; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Tilly JL, 2001, NAT REV MOL CELL BIO, V2, P838, DOI 10.1038/35099086; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5	23	655	687	2	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2003	301	5630					215	218		10.1126/science.1086336	http://dx.doi.org/10.1126/science.1086336			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855809				2022-12-24	WOS:000184056200044
J	Munker, C; Pfander, JA; Weyer, S; Buchl, A; Kleine, T; Mezger, K				Munker, C; Pfander, JA; Weyer, S; Buchl, A; Kleine, T; Mezger, K			Evolution of planetary cores and the earth-moon system from Nb/Ta systematics	SCIENCE			English	Article							OCEANIC BASALTS; SOLAR-SYSTEM; MANTLE; ORIGIN; ZR/HF; FRACTIONATION; NIOBIUM; IMPACT; NB; DIFFERENTIATION	It has been assumed that Nb and Ta are not fractionated during differentiation processes on terrestrial planets and that both elements are lithophile. High-precision measurements of Nb/Ta and Zr/Hf reveal that Nb is moderately siderophile at high pressures. Nb/Ta values in the bulk silicate Earth (14.0 +/- 0.3) and the Moon (17.0 +/- 0.8) are below the chondritic ratio of 19.9 +/- 0.6, in contrast to Mars and asteroids. The lunar Nb/Ta constrains the mass fraction of impactor material in the Moon to less than 65%. Moreover, the Moon-forming impact can be linked in time with the final core-mantle equilibration on Earth 4.533 billion years ago.	Univ Munster, Inst Mineral, D-48149 Munster, Germany; Max Planck Inst Chem, D-55020 Mainz, Germany	University of Munster; Max Planck Society	Munker, C (corresponding author), Univ Munster, Inst Mineral, Corrensstr 24, D-48149 Munster, Germany.	muenker@nwz.uni-muenster.de	Kleine, Thorsten/S-2792-2017; Mezger, Klaus/D-9502-2011; Munker, Carsten/O-7606-2015; Weyer, Stefan/AAA-8827-2020	Kleine, Thorsten/0000-0003-4657-5961; Mezger, Klaus/0000-0002-2443-8539; Munker, Carsten/0000-0001-6406-559X				Barth MG, 2000, CHEM GEOL, V165, P197, DOI 10.1016/S0009-2541(99)00173-4; BENZ W, 1989, ICARUS, V81, P113, DOI 10.1016/0019-1035(89)90129-2; CAMERON AGW, 1991, ICARUS, V92, P204, DOI 10.1016/0019-1035(91)90046-V; Cameron AGW, 2001, METEORIT PLANET SCI, V36, P9, DOI 10.1111/j.1945-5100.2001.tb01806.x; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; David K, 2000, EARTH PLANET SC LETT, V178, P285, DOI 10.1016/S0012-821X(00)00088-1; El Goresy A, 2001, EARTH PLANET SC LETT, V192, P485, DOI 10.1016/S0012-821X(01)00480-0; HART SR, 1993, CONTRIB MINERAL PETR, V113, P1, DOI 10.1007/BF00320827; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; JOCHUM KP, 1986, GEOCHIM COSMOCHIM AC, V50, P1173, DOI 10.1016/0016-7037(86)90400-X; Jochum KP, 2000, METEORIT PLANET SCI, V35, P229, DOI 10.1111/j.1945-5100.2000.tb01771.x; Jochum KP, 2002, GEOCHIM COSMOCHIM AC, V66, pA368; JOCHUM KP, 1996, EOS S, V77, P785; Jones J. H., 2000, ORIGIN EARTH MOON, P197, DOI DOI 10.1016/0016-7037(83)90024-8.; Kamber BS, 2000, CHEM GEOL, V166, P241, DOI 10.1016/S0009-2541(99)00218-1; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; Lee DC, 2002, EARTH PLANET SC LETT, V198, P267, DOI 10.1016/S0012-821X(02)00533-2; Munker C, 1998, CHEM GEOL, V144, P23, DOI 10.1016/S0009-2541(97)00105-8; Munker C, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2001GC000183; MUNKER C, 2001, EOS S, V82, P1173; Niu YL, 1997, EARTH PLANET SC LETT, V148, P471, DOI 10.1016/S0012-821X(97)00048-4; Pfander JA, 2002, GEOCHIM COSMOCHIM AC, V66, pA597; Rudnick RL, 2000, SCIENCE, V287, P278, DOI 10.1126/science.287.5451.278; Schoenberg R, 2002, GEOCHIM COSMOCHIM AC, V66, P3151, DOI 10.1016/S0016-7037(02)00911-0; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Stolz AJ, 1996, GEOLOGY, V24, P587, DOI 10.1130/0091-7613(1996)024<0587:FAMREI>2.3.CO;2; van Westrenen W, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2000GC000133; Wade J, 2001, NATURE, V409, P75, DOI 10.1038/35051064; WANKE H, 1975, P LUNAR PLANET SCI C, V6, P1313; Weyer S, 2003, EARTH PLANET SC LETT, V205, P309, DOI 10.1016/S0012-821X(02)01059-2; Weyer S, 2002, CHEM GEOL, V187, P295, DOI 10.1016/S0009-2541(02)00129-8; Yi W, 2000, J GEOPHYS RES-SOL EA, V105, P18927, DOI 10.1029/2000JB900152; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995	33	321	350	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2003	301	5629					84	87		10.1126/science.1084662	http://dx.doi.org/10.1126/science.1084662			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843390				2022-12-24	WOS:000183914700037
J	Kim, J; Chung, YD; Park, DY; Choi, SK; Shin, DW; Soh, H; Lee, HW; Son, W; Yim, J; Park, CS; Kernan, MJ; Kim, C				Kim, J; Chung, YD; Park, DY; Choi, SK; Shin, DW; Soh, H; Lee, HW; Son, W; Yim, J; Park, CS; Kernan, MJ; Kim, C			A TRPV family ion channel required for hearing in Drosophila	NATURE			English	Article							REGULATORY FACTOR-X; CAPSAICIN-RECEPTOR; MECHANOSENSORY TRANSDUCTION; HEAT; EXPRESSION; MECHANISMS; ACTIVATION; ELEGANS; PROTEIN; GENOME	The many types of insect ear share a common sensory element, the chordotonal organ, in which sound-induced antennal or tympanal vibrations are transmitted to ciliated sensory neurons and transduced to receptor potentials(1,2). However, the molecular identity of the transducing ion channels in chordotonal neurons, or in any auditory system, is still unknown(3,4). Drosophila that are mutant for NOMPC, a transient receptor potential (TRP) superfamily ion channel, lack receptor potentials and currents in tactile bristles(5,6) but retain most of the antennal sound-evoked response(7), suggesting that a different channel is the primary transducer in chordotonal organs. Here we describe the Drosophila Nanchung (Nan) protein, an ion channel subunit similar to vanilloid-receptor-related (TRPV) channels of the TRP superfamily. Nan mediates hypo-osmotically activated calcium influx and cation currents in cultured cells. It is expressed in vivo exclusively in chordotonal neurons and is localized to their sensory cilia. Antennal sound-evoked potentials are completely absent in mutants lacking Nan, showing that it is an essential component of the chordotonal mechanotransducer.	Hanwha Chem Co R&D Ctr, Dept Genet, Taejon 305345, South Korea; Chungnam Natl Univ, Dept Microbiol, Taejon 305764, South Korea; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; K JIST, Dept Life Sci, Gwangju 500712, South Korea; Seoul Natl Univ, Natl Creat Res Inst Genet Reprogramming, Seoul 151742, South Korea	Chungnam National University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Gwangju Institute of Science & Technology (GIST); Seoul National University (SNU)	Kim, C (corresponding author), Hanwha Chem Co R&D Ctr, Dept Genet, Taejon 305345, South Korea.		Kim, Janghwan/B-4522-2009	Park, Chul-Seung/0000-0003-0209-1412; Kernan, Maurice/0000-0002-1546-6159; Son, Wonseok/0000-0003-1623-1236	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002780] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002780] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Benham CD, 2002, NEUROPHARMACOLOGY, V42, P873, DOI 10.1016/S0028-3908(02)00047-3; BRAND AH, 1993, DEVELOPMENT, V118, P401; Caldwell JC, 2002, J NEUROBIOL, V53, P172, DOI 10.1002/neu.10126; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Colbert HA, 1997, J NEUROSCI, V17, P8259; Dubruille R, 2002, DEVELOPMENT, V129, P5487, DOI 10.1242/dev.00148; Eberl DF, 1999, CURR OPIN NEUROBIOL, V9, P389, DOI 10.1016/S0959-4388(99)80058-0; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Guler AD, 2002, J NEUROSCI, V22, P6408; Gunthorpe MJ, 2002, TRENDS PHARMACOL SCI, V23, P183, DOI 10.1016/S0165-6147(02)01999-5; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Strassmaier M, 2002, CURR OPIN NEUROBIOL, V12, P380, DOI 10.1016/S0959-4388(02)00344-6; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Vandaele C, 2001, MECH DEVELOP, V103, P159, DOI 10.1016/S0925-4773(01)00340-9; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xu HS, 2003, J BIOL CHEM, V278, P11520, DOI 10.1074/jbc.M211061200; Yager DD, 1999, MICROSC RES TECHNIQ, V47, P380, DOI 10.1002/(SICI)1097-0029(19991215)47:6<380::AID-JEMT3>3.0.CO;2-P	27	281	303	3	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					81	84		10.1038/nature01733	http://dx.doi.org/10.1038/nature01733			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12819662				2022-12-24	WOS:000183912800044
J	Boulanger, MJ; Chow, DC; Brevnova, EE; Garcia, KC				Boulanger, MJ; Chow, DC; Brevnova, EE; Garcia, KC			Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex	SCIENCE			English	Article							PROXIMAL EXTRACELLULAR DOMAINS; RECEPTOR COMPLEXES; CRYSTAL-STRUCTURE; GP130; ACTIVATION; CYTOKINES; DISTINCT; PROGRAM; FAMILY; SITES	Interleukin-6 (IL-6) is an immunoregulatory cytokine that activates a cell-surface signaling assembly composed of IL-6, the IL-6 alpha-receptor (IL-6Ralpha), and the shared signaling receptor gp130. The 3.65 angstrom - resolution structure of the extracellular signaling complex reveals a hexameric, interlocking assembly mediated by a total of 10 symmetry-related, thermodynamically coupled interfaces. Assembly of the hexameric complex occurs sequentially: IL-6 is. rst engaged by IL-6Ralpha and then presented to gp130 in the proper geometry to facilitate a cooperative transition into the high-affinity, signaling-competent hexamer. The quaternary structures of other IL-6/IL-12 family signaling complexes are likely constructed by means of a similar topological blueprint.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Fairchild D319,299 Campus Dr, Stanford, CA 94305 USA.	kcgarcia@stanford.edu			NIAID NIH HHS [AI51321] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051321] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barton VA, 1999, J BIOL CHEM, V274, P5755, DOI 10.1074/jbc.274.9.5755; Benigni F, 1996, BLOOD, V87, P1851, DOI 10.1182/blood.V87.5.1851.bloodjournal8751851; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; Chow DC, 2002, BBA-MOL CELL RES, V1592, P225, DOI 10.1016/S0167-4889(02)00317-8; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Chow DC, 2001, BIOCHEMISTRY-US, V40, P7593, DOI 10.1021/bi010192q; Grotzinger J, 1999, BIOL CHEM, V380, P803, DOI 10.1515/BC.1999.100; Grotzinger J, 1997, PROTEINS, V27, P96; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Kalai M, 1997, BLOOD, V89, P1319, DOI 10.1182/blood.V89.4.1319; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurth I, 2000, J IMMUNOL, V164, P273, DOI 10.4049/jimmunol.164.1.273; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; PAONESSA G, 1995, EMBO J, V14, P1942, DOI 10.1002/j.1460-2075.1995.tb07186.x; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Timmermann A, 2002, EUR J BIOCHEM, V269, P2716, DOI 10.1046/j.1432-1033.2002.02941.x; Varghese JN, 2002, P NATL ACAD SCI USA, V99, P15959, DOI 10.1073/pnas.232432399; WARD LD, 1994, J BIOL CHEM, V269, P23286	22	443	490	4	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2003	300	5628					2101	2104		10.1126/science.1083901	http://dx.doi.org/10.1126/science.1083901			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12829785				2022-12-24	WOS:000183774900049
J	Zhou, ZY; Zheng, SL				Zhou, ZY; Zheng, SL			Palaeobiology: The missing link in Ginkgo evolution - The modern maidenhair tree has barely changed since the days of the dinosaurs.	NATURE			English	Editorial Material									Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Nanjing 210008, Peoples R China; Minist Natl Land & Resources, Shenyang Inst Geol & Mineral Resources, Shenyang 110032, Peoples R China	Chinese Academy of Sciences	Zhou, ZY (corresponding author), Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Nanjing 210008, Peoples R China.							ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Chang M.M., 2001, JEHOL BIOTA; Crane P.R., 1990, FIELDIANA GEOLOGY, V20, P1, DOI [10.5962/bhl.title.100826, DOI 10.5962/BHL.TITLE.100826]; Fuji K, 1896, BOT MAG TOKYO, V10, P104; Harris T.M., 1974, YORKSHIRE JURASSIC F, V4; Rothwell G.W., 1997, GINKGO BILOBA GLOBAL, P223; Seward A.C., 1919, FOSSIL PLANTS, V4; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Zhou Z. Y., 1994, ACTA PALAEONTOL SIN, V33, P131; Zhou ZY, 1989, PALAEONTOGR ABT B, V211, P113	10	147	185	6	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					821	822		10.1038/423821a	http://dx.doi.org/10.1038/423821a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815417				2022-12-24	WOS:000183585300030
J	Kirkwood, T				Kirkwood, T			The most pressing problem of our age	BRITISH MEDICAL JOURNAL			English	Article									Newcastle Gen Hosp, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	Newcastle General Hospital; Newcastle University - UK	Kirkwood, T (corresponding author), Newcastle Gen Hosp, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.								0	16	18	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2003	326	7402					1297	1299		10.1136/bmj.326.7402.1297	http://dx.doi.org/10.1136/bmj.326.7402.1297			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691VK	12805160	Green Published			2022-12-24	WOS:000183626500024
J	Gao, HX; Sengupta, J; Valle, M; Korostelev, A; Eswar, N; Stagg, SM; Van Roey, P; Agrawal, RK; Harvey, SC; Sali, A; Chapman, MS; Frank, J				Gao, HX; Sengupta, J; Valle, M; Korostelev, A; Eswar, N; Stagg, SM; Van Roey, P; Agrawal, RK; Harvey, SC; Sali, A; Chapman, MS; Frank, J			Study of the structural dynamics of the E-coli 70S ribosome using real-space refinement	CELL			English	Article							AMINOACYL-TRANSFER-RNA; CRYOELECTRON MICROSCOPY; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; ATOMIC MODELS; 80S RIBOSOME; PROTEIN S1; PSI-BLAST; SUBUNIT	Cryo-EM density maps showing the 70S ribosome of E. coli in two different functional states related by a ratchet-like motion were analyzed using real-space refinement. Comparison of the two resulting atomic models shows that the ribosome changes from a compact structure to a looser one, coupled with the rearrangement of many of the proteins. Furthermore, in contrast to the unchanged inter-subunit bridges formed wholly by RNA, the bridges involving proteins undergo large conformational changes following the ratchet-like motion, suggesting an important role of ribosomal proteins in facilitating the dynamics of translation.	Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA; Wadsworth Ctr Labs & Res, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA; Florida State Univ, Inst Mol Biophys, Kasha Lab, Tallahassee, FL 32306 USA; Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA; Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	Health Research Inc; Howard Hughes Medical Institute; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University System of Georgia; Georgia Institute of Technology	Frank, J (corresponding author), Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA.	joachim@wadsworth.org	Stagg, Scott/AAW-9294-2020; Valle, Mikel/F-7598-2011	Valle, Mikel/0000-0001-8268-6912; Korostelev, Andrei/0000-0003-1588-717X; Chapman, Michael/0000-0001-8525-8585	NIGMS NIH HHS [R01 GM061576, R01 GM54762, R01 GM53827, P01 GM64676, R01 GM61576, R37 GM29169, R01 GM55440, P50 GM62529] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029169, R01GM054762, R01GM053827, R01GM061576, R01GM055440, P50GM062529, P01GM064676] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 1999, J BIOL CHEM, V274, P8723, DOI 10.1074/jbc.274.13.8723; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Agrawal RK, 2001, J MOL BIOL, V311, P777, DOI 10.1006/jmbi.2001.4907; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; CHAPMAN MS, 1995, ACTA CRYSTALLOGR A, V51, P69, DOI 10.1107/S0108767394007130; Chen LF, 2001, J STRUCT BIOL, V133, P221, DOI 10.1006/jsbi.2000.4321; Cooperman BS, 1995, BIOCHEM CELL BIOL, V73, P1087, DOI 10.1139/o95-117; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; Frank J, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P45; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2001, COLD SPRING HARB SYM, V66, P67, DOI 10.1101/sqb.2001.66.67; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Frank J., 1996, 3 DIMENSIONAL ELECT, Ved, ppp 54; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gabashvili IS, 1999, EMBO J, V18, P6501, DOI 10.1093/emboj/18.22.6501; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LAUGHREA M, 1977, J MOL BIOL, V112, P399, DOI 10.1016/S0022-2836(77)80189-7; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Moore PB, 2002, NATURE, V418, P229, DOI 10.1038/418229a; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pieper U, 2002, NUCLEIC ACIDS RES, V30, P255, DOI 10.1093/nar/30.1.255; Roseman AM, 2000, ACTA CRYSTALLOGR D, V56, P1332, DOI 10.1107/S0907444900010908; Rossmann MG, 2000, ACTA CRYSTALLOGR D, V56, P1341, DOI 10.1107/S0907444900009562; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597; Schaffer AA, 1999, BIOINFORMATICS, V15, P1000; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; SERDYUK I, 1992, BIOCHIMIE, V74, P299, DOI 10.1016/0300-9084(92)90107-P; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Tung CS, 2002, NAT STRUCT BIOL, V9, P750, DOI 10.1038/nsb841; Uhlein M, 1998, BIOCHEM J, V331, P423; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Volkmann N, 1999, J STRUCT BIOL, V125, P176, DOI 10.1006/jsbi.1998.4074; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wriggers W, 2001, J STRUCT BIOL, V133, P193, DOI 10.1006/jsbi.2000.4350; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	51	233	287	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2003	113	6					789	801		10.1016/S0092-8674(03)00427-6	http://dx.doi.org/10.1016/S0092-8674(03)00427-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809609	Bronze			2022-12-24	WOS:000183514400013
J	Lauber, K; Bohn, E; Krober, SM; Xiao, YJ; Blumenthal, SG; Lindemann, RK; Marini, P; Wiedig, C; Zobywalski, A; Baksh, S; Xu, Y; Autenrieth, IB; Schulze-Osthoff, K; Belka, C; Stuhler, G; Wesselborg, S				Lauber, K; Bohn, E; Krober, SM; Xiao, YJ; Blumenthal, SG; Lindemann, RK; Marini, P; Wiedig, C; Zobywalski, A; Baksh, S; Xu, Y; Autenrieth, IB; Schulze-Osthoff, K; Belka, C; Stuhler, G; Wesselborg, S			Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal	CELL			English	Article							RETRACTED ARTICLE. SEE; SECRETORY PHOSPHOLIPASE A(2); MORPHOLOGICAL-CHANGES; DISTINCT ROLES; ACID RELEASE; MEMBRANE; LYSOPHOSPHATIDYLCHOLINE; RECEPTOR; BINDING; SPHINGOSYLPHOSPHORYLCHOLINE	Efficient engulfment of the intact cell corpse is a critical end point of apoptosis, required to prevent secondary necrosis and inflammation. The presentation of "eat-me" signals on the dying cell is an important part of this process of recognition and engulfment by professional phagocytes. Here, we present evidence that apoptotic cells secrete chemotactic factor(s) that stimulate the attraction of monocytic cells and primary macrophages. The activation of caspase-3 in the apoptotic cell was found to be required for the release of this chemotactic factor(s). The putative chemoattractant was identified as the phospholipid, lysophosphatidylcholine. Further analysis showed that lysophosphatidylcholine was released from apoptotic cells due to the caspase-3 mediated activation of the calcium-independent phospholipase A(2). These data suggest that in addition to eat-me signals, apoptotic cells display attraction signals to ensure the efficient removal of apoptotic cells and prevent postapoptotic necrosis.	Univ Tubingen, Dept Internal Med 1, D-72074 Tubingen, Germany; Univ Tubingen, Inst Med Microbiol, D-72074 Tubingen, Germany; Univ Tubingen, Inst Pathol, D-72074 Tubingen, Germany; Cleveland Clin Fdn, Dept Canc Biol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Gynecol & Obstet, Cleveland, OH 44195 USA; Univ Tubingen, Dept Radiat Oncol, D-72074 Tubingen, Germany; Univ Tubingen, Dept Internal Med 2, D-72074 Tubingen, Germany; Harvard Univ, Sch Med, Beth Israel Deaconess Hosp, Dept Med, Boston, MA 02115 USA; Univ Dusseldorf, Inst Mol Med, D-4000 Dusseldorf, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Heinrich Heine University Dusseldorf	Wesselborg, S (corresponding author), Univ Tubingen, Dept Internal Med 1, D-72074 Tubingen, Germany.	snwessel@med.uni-tuebingen.de	Schulze-Osthoff, Klaus/N-9025-2013	Schulze-Osthoff, Klaus/0000-0003-1443-2720; Wesselborg, Sebastian/0000-0002-5236-942X				Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Atsumi G, 1997, BBA-LIPID LIPID MET, V1349, P43, DOI 10.1016/S0005-2760(97)00082-9; Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; Binder RJ, 2000, J IMMUNOL, V165, P6029, DOI 10.4049/jimmunol.165.11.6029; Brown S, 2002, NATURE, V418, P200, DOI 10.1038/nature00811; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hengartner MO, 2001, CELL, V104, P325, DOI 10.1016/S0092-8674(01)00219-7; HOFFMAN RD, 1982, P NATL ACAD SCI-BIOL, V79, P3285, DOI 10.1073/pnas.79.10.3285; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Larsson PKA, 1998, J BIOL CHEM, V273, P207, DOI 10.1074/jbc.273.1.207; Lauber K, 2001, J BIOL CHEM, V276, P29772, DOI 10.1074/jbc.M101524200; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Murakami M, 2000, BBA-MOL CELL BIOL L, V1488, P159, DOI 10.1016/S1388-1981(00)00118-9; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Rosen A, 1999, CELL DEATH DIFFER, V6, P6, DOI 10.1038/sj.cdd.4400460; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Segundo C, 1999, BLOOD, V94, P1012, DOI 10.1182/blood.V94.3.1012.415k05_1012_1020; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; Xiao YJ, 2000, ANN NY ACAD SCI, V905, P242; Xu Y, 2000, NAT CELL BIOL, V2, P261, DOI 10.1038/35010529; Zhu K, 2001, J BIOL CHEM, V276, P41325, DOI 10.1074/jbc.M008057200	34	664	694	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2003	113	6					717	730		10.1016/S0092-8674(03)00422-7	http://dx.doi.org/10.1016/S0092-8674(03)00422-7			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809603	Bronze			2022-12-24	WOS:000183514400007
J	Nemani, RR; Keeling, CD; Hashimoto, H; Jolly, WM; Piper, SC; Tucker, CJ; Myneni, RB; Running, SW				Nemani, RR; Keeling, CD; Hashimoto, H; Jolly, WM; Piper, SC; Tucker, CJ; Myneni, RB; Running, SW			Climate-driven increases in global terrestrial net primary production from 1982 to 1999	SCIENCE			English	Article							VARIABILITY; RESOLUTION; BUDGET; INDEX	Recent climatic changes have enhanced plant growth in northern mid-latitudes and high latitudes. However, a comprehensive analysis of the impact of global climatic changes on vegetation productivity has not before been expressed in the context of variable limiting factors to plant growth. We present a global investigation of vegetation responses to climatic changes by analyzing 18 years (1982 to 1999) of both climatic data and satellite observations of vegetation activity. Our results indicate that global changes in climate have eased several critical climatic constraints to plant growth, such that net primary production increased 6% (3.4 petagrams of carbon over 18 years) globally. The largest increase was in tropical ecosystems. Amazon rain forests accounted for 42% of the global increase in net primary production, owing mainly to decreased cloud cover and the resulting increase in solar radiation.	Univ Montana, Sch Forestry, Missoula, MT 59801 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA; Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 113, Japan; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Boston Univ, Dept Geog, Boston, MA 02215 USA	University of Montana System; University of Montana; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Tokyo; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Boston University	Nemani, RR (corresponding author), Univ Montana, Sch Forestry, Missoula, MT 59801 USA.		Zhong, Hong Lin/C-2633-2012; Myneni, Ranga B./AAU-6088-2021; Noojipady, Praveen/B-2511-2010; Myneni, Ranga B/F-5129-2012; Mitchard, Edward T A/C-6346-2009	Myneni, Ranga B/0000-0002-0234-6393; Mitchard, Edward T A/0000-0002-5690-4055; Hashimoto, Hirofumi/0000-0001-7706-1854				[Anonymous], 2000, EARTH INTERACT, DOI DOI 10.1175/1087-3562(2000)004%3C0003:PASAOT%3E2.0.CO;2; BARRETT DJ, 2002, GLOBAL BIOGEOCHEM CY, V16; Churkina G, 1998, ECOSYSTEMS, V1, P206, DOI 10.1007/s100219900016; Costa MH, 1999, J GEOPHYS RES-ATMOS, V104, P14189, DOI 10.1029/1998JD200126; Curtis PS, 1998, OECOLOGIA, V113, P299, DOI 10.1007/s004420050381; De Fries RS, 1998, INT J REMOTE SENS, V19, P3141, DOI 10.1080/014311698214235; FAN SM, 1990, J GEOPHYS RES-ATMOS, V95, P16851, DOI 10.1029/JD095iD10p16851; FRIEDLINGSTEIN P, 1995, GLOBAL BIOGEOCHEM CY, V9, P541, DOI 10.1029/95GB02381; Graham EA, 2003, P NATL ACAD SCI USA, V100, P572, DOI 10.1073/pnas.0133045100; Gu LH, 2003, SCIENCE, V299, P2035, DOI 10.1126/science.1078366; HICKE JA, 2002, GEOPHYS RES LETT, V29; Houghton J. T., 2001, CLIMATE CHANGE 2001; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; JAMES ME, 1994, INT J REMOTE SENS, V15, P3347, DOI 10.1080/01431169408954335; KEELING CD, 2001, SIO REFERENCE SERIES, V21; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; Kumar KK, 1999, SCIENCE, V284, P2156, DOI 10.1126/science.284.5423.2156; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Myneni RB, 1997, IEEE T GEOSCI REMOTE, V35, P1380, DOI 10.1109/36.649788; NEMANI RR, 2002, GEOPHYS RES LETT; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Potter C, 2001, J GEOPHYS RES-ATMOS, V106, P10423, DOI 10.1029/2000JD900563; Prince SD, 1995, J BIOGEOGR, V22, P815, DOI 10.2307/2845983; Running SW, 2000, METHODS IN ECOSYSTEM SCIENCE, P44; Townsend AR, 1996, ECOL APPL, V6, P806, DOI 10.2307/2269486; Trigo RM, 2002, CLIMATE RES, V20, P9, DOI 10.3354/cr020009; Wielicki BA, 2002, SCIENCE, V295, P841, DOI 10.1126/science.1065837; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	30	2390	2726	73	1145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1560	1563		10.1126/science.1082750	http://dx.doi.org/10.1126/science.1082750			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791990				2022-12-24	WOS:000183333100052
J	Kettenberger, H; Armache, KJ; Cramer, P				Kettenberger, H; Armache, KJ; Cramer, P			Architecture of the RNA polymerase II-TFIIS complex and implications for mRNA cleavage	CELL			English	Article							ELONGATION-FACTOR TFIIS; FACILITATED TRANSCRIPT CLEAVAGE; STRUCTURAL BASIS; EXONUCLEASE ACTIVITY; NASCENT TRANSCRIPT; CRYSTAL-STRUCTURE; SUBUNIT RPB9; ACTIVE-SITE; INITIATION; DOMAIN	The transcription elongation factor TFIIS induces mRNA cleavage by enhancing the intrinsic nuclease activity of RNA polymerase (Pol) II. We have diffused TFIIS into Pol II crystals and derived a model of the Pol II-TFIIS complex from X-ray diffraction data to 3.8 Angstrom resolution. TFIIS extends from the polymerase surface via a pore to the internal active site, spanning a distance of 100 Angstrom. Two essential and invariant acidic residues in a TFIIS loop complement the Pol II active site and could position a metal ion and a water molecule for hydrolytic RNA cleavage. TFIIS also induces extensive structural changes in Pol II that would realign nucleic acids in the active center. Our results support the idea that Pol II contains a single tunable active site for RNA polymerization and cleavage, in contrast to DNA polymerases with two separate active sites for DNA polymerization and cleavage.	Univ Munich, Inst Biochem, Gene Ctr, D-81377 Munich, Germany	University of Munich	Cramer, P (corresponding author), Univ Munich, Inst Biochem, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de						Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; CIPRESPALACIN G, 1994, P NATL ACAD SCI USA, V91, P8087, DOI 10.1073/pnas.91.17.8087; Cramer P, 2002, BIOESSAYS, V24, P724, DOI 10.1002/bies.10127; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Davie JK, 2000, MOL CELL BIOL, V20, P5960, DOI 10.1128/MCB.20.16.5960-5973.2000; Ederth J, 2002, J BIOL CHEM, V277, P37456, DOI 10.1074/jbc.M207038200; Erie DA, 2002, BBA-GENE STRUCT EXPR, V1577, P224, DOI 10.1016/S0167-4781(02)00454-2; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gu WG, 1995, J BIOL CHEM, V270, P30441, DOI 10.1074/jbc.270.51.30441; Hausner W, 2000, J BIOL CHEM, V275, P12393, DOI 10.1074/jbc.275.17.12393; Hemming SA, 2000, J BIOL CHEM, V275, P35506, DOI 10.1074/jbc.M004721200; HORIKOSHI M, 1984, J BIOL CHEM, V259, P608; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; IZBAN MG, 1993, J BIOL CHEM, V268, P12864; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; JOHNSON TL, 1994, CELL, V77, P217, DOI 10.1016/0092-8674(94)90314-X; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Koulich D, 1997, J BIOL CHEM, V272, P7201, DOI 10.1074/jbc.272.11.7201; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; Morin PE, 1996, P NATL ACAD SCI USA, V93, P10604, DOI 10.1073/pnas.93.20.10604; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEDLALKOV YA, 2003, J BIOL CHEM, V278, P18303; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Olmsted VK, 1998, J BIOL CHEM, V273, P22589, DOI 10.1074/jbc.273.35.22589; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Powell W, 1996, J BIOL CHEM, V271, P22301, DOI 10.1074/jbc.271.37.22301; QIAN XQ, 1993, BIOCHEMISTRY-US, V32, P9944, DOI 10.1021/bi00089a010; REINES D, 1992, J BIOL CHEM, V267, P3795; RUDD MD, 1994, P NATL ACAD SCI USA, V91, P8057, DOI 10.1073/pnas.91.17.8057; Rudd MD, 1996, J BIOL CHEM, V271, P21549, DOI 10.1074/jbc.271.35.21549; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SEKIMIZU K, 1976, BIOCHEMISTRY-US, V15, P5064, DOI 10.1021/bi00668a018; Shaw RJ, 2002, J BIOL CHEM, V277, P24420, DOI 10.1074/jbc.M202059200; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Shimasaki NB, 2000, J BIOL CHEM, V275, P36541, DOI 10.1074/jbc.M005834200; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WANG DG, 1993, P NATL ACAD SCI USA, V90, P843, DOI 10.1073/pnas.90.3.843; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Wu JS, 1996, P NATL ACAD SCI USA, V93, P11552, DOI 10.1073/pnas.93.21.11552	62	258	277	3	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2003	114	3					347	357		10.1016/S0092-8674(03)00598-1	http://dx.doi.org/10.1016/S0092-8674(03)00598-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914699	Bronze, Green Published			2022-12-24	WOS:000184679200011
J	Passafaro, M; Nakagawa, T; Sala, C; Sheng, M				Passafaro, M; Nakagawa, T; Sala, C; Sheng, M			Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR2	NATURE			English	Article							N-TERMINAL DOMAINS; NMDA RECEPTORS; GLUTAMATE RECEPTORS; BINDING-PROTEINS; EXPRESSION; SYNAPSES; NEURONS; DESENSITIZATION; DEPENDENCE; CHANNELS	Synaptic transmission from excitatory nerve cells in the mammalian brain is largely mediated by AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)-type glutamate receptors located at the surface of dendritic spines. The abundance of postsynaptic AMPA receptors correlates with the size of the synapse and the dimensions of the dendritic spine head(1-4). Moreover, long-term potentiation is associated with the formation of dendritic spines as well as synaptic delivery of AMPA receptors(5-8). The molecular mechanisms that coordinate AMPA receptor delivery and spine morphogenesis are unknown. Here we show that overexpression of the glutamate receptor 2 (GluR2) subunit of AMPA receptors increases spine size and density in hippocampal neurons, and more remarkably, induces spine formation in GABA-releasing interneurons that normally lack spines. The extracellular N-terminal domain (NTD) of GluR2 is responsible for this effect, and heterologous fusion proteins of the NTD of GluR2 inhibit spine morphogenesis. We propose that the NTD of GluR2 functions at the cell surface as part of a receptor-ligand interaction that is important for spine growth and/or stability.	MIT, Howard Hughes Med Inst, RIKEN,Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; Univ Milan, Dept Pharmacol, CNR, Inst Neurosci Cellular & Mol Pharmacol, I-20129 Milan, Italy	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Consiglio Nazionale delle Ricerche (CNR); University of Milan	Sheng, M (corresponding author), MIT, Howard Hughes Med Inst, RIKEN,Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA.		Sala, Carlo/A-2493-2009	Sala, Carlo/0000-0003-0662-9523; Sheng, Morgan/0000-0002-8703-5366	Telethon [TCP01014] Funding Source: Medline	Telethon(Fondazione Telethon)		Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Nusser Z, 2000, CURR OPIN NEUROBIOL, V10, P337, DOI 10.1016/S0959-4388(00)00086-6; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; Washburn MS, 1997, J NEUROSCI, V17, P9393	30	249	257	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					677	681		10.1038/nature01781	http://dx.doi.org/10.1038/nature01781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904794				2022-12-24	WOS:000184578800046
J	Straume, T; Rugel, G; Marchetti, AA; Ruhm, W; Korschinek, G; McAninch, JE; Carroll, K; Egbert, S; Faestermann, T; Knie, K; Martinelli, R; Wallner, A; Wallner, C				Straume, T; Rugel, G; Marchetti, AA; Ruhm, W; Korschinek, G; McAninch, JE; Carroll, K; Egbert, S; Faestermann, T; Knie, K; Martinelli, R; Wallner, A; Wallner, C			Measuring fast neutrons in Hiroshima at distances relevant to atomic-bomb survivors	NATURE			English	Article							ACCELERATOR MASS-SPECTROMETRY; DOSIMETRY SYSTEM 1986; NI-63; NAGASAKI; EU-152; CO-60; CL-36; MAGNET; CA-41; IONS	Data from the survivors of the atomic bombs serve as the major basis for risk calculations of radiation-induced cancer in humans(1). A controversy has existed for almost two decades, however, concerning the possibility that neutron doses in Hiroshima may have been much larger than estimated. This controversy was based on measurements of radioisotopes activated by thermal neutrons that suggested much higher fluences at larger distances than expected(2-6). For fast neutrons, which contributed almost all the neutron dose, clear measurement validation has so far proved impossible at the large distances (900 to 1,500 m) most relevant to survivor locations(6). Here, the first results are reported for the detection of Ni-63 produced predominantly by fast neutrons (above about 1 MeV) in copper samples from Hiroshima. This breakthrough was made possible by the development of chemical extraction methods(7,8) and major improvements in the sensitivity of accelerator mass spectrometry for detection of Ni-63 atoms (refs 8-11). When results are compared with Ni-63 activation predicted by neutron doses for Hiroshima survivors(6), good agreement is observed at the distances most relevant to survivor data. These findings provide, for the first time, clear measurement validation of the neutron doses to survivors in Hiroshima.	Univ Utah, Salt Lake City, UT 84108 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Tech Univ Munich, D-85747 Garching, Germany; Univ Munich, D-80336 Munich, Germany; Sci Applicat Int Corp, San Diego, CA 92121 USA	Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Technical University of Munich; University of Munich; Science Applications International Corporation (SAIC)	Straume, T (corresponding author), Univ Utah, 729 Arapeen Dr,Suite 2334, Salt Lake City, UT 84108 USA.		Wallner, Anton/G-1480-2011; Faestermann, Thomas/ABE-2360-2020; Rühm, Werner/C-4302-2011	Wallner, Anton/0000-0003-2804-3670; Faestermann, Thomas/0000-0002-6603-8787; Ruhm, Werner/0000-0002-6354-7359				ARAKATSU B, 1953, COLLECTION INVESTIGA, P34; BARNES IL, 1971, INT J APPL RADIAT IS, V22, P781; *BEIR, 1990, 5 BEIR; Feldman GJ, 1998, PHYS REV D, V57, P3873, DOI 10.1103/PhysRevD.57.3873; GRITZNER ML, 1987, US JAPAN JOINT REASS, V2, P283; HABERSTOCK G, 1986, RADIOCARBON, V28, P204, DOI 10.1017/S0033822200007281; HASHIZUME T, 1967, HEALTH PHYS, V13, P149, DOI 10.1097/00004032-196702000-00004; HOSHI M, 1989, HEALTH PHYS, V57, P831; JOHNSON JO, 1999, USERS MANUAL MASH V; KATO K, 1990, INT J RADIAT BIOL, V58, P661, DOI 10.1080/09553009014552011; Knie K, 1997, NUCL INSTRUM METH B, V123, P128, DOI 10.1016/S0168-583X(96)00753-7; KORSCHINEK G, 1987, NUCL INSTRUM METH B, V29, P67, DOI 10.1016/0168-583X(87)90206-0; Marchetti AA, 1996, APPL RADIAT ISOTOPES, V47, P97, DOI 10.1016/0969-8043(95)00240-5; Marchetti AA, 1997, NUCL INSTRUM METH B, V123, P230, DOI 10.1016/S0168-583X(96)00611-8; McAninch JE, 1997, NUCL INSTRUM METH B, V123, P137, DOI 10.1016/S0168-583X(96)00411-9; NAKANISHI T, 1983, NATURE, V302, P132, DOI 10.1038/302132a0; ROESCH WC, 1987, US JAP JOINT REASS A; ROSE PF, 1991, ENDF B 6 SUMMARY DOC; Rugel G, 2000, NUCL INSTRUM METH B, V172, P934, DOI 10.1016/S0168-583X(00)00108-7; Ruhm W, 2000, HEALTH PHYS, V79, P358, DOI 10.1097/00004032-200010000-00003; RUHM W, 1992, Z PHYS A-HADRON NUCL, V341, P235, DOI 10.1007/BF01298486; Ruhm W, 1998, RADIAT ENVIRON BIOPH, V37, P293, DOI 10.1007/s004110050131; SHIBATA T, 1994, J PHYS SOC JPN, V63, P3546, DOI 10.1143/JPSJ.63.3546; SHIZUMA K, 1993, HEALTH PHYS, V65, P272, DOI 10.1097/00004032-199309000-00004; Shizuma K, 1998, HEALTH PHYS, V75, P278, DOI 10.1097/00004032-199809000-00006; STRANDBERG TE, 1992, CIRCULATION, V86, P63; Straume T, 1996, RADIAT PROT DOSIM, V67, P5, DOI 10.1093/oxfordjournals.rpd.a031797; STRAUME T, 1994, RADIAT RES, V138, P193, DOI 10.2307/3578589; STRAUME T, 1990, NUCL INSTRUM METH B, V52, P552, DOI 10.1016/0168-583X(90)90475-A; YAMASAKI F, 1953, COLLECTION INVESTIGA, P18	30	49	50	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					539	542		10.1038/nature01815	http://dx.doi.org/10.1038/nature01815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891354				2022-12-24	WOS:000184454700039
J	Grill, SW; Howard, J; Schaffer, E; Stelzer, EHK; Hyman, A				Grill, SW; Howard, J; Schaffer, E; Stelzer, EHK; Hyman, A			The distribution of active force generators controls mitotic spindle position	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS EMBRYOS; C-ELEGANS; CELL-DIVISION; POLARITY; MECHANISMS; DROSOPHILA; GEOMETRY; MITOSIS; PROTEIN; COMPLEX	During unequal cell divisions a mitotic spindle is eccentrically positioned before cell cleavage. To determine the basis of the net force imbalance that causes spindle displacement in one-cell Caenorhabditis elegans embryos, we fragmented centrosomes with an ultraviolet laser. Analysis of the mean and variance of fragment speeds suggests that the force imbalance is due to a larger number of force generators pulling on astral microtubules of the posterior aster relative to the anterior aster. Moreover, activation of heterotrimeric guanine nucleotide-binding protein (G protein) alpha subunits is required to generate these astral forces.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Grill, SW (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	grill@mpi-cbg.de; howard@mpi-cbg.de	Schäffer, Erik/A-4664-2010; Hyman, Tony/F-1923-2011; Grill, Stephan/D-9427-2012; Stelzer, Ernst H K/A-7648-2011; Howard, Jonathon/J-7492-2016; Howard, Jonathon/D-4229-2011; Hyman, Anthony A/B-3917-2017	Schäffer, Erik/0000-0001-7876-085X; Stelzer, Ernst H K/0000-0003-1545-0736; Howard, Jonathon/0000-0003-0086-1196; Howard, Jonathon/0000-0003-0086-1196; Hyman, Anthony A/0000-0003-3664-154X				ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Gonczy P, 2002, TRENDS CELL BIOL, V12, P332, DOI 10.1016/S0962-8924(02)02306-1; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; KEMPHUES KJ, 1997, C ELEGANS, V0002, P00335; Lyczak R, 2002, DEV CELL, V3, P157, DOI 10.1016/S1534-5807(02)00226-5; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Pellettieri J, 2002, SCIENCE, V298, P1946, DOI 10.1126/science.1072162; Sachs L, 1984, APPL STAT HDB TECHNI; SCHMIDT DMZ, UNPUB; Schuyler SC, 2001, J CELL SCI, V114, P247; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; SIGWORTH FJ, 1977, NATURE, V270, P265, DOI 10.1038/270265a0; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Tsou MFB, 2003, J CELL BIOL, V160, P845, DOI 10.1083/jcb.200209079	26	264	275	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					518	521		10.1126/science.1086560	http://dx.doi.org/10.1126/science.1086560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881570				2022-12-24	WOS:000184340500043
J	Caspi, A; Sugden, K; Moffitt, TE; Taylor, A; Craig, IW; Harrington, H; McClay, J; Mill, J; Martin, J; Braithwaite, A; Poulton, R				Caspi, A; Sugden, K; Moffitt, TE; Taylor, A; Craig, IW; Harrington, H; McClay, J; Mill, J; Martin, J; Braithwaite, A; Poulton, R			Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene	SCIENCE			English	Article							MAJOR DEPRESSION; EVENTS; HISTORY; PERSPECTIVES; LIABILITY; GENOMICS; ONSET	In a prospective-longitudinal study of a representative birth cohort, we tested why stressful experiences lead to depression in some people but not in others. A functional polymorphism in the promoter region of the serotonin transporter (5-HTT) gene was found to moderate the influence of stressful life events on depression. Individuals with one or two copies of the short allele of the 5-HTT promoter polymorphism exhibited more depressive symptoms, diagnosable depression, and suicidality in relation to stressful life events than individuals homozygous for the long allele. This epidemiological study thus provides evidence of a gene-by-environment interaction, in which an individual's response to environmental insults is moderated by his or her genetic makeup.	Kings Coll London, Inst Psychiat, PSychiat Res Ctr, MRC Social Genet & Dev Psychiat Res Ctr, London SE5 8AF, England; Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; Univ Otago, Dept Pathol, Dunedin, New Zealand; Univ Otago, Dunedin Sch Med, Dunedin, New Zealand	University of London; King's College London; University of Wisconsin System; University of Wisconsin Madison; University of Otago; University of Otago	Moffitt, TE (corresponding author), Kings Coll London, Inst Psychiat, PSychiat Res Ctr, MRC Social Genet & Dev Psychiat Res Ctr, PO80 De Crespigny Pk, London SE5 8AF, England.	t.moffitt@iop.kcl.ac.uk	Craig, Ian/AAF-9167-2019; anand, amit/A-7222-2009; Moffitt, Terrie E/D-5295-2011; McClay, Joseph/C-9931-2009; Sugden, Karen/I-8531-2016; caspi, avshalom/AAJ-5874-2020; Zhang, Xiao/V-9027-2017; caspi, avshalom/D-5294-2011; Sugden, Karen/O-6046-2019; Mill, Jonathan/B-5678-2014; Mill, Jonathan S/B-3276-2010	Moffitt, Terrie E/0000-0002-8589-6760; McClay, Joseph/0000-0002-3628-2447; Sugden, Karen/0000-0002-4076-5927; caspi, avshalom/0000-0003-0082-4600; Zhang, Xiao/0000-0002-2932-5875; caspi, avshalom/0000-0003-0082-4600; Sugden, Karen/0000-0002-4076-5927; Mill, Jonathan/0000-0003-1115-3224; Mill, Jonathan S/0000-0003-1115-3224; Craig, Ian/0000-0002-4063-1005	Economic and Social Research Council [L330253002] Funding Source: researchfish; NIMH NIH HHS [MH45070, MH49414] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH049414, R01MH049414, R01MH045070] Funding Source: NIH RePORTER	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aiken L.S., 1991, MULTIPLE REGRESSION; APA, 1994, DIAGN STAT MAN MENT; Belli RF, 2001, PUBLIC OPIN QUART, V65, P45, DOI 10.1086/320037; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; Brown GW, 1998, SOC PSYCH PSYCH EPID, V33, P363, DOI 10.1007/s001270050067; Caspi A, 1996, INT J METHOD PSYCH, V6, P101, DOI 10.1002/(SICI)1234-988X(199607)6:2<101::AID-MPR156>3.3.CO;2-E; Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290; Costello EJ, 2002, BIOL PSYCHIAT, V52, P529, DOI 10.1016/S0006-3223(02)01372-0; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Hamer D, 2002, SCIENCE, V298, P71, DOI 10.1126/science.1077582; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hill AVS, 1999, BRIT MED BULL, V55, P401, DOI 10.1258/0007142991902457; Kendler KS, 1997, PSYCHOL MED, V27, P539, DOI 10.1017/S0033291797004716; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2003, BEHAVIORAL GENETICS IN THE POSTGENOMIC ERA, P389, DOI 10.1037/10480-020; Lesch KP, 2002, MOL GENETICS HUMAN P, P109; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Murphy DL, 2001, BRAIN RES BULL, V56, P487, DOI 10.1016/S0361-9230(01)00622-0; Pine DS, 2002, J AFFECT DISORDERS, V68, P49, DOI 10.1016/S0165-0327(00)00331-1; PLOMIN R, 1991, BEHAV BRAIN SCI, V14, P373, DOI 10.1017/S0140525X00070278; Robins L, 1995, DIAGNOSTIC INTERVIEW; Salichon N, 2001, J NEUROSCI, V21, P884, DOI 10.1523/JNEUROSCI.21-03-00884.2001; Tamminga CA, 2002, BIOL PSYCHIAT, V52, P589, DOI 10.1016/S0006-3223(02)01470-1; TANG CJ, 1997, LANCET, V349, P1498	29	5378	5538	29	1461	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					386	389		10.1126/science.1083968	http://dx.doi.org/10.1126/science.1083968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	702CG	12869766				2022-12-24	WOS:000184207300050
J	Bryant, Z; Stone, MD; Gore, J; Smith, SB; Cozzarelli, NR; Bustamante, C				Bryant, Z; Stone, MD; Gore, J; Smith, SB; Cozzarelli, NR; Bustamante, C			Structural transitions and elasticity from torque measurements on DNA	NATURE			English	Article								Knowledge of the elastic properties of DNA is required to understand the structural dynamics of cellular processes such as replication and transcription. Measurements of force and extension on single molecules of DNA(1-3) have allowed direct determination of the molecule's mechanical properties, provided rigorous tests of theories of polymer elasticity(4), revealed unforeseen structural transitions induced by mechanical stresses(3,5-7), and established an experimental and conceptual framework for mechanical assays of enzymes that act on DNA(8). However, a complete description of DNA mechanics must also consider the effects of torque, a quantity that has hitherto not been directly measured in micromanipulation experiments. We have measured torque as a function of twist for stretched DNA-torsional strain in over- or underwound molecules was used to power the rotation of submicrometre beads serving as calibrated loads. Here we report tests of the linearity of DNA's twist elasticity, direct measurements of the torsional modulus (finding a value similar to40% higher than generally accepted), characterization of torque-induced structural transitions, and the establishment of a framework for future assays of torque and twist generation by DNA-dependent enzymes. We also show that cooperative structural transitions in DNA can be exploited to construct constant-torque wind-up motors and force-torque converters.	Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.			Bustamante, Carlos/0000-0002-2970-0073				Allemand JF, 1998, P NATL ACAD SCI USA, V95, P14152, DOI 10.1073/pnas.95.24.14152; Bouchiat C, 1998, PHYS REV LETT, V80, P1556, DOI 10.1103/PhysRevLett.80.1556; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; CROTHERS DM, 1992, METHOD ENZYMOL, V212, P3; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; DAVIS MH, 1969, CHEM ENG SCI, V24, P1769, DOI 10.1016/0009-2509(69)87020-X; Harada Y, 2001, NATURE, V409, P113, DOI 10.1038/35051126; Heath PJ, 1996, J MOL BIOL, V260, P718, DOI 10.1006/jmbi.1996.0432; HOROWITZ DS, 1984, J MOL BIOL, V173, P75, DOI 10.1016/0022-2836(84)90404-2; Leger JF, 1999, PHYS REV LETT, V83, P1066, DOI 10.1103/PhysRevLett.83.1066; MILLAR DP, 1980, P NATL ACAD SCI USA, V77, P5593, DOI 10.1073/pnas.77.10.5593; Moroz JD, 1998, MACROMOLECULES, V31, P6333, DOI 10.1021/ma971804a; Sarkar A, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.051903; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; SELVIN PR, 1992, SCIENCE, V255, P82, DOI 10.1126/science.1553534; SHORE D, 1983, J MOL BIOL, V170, P983, DOI 10.1016/S0022-2836(83)80199-5; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Soong RK, 2000, SCIENCE, V290, P1555, DOI 10.1126/science.290.5496.1555; Strick TR, 1999, GENETICA, V106, P57, DOI 10.1023/A:1003772626927; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Vologodskii AV, 1997, BIOPHYS J, V73, P123, DOI 10.1016/S0006-3495(97)78053-6; Williams MC, 2002, ACCOUNTS CHEM RES, V35, P159, DOI 10.1021/ar010045k; WOBBE CR, 1985, P NATL ACAD SCI USA, V82, P5710, DOI 10.1073/pnas.82.17.5710; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yasuda R, 1996, J MOL BIOL, V263, P227, DOI 10.1006/jmbi.1996.0571	29	439	460	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					338	341		10.1038/nature01810	http://dx.doi.org/10.1038/nature01810			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867987				2022-12-24	WOS:000184183900048
J	Greenberg, EP				Greenberg, EP			Tiny teamwork	NATURE			English	Editorial Material									Univ Iowa, Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Greenberg, EP (corresponding author), Univ Iowa, Carver Coll Med, Iowa City, IA 52242 USA.			Greenberg, Everett/0000-0001-9474-8041				Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x	4	69	75	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2003	424	6945					134	134		10.1038/424134a	http://dx.doi.org/10.1038/424134a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853935	Bronze			2022-12-24	WOS:000184032700022
J	Joron, M; Brakefield, PM				Joron, M; Brakefield, PM			Captivity masks inbreeding effects on male mating success in butterflies	NATURE			English	Article							BICYCLUS-ANYNANA; CONSERVATION BIOLOGY; EXTINCTION RISK; SONG SPARROWS; DEPRESSION; POPULATIONS; DROSOPHILA; FITNESS; METAPOPULATION; SATYRIDAE	Small isolated populations are frequently genetically less diverse than core populations, resulting in higher homozygosity that can hamper their long-term survival(1-4). The decrease in fitness of organisms owing to matings between relatives is well known from captive and laboratory animals. Such inbreeding can have strongly deleterious effects on life-history traits and survival(5-11), and can be critical to the success of population conservation(2,4,12). Because pedigrees are hard to follow in the wild, most field studies have used marker loci to establish that fitness declines with increasing homozygosity(1,13,14). Very few have experimentally explored the effects of inbreeding in the wild(15), or compared observations in the laboratory with field conditions(8,9). Here, using a technique involving the transfer of marker dusts during copulation, we show that a small decrease in mating success of captive inbred male butterflies in cages is greatly accentuated in conditions with unconstrained flight. Our results have important implications for conservation and for studies of sexual selection because they show that the behaviours underlying patterns of mating can be profoundly influenced by a history of inbreeding or by any restraining experimental conditions.	Leiden Univ, Inst Biol, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Joron, M (corresponding author), UCL, Galton Lab, 4 Stephenson Way, London NW1 2HE, England.	m.joron@ucl.ac.uk; brakefield@rulsfb.leidenuniv.nl	Joron, Mathieu/C-9178-2009	Joron, Mathieu/0000-0003-1043-4147				Armbruster P, 2000, P ROY SOC B-BIOL SCI, V267, P1939, DOI 10.1098/rspb.2000.1233; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Brakefield PM, 2001, J EVOLUTION BIOL, V14, P148, DOI 10.1046/j.1420-9101.2001.00248.x; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Breuker CJ, 2002, P ROY SOC B-BIOL SCI, V269, P1233, DOI 10.1098/rspb.2002.2005; Coulson TN, 1998, J ANIM ECOL, V67, P434, DOI 10.1046/j.1365-2656.1998.00205.x; DeRose MA, 1999, EVOLUTION, V53, P1288, DOI 10.2307/2640831; Ebert D, 2002, SCIENCE, V295, P485, DOI 10.1126/science.1067485; Hanski I., 1996, METAPOPULATION BIOL; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Hoglund J, 2002, P ROY SOC B-BIOL SCI, V269, P711, DOI 10.1098/rspb.2001.1937; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; KELLER LF, 1994, NATURE, V372, P356, DOI 10.1038/372356a0; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Lynch M., 1998, AM J HUM GENET; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Marr AB, 2002, EVOLUTION, V56, P131; Meagher S, 2000, P NATL ACAD SCI USA, V97, P3324, DOI 10.1073/pnas.060284797; MEFFERT LM, 1991, EVOLUTION, V45, P293, DOI 10.1111/j.1558-5646.1991.tb04404.x; MILLER PS, 1993, GENETICA, V88, P29, DOI 10.1007/BF02424449; MILLER PS, 1993, ZOO BIOL, V12, P333, DOI 10.1002/zoo.1430120404; Nieminen M, 2001, AM NAT, V157, P237, DOI 10.1086/318630; Roff DA, 2001, EVOLUTION, V55, P111, DOI 10.1111/j.0014-3820.2001.tb01277.x; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Saccheri IJ, 1996, EVOLUTION, V50, P2000, DOI 10.1111/j.1558-5646.1996.tb03587.x; Saccheri IJ, 2002, P ROY SOC B-BIOL SCI, V269, P1073, DOI 10.1098/rspb.2002.1963; SMITH J. M., 1956, JOUR GENETICS, V54, P261, DOI 10.1007/BF02982781; Sokal R. R., 2009, INTRO BASIC STAT, V2; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; van Oosterhout C, 2000, EVOLUTION, V54, P218, DOI 10.1554/0014-3820(2000)054[0218:IDAGLI]2.0.CO;2	30	129	130	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					191	194		10.1038/nature01713	http://dx.doi.org/10.1038/nature01713			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853956				2022-12-24	WOS:000184032700041
J	Miller-Butterworth, CM; Jacobs, DS; Harley, EH				Miller-Butterworth, CM; Jacobs, DS; Harley, EH			Strong population substructure is correlated with morphology and ecology in a migratory bat	NATURE			English	Article							LONG-FINGERED BAT; MITOCHONDRIAL-DNA; MINIOPTERUS-SCHREIBERSII; GENETIC-STRUCTURE; MICROSATELLITE DATA; PHILOPATRY; DISPERSAL; MTDNA	Examining patterns of inter-population genetic diversity can provide valuable information about both historical and current evolutionary processes affecting a species. Population genetic studies of flying and migratory species such as bats and birds have traditionally shown minimal population substructure, characterized by high levels of gene flow between populations(1,2). In general, strongly substructured mammalian populations either are separated by non-traversable barriers or belong to terrestrial species with low dispersal abilities(3). Species with female philopatry ( the tendency to remain in or consistently return to the natal territory) might show strong substructure when examined with maternally inherited mitochondrial DNA, but this substructure generally disappears when biparentally inherited markers are used, owing to male-mediated gene flow(4). Male-biased dispersal is considered typical for mammals(5), and philopatry in both sexes is rare. Here we show strong population substructure in a migratory bat species, and philopatry in both sexes, as indicated by concordance of nuclear and mtDNA findings. Furthermore, the genetic structure correlates with local biomes and differentiation in wing morphology. There is therefore a close correlation of genetic and morphological differentiation in sympatric subspecific populations of this mammalian species.	Univ Cape Town, Dept Zool, ZA-7701 Rondebosch, South Africa; Univ Cape Town, Div Chem Pathol, Wildlife Genet Unit, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Miller-Butterworth, CM (corresponding author), NCI, Lab Genom Divers, POB B, Frederick, MD 21702 USA.	cbutterworth@mail.ncifcrf.gov	Miller-Butterworth, Cassandra/H-5994-2013; Jacobs, David Steve/L-9118-2013	Jacobs, David Steve/0000-0002-3243-8571				AMOS B, 1993, SCIENCE, V260, P670, DOI 10.1126/science.8480176; [Anonymous], 1997, VEGETATION SO AFRICA; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BALL RM, 1988, P NATL ACAD SCI USA, V85, P1558, DOI 10.1073/pnas.85.5.1558; BERNARD RTF, 1994, J ZOOL, V232, P485, DOI 10.1111/j.1469-7998.1994.tb01589.x; Burland TM, 1999, P ROY SOC B-BIOL SCI, V266, P975, DOI 10.1098/rspb.1999.0732; Cardinal BR, 2000, AUST J ZOOL, V48, P1, DOI 10.1071/ZO99067; FENTON MB, 1990, CAN J ZOOL, V68, P411, DOI 10.1139/z90-061; Goodman SJ, 1997, MOL ECOL, V6, P881, DOI 10.1046/j.1365-294X.1997.00260.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; HARLEY EH, 2000, BAT RES NEWS, V41, P99; Kerth G, 2000, MOL ECOL, V9, P793, DOI 10.1046/j.1365-294x.2000.00934.x; MCCRACKEN GF, 1994, J MAMMAL, V75, P500, DOI 10.2307/1382574; Miller-Butterworth CM, 2002, MOL ECOL NOTES, V2, P139, DOI 10.1046/j.1471-8286.2002.00170.x; Moore SS, 1998, ANIM GENET, V29, P33, DOI 10.1046/j.1365-2052.1998.00234.x; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; NORMAN JA, 1994, MOL ECOL, V3, P363, DOI 10.1111/j.1365-294X.1994.tb00076.x; Paetkau D, 1997, GENETICS, V147, P1943; Palmeirim JM, 1995, SYM ZOOL S, P219; Petit E, 1999, P ROY SOC B-BIOL SCI, V266, P1717, DOI 10.1098/rspb.1999.0837; Racey Paul A., 2000, P363, DOI 10.1016/B978-012195670-7/50010-2; RAUTENBACH IL, 1988, KOEDOE, V31, P77; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; SAUNDERS MB, 1992, ECOLOGY, V73, P1335, DOI 10.2307/1940680; THOMPSON MJA, 1992, J ZOOL, V228, P673, DOI 10.1111/j.1469-7998.1992.tb04466.x; Van der Merwe M., 1973, Mammalia, V37, P379, DOI 10.1515/mamm.1973.37.3.379; WILKINSON GS, 1985, BEHAV ECOL SOCIOBIOL, V17, P123; WILKINSON GS, 1991, GENETICS, V128, P607; Wilmer Jessica Worthington, 1996, Bat Research News, V37, P1; Worthington Wilmer J., 1994, Proceedings of the Royal Society of London Series B Biological Sciences, V257, P193	30	96	98	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					187	191		10.1038/nature01742	http://dx.doi.org/10.1038/nature01742			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853955				2022-12-24	WOS:000184032700040
J	Molina-Heredia, FP; Wastl, J; Navarro, JA; Bendall, DS; Hervas, M; Howe, CJ; De la Rosa, MA				Molina-Heredia, FP; Wastl, J; Navarro, JA; Bendall, DS; Hervas, M; Howe, CJ; De la Rosa, MA			A new function for an old cytochrome?	NATURE			English	Article							PHOTOSYSTEM-I; PLASTOCYANIN; C(6); MECHANISMS		Univ Sevilla, Inst Bioquim Vegetal & Fotosintesis, Seville 41092, Spain; CSIC, Ctr Isla Cartuja, Seville 41092, Spain; Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); Consejo Superior de Investigaciones Cientificas (CSIC); University of Cambridge	Molina-Heredia, FP (corresponding author), Univ Sevilla, Inst Bioquim Vegetal & Fotosintesis, Americo Vespucio S-N, Seville 41092, Spain.		Hervas, Manuel/K-9279-2014; navarro, jose a/B-6354-2015; De la Rosa, Miguel/B-2545-2014; Molina-Heredia, Fernando P./F-7877-2015; Wastl, Juergen/C-6876-2016	Hervas, Manuel/0000-0003-4523-8891; navarro, jose a/0000-0002-0536-6074; De la Rosa, Miguel/0000-0003-1187-5737; Molina-Heredia, Fernando P./0000-0002-3637-0519; Wastl, Juergen/0000-0001-7757-8001				De la Rosa MA, 2002, BIOELECTROCHEMISTRY, V55, P41, DOI 10.1016/S1567-5394(01)00136-0; Gupta R, 2002, NATURE, V417, P567, DOI 10.1038/417567a; HERVAS M, 1995, BIOCHEMISTRY-US, V34, P11321, DOI 10.1021/bi00036a004; Hope AB, 2000, BBA-BIOENERGETICS, V1456, P5, DOI 10.1016/S0005-2728(99)00101-2; Metzger SU, 1995, PHOTOSYNTHESIS LIGHT, V2, P823; Navarro JA, 1997, J BIOL INORG CHEM, V2, P11, DOI 10.1007/s007750050101; Wastl J, 2002, TRENDS PLANT SCI, V7, P244, DOI 10.1016/S1360-1385(02)02280-X	7	61	66	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					33	34		10.1038/424033b	http://dx.doi.org/10.1038/424033b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840749				2022-12-24	WOS:000183912800030
J	Schaal, B; Coureaud, G; Langlois, D; Ginies, C; Semon, E; Perrier, G				Schaal, B; Coureaud, G; Langlois, D; Ginies, C; Semon, E; Perrier, G			Chemical and behavioural characterization of the rabbit mammary pheromone	NATURE			English	Article							NEWBORN RABBITS; OLFACTION; ODORS; RATS; PUP	Mammals owe part of their evolutionary success to the harmonious exchanges of information, energy and immunity between females and their offspring. This functional reciprocity is vital for the survival and normal development of infants, and for the inclusive fitness of parents(1,2). It is best seen in the intense exchanges taking place around the mother's offering of, and the infant's quest for, milk. All mammalian females have evolved behavioural and sensory methods of stimulating and guiding their inexperienced newborns to their mammae, whereas newborns have coevolved means to respond to them efficiently(3). Among these cues, maternal odours have repeatedly been shown to be involved(4-6), but the chemical identity and pheromonal nature of these cues have not been definitively characterized until now. Here we focus on the nature of an odour signal emitted by the female rabbit to which newborn pups respond by attraction and oral grasping, and provide a complete chemical and behavioural description of a pheromone of mammary origin in a mammalian species.	Ctr Europeen Sci Gout, CNRS, Fre 2328, F-21000 Dijon, France; INRA, Unite Mixte Rech Aromes, F-21000 Dijon, France; Etab Natl Enseignement Super Agr, F-21000 Dijon, France	Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; INRAE	Schaal, B (corresponding author), Ctr Europeen Sci Gout, CNRS, Fre 2328, F-21000 Dijon, France.	schaal@cesg.cnrs.fr	Coureaud, Gérard/N-9108-2017; Coureaud, Gérard/ABF-1205-2020	Coureaud, Gérard/0000-0001-6754-3884; Coureaud, Gérard/0000-0001-6754-3884				ABBOTT N, 1993, J AGR FOOD CHEM, V41, P1698, DOI 10.1021/jf00034a034; BEAUCHAMP GK, 1976, OLFACTION BEHAV MAMM, P143; BLASS EM, 1980, SCIENCE, V210, P15, DOI 10.1126/science.6997992; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Coureaud G, 2002, DEV PSYCHOBIOL, V40, P372, DOI 10.1002/dev.10038; Coureaud G, 2001, ANIM BEHAV, V61, P153, DOI 10.1006/anbe.2000.1563; Coureaud G, 2000, DEV PSYCHOBIOL, V36, P271, DOI 10.1002/(SICI)1098-2302(200005)36:4<271::AID-DEV2>3.0.CO;2-3; Coureaud G, 2000, REPROD NUTR DEV, V40, P19, DOI 10.1051/rnd:2000117; COUREAUD G, 2001, THESIS U PARIS 13; GALEF BG, 1988, PHYSIOL BEHAV, V42, P119, DOI 10.1016/0031-9384(88)90285-5; GOODRICH BS, 1981, J CHEM ECOL, V7, P817, DOI 10.1007/BF00992380; HUDSON R, 1983, BEHAVIOUR, V85, P260, DOI 10.1163/156853983X00255; Johnson BA, 2000, J COMP NEUROL, V426, P330, DOI 10.1002/1096-9861(20001016)426:2<330::AID-CNE12>3.0.CO;2-5; JOHNSTON RE, 2000, NEUROBIOLOGY TASTE S, P101; KEIL W, 1990, PHYSIOL BEHAV, V47, P525, DOI 10.1016/0031-9384(90)90120-S; LEBAS F, 1970, ANN ZOOTECH, V19, P223, DOI 10.1051/animres:19700207; LEON M, 1971, PHYSIOL BEHAV, V7, P265, DOI 10.1016/0031-9384(71)90296-4; Macfarlane A, 1975, Ciba Found Symp, P103; MORROWTESCH J, 1990, PHYSIOL BEHAV, V47, P1, DOI 10.1016/0031-9384(90)90034-2; Pedersen P. E., 1981, DEV PERCEPTION PSYCH, P359; Rosenblatt J. S., 1996, ADV STUD BEHAV, V715; ROSENBLATT JS, 1983, DEV PSYCHOBIOL, V16, P347, DOI 10.1002/dev.420160502; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; SCHLEY P, 1981, KLEINTIERPRAXIS, V26, P261; SCHLEY P, 1976, THESIS U GIESEN; TEICHER MH, 1977, SCIENCE, V198, P635, DOI 10.1126/science.918660; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; ZARROW MX, 1965, SCIENCE, V150, P1835, DOI 10.1126/science.150.3705.1835; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506; [No title captured]	30	258	272	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2003	424	6944					68	72		10.1038/nature01739	http://dx.doi.org/10.1038/nature01739			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840760				2022-12-24	WOS:000183912800041
J	Iribarne, A				Iribarne, A			Orphan diseases and adoptive initiatives	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEGLECTED DISEASES; DRUGS		Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Iribarne, A (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Davies D M, 1983, Lancet, V1, P290; FRANCISCO A, 2002, LANCET, V360, P1102; Kettler HE, 2001, B WORLD HEALTH ORGAN, V79, P742; Lavandeira A, 2002, HAEMOPHILIA, V8, P194, DOI 10.1046/j.1365-2516.2002.00643.x; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Schieppati A, 2001, LANCET, V358, P1638, DOI 10.1016/S0140-6736(01)06658-2; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; *US DEP HHS, 1989, PUBL US DEP HLTH HUM; Wheeler C, 2001, B WORLD HEALTH ORGAN, V79, P728	9	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2003	290	1					116	116		10.1001/jama.290.1.116	http://dx.doi.org/10.1001/jama.290.1.116			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696CR	12837724	Bronze			2022-12-24	WOS:000183868600032
J	Maki, M; Mustalahti, K; Kokkonen, J; Kulmala, P; Haapalahti, M; Karttunen, T; Ilonen, J; Laurila, K; Dahlbom, I; Hansson, T; Hopfl, P; Knip, M				Maki, M; Mustalahti, K; Kokkonen, J; Kulmala, P; Haapalahti, M; Karttunen, T; Ilonen, J; Laurila, K; Dahlbom, I; Hansson, T; Hopfl, P; Knip, M			Prevalence of celiac disease among children in Finland	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SMALL-BOWEL BIOPSY; TISSUE TRANSGLUTAMINASE; DIABETES-MELLITUS; VILLOUS ATROPHY; ANTIBODY TESTS; FOLLOW-UP; SCHOOLCHILDREN; NETHERLANDS; RETICULIN; ICEBERG	BACKGROUND: Wheat, rye, and barley proteins induce celiac disease, an autoimmune type of gastrointestinal disorder, in genetically susceptible persons. Because the disease may be underdiagnosed, we estimated the prevalence of the disease and tested the hypothesis that assays for serum autoantibodies can be used to detect untreated celiac disease and that positive findings correlate with specific HLA haplotypes. METHODS: Serum samples were collected from 3654 students (age range, 7 to 16 years) in 1994 and screened in 2001 for endomysial and tissue transglutaminase antibodies. HLA typing was also performed on stored blood samples. All antibody-positive subjects were asked to undergo small-bowel biopsy in 2001. RESULTS: Of the 3654 subjects, 56 (1.5 percent) had positive antibody tests, as determined in 2001. Results of the two antibody tests were highly concordant. As of 1994, none of the subjects had received a clinical diagnosis of celiac disease, but 10 who had positive tests for both antibodies in serum obtained in 1994 received the diagnosis between 1994 and 2001. Of the 36 other subjects with positive antibody assays who agreed to undergo biopsy in 2001, 27 had evidence of celiac disease on biopsy. Thus, the estimated biopsy-proved prevalence was 1 case in 99 children. All but two of the antibody-positive subjects had either the HLA-DQ2 or the HLA-DQ8 haplotype. The prevalence of the combination of antibody positivity and an HLA haplotype associated with celiac disease was 1 in 67. CONCLUSIONS: The presence of serum tissue transglutaminase and endomysial autoantibodies is predictive of small-bowel abnormalities indicative of celiac disease. There is a good correlation between autoantibody positivity and specific HLA haplotypes. We estimate that the prevalence of celiac disease among Finnish schoolchildren is at least 1 case in 99 children.	Univ Tampere, Sch Med, Pediat Res Ctr, Celiac Dis Study Grp, Tampere, Finland; Tampere Univ Hosp, Dept Pediat, Tampere, Finland; Oulu Univ Hosp, Dept Pediat, Oulu, Finland; Oulu Univ Hosp, Dept Pathol, Oulu, Finland; Univ Turku, Turku Immunol Ctr, Turku, Finland; Univ Turku, Dept Virol, Turku, Finland; Pharmacia Diagnost AB, S-75182 Uppsala, Sweden; Pharmacia Diagnost AB, Freiburg, Germany; Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Oulu; University of Oulu; University of Turku; University of Turku; Pfizer; Pharmacia Corporation; Pfizer; University of Helsinki	Maki, M (corresponding author), Univ Tampere, Sch Med, Pediat Res Ctr, Celiac Dis Study Grp, Bldg FM3, Tampere, Finland.	markku.maki@uta.fi	Knip, Mikael/AAL-3773-2020	Karttunen, Tuomo/0000-0002-8843-7957; Hyytinen, Mila Maarit/0000-0001-5361-6421; Knip, Mikael/0000-0003-0474-0033				CATASSI C, 1994, LANCET, V343, P200, DOI 10.1016/S0140-6736(94)90989-X; COLLIN P, 1993, SCAND J GASTROENTERO, V28, P595, DOI 10.3109/00365529309096094; Collin P, 1997, SCAND J GASTROENTERO, V32, P1129, DOI 10.3109/00365529709002992; Collin P, 2002, ENDOCR REV, V23, P464, DOI 10.1210/er.2001-0035; Csizmadia CGDS, 1999, LANCET, V353, P813, DOI 10.1016/S0140-6736(99)00243-3; Dieterich W, 1998, GASTROENTEROLOGY, V115, P1317, DOI 10.1016/S0016-5085(98)70007-1; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Farrell RJ, 2002, NEW ENGL J MED, V346, P180, DOI 10.1056/NEJMra010852; GEORGE EK, 1995, PEDIATR RES, V37, P213, DOI 10.1203/00006450-199502000-00015; Hansson T, 2002, PEDIATR RES, V51, P700, DOI 10.1023/01.PDR.0000015105.38277.9B; Hill I, 2000, J PEDIATR-US, V136, P86, DOI 10.1016/S0022-3476(00)90055-6; Iltanen S, 1999, AUTOIMMUNITY, V29, P179, DOI 10.3109/08916939908998533; Kaukinen K, 1998, SCAND J GASTROENTERO, V33, P944; Kaukinen K, 2001, DIGEST DIS SCI, V46, P879, DOI 10.1023/A:1010729207320; Kaukinen K, 2000, SCAND J GASTROENTERO, V35, P942, DOI 10.1080/003655200750022995; Korponay-Szabo IR, 1999, J PEDIATR GASTR NUTR, V28, P26, DOI 10.1097/00005176-199901000-00008; Kulmala P, 2001, DIABETES CARE, V24, P171, DOI 10.2337/diacare.24.1.171-a; KUTLU T, 1993, GUT, V34, P208, DOI 10.1136/gut.34.2.208; MAKI M, 1991, LANCET, V338, P1350, DOI 10.1016/0140-6736(91)92234-S; Maki M, 1997, LANCET, V349, P1755, DOI 10.1016/S0140-6736(96)70237-4; Meloni G, 1999, LANCET, V353, P37, DOI 10.1016/S0140-6736(05)74871-6; Mustalahti K, 2002, SCAND J GASTROENTERO, V37, P161, DOI 10.1080/003655202753416812; Mustalahti Kirsi, 2002, Eff Clin Pract, V5, P105; Nejentsev S, 1999, DIABETIC MED, V16, P985, DOI 10.1046/j.1464-5491.1999.00186.x; PAGANO M, 1993, PRINCIPLES BIOSTATIS; ROSSI TM, 1993, J PEDIATR-US, V123, P262, DOI 10.1016/S0022-3476(05)81699-3; Sblattero D, 2000, AM J GASTROENTEROL, V95, P1253; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Stern M, 2000, J PEDIATR GASTR NUTR, V31, P513, DOI 10.1097/00005176-200011000-00012; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Sulkanen S, 1998, SCAND J GASTROENTERO, V33, P251; Troncone R, 1996, ACTA PAEDIATR, V85, P10, DOI 10.1111/j.1651-2227.1996.tb14240.x; Valdimarsson T, 1996, DIGEST DIS SCI, V41, P83, DOI 10.1007/BF02208588	33	732	758	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2003	348	25					2517	2524		10.1056/NEJMoa021687	http://dx.doi.org/10.1056/NEJMoa021687			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	690YC	12815137				2022-12-24	WOS:000183577200006
J	Viswanath, V; Story, GM; Peier, AM; Petrus, MJ; Hwang, SW; Patapoutian, A; Jegla, T				Viswanath, V; Story, GM; Peier, AM; Petrus, MJ; Hwang, SW; Patapoutian, A; Jegla, T			Ion channels - Opposite thermosensor in fruitfly and mouse	NATURE			English	Editorial Material							TRP CHANNEL; DROSOPHILA; RECEPTOR		Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Novartis; Scripps Research Institute	Viswanath, V (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.			Jegla, Timothy/0000-0001-8616-2390; Hwang, Sun Wook/0000-0001-8460-7480				Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Guler AD, 2002, J NEUROSCI, V22, P6408; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229	11	203	215	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					822	823		10.1038/423822a	http://dx.doi.org/10.1038/423822a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815418				2022-12-24	WOS:000183585300031
J	Harris, RS; Bishop, KN; Sheehy, AM; Craig, HM; Petersen-Mahrt, SK; Watt, IN; Neuberger, MS; Malim, MH				Harris, RS; Bishop, KN; Sheehy, AM; Craig, HM; Petersen-Mahrt, SK; Watt, IN; Neuberger, MS; Malim, MH			DNA determination mediates innate immunity to retroviral infection	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE-STRANDED-DNA; VIRAL VIF PROTEIN; REVERSE TRANSCRIPTION; SOR GENE; TYPE-1; HYPERMUTATION; CELLS; HIV-1; TRANSMISSION	CEM15/APOBEC3G is a cellular protein required for resistance to infection by virion infectivity factor (Vif)-deficient human immunodeficiency virus (HIV). Here, using a murine leukemia virus (MLV)-based system, we provide evidence that CEM15/APOBEC3G is a DNA deaminase that is incorporated into virions during viral production and subsequently triggers massive deamination of deoxycytidine to deoxyuridine within the retroviral minus (first)-strand cDNA, thus providing a probable trigger for viral destruction. Furthermore, HIV Vif can protect MLV from this CEM15/APOBEC3G-dependent restriction. These findings imply that targeted DNA deamination is a major strategy of innate immunity to retroviruses and likely also contributes to the sequence variation observed in many viruses (including HIV).	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Infect Dis, London SE1 9RT, England	MRC Laboratory Molecular Biology; University of London; King's College London	Harris, RS (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	rsharris@mrc-imb.cam.ac.uk		Malim, Michael/0000-0002-7699-2064				Bock M, 2000, J VIROL, V74, P7422, DOI 10.1128/JVI.74.16.7422-7430.2000; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; FISHER AG, 1987, SCIENCE, V237, P888, DOI 10.1126/science.3497453; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; HARRIS RS, 2003, IN PRESS NAT IMMUNOL; Janini M, 2001, J VIROL, V75, P7973, DOI 10.1128/JVI.75.17.7973-7986.2001; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Klarmann GJ, 2003, J BIOL CHEM, V278, P7902, DOI 10.1074/jbc.M207223200; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; NEUBERGER MS, 2003, IN PRESS TRENDS 0523; Petersen-Mahrt SK, 2003, J BIOL CHEM, V278, P19583, DOI 10.1074/jbc.C300114200; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; Simon JHM, 1998, EMBO J, V17, P1259, DOI 10.1093/emboj/17.5.1259; SOVA P, 1993, J VIROL, V67, P6322, DOI 10.1128/JVI.67.10.6322-6326.1993; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; VARTANIAN JP, 1994, P NATL ACAD SCI USA, V91, P3092, DOI 10.1073/pnas.91.8.3092; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993	23	1095	1137	3	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 13	2003	113	6					803	809		10.1016/S0092-8674(03)00423-9	http://dx.doi.org/10.1016/S0092-8674(03)00423-9			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809610	Bronze			2022-12-24	WOS:000183514400014
J	Golder, M; Burleigh, DE; Belai, A; Ghali, L; Ashby, D; Lunniss, PJ; Navsaria, HA; Williams, NS				Golder, M; Burleigh, DE; Belai, A; Ghali, L; Ashby, D; Lunniss, PJ; Navsaria, HA; Williams, NS			Smooth muscle cholinergic denervation hypersensitivity in diverticular disease	LANCET			English	Article							IRRITABLE-COLON-SYNDROME; INTRALUMINAL PRESSURE; SIGMOID COLON; MOTILITY; FOOD	Background Evidence from clinical and laboratory investigations into the causes of diverticular disease suggests that disturbances in cholinergic activity are important, the effector mechanisms of which have yet to be established. We aimed to investigate the role of smooth muscle and neural cholinergic activity in the pathogenesis of this disease. Methods Two investigators independently did a blinded immunohistochemical image analysis of localising antibodies to choline acetyltransferase, co-localised with protein gene product (PGP)-a marker of general neural tissue-and smooth muscle muscarinic M3 receptors, on three histological sections of sigmoid colons from ten patients with diverticular disease and ten controls, after resections for rectal tumours. We also did isotonic organ bath experiments to assess muscle strip sensitivities to exogenous acetylcholine. Findings In circular muscle, activity of choline acetyltransferase was lower in patients with diverticular disease than in controls: median percentage surface area of choline acetyltransferase over PGIP was 17.5% (range 10.0-37.0) in patients with diverticular disease and 47.0% (29.0-54.0) in controls (p<0.0001). M3 receptors were upregulated in patients with diverticular disease compared with controls: the median surface area was 13.2% (6.0-23.3) in patients with diverticular disease and 2.5% (1.6-3.7) in controls (p<0.0001). The sensitivity to exogenous acetylcholine was increased in patients with diverticular disease (mean -log EC50 5.6 [SD 0.3]) compared with controls (4.9 [0.5]; difference 0.7 [95% Cl 0.3-1.1], p=0.006). In longitudinal muscle, choline acetyltransferase activity was lower in patients with diverticular disease (median 19.5%, range 12.0-30.0) than in controls (47.0%, 35.0-60.0; p<0.0001), with upregulation of M3 receptors in diverticular disease (diverticular disease 7.8% [1.9-20.4], controls 1.7% [0-8-3.0]; p<0.0001). However, sensitivity to exogenous acetylcholine did not differ between the two groups (diverticular disease mean 5.6% [SD 0.3], controls 5.2% [0.4]; difference 0.4% [95% Cl -0.02-0.7], p=0.06). Interpretation Our results suggest that cholinergic denervation hypersensitivity can affect smooth muscle. Upregulation of smooth muscle M3 receptors might account for specific clinical, physiological, and pharmacological abnormalities associated with diverticular disease.	Barts & London Queen Marys Sch Med & Dent, Acad Dept Surg, London, England; Barts & London Queen Marys Sch Med & Dent, Dept Adult & Paediat Gastroenterol, London, England; Barts & London Queen Marys Sch Med & Dent, Ctr Cutaneous Res, London, England; Barts & London Queen Marys Sch Med & Dent, Dept Environm & Prevent Med, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London	Golder, M (corresponding author), Royal London Hosp, Acad Dept Surg, 4th Floor Alex Wing, London E1 1BB, England.	m.s.golder@qmul.ac.uk		Belai, Abi (Abebech)/0000-0001-9113-006X				BELAI A, 1988, GASTROENTEROLOGY, V95, P1234, DOI 10.1016/0016-5085(88)90356-3; BURLEIGH DE, 1990, DIGEST DIS SCI, V35, P617, DOI 10.1007/BF01540410; Delahaye N, 2001, CIRCULATION, V104, P2911, DOI 10.1161/hc4901.100380; DOYLE JR, 1981, J HAND SURG-AM, V6, P40, DOI 10.1016/S0363-5023(81)80009-3; Eggenberger, 1999, Curr Treat Options Gastroenterol, V2, P507, DOI 10.1007/s11938-999-0054-x; Gomes OA, 1997, GERONTOLOGY, V43, P210, DOI 10.1159/000213852; HAVIA T, 1971, ACTA CHIR SCAND, V137, P569; Huizinga JD, 1999, SCAND J GASTROENTERO, V34, P683; KERR PM, 1995, BRIT J PHARMACOL, V115, P1518, DOI 10.1111/j.1476-5381.1995.tb16645.x; Kobayashi S, 2001, JPN J PHARMACOL, V86, P281, DOI 10.1254/jjp.86.281; Li JC, 2001, WORLD J GASTROENTERO, V7, P16; Lin WM, 1997, NEUROREPORT, V8, P2999, DOI 10.1097/00001756-199709290-00002; MANOUSOS O, 1985, GUT, V26, P544, DOI 10.1136/gut.26.6.544; MANOUSOS ON, 1967, BRIT MED J, V3, P760, DOI 10.1136/bmj.3.5568.760; OTTE JJ, 1986, AM J GASTROENTEROL, V81, P529; PAINTER NS, 1971, BMJ-BRIT MED J, V2, P450, DOI 10.1136/bmj.2.5759.450; PAINTER NS, 1964, GUT, V5, P201, DOI 10.1136/gut.5.3.201; PARKS TG, 1969, GUT, V10, P534, DOI 10.1136/gut.10.7.534; Porter AJ, 1996, GASTROENTEROLOGY, V111, P401, DOI 10.1053/gast.1996.v111.pm8690205; REES BI, 1980, BRIT J CLIN PHARMACO, V9, P229, DOI 10.1111/j.1365-2125.1980.tb04831.x; SMITH AN, 1986, CLIN GASTROENTEROL, V15, P917; STRETTON CD, 1990, AM REV RESPIR DIS, V142, P1030, DOI 10.1164/ajrccm/142.5.1030; SUCHOWIECKY M, 1987, DIGEST DIS SCI, V32, P833, DOI 10.1007/BF01296705; SUGIHARA K, 1983, GUT, V24, P1130, DOI 10.1136/gut.24.12.1130; Tomita R, 1999, HEPATO-GASTROENTEROL, V46, P2839; TROTMAN IF, 1988, GUT, V29, P218, DOI 10.1136/gut.29.2.218; WEINREICH J, 1976, SCAND J GASTROENTERO, V11, P581; WHITEWAY J, 1985, GUT, V26, P258, DOI 10.1136/gut.26.3.258; WHITEWAY J, 1985, CLIN GASTROENTEROL, V14, P829; YAP I, 1991, SMJ Singapore Medical Journal, V32, P218	30	90	90	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2003	361	9373					1945	1951		10.1016/S0140-6736(03)13583-0	http://dx.doi.org/10.1016/S0140-6736(03)13583-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687DB	12801738				2022-12-24	WOS:000183359700010
J	Ishii, D; Kinbara, K; Ishida, Y; Ishii, N; Okochi, M; Yohda, M; Aida, T				Ishii, D; Kinbara, K; Ishida, Y; Ishii, N; Okochi, M; Yohda, M; Aida, T			Chaperonin-mediated stabilization and ATP-triggered release of semiconductor nanoparticles	NATURE			English	Article							CADMIUM-SULFIDE; THERMOPHILIC BACTERIUM; THERMUS-THERMOPHILUS; CDS NANOCRYSTALLITES; HOLO-CHAPERONIN; QUANTUM DOTS; GROEL; PROTEIN; NANOCOMPOSITES; NANOCLUSTERS	Various properties of semiconductor nanoparticles, including photoluminescence and catalytic activity, make these materials attractive for a range of applications(1,2). As nanoparticles readily coagulate and so lose their size-dependent properties, shape-persistent three-dimensional stabilizers that enfold nanoparticles have been exploited(3-9). However, such wrapping approaches also make the nanoparticles insensitive to external stimuli, and so may limit their application. The chaperonin proteins GroEL (from Escherichia coli) and T.th ('T.th cpn', from Thermus thermophilus HB8) encapsulate denatured proteins inside a cylindrical cavity; after refolding, the encapsulated proteins are released by the action of ATP inducing a conformational change of the cavity(10,11). Here we report that GroEL and T.th cpn can also enfold CdS semiconductor nanoparticles, giving them high thermal and chemical stability in aqueous media. Analogous to the biological function of the chaperonins, the nanoparticles can be readily released from the protein cavities by the action of ATP. We expect that integration of such biological mechanisms into materials science will open a door to conceptually new bioresponsive devices.	Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tsukuba, Ibaraki 3058566, Japan; Tokyo Univ Agr & Technol, Fac Technol, Dept Biotechnol, Tokyo 1848588, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo University of Agriculture & Technology	Aida, T (corresponding author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.		Kinbara, Kazushi/E-6347-2017; Yohda, Masafumi/A-5149-2013; Aida, Takuzo/I-9117-2012; Ishii, Noriyuki/E-5661-2011; Ishida, Yasuhiro/I-8204-2012	Kinbara, Kazushi/0000-0002-5945-9612; Yohda, Masafumi/0000-0001-8307-9671; Ishii, Noriyuki/0000-0002-4120-6203; 				Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; AMADA K, 1995, J BIOCHEM-TOKYO, V118, P347, DOI 10.1093/oxfordjournals.jbchem.a124913; Balogh L, 1998, J AM CHEM SOC, V120, P7355, DOI 10.1021/ja980861w; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRUS LE, 1984, J CHEM PHYS, V80, P4403, DOI 10.1063/1.447218; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; HENDRIX RW, 1979, J MOL BIOL, V129, P375, DOI 10.1016/0022-2836(79)90502-3; HENGLEIN A, 1982, J PHYS CHEM-US, V86, P2291, DOI 10.1021/j100210a010; Hosokawa H, 1996, J PHYS CHEM-US, V100, P6649, DOI 10.1021/jp952603g; ISHII N, 1992, FEBS LETT, V299, P169, DOI 10.1016/0014-5793(92)80240-H; ISHII N, 1994, J MOL BIOL, V236, P691, DOI 10.1006/jmbi.1994.1181; Lemon BI, 2000, J AM CHEM SOC, V122, P12886, DOI 10.1021/ja0031321; Llorca O, 1998, J BIOL CHEM, V273, P32587, DOI 10.1074/jbc.273.49.32587; MARTIN J, 1992, SCIENCE, V258, P995, DOI 10.1126/science.1359644; McMillan RA, 2002, NAT MATER, V1, P247, DOI 10.1038/nmat775; MELDRUM FC, 1992, SCIENCE, V257, P522, DOI 10.1126/science.1636086; Murakoshi K, 1998, J CHEM SOC FARADAY T, V94, P579, DOI 10.1039/a707192b; RAMSDEN JJ, 1984, J CHEM SOC FARAD T 1, V80, P919, DOI 10.1039/f19848000919; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Schmid G, 1999, CHEM SOC REV, V28, P179, DOI 10.1039/a801153b; Shenton W, 1997, NATURE, V389, P585, DOI 10.1038/39287; Shenton W, 2001, ANGEW CHEM INT EDIT, V40, P442, DOI 10.1002/1521-3773(20010119)40:2<442::AID-ANIE442>3.0.CO;2-2; TAGUCHI H, 1991, J BIOL CHEM, V266, P22411; TODD MJ, 1993, BIOCHEMISTRY-US, V32, P8560, DOI 10.1021/bi00084a024; Wong KKW, 1996, ADV MATER, V8, P928, DOI 10.1002/adma.19960081114	26	198	204	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					628	632		10.1038/nature01663	http://dx.doi.org/10.1038/nature01663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789335				2022-12-24	WOS:000183301200037
J	Chen, XM				Chen, XM			A microRNA as a translational repressor of APETALA2 in Arabidopsis flower development	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; EXPRESSION; PROTEIN; TARGETS; PLANTS; MIRNA; HEN1	Plant microRNAs ( miRNAs) show a high degree of sequence complementarity to, and are believed to guide the cleavage of, their target messenger RNAs. Here, I show that miRNA172, which can base-pair with the messenger RNA of a. oral homeotic gene, APETALA2, regulates APETALA2 expression primarily through translational inhibition. Elevated miRNA172 accumulation results in. oral organ identity defects similar to those in loss-of-function apetala2 mutants. Elevated levels of mutant APETALA2 RNA with disrupted miRNA172 base pairing, but not wild-type APETALA2 RNA, result in elevated levels of APETALA2 protein and severe. oral patterningdefects. Therefore, miRNA172 likely acts in cell-fate specification as a translational repressor of APETALA2 in Arabidopsis flower development.	Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Chen, XM (corresponding author), Rutgers State Univ, Waksman Inst, POB 759, Piscataway, NJ 08854 USA.	xuemei@waksman.rutgers.edu		Chen, Xuemei/0000-0002-5209-1157	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM61146, R01 GM061146] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061146] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; AUKERMAN M, PLANT CELL, V15, P2730; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Chen XM, 2002, DEVELOPMENT, V129, P1085; Chen XM, 1999, MOL CELL, V3, P349, DOI 10.1016/S1097-2765(00)80462-1; CHEN XQ, UNPUB; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lohmann JU, 2002, DEV CELL, V2, P135, DOI 10.1016/S1534-5807(02)00122-3; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1	19	1287	1482	23	266	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2004	303	5666					2022	2025		10.1126/science.1088060	http://dx.doi.org/10.1126/science.1088060			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806JI	12893888	Green Accepted			2022-12-24	WOS:000220429800043
J	Ross, L; Johansen, C; Dalton, SO; Mellemkjae, L; Thomassen, LH; Mortensen, PB; Olsen, JH				Ross, L; Johansen, C; Dalton, SO; Mellemkjae, L; Thomassen, LH; Mortensen, PB; Olsen, JH			Psychiatric hospitalizations among survivors of cancer in childhood or adolescence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VOLUME CHANGES; SCHIZOPHRENIA; DISORDER; REGISTER; CONSEQUENCES; RADIATION; DENMARK	BACKGROUND We investigated whether children and adolescents who survive cancer are at increased risk for psychiatric hospitalization. METHODS In a nationwide, population-based, retrospective cohort study, 3710 persons who survived at least three years after a diagnosis of cancer in childhood or adolescence in the period from 1943 to 1990, and who were alive on January 1, 1970, or were born after that date, were identified in the Danish Cancer Registry. This population was followed up for psychiatric hospitalization from January 1, 1970, through 1993 by linkage with the Danish national Psychiatric Central Register. The number of expected cases was based on the national rates of hospitalization for psychiatric disease. RESULTS Among the 3710 survivors of cancer in childhood or adolescence, there was a total of 88 psychiatric hospitalizations. The risk of hospitalization for any psychiatric disease was higher among the survivors than in the general population, but the excess risk was restricted to survivors of brain tumor (the standardized hospitalization ratio [SHR], corresponding to the ratio of observed to expected cases of hospitalization for psychiatric disease, was 1.8; 95 percent confidence interval, 1.5 to 2.2). An increased risk of psychoses of somatic, cerebral causes (SHR, 7.7; 95 percent confidence interval, 4.1 to 13.2), psychiatric disorders in somatic disease (SHR, 5.1; 95 percent confidence interval, 2.5 to 9.1), and schizophrenia and related disorders (SHR, 2.4; 95 percent confidence interval, 1.2 to 4.4) was observed among survivors of brain tumor. There was no evidence of a significantly increased risk of major depression. CONCLUSIONS The risk of hospitalization for a psychiatric disorder is not increased among survivors of cancer in childhood or adolescence, except among survivors of brain tumor.	Danish Canc Soc, Inst Canc Epidemiol, DK-2100 Copenhagen, Denmark; Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark	Danish Cancer Society; Aarhus University	Johansen, C (corresponding author), Danish Canc Soc, Inst Canc Epidemiol, Strandblvd 49, DK-2100 Copenhagen, Denmark.	christof@cancer.dk	Mortensen, Preben B/D-2358-2015; Johansen, Christoffer/AAG-7916-2020	Mortensen, Preben B/0000-0002-5230-9865; Johansen, Christoffer/0000-0002-4384-206X; Olsen, Jorgen Helge/0000-0001-9633-5662; Ross, Lone/0000-0002-4406-604X; Dalton, Susanne Oksbjerg/0000-0002-5485-2730				Arvidson J, 1999, PSYCHO-ONCOLOGY, V8, P123; BIRCH JM, 1987, INT J CANCER, V40, P620, DOI 10.1002/ijc.2910400508; BROWN PD, 1995, ACTA PAEDIATR, V84, P316, DOI 10.1111/j.1651-2227.1995.tb13636.x; COUSENS P, 1988, J CHILD PSYCHOL PSYC, V29, P839, DOI 10.1111/j.1469-7610.1988.tb00757.x; *DAN NAT BOARD HLT, 2003, CANC INC DENM 1998; *DAN NAT BOARD HLT, 1976, KLASS SYGD; Eiser C, 1998, J CHILD PSYCHOL PSYC, V39, P621, DOI 10.1111/1469-7610.00362; Garwicz S, 2000, INT J CANCER, V88, P672, DOI 10.1002/1097-0215(20001115)88:4<672::AID-IJC24>3.0.CO;2-N; GLAUSER TA, 1991, CHILD NERV SYST, V7, P2, DOI 10.1007/BF00263824; Gray R. E., 1992, PSYCHO-ONCOLOGY, V1, P235, DOI [10.1002/pon.2960010406, DOI 10.1002/PON.2960010406]; GREENBERG HS, 1989, J PEDIATR-US, V114, P488, DOI 10.1016/S0022-3476(89)80581-5; Hulshoff HE, 2002, AM J PSYCHIAT, V159, P244, DOI 10.1176/appi.ajp.159.2.244; *I PSYCH DEM, 1994, ANN REP 1993; Kessing LV, 1998, EUR PSYCHIAT, V13, P392, DOI 10.1016/S0924-9338(99)80685-3; Kokkonen J, 1997, PEDIATR HEMAT ONCOL, V14, P223, DOI 10.3109/08880019709009492; LESKO LM, 1990, PROG CLIN BIOL RES, V352, P423; Lieberman JA, 1999, BIOL PSYCHIAT, V46, P729, DOI 10.1016/S0006-3223(99)00147-X; LOFFLER W, 1994, ACTA PSYCHIAT SCAND, V90, P196, DOI 10.1111/j.1600-0447.1994.tb01577.x; Loganovsky KN, 2000, SCHIZOPHRENIA BULL, V26, P751, DOI 10.1093/oxfordjournals.schbul.a033492; Mathalon DH, 2001, ARCH GEN PSYCHIAT, V58, P148, DOI 10.1001/archpsyc.58.2.148; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; MUNKJORGENSEN P, 1992, BRIT J PSYCHIAT, V161, P489, DOI 10.1192/bjp.161.4.489; Percy C., 1990, INT CLASSIFICATION D; ROMAN DD, 1995, INT J RADIAT ONCOL, V31, P983, DOI 10.1016/0360-3016(94)00550-8; Rothman K, 1979, NIH PUBL; SCHMALE AH, 1983, PSYCHOSOM MED, V45, P163, DOI 10.1097/00006842-198305000-00008; Storm HH, 1997, DAN MED BULL, V44, P535; TETA MJ, 1986, J CHRON DIS, V39, P751, DOI 10.1016/0021-9681(86)90158-X; Woods BT, 1998, AM J PSYCHIAT, V155, P1661, DOI 10.1176/ajp.155.12.1661	30	50	51	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2003	349	7					650	657		10.1056/NEJMoa022672	http://dx.doi.org/10.1056/NEJMoa022672			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711FL	12917301				2022-12-24	WOS:000184728900005
J	Witte, U; Wenzhofer, F; Sommer, S; Boetius, A; Heinz, P; Aberle, N; Sand, M; Cremer, A; Abraham, WR; Jorgensen, BB; Pfannkuche, O				Witte, U; Wenzhofer, F; Sommer, S; Boetius, A; Heinz, P; Aberle, N; Sand, M; Cremer, A; Abraham, WR; Jorgensen, BB; Pfannkuche, O			In situ experimental evidence of the fate of a phytodetritus pulse at the abyssal sea floor	NATURE			English	Article							EASTERN NORTH PACIFIC; DEEP-SEA; ORGANIC-MATTER; BENTHIC COMMUNITY; SEASONAL DEPOSITION; ARABIAN SEA; NE ATLANTIC; CARBON; BACTERIA; SEDIMENTATION	More than 50% of the Earth's surface is sea floor below 3,000 m of water. Most of this major reservoir in the global carbon cycle and final repository for anthropogenic wastes is characterized by severe food limitation. Phytodetritus is the major food source for abyssal benthic communities, and a large fraction of the annual food load can arrive in pulses within a few days(1,2). Owing to logistical constraints, the available data concerning the fate of such a pulse are scattered(3,4) and often contradictory(5-10), hampering global carbon modelling and anthropogenic impact assessments. We quantified (over a period of 2.5 to 23 days) the response of an abyssal benthic community to a phytodetritus pulse, on the basis of 11 in situ experiments. Here we report that, in contrast to previous hypotheses(5-11), the sediment community oxygen consumption doubled immediately, and that macrofauna were very important for initial carbon degradation. The retarded response of bacteria and Foraminifera, the restriction of microbial carbon degradation to the sediment surface, and the low total carbon turnover distinguish abyssal from continental-slope 'deep-sea' sediments.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; GEOMAR Res Ctr, D-24148 Kiel, Germany; Univ Tubingen, Inst Geosci, D-72076 Tubingen, Germany; Gesell Biotechnol Forsch mbH, D-38124 Braunschweig, Germany	Max Planck Society; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Eberhard Karls University of Tubingen; Gesellschaft fur Biotechnologische Forschung mbH	Witte, U (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	uwitte@mpi-bremen.de	Jorgensen, Bo B/C-2214-2013; Boetius, Antje/D-5459-2013; Abraham, Wolf-Rainer/I-2179-2019; Aberle, Nicole/C-7366-2014	Jorgensen, Bo B/0000-0001-9398-8027; Boetius, Antje/0000-0003-2117-4176; Abraham, Wolf-Rainer/0000-0002-2850-2649; Aberle, Nicole/0000-0003-3254-5710; Heinz, Petra/0000-0002-3428-3374				Aberle N, 2003, MAR ECOL PROG SER, V251, P37, DOI 10.3354/meps251037; Bett BJ, 2001, PROG OCEANOGR, V50, P349, DOI 10.1016/S0079-6611(01)00066-0; BILLETT DSM, 1983, NATURE, V302, P520, DOI 10.1038/302520a0; Billett DSM, 2001, PROG OCEANOGR, V50, P13, DOI 10.1016/S0079-6611(01)00046-5; Billett DSM, 2001, PROG OCEANOGR, V50, P325, DOI 10.1016/S0079-6611(01)00060-X; Boetius A, 2000, DEEP-SEA RES PT II, V47, P2835, DOI 10.1016/S0967-0645(00)00051-5; Boetius A, 1996, MAR ECOL PROG SER, V140, P239, DOI 10.3354/meps140239; Boschker HTS, 1999, LIMNOL OCEANOGR, V44, P309, DOI 10.4319/lo.1999.44.2.0309; Drazen JC, 1998, DEEP-SEA RES PT II, V45, P893, DOI 10.1016/S0967-0645(98)00007-1; Gooday AJ, 2002, J OCEANOGR, V58, P305, DOI 10.1023/A:1015865826379; GRAF G, 1989, NATURE, V341, P437, DOI 10.1038/341437a0; LAMPITT RS, 1985, DEEP-SEA RES, V32, P885, DOI 10.1016/0198-0149(85)90034-2; Lampitt RS, 2001, PROG OCEANOGR, V50, P27, DOI 10.1016/S0079-6611(01)00047-7; Levin L, 1997, J MAR RES, V55, P595, DOI 10.1357/0022240973224337; LOCHTE K, 1988, NATURE, V333, P67, DOI 10.1038/333067a0; Middelburg JJ, 2000, LIMNOL OCEANOGR, V45, P1224, DOI 10.4319/lo.2000.45.6.1224; Moodley L, 2002, MAR ECOL PROG SER, V236, P23, DOI 10.3354/meps236023; PFANNKUCHE O, 1993, DEEP-SEA RES PT II, V40, P135, DOI 10.1016/0967-0645(93)90010-K; ROWE G, 1991, MAR ECOL PROG SER, V79, P99, DOI 10.3354/meps079099; SAYLES FL, 1994, NATURE, V371, P686, DOI 10.1038/371686a0; Smith KL, 1999, SCIENCE, V284, P1174, DOI 10.1126/science.284.5417.1174; Smith KL, 2002, DEEP-SEA RES PT I, V49, P971, DOI 10.1016/S0967-0637(02)00006-7; SMITH KL, 1984, NATURE, V307, P624, DOI 10.1038/307624a0; Turley C, 2000, FEMS MICROBIOL ECOL, V33, P89, DOI 10.1111/j.1574-6941.2000.tb00731.x; TYLER PA, 1988, OCEANOGR MAR BIOL, V26, P227; Wenzhofer F, 2001, DEEP-SEA RES PT I, V48, P1741, DOI 10.1016/S0967-0637(00)00108-4; Witbaard R, 2000, J SEA RES, V43, P15, DOI 10.1016/S1385-1101(99)00040-4; Witte U, 2000, DEEP-SEA RES PT II, V47, P2785, DOI 10.1016/S0967-0645(00)00049-7; Witte U, 2003, MAR ECOL PROG SER, V251, P27, DOI 10.3354/meps251027	29	188	194	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2003	424	6950					763	766		10.1038/nature01799	http://dx.doi.org/10.1038/nature01799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917681	Green Published			2022-12-24	WOS:000184733900036
J	Reefhuis, J; Honein, MA; Whitney, CG; Chamany, S; Mann, EA; Biernath, KR; Broder, K; Manning, S; Avashia, S; Victor, M; Costa, P; Devine, O; Graham, A; Boyle, C				Reefhuis, J; Honein, MA; Whitney, CG; Chamany, S; Mann, EA; Biernath, KR; Broder, K; Manning, S; Avashia, S; Victor, M; Costa, P; Devine, O; Graham, A; Boyle, C			Risk of bacterial meningitis in children with cochlear implants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECURRENT MENINGITIS; DYSPLASIA	BACKGROUND: In June 2002, the Food and Drug Administration received reports of bacterial meningitis in patients with cochlear implants for treatment of hearing loss. Implants that included a positioner (a wedge inserted next to the implanted electrode to facilitate transmission of the electrical signal by pushing the electrode against the medial wall of the cochlea) were voluntarily recalled in the United States in July 2002. METHODS: We identified patients with meningitis and conducted a cohort study and a nested case-control investigation involving 4264 children who had received cochlear implants in the United States between January 1, 1997, and August 6, 2002, and who were less than six years of age when they received the implants. We calculated the incidence of meningitis in the cohort and assessed risk factors for meningitis among patients and among 199 controls, using data from interviews with parents and abstracted from medical records. RESULTS: We identified 26 children with bacterial meningitis. The incidence of meningitis caused by Streptococcus pneumoniae was 138.2 cases per 100,000 person-years - more than 30 times the incidence in a cohort of the same age in the general U.S. population. Postimplantation bacterial meningitis was strongly associated with the use of an implant with a positioner (odds ratio, 4.5 [95 percent confidence interval, 1.3 to 17.9], with adjustment for medical, surgical, and environmental factors) and with the joint presence of radiographic evidence of a malformation of the inner ear and a cerebrospinal fluid leak (adjusted odds ratio, 9.3 [95 percent confidence interval, 1.2 to 94.5]). The incidence of meningitis among patients who had received an implant with a positioner remained higher than the incidence among those whose implants did not have a positioner for the duration of follow-up (24 months from the time of implantation). CONCLUSIONS: Parents and health care providers should ensure that all children who receive cochlear implants are appropriately vaccinated and are then monitored and treated promptly for any bacterial infections after receiving the implant.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Epidemiol Program Off, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA; US FDA, Rockville, MD 20857 USA; New York City Dept Hlth & Mental Hyg, New York, NY USA; Texas Dept Hlth, Austin, TX 78756 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA); New York City Department of Health & Mental Hygiene; Texas Department of State Health Services	Reefhuis, J (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 1600 Clifton Rd NE,MS E-86, Atlanta, GA 30333 USA.		Reefhuis, Jennita/E-1793-2011	Reefhuis, Jennita/0000-0002-4747-4831				*ADV BION CORP, EL POS; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arnold W, 2002, ORL J OTO-RHINO-LARY, V64, P382, DOI 10.1159/000067579; BERMAN S, 1995, NEW ENGL J MED, V332, P1560, DOI 10.1056/NEJM199506083322307; GATES GA, 1995, JAMA-J AM MED ASSOC, V274, P1955, DOI 10.1001/jama.1995.03530240065043; Govaerts PJ, 2002, OTOL NEUROTOL, V23, P885, DOI 10.1097/00129492-200211000-00013; Greenland S., 1998, MODERN EPIDEMIOLOGY; Hammes DM, 2002, ANN OTO RHINOL LARYN, V111, P74, DOI 10.1177/00034894021110S516; HAYASHI N, 1989, CLIN PEDIATR, V28, P139, DOI 10.1177/000992288902800308; HERTHER C, 1985, LARYNGOSCOPE, V95, P655; Iles K, 2001, J PAEDIATR CHILD H, V37, P388, DOI 10.1046/j.1440-1754.2001.00698.x; JACKLER RK, 1987, LARYNGOSCOPE, V97, P2; KLEIN JO, 1994, CLIN INFECT DIS, V19, P823, DOI 10.1093/clinids/19.5.823; KLINE MW, 1989, PEDIATR INFECT DIS J, V8, P630, DOI 10.1097/00006454-198909000-00013; *NAT I DEAFN OTH C, 2003, COCHL IMPL; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; OHLMS LA, 1990, ARCH OTOLARYNGOL, V116, P608; PHELPS PD, 1994, AM J OTOL, V15, P551; Richter B, 2002, J LARYNGOL OTOL, V116, P507, DOI 10.1258/002221502760132584; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Sharman RL, 2002, AM BOOK REV, V23, P9; VALMARI P, 1986, INFECTION, V14, P36, DOI 10.1007/BF01644809; 2002, MMWR MORB MORTAL WKL, V51, P931; 2003, MMWR MORB MORTAL WKL, V52, P191; 2002, MMWR MORB MORTAL WKL, V51, P706; 2003, MMWR MORB MORTAL WKL, V52, pQ1	26	185	197	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2003	349	5					435	445		10.1056/NEJMoa031101	http://dx.doi.org/10.1056/NEJMoa031101			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706FV	12890842				2022-12-24	WOS:000184443700005
J	Kim, PJ; Plescia, J; Clevers, H; Fearon, ER; Altieri, DC				Kim, PJ; Plescia, J; Clevers, H; Fearon, ER; Altieri, DC			Survivin and molecular pathogenesis of colorectal cancer	LANCET			English	Article							ANTI-APOPTOSIS GENE; BETA-CATENIN; C-MYC; COLON-CARCINOMA; EXPRESSION; APC; ACTIVATION; IDENTIFICATION; TRANSFORMATION; TRANSCRIPTION	Background Colorectal cancer is thought to originate in the expansion of colonic crypt cells as a result of aberrant gene expression caused by transcription factors of the T-cell factor (TCF)/beta-catenin family. Survivin is a bifunctional regulator of cell death and cell proliferation expressed during embryonic development but undetectable in healthy adult tissues and re-expressed in many cancers, including colorectal cancer. Methods We investigated gene expression by promoter analysis, mutagenesis, and electrophoretic mobility shift assay in colorectal cancer cells. Survivin expression in human and mouse embryonic intestine was determined by in-situ hybridisation and immunohistochemistry. Changes in apoptosis were monitored in cell lines engineered to express stabilising mutations in beta catenin. Findings TCF/beta catenin stimulated a six-fold to 12-fold increased expression of the survivin gene in colorectal cancer cells. Three TCF-binding elements (TBE) in the survivin promoter were occupied by nuclear factors in colorectal cancer cells, and mutagenesis of the two proximal TBE sites abolished survivin gene expression by 75-79%. Strongly expressed at the bottom of human and mouse embryonic intestinal crypts, expression of survivin was lost in TCF-4 knockout animals, and a TCF-4 dominant negative mutant blocked survivin gene transcription in colorectal cancer cells. Expression of non-destructible beta catenin mutants increased survivin expression and protected against ultraviolet-B-induced apoptosis. Interpretation Stimulation of survivin expression by TCF/beta catenin might impose a stem cell-like phenotype to colonic crypt epithelium coupling enhanced cell proliferation with resistance to apoptosis, and contribute to the molecular pathogenesis of colorectal cancer.	Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01605 USA; Ctr Biomed Genet, Humbrecht Lab, NL-3584 CT Utrecht, Netherlands; Univ Michigan, Sch Med, Div Med & Mol Genet, Ann Arbor, MI USA; Univ Michigan, Sch Med, Ctr Canc, Ann Arbor, MI USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Altieri, DC (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, LRB-428,364 Plantat St, Worcester, MA 01605 USA.				NCI NIH HHS [CA78810, CA85463, CA90917] Funding Source: Medline; NHLBI NIH HHS [HL54131] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078810, R01CA085463, R01CA090917] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL054131, R01HL054131] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adida C, 1998, LANCET, V351, P882, DOI 10.1016/S0140-6736(05)70294-4; Adida C, 1998, AM J PATHOL, V152, P43; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Grossman D, 1999, J INVEST DERMATOL, V113, P1076, DOI 10.1046/j.1523-1747.1999.00776.x; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Kawasaki H, 1998, CANCER RES, V58, P5071; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Mesri M, 2001, J CLIN INVEST, V108, P981, DOI 10.1172/JCI12983; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NUSSE R, WNT GENE HOMEPAGE; Polakis P, 2000, GENE DEV, V14, P1837; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sarela AI, 2001, ANN SURG ONCOL, V8, P305; Smith SD, 2001, JAMA-J AM MED ASSOC, V285, P324, DOI 10.1001/jama.285.3.324; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Zhang T, 2001, CANCER RES, V61, P8664	28	283	305	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					205	209		10.1016/S0140-6736(03)13910-4	http://dx.doi.org/10.1016/S0140-6736(03)13910-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885482				2022-12-24	WOS:000184232000011
J	Hohnloser, SH; Ikeda, T; Bloomfield, DM; Dabbous, OH; Cohen, RJ				Hohnloser, SH; Ikeda, T; Bloomfield, DM; Dabbous, OH; Cohen, RJ			T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation	LANCET			English	Article							MYOCARDIAL-INFARCTION	In a trial of prophylactic implantation of a defibrillator, a mortality benefit was seen among patients with previous myocardial infarction and a left-ventricular ejection fraction of 0.30 or less. We identified 1.29 similar patients from two previously published clinical trials in which microvolt T-wave altemans testing was prospectively assessed. At 24 months of follow-up, no sudden cardiac death or cardiac arrest was seen among patients who tested T-wave alternans negative, compared with an event rate of 15.6% among the remaining patients. Testing of T-wave alternans seems to identify patients who are at low risk of ventricular tachyarrhythimic event and who may not benefit from defibrillator therapy.	MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02142 USA; Univ Frankfurt, D-6000 Frankfurt, Germany; Toho Univ, Tokyo, Japan; Columbia Univ, New York, NY USA; Univ Massachusetts, Worcester, MA 01605 USA	Harvard University; Massachusetts Institute of Technology (MIT); Goethe University Frankfurt; Toho University; Columbia University; University of Massachusetts System; University of Massachusetts Worcester	Cohen, RJ (corresponding author), MIT, Harvard MIT Div Hlth Sci & Technol, Room E25-335A,45 Carleton St, Cambridge, MA 02142 USA.							Bloomfield DM, 2002, J CARDIOVASC ELECTR, V13, P502, DOI 10.1046/j.1540-8167.2002.00502.x; Ikeda T, 2002, AM J CARDIOL, V89, P79, DOI 10.1016/S0002-9149(01)02171-3; Klingenheben T, 2000, LANCET, V356, P651, DOI 10.1016/S0140-6736(00)02609-X; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474	4	124	128	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 12	2003	362	9378					125	126		10.1016/S0140-6736(03)13865-2	http://dx.doi.org/10.1016/S0140-6736(03)13865-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699ZY	12867114				2022-12-24	WOS:000184089200013
J	Hamilton, JTG; McRoberts, WC; Keppler, F; Kalin, RM; Harper, DB				Hamilton, JTG; McRoberts, WC; Keppler, F; Kalin, RM; Harper, DB			Chloride methylation by plant pectin: An efficient environmentally significant process	SCIENCE			English	Article							EMISSIONS; CHLOROMETHANE; HALOCARBONS; ATMOSPHERE; COMBUSTION; AFRICA; MATTER	Atmospheric chloromethane (CH3Cl) plays an important role in stratospheric ozone destruction, but many uncertainties exist regarding the strengths of its sources and sinks and particularly regarding the processes generating this naturally occurring gas. Evidence is presented here that CH3Cl is produced in many terrestrial environments by a common mechanism. Abiotic conversion of chloride to CH3Cl occurs readily in plant material, with the widespread plant component pectin acting as a methyl donor. Significant CH3Cl emissions from senescent and dead leaves were observed at ambient temperatures; those emissions rose dramatically when temperatures increased. This ubiquitous process acting in terrestrial ecosystems and during biomass burning could contribute the bulk of atmospheric CH3Cl.	Dept Agr & Rural Dev No Ireland, Belfast BT9 5PX, Antrim, North Ireland; Queens Univ Belfast, Belfast BT9 5PX, Antrim, North Ireland; Queens Univ Belfast, Questor Res Ctr, Belfast BT9 5AG, Antrim, North Ireland; Queens Univ Belfast, Environm Engn Res Ctr, Belfast BT9 5AG, Antrim, North Ireland	Queens University Belfast; Queens University Belfast; Queens University Belfast	Hamilton, JTG (corresponding author), Dept Agr & Rural Dev No Ireland, Newforge Lane, Belfast BT9 5PX, Antrim, North Ireland.		Keppler, Frank/F-4401-2012; Kalin, Robert/E-8620-2011	Keppler, Frank/0000-0003-2766-8812; Kalin, Robert/0000-0003-3768-3848				Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Andreae MO, 1996, J GEOPHYS RES-ATMOS, V101, P23603, DOI 10.1029/95JD01733; Attieh J, 2000, PLANT CELL ENVIRON, V23, P165, DOI 10.1046/j.1365-3040.2000.00541.x; Bowen H. J. M, 1979, ENV CHEM ELEMENTS; Dimmer CH, 2001, ATMOS ENVIRON, V35, P321, DOI 10.1016/S1352-2310(00)00151-5; EKLUND G, 1988, CHEMOSPHERE, V17, P575, DOI 10.1016/0045-6535(88)90032-X; FUNG I, 1993, BIOGEOCHEMISTRY OF GLOBAL CHANGE, P166; Hafren J, 2001, NORD PULP PAP RES J, V16, P284, DOI 10.3183/npprj-2001-16-04-p284-290; Harper DB, 1999, NEW PHYTOL, V142, P5, DOI 10.1046/j.1469-8137.1999.00382.x; Harper DB, 2003, HANDB ENVIRON CHEM, V3, P17; Harper DB, 2000, NAT PROD REP, V17, P337, DOI 10.1039/a809400d; Hu HN, 1996, J EXP BOT, V47, P227, DOI 10.1093/jxb/47.2.227; Keppler F, 2000, NATURE, V403, P298, DOI 10.1038/35002055; Khalil MAK, 1999, ATMOS ENVIRON, V33, P1305, DOI 10.1016/S1352-2310(98)00234-9; Lobert JM, 1999, J GEOPHYS RES-ATMOS, V104, P8373, DOI 10.1029/1998JD100077; LOVELOCK JE, 1975, NATURE, V256, P193, DOI 10.1038/256193a0; Mellerowicz EJ, 2001, PLANT MOL BIOL, V47, P239, DOI 10.1023/A:1010699919325; MONTZKA SA, 2003, 47 WORLD MET ORG, pCH1; Moore RM, 1996, J GEOPHYS RES-OCEANS, V101, P28529, DOI 10.1029/96JC02915; Myneni SCB, 2002, SCIENCE, V295, P1039, DOI 10.1126/science.1067153; PALMER TY, 1976, NATURE, V263, P44, DOI 10.1038/263044a0; RASMUSSEN RA, 1980, J GEOPHYS RES-OCEANS, V85, P7350, DOI 10.1029/JC085iC12p07350; REINHARDT TE, 1995, ENVIRON SCI TECHNOL, V29, P825, DOI 10.1021/es00003a034; Rhew RC, 2000, NATURE, V403, P292, DOI 10.1038/35002043; RUDOLPH J, 1995, J ATMOS CHEM, V22, P67, DOI 10.1007/BF00708182; Saxena D, 1998, APPL ENVIRON MICROB, V64, P2831; Warneke C, 1999, GLOBAL BIOGEOCHEM CY, V13, P9, DOI 10.1029/98GB02428; Watling R, 1998, MYCOL RES, V102, P769, DOI 10.1017/S0953756298006157; Yokouchi Y, 2002, NATURE, V416, P163, DOI 10.1038/416163a	29	148	152	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2003	301	5630					206	209		10.1126/science.1085036	http://dx.doi.org/10.1126/science.1085036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855805				2022-12-24	WOS:000184056200040
J	Rider, TH; Petrovick, MS; Nargi, FE; Harper, JD; Schwoebel, ED; Mathews, RH; Blanchard, DJ; Bortolin, LT; Young, AM; Chen, JZ; Hollis, MA				Rider, TH; Petrovick, MS; Nargi, FE; Harper, JD; Schwoebel, ED; Mathews, RH; Blanchard, DJ; Bortolin, LT; Young, AM; Chen, JZ; Hollis, MA			A B cell-based sensor for rapid identification of pathogens	SCIENCE			English	Article							PHOTOPROTEIN; BACTERIA; FOOD; SITE	We report the use of genetically engineered cells in a pathogen identification sensor. This sensor uses B lymphocytes that have been engineered to emit light within seconds of exposure to specific bacteria and viruses. We demonstrated rapid screening of relevant samples and identification of a variety of pathogens at very low levels. Because of its speed, sensitivity, and specificity, this pathogen identification technology could prove useful for medical diagnostics, biowarfare defense, food- and water-quality monitoring, and other applications.	MIT, Lincoln Lab, Lexington, MA 02420 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Lincoln Laboratory; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Rider, TH (corresponding author), MIT, Lincoln Lab, Lexington, MA 02420 USA.	thor@ll.mit.edu	Harper, James D/B-8701-2011	Harper, James/0000-0001-7895-8268				Ackers ML, 1998, J INFECT DIS, V177, P1588, DOI 10.1086/515323; Belgrader P, 1999, SCIENCE, V284, P449, DOI 10.1126/science.284.5413.449; BUTTON D, 1993, CELL CALCIUM, V14, P663, DOI 10.1016/0143-4160(93)90091-J; CORMIER MJ, 1989, PHOTOCHEM PHOTOBIOL, V49, P509, DOI 10.1111/j.1751-1097.1989.tb09202.x; Hough AJ, 2002, J FOOD PROTECT, V65, P1329, DOI 10.4315/0362-028X-65.8.1329; Lindqvist R, 1997, INT J FOOD MICROBIOL, V37, P73, DOI 10.1016/S0168-1605(97)00054-8; Lucore LA, 2000, APPL ENVIRON MICROB, V66, P1769, DOI 10.1128/AEM.66.5.1769-1776.2000; PARIKH VS, 1991, J EXP MED, V174, P1103, DOI 10.1084/jem.174.5.1103; Pourahmadi F, 2000, CLIN CHEM, V46, P1511; ROEHRIG JT, 1985, VIROLOGY, V142, P347, DOI 10.1016/0042-6822(85)90343-5; Rowe CA, 1999, ANAL CHEM, V71, P3846, DOI 10.1021/ac981425v; SHIMOMURA O, 1989, BIOCHEM J, V261, P913, DOI 10.1042/bj2610913; SHIMOMURA O, 1978, P NATL ACAD SCI USA, V75, P2611, DOI 10.1073/pnas.75.6.2611; TSUJI FI, 1986, P NATL ACAD SCI USA, V83, P8107, DOI 10.1073/pnas.83.21.8107; WILSON HA, 1987, J EXP MED, V166, P601, DOI 10.1084/jem.166.2.601	15	204	248	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2003	301	5630					213	215		10.1126/science.1084920	http://dx.doi.org/10.1126/science.1084920			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855808				2022-12-24	WOS:000184056200043
J	Sage, J; Miller, AL; Perez-Mancera, PA; Wysocki, JM; Jacks, T				Sage, J; Miller, AL; Perez-Mancera, PA; Wysocki, JM; Jacks, T			Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry	NATURE			English	Article							TUMOR-SUPPRESSOR; G(1) CONTROL; RB; SENESCENCE; GROWTH; INACTIVATION; FIBROBLASTS; EXPRESSION; APOPTOSIS; SYSTEM	Cancer cells arise from normal cells through the acquisition of a series of mutations in oncogenes and tumour suppressor genes(1). Mouse models of human cancer often rely on germline alterations that activate or inactivate genes of interest. One limitation of this approach is that germline mutations might have effects other than somatic mutations, owing to developmental compensation(2,3). To model sporadic cancers associated with inactivation of the retinoblastoma (RB) tumour suppressor gene in humans, we have produced a conditional allele of the mouse Rb gene. We show here that acute loss of Rb in primary quiescent cells is sufficient for cell cycle entry and has phenotypic consequences different from germline loss of Rb function. This difference is explained in part by functional compensation by the Rb-related gene p107. We also show that acute loss of Rb in senescent cells leads to reversal of the cellular senescence programme. Thus, the use of conditional knockout strategies might refine our understanding of gene function and help to model human cancer more accurately.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Salamanca 37007, Spain	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Jacks, T (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu						Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)82148-6; Carneiro C, 2003, ONCOGENE, V22, P361, DOI 10.1038/sj.onc.1206163; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Gire V, 1998, MOL CELL BIOL, V18, P1611, DOI 10.1128/MCB.18.3.1611; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; JAT PS, 1989, MOL CELL BIOL, V9, P1672, DOI 10.1128/MCB.9.4.1672; Jonkers J, 2002, NAT REV CANCER, V2, P251, DOI 10.1038/nrc777; Lomazzi M, 2002, NAT GENET, V31, P190, DOI 10.1038/ng891; MacPherson D, 2003, MOL CELL BIOL, V23, P1044, DOI 10.1128/MCB.23.3.1044-1053.2003; Marino S, 2000, GENE DEV, V14, P994; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Vooijs M, 1998, ONCOGENE, V17, P1, DOI 10.1038/sj.onc.1202169	24	423	430	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					223	228		10.1038/nature01764	http://dx.doi.org/10.1038/nature01764			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853964				2022-12-24	WOS:000184032700049
J	Sampson, JR; Dolwani, S; Jones, S; Eccles, D; Ellis, A; Evans, DG; Frayling, I; Jordan, S; Maher, ER; Mak, T; Maynard, J; Pigatto, F; Shaw, J; Cheadle, JP				Sampson, JR; Dolwani, S; Jones, S; Eccles, D; Ellis, A; Evans, DG; Frayling, I; Jordan, S; Maher, ER; Mak, T; Maynard, J; Pigatto, F; Shaw, J; Cheadle, JP			Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH	LANCET			English	Article								Familial, adenomatous polyposis (FAP) and attenuated FAP are autosomal dominant disorders characterised by multiple colorectal adenomas and cancers. Both are caused by inherited mutations in the APC gene, and management includes genetic testing, colonoscopic surveillance, and prophylactic surgery for the relatives of index cases. Among 614 families recorded in six regional registers of polyposis in the UK, we identified 111 with neither dominant transmission nor evidence of APC mutation. Molecular genetic analysis showed that 25 had biallelic mutations of the MYH gene. Since our data show that MYH polyposis can be transmitted as an autosomal recessive trait, a change in genetic counselling, testing, and surveillance Is needed.	Univ Wales Coll Med, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; Royal Liverpool Hosp, Dept Gastroenterol, Liverpool L7 8XP, Merseyside, England; St Marys Hosp, Acad Unit med Genet, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Addenbrookes Hosp, Dept Med Genet, Genet Mol Lab, Cambridge, England; Univ Birmingham, Sect Med & Mol Genet, Birmingham, W Midlands, England; W Midlands Reg Genet Serv, Birmingham, W Midlands, England	Cardiff University; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Manchester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Birmingham	Sampson, JR (corresponding author), Univ Wales Coll Med, Inst Med Genet, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.		Evans, D Gareth/AAB-4308-2022; MAHER, EAMONN R/A-9507-2008; Dolwani, Sunil/C-9187-2013; Dolwani, Sunil/G-9730-2012; Dolwani, Sunil/M-4241-2016; Jones, Sian/A-5050-2012; Eccles, Diana/K-6327-2019	Evans, D Gareth/0000-0002-8482-5784; MAHER, EAMONN R/0000-0002-6226-6918; Eccles, Diana/0000-0002-9935-3169; Frayling, Ian/0000-0002-3420-0794					0	317	332	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 5	2003	362	9377					39	41		10.1016/S0140-6736(03)13805-6	http://dx.doi.org/10.1016/S0140-6736(03)13805-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699KW	12853198				2022-12-24	WOS:000184056900012
J	Hattar, S; Lucas, RJ; Mrosovsky, N; Thompson, S; Douglas, RH; Hankins, MW; Lem, J; Biel, M; Hofmann, F; Foster, RG; Yau, KW				Hattar, S; Lucas, RJ; Mrosovsky, N; Thompson, S; Douglas, RH; Hankins, MW; Lem, J; Biel, M; Hofmann, F; Foster, RG; Yau, KW			Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice	NATURE			English	Article							RETINAL GANGLION-CELLS; CIRCADIAN-RHYTHMS; RETINOHYPOTHALAMIC TRACT; LIGHT; RESPONSES; MASKING; LACKING; CLOCK; PHOTOTRANSDUCTION; PHOTOSENSITIVITY	In the mammalian retina, besides the conventional rod-cone system, a melanopsin-associated photoreceptive system exists that conveys photic information for accessory visual functions such as pupillary light reflex and circadian photo-entrainment(1-7). On ablation of the melanopsin gene, retinal ganglion cells that normally express melanopsin are no longer intrinsically photosensitive(8). Furthermore, pupil reflex(8), light-induced phase delays of the circadian clock(9,10) and period lengthening of the circadian rhythm in constant light(9,10) are all partially impaired. Here, we investigated whether additional photoreceptive systems participate in these responses. Using mice lacking rods and cones, we measured the action spectrum for phase-shifting the circadian rhythm of locomotor behaviour. This spectrum matches that for the pupillary light reflex in mice of the same genotype(11), and that for the intrinsic photosensitivity of the melanopsin-expressing retinal ganglion cells(7). We have also generated mice lacking melanopsin coupled with disabled rod and cone phototransduction mechanisms. These animals have an intact retina but fail to show any significant pupil reflex, to entrain to light/dark cycles, and to show any masking response to light. Thus, the rod-cone and melanopsin systems together seem to provide all of the photic input for these accessory visual functions.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Integrat & Mol Neurosci, Div Neurosci & Psychol Med, London W6 8RF, England; Univ Toronto, Dept Zool, Toronto, ON M5S 3G5, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 3G5, Canada; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G5, Canada; City Univ London, Dept Optometry & Visual Sci, Appl Vis Res Ctr, London EC1V 0HB, England; Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA; Univ Munich, Zentrum Pharmaforsch, Lehrstuhl Pharmakol Nat Wissensch, D-81377 Munich, Germany; Tech Univ Munich, Inst Pharmakol & Toxikol, D-80802 Munich, Germany	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Imperial College London; University of Toronto; University of Toronto; University of Toronto; City University London; Tufts University; University of Munich; Technical University of Munich	Yau, KW (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.		Biel, Martin/G-1175-2014; Hattar, Samer/W-6927-2019	Biel, Martin/0000-0002-9974-3052; FOSTER, RUSSELL/0000-0001-6055-2067; Lucas, Robert/0000-0002-1088-8029	NEI NIH HHS [R37 EY006837-13, R37 EY006837-14, R37 EY006837-15, R37 EY006837, R01 EY006837-16A1, R01 EY014596-01, R37 EY006837-15S1, R01 EY014596, R01 EY006837] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY006837, R01EY006837, R01EY014596] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aschoff J., 1988, Advances in the Biosciences, V73, P149; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Bradley J, 2001, SCIENCE, V294, P2095, DOI 10.1126/science.294.5549.2095; Brockerhoff SE, 2003, J NEUROSCI, V23, P470, DOI 10.1523/JNEUROSCI.23-02-00470.2003; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; CONE RA, 1967, SCIENCE, V155, P1128, DOI 10.1126/science.155.3766.1128; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Mrosovsky N, 2001, J BIOL RHYTHM, V16, P585, DOI 10.1177/074873001129002277; Mrosovsky N, 2001, CHRONOBIOL INT, V18, P613, DOI 10.1081/CBI-100106076; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; MURAKAMI M, 1970, VISION RES, V10, P965, DOI 10.1016/0042-6989(70)90074-X; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; Redlin U, 1999, J COMP PHYSIOL A, V184, P429, DOI 10.1007/s003590050342; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Van Gelder R N, 2001, Ophthalmic Genet, V22, P195, DOI 10.1076/opge.22.4.195.2215; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Wee R, 2002, J NEUROSCI, V22, P10427; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797	32	854	880	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					76	81		10.1038/nature01761	http://dx.doi.org/10.1038/nature01761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12808468	Green Accepted			2022-12-24	WOS:000183912800043
J	Cohn, BA; Cirillo, PM; Wolff, MS; Schwingi, PJ; Cohen, RD; Sholtz, RI; Ferrara, A; Christianson, RE; van den Berg, BJ; Siiteri, PK				Cohn, BA; Cirillo, PM; Wolff, MS; Schwingi, PJ; Cohen, RD; Sholtz, RI; Ferrara, A; Christianson, RE; van den Berg, BJ; Siiteri, PK			DDT and DDE exposure in mothers and time to pregnancy in daughters	LANCET			English	Article							ORGANOCHLORINES	Reproductive-tract anomalies after administration of the potent oestrogen, diethylstilboestrol, in pregnant women raised concerns about the reproductive effects of exposure to weakly oestrogenic environmental contaminants such as bis[4-chlorophenyl]-1,1,1-trichloroethane (p,p'-DDT) or its metabolites, such as bis[4-chlorophenyl]-1,1-dichloroethene (p,p'-DDE). We measured p,p'-DDT and p,p'-DDE in preserved maternal serum samples drawn 1-3 days after delivery between 1960 and 1963. We recorded time to pregnancy In 289 eldest daughters 28-31 years later. Daughters' probability of pregnancy fell by 32% per 10 mug/L p,p'-DDT in maternal serum (95% CI 11-48). By contrast, the probability of pregnancy increased 16% per 10 mug/L p,p'-DDE (6-27). The decreased fecundability associated with prenatal p,p'-DDT remains unexplained. We speculate that the antiandrogenic activity of p,p'-DDE may mitigate harmful androgen effects on the ovary during gestation or early life.	Inst Publ Hlth, Ctr Res Womens & Childrens Hlth, Berkeley, CA 94709 USA; Mt Sinai Sch Med, New York, NY USA; Univ N Carolina, Chapel Hill, NC USA; Kaiser Permanente, Div Res, Oakland, CA USA; Univ Calif San Francisco, Sch Med, Dept Obstet, San Francisco, CA USA; Univ Calif San Francisco, Sch Med, Dept Gynecol, San Francisco, CA USA; Univ Calif San Francisco, Sch Med, Dept Reprod Sci, San Francisco, CA USA	Public Health Institute; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cohn, BA (corresponding author), Inst Publ Hlth, Ctr Res Womens & Childrens Hlth, 1683 Shattuck Ave,Suite B, Berkeley, CA 94709 USA.				NICHD NIH HHS [N01 HD 63258] Funding Source: Medline; NIEHS NIH HHS [R01 ES08345] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD063258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008345] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abbott DH, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740001; BAIRD DD, 1986, AM J EPIDEMIOL, V124, P47; KELCE WR, 1995, NATURE, V375, P581, DOI 10.1038/375581a0; Longnecker MP, 1997, ANNU REV PUBL HEALTH, V18, P211, DOI 10.1146/annurev.publhealth.18.1.211; Longnecker MP, 1999, ARCH ENVIRON HEALTH, V54, P110, DOI 10.1080/00039899909602244; McLachlan JA, 2001, ENDOCR REV, V22, P319, DOI 10.1210/er.22.3.319; SAXENA MC, 1981, ARCH TOXICOL, V48, P127, DOI 10.1007/BF00310482; van den Berg B J, 1988, Paediatr Perinat Epidemiol, V2, P265; WEINBERG CR, 1989, AM J EPIDEMIOL, V129, P1072, DOI 10.1093/oxfordjournals.aje.a115211	9	104	106	1	20	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 28	2003	361	9376					2205	2206		10.1016/S0140-6736(03)13776-2	http://dx.doi.org/10.1016/S0140-6736(03)13776-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	695DJ	12842376				2022-12-24	WOS:000183815600015
J	Chan, RC; Chan, A; Jeon, M; Wu, TF; Pasqualone, D; Rougvie, AE; Meyer, BJ				Chan, RC; Chan, A; Jeon, M; Wu, TF; Pasqualone, D; Rougvie, AE; Meyer, BJ			Chromosome cohesion is regulated by a clock gene paralogue TIM-1	NATURE			English	Article							SISTER-CHROMATID COHESION; CAENORHABDITIS-ELEGANS; C-ELEGANS; X-CHROMOSOME; DOSAGE COMPENSATION; MEIOTIC PROPHASE; PROTEIN; RECOMBINATION; CONDENSATION; DROSOPHILA	Faithful transmission of the genome requires that a protein complex called cohesin establishes and maintains the regulated linkage between replicated chromosomes before their segregation(1,2). Here we report the unforeseen participation of Caenorhabditis elegans TIM-1, a paralogue of the Drosophila clock protein TIMELESS, in the regulation of chromosome cohesion. Our biochemical experiments defined the C. elegans cohesin complex and revealed its physical association with TIM-1. Functional relevance of the interaction was demonstrated by aberrant mitotic chromosome behaviour, embryonic lethality and defective meiotic chromosome cohesion caused by the disruption of either TIM-1 or cohesin. TIM-1 depletion prevented the assembly of non-SMC ( structural maintenance of chromosome) cohesin subunits onto meiotic chromosomes; however, unexpectedly, a partial cohesin complex composed of SMC components still loaded. Further disruption of cohesin activity in meiosis by the simultaneous depletion of TIM-1 and an SMC subunit decreased homologous chromosome pairing before synapsis, revealing a new role for cohesin in metazoans. On the basis of comparisons between TIMELESS homologues in worms, flies and mice, we propose that chromosome cohesion, rather than circadian clock regulation, is the ancient and conserved function for TIMELESS-like proteins.	Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Minnesota, Dept Biochem, St Paul, MN 55108 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Meyer, BJ (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.			Meyer, Barbara/0000-0002-6530-4588; Chan, Raymond/0000-0003-3397-2351				Benna C, 2000, CURR BIOL, V10, pR512, DOI 10.1016/S0960-9822(00)00594-7; BROVERMAN SA, 1994, GENETICS, V136, P119; Chu DS, 2002, GENE DEV, V16, P796, DOI 10.1101/gad.972702; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hartman T, 2000, J CELL BIOL, V151, P613, DOI 10.1083/jcb.151.3.613; Hirano T, 2000, ANNU REV BIOCHEM, V69, P115, DOI 10.1146/annurev.biochem.69.1.115; HODGKIN J, 1979, GENETICS, V91, P67; Howe M, 2001, J CELL BIOL, V153, P1227, DOI 10.1083/jcb.153.6.1227; HOWELL AM, 1987, GENET RES, V49, P207, DOI 10.1017/S0016672300027099; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lieb JD, 1998, CELL, V92, P265, DOI 10.1016/S0092-8674(00)80920-4; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; SCHEDL T, 1997, C ELEGANS, V2, P241; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Vodovar N, 2002, CURR BIOL, V12, pR610, DOI 10.1016/S0960-9822(02)01130-2; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	29	128	143	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					1002	1009		10.1038/nature01697	http://dx.doi.org/10.1038/nature01697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827206				2022-12-24	WOS:000183753900054
J	Baker, KD; Shewchuk, LM; Kozlova, T; Makishima, M; Hassell, A; Wisely, B; Caravella, JA; Lambert, MH; Reinking, JL; Krause, H; Thummel, CS; Willson, TM; Mangelsdorf, DJ				Baker, KD; Shewchuk, LM; Kozlova, T; Makishima, M; Hassell, A; Wisely, B; Caravella, JA; Lambert, MH; Reinking, JL; Krause, H; Thummel, CS; Willson, TM; Mangelsdorf, DJ			The Drosophila orphan nuclear receptor DHR38 mediates an atypical ecdysteroid signaling pathway	CELL			English	Article							RETINOID-X-RECEPTOR; LIGAND-BINDING DOMAIN; ECDYSONE RECEPTOR; NGFI-B; CRYSTAL-STRUCTURE; COACTIVATOR RECRUITMENT; MOLECULAR-BASIS; MANDUCA-SEXTA; ULTRASPIRACLE; MELANOGASTER	Ecdysteroid pulses trigger the major developmental transitions during the Drosophila life cycle. These hormonal responses are thought to be mediated by the ecdysteroid receptor (EcR) and its heterodimeric partner Ultraspiracle (USP). We provide evidence for a second ecdysteroid signaling pathway mediated by DHR38, the Drosophila ortholog of the mammalian NGFI-B subfamily of orphan nuclear receptors. DHR38 also heterodimerizes with USP, and this complex responds to a distinct class of ecdysteroids in a manner that is independent of EcR. This response is unusual in that it does not involve direct binding of ecdysteroids to either DHR38 or USP. X-ray crystallographic analysis of DHR38 reveals the absence of both a classic ligand binding pocket and coactivator binding site, features that seem to be common to all NGFI-B subfamily members. Taken together, these data reveal the existence of a separate structural class of nuclear receptors that is conserved from fly to humans.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; GlaxoSmithKline, Discovery Res, Res Triangle Pk, NC 27709 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2C4, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C4, Canada; Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; GlaxoSmithKline; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Mangelsdorf, DJ (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	davo.mango@utsouthwestern.edu	feinstein, doug/M-9414-2019; ID, IMCACAT/D-5867-2014	Mangelsdorf, David/0000-0002-4355-0796; Krause, Henry/0000-0002-6182-7074; Baker, Keith/0000-0002-6755-1697				ANDRES AJ, 1994, METHOD CELL BIOL, V44, P565, DOI 10.1016/S0091-679X(08)60932-2; ANDRES AJ, 1992, DEVELOPMENT, V116, P865; ANDRES AJ, 1993, DEV BIOL, V160, P388, DOI 10.1006/dbio.1993.1315; Baker KD, 2000, INSECT BIOCHEM MOLEC, V30, P1037, DOI 10.1016/S0965-1748(00)00075-8; BASHIRULLAH A, 2003, IN PRESS DEV BI 0325, DOI DOI 10.1016/S0012-1606(3)00063-0; BENYAJATI C, 1983, CELL, V33, P125, DOI 10.1016/0092-8674(83)90341-0; Billas IML, 2001, J BIOL CHEM, V276, P7465, DOI 10.1074/jbc.M008926200; BOEHM MF, 1995, J MED CHEM, V38, P3146, DOI 10.1021/jm00016a018; Botling J, 1997, J BIOL CHEM, V272, P9443; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Castro DS, 1999, J BIOL CHEM, V274, P37483, DOI 10.1074/jbc.274.52.37483; Champlin DT, 1998, DEVELOPMENT, V125, P269; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; CHERBAS L, 1970, BIOL BULL, V138, P115, DOI 10.2307/1540196; CHERBAS L, 1980, ROUX ARCH DEV BIOL, V189, P1, DOI 10.1007/BF00848562; Clayton GM, 2001, P NATL ACAD SCI USA, V98, P1549, DOI 10.1073/pnas.041611298; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; DELACRUZ EM, 1996, J AESTHET EDUC, V30, P85, DOI 10.2307/3333235; Dinan L, 2001, PHYTOCHEMISTRY, V57, P325, DOI 10.1016/S0031-9422(01)00078-4; FISK GJ, 1995, P NATL ACAD SCI USA, V92, P10604, DOI 10.1073/pnas.92.23.10604; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Gilbert Lawrence I., 1997, Invertebrate Neuroscience, V3, P205, DOI 10.1007/BF02480376; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; GILLILAND GL, 1984, METHOD ENZYMOL, V104, P370; GRAU V, 1994, INSECT BIOCHEM MOLEC, V24, P49, DOI 10.1016/0965-1748(94)90122-8; Hall BL, 1998, DEVELOPMENT, V125, P4709; HENRICH VC, 1994, DEV BIOL, V165, P38, DOI 10.1006/dbio.1994.1232; Hiruma K, 1997, GEN COMP ENDOCR, V107, P84, DOI 10.1006/gcen.1997.6901; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; KOELLE MR, 1992, THESIS STANFORD U ST; Kozlova T, 1998, GENETICS, V149, P1465; Kozlova T, 2002, DEVELOPMENT, V129, P1739; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MOUGNEAU E, 1993, MOL CELL BIOL, V13, P184, DOI 10.1128/MCB.13.1.184; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Paulsen RE, 1995, J MOL NEUROSCI, V6, P249, DOI 10.1007/BF02736784; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; PERRIMON N, 1985, GENETICS, V111, P23; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; RIDDIFORD LM, 1996, DEV DROSOPHILA MELAN, P899; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Solomin L, 1998, NATURE, V395, P398, DOI 10.1038/26515; SOMMEMARTIN G, 1990, ARCH INSECT BIOCHEM, V15, P43, DOI 10.1002/arch.940150105; SOMMEMARTIN G, 1988, INSECT BIOCHEM, V18, P729, DOI 10.1016/0020-1790(88)90082-0; SUTHERLAND JD, 1995, P NATL ACAD SCI USA, V92, P7966, DOI 10.1073/pnas.92.17.7966; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Thummel CS, 2002, GENE DEV, V16, P3113, DOI 10.1101/gad.1042102; Wansa KDSA, 2002, J BIOL CHEM, V277, P33001, DOI 10.1074/jbc.M203572200; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656	64	182	197	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2003	113	6					731	742		10.1016/S0092-8674(03)00420-3	http://dx.doi.org/10.1016/S0092-8674(03)00420-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809604	Bronze, Green Published			2022-12-24	WOS:000183514400008
J	Kimmel, AR; Parent, CA				Kimmel, AR; Parent, CA			The signal to move: D-discoideum go orienteering	SCIENCE			English	Editorial Material							DICTYOSTELIUM; CHEMOTAXIS; CELLS; SUPPRESSOR; GRADIENTS; MODEL	Cells migrating directionally toward a chemoattractant source display a highly polarized cytoskeletal organization, with F-actin localized predominantly at the anterior and myosin II at the lateral and posterior regions. Dictyostelium discoideum has proven a useful system for elucidating signaling pathways that regulate this chemotactic response. During development, extracellular adenosine 3', 5' monophosphate (cAMP) functions as a primary signal to activate cell surface cAMP receptors (cARs). These receptors transduce different signals depending on whether or not they are coupled to heterotrimeric guanine nucleotide-binding proteins (G proteins) (see the STKE Connections Maps). Multiple G protein-stimulated pathways interact to establish polarity in chemotaxing D. discoideum cells by localizing F-actin at their leading edge and by regulating the phosphorylation state and assembly of myosin II. Many of the molecular interactions described are fundamental to the regulation of chemotaxis in other eukaryotic cells.	NCI, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NIDDKD, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Parent, CA (corresponding author), NCI, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.				NATIONAL CANCER INSTITUTE [Z01BC010418, ZIABC010418] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; Bear JE, 1998, J CELL BIOL, V142, P1325, DOI 10.1083/jcb.142.5.1325; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; DELAROCHE MA, IN PRESS J MUSCLE RE; DRAYER AL, 1994, EMBO J, V13, P1601, DOI 10.1002/j.1460-2075.1994.tb06423.x; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Han YH, 2002, J BIOL CHEM, V277, P49877, DOI 10.1074/jbc.M209107200; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; KIMMEL AR, 2003, SCI STKE; Kreppel L, 2002, NUCLEIC ACIDS RES, V30, P84, DOI 10.1093/nar/30.1.84; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; Narang A, 2001, ANN BIOMED ENG, V29, P677, DOI 10.1114/1.1385805; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Postma M, 2001, BIOPHYS J, V81, P1314, DOI 10.1016/S0006-3495(01)75788-8; Traynor D, 2000, EMBO J, V19, P4846, DOI 10.1093/emboj/19.17.4846; Wessels DJ, 2000, MOL BIOL CELL, V11, P2803, DOI 10.1091/mbc.11.8.2803; Wilkins A, 2001, TRENDS GENET, V17, P41, DOI 10.1016/S0168-9525(00)02181-8; Zhang H, 2003, EUKARYOT CELL, V2, P62, DOI 10.1128/EC.2.1.62-75.2003; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	22	67	68	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1525	1527		10.1126/science.1085439	http://dx.doi.org/10.1126/science.1085439			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791977				2022-12-24	WOS:000183333100037
J	Yu, YS; Rambo, T; Currie, J; Saski, C; Kim, HR; Collura, K; Thompson, S; Simmons, J; Yang, TJ; Nah, G; Patel, AJ; Thurmond, S; Henry, D; Oates, R; Palmer, M; Pries, G; Gibson, J; Anderson, H; Paradkar, M; Crane, L; Dale, J; Carver, MB; Wood, T; Frisch, D; Engler, F; Soderlund, C; Palmer, LE; Tetylman, L; Nascimento, L; de la Bastide, M; Spiegel, L; Ware, D; O'Shaughnessy, A; Dike, S; Dedhia, N; Preston, R; Huang, E; Ferraro, K; Kuit, K; Miller, B; Zutavern, T; Katzenberger, F; Muller, S; Balija, V; Martienssen, RA; Stein, L; Minx, P; Johnson, D; Cordum, H; Mardis, E; Cheng, ZK; Jiang, JM; Wilson, R; McCombie, WR; Wing, RA; Yuan, QP; Shu, OY; Liu, J; Jones, KM; Gansberger, K; Moffat, K; Hill, J; Tsitrin, T; Overton, L; Bera, J; Kim, M; Jin, SH; Tallon, L; Ciecko, A; Pai, G; Van Aken, S; Utterback, T; Reidmuller, S; Bormann, J; Feldblyum, T; Hsiao, J; Zismann, V; Blunt, S; de Vazeilles, A; Shaffer, T; Koo, H; Suh, B; Yang, Q; Haas, B; Peterson, J; Pertea, M; Volfovsky, N; Wortman, J; White, O; Salzberg, SL; Fraser, CM; Buell, CR; Messing, J; Song, RT; Fuks, G; Llaca, V; Kovchak, S; Young, S; Bowers, JE; Paterson, AH; Johns, MA; Mao, L; Pan, HQ; Dean, RA				Yu, YS; Rambo, T; Currie, J; Saski, C; Kim, HR; Collura, K; Thompson, S; Simmons, J; Yang, TJ; Nah, G; Patel, AJ; Thurmond, S; Henry, D; Oates, R; Palmer, M; Pries, G; Gibson, J; Anderson, H; Paradkar, M; Crane, L; Dale, J; Carver, MB; Wood, T; Frisch, D; Engler, F; Soderlund, C; Palmer, LE; Tetylman, L; Nascimento, L; de la Bastide, M; Spiegel, L; Ware, D; O'Shaughnessy, A; Dike, S; Dedhia, N; Preston, R; Huang, E; Ferraro, K; Kuit, K; Miller, B; Zutavern, T; Katzenberger, F; Muller, S; Balija, V; Martienssen, RA; Stein, L; Minx, P; Johnson, D; Cordum, H; Mardis, E; Cheng, ZK; Jiang, JM; Wilson, R; McCombie, WR; Wing, RA; Yuan, QP; Shu, OY; Liu, J; Jones, KM; Gansberger, K; Moffat, K; Hill, J; Tsitrin, T; Overton, L; Bera, J; Kim, M; Jin, SH; Tallon, L; Ciecko, A; Pai, G; Van Aken, S; Utterback, T; Reidmuller, S; Bormann, J; Feldblyum, T; Hsiao, J; Zismann, V; Blunt, S; de Vazeilles, A; Shaffer, T; Koo, H; Suh, B; Yang, Q; Haas, B; Peterson, J; Pertea, M; Volfovsky, N; Wortman, J; White, O; Salzberg, SL; Fraser, CM; Buell, CR; Messing, J; Song, RT; Fuks, G; Llaca, V; Kovchak, S; Young, S; Bowers, JE; Paterson, AH; Johns, MA; Mao, L; Pan, HQ; Dean, RA		Rice Chromosome 10 Sequencing Cons	In-depth view of structure, activity, and evolution of rice chromosome 10	SCIENCE			English	Article							GENOME SEQUENCE; DRAFT SEQUENCE; RESISTANCE; GENES	Rice is the world's most important food crop and a model for cereal research. At 430 megabases in size, its genome is the most compact of the cereals. We report the sequence of chromosome 10, the smallest of the 12 rice chromosomes (22.4 megabases), which contains 3471 genes. Chromosome 10 contains considerable heterochromatin with an enrichment of repetitive elements on 10S and an enrichment of expressed genes on 10L. Multiple insertions from organellar genomes were detected. Collinearity was apparent between rice chromosome 10 and sorghum and maize. Comparison between the draft and finished sequence demonstrates the importance of finished sequence.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Arizona, Arizona Genom Inst, Tucson, AZ 85721 USA; Univ Arizona, Arizona Genom Computat Lab, Dept Plant Sci, Tucson, AZ 85721 USA; Clemson Univ, Genom Inst, Clemson, SC 29634 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; Inst Genome Res, Rockville, MD 20850 USA; Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Rutgers State Univ, PGIR Waksman Inst, Piscataway, NJ 08854 USA; Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; N Carolina State Univ, Ctr Integrated Fungal Res, Raleigh, NC 27695 USA	Cold Spring Harbor Laboratory; University of Arizona; University of Arizona; Clemson University; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; J. Craig Venter Institute; Johns Hopkins University; Johns Hopkins University; Rutgers State University New Brunswick; University System of Georgia; University of Georgia; Northern Illinois University; University of North Carolina; North Carolina State University	McCombie, WR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	mccombie@cshl.edu; rwing@ag.arizona.edu; rbuell@tigr.org; messing@waksman.rutgers.edu	Song, Rentao/AAG-9107-2021; Song, Rentao/A-6544-2012; Wing, Rod A/Z-2885-2019; Salzberg, Steven/Q-6514-2019; Yang, Tae-Jin/AAT-5274-2020; Bowers, John/B-9245-2009; Jiang, Jiming/V-6060-2019; Pertea, Mihaela/AAT-2705-2021; Jiang, Jiming/A-9614-2009; Salzberg, Steven L/F-6162-2011; Bowers, John/AAD-7601-2019; Mardis, Elaine/W-2202-2019	Song, Rentao/0000-0003-1810-9875; Song, Rentao/0000-0003-1810-9875; Wing, Rod A/0000-0001-6633-6226; Salzberg, Steven/0000-0002-8859-7432; Bowers, John/0000-0001-8984-9796; Jiang, Jiming/0000-0002-6435-6140; Pertea, Mihaela/0000-0003-0762-8637; Jiang, Jiming/0000-0002-6435-6140; Salzberg, Steven L/0000-0002-8859-7432; Fraser, Claire/0000-0003-1462-2428; Pan, Huaqin/0000-0002-7166-108X; Iobst, Stacey E./0000-0002-6954-2903; Yuan, Qiaoping/0000-0002-5880-8702; McCombie, W. Richard/0000-0003-1899-0682; Messing, Joachim/0000-0001-8260-2643; Buell, C Robin/0000-0002-6727-4677	NLM NIH HHS [R01-LM06845] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Barry GF, 2001, PLANT PHYSIOL, V125, P1164, DOI 10.1104/pp.125.3.1164; BOWERS JE, IN PRESS GENETICS; Cheng ZK, 2001, GENOME RES, V11, P2133, DOI 10.1101/gr.194601; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Harushima Y, 1998, GENETICS, V148, P479; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; McCombie WR, 2000, CELL, V100, P377, DOI 10.1016/S0092-8674(00)80673-X; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Pan QL, 2000, J MOL EVOL, V50, P203, DOI 10.1007/s002399910023; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Song R, 2002, GENOME RES, V12, P1549, DOI 10.1101/gr.268302; Thomas CM, 1998, PHILOS T ROY SOC B, V353, P1413, DOI 10.1098/rstb.1998.0296; Yamazaki M, 2001, MOL GENET GENOMICS, V265, P336, DOI 10.1007/s004380000421; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yuan Q, 2002, MOL GENET GENOMICS, V267, P713, DOI 10.1007/s00438-002-0706-1	22	148	353	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2003	300	5625					1566	1569						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791992				2022-12-24	WOS:000183333100054
J	Snaith, HA; Sawin, KE				Snaith, HA; Sawin, KE			Fission yeast mod5p regulates polarized growth through anchoring of tea1p at cell tips	NATURE			English	Article							SCHIZOSACCHAROMYCES-POMBE; MICROTUBULAR CYTOSKELETON; PROTEINS; MECHANISMS; DYNAMICS; ESTABLISHMENT; END	Microtubules have a central role in eukaryotic cell polarity(1), in part through interactions between microtubule end-binding proteins and the cell cortex(2,3). In the fission yeast Schizosaccharomyces pombe, microtubules and the polarity modulator tea1p maintain cylindrical cell shape and strictly antipodal cell growth(4-7). The tea1p protein is transported to cell tips by association with growing microtubule plus ends(8); once at cell tips, tea1p releases from microtubule ends and associates with the cell cortex, where it coordinates polarized growth(4,6). Here we describe a cortical protein, mod5p, that regulates the dynamic behaviour of tea1p. In mod5Delta cells, tea1p is efficiently transported on microtubules to cell tips but fails to anchor properly at the cortex and thus fails to accumulate to normal levels. mod5p contains a signal for carboxy-terminal prenylation and in wildtype cells is associated with the plasma membrane at cell tips. However, in tea1Delta cells, although mod5p remains localized to the plasma membrane, mod5p is no longer restricted to the cell tips. We propose that tea1p and mod5p act in a positive-feedback loop in the microtubule-mediated regulation of cell polarity.	Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Sawin, KE (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Swann Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	ken.sawin@ed.ac.uk		Snaith, Hilary/0000-0003-4863-8436; Sawin, Kenneth/0000-0002-2607-2219				ADACHI Y, 1986, MOL CELL BIOL, V6, P2168, DOI 10.1128/MCB.6.6.2168; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Arellano M, 2002, CURR BIOL, V12, P751, DOI 10.1016/S0960-9822(02)00821-7; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Browning H, 2000, J CELL BIOL, V151, P15, DOI 10.1083/jcb.151.1.15; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Chang F, 2001, TRENDS GENET, V17, P273, DOI 10.1016/S0168-9525(01)02279-X; Ding DQ, 1998, J CELL SCI, V111, P701; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Miller RK, 2000, MOL BIOL CELL, V11, P2949, DOI 10.1091/mbc.11.9.2949; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Sawin KE, 1998, J CELL BIOL, V142, P457, DOI 10.1083/jcb.142.2.457; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; WOODS A, 1989, J CELL SCI, V93, P491; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	30	98	101	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2003	423	6940					647	651		10.1038/nature01672	http://dx.doi.org/10.1038/nature01672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789340	Green Published			2022-12-24	WOS:000183301200042
J	Pui, CH; Cheng, C; Leung, W; Rai, SN; Rivera, GK; Sandlund, JT; Ribeiro, RC; Relling, MV; Kun, LE; Evans, WE; Hudson, MM				Pui, CH; Cheng, C; Leung, W; Rai, SN; Rivera, GK; Sandlund, JT; Ribeiro, RC; Relling, MV; Kun, LE; Evans, WE; Hudson, MM			Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SECONDARY BRAIN-TUMORS; CENTRAL-NERVOUS-SYSTEM; CRANIAL RADIOTHERAPY; ADOLESCENT CANCER; ADULT SURVIVORS; COMPETING RISK; LATE MORTALITY; 2ND NEOPLASMS; TOTAL-THERAPY; CHILDREN	BACKGROUND Children who survive acute lymphoblastic leukemia are at risk for leukemia-related or treatment-related complications, which can adversely affect survival and socioeconomic status. We determined the long-term survival and the rates of health insurance coverage, marriage, and employment among patients who had attained at least 10 years of event-free survival. METHODS A total of 856 eligible patients were treated between 1962 and 1992 in 13 consecutive clinical trials. Survival rates, the cumulative risk of a second neoplasm, and selected indicators of socioeconomic status were analyzed for the entire group and for patients who did or did not receive cranial or craniospinal radiation therapy during initial treatment. RESULTS Fifty-six patients had major adverse events, including 8 deaths during remission, 4 relapses, and 44 second neoplasms (41 of them radiation-related); most of the second neoplasms were benign or of a low grade of malignant potential. The risk of a second neoplasm was significantly higher in the 597 patients who received radiation therapy (irradiated group) than in the 259 patients who did not receive radiation therapy (nonirradiated group) (P=0.04; estimated cumulative risk [+/-SE] at 20 years, 20.9+/-3.9 percent vs. 0.95+/-0.9 percent). The death rate for the irradiated group slightly exceeded the expected rate in the general U.S. population (standardized mortality ratio, 1.90; 95 percent confidence interval, 1.12 to 3.00), whereas that for the nonirradiated group did not differ from the population norm (standardized mortality ratio, 1.75; 95 percent confidence interval, 0.34 to 5.00). The rates of health insurance coverage, marriage, and employment in the nonirradiated group were similar to the age- and sex-adjusted national averages. Despite having health insurance rates similar to those in the general population, men and women in the irradiated group had higher-than-average unemployment rates (15.1 percent vs. 5.4 percent and 35.4 percent vs. 5.2 percent, respectively), and women in the irradiated group were less likely to be married (35.2 percent vs. 48.8 percent). CONCLUSIONS Children with acute lymphoblastic leukemia who did not receive radiation therapy and who have attained 10 or more years of event-free survival can expect a normal long-term survival. Irradiation is associated with the development of second neoplasms, a slight excess in mortality, and an increased unemployment rate.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Radiat Oncol, Memphis, TN 38105 USA; Univ Tennessee, Hlth Sci Ctr, Coll Med, Knoxville, TN 37996 USA; Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Knoxville, TN 37996 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Pui, CH (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	pui@stjude.org	Hudson, Melissa M/N-4441-2018; Relling, Mary/N-5032-2018; Pui, Ching-Hon/N-8076-2018; Cheng, Cheng/N-8075-2018; Evans, William E./C-2069-2012	Hudson, Melissa M/0000-0001-6984-2407; Pui, Ching-Hon/0000-0003-0303-5658; Evans, William E./0000-0002-9333-5322; Leung, Wing Hang/0000-0002-2996-7229	PHS HHS [21765] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bhatia S, 2002, BLOOD, V99, P4257, DOI 10.1182/blood.V99.12.4257; Blackwell D. L., 2002, VITAL HLTH STAT SERI; Brenner H, 2001, CANCER, V92, P1977, DOI 10.1002/1097-0142(20011001)92:7<1977::AID-CNCR1717>3.0.CO;2-W; Breslow N E, 1987, IARC Sci Publ, P1; *BUR LAB STAT, 2002, CURR POP SURV REP; BYRNE J, 1989, JAMA-J AM MED ASSOC, V262, P2693, DOI 10.1001/jama.262.19.2693; CHRISTIE D, 1995, ARCH DIS CHILD, V73, P136, DOI 10.1136/adc.73.2.136; *CTR COST FIN STUD, 2000, MED EXP PAN SURV HOU; Dalton VMK, 1998, J CLIN ONCOL, V16, P2848, DOI 10.1200/JCO.1998.16.8.2848; *EP SOFTW, 1993, EP PLUS STAT PACK EP; Evans WE, 1998, NEW ENGL J MED, V338, P499, DOI 10.1056/NEJM199802193380803; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; GREEN DM, 1991, CANCER, V67, P206, DOI 10.1002/1097-0142(19910101)67:1<206::AID-CNCR2820670134>3.0.CO;2-2; Green DM, 1999, J CLIN ONCOL, V17, P3207, DOI 10.1200/JCO.1999.17.10.3207; HAUPT R, 1994, JAMA-J AM MED ASSOC, V272, P1427, DOI 10.1001/jama.272.18.1427; HAYS DM, 1992, J CLIN ONCOL, V10, P1397, DOI 10.1200/JCO.1992.10.9.1397; Hoffman B, 1999, ONCOLOGY-NY, V13, P841; HOLMES GE, 1986, CANCER, V57, P190, DOI 10.1002/1097-0142(19860101)57:1<190::AID-CNCR2820570136>3.0.CO;2-8; Hudson MM, 1997, J CLIN ONCOL, V15, P2205, DOI 10.1200/JCO.1997.15.6.2205; Kamps WA, 2002, LEUKEMIA, V16, P1099, DOI 10.1038/sj.leu.2402489; Loning L, 2000, BLOOD, V95, P2770, DOI 10.1182/blood.V95.9.2770.009k16_2770_2775; Manera R, 2000, LEUKEMIA, V14, P1354, DOI 10.1038/sj.leu.2401835; Marina N, 1997, PEDIATR CLIN N AM, V44, P1021, DOI 10.1016/S0031-3955(05)70543-5; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; NEGLIA JP, 1991, NEW ENGL J MED, V325, P1330, DOI 10.1056/NEJM199111073251902; Novakovic B, 1997, J PEDIAT HEMATOL ONC, V19, P220, DOI 10.1097/00043426-199705000-00008; NYGAARD R, 1991, ACTA PAEDIATR SCAND, V80, P1220, DOI 10.1111/j.1651-2227.1991.tb11812.x; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PINKEL D, 1979, AM CANC SOC P NAT C, P191; Pui CH, 2003, J CLIN ONCOL, V21, P179, DOI 10.1200/JCO.2003.10.032; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; PUI CH, 1991, J CLIN ONCOL, V9, P1341, DOI 10.1200/JCO.1991.9.8.1341; Pui CH, 1998, BLOOD, V92, P411, DOI 10.1182/blood.V92.2.411.414k34_411_415; Rauck AM, 1999, MED PEDIATR ONCOL, V33, P60, DOI 10.1002/(SICI)1096-911X(199907)33:1<60::AID-MPO11>3.0.CO;2-H; Reis L.A.G., 2001, SEER CANC STAT REV 1; Relling MV, 1999, LANCET, V354, P34, DOI 10.1016/S0140-6736(98)11079-6; RIVERA GK, 1993, NEW ENGL J MED, V329, P1289, DOI 10.1056/NEJM199310283291801; RIVERA GK, 1991, LANCET, V337, P61, DOI 10.1016/0140-6736(91)90733-6; Schrappe M, 2000, BLOOD, V95, P3310; Silverman LB, 2001, BLOOD, V97, P1211, DOI 10.1182/blood.V97.5.1211; SIMONE J, 1972, CANCER-AM CANCER SOC, V30, P1488, DOI 10.1002/1097-0142(197212)30:6<1488::AID-CNCR2820300612>3.0.CO;2-D; TEBBI CK, 1989, CANCER, V63, P213, DOI 10.1002/1097-0142(19890101)63:1<213::AID-CNCR2820630134>3.0.CO;2-T; TEETER M A, 1987, Journal of Psychosocial Oncology, V5, P59; TETA MJ, 1986, J CHRON DIS, V39, P751, DOI 10.1016/0021-9681(86)90158-X; *US BUR CENS, 2001, CURR POP SURV REP; VANN JCJ, 1995, MED PEDIATR ONCOL, V25, P389, DOI 10.1002/mpo.2950250505; Vilmer E, 2000, LEUKEMIA, V14, P2257, DOI 10.1038/sj.leu.2401960; von der Weid N, 2003, EUR J CANCER, V39, P359, DOI 10.1016/S0959-8049(02)00260-5; Vora A, 1998, BLOOD, V92, P2334, DOI 10.1182/blood.V92.7.2334.2334_2334_2337; Waber Deborah P, 1997, Oncology (Williston Park), V11, P259; Walter AW, 1998, J CLIN ONCOL, V16, P3761, DOI 10.1200/JCO.1998.16.12.3761; ZEVON MA, 1990, AM J PEDIAT HEMATOL, V12, P454; 1991, FED REG, V56, P35725	54	312	325	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2003	349	7					640	649		10.1056/NEJMoa035091	http://dx.doi.org/10.1056/NEJMoa035091			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711FL	12917300				2022-12-24	WOS:000184728900004
J	Santarelli, L; Saxe, M; Gross, C; Surget, A; Battaglia, F; Dulawa, S; Weisstaub, N; Lee, J; Duman, R; Arancio, O; Belzung, C; Hen, R				Santarelli, L; Saxe, M; Gross, C; Surget, A; Battaglia, F; Dulawa, S; Weisstaub, N; Lee, J; Duman, R; Arancio, O; Belzung, C; Hen, R			Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants	SCIENCE			English	Article							CHOLINERGIC SYSTEMS; CELL-PROLIFERATION; MAJOR DEPRESSION; ANXIETY DISORDER; DENTATE GYRUS; ANIMAL-MODEL; GREY-MATTER; ADULT; STRESS; DESIPRAMINE	Various chronic antidepressant treatments increase adult hippocampal neurogenesis, but the functional importance of this phenomenon remains unclear. Here, using genetic and radiological methods, we show that disrupting antidepressant-induced neurogenesis blocks behavioral responses to antidepressants. Serotonin 1A receptor null mice were insensitive to the neurogenic and behavioral effects of fluoxetine, a serotonin selective reuptake inhibitor. X-irradiation of a restricted region of mouse brain containing the hippocampus prevented the neurogenic and behavioral effects of two classes of antidepressants. These findings suggest that the behavioral effects of chronic antidepressants may be mediated by the stimulation of neurogenesis in the hippocampus.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Tours, F-37200 Tours, France; NYU, Sch Med, Nathan Kline Res Inst, New York, NY 10016 USA; Yale Univ, Lab Mol Psychiat, Dept Psychiat, New Haven, CT 06508 USA	Columbia University; Universite de Tours; Nathan Kline Institute for Psychiatric Research; New York University; Yale University	Hen, R (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.		Dulawa, Stephanie/M-8070-2016; Weisstaub, Noelia/ABA-1706-2021; Surget, Alexandre/C-6630-2013; arancio, ottavio/AAB-7959-2019; Belzung, Catherine/P-6512-2016	Dulawa, Stephanie/0000-0003-1281-782X; Surget, Alexandre/0000-0002-0333-4634; Belzung, Catherine/0000-0001-6095-5974; arancio, ottavio/0000-0001-6335-164X				Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; BODNOFF SR, 1988, PSYCHOPHARMACOLOGY, V95, P298; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Deacon RMJ, 2002, BEHAV NEUROSCI, V116, P494, DOI 10.1037//0735-7044.116.3.494; Degroot A, 2002, BRAIN RES, V949, P60, DOI 10.1016/S0006-8993(02)02965-7; Delgado PL, 1999, BIOL PSYCHIAT, V46, P212, DOI 10.1016/S0006-3223(99)00014-1; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Eichenbaum H, 1999, CURR BIOL, V9, pR482, DOI 10.1016/S0960-9822(99)80301-7; File SE, 2000, PHARMACOL BIOCHEM BE, V66, P65, DOI 10.1016/S0091-3057(00)00198-2; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Gorman JM, 2002, J CLIN PSYCHIAT, V63, P17; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Griebel G, 2002, P NATL ACAD SCI USA, V99, P6370, DOI 10.1073/pnas.092012099; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Kempermann G, 2002, BIPOLAR DISORD, V4, P17, DOI 10.1034/j.1399-5618.2002.40101.x; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McNaughton N, 1997, PHARMACOL BIOCHEM BE, V56, P603, DOI 10.1016/S0091-3057(96)00419-4; Menard J, 2001, BRAIN RES, V888, P163, DOI 10.1016/S0006-8993(00)03046-8; Menard J, 1998, BEHAV PHARMACOL, V9, P93; Moore GJ, 2000, LANCET, V356, P1241, DOI 10.1016/S0140-6736(00)02793-8; Nagai R, 2000, SURG NEUROL, V53, P503, DOI 10.1016/S0090-3019(00)00214-7; Page ME, 1999, PSYCHOPHARMACOLOGY, V147, P162, DOI 10.1007/s002130051156; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Sapolsky RM, 1992, STRESS AGING BRAIN M; Sargent PA, 2000, ARCH GEN PSYCHIAT, V57, P174, DOI 10.1001/archpsyc.57.2.174; Shah PJ, 1998, BRIT J PSYCHIAT, V172, P527, DOI 10.1192/bjp.172.6.527; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566	37	3273	3465	13	477	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					805	809		10.1126/science.1083328	http://dx.doi.org/10.1126/science.1083328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907793				2022-12-24	WOS:000184615700036
J	Huang, YF; Lemieux, MJ; Song, JM; Auer, M; Wang, DN				Huang, YF; Lemieux, MJ; Song, JM; Auer, M; Wang, DN			Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli	SCIENCE			English	Article								The major facilitator superfamily represents the largest group of secondary membrane transporters in the cell. Here we report the 3.3 angstrom resolution structure of a member of this superfamily, GlpT, which transports glycerol-3-phosphate into the cytoplasm and inorganic phosphate into the periplasm. The amino- and carboxyl-terminal halves of the protein exhibit a pseudo two-fold symmetry. Closed off to the periplasm, a centrally located substrate-translocation pore contains two arginines at its closed end, which comprise the substrate-binding site. Upon substrate binding, the protein adopts a more compact conformation. We propose that GlpT operates by a single-binding site, alternating-access mechanism through a rocker-switch type of movement.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Wang, DN (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.			Wang, Da-Neng/0000-0002-6496-4699; Lemieux, Joanne/0000-0003-4745-9153				AMBUDKAR SV, 1990, J BIOL CHEM, V265, P12287; AMBUDKAR SV, 1986, J BIOL CHEM, V261, P9083; ASANO T, 1992, FEBS LETT, V298, P129, DOI 10.1016/0014-5793(92)80038-I; Auer M, 2001, BIOCHEMISTRY-US, V40, P6628, DOI 10.1021/bi010138+; Chamberlain AK, 2003, ADV PROTEIN CHEM, V63, P19; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chen LY, 2002, HUM MOL GENET, V11, P3199, DOI 10.1093/hmg/11.25.3199; CHIN JJ, 1986, J BIOL CHEM, V261, P7101; CREIGHTON TE, 1983, PROTEINS STRUCTURES, P137; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; ELVIN CM, 1985, J BACTERIOL, V161, P1054, DOI 10.1128/JB.161.3.1054-1058.1985; Fann MC, 1998, J MEMBRANE BIOL, V164, P187, DOI 10.1007/s002329900404; Fann MC, 1998, J BIOL CHEM, V273, P33735, DOI 10.1074/jbc.273.50.33735; GOTT P, 1988, MOL MICROBIOL, V2, P655, DOI 10.1111/j.1365-2958.1988.tb00074.x; Green AL, 2000, J BIOL CHEM, V275, P23240, DOI 10.1074/jbc.M909202199; Hall JA, 1999, J BIOL CHEM, V274, P6148, DOI 10.1074/jbc.274.10.6148; HAYASHI S, 1964, J BIOL CHEM, V239, P3098; Henderson PJF, 1993, CURR OPIN CELL BIOL, V5, P708, DOI 10.1016/0955-0674(93)90144-F; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; Jencks W P, 1980, Adv Enzymol Relat Areas Mol Biol, V51, P75; JessenMarshall AE, 1996, J BIOL CHEM, V271, P1400, DOI 10.1074/jbc.271.3.1400; JUNG EKY, 1986, J BIOL CHEM, V261, P9155; Kaback HR, 1997, Q REV BIOPHYS, V30, P333, DOI 10.1017/S0033583597003387; KAHN BB, 1992, J CLIN INVEST, V89, P1367, DOI 10.1172/JCI115724; LEMIEUX MA, UNPUB; Levy SB, 2002, J APPL MICROBIOL, V92, p65S, DOI 10.1046/j.1365-2672.92.5s1.4.x; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; MALONEY PC, 1990, MICROBIOL REV, V54, P1; Matos M, 1996, J BIOL CHEM, V271, P18571, DOI 10.1074/jbc.271.31.18571; Mitchell P, 1963, BIOCH SOC S, V22, P141; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OLSEN SG, 1993, J BACTERIOL, V175, P6269, DOI 10.1128/JB.175.19.6269-6275.1993; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; REIZER J, 1993, PROTEIN SCI, V2, P20, DOI 10.1002/pro.5560020103; RIORDAN JF, 1979, MOL CELL BIOCHEM, V26, P71; ROCK CO, 1985, BIOCH LIPIDS MEMBRAN, P73; Sato M, 1999, J BIOL CHEM, V274, P24721, DOI 10.1074/jbc.274.35.24721; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; TANFORD C, 1983, ANNU REV BIOCHEM, V52, P379, DOI 10.1146/annurev.bi.52.070183.002115; Wang D, 2000, HUM MUTAT, V16, P224, DOI 10.1002/1098-1004(200009)16:3<224::AID-HUMU5>3.0.CO;2-P; West IC, 1997, BBA-REV BIOMEMBRANES, V1331, P213, DOI 10.1016/S0304-4157(97)00007-5	44	823	849	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					616	620		10.1126/science.1087619	http://dx.doi.org/10.1126/science.1087619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893936				2022-12-24	WOS:000184473600031
J	Gordon, JM; Feuermann, D; Huleihil, M; Mizrahi, S; Shaco-Levy, R				Gordon, JM; Feuermann, D; Huleihil, M; Mizrahi, S; Shaco-Levy, R			Fibre optics - Surgery by sunlight on live animals	NATURE			English	Editorial Material							SOLAR SURGERY		Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Dept Solar Energy & Environm Phys, IL-84990 Sede Boqer, Israel; Ben Gurion Univ Negev, Dept Mech Engn, Pearlstone Ctr Aeronaut Engn Studies, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Dept Surg A, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Dept Pathol, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University	Gordon, JM (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Dept Solar Energy & Environm Phys, IL-84990 Sede Boqer, Israel.		GORDON, JEFFREY/F-1432-2012; feuermann, daniel/G-7545-2011	feuermann, daniel/0000-0002-9381-2387				De Sanctis JT, 1998, CARDIOVASC INTER RAD, V21, P273, DOI 10.1007/s002709900263; Feuermann D, 1998, OPT ENG, V37, P2760, DOI 10.1117/1.601813; Feuermann D, 2002, SOL ENERGY, V72, P459, DOI 10.1016/S0038-092X(02)00025-7; Fujitomi Y, 1999, LASER SURG MED, V24, P14, DOI 10.1002/(SICI)1096-9101(1999)24:1<14::AID-LSM4>3.0.CO;2-2; Gordon JM, 2003, J APPL PHYS, V93, P4843, DOI 10.1063/1.1558999; Gordon JM, 2002, APPL PHYS LETT, V81, P2653, DOI 10.1063/1.1510942; Katzir A., 1993, LASERS OPTICAL FIBER	7	14	14	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					510	510		10.1038/424510a	http://dx.doi.org/10.1038/424510a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891346	Bronze			2022-12-24	WOS:000184454700030
J	Harris, KD; Csicsvari, J; Hirase, H; Dragoi, G; Buzsaki, G				Harris, KD; Csicsvari, J; Hirase, H; Dragoi, G; Buzsaki, G			Organization of cell assemblies in the hippocampus	NATURE			English	Article							PYRAMIDAL CELLS; PHASE PRECESSION; BEHAVING RAT; PLACE CELLS; NEURONS; OSCILLATIONS; ENSEMBLE; CODE; DYNAMICS; PATTERNS	Neurons can produce action potentials with high temporal precision(1). A fundamental issue is whether, and how, this capability is used in information processing. According to the 'cell assembly' hypothesis, transient synchrony of anatomically distributed groups of neurons underlies processing of both external sensory input and internal cognitive mechanisms(2-4). Accordingly, neuron populations should be arranged into groups whose synchrony exceeds that predicted by common modulation by sensory input. Here we find that the spike times of hippocampal pyramidal cells can be predicted more accurately by using the spike times of simultaneously recorded neurons in addition to the animals location in space. This improvement remained when the spatial prediction was refined with a spatially dependent theta phase modulation(5-8). The time window in which spike times are best predicted from simultaneous peer activity is 10-30 ms, suggesting that cell assemblies are synchronized at this timescale. Because this temporal window matches the membrane time constant of pyramidal neurons(9), the period of the hippocampal gamma oscillation(10) and the time window for synaptic plasticity(11), we propose that cooperative activity at this timescale is optimal for information transmission and storage in cortical circuits.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.		Hirase, Hajime/A-3709-2012; Harris, Kenneth/B-3469-2009	Hirase, Hajime/0000-0003-3806-6905; Harris, Kenneth/0000-0002-5930-6456; Buzsaki, Gyorgy/0000-0002-3100-4800				Brown EN, 1998, J NEUROSCI, V18, P7411; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; Cox D., 1980, POINT PROCESSES; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Freiwald W A, 2001, Prog Brain Res, V130, P111; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hebb D.O., 1949, ORG BEHAV; Hirase H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0003.2001; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; Reinagel P, 2002, J NEUROSCI, V22, P6837; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	30	554	559	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					552	556		10.1038/nature01834	http://dx.doi.org/10.1038/nature01834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891358				2022-12-24	WOS:000184454700043
J	Takaoka, A; Hayakawa, S; Yanai, H; Stoiber, D; Negishi, H; Kikuchi, H; Sasaki, S; Imai, K; Shibue, T; Honda, K; Taniguchi, T				Takaoka, A; Hayakawa, S; Yanai, H; Stoiber, D; Negishi, H; Kikuchi, H; Sasaki, S; Imai, K; Shibue, T; Honda, K; Taniguchi, T			Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence	NATURE			English	Article							DNA-DAMAGE; TRANSCRIPTIONAL ACTIVATION; P53-INDUCED APOPTOSIS; CANCER-CELLS; GENE; PHOSPHORYLATION; VIRUSES; PROTEIN; PATHWAY; AGENTS	Swift elimination of undesirable cells is an important feature in tumour suppression and immunity. The tumour suppressor p53 and interferon-alpha and -beta (IFN-alpha/beta) are essential for the induction of apoptosis in cancerous cells and in antiviral immune responses, respectively, but little is known about their interrelationship. Here we show that transcription of the p53 gene is induced by IFN-alpha/beta, accompanied by an increase in p53 protein level. IFN-alpha/beta signalling itself does not activate p53; rather, it contributes to boosting p53 responses to stress signals. We show examples in which p53 gene induction by IFN-alpha/beta contributes to tumour suppression. Furthermore, we show that p53 is activated in virally infected cells to evoke an apoptotic response and that p53 is critical for antiviral defence of the host. Our study reveals a hitherto unrecognized link between p53 and IFN-alpha/beta in tumour suppression and antiviral immunity, which may have therapeutic implications.	Univ Tokyo, Fac Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Sapporo Med Univ, Sch Med, Dept Internal Med 1, Chuo Ku, Sapporo, Hokkaido 0608556, Japan	University of Tokyo; University of Tokyo; Sapporo Medical University	Taniguchi, T (corresponding author), Univ Tokyo, Fac Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.		Yang, Chen/G-1379-2010; Honda, Kenya/N-5297-2015; Yanai, Hideyuki/AGK-5933-2022	Yanai, Hideyuki/0000-0002-0115-9000; Stoiber-Sakaguchi, Dagmar/0000-0002-8824-0767				Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Bluyssen Hans A. R., 1996, Cytokine and Growth Factor Reviews, V7, P11, DOI 10.1016/1359-6101(96)00005-6; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; BUTZ K, 1995, ONCOGENE, V10, P927; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Demaeyer E., 1988, INTERFERONS OTHER RE; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; FUJITA T, 1985, CELL, V41, P489, DOI 10.1016/S0092-8674(85)80022-2; GINSBERG D, 1990, ONCOGENE, V5, P1285; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Gresser I, 2002, CYTOKINE GROWTH F R, V13, P111, DOI 10.1016/S1359-6101(01)00035-1; GUTTERMAN JU, 1994, P NATL ACAD SCI USA, V91, P1198, DOI 10.1073/pnas.91.4.1198; HAQUE SJ, 1994, J BIOL CHEM, V269, P19523; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987; Jacks T, 1996, NATURE, V381, P643, DOI 10.1038/381643a0; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; Koromilas AE, 2001, CYTOKINE GROWTH F R, V12, P157, DOI 10.1016/S1359-6101(00)00023-X; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Mendonca MS, 1999, CANCER RES, V59, P3972; Miyamoto A, 2000, J GASTROEN HEPATOL, V15, P1447, DOI 10.1046/j.1440-1746.2000.02289.x; Neil JC, 1997, TRENDS MICROBIOL, V5, P115, DOI 10.1016/S0966-842X(96)10083-4; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OREN M, 1994, SEMIN CANCER BIOL, V5, P221; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Pfeffer LM, 1998, CANCER RES, V58, P2489; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Prives C, 1999, J PATHOL, V187, P112; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Strander H, 1996, BIOTHERAPY, V8, P213, DOI 10.1007/BF01877207; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; TSUKADA T, 1993, ONCOGENE, V8, P3313; Veldman T, 2001, J VIROL, V75, P4467, DOI 10.1128/JVI.75.9.4467-4472.2001; VILCEK J, 1996, FIELDS VIROLOGY, P375; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WADLER S, 1990, CANCER RES, V50, P3473; Westphal CH, 1997, CANCER RES, V57, P1664; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	50	692	772	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					516	523		10.1038/nature01850	http://dx.doi.org/10.1038/nature01850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12872134	Bronze			2022-12-24	WOS:000184454700033
J	Marquet, RL; Bartelds, A; Visser, GJ; Spreeuwenberg, P; Peters, L				Marquet, RL; Bartelds, A; Visser, GJ; Spreeuwenberg, P; Peters, L			Twenty five years of requests for euthanasia and physician assisted suicide in Dutch general practice: trend analysis	BRITISH MEDICAL JOURNAL			English	Article									Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands	Netherlands Institute for Health Services Research	Marquet, RL (corresponding author), Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands.							de Wit MAS, 2001, EMERG INFECT DIS, V7, P82, DOI 10.3201/eid0701.010113; Hughes J, 2000, J Appl Philos, V17, P213, DOI 10.1111/1468-5930.00155; Lavery JV, 2001, LANCET, V358, P362, DOI 10.1016/S0140-6736(01)05555-6; ONWUTEAKAPHILIP.BD, 1990, LANCET; Thynne Kelisiana, 2002, J Law Med, V10, P232	5	30	30	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2003	327	7408					201	202		10.1136/bmj.327.7408.201	http://dx.doi.org/10.1136/bmj.327.7408.201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706DL	12881262	Bronze, Green Published			2022-12-24	WOS:000184437300018
J	Cheng, EHY; Sheiko, TV; Fisher, JK; Craigen, WJ; Korsmeyer, SJ				Cheng, EHY; Sheiko, TV; Fisher, JK; Craigen, WJ; Korsmeyer, SJ			VDAC2 inhibits BAK activation and mitochondrial apoptosis	SCIENCE			English	Article							DEPENDENT ANION CHANNEL; BCL-X-L; CYTOCHROME-C; PERMEABILITY TRANSITION; PROTEIN; FAMILY; DEATH; RELEASE; DYSFUNCTION; RESPIRATION	The multidomain proapoptotic molecules BAK or BAX are required to initiate the mitochondrial pathway of apoptosis. How cells maintain the potentially lethal proapoptotic effector BAK in a monomeric inactive conformation at mitochondria is unknown. In viable cells, we found BAK complexed with mitochondrial outer-membrane protein VDAC2, a VDAC isoform present in low abundance that interacts specifically with the inactive conformer of BAK. Cells deficient in VDAC2, but not cells lacking the more abundant VDAC1, exhibited enhanced BAK oligomerization and were more susceptible to apoptotic death. Conversely, overexpression of VDAC2 selectively prevented BAK activation and inhibited the mitochondrial apoptotic pathway. Death signals activate "BH3-only" molecules such as tBID, BIM, or BAD, which displace VDAC2 from BAK, enabling homo-oligomerization of BAK and apoptosis. Thus, VDAC2, an isoform restricted to mammals, regulates the activity of BAK and provides a connection between mitochondrial physiology and the core apoptotic pathway.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Baylor College of Medicine	Korsmeyer, SJ (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, 44 Binney St, Boston, MA 02115 USA.	stanley_korsmeyer@dfci.harvard.edu			NATIONAL CANCER INSTITUTE [R37CA050239] Funding Source: NIH RePORTER; NCI NIH HHS [R37CA50239] Funding Source: Medline; NINDS NIH HHS [NS42319] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; CHENG EH, UNPUB; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; CRAIGEN WJ, UNPUB; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, J BIOL CHEM, V275, P12321, DOI 10.1074/jbc.275.16.12321; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Vander Heiden MG, 1999, MOL CELL, V3, P159; Weeber EJ, 2002, J BIOL CHEM, V277, P18891, DOI 10.1074/jbc.M201649200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wu SL, 1999, BBA-MOL CELL RES, V1452, P68, DOI 10.1016/S0167-4889(99)00120-2; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	29	619	643	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					513	517		10.1126/science.1083995	http://dx.doi.org/10.1126/science.1083995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881569				2022-12-24	WOS:000184340500042
J	Roman, J; Palumbi, SR				Roman, J; Palumbi, SR			Whales before whaling in the North Atlantic	SCIENCE			English	Article							POPULATION-SIZE; HUMPBACK WHALES; CONSERVATION; POLYMORPHISM; JAPANESE; COLLAPSE	It is well known that hunting dramatically reduced all baleen whale populations, yet reliable estimates of former whale abundances are elusive. Based on coalescent models for mitochondrial DNA sequence variation, the genetic diversity of North Atlantic whales suggests population sizes of approximately 240,000 humpback, 360,000 fin, and 265,000 minke whales. Estimates for fin and humpback whales are far greater than those previously calculated for prewhaling populations and 6 to 20 times higher than present-day population estimates. Such discrepancies suggest the need for a quantitative reevaluation of historical whale populations and a fundamental revision in our conception of the natural state of the oceans.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Roman, J (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.							Angliss RP, 1995, REP INT WHAL COMM, V45, P313; [Anonymous], 1999, WALKERS MAMMALS WORL; AVISE JC, 1988, MOL BIOL EVOL, V5, P331; Baker CS, 2000, P ROY SOC B-BIOL SCI, V267, P1191, DOI 10.1098/rspb.2000.1128; BAKER CS, 1993, P NATL ACAD SCI USA, V90, P8239, DOI 10.1073/pnas.90.17.8239; Barlow J, 1997, ECOLOGY, V78, P535; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Horwood J, 1990, BIOL EXPLOITATION MI; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kellogg R., 1922, Proceedings of the United States National Museum, V61, P1; KISHINO H, 1991, ANN I STAT MATH, V43, P435, DOI 10.1007/BF00053365; Klinowska M., 1991, DOLPHINS PORPOISES W; Lockyer C, 1977, Report int Whal Commn, V27, P427; Lockyer C., 1984, REP INT WHAL COMMN S, V6, P27; Lockyer C, 1981, REP INT WHAL COMMN, V31, P389; MATHER R, 1850, J R MATHER; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Neigel JE, 2002, CONSERV GENET, V3, P167, DOI 10.1023/A:1015213626922; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Rand DM, 1996, CONSERV BIOL, V10, P665, DOI 10.1046/j.1523-1739.1996.10020665.x; ROMAN JM, UNPUB; Rooney AP, 2001, EVOLUTION, V55, P1678; Rosenbaum HC, 2002, J HERED, V93, P389, DOI 10.1093/jhered/93.6.389; Sergeant D. E., 1977, Report int. Whal. Commn, V27, P460; Sigurjonsson J, 1995, DEV MAR BIO, V4, P425; Smith TD, 1999, MAR MAMMAL SCI, V15, P1, DOI 10.1111/j.1748-7692.1999.tb00779.x; Soule M., 1976, Molecular evolution., P60; STEVICK PT, 2001, SC53NAH2 IWC; WADA S, 1991, REPORTS INT WHALING, V13, P125; WAPLES R, 1991, REP INT WHALING COMM, V15, P279; Weller David W., 2002, Journal of Cetacean Research and Management, V4, P7; Winn H.E., 1985, HDB MARINE MAMMALS, V3, P241	36	219	238	2	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					508	510		10.1126/science.1084524	http://dx.doi.org/10.1126/science.1084524			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881568				2022-12-24	WOS:000184340500040
J	Buffelli, M; Burgess, RW; Feng, GP; Lobe, CG; Lichtman, JW; Sanes, JR				Buffelli, M; Burgess, RW; Feng, GP; Lobe, CG; Lichtman, JW; Sanes, JR			Genetic evidence that relative synaptic efficacy biases the outcome of synaptic competition	NATURE			English	Article								Synaptic activity drives synaptic rearrangement in the vertebrate nervous system; indeed, this appears to be a main way in which experience shapes neural connectivity(1,2). One rearrangement that occurs in many parts of the nervous system during early postnatal life is a competitive process called 'synapse elimination'(3,4). At the neuromuscular junction, where synapse elimination has been analysed in detail, muscle fibres are initially innervated by multiple axons, then all but one are withdrawn and the 'winner' enlarges(4-6). In support of the idea that synapse elimination is activity dependent, it is slowed or speeded when total neuromuscular activity is decreased or increased, respectively(4,7-13). However, most hypotheses about synaptic rearrangement postulate that change depends less on total activity than on the relative activity of the competitors(1-4,13,14). Intuitively, it seems that the input best able to excite its postsynaptic target would be most likely to win the competition, but some theories and results make other predictions(14-18). Here we use a genetic method to selectively inhibit neurotransmission from one of two inputs to a single target cell. We show that more powerful inputs are strongly favoured competitors during synapse elimination.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Verona, Dipartimento Sci Neurol & Vis, I-37129 Verona, Italy; Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON MN4 3M5, Canada	Washington University (WUSTL); University of Verona; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Sanes, JR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid, St Louis, MO 63110 USA.	sanesj@pcg.wustl.edu	Buffelli, Mario/C-6953-2018; Feng, Guoping/Y-2827-2019	Buffelli, Mario/0000-0002-3709-013X; Burgess, Robert/0000-0002-9229-3407				Barber MJ, 1999, J NEUROSCI, V19, P9975; BENOIT P, 1975, BRAIN RES, V99, P354, DOI 10.1016/0006-8993(75)90036-0; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Buffelli M, 2002, P NATL ACAD SCI USA, V99, P13200, DOI 10.1073/pnas.202471199; Busetto G, 2000, J NEUROSCI, V20, P685, DOI 10.1523/JNEUROSCI.20-02-00685.2000; CALLAWAY EM, 1987, NATURE, V328, P422, DOI 10.1038/328422a0; Costanzo EM, 2000, NAT NEUROSCI, V3, P694, DOI 10.1038/76649; DING R, 1983, J NEUROCYTOL, V12, P887, DOI 10.1007/BF01153341; DUXSON MJ, 1982, J NEUROCYTOL, V11, P395, DOI 10.1007/BF01257985; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Hata Y, 1999, NEURON, V22, P375, DOI 10.1016/S0896-6273(00)81097-1; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; OBRIEN RAD, 1978, J PHYSIOL-LONDON, V282, P571, DOI 10.1113/jphysiol.1978.sp012482; Personius KE, 2002, NEUROSCIENTIST, V8, P414, DOI 10.1177/107385802236970; Personius KE, 2001, NEURON, V31, P395, DOI 10.1016/S0896-6273(01)00369-5; RIDGE RMAP, 1984, J NEUROSCI, V4, P2614; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; THOMPSON W, 1983, NATURE, V302, P614, DOI 10.1038/302614a0; THOMPSON W, 1979, NEUROSCIENCE, V4, P271, DOI 10.1016/0306-4522(79)90088-5; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X	30	231	234	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					430	434		10.1038/nature01844	http://dx.doi.org/10.1038/nature01844			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879071				2022-12-24	WOS:000184318400044
J	Punglia, RS; D'Amico, AV; Catalona, WJ; Roehl, KA; Kuntz, KM				Punglia, RS; D'Amico, AV; Catalona, WJ; Roehl, KA; Kuntz, KM			Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RADICAL PROSTATECTOMY; REFERENCE RANGES; BIOPSY STRATEGY; 4.0 NG/ML; FREE PSA; MEN; POPULATION; DISEASE; AGE; HYPERPLASIA	Background: The sensitivity and specificity of a screening test are biased when disease status is not verified in all subjects and when the likelihood of confirmation depends on the test result itself. We assessed the screening characteristics of the prostate-specific antigen (PSA) measurement after correction for verification bias. Methods: Between 1995 and 2001, 6691 men underwent PSA-based screening for prostate cancer. Of these men, 705 (11 percent) subsequently underwent biopsy of the prostate. Under the assumption that the chance of undergoing a biopsy depends only on the PSA-test result and other observed clinical variables, we used a mathematical model to estimate adjusted receiver-operating-characteristic (ROC) curves. Results: Adjusting for verification bias significantly increased the area under the ROC curve (i.e., the overall diagnostic performance) of the PSA test, as compared with an unadjusted analysis (0.86 vs. 0.69, P<0.001, for men less than 60 years of age; 0.72 vs. 0.62, P=0.008, for men 60 years of age or older). If the threshold PSA value for undergoing biopsy were set at 4.1 ng per milliliter, 82 percent of cancers in younger men and 65 percent of cancers in older men would be missed. A digital rectal examination that is abnormal but not suspicious for cancer does not affect the overall performance characteristics of the test. Conclusions: A lower threshold level of PSA for recommending prostate biopsy, particularly in younger men, may improve the clinical value of the PSA test.	Harvard Univ, Sch Med, Joint Ctr Radiat Therapy, Boston, MA USA; Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Washington Univ, Sch Med, Div Urol Surg, St Louis, MO USA; Northwestern Univ, Fineberg Sch Med, Dept Urol, Chicago, IL USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Washington University (WUSTL); Northwestern University; Feinberg School of Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Kuntz, KM (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, 718 Huntington Ave, Boston, MA 02115 USA.				AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000020] Funding Source: NIH RePORTER; AHRQ HHS [T32 HS00020-16] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Babaian RJ, 2000, J UROLOGY, V163, P152, DOI 10.1016/S0022-5347(05)67993-1; Babaian RJ, 2001, J UROLOGY, V165, P757, DOI 10.1016/S0022-5347(05)66519-6; BEGG CB, 1983, BIOMETRICS, V39, P207, DOI 10.2307/2530820; Carvalhal GF, 1999, J UROLOGY, V161, P835, DOI 10.1016/S0022-5347(01)61785-3; Catalona WJ, 2000, UROLOGY, V55, P791, DOI 10.1016/S0090-4295(99)00602-0; CATALONA WJ, 1993, JAMA-J AM MED ASSOC, V270, P948, DOI 10.1001/jama.270.8.948; Catalona WJ, 1997, JAMA-J AM MED ASSOC, V277, P1452, DOI 10.1001/jama.277.18.1452; Cotter MP, 2002, PROSTATE, V50, P216, DOI 10.1002/pros.10051; Durkan GC, 2002, BJU INT, V89, P33, DOI 10.1046/j.1464-410X.2002.02555.x; Eskew LA, 1997, J UROLOGY, V157, P199, DOI 10.1016/S0022-5347(01)65322-9; Froelicher VF, 1998, ANN INTERN MED, V128, P965, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00001; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Krumholtz JS, 2002, UROLOGY, V60, P469, DOI 10.1016/S0090-4295(02)01875-7; Meigs JB, 1996, J GEN INTERN MED, V11, P505, DOI 10.1007/BF02599596; Miller MC, 2001, UROLOGY, V57, P1105, DOI 10.1016/S0090-4295(01)00953-0; Morgan TO, 1996, NEW ENGL J MED, V335, P304, DOI 10.1056/NEJM199608013350502; NADLER RB, 1995, J UROLOGY, V154, P407, DOI 10.1016/S0022-5347(01)67064-2; Naughton CK, 2000, J UROLOGY, V164, P388, DOI 10.1016/S0022-5347(05)67367-3; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; Richter F, 2001, J CANCER EDUC, V16, P38; Sirovich BE, 2002, J GEN INTERN MED, V17, P212; Smith DS, 1998, J UROLOGY, V160, P1734, DOI 10.1016/S0022-5347(01)62395-4; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Walsh P C, 1994, Important Adv Oncol, P211; Wolff JM, 1996, UROL INT, V57, P170, DOI 10.1159/000282904	28	237	261	2	11	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					335	342		10.1056/NEJMoa021659	http://dx.doi.org/10.1056/NEJMoa021659			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878740				2022-12-24	WOS:000184312800006
J	Vincentelli, A; Susen, S; Le Tourneau, T; Six, I; Fabre, O; Juthier, F; Bauters, A; Decoene, C; Goudemand, J; Prat, A; Jude, B				Vincentelli, A; Susen, S; Le Tourneau, T; Six, I; Fabre, O; Juthier, F; Bauters, A; Decoene, C; Goudemand, J; Prat, A; Jude, B			Acquired von Willebrand syndrome in aortic stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLEEDING GASTROINTESTINAL ANGIODYSPLASIA; VONWILLEBRAND-FACTOR; SHEAR-STRESS; VALVE REPLACEMENT; DISEASE; PLASMA; PROTEOLYSIS; SUBTYPES; CLEAVAGE; TESTS	Background: Aortic-valve stenosis can be complicated by bleeding that is associated with acquired type 2A von Willebrand syndrome. However, the prevalence and cause of the hemostatic abnormality in aortic stenosis are unknown. Methods: We enrolled 50 consecutive patients with aortic stenosis, who completed a standardized screening questionnaire to detect a history of bleeding. Forty-two patients with severe aortic stenosis underwent valve replacement. Platelet function under conditions of high shear stress, von Willebrand factor collagen-binding activity and antigen levels, and the multimeric structure of von Willebrand factor were assessed at base line and one day, seven days, and six months postoperatively. Results: Skin or mucosal bleeding occurred in 21 percent of the patients with severe aortic stenosis. Platelet-function abnormalities under conditions of high shear stress, decreased von Willebrand factor collagen-binding activity and the loss of the largest multimers, or a combination of these was present in 67 to 92 percent of patients with severe aortic stenosis and correlated significantly with the severity of valve stenosis. Primary hemostatic abnormalities were completely corrected on the first day after surgery but tended to recur at six months, especially when there was a mismatch between patient and prosthesis (with an effective orifice area of less than 0.8 cm(sup 2) per square meter of body-surface area). Conclusions: Type 2A von Willebrand syndrome is common in patients with severe aortic stenosis. Von Willebrand factor abnormalities are directly related to the severity of aortic stenosis and are improved by valve replacement in the absence of mismatch between patient and prosthesis.	Univ Lille 2, Equipe Accueil 2693, Fac Med, Lille, France; Clin Chirurg Cardiovasc, Lille, France; Inst Hematol Biol & Hemobiol Transfus, Lille, France; Serv Explorat Fonct Cardiol, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Jude, B (corresponding author), Hop Cardiol, Inst Hematol Biol & Hemobiol Transfus, Blvd Prof J Leclercq, F-59037 Lille, France.		susen, sophie/G-4337-2018; Le Tourneau, Thierry/D-5428-2015	Vincentelli, Andre/0000-0003-4081-786X; Susen, Sophie/0000-0001-5953-163X; Juthier, Francis/0000-0002-5072-9073				Anderson RP, 1996, LANCET, V347, P689, DOI 10.1016/S0140-6736(96)91240-4; BLERY C, 1986, LANCET, V1, P139; Bonow R O, 1998, J Heart Valve Dis, V7, P672; CAPPELL MS, 1986, ANN INTERN MED, V105, P54, DOI 10.7326/0003-4819-105-1-54; Carabello BA, 2002, NEW ENGL J MED, V346, P677, DOI 10.1056/NEJMcp010846; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; Favaloro EJ, 2000, THROMB HAEMOSTASIS, V84, P541; Federici, 2000, THROMB HAEMOSTASIS, V84, P739; Federici AB, 2000, THROMB HAEMOSTASIS, V84, P345; Fressinaud E, 1998, BLOOD, V91, P1325, DOI 10.1182/blood.V91.4.1325; GILL JC, 1986, BLOOD, V67, P758; GREENSTEIN RJ, 1986, AM J SURG, V151, P347, DOI 10.1016/0002-9610(86)90465-4; HEYDE EC, 1958, NEW ENGL J MED, V259, P196; KING RM, 1987, ANN THORAC SURG, V44, P514, DOI 10.1016/S0003-4975(10)62112-1; MAMMEN EF, 1995, SEMIN THROMB HEMOST, V21, P113; Mazurier C, 1998, HAEMOPHILIA, V4, P40; Pareti FI, 2000, CIRCULATION, V102, P1290, DOI 10.1161/01.CIR.102.11.1290; RAPAPORT SI, 1983, BLOOD, V61, P229; RUGGERI ZM, 1980, J CLIN INVEST, V65, P1318, DOI 10.1172/JCI109795; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Sugimoto M, 2003, BLOOD, V101, P915, DOI 10.1182/blood-2002-03-0944; TSAI HM, 1994, BLOOD, V83, P2171; Veyradier A, 2001, GASTROENTEROLOGY, V120, P346, DOI 10.1053/gast.2001.21204; Veyradier A, 2000, THROMB HAEMOSTASIS, V84, P175, DOI 10.1055/s-0037-1613993; WARKENTIN TE, 1992, LANCET, V340, P35, DOI 10.1016/0140-6736(92)92434-H; Warkentin TE, 2002, NEW ENGL J MED, V347, P858, DOI 10.1056/NEJM200209123471122; ZIMMERMAN TS, 1986, J CLIN INVEST, V77, P947, DOI 10.1172/JCI112394	27	570	589	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					343	349		10.1056/NEJMoa022831	http://dx.doi.org/10.1056/NEJMoa022831			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878741				2022-12-24	WOS:000184312800007
J	de Craen, AJ; Gussekloo, J; Teng, YKO; Macfarlane, PW; Westendorp, RGJ				de Craen, AJ; Gussekloo, J; Teng, YKO; Macfarlane, PW; Westendorp, RGJ			Prevalence of five common clinical abnormalities in very elderly people: population based cross sectional study	BRITISH MEDICAL JOURNAL			English	Article									Leiden Univ, Med Ctr, Sect Gerontol & Geriatr, Dept Gen Internal Med, NL-2300 RC Leiden, Netherlands; Univ Glasgow, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Glasgow	de Craen, AJ (corresponding author), Leiden Univ, Med Ctr, Sect Gerontol & Geriatr, Dept Gen Internal Med, POB 9600, NL-2300 RC Leiden, Netherlands.		Gussekloo, Jacobijn/ABE-3879-2021; Teng, Yoe Kie Onno/S-1765-2019	Gussekloo, Jacobijn/0000-0001-7186-8278; Teng, Yoe Kie Onno/0000-0001-9920-2195				IZAKS GJ, 1999, JAMA-J AM MED ASSOC, V18, P714; Macfarlane PW, 1996, J ELECTROCARDIOL, V29, P29, DOI 10.1016/S0022-0736(96)80016-1; TOPOL E.J., 1998, TXB CARDIOVASCULAR M; von Faber M, 2001, ARCH INTERN MED, V161, P2694, DOI 10.1001/archinte.161.22.2694; *WHO, 1996, GUID ATC CLASS DDD A	5	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2003	327	7407					131	132		10.1136/bmj.327.7407.131	http://dx.doi.org/10.1136/bmj.327.7407.131			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869453	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000184247500016
J	Grimsby, J; Sarabu, R; Corbett, WL; Haynes, NE; Bizzarro, FT; Coffey, JW; Guertin, KR; Hilliard, DW; Kester, RF; Mahaney, PE; Marcus, L; Qi, LD; Spence, CL; Tengi, J; Magnuson, MA; Chu, CA; Dvorozniak, MT; Matschinsky, FM; Grippo, JF				Grimsby, J; Sarabu, R; Corbett, WL; Haynes, NE; Bizzarro, FT; Coffey, JW; Guertin, KR; Hilliard, DW; Kester, RF; Mahaney, PE; Marcus, L; Qi, LD; Spence, CL; Tengi, J; Magnuson, MA; Chu, CA; Dvorozniak, MT; Matschinsky, FM; Grippo, JF			Allosteric activators of glucokinase: Potential role in diabetes therapy	SCIENCE			English	Article							GLUCOSE-HOMEOSTASIS; BETA-CELL; MUTATIONS; MELLITUS; MUTANTS; MODY-2; LIVER; MICE	Glucokinase (GK) plays a key role in whole-body glucose homeostasis by catalyzing the phosphorylation of glucose in cells that express this enzyme, such as pancreatic beta cells and hepatocytes. We describe a class of antidiabetic agents that act as nonessential, mixed-type GK activators (GKAs) that increase the glucose affinity and maximum velocity (V-max) of GK. GKAs augment both hepatic glucose metabolism and glucose-induced insulin secretion from isolated rodent pancreatic islets, consistent with the expression and function of GK in both cell types. In several rodent models of type 2 diabetes mellitus, GKAs lowered blood glucose levels, improved the results of glucose tolerance tests, and increased hepatic glucose uptake. These findings may lead to the development of new drug therapies for diabetes.	Hoffmann La Roche Inc, Dept Metab Dis, Nutley, NJ 07110 USA; Vanderbilt Univ, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; Univ Penn, Sch Med, Dept Biochem, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Diabet, Philadelphia, PA 19104 USA	Roche Holding; Vanderbilt University; University of Pennsylvania; University of Pennsylvania	Grippo, JF (corresponding author), Hoffmann La Roche Inc, Dept Metab Dis, 340 Kingsland St, Nutley, NJ 07110 USA.		Magnuson, Mark A/B-1335-2009; Magnuson, Mark/AAY-7172-2021	Magnuson, Mark A/0000-0002-8824-6499; Magnuson, Mark/0000-0002-8824-6499				BELL GI, 2002, ENCY MOL MED, P1437; Christesen HBT, 2002, DIABETES, V51, P1240, DOI 10.2337/diabetes.51.4.1240; Clement K, 1996, DIABETOLOGIA, V39, P82; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Desai UJ, 2001, DIABETES, V50, P2287, DOI 10.2337/diabetes.50.10.2287; Ferre T, 1996, P NATL ACAD SCI USA, V93, P7225, DOI 10.1073/pnas.93.14.7225; GIDHJAIN M, 1993, P NATL ACAD SCI USA, V90, P1932, DOI 10.1073/pnas.90.5.1932; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; GRIMSBY J, UNPUB; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; LIANG Y, 1995, BIOCHEM J, V309, P167, DOI 10.1042/bj3090167; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Miller SP, 1999, DIABETES, V48, P1645, DOI 10.2337/diabetes.48.8.1645; Morral N, 2002, HUM GENE THER, V13, P1561, DOI 10.1089/10430340260201653; Segel I.H., 1993, ENZYME KINETICS, P227; Shiota M, 2001, DIABETES, V50, P622, DOI 10.2337/diabetes.50.3.622; Sweet IR, 1996, AM J PHYSIOL-ENDOC M, V271, pE606, DOI 10.1152/ajpendo.1996.271.3.E606; TAKEDA J, 1993, J BIOL CHEM, V268, P15200; Velho G, 1996, J CLIN INVEST, V98, P1755, DOI 10.1172/JCI118974; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0	21	404	459	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					370	373		10.1126/science.1084073	http://dx.doi.org/10.1126/science.1084073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869762				2022-12-24	WOS:000184207300045
J	Lew, TWK; Kwek, TK; Tai, D; Earnest, A; Loo, S; Singh, K; Kwan, KM; Chan, Y; Yim, CF; Bek, SL; Kor, AC; Yap, WS; Chelliah, YR; Lai, YC; Goh, SK				Lew, TWK; Kwek, TK; Tai, D; Earnest, A; Loo, S; Singh, K; Kwan, KM; Chan, Y; Yim, CF; Bek, SL; Kor, AC; Yap, WS; Chelliah, YR; Lai, YC; Goh, SK			Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LUNG INJURY; CLINICAL-FEATURES; MORTALITY; SARS; OUTBREAK; OUTCOMES; CARE; ARDS	Context Severe acute respiratory syndrome (SARS) is an emerging infectious disease with a 25% incidence of progression to acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and mortality exceeding 10%. Objective To describe the clinical spectrum and outcomes of ALI/ARDS in patients with SARS-related critical illness. Design, Setting, and Patients Retrospective case series of adult patients with probable SARS admitted to the intensive care unit (ICU) of a hospital in Singapore between March 6 and June 6, 2003. Main Outcome Measures The primary outcome measure was 28-day mortality after symptom onset. Results Of 199 patients hospitalized with SARS, 46 (23%) were admitted to the ICU, including 45 who fulfilled criteria for ALI/ARDS. Mortality at 28 days for the entire cohort was 20 (10.1%) of 199 and for ICU patients was 17 (37%) of 46. Intensive care unit mortality at 13 weeks was 24 (52.2%) of 46. Nineteen of 24 ICU deaths occurred late ( greater than or equal to7 days after ICU admission) and were attributed to complications related to severe ARDS, multiorgan failure, thromboembolic complications, or septicemic shock. ARDS was characterized by ease of derecruitment of alveoli and paucity of airway secretion, bronchospasm, or dynamic hyperinflation. Lower Acute Physiology and Chronic Health Evaluation if scores and higher baseline ratios of Pao(2) to fraction of inspired oxygen were associated with earlier recovery. Conclusions Critically ill patients with SARS and ALI/ARDS had characteristic clinical findings, high rates of complications; and high mortality. These findings may provide useful information for optimizing supportive care for SARS-related critical illness.	Tan Tock Seng Hosp, Dept Anaesthesiol, Singapore 308433, Singapore; Tan Tock Seng Hosp, Dept Gen Med, Med Intens Care Unit, Singapore, Singapore; Tan Tock Seng Hosp, Clin Res Unit, Singapore, Singapore; Tan Tock Seng Hosp, Dept Resp Med, Singapore, Singapore; Alexandra Hosp, Dept Anaesthesia, Singapore, Singapore	Tan Tock Seng Hospital; Tan Tock Seng Hospital; Tan Tock Seng Hospital; Tan Tock Seng Hospital	Lew, TWK (corresponding author), Tan Tock Seng Hosp, Dept Anaesthesiol, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	thomas_lew@ttsh.com.sg	Earnest, Arul/L-4747-2013	Earnest, Arul/0000-0003-2693-5034				*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; BERNARD GR, 1987, NEW ENGL J MED, V317, P1565, DOI 10.1056/NEJM198712173172504; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124; BONE RC, 1989, CHEST, V96, P849, DOI 10.1378/chest.96.4.849; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; *CDCP, 2003, INF CONTR PREC AER G; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P405; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Ferring M, 1997, EUR RESPIR J, V10, P1297, DOI 10.1183/09031936.97.10061297; Hsu LY, 2003, EMERG INFECT DIS, V9, P713; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Lemanske RF, 2003, J PEDIATR-US, V142, pS3, DOI 10.1067/mpd.2003.19; LUCE JM, 1988, AM REV RESPIR DIS, V138, P62, DOI 10.1164/ajrccm/138.1.62; Masur H, 2003, JAMA-J AM MED ASSOC, V289, P2861, DOI 10.1001/jama.289.21.JED30036; MONTGOMERY AB, 1985, AM REV RESPIR DIS, V132, P485; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; Vincent JL, 2003, CRIT CARE MED, V31, pS296, DOI 10.1097/01.CCM.0000057906.89552.8F; *WHO, CAS DEF SURV SEV AC; World Health Organization, HOSP INF CONTR GUID; World Health Organization, 2003, CUM NUMB REP PROB CA	25	290	310	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2003	290	3					374	380		10.1001/jama.290.3.374	http://dx.doi.org/10.1001/jama.290.3.374			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699WK	12865379				2022-12-24	WOS:000184078800032
J	Brandel, JP; Preece, M; Brown, P; Croes, E; Laplanche, JL; Agid, Y; Will, R; Alperovitch, A				Brandel, JP; Preece, M; Brown, P; Croes, E; Laplanche, JL; Agid, Y; Will, R; Alperovitch, A			Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE	Since homozygosity MM at codon 129 of the prion protein gene is a recognised risk factor in all forms of Creutzfeldt-Jakob disease (CJD), we studied the distribution of codon 129 polymorphism in patients in France and in the UK with CJD transmitted iatrogenically by human growth hormone. The overall frequencies of codon 1.29 genotypes in these patients differed from those in the population unaffected by CJD. An excess of VV homozygotes was noted among those with iatrogenic CJD compared with sporadic CJD cases. The proportion of MM genotype in UK patients was surprisingly low (4%) compared with that in French patients (62%). There is no evident explanation for this different distribution, which might be due to infection with different strains of prion in human growth hormone.	Salpetriere Hosp, Natl Reference Ctr Latrogen CJD, F-75651 Paris 13, France; Salpetriere Hosp, INSERM, U360, F-75651 Paris, France; Inst Child Hlth, London, England; NIH, Lab CNS Studies, Bethesda, MD 20892 USA; Erasmus Univ, Sch Med, Rotterdam, Netherlands; Lariboisiere Hosp, Cent Lab Biochem, Paris, France; Western Gen Hosp, CJD Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; National Institutes of Health (NIH) - USA; Erasmus University Rotterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Edinburgh	Brandel, JP (corresponding author), Salpetriere Hosp, Natl Reference Ctr Latrogen CJD, F-75651 Paris 13, France.		LAPLANCHE, Jean-Louis/S-8707-2016	LAPLANCHE, Jean-Louis/0000-0003-2836-2903				Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; LAPLANCHE JL, 1994, NEUROLOGY, V44, P2347, DOI 10.1212/WNL.44.12.2347; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Swerdlow AJ, 2002, LANCET, V360, P273, DOI 10.1016/S0140-6736(02)09519-3	5	74	75	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 12	2003	362	9378					128	130		10.1016/S0140-6736(03)13867-6	http://dx.doi.org/10.1016/S0140-6736(03)13867-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699ZY	12867116				2022-12-24	WOS:000184089200015
J	Palanivelu, R; Brass, L; Edlund, AF; Preuss, D				Palanivelu, R; Brass, L; Edlund, AF; Preuss, D			Pollen tube growth and guidance is regulated by POP2, an Arabidopsis gene that controls GABA levels	CELL			English	Article							CELL-MOVEMENT; TIP GROWTH; GLUTAMATE; RECEPTORS; FEMALE; ACID; SIGNALS; IDENTIFICATION; FERTILIZATION; TRANSAMINASE	During angiosperm reproduction, pollen grains form a tube that navigates through female tissues to the micropyle, delivering sperm to the egg; the signals that mediate this process are poorly understood. Here, we describe a role for gamma-amino butyric acid (GABA) in pollen tube growth and guidance. In vitro, GABA stimulates pollen tube growth, although vast excesses are inhibitory. The Arabidopsis POP2 gene encodes a transaminase that degrades GABA and contributes to the formation of a gradient leading up to the micropyle. pop2 flowers accumulate GABA, and the growth of many pop2 pollen tubes is arrested, consistent with their in vitro GABA hypersensitivity. Some pop2 tubes continue to grow toward ovules, yet they are misguided, presumably because they target ectopic GABA on the ovule surface. Interestingly, wild-type tubes exhibit normal growth and guidance in pop2 pistils, perhaps by degrading excess GABA and sharpening the gradient leading to the micropyle.	Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago	Preuss, D (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA.	dpreuss@midway.uchicago.edu	Palanivelu, Ravishankar/AAE-6664-2020					Barker JL, 1998, PERSPECT DEV NEUROBI, V5, P305; Baum G, 1996, EMBO J, V15, P2988, DOI 10.1002/j.1460-2075.1996.tb00662.x; Behar TN, 2001, CEREB CORTEX, V11, P744, DOI 10.1093/cercor/11.8.744; BOWMAN JL, 1993, ARABIDOPSIS ATLAS MO, P135; Brenner ED, 2000, PLANT PHYSIOL, V124, P1615, DOI 10.1104/pp.124.4.1615; Brice NL, 2002, DIABETOLOGIA, V45, P242, DOI 10.1007/s00125-001-0750-0; CHAO CY, 1971, AM J BOT, V58, P649, DOI 10.2307/2441009; Christensen CA, 2002, PLANT CELL, V14, P2215, DOI 10.1105/tpc.002170; CHUNG ID, 1992, PLANT PHYSIOL, V99, P659, DOI 10.1104/pp.99.2.659; Firtel RA, 2000, CURR OPIN GENET DEV, V10, P421, DOI 10.1016/S0959-437X(00)00107-6; Gamel-Didelon K, 2002, NEUROENDOCRINOLOGY, V76, P170, DOI 10.1159/000064523; GIBSON KM, 1990, BIOMED ENVIRON MASS, V19, P89, DOI 10.1002/bms.1200190207; HANSEN GH, 1987, NEUROTROPHIC ACTIVIT, P109; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; Huck N, 2003, DEVELOPMENT, V130, P2149, DOI 10.1242/dev.00458; Johnson MA, 2002, DEV CELL, V2, P273, DOI 10.1016/S1534-5807(02)00130-2; KANDASAMY MK, 1994, DEVELOPMENT, V120, P3405; KANDASAMY MK, 1989, DEV BIOL, V134, P462, DOI 10.1016/0012-1606(89)90119-X; KATER SB, 1991, J NEUROSCI, V11, P891; Kathiresan A, 1998, PLANT GROWTH REGUL, V26, P131, DOI 10.1023/A:1006107815064; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Lam HM, 1998, NATURE, V396, P125, DOI 10.1038/24066; Lasswell J, 2000, PLANT CELL, V12, P2395, DOI 10.1105/tpc.12.12.2395; Li H, 1999, PLANT CELL, V11, P1731, DOI 10.1105/tpc.11.9.1731; Lord E, 2000, TRENDS PLANT SCI, V5, P368, DOI 10.1016/S1360-1385(00)01744-1; Maitre M, 2000, ALCOHOL, V20, P277, DOI 10.1016/S0741-8329(99)00092-0; MASCARENHAS JP, 1993, PLANT CELL, V5, P1303, DOI 10.1105/tpc.5.10.1303; Mayfield JA, 2001, SCIENCE, V292, P2482, DOI 10.1126/science.1060972; Medina-Kauwe LK, 1998, NEUROBIOL DIS, V5, P89, DOI 10.1006/nbdi.1998.0184; Mollet JC, 2000, PLANT CELL, V12, P1737, DOI 10.1105/tpc.12.9.1737; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; Palanivelu R, 2000, TRENDS CELL BIOL, V10, P517, DOI 10.1016/S0962-8924(00)01849-3; Pinal CS, 1998, PERSPECT DEV NEUROBI, V5, P109; Prell J, 2002, MICROBIOL-SGM, V148, P615, DOI 10.1099/00221287-148-2-615; PREUSS D, 1993, GENE DEV, V7, P974, DOI 10.1101/gad.7.6.974; Ray S, 1997, DEVELOPMENT, V124, P2489; Riffell JA, 2002, J EXP BIOL, V205, P1439; ROSENTHAL GA, 1994, BIOSYNTHESIS MOL REG, P245; Rotman N, 2003, CURR BIOL, V13, P432, DOI 10.1016/S0960-9822(03)00093-9; Satin LS, 1998, ENDOCRINE, V8, P213, DOI 10.1385/ENDO:8:3:213; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; Shimizu KK, 2000, DEVELOPMENT, V127, P4511; Van Cauwenberghe OR, 2002, CAN J BOT, V80, P933, DOI [10.1139/B02-087, 10.1139/b02-087]; Villanneva JM, 1999, GENE DEV, V13, P3160, DOI 10.1101/gad.13.23.3160; Wilhelmi LK, 1996, SCIENCE, V274, P1535, DOI 10.1126/science.274.5292.1535; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; Wu HM, 2000, PLANT J, V22, P165, DOI 10.1046/j.1365-313x.2000.00731.x	47	391	423	2	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2003	114	1					47	59		10.1016/S0092-8674(03)00479-3	http://dx.doi.org/10.1016/S0092-8674(03)00479-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859897	Bronze			2022-12-24	WOS:000184219900005
J	Zhang, LI; Tan, AYY; Schreiner, CE; Merzenich, MM				Zhang, LI; Tan, AYY; Schreiner, CE; Merzenich, MM			Topography and synaptic shaping of direction selectivity in primary auditory cortex	NATURE			English	Article							RECEPTIVE-FIELDS; CORTICAL-NEURONS; UNIT RESPONSES; IN-VIVO; CAT; FREQUENCY; RAT; ORGANIZATION; INHIBITION; PATTERNS	The direction of frequency-modulated ( FM) sweeps is an important temporal cue in animal and human communication. FM direction-selective neurons are found in the primary auditory cortex (A1)(1,2), but their topography and the mechanisms underlying their selectivity remain largely unknown. Here we report that in the rat A1, direction selectivity is topographically ordered in parallel with characteristic frequency (CF): low CF neurons preferred upward sweeps, whereas high CF neurons preferred downward sweeps. The asymmetry of 'inhibitory sidebands', suppressive regions flanking the tonal receptive field (TRF) of the spike response, also co-varied with CF. In vivo whole-cell recordings showed that the direction selectivity already present in the synaptic inputs was enhanced by cortical synaptic inhibition, which suppressed the synaptic excitation of the nonpreferred direction more than that of the preferred. The excitatory and inhibitory synaptic TRFs had identical spectral tuning, but with inhibition delayed relative to excitation. The spectral asymmetry of the synaptic TRFs co-varied with CF, as had direction selectivity and sideband asymmetry, and thus suggested a synaptic mechanism for the shaping of FM direction selectivity and its topographic ordering.	Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Zhang, LI (corresponding author), Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA.	lizhang@phy.ucsf.edu	Tan, Andrew/E-7752-2011	Tan, Andrew/0000-0002-4696-1347; Schreiner, Christoph/0000-0002-4571-4328	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002260] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002260-08, R01 DC002260] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BRITT R, 1976, J NEUROPHYSIOL, V39, P179, DOI 10.1152/jn.1976.39.1.179; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; CLOPTON BM, 1974, EXP NEUROL, V42, P532, DOI 10.1016/0014-4886(74)90076-4; De Ribaupierre F, 1972, Brain Res, V48, P185, DOI 10.1016/0006-8993(72)90178-3; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3524, DOI 10.1152/jn.1996.76.5.3524; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; MENDELSON JR, 1985, BRAIN RES, V327, P331, DOI 10.1016/0006-8993(85)91530-6; MERZENICH MM, 1975, J NEUROPHYSIOL, V38, P231, DOI 10.1152/jn.1975.38.2.231; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Nelken I, 2000, EUR J NEUROSCI, V12, P549, DOI 10.1046/j.1460-9568.2000.00935.x; Ojima H, 2002, CEREB CORTEX, V12, P1079, DOI 10.1093/cercor/12.10.1079; Poon PWF, 2000, NEUROSCI LETT, V289, P9, DOI 10.1016/S0304-3940(00)01251-9; Rao RPN, 2000, ADV NEUR IN, V12, P164; Ricketts C, 1998, HEARING RES, V123, P27, DOI 10.1016/S0378-5955(98)00086-0; SALLY SL, 1988, J NEUROPHYSIOL, V59, P1627, DOI 10.1152/jn.1988.59.5.1627; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; SHAMMA SA, 1993, J NEUROPHYSIOL, V69, P367, DOI 10.1152/jn.1993.69.2.367; SUGA N, 1965, J PHYSIOL-LONDON, V181, P671, DOI 10.1113/jphysiol.1965.sp007791; VOLKOV IO, 1991, NEUROSCIENCE, V43, P307, DOI 10.1016/0306-4522(91)90295-Y; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	30	298	302	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					201	205		10.1038/nature01796	http://dx.doi.org/10.1038/nature01796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853959				2022-12-24	WOS:000184032700044
J	He, JZ; Ritalahti, KM; Yang, KL; Koenigsberg, SS; Loffler, FE				He, JZ; Ritalahti, KM; Yang, KL; Koenigsberg, SS; Loffler, FE			Detoxification of vinyl chloride to ethene coupled to growth of an anaerobic bacterium	NATURE			English	Article							CHLOROETHENE-CONTAMINATED SITES; CIS-DICHLOROETHENE; REDUCTIVE DEHALOGENATION; TETRACHLOROETHENE; DECHLORINATION; DESULFUROMONAS; HYDROGEN; ACETATE	Tetrachloroethene (PCE) and trichloroethene (TCE) are ideal solvents for numerous applications, and their widespread use makes them prominent groundwater pollutants. Even more troubling, natural biotic and abiotic processes acting on these solvents lead to the accumulation of toxic intermediates (such as dichloroethenes) and carcinogenic intermediates (such as vinyl chloride)(1-4). Vinyl chloride was found in at least 496 of the 1,430 National Priorities List sites identified by the US Environmental Protection Agency, and its precursors PCE and TCE are present in at least 771 and 852 of these sites, respectively(5). Here we describe an unusual, strictly anaerobic bacterium that destroys dichloroethenes and vinyl chloride as part of its energy metabolism, generating environmentally benign products (biomass, ethene and inorganic chloride). This organism might be useful for cleaning contaminated subsurface environments and restoring drinking-water reservoirs.	Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA; Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Regenesis Bioremediat Prod, San Clemente, CA 92672 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Loffler, FE (corresponding author), Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.		Loeffler, Frank E/M-8216-2013; Yang, Kun-Lin/C-2247-2011; Ritalahti, Kirsti M/B-4624-2010; He, Jianzhong/J-2704-2018	Yang, Kun-Lin/0000-0002-7958-9334; He, Jianzhong/0000-0003-1895-6628				Adrian L, 2000, NATURE, V408, P580, DOI 10.1038/35046063; Bunge M, 2003, NATURE, V421, P357, DOI 10.1038/nature01237; Coleman NV, 2002, APPL ENVIRON MICROB, V68, P6162, DOI 10.1128/AEM.68.12.6162-6171.2002; Coleman NV, 2002, APPL ENVIRON MICROB, V68, P2726, DOI 10.1128/AEM.68.6.2726-2730.2002; Cupples AM, 2003, APPL ENVIRON MICROB, V69, P953, DOI 10.1128/AEM.69.2.953-959.2003; Duhamel M, 2002, WATER RES, V36, P4193, DOI 10.1016/S0043-1354(02)00151-3; Gerhardt P, 1981, MANUAL METHODS GEN B; GRIBBLE GW, 1998, CHLORINATED COMPOUND, P972; He JZ, 2002, ENVIRON SCI TECHNOL, V36, P3945, DOI 10.1021/es025528d; He JZ, 2003, APPL ENVIRON MICROB, V69, P996, DOI 10.1128/AEM.69.2.996-1003.2003; Hendrickson ER, 2002, APPL ENVIRON MICROB, V68, P485, DOI 10.1128/AEM.68.2.485-495.2002; Holliger C, 1998, FEMS MICROBIOL REV, V22, P383, DOI 10.1016/S0168-6445(98)00030-8; Keppler F, 2002, ENVIRON SCI TECHNOL, V36, P2479, DOI 10.1021/es015611l; Kielhorn J, 2000, ENVIRON HEALTH PERSP, V108, P579, DOI 10.2307/3434875; Lendvay JM, 2003, ENVIRON SCI TECHNOL, V37, P1422, DOI 10.1021/es025985u; Loffler FE, 1999, APPL ENVIRON MICROB, V65, P4049; Loffler FE, 1997, APPL ENVIRON MICROB, V63, P4982, DOI 10.1128/AEM.63.12.4982-4985.1997; Loffler FE, 2003, DEHALOGENATION: MICROBIAL PROCESSES AND ENVIRONMENTAL APPLICATIONS, P53; Loffler FE, 2000, APPL ENVIRON MICROB, V66, P1369, DOI 10.1128/AEM.66.4.1369-1374.2000; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; MOHN WW, 1992, MICROBIOL REV, V56, P482, DOI 10.1128/MMBR.56.3.482-507.1992; Roberts AL, 1996, ENVIRON SCI TECHNOL, V30, P2654, DOI 10.1021/es9509644; Sung Y, 2003, APPL ENVIRON MICROB, V69, P2964, DOI 10.1128/AEM.69.5.2964-2974.2003; *US EPA, 1996, AG TOX SUBST DIS REG; VOGEL TM, 1987, ENVIRON SCI TECHNOL, V21, P722, DOI 10.1021/es00162a001	25	387	403	14	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					62	65		10.1038/nature01717	http://dx.doi.org/10.1038/nature01717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840758				2022-12-24	WOS:000183912800039
J	Nunnari, G; Nigro, L; Palermo, F; Attanasio, M; Berger, A; Doerr, HW; Pomerantz, RJ; Cacopardo, B				Nunnari, G; Nigro, L; Palermo, F; Attanasio, M; Berger, A; Doerr, HW; Pomerantz, RJ; Cacopardo, B			Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-Helper 1 cytokine profile	ANNALS OF INTERNAL MEDICINE			English	Article							HEPATITIS-G VIRUS; RNA; DISEASE; TYPE-1; CELLS	Background: Progression to AIDS is slower in persons infected with both HIV-1 and GB virus C (GBV-C), also known as hepatitis G virus. Objective: To compare clinical, virologic, and immunologic variables in HIV-1-seropositive patients with and without GBV-C co-infection. Design: Subanalysis of a prospective cohort study. Setting: Institute of Infectious Diseases, University of Catania, Catania, Italy. Patients: go asymptomatic HIV-1-seropositive patients. Measurements: GBV-C RNA level; plasma HIV-1 viral load; CD4(+) cell counts; and serum levels of interleukin (IL)-2, IL-4, IL-10, and IL-12. Results: At the start of the study, plasma GBV-C RNA was detected in 17 patients (21%). During follow-up, IL-2 and IL-12 levels decreased significantly (P = 0.005 and P = 0.01, respectively) and IL-4 and IL-10 levels increased significantly (P = 0.01 and P = 0.004, respectively) in the GBV-C-negative group but did not change substantially in the GBV-C-positive group. Each measured variable differed significantly between GBV-C-positive and GBV-C-negative groups during follow-up (P < 0.001 for IL-12, IL-4, and IL-10; P = 0.002 for IL-2). Conclusion: GB virus C may immunologically interfere with progression of HIV-1 infection to AIDS by maintaining an intact T-helper 1 cytokine profile.	Thomas Jefferson Univ, Philadelphia, PA 19107 USA; Univ Catania, Catania, Italy; Univ Palermo, Palermo, Italy; Goethe Univ Frankfurt, D-6000 Frankfurt, Germany	Jefferson University; University of Catania; University of Palermo; Goethe University Frankfurt	Nunnari, G (corresponding author), Thomas Jefferson Univ, Jefferson Alumni Hall,1020 Locust St,Suite 329, Philadelphia, PA 19107 USA.	gnunnari@hotmail.com	Nunnari, Giuseppe/AAC-1928-2019; Attanasio, Massimo/A-6295-2016	Nunnari, Giuseppe/0000-0002-8113-8452; Attanasio, Massimo/0000-0003-2684-5530; cacopardo, bruno/0000-0002-7465-0714				Aikawa T, 1996, NEW ENGL J MED, V334, P195, DOI 10.1056/NEJM199601183340316; Alter HJ, 1997, NEW ENGL J MED, V336, P747, DOI 10.1056/NEJM199703133361102; Cacopardo B, 1998, J INFECTION, V36, P179, DOI 10.1016/S0163-4453(98)80010-8; Campo N, 2000, HEPATO-GASTROENTEROL, V47, P1385; Fogeda M, 1999, J VIROL, V73, P4052, DOI 10.1128/JVI.73.5.4052-4061.1999; HAND D, 1996, PRACTICAL LONGITUDIN; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; Lefrere JJ, 1999, J INFECT DIS, V179, P783, DOI 10.1086/314671; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; Rey D, 2000, EUR J CLIN MICROBIOL, V19, P721, DOI 10.1007/s100960000352; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Spellberg B, 2001, CLIN INFECT DIS, V32, P76, DOI 10.1086/317537; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Xiang JH, 2000, J VIROL, V74, P9125, DOI 10.1128/JVI.74.19.9125-9133.2000; Yeo AET, 2000, ANN INTERN MED, V132, P959, DOI 10.7326/0003-4819-132-12-200006200-00006	16	75	82	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2003	139	1					26	30		10.7326/0003-4819-139-1-200307010-00009	http://dx.doi.org/10.7326/0003-4819-139-1-200307010-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	695GR	12834315				2022-12-24	WOS:000183823200004
J	Fahrner, KA; Ryu, WS; Berg, HC				Fahrner, KA; Ryu, WS; Berg, HC			Biomechanics: Bacterial flagellar switching under load	NATURE			English	Editorial Material							ESCHERICHIA-COLI; MOTOR; CHEMOTAXIS; ROTATION		Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Rowland Inst, Cambridge, MA 02142 USA	Harvard University; Harvard University	Fahrner, KA (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.							BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; Bourret RB, 2002, J BIOL CHEM, V277, P9625, DOI 10.1074/jbc.R100066200; Chen XB, 2000, BIOPHYS J, V78, P1036, DOI 10.1016/S0006-3495(00)76662-8; Chen XB, 2000, BIOPHYS J, V78, P2280, DOI 10.1016/S0006-3495(00)76774-9; HARSHEY RM, 1994, MOL MICROBIOL, V13, P389, DOI 10.1111/j.1365-2958.1994.tb00433.x; Kawagishi I, 1996, MOL MICROBIOL, V20, P693, DOI 10.1111/j.1365-2958.1996.tb02509.x; McCarter LL, 2001, MICROBIOL MOL BIOL R, V65, P445, DOI 10.1128/MMBR.65.3.445-462.2001; MEISTER M, 1987, CELL, V49, P643, DOI 10.1016/0092-8674(87)90540-X; Prasad K, 1998, J MOL BIOL, V280, P821, DOI 10.1006/jmbi.1998.1922; Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201	11	50	51	4	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					938	938		10.1038/423938a	http://dx.doi.org/10.1038/423938a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827190	Bronze			2022-12-24	WOS:000183753900037
J	McGlynn, EA; Asch, SM; Adams, J; Keesey, J; Hicks, J; DeCristofaro, A; Kerr, EA				McGlynn, EA; Asch, SM; Adams, J; Keesey, J; Hicks, J; DeCristofaro, A; Kerr, EA			The quality of health care delivered to adults in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ELDERLY MEDICARE BENEFICIARIES; STANDARDIZED PATIENTS; UNDERUSE; APPROPRIATENESS; OUTCOMES; TRIALS; WOMEN	BACKGROUND: We have little systematic information about the extent to which standard processes involved in health care -- a key element of quality -- are delivered in the United States. METHODS: We telephoned a random sample of adults living in 12 metropolitan areas in the United States and asked them about selected health care experiences. We also received written consent to copy their medical records for the most recent two-year period and used this information to evaluate performance on 439 indicators of quality of care for 30 acute and chronic conditions as well as preventive care. We then constructed aggregate scores. RESULTS: Participants received 54.9 percent (95 percent confidence interval, 54.3 to 55.5) of recommended care. We found little difference among the proportion of recommended preventive care provided (54.9 percent), the proportion of recommended acute care provided (53.5 percent), and the proportion of recommended care provided for chronic conditions (56.1 percent). Among different medical functions, adherence to the processes involved in care ranged from 52.2 percent for screening to 58.5 percent for follow-up care. Quality varied substantially according to the particular medical condition, ranging from 78.7 percent of recommended care (95 percent confidence interval, 73.3 to 84.2) for senile cataract to 10.5 percent of recommended care (95 percent confidence interval, 6.8 to 14.6) for alcohol dependence. CONCLUSIONS: The deficits we have identified in adherence to recommended processes for basic care pose serious threats to the health of the American public. Strategies to reduce these deficits in care are warranted.	RAND Corp, Santa Monica, CA 90407 USA; Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; VA Ann Arbor Hlth Care Syst, VA Ctr Practice Management & Outcomes Res, Ann Arbor, MI USA; Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA	RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	McGlynn, EA (corresponding author), RAND Corp, 1700 Main St,POB 2138, Santa Monica, CA 90407 USA.	beth_mcglynn@rand.org	Wilkins, Thad/G-2541-2010; Greiver, Michelle/N-8764-2015; Young, Alexander/A-1523-2009	Greiver, Michelle/0000-0001-8957-0285; Young, Alexander/0000-0002-9367-9213				ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Asch SM, 2000, JAMA-J AM MED ASSOC, V284, P2325, DOI 10.1001/jama.284.18.2325; Asch SM, 2001, ARCH INTERN MED, V161, P1329, DOI 10.1001/archinte.161.10.1329; Asch SM, 2001, J ACQ IMMUN DEF SYND, V28, P340, DOI 10.1097/00126334-200112010-00006; Asch SM, 2000, QUALITY CARE ONCOLOG; Berwick DM, 2003, MED CARE, V41, pI30; BRECHNER RJ, 1993, JAMA-J AM MED ASSOC, V270, P1714, DOI 10.1001/jama.270.14.1714; Brook R. H., 1994, AHCPR PUB, P59; CHERRY DK, 1999, ADV DATA VITAL HLTH, V322; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Cunningham PJ, 2002, MED CARE RES REV, V59, P79, DOI 10.1177/107755870205900104; Draper DA, 2002, HEALTH AFFAIR, V21, P11, DOI 10.1377/hlthaff.21.1.11; Dresselhaus TR, 2002, J MED ETHICS, V28, P293, DOI 10.1136/jme.28.5.291; Efron Bradley., 1994, INTRO BOOTSTRAP; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; Hemingway H, 2001, NEW ENGL J MED, V344, P645, DOI 10.1056/NEJM200103013440906; Hennekens CH, 1996, NEW ENGL J MED, V335, P1660, DOI 10.1056/NEJM199611283352207; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; HYMAN DJ, 2002, NEW ENGL J MED, V346, P544; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1984, DOI 10.1001/jama.264.15.1984; Kemper P, 1996, INQUIRY-J HEALTH CAR, V33, P195; Kerr EA, 2000, QUALITY CARE CARDIOP; KERR EA, 2000, QUALITY CARE GEN MED; Kravitz RL, 1997, HEALTH POLICY, V42, P135, DOI 10.1016/S0168-8510(97)00064-X; KRUMHOLZ HM, 1995, CIRCULATION, V92, P2841, DOI 10.1161/01.CIR.92.10.2841; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Luck J, 2002, BMJ-BRIT MED J, V325, P679, DOI 10.1136/bmj.325.7366.679; McGlynn E A, 1998, Jt Comm J Qual Improv, V24, P470; McGlynn EA, 2001, HEALTH AFFAIR, V20, P82, DOI 10.1377/hlthaff.20.3.82; McGlynn EA, 1999, WOMEN HEALTH ISS, V9, P184, DOI 10.1016/S1049-3867(99)00009-2; McGlynn EA, 2000, QUALITY CARE WOMEN; MILLER RH, 1994, JAMA-J AM MED ASSOC, V271, P1512, DOI 10.1001/jama.271.19.1512; Murata PJ, 1994, ARCH FAM MED, V3, P41; *NAT COMM QUAL ASS, 2002, STAT HLTH CAR QUAL; Nelson DE, 2002, JAMA-J AM MED ASSOC, V287, P2659, DOI 10.1001/jama.287.20.2659; PAYNE SMC, 1995, ARCH PEDIAT ADOL MED, V149, P162, DOI 10.1001/archpedi.1995.02170140044006; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Selby JV, 1996, NEW ENGL J MED, V335, P1888, DOI 10.1056/NEJM199612193352506; Shekelle PG, 1998, INT J TECHNOL ASSESS, V14, P707, DOI 10.1017/S0266462300012022; Shekelle PG, 1998, NEW ENGL J MED, V338, P1888, DOI 10.1056/NEJM199806253382607; STARFIELD B, 1994, JAMA-J AM MED ASSOC, V272, P1903, DOI 10.1001/jama.272.24.1903; STRUNK BC, 2001, TRACKING HLTH CARE C; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UDVARHELYI IS, 1991, ANN INTERN MED, V115, P394, DOI 10.7326/0003-4819-115-5-394; Woolf SH, 1999, JAMA-J AM MED ASSOC, V282, P2358, DOI 10.1001/jama.282.24.2358	50	3441	3469	1	152	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2003	348	26					2635	2645		10.1056/NEJMsa022615	http://dx.doi.org/10.1056/NEJMsa022615			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	693PN	12826639				2022-12-24	WOS:000183726400008
J	Trichopoulou, A; Costacou, T; Bamia, C; Trichopoulos, D				Trichopoulou, A; Costacou, T; Bamia, C; Trichopoulos, D			Adherence to a Mediterranean diet and survival in a Greek population	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; FOOD FREQUENCY QUESTIONNAIRE; ENERGY-INTAKE; SUBSEQUENT MORTALITY; EATING PATTERNS; RISK; COHORT; MEN; REPRODUCIBILITY; VALIDITY	BACKGROUND: Adherence to a Mediterranean diet may improve longevity, but relevant data are limited. METHODS: We conducted a population-based, prospective investigation involving 22,043 adults in Greece who completed an extensive, validated, food-frequency questionnaire at base line. Adherence to the traditional Mediterranean diet was assessed by a 10-point Mediterranean-diet scale that incorporated the salient characteristics of this diet (range of scores, 0 to 9, with higher scores indicating greater adherence). We used proportional-hazards regression to assess the relation between adherence to the Mediterranean diet and total mortality, as well as mortality due to coronary heart disease and mortality due to cancer, with adjustment for age, sex, body-mass index, physical-activity level, and other potential confounders. RESULTS: During a median of 44 months of follow-up, there were 275 deaths. A higher degree of adherence to the Mediterranean diet was associated with a reduction in total mortality (adjusted hazard ratio for death associated with a two-point increment in the Mediterranean-diet score, 0.75 [95 percent confidence interval, 0.64 to 0.87]). An inverse association with greater adherence to this diet was evident for both death due to coronary heart disease (adjusted hazard ratio, 0.67 [95 percent confidence interval, 0.47 to 0.94]) and death due to cancer (adjusted hazard ratio, 0.76 [95 percent confidence interval, 0.59 to 0.98]). Associations between individual food groups contributing to the Mediterranean-diet score and total mortality were generally not significant. CONCLUSIONS: Greater adherence to the traditional Mediterranean diet is associated with a significant reduction in total mortality.	Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-11527 Athens, Greece; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Athens Medical School; National & Kapodistrian University of Athens; Harvard University; Harvard T.H. Chan School of Public Health	Trichopoulou, A (corresponding author), Univ Athens, Sch Med, Dept Hyg & Epidemiol, 75 Mikras Asias St, GR-11527 Athens, Greece.	antonia@nut.uoa.gr	TRICHOPOULOU, ANTONIA/ABF-8727-2021	TRICHOPOULOU, ANTONIA/0000-0002-7204-6396				AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; CHATFIELD C, 1995, INTRO MULTIVARIATE A; COSTACOU T, IN PRESS EUR J CLIN; DELORGERIL, 1995, LANCET, V345, P738; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; FARCHI G, 1995, EUR J CLIN NUTR, V49, P408; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; GNARDELLIS C, 1995, EPIDEMIOLOGY, V6, P74, DOI 10.1097/00001648-199501000-00015; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Huijbregts P, 1997, BRIT MED J, V315, P13, DOI 10.1136/bmj.315.7099.13; Jacques PF, 2001, AM J CLIN NUTR, V73, P1, DOI 10.1093/ajcn/73.1.1; KANT AK, 1993, AM J CLIN NUTR, V57, P434, DOI 10.1093/ajcn/57.3.434; Kant AK, 2000, JAMA-J AM MED ASSOC, V283, P2109, DOI 10.1001/jama.283.16.2109; Katsouyanni K, 1997, INT J EPIDEMIOL, V26, pS118, DOI 10.1093/ije/26.suppl_1.S118; Keys A., 1980, SCIENCE, DOI DOI 10.1126/SCIENCE.208.4448.1138; Kouris-Blazos A, 1999, BRIT J NUTR, V82, P57, DOI 10.1017/S0007114599001129; Kumagai S, 1999, J Nutr Health Aging, V3, P29; Lasheras C, 2000, AM J CLIN NUTR, V71, P987; Michels KB, 2002, INT J EPIDEMIOL, V31, P847, DOI 10.1093/ije/31.4.847; NUBE M, 1987, J AM DIET ASSOC, V87, P171; Osler M, 1997, INT J EPIDEMIOL, V26, P155, DOI 10.1093/ije/26.1.155; Osler M, 2002, EUR J CLIN NUTR, V56, P568, DOI 10.1038/sj.ejcn.1601360; Osler M, 2001, BRIT J NUTR, V85, P219, DOI 10.1079/BJN2000240; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; SAS Institute, 1999, SAS STAT US GUID VER; Singh RB, 2002, LANCET, V360, P1455, DOI 10.1016/S0140-6736(02)11472-3; Slattery ML, 1998, AM J EPIDEMIOL, V148, P4, DOI 10.1093/aje/148.1.4-a; Terry P, 2001, AM J EPIDEMIOL, V154, P1143, DOI 10.1093/aje/154.12.1143; TOMASSON H, 1995, STAT MED, V14, P1331, DOI 10.1002/sim.4780141206; Trichopoulos D, 2001, BRIT J NUTR, V85, P133, DOI 10.1079/BJN2000282; Trichopoulou A, 2001, AM J CLIN NUTR, V74, P574; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2000, EPIDEMIOLOGY, V11, P333, DOI 10.1097/00001648-200005000-00018; TRICHOPOULOU A, 1992, COMPOSITION GREEK FO; TRICHOPOULOU A, IN PRESS COMPOSITION; *WHO, 1997 1999 WORLD HLTH; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT W, 1998, NUTR EPIDEMIOLOGY, P414; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI DOI 10.1093/ACPROF:OSO/9780195122978.003.11; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; *WORLD CANC RES FU, 1997, FLOOD NUTR PREV CANC, P92; World Health Organization, 1977, INT CLASS DIS MAN IN	43	2804	2863	5	266	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2003	348	26					2599	2608		10.1056/NEJMoa025039	http://dx.doi.org/10.1056/NEJMoa025039			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	693PN	12826634	Bronze			2022-12-24	WOS:000183726400003
J	Milani, A				Milani, A			Astronomy - Extraterrestrial material - Virtual or real hazards?	SCIENCE			English	Editorial Material							ASTEROIDS; EARTH; IMPACTS		Univ Pisa, Dipartimento Matemat, I-56127 Pisa, Italy	University of Pisa	Milani, A (corresponding author), Univ Pisa, Dipartimento Matemat, Via Buonarroti 2, I-56127 Pisa, Italy.							Beust H, 1996, ASTRON ASTROPHYS, V310, P181; CARUSI A, 1994, HAZARDS DUE COMETS A, P127; CHAPMAN CR, 1994, NATURE, V367, P33, DOI 10.1038/367033a0; Chesley SR, 2002, ICARUS, V159, P423, DOI 10.1006/icar.2002.6910; FARINELLA P, 1994, NATURE, V371, P314, DOI 10.1038/371314a0; HARRIS AW, 2002, DIV PLAN SCI AM ASTR, V34; Milani A, 1999, ICARUS, V137, P269, DOI 10.1006/icar.1999.6045; Milani A, 1999, ASTRON ASTROPHYS, V346, pL65; MILANI A, 2003, ASTEROIDS, V3, P55; Morbidelli A, 2002, ICARUS, V158, P329, DOI 10.1006/icar.2002.6887; MORRISON D, 1994, HAZARDS DUE COMETS A, P59	11	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2003	300	5627					1882	1883		10.1126/science.1077708	http://dx.doi.org/10.1126/science.1077708			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12817129				2022-12-24	WOS:000183619400023
J	Cerdan, PD; Chory, J				Cerdan, PD; Chory, J			Regulation of flowering time by light quality	NATURE			English	Article							PHYTOCHROME-B; ARABIDOPSIS-THALIANA; CONSTANS; GENE; DOMAIN; ROLES	The transition to flowering in plants is regulated by environmental factors such as temperature and light(1). Plants grown under dense canopies or at high density perceive a decrease in the ratio of red to far-red incoming light. This change in light quality serves as a warning of competition, triggering a series of responses known collectively as the 'shade-avoidance syndrome'. During shade avoidance, stems elongate at the expense of leaf expansion, and flowering is accelerated(2,3). Of the five phytochromes-a family of red/far-red light photoreceptors-in Arabidopsis, phytochrome B (phyB) has the most significant role in shade-avoidance responses(4,5), but the mechanisms by which phyB regulates flowering in response to altered ratios of red to far-red light are largely unknown. Here we identify PFT1(PHYTOCHROME AND FLOWERING TIME 1), a nuclear protein that acts in a phyB pathway and induces flowering in response to suboptimal light conditions. PFT1 functions downstream of phyB to regulate the expression of FLOWERING LOCUS T (FT), providing evidence for the existence of a light-quality pathway that regulates flowering time in plants.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.				NIGMS NIH HHS [GM52413] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aukerman MJ, 1997, PLANT CELL, V9, P1317, DOI 10.1105/tpc.9.8.1317; Ballare CL, 1999, TRENDS PLANT SCI, V4, P201, DOI 10.1016/S1360-1385(99)01408-9; Blazquez MA, 2002, PLANT PHYSIOL, V130, P1770, DOI 10.1104/pp.007625; Blazquez MA, 1999, PLANT PHYSIOL, V120, P1025, DOI 10.1104/pp.120.4.1025; Cerdan PD, 1999, PLANT J, V18, P499, DOI 10.1046/j.1365-313X.1999.00475.x; Devlin PF, 1998, PLANT CELL, V10, P1479, DOI 10.1105/tpc.10.9.1479; Escher D, 2000, MOL CELL BIOL, V20, P2774, DOI 10.1128/MCB.20.8.2774-2782.2000; HALLIDAY KJ, 1994, PLANT PHYSIOL, V104, P1311, DOI 10.1104/pp.104.4.1311; Hennig L, 2001, PLANT PHYSIOL, V125, P1036, DOI 10.1104/pp.125.2.1036; Hepworth SR, 2002, EMBO J, V21, P4327, DOI 10.1093/emboj/cdf432; Hinshelwood J, 2000, J MOL BIOL, V298, P135, DOI 10.1006/jmbi.2000.3632; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; KOORNNEEF M, 1995, PHYSIOL PLANTARUM, V95, P260, DOI 10.1111/j.1399-3054.1995.tb00836.x; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Levy YY, 1998, CURR OPIN PLANT BIOL, V1, P49, DOI 10.1016/S1369-5266(98)80127-1; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Lin CT, 2000, PLANT PHYSIOL, V123, P39, DOI 10.1104/pp.123.1.39; Mockler T, 2003, P NATL ACAD SCI USA, V100, P2140, DOI 10.1073/pnas.0437826100; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	27	359	403	13	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					881	885		10.1038/nature01636	http://dx.doi.org/10.1038/nature01636			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815435				2022-12-24	WOS:000183585300049
J	Ashraf, H				Ashraf, H			Alliance offers healthy diet	LANCET			English	News Item																			0	2	2	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 14	2003	361	9374					2051	2051						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814720				2022-12-24	WOS:000183488900017
J	Chung, HJ; Steinberg, JP; Huganir, RL; Linden, DJ				Chung, HJ; Steinberg, JP; Huganir, RL; Linden, DJ			Requirement of AMPA receptor GluR2 phosphorylation for cerebellar long-term depression	SCIENCE			English	Article							KINASE-C INHIBITOR; PURKINJE-CELLS; GLUTAMATE SENSITIVITY; PROTEIN; PKC; EXPRESSION; BINDING; LTD; NSF; ACTIVATION	Cerebellar long-term depression (LTD) is a model of synaptic memory that requires protein kinase C (PKC) activation and is expressed as a reduction in the number of postsynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate ( AMPA) receptors. LTD was absent in cultured cerebellar Purkinje cells from mutant mice lacking the AMPA receptor GluR2 subunit and could be rescued by transient transfection with the wild-type GluR2 subunit. Transfection with a point mutant that eliminated PKC phosphorylation of Ser(880) in the carboxyterminal PDZ ligand of GluR2 failed to restore LTD. In contrast, transfection with a point mutant that mimicked phosphorylation at Ser(880) occluded subsequent LTD. Thus, PKC phosphorylation of GluR2 Ser(880) is a critical event in the induction of cerebellar LTD.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	dlinden@jhmi.edu	Steinberg, Jordan P./AAP-5568-2020	Steinberg, Jordan P./0000-0001-7930-3394; Chung, Hee Jung/0000-0002-5555-9907	NIMH NIH HHS [MH51106, MH01590] Funding Source: Medline; NINDS NIH HHS [R01 NS036715, NS36715] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH051106, R01MH051106, R29MH051106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bear MF, 2001, SYNAPSES, P455; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Chung HJ, 2000, J NEUROSCI, V20, P7258; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Eto M, 2002, NEURON, V36, P1145, DOI 10.1016/S0896-6273(02)01107-8; Freeman JH, 1998, NEUROREPORT, V9, P2237, DOI 10.1097/00001756-199807130-00016; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Linden D J, 1994, Learn Mem, V1, P121; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Narasimhan K, 1996, NEURON, V17, P333, DOI 10.1016/S0896-6273(00)80164-6; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	33	252	271	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1751	1755		10.1126/science.1082915	http://dx.doi.org/10.1126/science.1082915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805550				2022-12-24	WOS:000183459700053
J	Adams, RB; Gordon, HL; Baird, AA; Ambady, N; Kleck, RE				Adams, RB; Gordon, HL; Baird, AA; Ambady, N; Kleck, RE			Effects of gaze on amygdala sensitivity to anger and fear faces	SCIENCE			English	Article									Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Dartmouth College; Harvard University	Adams, RB (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, 6207 Moore Hall, Hanover, NH 03755 USA.		Tudusciuc, Oana/C-1339-2011		NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH067294] Funding Source: NIH RePORTER; NIMH NIH HHS [1F32MH067294-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADAMS RB, IN PRESS PSYCHOL SCI; Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Wicker B, 2003, NEUROPSYCHOLOGIA, V41, P139, DOI 10.1016/S0028-3932(02)00144-6; YOUNG AW, 1995, BRAIN, V118, P15, DOI 10.1093/brain/118.1.15	5	325	329	0	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1536	1536		10.1126/science.1082244	http://dx.doi.org/10.1126/science.1082244			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791983				2022-12-24	WOS:000183333100043
J	Xiang, Y; Kobilka, BK				Xiang, Y; Kobilka, BK			Myocyte adrenoceptor signaling pathways	SCIENCE			English	Editorial Material							CARDIAC MYOCYTES; RECEPTOR INTERNALIZATION; ADENYLYL-CYCLASE; MICE; HYPERTROPHY; APOPTOSIS; PROTEINS; HEART; ASSOCIATION; CAVEOLAE	Adrenoceptors (ARs), members of the G protein-coupled receptor superfamily, form the interface between the sympathetic nervous system and the cardiovascular system, with integral roles in the rapid regulation of myocardial function. However, in heart failure, chronic catecholamine stimulation of adrenoceptors has been linked to pathologic cardiac remodeling, including myocyte apoptosis and hypertrophy. In cardiac myocytes, activation of AR subtypes results in coupling to different G proteins and induction of specific signaling pathways, which is partly regulated by the subtype-specific distribution of receptors in plasma membrane compartments containing distinct complexes of signaling molecules. The Connections Maps of the Adrenergic and Myocyte Adrenergic Signaling Pathways bring into focus the specific signaling pathways of individual AR subtypes and their relevant functions in vivo.	Stanford Med Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Kobilka, BK (corresponding author), Stanford Med Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.			Kobilka, Brian/0000-0001-5958-3990				Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chalothorn D, 2003, J PHARMACOL EXP THER, V305, P1045, DOI 10.1124/jpet.102.048553; Chen CH, 1999, P NATL ACAD SCI USA, V96, P12784, DOI 10.1073/pnas.96.22.12784; Clerk A, 2000, CIRC RES, V86, P1019, DOI 10.1161/01.RES.86.10.1019; Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; Devic E, 2001, MOL PHARMACOL, V60, P577; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Gauthier C, 1996, J CLIN INVEST, V98, P556, DOI 10.1172/JCI118823; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; Hein L, 1997, TRENDS CARDIOVAS MED, V7, P137, DOI 10.1016/S1050-1738(97)00034-0; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Kohout TA, 2001, CIRCULATION, V104, P2485, DOI 10.1161/hc4501.098933; Marks AR, 2002, CIRCULATION, V105, P272, DOI 10.1161/circ.105.3.272; OCONNELL TD, 2000, AM HEART ASS NEW ORL; Ostrom RS, 2000, MOL PHARMACOL, V57, P1075; Piascik MT, 2001, J PHARMACOL EXP THER, V298, P403; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; SIMPSON P, 1983, J CLIN INVEST, V72, P732, DOI 10.1172/JCI111023; Singh K, 2001, J CELL PHYSIOL, V189, P257, DOI 10.1002/jcp.10024; Steinberg SF, 2002, J MOL CELL CARDIOL, V34, P1141, DOI 10.1006/jmcc.2002.2057; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Sugden PH, 2001, ANN MED, V33, P611; Tanoue A, 2003, TRENDS ENDOCRIN MET, V14, P107, DOI 10.1016/S1043-2760(03)00026-2; Vecchione C, 2002, CIRCULATION, V105, P1700, DOI 10.1161/01.CIR.0000012750.08480.55; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; XIANG Y, 2003, SCI STKE; Xiao RP, 2000, CIRC RES, V87, P635, DOI 10.1161/01.RES.87.8.635; Xu JG, 2001, J BIOL CHEM, V276, P41310, DOI 10.1074/jbc.M107480200; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607	36	169	174	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1530	1532		10.1126/science.1079206	http://dx.doi.org/10.1126/science.1079206			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791980				2022-12-24	WOS:000183333100040
J	Zou, L; Elledge, SJ				Zou, L; Elledge, SJ			Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes	SCIENCE			English	Article							REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; SACCHAROMYCES-CEREVISIAE; CHECKPOINT PROTEINS; GENOTOXIC STRESS; BINDING-PROTEIN; BUDDING YEAST; HUMAN RAD17; IN-VIVO; PHOSPHORYLATION	The function of the ATR (ataxia-telangiectasia mutated- and Rad3-related) ATRIP (ATR-interacting protein) protein kinase complex is crucial for the cellular response to replication stress and DNA damage. Here, we show that replication protein A (RPA), a protein complex that associates with single-stranded DNA (ssDNA), is required for the recruitment of ATR to sites of DNA damage and for ATR-mediated Chk1 activation in human cells. In vitro, RPA stimulates the binding of ATRIP to ssDNA. The binding of ATRIP to RPA-coated ssDNA enables the ATR-ATRIP complex to associate with DNA and stimulates phosphorylation of the Rad17 protein that is bound to DNA. Furthermore, Ddc2, the budding yeast homolog of ATRIP, is specifically recruited to double-strand DNA breaks in an RPA-dependent manner. A checkpoint-deficient mutant of RPA, rfa1-t11, is defective for recruiting Ddc2 to ssDNA both in vivo and in vitro. Our data suggest that RPA-coated ssDNA is the critical structure at sites of DNA damage that recruits the ATR-ATRIP complex and facilitates its recognition of substrates for phosphorylation and the initiation of checkpoint signaling.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Elledge, SJ (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA.				NIGMS NIH HHS [GM44664] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044664, R37GM044664] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Brush GS, 2000, NUCLEIC ACIDS RES, V28, P3725, DOI 10.1093/nar/28.19.3725; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Lindsey-Boltz LA, 2001, P NATL ACAD SCI USA, V98, P11236, DOI 10.1073/pnas.201373498; Liu QH, 2000, GENE DEV, V14, P1448; Longhese MP, 1996, NUCLEIC ACIDS RES, V24, P3533, DOI 10.1093/nar/24.18.3533; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Melo JA, 2001, GENE DEV, V15, P2809; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Paciotti V, 2000, GENE DEV, V14, P2046; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Post S, 2001, P NATL ACAD SCI USA, V98, P13102, DOI 10.1073/pnas.231364598; Rouse J, 2000, EMBO J, V19, P5801, DOI 10.1093/emboj/19.21.5801; Rouse J, 2002, MOL CELL, V9, P857, DOI 10.1016/S1097-2765(02)00507-5; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Umezu K, 1998, GENETICS, V148, P989; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Wakayama T, 2001, MOL CELL BIOL, V21, P755, DOI 10.1128/MCB.21.3.755-764.2001; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; ZOU L, 1906, UNPUB	38	1982	2036	5	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1542	1548		10.1126/science.1083430	http://dx.doi.org/10.1126/science.1083430			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791985				2022-12-24	WOS:000183333100046
J	Clark, JS; McLachlan, JS				Clark, JS; McLachlan, JS			Stability of forest biodiversity	NATURE			English	Article							EASTERN NORTH-AMERICA; SOUTHERN ONTARIO; COMPETITION; HISTORY; POLLEN; DIVERSITY; DISTURBANCE; DYNAMICS	Two hypotheses to explain potentially high forest biodiversity have different implications for the number and kinds of species that can coexist and the potential loss of biodiversity in the absence of speciation. The first hypothesis involves stabilizing mechanisms, which include tradeoffs between species in terms of their capacities to disperse to sites where competition is weak(1-4), to exploit abundant resources effectively(5,6) and to compete for scarce resources(7). Stabilization results because competitors thrive at different times and places. An alternative, 'neutral model' suggests that stabilizing mechanisms may be superfluous. This explanation emphasizes 'equalizing' mechanisms(8), because competitive exclusion of similar species is slow. Lack of ecologically relevant differences means that abundances experience random 'neutral drift', with slow extinction(9-11). The relative importance of these two mechanisms is unknown, because assumptions and predictions involve broad temporal and spatial scales. Here we demonstrate that predictions of neutral drift are testable using palaeodata. The results demonstrate strong stabilizing forces. By contrast with the neutral prediction of increasing variance among sites over time, we show that variances in post-Glacial tree abundances among sites stabilize rapidly, and abundances remain coherent over broad geographical scales.	Duke Univ, Ctr Global Change, Durham, NC 27708 USA; Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Duke University; Duke University	Clark, JS (corresponding author), Duke Univ, Ctr Global Change, Durham, NC 27708 USA.	jimclark@duke.edu	Bond, Alexander L/A-3786-2010					ALLISON TD, 1986, ECOLOGY, V67, P1101, DOI 10.2307/1939835; BENNETT KD, 1987, CAN J BOT, V65, P1792, DOI 10.1139/b87-248; Bennett KD, 2002, HOLOCENE, V12, P421, DOI 10.1191/0959683602hl556rp; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; BURDEN ET, 1986, CAN J EARTH SCI, V23, P43, DOI 10.1139/e86-005; Bush MB, 2000, HOLOCENE, V10, P543, DOI 10.1191/095968300672647521; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARK JS, IN PRESS ECOLOGY; CLARK JS, IN PRESS ECOLOGICAL; DENNIS B, 1994, ECOL MONOGR, V64, P205, DOI 10.2307/2937041; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Fuller JL, 1997, CAN J BOT, V75, P1714, DOI 10.1139/b97-886; HASTINGS A, 1980, THEOR POPUL BIOL, V18, P363, DOI 10.1016/0040-5809(80)90059-3; Hixon MA, 2002, ECOLOGY, V83, P1490, DOI 10.2307/3071969; HORN HS, 1972, ECOLOGY, V53, P749, DOI 10.2307/1934797; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbell Stephen P., 2001, V32, pi; Huntley B., 1983, ATLAS PAST PRESENT P; HUSTON M, 1987, AM NAT, V130, P168, DOI 10.1086/284704; Jackson ST, 1997, QUATERNARY SCI REV, V16, P1, DOI 10.1016/S0277-3791(96)00047-9; JACOBSON GL, 1981, QUATERNARY RES, V16, P80, DOI 10.1016/0033-5894(81)90129-0; McAndrews JH, 1993, CANADIAN GLOBAL CHAN, P22; Pacala SW, 1998, AM NAT, V152, P729, DOI 10.1086/286203; PRENTICE IC, 1985, QUATERNARY RES, V23, P76, DOI 10.1016/0033-5894(85)90073-0; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; SZEICZ JM, 1991, CAN J BOT, V69, P1507, DOI 10.1139/b91-195; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D., 1998, PLANT STRATEGIES DYN	29	141	153	3	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2003	423	6940					635	638		10.1038/nature01632	http://dx.doi.org/10.1038/nature01632			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789337	Bronze			2022-12-24	WOS:000183301200039
J	Corrie, P; Shaw, J; Harris, R				Corrie, P; Shaw, J; Harris, R			Rate limiting factors in recruitment of patients to clinical trials in cancer research: descriptive study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Addenbrookes NHS Trust, Ctr Oncol, Cambridge CB2 2QQ, England	Addenbrooke's Hospital	Corrie, P (corresponding author), Addenbrookes NHS Trust, Ctr Oncol, Box 193, Cambridge CB2 2QQ, England.	pippa.corrie@addenbrookes.nhs.uk						Baum M, 2002, EUR J CANCER, V38, P1984, DOI 10.1016/S0959-8049(02)00154-5; Comis RL, 2003, J CLIN ONCOL, V21, P830, DOI 10.1200/JCO.2003.02.105; KMIETOWICZ Z, 2001, BRIT MED J, V325, P920; *NAT CANC RES I, 2002, STRAT AN OV CANC RES	4	31	31	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2003	327	7410					320	321		10.1136/bmj.327.7410.320	http://dx.doi.org/10.1136/bmj.327.7410.320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	710JE	12907485	Green Published, Bronze			2022-12-24	WOS:000184676400017
J	Ahlborg, HG; Johnell, O; Turner, CH; Rannevik, G; Karlsson, MK				Ahlborg, HG; Johnell, O; Turner, CH; Rannevik, G; Karlsson, MK			Bone loss and bone size after menopause	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VOLUMETRIC DENSITY; MINERAL DENSITY; SEX-DIFFERENCES; HEALTHY WOMEN; HIP FRACTURE; BODY-SIZE; AGE; RISK; MEN; OSTEOPOROSIS	Background: Bone loss increases after menopause. However, bone strength also depends on structural characteristics such as bone size. Whether bone size increases as a result of periosteal apposition and whether a strength index accounting for both bone density and bone size might predict the risk of fracture better than bone density alone are unclear. Methods: Bone mass and the skeletal structure of the distal radius were evaluated by single-photon absorptiometry every other year in 108 women, all of whom were followed from the time of menopause for a mean period of 15 years. Postmenopausal serum estradiol levels and fractures of the distal radius were noted. Results: The mean (+/-SD) annual decrease in bone mineral density was 1.9+/-0.7 percent. The medullary bone diameter increased annually by 1.1+/-0.9 percent, and the periosteal diameter by 0.7+/-0.3 percent; the strength index decreased by 0.7+/-0.7 percent. The expansion of the medullary diameter and the expansion of the periosteal diameter were correlated with one another (r = 0.54, P<0.001), and women in the highest quartile of medullary expansion had more loss of bone mineral density and greater periosteal apposition than women in the lowest quartile (P<0.001 for both comparisons). The postmenopausal serum estradiol level was correlated with changes in the periosteal diameter (r = -0.25, P=0.009) and with changes in bone mineral density (r = 0.34, P<0.001). A 1-SD decrement in the strength index at base line was associated with a risk ratio for fracture of the distal radius of 3.8 (95 percent confidence interval, 1.8 to 8.0). Conclusions: Increased bone loss after menopause is associated with increased periosteal apposition, which partially preserves bone strength. A strength index may be a helpful predictor of the risk of fracture.	Malmo Univ Hosp, Dept Orthoped, SE-20502 Malmo, Sweden; Malmo Univ Hosp, Dept Obstet & Gynecol, SE-20502 Malmo, Sweden; Indiana Univ, Dept Orthoped Surg, Indianapolis, IN 46204 USA; Indiana Univ, Biomech & Biomat Res Ctr, Indianapolis, IN 46204 USA	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Ahlborg, HG (corresponding author), Malmo Univ Hosp, Dept Orthoped, SE-20502 Malmo, Sweden.	henrik.ahlborg@skane.se						Ahlborg HG, 2001, BONE, V28, P327, DOI 10.1016/S8756-3282(00)00451-8; Augat P, 1996, J BONE MINER RES, V11, P1356; BALENA R, 1992, J BONE MINER RES, V7, P1475; BENGNER U, 1985, ACTA ORTHOP SCAND, V56, P158, DOI 10.3109/17453678508994345; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; BOUXSEIN ML, 1994, CALCIFIED TISSUE INT, V54, P113, DOI 10.1007/BF00296061; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Duan YB, 2001, J BONE MINER RES, V16, P2276, DOI 10.1359/jbmr.2001.16.12.2276; Duan YB, 1999, J BONE MINER RES, V14, P1796, DOI 10.1359/jbmr.1999.14.10.1796; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P2124; Ferretti JL, 1996, BONE, V18, P97, DOI 10.1016/8756-3282(95)00438-6; Frost HM, 1999, J BONE MINER RES, V14, P1473, DOI 10.1359/jbmr.1999.14.9.1473; HAYES WC, 1982, SCIENCE, V217, P945, DOI 10.1126/science.7112107; Heaney RP, 1997, OSTEOPOROSIS INT, V7, P426, DOI 10.1007/PL00004150; HSU ES, 1993, J BIOMECH, V26, P1307, DOI 10.1016/0021-9290(93)90354-H; JOHNELL O, 1984, CALCIFIED TISSUE INT, V36, P354, DOI 10.1007/BF02405345; JONSSON B, 1994, J EPIDEMIOL COMMUN H, V48, P489, DOI 10.1136/jech.48.5.489; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; MOSEKILDE L, 1990, BONE, V11, P67, DOI 10.1016/8756-3282(90)90052-Z; Naucler L, 1974, OPUSC MED TECH LUND, V12, P19; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; RANNEVIK G, 1995, MATURITAS, V21, P103, DOI 10.1016/0378-5122(94)00869-9; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; RIGGS BL, 1986, J CLIN INVEST, V77, P1487, DOI 10.1172/JCI112462; RUFF CB, 1988, J ORTHOP RES, V6, P886, DOI 10.1002/jor.1100060613; Seeman E, 2001, J BONE MINER RES, V16, P120, DOI 10.1359/jbmr.2001.16.1.120; SMITH RW, 1964, SCIENCE, V145, P156, DOI 10.1126/science.145.3628.156; THORELL JI, 1978, RADIOIMMUNOASSAY REL, P137; TURNER RT, 1987, J BONE MINER RES, V2, P115; World Health Organization (WHO), 1981, WHO TECHN REP SER, V670, P1	31	440	459	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					327	334		10.1056/NEJMoa022464	http://dx.doi.org/10.1056/NEJMoa022464			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878739	Green Published			2022-12-24	WOS:000184312800005
J	Garg, V; Kathiriyra, IS; Barnes, R; Schluterman, MK; King, IN; Butler, CA; Rothrock, CR; Eapen, RS; Hirayama-Yamada, K; Joo, K; Matsuoka, R; Cohen, JC; Srivastava, D				Garg, V; Kathiriyra, IS; Barnes, R; Schluterman, MK; King, IN; Butler, CA; Rothrock, CR; Eapen, RS; Hirayama-Yamada, K; Joo, K; Matsuoka, R; Cohen, JC; Srivastava, D			GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5	NATURE			English	Article								Congenital heart defects (CHDs) are the most common developmental anomaly and are the leading non-infectious cause of mortality in newborns(1). Only one causative gene, NKX2-5, has been identified through genetic linkage analysis of pedigrees with non-syndromic CHDs(2,3). Here, we show that isolated cardiac septal defects in a large pedigree were linked to chromosome 8p22-23. A heterozygous G296S missense mutation of GATA4, a transcription factor essential for heart formation(4-7), was found in all available affected family members but not in any control individuals. This mutation resulted in diminished DNA-binding affinity and transcriptional activity of Gata4. Furthermore, the Gata4 mutation abrogated a physical interaction between Gata4 and TBX5, a T-box protein responsible for a subset of syndromic cardiac septal defects(8,9). Conversely, interaction of Gata4 and TBX5 was disrupted by specific human TBX5 missense mutations that cause similar cardiac septal defects. In a second family, we identified a frame-shift mutation of GATA4 (E359del) that was transcriptionally inactive and segregated with cardiac septal defects. These results implicate GATA4 as a genetic cause of human cardiac septal defects, perhaps through its interaction with TBX5.	Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Tokyo Womens Med Univ, Grad Sch Med, Inst Adv Biomed Engn & Sci, Div Genom Med, Tokyo 1628666, Japan; Tokyo Womens Med Univ, Heart Inst Japan, Tokyo 1628666, Japan; Kyusyu Kosei Nenkin Hosp, Dept Pediat, Fukuoka 8068501, Japan	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Tokyo Women's Medical University; Tokyo Women's Medical University	Garg, V (corresponding author), Univ Texas, SW Med Ctr, Dept Pediat, 6000 Harry Hines Blvd,Rm NA8-124, Dallas, TX 75390 USA.	Vidu.Garg@UTSouthwestern.edu; Deepak.Srivastava@UTSouthwestern.edu	Garg, Vidu/E-3101-2011; Garg, Vidu/D-8240-2012; Burdine, Marie Schluterman/GLU-1812-2022	Garg, Vidu/0000-0002-3778-5927; Burdine, Marie Schluterman/0000-0002-3940-5748	NHLBI NIH HHS [L40 HL078465, L40 HL078465-02] Funding Source: Medline; NICHD NIH HHS [K08 HD001382] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Cross SJ, 2000, J MED GENET, V37, P785, DOI 10.1136/jmg.37.10.785; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gajewski K, 1999, DEVELOPMENT, V126, P5679; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; HOFFMAN JIE, 1995, PEDIATR CARDIOL, V16, P103, DOI 10.1007/BF00801907; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Li QY, 1997, NAT GENET, V15, P21; McFadden DG, 2000, DEVELOPMENT, V127, P5331; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morrisey EE, 1997, J BIOL CHEM, V272, P8515, DOI 10.1074/jbc.272.13.8515; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Pehlivan T, 1999, AM J MED GENET, V83, P201, DOI 10.1002/(SICI)1096-8628(19990319)83:3<201::AID-AJMG11>3.0.CO;2-V; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; SPRENKLE AB, 1995, CIRC RES, V77, P1060, DOI 10.1161/01.RES.77.6.1060; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Yang JF, 2000, AM J MED GENET, V92, P237, DOI 10.1002/(SICI)1096-8628(20000605)92:4<237::AID-AJMG2>3.0.CO;2-G	30	884	934	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					443	447		10.1038/nature01827	http://dx.doi.org/10.1038/nature01827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12845333				2022-12-24	WOS:000184318400047
J	Serini, G; Valdembri, D; Zanivan, S; Morterra, G; Burkhardt, C; Caccavari, F; Zammataro, L; Primo, L; Tamagnone, L; Logan, M; Tesssier-Lavigne, M; Taniguchi, M; Puschel, AW; Bussolino, F				Serini, G; Valdembri, D; Zanivan, S; Morterra, G; Burkhardt, C; Caccavari, F; Zammataro, L; Primo, L; Tamagnone, L; Logan, M; Tesssier-Lavigne, M; Taniguchi, M; Puschel, AW; Bussolino, F			Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function	NATURE			English	Article							SUPPRESSES TUMOR-FORMATION; ENDOTHELIAL-CELLS; MOUSE EMBRYOS; SEMAPHORIN; ACTIVATION; GROWTH; GENE; ALPHA(V)BETA(3); ALPHA-V-BETA-3; ANGIOGENESIS	The motility and morphogenesis of endothelial cells is controlled by spatio-temporally regulated activation of integrin adhesion receptors, and integrin activation is stimulated by major determinants of vascular remodelling. In order for endothelial cells to be responsive to changes in activator gradients, the adhesiveness of these cells to the extracellular matrix must be dynamic, and negative regulators of integrins could be required. Here we show that during vascular development and experimental angiogenesis, endothelial cells generate autocrine chemorepulsive signals of class 3 semaphorins (SEMA3 proteins) that localize at nascent adhesive sites in spreading endothelial cells. Disrupting endogenous SEMA3 function in endothelial cells stimulates integrin-mediated adhesion and migration to extracellular matrices, whereas exogenous SEMA3 proteins antagonize integrin activation. Misexpression of dominant negative SEMA3 receptors in chick embryo endothelial cells locks integrins in an active conformation, and severely impairs vascular remodelling. Sema3a null mice show vascular defects as well. Thus during angiogenesis endothelial SEMA3 proteins endow the vascular system with the plasticity required for its reshaping by controlling integrin function.	Univ Turin, Sch Med, Div Mol Angiogenesis, I-10060 Candiolo, TO, Italy; Univ Turin, Sch Med, Inst Canc Res & Treatment, IRCC,Div Mol Oncol, I-10060 Candiolo, TO, Italy; Univ Turin, Sch Med, Dept Oncol Sci, I-10060 Candiolo, TO, Italy; Univ Munster, Inst Allgemeine Zool & Genet, Mol Biol Abt, D-48149 Munster, Germany; Natl Inst Med Res, Div Dev Biol, London NW7 1AA, England; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Univ Tokyo, Grad Sch Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan	University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; University of Turin; University of Munster; MRC National Institute for Medical Research; Howard Hughes Medical Institute; Stanford University; University of Tokyo	Serini, G (corresponding author), Univ Turin, Sch Med, Div Mol Angiogenesis, I-10060 Candiolo, TO, Italy.	guido.serini@ircc.it; federico.bussolino@ircc.it	Zanivan, Sara/C-4340-2008; Bussolino, Federico/AES-3951-2022; Zanivan, Sara/GOV-5505-2022; Tamagnone, Luca/J-8948-2018; Serini, Guido/AAF-2873-2021; Bussolino, Federico/K-2500-2016	Tamagnone, Luca/0000-0002-2884-7946; Serini, Guido/0000-0002-3502-8367; Zanivan, Sara/0000-0002-9880-9099; PRIMO, Luca/0000-0002-1294-0441; Valdembri, Donatella/0000-0003-4590-417X; Zammataro, Luca/0000-0002-4348-6341; Bussolino, Federico/0000-0002-5348-1341				Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Brown CB, 2001, DEVELOPMENT, V128, P3071; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Cruz MT, 1997, J CELL SCI, V110, P2647; Evans HM, 1909, ANAT REC, V3, P498, DOI 10.1002/ar.1090030903; Feiner L, 2001, DEVELOPMENT, V128, P3061; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Grignani F, 1998, CANCER RES, V58, P14; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; Martin-Bermudo MD, 1998, J CELL BIOL, V141, P1073, DOI 10.1083/jcb.141.4.1073; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; NEUGEBAUER KM, 1991, NATURE, V350, P68, DOI 10.1038/350068a0; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Primo L, 2000, ONCOGENE, V19, P3632, DOI 10.1038/sj.onc.1203708; Robson Paul, 2002, P97; Sabin FR, 1917, CONTRIB EMBRYOL, V6, P63; SEIFERT R, 1992, ANAT EMBRYOL, V186, P601; Sigmund CD, 2000, ARTERIOSCL THROM VAS, V20, P1425, DOI 10.1161/01.ATV.20.6.1425; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; STUPACK DG, 2002, SCI STKE, V119, pPE7; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Trusolino L, 1998, J CELL BIOL, V142, P1145, DOI 10.1083/jcb.142.4.1145; Tse C, 2002, CANCER RES, V62, P542; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Xiang RH, 2002, CANCER RES, V62, P2637; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	49	464	497	4	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					391	397		10.1038/nature01784	http://dx.doi.org/10.1038/nature01784			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879061				2022-12-24	WOS:000184318400034
J	Coppin, H; Bensaid, M; Fruchon, S; Borot, N; Blanche, H; Roth, MP				Coppin, H; Bensaid, M; Fruchon, S; Borot, N; Blanche, H; Roth, MP			Longevity and carrying the C282Y mutation for haemochromatosis on the HFE gene: case control study of 492 French centenarians	BRITISH MEDICAL JOURNAL			English	Article							RISK		CHU Purpan, Unite Physiopathol Cellulaire, CNRS, UPR 2163, F-31059 Toulouse 3, France; Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France	Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Foundation Jean Dausset-CEPH	Roth, MP (corresponding author), CHU Purpan, Unite Physiopathol Cellulaire, CNRS, UPR 2163, F-31059 Toulouse 3, France.		Coppin, Hélène/G-4326-2013; Roth, Marie-Paule/Q-2866-2018	Coppin, Hélène/0000-0001-7911-6353; Roth, Marie-Paule/0000-0001-9691-4234; bensaid, Mounia/0000-0001-7322-0627				Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Blanche H, 2001, CR ACAD SCI III-VIE, V324, P129, DOI 10.1016/S0764-4469(00)01274-9; Fruchon S, 2003, CLIN CHEM, V49, P822, DOI 10.1373/49.5.822; Fuchs J, 2002, TOXICOLOGY, V180, P169, DOI 10.1016/S0300-483X(02)00389-X; Worwood M, 2002, BEST PRACT RES CL HA, V15, P295, DOI 10.1053/beha.2002.0005	5	35	37	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2003	327	7407					132	133		10.1136/bmj.327.7407.132	http://dx.doi.org/10.1136/bmj.327.7407.132			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869454	Green Published, Bronze			2022-12-24	WOS:000184247500017
J	Kikuchi, S; Satoh, K; Nagata, T; Kawagashira, N; Doi, K; Kishimoto, N; Yazaki, J; Ishikawa, M; Yamada, H; Ooka, H; Hotta, I; Kojima, K; Namiki, T; Ohneda, E; Yahagi, W; Suzuki, K; Li, CJ; Ohtsuki, K; Shishiki, T; Otomo, Y; Murakami, K; Iida, Y; Sugano, S; Fujimura, T; Suzuki, Y; Tsunoda, Y; Kurosaki, T; Kodama, T; Masuda, H; Kobayashi, M; Xie, QH; Lu, M; Narikawa, R; Sugiyama, A; Mizuno, K; Yokomizo, S; Niikura, J; Ikeda, R; Ishibiki, J; Kawamata, M; Yoshimura, A; Miura, J; Kusumegi, T; Oka, M; Ryu, R; Ueda, M; Matsubara, K; Kawai, J; Carninci, P; Adachi, J; Aizawa, K; Arakawa, T; Fukuda, S; Hara, A; Hashizume, W; Hayatsu, N; Imotani, K; Ishii, Y; Itoh, M; Kagawa, I; Kondo, S; Konno, H; Miyazaki, A; Osato, N; Ota, Y; Saito, R; Sasaki, D; Sato, K; Shibata, K; Shinagawa, A; Shiraki, T; Yoshino, M; Hayashizaki, Y; Yasunishi, A				Kikuchi, S; Satoh, K; Nagata, T; Kawagashira, N; Doi, K; Kishimoto, N; Yazaki, J; Ishikawa, M; Yamada, H; Ooka, H; Hotta, I; Kojima, K; Namiki, T; Ohneda, E; Yahagi, W; Suzuki, K; Li, CJ; Ohtsuki, K; Shishiki, T; Otomo, Y; Murakami, K; Iida, Y; Sugano, S; Fujimura, T; Suzuki, Y; Tsunoda, Y; Kurosaki, T; Kodama, T; Masuda, H; Kobayashi, M; Xie, QH; Lu, M; Narikawa, R; Sugiyama, A; Mizuno, K; Yokomizo, S; Niikura, J; Ikeda, R; Ishibiki, J; Kawamata, M; Yoshimura, A; Miura, J; Kusumegi, T; Oka, M; Ryu, R; Ueda, M; Matsubara, K; Kawai, J; Carninci, P; Adachi, J; Aizawa, K; Arakawa, T; Fukuda, S; Hara, A; Hashizume, W; Hayatsu, N; Imotani, K; Ishii, Y; Itoh, M; Kagawa, I; Kondo, S; Konno, H; Miyazaki, A; Osato, N; Ota, Y; Saito, R; Sasaki, D; Sato, K; Shibata, K; Shinagawa, A; Shiraki, T; Yoshino, M; Hayashizaki, Y; Yasunishi, A		Rice Full-length cDNA Consortium; Natl Inst Agrobological Sci; Fdn Adv Int Sci Genome Sequencing; RIKEN	Collection, mapping, and annotation of over 28,000 cDNA clones from japonica rice	SCIENCE			English	Article							DRAFT SEQUENCE; DATABASE	We collected and completely sequenced 28,469 full-length complementary DNA clones from Oryza sativa L. ssp. japonica cv. Nipponbare. Through homology searches of publicly available sequence data, we assigned tentative protein functions to 21,596 clones (75.86%). Mapping of the cDNA clones to genomic DNA revealed that there are 19,000 to 20,500 transcription units in the rice genome. Protein informatics analysis against the InterPro database revealed the existence of proteins presented in rice but not in Arabidopsis. Sixty-four percent of our cDNAs are homologous to Arabidopsis proteins.	Natl Inst Agrobiol Sci, Dept Mol Biol, Tsukuba, Ibaraki 3058602, Japan; Hitachi Software Engn Co, Naka Ku, Yokohama, Kanagawa 2310015, Japan; FAIS, Lab Genome Sequencing, Tsukuba, Ibaraki 3050062, Japan; Univ Tokyo, Inst Med Sci, Dept Virol, Minato Ku, Tokyo 1088639, Japan; Univ Tsukuba, Inst Agr & Forest Engn, Tsukuba, Ibaraki 3058577, Japan; NAIST, Nara 6300101, Japan; RIKEN, RIKEN Yokohama Inst, Inst Phys & Chem Res, Lab Genome Explorat Res Grp,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Genome Sci Lab, Wako, Saitama 3510198, Japan; FAIS, Anal Grp, Tsukuba, Ibaraki 3050062, Japan	National Institute of Agrobiological Sciences - Japan; University of Tokyo; University of Tsukuba; Nara Institute of Science & Technology; RIKEN	Kikuchi, S (corresponding author), Natl Inst Agrobiol Sci, Dept Mol Biol, 2-1-2 Kannon Dai, Tsukuba, Ibaraki 3058602, Japan.	skikuchi@nias.affrc.go.jp	Hayashizaki, Yoshihide/N-6590-2015; Carninci, Piero/K-1568-2014; Yazaki, Junshi/B-1557-2012; shibata, kazuhiro/A-9527-2008; Konno, Hideaki/A-9191-2012; Kurosaki, Tomohiro/D-1306-2009; Kawai, Jun/A-6451-2016; Konno, Hideaki/N-4366-2014; Itoh, Masayoshi/N-5363-2015	Carninci, Piero/0000-0001-7202-7243; Kurosaki, Tomohiro/0000-0002-6352-304X; Konno, Hideaki/0000-0002-8470-4835; Itoh, Masayoshi/0000-0002-1772-318X; Fukuda, Shiro/0000-0002-0065-662X; Osato, Naoki/0000-0002-7584-5388; Osato, Naoki/0000-0001-9716-6725				Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; NAGATA T, COMMUNICATION; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	13	681	3048	8	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					376	379		10.1126/science.1081288	http://dx.doi.org/10.1126/science.1081288			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869764				2022-12-24	WOS:000184207300047
J	Celikel, R; McClintock, RA; Roberts, JR; Mendolicchio, GL; Ware, J; Varughese, KI; Ruggeri, ZM				Celikel, R; McClintock, RA; Roberts, JR; Mendolicchio, GL; Ware, J; Varughese, KI; Ruggeri, ZM			Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ib-alpha	SCIENCE			English	Article							SITE-DIRECTED MUTAGENESIS; VON-WILLEBRAND-FACTOR; PROCOAGULANT ACTIVITY; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; BINDING SITE; ACTIVATION; COMPLEX; IDENTIFICATION; RESIDUES	Thrombin bound to platelets contributes to stop bleeding and, in pathological conditions, may cause vascular thrombosis. We have determined the structure of platelet glycoprotein Ibalpha (GpIbalpha) bound to thrombin at 2.3 angstrom resolution and defined two sites in GpIbalpha that bind to exosite II and exosite I of two distinct alpha-thrombin molecules, respectively. GpIbalpha occupancy may be sequential, as the site binding to alpha-thrombin exosite I appears to be cryptic in the unoccupied receptor but exposed when a first thrombin molecule is bound through exosite II. These interactions may modulate alpha-thrombin function by mediating GpIbalpha clustering and cleavage of protease-activated receptors, which promote platelet activation, while limiting fibrinogen clotting through blockade of exosite I.	Scripps Res Inst, Roon Res Ctr Arteriosclerosis & Thrombosis, Div Expt Thrombosis & Hemostasis, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol & Expt Med, Div Cellular Pathol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Varughese, KI (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, Div Cellular Pathol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Roberts, James/AAI-3283-2020	Roberts, James/0000-0002-2671-3207	NCRR NIH HHS [RR0833] Funding Source: Medline; NHLBI NIH HHS [HL-48728, R01 HL042846, HL-31950, HL-55375, HL-42846] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042846, P01HL048728, P01HL031950, R01HL055375, R37HL042846] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andrews RK, 1999, THROMB HAEMOSTASIS, V82, P357, DOI 10.1055/s-0037-1615854; BEVERS EM, 1991, BLOOD REV, V5, P146, DOI 10.1016/0268-960X(91)90031-7; BODE W, 1992, PROTEIN SCI, V1, P426; Bouton MC, 1998, THROMB HAEMOSTASIS, V80, P310, DOI 10.1055/s-0037-1615193; Dahlback B, 2000, LANCET, V355, P1627, DOI 10.1016/S0140-6736(00)02225-X; De Candia E, 2001, J BIOL CHEM, V276, P4692, DOI 10.1074/jbc.M008160200; De Cristofaro R, 2001, BIOCHEMISTRY-US, V40, P13268, DOI 10.1021/bi010491f; DEMARCO L, 1994, J BIOL CHEM, V269, P6478; Dormann D, 2000, BLOOD, V96, P2469, DOI 10.1182/blood.V96.7.2469.h8002469_2469_2478; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; GRALNICK HR, 1994, P NATL ACAD SCI USA, V91, P6334, DOI 10.1073/pnas.91.14.6334; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Li CQ, 2001, J BIOL CHEM, V276, P6161, DOI 10.1074/jbc.M004164200; LOPEZ JA, 1987, P NATL ACAD SCI USA, V84, P5615, DOI 10.1073/pnas.84.16.5615; Marchese P, 1999, P NATL ACAD SCI USA, V96, P7837, DOI 10.1073/pnas.96.14.7837; MARCHESE P, 1995, J BIOL CHEM, V270, P9571, DOI 10.1074/jbc.270.16.9571; Mazzucato M, 1998, J BIOL CHEM, V273, P1880, DOI 10.1074/jbc.273.4.1880; MURATA M, 1991, J BIOL CHEM, V266, P15474; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Ramakrishnan V, 2001, P NATL ACAD SCI USA, V98, P1823, DOI 10.1073/pnas.98.4.1823; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; SIMS PJ, 1989, J BIOL CHEM, V264, P17049; Soslau G, 2001, J BIOL CHEM, V276, P21173, DOI 10.1074/jbc.M008249200; Tait AS, 2002, BLOOD, V99, P4422, DOI 10.1182/blood.V99.12.4422; Uff S, 2002, J BIOL CHEM, V277, P35657, DOI 10.1074/jbc.M205271200	28	155	162	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2003	301	5630					218	221		10.1126/science.1084183	http://dx.doi.org/10.1126/science.1084183			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855810				2022-12-24	WOS:000184056200045
J	Day, M; Langston, R; Morris, RGM				Day, M; Langston, R; Morris, RGM			Glutamate-receptor-mediated encoding and retrieval of paired-associate learning	NATURE			English	Article							HIPPOCAMPAL CIRCUITRY; SYNAPTIC PLASTICITY; PLACE CELLS; MEMORY; POTENTIATION; TRANSMISSION; IMPAIRMENT; EXPERIENCE; SEQUENCES; AMNESIA	Paired-associate learning is often used to examine episodic memory in humans(1). Animal models include the recall of food-cache locations by scrub jays(2) and sequential memory(3,4). Here we report a model in which rats encode, during successive sample trials, two paired associates ( flavours of food and their spatial locations) and display better-than-chance recall of one item when cued by the other. In a first study, pairings of a particular foodstuff and its location were never repeated, so ensuring unique 'what-where' attributes. Blocking N-methyl-D-aspartate receptors in the hippocampus - crucial for the induction of certain forms of activity-dependent synaptic plasticity(5,6) impaired memory encoding but had no effect on recall. Inactivating hippocampal neural activity by blocking alpha-amino-3-hydroxy- 5-methyl-4-isoxazole propionic acid ( AMPA) receptors impaired both encoding and recall. In a second study, two paired associates were trained repeatedly over 8 weeks in new pairs, but blocking of hippocampal AMPA receptors did not affect their recall. Thus we conclude that unique what - where paired associates depend on encoding and retrieval within a hippocampal memory space(7,8), with consolidation of the memory traces representing repeated paired associates in circuits elsewhere.	Univ Edinburgh, Div Neurosci, Cognit Neurosci Lab, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Edinburgh, Ctr Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Morris, RGM (corresponding author), Univ Edinburgh, Div Neurosci, Cognit Neurosci Lab, 1 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.	r.g.m.morris@ed.ac.uk	Morris, Richard G M/C-9982-2013	Langston, Rosamund/0000-0002-4668-3105				[Anonymous], 1983, CANADIAN PSYCHOL; Bleakman D, 1998, NEUROPHARMACOLOGY, V37, P1187, DOI 10.1016/S0028-3908(98)00139-7; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; COWAN WM, 2001, SYNAPSES; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; GAFFAN D, 1994, J COGNITIVE NEUROSCI, V6, P305, DOI 10.1162/jocn.1994.6.4.305; Gardiner JM, 2001, EPISODIC MEMORY NEW, P11; Gilbert PE, 2002, BEHAV NEUROSCI, V116, P63, DOI 10.1037//0735-7044.116.1.63; Kesner RP, 2002, BEHAV NEUROSCI, V116, P286, DOI 10.1037//0735-7044.116.2.286; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MISHKIN M, 1975, J EXP PSYCHOL-ANIM B, V1, P326, DOI 10.1037/0097-7403.1.4.326; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Swainson R, 2001, DEMENT GERIATR COGN, V12, P265, DOI 10.1159/000051269; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Zeineh MM, 2003, SCIENCE, V299, P577, DOI 10.1126/science.1077775; ZOLAMORGAN S, 1985, BEHAV NEUROSCI, V99, P22, DOI 10.1037/0735-7044.99.1.22	25	197	201	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2003	424	6945					205	209		10.1038/nature01769	http://dx.doi.org/10.1038/nature01769			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853960	Green Published			2022-12-24	WOS:000184032700045
J	Salomon, JA; Weinstein, MC; Hammitt, JK; Goldie, SJ				Salomon, JA; Weinstein, MC; Hammitt, JK; Goldie, SJ			Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERFERON-ALPHA-2B PLUS RIBAVIRIN; LIVER FIBROSIS PROGRESSION; TERM-FOLLOW-UP; INITIAL TREATMENT; VIRUS-INFECTION; NON-A; NON-B; COMBINATION THERAPY; NATURAL-HISTORY; HEPATOCELLULAR-CARCINOMA	Context Approximately 2.7 million US individuals are chronically infected with the hepatitis C virus (HCV). As public health campaigns are pursued, a growing number of treatment candidates are likely to have minimal evidence of liver damage. Objective To examine the clinical benefits and cost-effectiveness of newer treatments for chronic hepatitis C infection in a population of asymptomatic, HCV seropositive but otherwise healthy individuals. Design and Setting Cost-effectiveness analysis using a Markov model of the natural history of HCV infection and impact of treatment. We used an epidemiologic model to derive a range of natural history parameters that were empirically calibrated to provide a good fit to observed data on both prevalence of HCV seropositivity and time trends in outcomes related to HCV infection. Patients Cohorts of 40-year-old men and women with elevated levels of alanine aminotransferase, positive results on quantitative HCV RNA assays and serologic tests for antibody to HCV, and no histological evidence of fibrosis on liver biopsy. Interventions Monotherapy with standard or pegylated interferon alfa-2b; combination therapy with standard or pegylated interferon plus ribavirin. Main Outcome Measures Lifetime costs, life expectancy, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios. Results The probability of patients with chronic HCV developing cirrhosis over a 30-year period ranged from 13% to 46% for men and from 1% to 29% for women. The incremental cost-effectiveness of combination therapy with pegylated interferon for men ranged from $26000 to $64000 per QALY for genotype 1 and from $10000 to $28000 per QALY for other genotypes; and for women ranged from $32000 to $90000 for genotype 1 and from $12000 to $42000 for other genotypes. Because the benefits of treatment were realized largely in the form of improvements in health-related quality of life, rather than prolonged survivorship, cost-effectiveness ratios expressed as dollars per year of life were substantially higher. Results were most sensitive to assumptions about the gains and decrements in health-related quality of life associated with treatment. Conclusions While newer treatment options for hepatitis C appear to be reasonably cost-effective on average, these results vary widely across different patient subgroups and depend critically on quality-of-life assumptions. As the pool of persons eligible for treatment for HCV infection expands to the more general population, it will be imperative for patients and their physicians to consider these assumptions in making individual-level treatment decisions.	Harvard Univ, Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; WHO, Global Programme Evidence Hlth Policy, CH-1211 Geneva, Switzerland; Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Boston, MA 02115 USA	Harvard University; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health	Salomon, JA (corresponding author), Harvard Univ, Ctr Populat & Dev Studies, 9 Bow St, Cambridge, MA 02138 USA.	jsalomon@hsph.harvard.edu	Salomon, Joshua/S-1929-2019; Salomon, Joshua A/D-3898-2009	Salomon, Joshua/0000-0003-3929-5515; Salomon, Joshua A/0000-0003-3929-5515	OHS HRSA HHS [ST32HS00055-03] Funding Source: Medline	OHS HRSA HHS		Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; [Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; [Anonymous], COMMUNICATION; Barbaro G, 2000, J HEPATOL, V33, P448, DOI 10.1016/S0168-8278(00)80281-0; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Buti M, 2000, J HEPATOL, V33, P651, DOI 10.1034/j.1600-0641.2000.033004651.x; Camma C, 1998, J HEPATOL, V28, P531, DOI 10.1016/S0168-8278(98)80274-2; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; CHRISTENSEN E, 1989, SCAND J GASTROENTERO, V24, P999, DOI 10.3109/00365528909089247; COLCHER MD, 1994, HEPATOLOGY, V20, P618; Cotler SJ, 2001, AM J GASTROENTEROL, V96, P2730, DOI 10.1111/j.1572-0241.2001.04132.x; DIBISCEGLIE AM, 1991, HEPATOLOGY, V14, P969, DOI 10.1016/0270-9139(91)90113-A; Dore GJ, 2002, J GASTROEN HEPATOL, V17, P423, DOI 10.1046/j.1440-1746.2002.02730.x; Dusheiko G, 1997, HEPATOLOGY, V26, pS112, DOI 10.1002/hep.510260720; Dusheiko GM, 1995, HEPATOLOGY, V22, P1863, DOI 10.1016/0270-9139(95)90216-3; Edlin BR, 2002, HEPATOLOGY, V36, pS210, DOI 10.1053/jhep.2002.36809; Fattovich G, 1996, J HEPATOL, V24, P38, DOI 10.1016/S0168-8278(96)80184-X; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gold MR, 1996, COST EFFECTIVENESS H; GORDON SC, 1993, HEPATOLOGY, V18, P1338, DOI 10.1002/hep.1840180609; HOPF U, 1990, J HEPATOL, V10, P69, DOI 10.1016/0168-8278(90)90075-3; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Kim WR, 1997, ANN INTERN MED, V127, P866, DOI 10.7326/0003-4819-127-10-199711150-00002; KIYOSAWA K, 1994, INTERVIROLOGY, V37, P101, DOI 10.1159/000150363; KORETZ RL, 1993, ANN INTERN MED, V119, P110, DOI 10.7326/0003-4819-119-2-199307150-00003; Kuehne FC, 2002, ARCH INTERN MED, V162, P2545, DOI 10.1001/archinte.162.22.2545; Lau DTY, 1998, HEPATOLOGY, V28, P1121, DOI 10.1002/hep.510280430; Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcellin P, 1997, ANN INTERN MED, V127, P875, DOI 10.7326/0003-4819-127-10-199711150-00003; Matsumura H, 2000, J VIRAL HEPATITIS, V7, P268; MATTSON L, 1993, LIVER, V13, P274; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; *MED EC, 2001, DRUG TOP RED BOOK; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; Okanoue T, 1999, J HEPATOL, V30, P653, DOI 10.1016/S0168-8278(99)80196-2; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; REICHARD O, 1995, HEPATOLOGY, V21, P918, DOI 10.1016/0270-9139(95)90234-1; ROBERTS JM, 1993, GASTROENTEROL JPN, V28, P37, DOI 10.1007/BF02989202; Rodger AJ, 2000, HEPATOLOGY, V32, P582, DOI 10.1053/jhep.2000.9714; Russo MW, 2000, HEPATOLOGY, V31, P358, DOI 10.1002/hep.510310215; Sagmeister M, 2001, EUR J GASTROEN HEPAT, V13, P483, DOI 10.1097/00042737-200105000-00004; SALERNO F, 1993, AM J GASTROENTEROL, V88, P514; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Seeff LB, 2001, HEPATOLOGY, V33, P455, DOI 10.1053/jhep.2001.21905; Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003; Seeff Leonard B., 1999, American Journal of Medicine, V107, p10S; Sennfalt K, 2001, SCAND J GASTROENTERO, V36, P870, DOI 10.1080/003655201750313414; Shiell A, 1999, MED J AUSTRALIA, V171, P189, DOI 10.5694/j.1326-5377.1999.tb123595.x; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; Sinha M, 2000, PEDIATR INFECT DIS J, V19, P23, DOI 10.1097/00006454-200001000-00006; Sobesky R, 1999, GASTROENTEROLOGY, V116, P378, DOI 10.1016/S0016-5085(99)70135-6; Stein K, 2002, GUT, V50, P253, DOI 10.1136/gut.50.2.253; Stinnett AA, 1997, MED DECIS MAKING, V17, P483, DOI 10.1177/0272989X9701700414; TAKAHASHI M, 1993, AM J GASTROENTEROL, V88, P240; Thomas DL, 2002, HEPATOLOGY, V36, pS201, DOI 10.1053/jhep.2002.36380; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202; TREMOLADA F, 1992, J HEPATOL, V16, P273, DOI 10.1016/S0168-8278(05)80657-9; *US DEP HHS, 2001, HEP C EM THREAT PUBL; Wiese M, 2000, HEPATOLOGY, V32, P91, DOI 10.1053/jhep.2000.8169; Wong J B, 1999, Am J Med, V107, p74S; Wong JB, 2000, ANN INTERN MED, V133, P665, DOI 10.7326/0003-4819-133-9-200011070-00008; Wong JB, 2000, AM J MED, V108, P366, DOI 10.1016/S0002-9343(00)00303-X; Wong JB, 2000, AM J GASTROENTEROL, V95, P1524; Wong JB, 2002, ACTA GASTRO-ENT BELG, V65, P110; Wong JB, 1998, JAMA-J AM MED ASSOC, V280, P2088, DOI 10.1001/jama.280.24.2088; Wong LL, 1997, ARCH INTERN MED, V157, P1429, DOI 10.1001/archinte.157.13.1429; Yano M, 1996, HEPATOLOGY, V23, P1334, DOI 10.1002/hep.510230607; YANO M, 1993, GUT, V34, pS13, DOI 10.1136/gut.34.2_Suppl.S13; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Younossi ZM, 1999, HEPATOLOGY, V30, P1318, DOI 10.1002/hep.510300518; Zaman A, 2000, AM J GASTROENTEROL, V95, P1323	78	192	198	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2003	290	2					228	237		10.1001/jama.290.2.228	http://dx.doi.org/10.1001/jama.290.2.228			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	698GH	12851278	Bronze			2022-12-24	WOS:000183989800028
J	Gardner, TS; di Bernardo, D; Lorenz, D; Collins, JJ				Gardner, TS; di Bernardo, D; Lorenz, D; Collins, JJ			Inferring genetic networks and identifying compound mode of action via expression profiling	SCIENCE			English	Article							TRANSCRIPTIONAL REGULATION; SIMULATION	The complexity of cellular gene, protein, and metabolite networks can hinder attempts to elucidate their structure and function. To address this problem, we used systematic transcriptional perturbations to construct a first-order model of regulatory interactions in a nine-gene subnetwork of the SOS pathway in Escherichia coli. The model correctly identified the major regulatory genes and the transcriptional targets of mitomycin C activity in the subnetwork. This approach, which is experimentally and computationally scalable, provides a framework for elucidating the functional properties of genetic networks and identifying molecular targets of pharmacological compounds.	Boston Univ, Ctr Biodynam, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Telethon Inst Genet & Med, I-80131 Naples, Italy	Boston University; Boston University; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Collins, JJ (corresponding author), Boston Univ, Ctr Biodynam, 44 Cummington St, Boston, MA 02215 USA.	jcollins@bu.edu	di Bernardo, Diego/I-9440-2012; di Bernardo, Diego/AAF-5881-2021	di Bernardo, Diego/0000-0002-1911-7407; di Bernardo, Diego/0000-0002-1911-7407; Lorenz, David/0000-0001-8732-3627	Telethon [TGM03P17, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		Arkin A, 1997, SCIENCE, V277, P1275, DOI 10.1126/science.277.5330.1275; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Courcelle J, 2001, GENETICS, V158, P41; D'haeseleer P, 1999, Pac Symp Biocomput, P41; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; de la Fuente A, 2002, TRENDS GENET, V18, P395, DOI 10.1016/S0168-9525(02)02692-6; Ding CM, 2003, P NATL ACAD SCI USA, V100, P3059, DOI 10.1073/pnas.0630494100; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56; Koch WH, 1998, CONT CANC RES, P107; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Liang S, 1998, Pac Symp Biocomput, P18; Ljung L., 1999, SYSTEM IDENTIFICATIO; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McAdams HH, 1998, ANNU REV BIOPH BIOM, V27, P199, DOI 10.1146/annurev.biophys.27.1.199; MONTGOMERY D. C., 2001, INTRO LINEAR REGRESS; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; VANSOMEREN EP, 2001, P 2 INT C SYST BIOL, P222; WALKER GC, 1996, CELLULAR MOL BIOL, P1400	27	842	877	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2003	301	5629					102	105		10.1126/science.1081900	http://dx.doi.org/10.1126/science.1081900			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843395				2022-12-24	WOS:000183914700043
J	Garrido, JJ; Giraud, P; Carlier, E; Fernandes, F; Moussif, A; Fache, MP; Debanne, D; Dargent, B				Garrido, JJ; Giraud, P; Carlier, E; Fernandes, F; Moussif, A; Fache, MP; Debanne, D; Dargent, B			A targeting motif involved in sodium channel clustering at the axonal initial segment	SCIENCE			English	Article							BETA-IV-SPECTRIN; POLARIZED NEURONS; ANKYRIN-G; RANVIER; NODES; LOCALIZATION; EXPRESSION; NA(V)1.6; DOMAINS; BARRIER	The sorting of sodium channels to axons and the formation of clusters are of primary importance for neuronal electrogenesis. Here, we showed that the cytoplasmic loop connecting domains II and III of the Na-v 1 subunit contains a determinant conferring compartmentalization in the axonal initial segment of rat hippocampal neurons. Expression of a soluble Na-v 1.2 II- III linker protein led to the disorganization of endogenous sodium channels. The motif was sufficient to redirect a somatodendritic potassium channel to the axonal initial segment, a process involving association with ankyrin G. Thus, this motif may play a fundamental role in controlling electrical excitability during development and plasticity.	Univ Mediterranee, Fac Med Secteur Nord, Inst Jean Roche, INSERM,U464, F-13916 Marseille 20, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Dargent, B (corresponding author), Univ Mediterranee, Fac Med Secteur Nord, Inst Jean Roche, INSERM,U464, Blvd P Dramard, F-13916 Marseille 20, France.		Garrido, Juan Jose/E-6782-2012; Debanne, Dominique/O-4673-2016	Garrido, Juan Jose/0000-0002-4499-4487; Debanne, Dominique/0000-0001-8581-5695				Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Alessandri-Haber N, 1999, J PHYSIOL-LONDON, V518, P203, DOI 10.1111/j.1469-7793.1999.0203r.x; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Boiko T, 2003, J NEUROSCI, V23, P2306; Bouzidi M, 2002, J BIOL CHEM, V277, P28996, DOI 10.1074/jbc.M201760200; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; DARGENT B, UNPUB; Fernandes F. M., UNPUB; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; Kazarinova-Noyes K, 2001, J NEUROSCI, V21, P7517, DOI 10.1523/JNEUROSCI.21-19-07517.2001; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; LEMAILLET G, 2003, J BIOL CHEM; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Madrid R, 2001, EMBO J, V20, P7008, DOI 10.1093/emboj/20.24.7008; Maier SKG, 2003, P NATL ACAD SCI USA, V100, P3507, DOI 10.1073/pnas.2627986100; MALHOTRA JD, 2002, J BIOL CHEM, V7, P7; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Waites CL, 2001, J CELL BIOL, V152, P1159, DOI 10.1083/jcb.152.6.1159; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang X, 1998, J CELL BIOL, V142, P1571, DOI 10.1083/jcb.142.6.1571; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	31	271	302	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2003	300	5628					2091	2094		10.1126/science.1085167	http://dx.doi.org/10.1126/science.1085167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12829783				2022-12-24	WOS:000183774900046
J	Aravanis, AM; Pyle, JL; Tsien, RW				Aravanis, AM; Pyle, JL; Tsien, RW			Single synaptic vesicles fusing transiently and successively without loss of identity	NATURE			English	Article							FROG NEUROMUSCULAR JUNCTION; READILY RELEASABLE POOL; RETINAL BIPOLAR CELLS; HIPPOCAMPAL SYNAPSES; NERVE-TERMINALS; ENDOCYTOSIS; MEMBRANE; EXOCYTOSIS; TRANSMITTER; TURNOVER	Vesicle fusion and recycling are particularly critical for ongoing neurotransmitter release(1-4) in the small nerve terminals of the brain, which typically contain about 30 functional vesicles(4,5). However, the modes of exocytosis and endocytosis that operate at synapses of the central nervous system are incompletely understood. Here we show real-time visualization of a single vesicle fusing at a small synapse of the central nervous system, made possible by highly intensified charge-coupled device imaging of hippocampal synaptic terminals, in which a single vesicle was labelled with the fluorescent membrane marker FM1-43 (ref. 6). In a small number of cases, full loss of fluorescent membrane dye was elicited by a single action potential, consistent with classical complete collapse(1). In most cases, however, action potentials triggered only partial loss of fluorescence, suggesting vesicular retention of membrane marker, consistent with 'kiss-and-run' vesicle cycling(3,4,7-9). An alternative hypothesis of independent fusion of partially stained vesicles arising from endosomal splitting could be excluded by observations on the size and timing of successive fusion events. Thus, our experimental evidence supports a predominance of kiss-and-run fusion events(10-12) and rapid vesicular re-use(11).	Stanford Univ, Beckman Ctr, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Tsien, RW (corresponding author), Stanford Univ, Beckman Ctr, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.							CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Palfrey HC, 1998, NEUROSCIENCE, V83, P969, DOI 10.1016/S0306-4522(97)00453-3; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Stevens CF, 1999, NEURON, V24, P1017, DOI 10.1016/S0896-6273(00)81047-8; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	23	309	316	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					643	647		10.1038/nature01686	http://dx.doi.org/10.1038/nature01686			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789339				2022-12-24	WOS:000183301200041
J	Anglana, M; Apiou, F; Bensimon, A; Debatisse, M				Anglana, M; Apiou, F; Bensimon, A; Debatisse, M			Dynamics of DNA replication in mammalian somatic cells: Nucleotide pool modulates origin choice and interorigin spacing	CELL			English	Article							SINGLE-MOLECULE ANALYSIS; CHINESE-HAMSTER; S-PHASE; SACCHAROMYCES-CEREVISIAE; INITIATION SITES; ADENYLATE DEAMINASE; SEQUENCE ELEMENTS; BUDDING YEAST; EGG EXTRACTS; LOCUS	Selection of active origins and regulation of interorigin spacing are poorly understood in mammalian cells. Using tricolor analysis of combed DNA molecules, we studied an amplified locus containing the known origin, oriGNAI3. We visualized replication firing events at this and other discrete regions and established a strict correlation between AT richness and initiation sites. We found that oriGNAI3 is the prominent origin of the domain, the firing of which correlates with silencing of neighboring sites and establishes large interorigin distances. We demonstrate that cells reversibly respond to a reduction in nucleotide availability by slowing the rate of replication fork progression; in addition, the efficiency of initiation at oriGNAI3 is lowered while other normally dormant origins in the region are activated, which results in an overall increase in the density of initiation events. Thus, nucleotide pools are involved in the specification of active origins, which in turn defines their density along chromosomes.	Inst Curie, F-75248 Paris, France; Inst Pasteur, Genomes Stabil Unit, F-75724 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Debatisse, M (corresponding author), Inst Curie, FRE 2584,26 Rue Ulm, F-75248 Paris, France.	michelle.debatisse@curie.fr						Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; Aladjem MI, 1998, SCIENCE, V281, P1005, DOI 10.1126/science.281.5379.1005; Aladjem MI, 2002, MOL CELL BIOL, V22, P442, DOI 10.1128/MCB.22.2.442-452.2002; Altman AL, 2001, MOL CELL BIOL, V21, P1098, DOI 10.1128/MCB.21.4.1098-1110.2001; Angus SP, 2002, J BIOL CHEM, V277, P44376, DOI 10.1074/jbc.M205911200; ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; Baron B, 1996, MAMM GENOME, V7, P429, DOI 10.1007/s003359900127; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bogan JA, 2000, J CELL PHYSIOL, V184, P139, DOI 10.1002/1097-4652(200008)184:2<139::AID-JCP1>3.0.CO;2-8; BREWER BJ, 1994, P NATL ACAD SCI USA, V91, P3418, DOI 10.1073/pnas.91.8.3418; COLLINS JM, 1978, J BIOL CHEM, V253, P8570; DEBATISSE M, 1988, MOL CELL BIOL, V8, P17, DOI 10.1128/MCB.8.1.17; DEBATISSE M, 1982, MOL CELL BIOL, V2, P1346, DOI 10.1128/MCB.2.11.1346; DePamphilis ML, 2000, J STRUCT BIOL, V129, P186, DOI 10.1006/jsbi.2000.4219; DEPAMPHILLIS M, 1996, DNA REPLICATION EUKA; Devault A, 2002, CURR BIOL, V12, P689, DOI 10.1016/S0960-9822(02)00768-6; DIJKWEL PA, 1991, MOL CELL BIOL, V11, P3850, DOI 10.1128/MCB.11.8.3850; Dijkwel PA, 2002, MOL CELL BIOL, V22, P3053, DOI 10.1128/MCB.22.9.3053-3065.2002; Fernandez MA, 1997, J CELL BIOCHEM, V67, P541, DOI 10.1002/(SICI)1097-4644(19971215)67:4<541::AID-JCB11>3.0.CO;2-C; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; Herrick J, 2000, J MOL BIOL, V300, P1133, DOI 10.1006/jmbi.2000.3930; Herrick J, 2002, J MOL BIOL, V320, P741, DOI 10.1016/S0022-2836(02)00522-3; Herrick J, 1999, BIOCHIMIE, V81, P859, DOI 10.1016/S0300-9084(00)87170-9; HOUSMAN D, 1975, J MOL BIOL, V94, P173, DOI 10.1016/0022-2836(75)90076-5; HYRIEN O, 1988, EMBO J, V7, P407, DOI 10.1002/j.1460-2075.1988.tb02828.x; HYRIEN O, 1995, SCIENCE, V270, P994, DOI 10.1126/science.270.5238.994; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Kobayashi T, 1998, MOL CELL BIOL, V18, P3266, DOI 10.1128/MCB.18.6.3266; Koc A, 2003, J BIOL CHEM, V278, P9345, DOI 10.1074/jbc.M213013200; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; Li F, 2003, J CELL BIOL, V161, P257, DOI 10.1083/jcb.200211127; Malinsky J, 2001, J CELL SCI, V114, P747; MARAHRENS Y, 1994, EMBO J, V13, P3395, DOI 10.1002/j.1460-2075.1994.tb06642.x; Marheineke K, 2001, J BIOL CHEM, V276, P17092, DOI 10.1074/jbc.M100271200; Mechali M, 2001, NAT REV GENET, V2, P640, DOI 10.1038/35084598; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Norio P, 2001, SCIENCE, V294, P2361, DOI 10.1126/science.1064603; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Santocanale C, 1999, GENE DEV, V13, P2360, DOI 10.1101/gad.13.18.2360; Santocanale C, 1996, EMBO J, V15, P6671, DOI 10.1002/j.1460-2075.1996.tb01057.x; Sasaki T, 1999, MOL CELL BIOL, V19, P547; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; SKOOG L, 1971, EUR J BIOCHEM, V19, P81, DOI 10.1111/j.1432-1033.1971.tb01290.x; Stevenson JB, 1999, GENE DEV, V13, P146, DOI 10.1101/gad.13.2.146; Svetlova EY, 2001, J CELL BIOCHEM, P170; Toledo F, 1999, NUCLEIC ACIDS RES, V27, P1600, DOI 10.1093/nar/27.7.1600; Toledo F, 1998, NUCLEIC ACIDS RES, V26, P2313, DOI 10.1093/nar/26.10.2313; Visser AE, 1998, EXP CELL RES, V243, P398, DOI 10.1006/excr.1998.4144; Vujcic M, 1999, MOL CELL BIOL, V19, P6098; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Wu JR, 1996, SCIENCE, V271, P1270, DOI 10.1126/science.271.5253.1270; ZANNISHADJOPOULOS M, 1980, J CELL BIOL, V85, P777, DOI 10.1083/jcb.85.3.777	55	260	270	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2003	114	3					385	394		10.1016/S0092-8674(03)00569-5	http://dx.doi.org/10.1016/S0092-8674(03)00569-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914702	Bronze			2022-12-24	WOS:000184679200014
J	Zhu, J; Shendure, J; Mitra, RD; Church, GM				Zhu, J; Shendure, J; Mitra, RD; Church, GM			Single molecule profiling of alternative pre-mRNA splicing	SCIENCE			English	Article							EPITHELIAL-CELLS; CD44; DIVERSITY; NONSENSE	Alternative pre-messenger RNA splicing is an important mechanism for generating protein diversity and may explain in part how mammalian complexity arises from a surprisingly small complement of genes. Here, we describe "digital polony exon profiling," a single molecule - based technology for studying complex alternative pre-messenger RNA splicing. This technology allows researchers to monitor the combinatorial diversity of exon inclusion in individual transcripts. A minisequencing strategy provides single nucleotide resolution, and the digital nature of the technology allows quantitation of individual splicing variants. Digital polony exon pro. ling can be used to investigate the physiological and pathological roles of alternately spliced messenger RNAs, as well as the mechanisms by which these messenger RNAs are produced.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Harvard University; Harvard Medical School; Washington University (WUSTL)	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.			church, george/0000-0001-6232-9969; Mitra, Robi/0000-0002-2680-4264; Shendure, Jay/0000-0002-1516-1865	NIGMS NIH HHS [5U54GM62119] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062119] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bajorath J, 2000, PROTEINS, V39, P103, DOI 10.1002/(SICI)1097-0134(20000501)39:2<103::AID-PROT1>3.3.CO;2-7; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bell MV, 1998, MOL CELL BIOL, V18, P5930, DOI 10.1128/MCB.18.10.5930; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Delacourte Andre, 2000, Current Opinion in Neurology, V13, P371, DOI 10.1097/00019052-200008000-00002; Herrlich P, 2000, ANN NY ACAD SCI, V910, P106; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; LESLEY J, 1998, FRONT BIOSCI, V3, P616; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Mitra RD, 2003, P NATL ACAD SCI USA, V100, P5926, DOI 10.1073/pnas.0936399100; MITRA RD, IN PRESS ANAL BIOCH; Mitra RD, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e34; Pinkas J, 2002, CANCER RES, V62, P4781; Roca X, 1998, AM J PATHOL, V153, P183, DOI 10.1016/S0002-9440(10)65559-9; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Soukka T, 1997, CANCER RES, V57, P2281; Valentine CR, 1998, MUTAT RES-REV MUTAT, V411, P87, DOI 10.1016/S1383-5742(98)00010-6; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Yeakley JM, 2002, NAT BIOTECHNOL, V20, P353, DOI 10.1038/nbt0402-353	24	83	101	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					836	838		10.1126/science.1085792	http://dx.doi.org/10.1126/science.1085792			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907803	Green Submitted			2022-12-24	WOS:000184615700046
J	Yonekura, K; Maki-Yonekura, S; Namba, K				Yonekura, K; Maki-Yonekura, S; Namba, K			Complete atomic model of the bacterial flagellar filament by electron cryomicroscopy	NATURE			English	Article							SALMONELLA-TYPHIMURIUM; MEMBRANE-PROTEINS; TUBULAR CRYSTALS; ANGSTROM RESOLUTION; MOLECULAR-DYNAMICS; FIBER DIFFRACTION; EXPORT APPARATUS; ESCHERICHIA-COLI; TERMINAL REGIONS; CRYSTALLOGRAPHY	The bacterial flagellar filament is a helical propeller for bacterial locomotion. It is a helical assembly of a single protein, flagellin, and its tubular structure is formed by 11 protofilaments in two distinct conformations, L- and R- type, for supercoiling. The X-ray crystal structure of a flagellin fragment lacking about 100 terminal residues revealed the protofilament structure, but the full filament structure is still essential for understanding the mechanism of supercoiling and polymerization. Here we report a complete atomic model of the R-type filament by electron cryomicroscopy. A density map obtained from image data up to 4Angstrom resolution shows the feature of alpha-helical backbone and some large side chains. The atomic model built on the map reveals intricate molecular packing and an alpha-helical coiled coil formed by the terminal chains in the inner core of the filament, with its intersubunit hydrophobic interactions having an important role in stabilizing the filament.	ERATO, JST, Proton NanoMachine Project, Tokyo, Japan; Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 565, Japan; ICORP, JST, Dynam NanoMachine Project, Kyoto 6190237, Japan	Japan Science & Technology Agency (JST); Osaka University; Japan Science & Technology Agency (JST)	Namba, K (corresponding author), ERATO, JST, Proton NanoMachine Project, Tokyo, Japan.		YONEKURA, Koji/N-5060-2015; Namba, Keiichi/A-9406-2016	Yonekura, Koji/0000-0001-5520-4391				Asakura S, 1970, Adv Biophys, V1, P99; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; Beroukhim R, 1997, ULTRAMICROSCOPY, V70, P57, DOI 10.1016/S0304-3991(97)00070-3; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CALLADINE CR, 1976, J THEOR BIOL, V57, P469, DOI 10.1016/0022-5193(76)90016-3; CALLADINE CR, 1978, J MOL BIOL, V118, P457, DOI 10.1016/0022-2836(78)90285-1; CALLADINE CR, 1975, NATURE, V225, P121; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; DeRosier DJ, 2000, ULTRAMICROSCOPY, V81, P83, DOI 10.1016/S0304-3991(99)00120-5; Drenth J, 1994, PRINCIPLES PROTEIN X; Fan F, 1997, MOL MICROBIOL, V26, P1035, DOI 10.1046/j.1365-2958.1997.6412010.x; Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)90004-1; HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; HOMMA M, 1990, J MOL BIOL, V213, P819, DOI 10.1016/S0022-2836(05)80266-9; HYMAN HC, 1991, J MOL BIOL, V220, P79, DOI 10.1016/0022-2836(91)90382-G; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KANTO S, 1991, J MOL BIOL, V219, P471, DOI 10.1016/0022-2836(91)90187-B; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; KUDO S, 1990, NATURE, V346, P677, DOI 10.1038/346677a0; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; LARSEN SH, 1974, NATURE, V249, P74, DOI 10.1038/249074a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MACNAB RM, 1977, J MOL BIOL, V112, P1, DOI 10.1016/S0022-2836(77)80153-8; Maki S, 1998, J MOL BIOL, V277, P771, DOI 10.1006/jmbi.1998.1663; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MIMORI Y, 1995, J MOL BIOL, V249, P69, DOI 10.1006/jmbi.1995.0281; Mimori-Kiyosue Y, 1998, J MOL BIOL, V284, P521, DOI 10.1006/jmbi.1998.2184; MimoriKiyosue Y, 1997, J MOL BIOL, V270, P222, DOI 10.1006/jmbi.1997.1111; MimoriKiyosue Y, 1996, P NATL ACAD SCI USA, V93, P15108, DOI 10.1073/pnas.93.26.15108; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; MORGAN DG, 1995, J MOL BIOL, V249, P88, DOI 10.1006/jmbi.1995.0282; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; OBRIEN EJ, 1972, J MOL BIOL, V70, P133, DOI 10.1016/0022-2836(72)90168-4; Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; SILVERMAN M, 1974, NATURE, V249, P73, DOI 10.1038/249073a0; Toyoshima C, 2000, ULTRAMICROSCOPY, V84, P1, DOI 10.1016/S0304-3991(00)00010-3; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; VONDERVISZT F, 1989, J MOL BIOL, V209, P127, DOI 10.1016/0022-2836(89)90176-9; WANG H, 1993, ACTA CRYSTALLOGR A, V49, P504, DOI 10.1107/S0108767392011255; Yamashita I, 1998, NAT STRUCT BIOL, V5, P125; Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148; Yonekura K, 2000, ULTRAMICROSCOPY, V84, P29, DOI 10.1016/S0304-3991(00)00008-5	47	542	567	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					643	650		10.1038/nature01830	http://dx.doi.org/10.1038/nature01830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904785				2022-12-24	WOS:000184578800037
J	Bacon, CG; Mittleman, MA; Kawachi, I; Giovannucci, E; Glasser, DB; Rimm, EB				Bacon, CG; Mittleman, MA; Kawachi, I; Giovannucci, E; Glasser, DB; Rimm, EB			Sexual function in men older than 50 years of age: Results from the health professionals follow-up study	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; TIME PHYSICAL-ACTIVITY; ERECTILE DYSFUNCTION; RISK-FACTORS; PROSTATE-CANCER; PREVALENCE; COMMUNITY; QUESTIONNAIRE; EPIDEMIOLOGY; PREDICTORS	Background: Although many studies have provided data on erectile dysfunction in specific settings, few studies have been large enough to precisely examine age-specific prevalence and correlates. Objective: To describe the association between age and several aspects of sexual functioning in men older than 50 years of age. Design: Cross-sectional analysis of data from a prospective cohort study. Setting: U.S. health professionals. Participants: 31 742 men, age 53 to 90 years. Measurements: Questionnaires mailed in 2000 asked about sexual function, physical activity, body weight, smoking, marital status, medical conditions, and medications. Previous biennial questionnaires since 1986 asked about date of birth, alcohol intake, and other health information. Results: When men with prostate cancer were excluded, the age-standardized prevalence of erectile dysfunction in the previous 3 months was 33%. Many aspects of sexual function (including overall function, desire, orgasm, and overall ability) decreased sharply by decade after 50 years of age. Physical activity was associated with lower risk for erectile dysfunction (multivariable relative risk, 0.7 [95% CI, 0.6 to 0.7] for >32.6 metabolic equivalent hours of exercise per week vs. 0 to 2.7 metabolic equivalent hours of exercise per week), and obesity was associated with higher risk (relative risk, 1.3 [CI, 1.2 to 1.4] for body mass index >28.7 kg/m(2) VS. <23.2 kg/m(2)). Smoking, alcohol consumption, and television viewing time were also associated with increased prevalence of erectile dysfunction. Men who had no chronic medical conditions and engaged in healthy behaviors had the lowest prevalence. Conclusions: several modifiable health behaviors were associated with maintenance of good erectile function, even after comorbid conditions were considered. Lifestyle factors most strongly associated with erectile dysfunction were physical activity and leanness.	Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Pfizer Inc, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Pfizer	Bacon, CG (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.			Mittleman, Murray/0000-0001-9788-7274	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NCI NIH HHS [CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ansong KS, 2000, ANN EPIDEMIOL, V10, P293, DOI 10.1016/S1047-2797(00)00050-8; Aytac IA, 2000, SOC SCI MED, V51, P771, DOI 10.1016/S0277-9536(00)00022-8; Bacon CG, 2001, J UROLOGY, V166, P1804, DOI 10.1016/S0022-5347(05)65679-0; Blanker MH, 2001, UROLOGY, V57, P763, DOI 10.1016/S0090-4295(00)01091-8; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Chew KK, 2000, INT J IMPOT RES, V12, P41, DOI 10.1038/sj.ijir.3900457; Derby CA, 2000, UROLOGY, V56, P302, DOI 10.1016/S0090-4295(00)00614-2; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Fung TT, 2000, AM J EPIDEMIOL, V152, P1171, DOI 10.1093/aje/152.12.1171; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; KINSEY AC, 1948, SEXUAL BEHAV HUMAN M, P218; Kongkanand A, 2000, INT J ANDROL, V23, P77, DOI 10.1046/j.1365-2605.2000.00022.x; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Leitzmann MF, 1998, ANN INTERN MED, V128, P417, DOI 10.7326/0003-4819-128-6-199803150-00001; Lewis RW, 2001, UROL CLIN N AM, V28, P209, DOI 10.1016/S0094-0143(05)70132-4; Litwin MS, 1998, MED CARE, V36, P1002, DOI 10.1097/00005650-199807000-00007; Litwin MS, 1998, J GEN INTERN MED, V13, P159, DOI 10.1046/j.1525-1497.1998.00050.x; Malmsten UGH, 1997, J UROLOGY, V158, P1733, DOI 10.1016/S0022-5347(01)64113-2; MANNINO DM, 1994, AM J EPIDEMIOL, V140, P1003, DOI 10.1093/oxfordjournals.aje.a117189; Masumori N, 1999, UROLOGY, V54, P335, DOI 10.1016/S0090-4295(99)00108-9; McVary KT, 2001, J UROLOGY, V166, P1624, DOI 10.1016/S0022-5347(05)65641-8; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; PANSER LA, 1995, J AM GERIATR SOC, V43, P1107, DOI 10.1111/j.1532-5415.1995.tb07009.x; Parazzini F, 2000, EUR UROL, V37, P43, DOI 10.1159/000020098; Pinnock CB, 1999, MED J AUSTRALIA, V171, P353, DOI 10.5694/j.1326-5377.1999.tb123691.x; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rothman K., 1998, MODERN EPIDEMIOLOGY; SOLSTAD K, 1993, ARCH SEX BEHAV, V22, P51, DOI 10.1007/BF01552912; Sullivan ME, 2001, BJU INT, V87, P838, DOI 10.1046/j.1464-410x.2001.02211.x; Ventegodt S, 1998, ARCH SEX BEHAV, V27, P295, DOI 10.1023/A:1018655219133; WEI M, 1994, AM J EPIDEMIOL, V140, P930, DOI 10.1093/oxfordjournals.aje.a117181	33	500	517	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2003	139	3					161	168		10.7326/0003-4819-139-3-200308050-00005	http://dx.doi.org/10.7326/0003-4819-139-3-200308050-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	707RH	12899583				2022-12-24	WOS:000184523300001
J	Meyerson, M				Meyerson, M			Human genetic variation and disease	LANCET			English	Editorial Material							DNA-SEQUENCES; ASSOCIATION		Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Meyerson, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	Matthew_Meyerson@dfci.harvard.edu	Meyerson, Matthew L/E-7123-2012					Britten RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/pnas.172510699; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Hallberg P, 2002, J HYPERTENS, V20, P2089, DOI 10.1097/00004872-200210000-00030; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Reich DE, 2003, NAT GENET, V33, P457, DOI 10.1038/ng1133; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878	11	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					259	260		10.1016/S0140-6736(03)14002-0	http://dx.doi.org/10.1016/S0140-6736(03)14002-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892951				2022-12-24	WOS:000184413400003
J	Panda, S; Provencio, I; Tu, DC; Pires, SS; Rollag, MD; Castrucci, AM; Pletcher, MT; Sato, TK; Wiltshire, T; Andahazy, M; Kay, SA; Van Gelder, RN; Hogenesch, JB				Panda, S; Provencio, I; Tu, DC; Pires, SS; Rollag, MD; Castrucci, AM; Pletcher, MT; Sato, TK; Wiltshire, T; Andahazy, M; Kay, SA; Van Gelder, RN; Hogenesch, JB			Melanopsin is required for non-image-forming photic responses in blind mice	SCIENCE			English	Article							RETINAL GANGLION-CELLS; CIRCADIAN CLOCK; NON-CONE; NON-ROD; LIGHT; PHOTORECEPTORS; ENTRAINMENT; PINEAL; PHOTOSENSITIVITY; CRYPTOCHROMES	Although mice lacking rod and cone photoreceptors are blind, they retain many eye-mediated responses to light, possibly through photosensitive retinal ganglion cells. These cells express melanopsin, a photopigment that confers this photosensitivity. Mice lacking melanopsin still retain nonvisual photoreception, suggesting that rods and cones could operate in this capacity. We observed that mice with both outer-retinal degeneration and a deficiency in melanopsin exhibited complete loss of photoentrainment of the circadian oscillator, pupillary light responses, photic suppression of arylalkylamine-N-acetyltransferase transcript, and acute suppression of locomotor activity by light. This indicates the importance of both nonvisual and classical visual photoreceptor systems for nonvisual photic responses in mammals.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Sao Paulo, Dept Physiol, Biosci Inst, BR-05508900 Sao Paulo, Brazil	Novartis; Scripps Research Institute; Scripps Research Institute; Uniformed Services University of the Health Sciences - USA; Washington University (WUSTL); Washington University (WUSTL); Universidade de Sao Paulo	Hogenesch, JB (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John J Hopkins Dr, San Diego, CA 92121 USA.		Panda, Satchidananda/J-6891-2012; Van Gelder, Russell/ABB-4225-2021; Castrucci, Ana Maria L/C-3296-2014; Jansen, Heiko T./A-5770-2008; Kay, Steve A/F-6025-2011	Van Gelder, Russell/0000-0001-5368-3659; Jansen, Heiko T./0000-0003-0178-396X; Kay, Steve A/0000-0002-0402-2878; Castrucci, Ana Maria/0000-0002-2065-8198; Provencio, Ignacio/0000-0003-1175-920X	NATIONAL EYE INSTITUTE [R01EY014988, K08EY000403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062405, R01MH051573] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY14988, K08-EY00403] Funding Source: Medline; NIMH NIH HHS [MH 62405, MH51573] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; FARADJI H, 1980, BRAIN RES, V202, P41, DOI 10.1016/0006-8993(80)90642-3; Foster RG, 2002, PROG RETIN EYE RES, V21, P507, DOI 10.1016/S1350-9462(02)00036-8; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; KLEIN DC, 1972, SCIENCE, V177, P532, DOI 10.1126/science.177.4048.532; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; NELSON RJ, 1981, COMP BIOCHEM PHYS A, V69, P145, DOI 10.1016/0300-9629(81)90651-4; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; PANDA S, UNPUB; Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Van Gelder RN, 2002, J NEUROGENET, V16, P181, DOI 10.1080/01677060215306; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Wee R, 2002, J NEUROSCI, V22, P10427	23	530	544	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					525	527		10.1126/science.1086179	http://dx.doi.org/10.1126/science.1086179			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12829787				2022-12-24	WOS:000184340500045
J	Drazen, JM				Drazen, JM			SARS - Looking back over the first 100 days	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Drazen, Jeffrey M/E-5841-2012	Drazen, Jeffrey/0000-0003-2715-9890				Holmes KV, 2003, NEW ENGL J MED, V348, P1948, DOI 10.1056/NEJMp030078	1	26	27	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					319	320		10.1056/NEJMp038118	http://dx.doi.org/10.1056/NEJMp038118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878735				2022-12-24	WOS:000184312800001
J	Huber, DL; Manginell, RP; Samara, MA; Kim, BI; Bunker, BC				Huber, DL; Manginell, RP; Samara, MA; Kim, BI; Bunker, BC			Programmed adsorption and release of proteins in a microfluidic device	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; SURFACE-PROPERTIES; SILICA; SYSTEMS; SILVER; GOLD	A microfluidic device has been developed that can adsorb proteins from solution, hold them with negligible denaturation, and release them on command. The active element in the device is a 4-nanometer-thick polymer film that can be thermally switched between an antifouling hydrophilic state and a protein-adsorbing state that is more hydrophobic. This active polymer has been integrated into a microfluidic hot plate that can be programmed to adsorb and desorb protein monolayers in less than 1 second. The rapid response characteristics of the device can be manipulated for proteomic functions, including preconcentration and separation of soluble proteins on an integrated fluidics chip.	Sandia Natl Labs, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories	Bunker, BC (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.		Huber, Dale L./A-6006-2008	Huber, Dale L./0000-0001-6872-8469; Kim, Byung/0000-0003-4484-1728				ABBOTT NL, 1995, LANGMUIR, V11, P16, DOI 10.1021/la00001a005; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; Burns MA, 1996, P NATL ACAD SCI USA, V93, P5556, DOI 10.1073/pnas.93.11.5556; Figeys D, 2001, ELECTROPHORESIS, V22, P208, DOI 10.1002/1522-2683(200101)22:2<208::AID-ELPS208>3.3.CO;2-F; Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z; JOYCE SA, 1991, REV SCI INSTRUM, V62, P710, DOI 10.1063/1.1142072; Kanazawa H, 1996, ANAL CHEM, V68, P100, DOI 10.1021/ac950359j; Kidoaki S, 2001, LANGMUIR, V17, P2402, DOI 10.1021/la001522v; Kleijn M, 1995, HETEROGEN CHEM REV, V2, P157; Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933; Lakhiari H, 1998, BBA-GEN SUBJECTS, V1379, P303, DOI 10.1016/S0304-4165(97)00110-4; Liang L, 1998, MACROMOLECULES, V31, P7845; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Ostuni E, 1999, COLLOID SURFACE B, V15, P3, DOI 10.1016/S0927-7765(99)00004-1; Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8; PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164; Revillon A, 1995, REACT FUNCT POLYM, V26, P105, DOI 10.1016/1381-5148(95)00009-5; TAKEI YG, 1994, MACROMOLECULES, V27, P6163, DOI 10.1021/ma00099a035; Whitesides GM, 2001, PHYS TODAY, V54, P42, DOI 10.1063/1.1387591; ZHANG J, 1995, LANGMUIR, V11, P2301	20	479	493	5	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					352	354		10.1126/science.1080759	http://dx.doi.org/10.1126/science.1080759			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869757				2022-12-24	WOS:000184207300039
J	King, N; Hittinger, CT; Carroll, SB				King, N; Hittinger, CT; Carroll, SB			Evolution of key cell signaling and adhesion protein families predates animal origins	SCIENCE			English	Article							TYROSINE KINASE; UNICELLULAR RELATIVES; MITOGENIC AGENTS; PHOSPHORYLATION; SEQUENCE	The evolution of animals from a unicellular ancestor involved many innovations. Choanoflagellates, unicellular and colonial protozoa closely related to Metazoa, provide a potential window into early animal evolution. We have found that choanoflagellates express representatives of a surprising number of cell signaling and adhesion protein families that have not previously been isolated from nonmetazoans, including cadherins, C-type lectins, several tyrosine kinases, and tyrosine kinase signaling pathway components. Choanoflagellates have a complex and dynamic tyrosine phosphoprotein pro. le, and cell proliferation is selectively affected by tyrosine kinase inhibitors. The expression in choanoflagellates of proteins involved in cell interactions in Metazoa demonstrates that these proteins evolved before the origin of animals and were later co-opted for development.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.				NIGMS NIH HHS [GM-20734] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Burger G, 2003, P NATL ACAD SCI USA, V100, P892, DOI 10.1073/pnas.0336115100; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; COOPER JA, 1984, MOL CELL BIOL, V4, P30, DOI 10.1128/MCB.4.1.30; Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R; HIBBERD DJ, 1975, J CELL SCI, V17, P191; King N, 2001, P NATL ACAD SCI USA, V98, P15032, DOI 10.1073/pnas.261477698; Kumar P, 2001, J BIOL CHEM, V276, P21039, DOI 10.1074/jbc.M009099200; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; MIYAZAWA K, 1992, BLOOD, V80, P1685; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; PASQUALE EB, 1988, J CELL PHYSIOL, V137, P146, DOI 10.1002/jcp.1041370118; Porter AC, 1998, ONCOGENE, V17, P1343, DOI 10.1038/sj.onc.1202171; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Saville Kent W., 1880, MANUAL INFUSORIA; SHAPIRO L, 1995, P NATL ACAD SCI USA, V92, P6793, DOI 10.1073/pnas.92.15.6793; Snell EA, 2001, CURR BIOL, V11, P967, DOI 10.1016/S0960-9822(01)00275-5; WAINRIGHT PO, 1993, SCIENCE, V260, P340, DOI 10.1126/science.8469985; Watkins RF, 1999, J MOL EVOL, V48, P542, DOI 10.1007/PL00006497; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	23	286	304	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					361	363		10.1126/science.1083853	http://dx.doi.org/10.1126/science.1083853			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869759				2022-12-24	WOS:000184207300042
J	Cahan, SH; Keller, L				Cahan, SH; Keller, L			Complex hybrid origin of genetic caste determination in harvester ants	NATURE			English	Article								Caste differentiation and division of labour are the hallmarks of insect societies(1) and at the root of their ecological success(2). Kin selection predicts that caste determination should result from environmentally induced differences in gene expression(3,4), a prediction largely supported by empirical data(5). However, two exceptional cases of genetically determined caste differentiation have recently been found in harvester ants(6-8). Here we show that genetic caste determination evolved in these populations after complex hybridization events. We identified four distinct genetic lineages, each consisting of unique blends of the genomes of the parental species, presumably Pogonomyrmex barbatus and P. rugosus. Crosses between lineages H1 and H2 and between J1 and J2 give rise to workers, whereas queens develop from within-lineage matings. Although historical gene flow is evident, genetic exchange among lineages and between lineages and the parental species no longer occurs. This unusual system of caste determination seems to be evolutionarily stable.	Univ Lausanne, Inst Ecol, CH-1015 Lausanne, Switzerland	University of Lausanne	Cahan, SH (corresponding author), Univ Lausanne, Inst Ecol, CH-1015 Lausanne, Switzerland.		keller, laurent/AAI-7175-2020	keller, laurent/0000-0002-5046-9953				Bourke AFG, 1997, P ROY SOC B-BIOL SCI, V264, P277, DOI 10.1098/rspb.1997.0039; Buschinger A., 1990, P37; Cahan SH, 2002, P ROY SOC B-BIOL SCI, V269, P1871, DOI 10.1098/rspb.2002.2061; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; Cole AC, 1968, POGONOMYRMEX HARVEST; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Foitzik S, 1997, INSECT SOC, V44, P219, DOI 10.1007/s000400050043; JONES TR, 1995, MOL PHYLOGENET EVOL, V4, P194, DOI 10.1006/mpev.1995.1019; Julian GE, 2002, P NATL ACAD SCI USA, V99, P8157, DOI 10.1073/pnas.112222099; OSTER GF, 1975, CASTE ECOLOGY SOCIAL; Parker JD, 2002, EVOLUTION, V56, P2017, DOI 10.1111/j.0014-3820.2002.tb00128.x; SEGER J, 1981, J THEOR BIOL, V91, P191, DOI 10.1016/0022-5193(81)90380-5; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Taber S. W., 1998, WORLD HARVESTER ANTS; Volny VP, 2002, P NATL ACAD SCI USA, V99, P6108, DOI 10.1073/pnas.092066699; Volny VP, 2002, MOL ECOL NOTES, V2, P302, DOI 10.1046/j.1471-8286.2002.00243.x; Welch ME, 2002, EVOLUTION, V56, P2126, DOI 10.1111/j.0014-3820.2002.tb00138.x; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536; Wilson EO., 1971, INSECT SOC; Xu SZ, 2000, MOL BIOL EVOL, V17, P897, DOI 10.1093/oxfordjournals.molbev.a026370	20	131	134	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					306	309		10.1038/nature01744	http://dx.doi.org/10.1038/nature01744			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867980	Green Published			2022-12-24	WOS:000184183900040
J	Skordalakes, E; Berger, JM				Skordalakes, E; Berger, JM			Structure of the Rho transcription terminator: Mechanism of mRNA recognition and helicase loading	CELL			English	Article							ESCHERICHIA-COLI RHO; RNP1-LIKE SEQUENCE MOTIF; TRP-T' TERMINATOR; DEPENDENT TERMINATION; CRYSTAL-STRUCTURE; BINDING DOMAIN; DNA HELICASE; PROTEIN-RHO; SHOCK PROTEIN; NMR STRUCTURE	In bacteria, one of the major transcriptional termination mechanisms requires a RNA/DNA helicase known as the Rho factor. We have determined two structures of Rho complexed with nucleic acid recognition site mimics in both free and nucleotide bound states to 3.0 Angstrom resolution. Both structures show that Rho forms a hexameric ring in which two RNA binding sites-a primary one responsible for target mRNA recognition and a secondary one required for mRNA translocation and unwinding-point toward the center of the ring. Rather than forming a closed ring, the Rho hexamer is split open, resembling a "lock washer" in its global architecture. The distance between subunits at the opening is sufficiently wide (12 Angstrom) to accommodate single-stranded RNA. This open configuration most likely resembles a state poised to load onto mRNA and suggests how related ring-shaped enzymes may be breached to bind nucleic acids.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 239 Hildebrand Hall,3206, Berkeley, CA 94720 USA.	jmberger@uclink4.berkeley.edu	Skordalakes, Emmanuel/H-7071-2019	Skordalakes, Emmanuel/0000-0002-7600-2833				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ALIFANO P, 1991, CELL, V64, P553; Allison TJ, 1998, NAT STRUCT BIOL, V5, P352, DOI 10.1038/nsb0598-352; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barcena M, 2001, EMBO J, V20, P1462, DOI 10.1093/emboj/20.6.1462; BEAR DG, 1988, J MOL BIOL, V199, P623, DOI 10.1016/0022-2836(88)90306-3; BEAR DG, 1985, P NATL ACAD SCI USA, V82, P1911, DOI 10.1073/pnas.82.7.1911; Bird LE, 1998, NUCLEIC ACIDS RES, V26, P2686, DOI 10.1093/nar/26.11.2686; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; Bogden CE, 1999, MOL CELL, V3, P487, DOI 10.1016/S1097-2765(00)80476-1; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRENNAN CA, 1990, J BIOL CHEM, V265, P5440; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; Briercheck DM, 1998, NAT STRUCT BIOL, V5, P393, DOI 10.1038/nsb0598-393; BROWN S, 1981, J BACTERIOL, V146, P422, DOI 10.1128/JB.146.1.422-425.1981; Burgess BR, 2001, J BIOL CHEM, V276, P4182, DOI 10.1074/jbc.M007066200; Burgess BR, 2001, J BIOL CHEM, V276, P17106, DOI 10.1074/jbc.M101856200; CAVARELLI J, 1993, NATURE, V362, P181, DOI 10.1038/362181a0; CHEN CYA, 1986, CELL, V46, P1023, DOI 10.1016/0092-8674(86)90701-4; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; DOLAN JW, 1990, J BIOL CHEM, V265, P5747; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; ENGEL D, 1984, NUCLEIC ACIDS RES, V12, P7389, DOI 10.1093/nar/12.19.7389; GALLUPPI GR, 1980, J MOL BIOL, V138, P513, DOI 10.1016/S0022-2836(80)80016-7; Gan E, 1999, BIOCHEMISTRY-US, V38, P16882, DOI 10.1021/bi991559i; GEISELMANN J, 1993, P NATL ACAD SCI USA, V90, P7754, DOI 10.1073/pnas.90.16.7754; GEISELMANN J, 1992, PROTEIN SCI, V1, P861, DOI 10.1002/pro.5560010704; GOGOL EP, 1991, J MOL BIOL, V221, P1127, DOI 10.1016/0022-2836(91)80116-C; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim DE, 2001, J BIOL CHEM, V276, P13902, DOI 10.1074/jbc.M011043200; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LOWERYGO.C, 1974, P NATL ACAD SCI USA, V71, P2003, DOI 10.1073/pnas.71.5.2003; LUSKY M, 1993, J BIOL CHEM, V268, P15795; Martinez A, 1996, J MOL BIOL, V257, P895, DOI 10.1006/jmbi.1996.0210; Martinez A, 1996, J MOL BIOL, V257, P909, DOI 10.1006/jmbi.1996.0211; MCSWIGGEN JA, 1988, J MOL BIOL, V199, P609, DOI 10.1016/0022-2836(88)90305-1; MIWA Y, 1995, J MOL BIOL, V254, P815, DOI 10.1006/jmbi.1995.0658; MODRAK D, 1994, BIOCHEMISTRY-US, V33, P8292, DOI 10.1021/bi00193a016; MORGAN WD, 1985, NUCLEIC ACIDS RES, V13, P3739, DOI 10.1093/nar/13.10.3739; MORGAN WD, 1983, J BIOL CHEM, V258, P9553; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NEWKIRK K, 1994, P NATL ACAD SCI USA, V91, P5114, DOI 10.1073/pnas.91.11.5114; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ODA T, 1972, J MOL BIOL, V71, P799; OPPERMAN T, 1994, J BACTERIOL, V176, P5033, DOI 10.1128/jb.176.16.5033-5043.1994; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PLATT T, 1994, MOL MICROBIOL, V11, P983, DOI 10.1111/j.1365-2958.1994.tb00376.x; RICHARDSON JP, 1982, J BIOL CHEM, V257, P5760; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; RICHARDSON JP, 1980, BIOCHEMISTRY-US, V19, P4293, DOI 10.1021/bi00559a022; RICHARDSON JP, 1996, CELLULAR MOL BIOL, P822; RICHARDSON LV, 1992, NUCLEIC ACIDS RES, V20, P5383, DOI 10.1093/nar/20.20.5383; ROBERTS JW, 1969, NATURE, V224, P1168, DOI 10.1038/2241168a0; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; SCHINDELIN H, 1994, P NATL ACAD SCI USA, V91, P5119, DOI 10.1073/pnas.91.11.5119; SEO YS, 1993, P NATL ACAD SCI USA, V90, P2865, DOI 10.1073/pnas.90.7.2865; SHIGESADA K, 1980, NUCLEIC ACIDS RES, V8, P3355, DOI 10.1093/nar/8.15.3355; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; STEINMETZ EJ, 1994, P NATL ACAD SCI USA, V91, P1401, DOI 10.1073/pnas.91.4.1401; Stitt BL, 2001, BIOCHEMISTRY-US, V40, P2276, DOI 10.1021/bi002253a; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; SULLIVAN SL, 1992, CELL, V68, P989, DOI 10.1016/0092-8674(92)90041-A; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7980, DOI 10.1021/bi963179s; Wei RR, 2001, J MOL BIOL, V314, P1007, DOI 10.1006/jmbi.2000.5207; Wei RR, 2001, J BIOL CHEM, V276, P28380, DOI 10.1074/jbc.M102444200; Weinreich M, 1999, P NATL ACAD SCI USA, V96, P441, DOI 10.1073/pnas.96.2.441; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu H, 2000, BIOCHEMISTRY-US, V39, P12225, DOI 10.1021/bi0008938; Xu Y, 2002, J BIOL CHEM, V277, P30023, DOI 10.1074/jbc.M111009200; Yu X, 2000, J MOL BIOL, V299, P1279, DOI 10.1006/jmbi.2000.3810; Zhu AQ, 1998, BIOCHEMISTRY-US, V37, P11215, DOI 10.1021/bi972912s; Zhu AQ, 1998, BIOCHEMISTRY-US, V37, P11202, DOI 10.1021/bi9729110	81	194	198	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2003	114	1					135	146		10.1016/S0092-8674(03)00512-9	http://dx.doi.org/10.1016/S0092-8674(03)00512-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859904	Bronze			2022-12-24	WOS:000184219900012
J	Ruo, B; Rumsfeld, JS; Hlatky, MA; Liu, HY; Browner, WS; Whooley, MA				Ruo, B; Rumsfeld, JS; Hlatky, MA; Liu, HY; Browner, WS; Whooley, MA			Depressive symptoms and health-related quality of life - The heart and soul study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SELF-RATED HEALTH; FUNCTIONAL STATUS; PRIMARY-CARE; PERCEIVED HEALTH; FOLLOW-UP; PRIME-MD; CORONARY; MORTALITY; DISEASE; ANGINA	Context Little is known regarding the extent to which patient-reported health status, including symptom burden, physical limitation, and quality of life, is determined by psychosocial vs physiological factors among patients with chronic disease. Objective To compare the contributions of depressive symptoms and measures of cardiac function to the health status of patients with coronary artery disease. Design, Setting, and Participants Cross-sectional study of 1024 adults with stable coronary artery disease recruited from outpatient clinics in the San Francisco Bay Area between September 2000 and December 2002. Main Measures Measurement of depressive symptoms using the Patient Health Questionnaire (PHQ); assessment of cardiac function by measuring left ventricular ejection fraction on echocardiography, exercise capacity on treadmill testing, and ischemia on stress echocardiography; and measurement of a range of health status outcomes, including symptom burden, physical limitation, and quality of life, using the Seattle Angina Questionnaire. Participants were also asked to rate their overall health as excellent, very good, good, fair, or poor. Results Of the 1024 participants, 201 (20%) had depressive symptoms (PHQ score :10). Participants with depressive symptoms were more likely than those without depressive symptoms to report at least mild symptom burden (60% vs 33%; P<.001), mild physical limitation (73% vs 40%; P<.001), mildly diminished quality of life (67% vs 31%; P<.001), and fair or poor overall health (66% vs 30%; P<.001). In multivariate analyses adjusting for measures of cardiac function and other patient characteristics, depressive symptoms were strongly associated with greater symptom burden (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.3-2.7; P=.002), greater physical limitation (OR, 3.1; 95% Cl, 2.1-4.6; P<.001), worse quality of life (OR, 3.1; 95% Cl, 2.2-4.6; P<.001), and worse overall health (OR, 2.0; 95% Cl, 1.3-2.9; P<.001). Although decreased exercise capacity was associated with worse health status, left ventricular ejection fraction and ischemia were not. Conclusions Among patients with coronary disease, depressive symptoms are strongly associated with patient-reported health status, including symptom burden, physical limitation, quality of life, and overall health. Conversely, 2 traditional measures of cardiac function-ejection fraction and ischemia-are not. Efforts to improve health status should include assessment and treatment of depressive symptoms.	Vet Affairs Med Ctr, Gen Internal Med Sect, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Denver Vet Affairs Med Ctr, Cardiol & Hlth Serv Res, Denver, CO USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Stanford University; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco	Whooley, MA (corresponding author), Vet Affairs Med Ctr, Gen Internal Med Sect, 111A1,4150 Clement St, San Francisco, CA 94121 USA.	whooley@itsa.ucsf.edu		Hlatky, Mark/0000-0003-4686-9441	NHLBI NIH HHS [R01 HL079235, R01 HL079235-01A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alonso J, 1997, EUR HEART J, V18, P414; American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; BURDON JGW, 1982, AM REV RESPIR DIS, V126, P825; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cossette S, 2001, PSYCHOSOM MED, V63, P257, DOI 10.1097/00006842-200103000-00009; CROOG SH, 1986, NEW ENGL J MED, V314, P1657, DOI 10.1056/NEJM198606263142602; CUNNY KA, 1991, PSYCHOL REP, V69, P127, DOI 10.2466/PR0.69.5.127-130; DWOSH IL, 1983, NEW ENGL J MED, V308, P1124, DOI 10.1056/NEJM198305123081903; FISHER L, 1983, CIRCULATION, V68, P951; FRIMODTMOLLER PC, 1984, J UROLOGY, V132, P272, DOI 10.1016/S0022-5347(17)49587-5; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; GORKIN L, 1994, QUAL LIFE RES, V3, P111, DOI 10.1007/BF00435254; GUYATT G, 1991, CONTROL CLIN TRIALS, V12, pS81, DOI 10.1016/S0197-2456(05)80014-5; Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203; IDLER EL, 1990, AM J PUBLIC HEALTH, V80, P446, DOI 10.2105/AJPH.80.4.446; IDLER EL, 1990, AM J EPIDEMIOL, V131, P91, DOI 10.1093/oxfordjournals.aje.a115489; KAPLAN GA, 1983, AM J EPIDEMIOL, V117, P292, DOI 10.1093/oxfordjournals.aje.a113541; MAHLER DA, 1984, CHEST, V85, P751, DOI 10.1378/chest.85.6.751; Mattera JA, 2000, AM HEART J, V140, P409, DOI 10.1067/mhj.2000.108518; Miller MD, 1996, AM J PSYCHIAT, V153, P1350; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; NELSON CL, 1991, AM J CARDIOL, V68, P973, DOI 10.1016/0002-9149(91)90423-I; NERENZ DR, 1992, MED CARE, V30, pMS112, DOI 10.1097/00005650-199205001-00010; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; PETERSON WL, 1977, NEW ENGL J MED, V297, P341, DOI 10.1056/NEJM197708182970701; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; Pilote L, 2002, ARCH INTERN MED, V162, P553, DOI 10.1001/archinte.162.5.553; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Rumsfeld JS, 2003, AM HEART J, V145, P493, DOI 10.1067/mhj.2003.177; Rumsfeld JS, 2002, CIRCULATION, V106, P5, DOI 10.1161/01.CIR.0000020805.31531.48; Rumsfeld JS, 2001, AM J CARDIOL, V88, P781, DOI 10.1016/S0002-9149(01)01852-5; Rumsfeld JS, 1999, JAMA-J AM MED ASSOC, V281, P1298, DOI 10.1001/jama.281.14.1298; Sauer WH, 2001, CIRCULATION, V104, P1894, DOI 10.1161/hc4101.097519; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SJOLAND H, 1995, INT J CARDIOL, V51, P221, DOI 10.1016/0167-5273(95)02424-U; Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90; SPERTUS JA, 1994, AM J CARDIOL, V74, P1240, DOI 10.1016/0002-9149(94)90555-X; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Spertus JA, 2000, AM HEART J, V140, P105, DOI 10.1067/mhj.2000.106600; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.1511; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Sullivan MD, 2000, AM J CARDIOL, V86, P1135, DOI 10.1016/S0002-9149(00)01174-7; Sullivan MD, 1997, AM J MED, V103, P348, DOI 10.1016/S0002-9343(97)00167-8; Sullivan MD, 2001, PSYCHOSOM MED, V63, P248, DOI 10.1097/00006842-200103000-00008; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; WENGER NK, 1984, AM J CARDIOL, V54, P908, DOI 10.1016/S0002-9149(84)80232-5; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Whooley MA, 2000, NEW ENGL J MED, V343, P1942, DOI 10.1056/NEJM200012283432607; WIESEL SW, 1984, SPINE, V9, P549, DOI 10.1097/00007632-198409000-00003; WIKLUND I, 1991, CLIN CARDIOL, V14, P204, DOI 10.1002/clc.4960140306; WILLIAMS RB, 1992, JAMA-J AM MED ASSOC, V267, P520, DOI 10.1001/jama.267.4.520; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Ziegelstein RC, 2001, JAMA-J AM MED ASSOC, V286, P1621, DOI 10.1001/jama.286.13.1621	55	574	595	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2003	290	2					215	221		10.1001/jama.290.2.215	http://dx.doi.org/10.1001/jama.290.2.215			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	698GH	12851276	Green Accepted			2022-12-24	WOS:000183989800026
J	Ahmadi, S; Muth-Selbach, U; Lauterbach, A; Lipfert, P; Neuhuber, WL; Zeilhofer, HU				Ahmadi, S; Muth-Selbach, U; Lauterbach, A; Lipfert, P; Neuhuber, WL; Zeilhofer, HU			Facilitation of spinal NMDA receptor currents by spillover of synaptically released glycine	SCIENCE			English	Article							D-ASPARTATE RECEPTOR; EXTRASYNAPTIC GLUTAMATE SPILLOVER; XENOPUS OOCYTES; D-SERINE; SITE; BRAIN; NEUROTRANSMITTER; TRANSMISSION; HIPPOCAMPUS; ACTIVATION	In the mammalian CNS, N-methyl-D-aspartate ( NMDA) receptors serve prominent roles in many physiological and pathophysiological processes including pain transmission. For full activation, NMDA receptors require the binding of glycine. It is not known whether the brain uses changes in extracellular glycine to modulate synaptic NMDA responses. Here, we show that synaptically released glycine facilitates NMDA receptor currents in the superficial dorsal horn, an area critically involved in pain processing. During high presynaptic activity, glycine released from inhibitory interneurons escapes the synaptic cleft and reaches nearby NMDA receptors by so-called spillover. In vivo, this process may contribute to the development of inflammatory hyperalgesia.	Univ Erlangen Nurnberg, Inst Expt & Klin Pharmakol & Toxikol, D-91054 Erlangen, Germany; Univ Klinikum Dusseldorf, Anasthesiol Klin, D-40225 Dusseldorf, Germany; Univ Erlangen Nurnberg, Inst Anat, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Erlangen Nuremberg	Zeilhofer, HU (corresponding author), Univ Erlangen Nurnberg, Inst Expt & Klin Pharmakol & Toxikol, Fahrstr 17, D-91054 Erlangen, Germany.		Zeilhofer, Hanns Ulrich/A-4600-2008	Zeilhofer, Hanns Ulrich/0000-0001-6954-4629				Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Berger AJ, 1998, J NEUROPHYSIOL, V80, P3336, DOI 10.1152/jn.1998.80.6.3336; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Chizh BA, 2001, TRENDS PHARMACOL SCI, V22, P636, DOI 10.1016/S0165-6147(00)01863-0; DOUBELL TP, 1999, TXB PAIN, pCH6; Fern R, 1996, NEUROREPORT, V7, P1953, DOI 10.1097/00001756-199608120-00018; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KEMP JA, 1993, TRENDS PHARMACOL SCI, V14, P20, DOI 10.1016/0165-6147(93)90108-V; KEMP JA, 1988, P NATL ACAD SCI USA, V85, P6547, DOI 10.1073/pnas.85.17.6547; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; KISHIMOTO H, 1981, J NEUROCHEM, V37, P1015, DOI 10.1111/j.1471-4159.1981.tb04489.x; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Kullmann DM, 2000, PROG BRAIN RES, V125, P339; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; LARSON AA, 1988, J NEUROSCI, V8, P3822; Lopez-Corcuera B, 2001, MOL MEMBR BIOL, V18, P13, DOI 10.1080/09687680120521; MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Okuda-Ashitaka E, 1998, NATURE, V392, P286, DOI 10.1038/32660; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Supplisson S, 1997, J NEUROSCI, V17, P4580; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; WESTERGREN I, 1994, J NEUROCHEM, V62, P159; Zeilhofer HU, 2000, J NEUROSCI, V20, P4922	26	108	110	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2003	300	5628					2094	2097		10.1126/science.1083970	http://dx.doi.org/10.1126/science.1083970			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12829784	Green Accepted			2022-12-24	WOS:000183774900047
J	Gundersen, GG; Bretscher, A				Gundersen, GG; Bretscher, A			Microtubule asymmetry	SCIENCE			English	Editorial Material							ORIENTATION; SPINDLE; YEAST		Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Columbia University; Columbia University; Cornell University	Gundersen, GG (corresponding author), Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA.							Beach DL, 2000, CURR BIOL, V10, P1497, DOI 10.1016/S0960-9822(00)00837-X; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Hwang E, 2003, J CELL BIOL, V161, P483, DOI 10.1083/jcb.200302030; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Yin HW, 2000, NATURE, V406, P1013, DOI 10.1038/35023024	14	43	44	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2003	300	5628					2040	2041		10.1126/science.1084938	http://dx.doi.org/10.1126/science.1084938			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12829769				2022-12-24	WOS:000183774900029
J	Benson, J; Britten, N				Benson, J; Britten, N			Patients' views about taking antihypertensive drugs: questionnaire study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICATION		Inst Publ Hlth, Gen Practice & Primary Care Res Unit, Cambridge CB2 2SR, England; Peninsula Med Sch, Inst Clin Educ, Exeter EX1 2LU, Devon, England	University of Cambridge; University of Exeter	Benson, J (corresponding author), Inst Publ Hlth, Gen Practice & Primary Care Res Unit, Cambridge CB2 2SR, England.	jab62@medschl.cam.ac.uk						Benson J, 2002, BRIT MED J, V325, P873, DOI 10.1136/bmj.325.7369.873; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; ROST K, 1989, SOC SCI MED, V28, P315, DOI 10.1016/0277-9536(89)90032-4; Svensson S, 2000, INT J CARDIOL, V76, P157, DOI 10.1016/S0167-5273(00)00374-0; Wallenius SH, 1995, ANN PHARMACOTHER, V29, P1213, DOI 10.1177/106002809502901204	5	33	40	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2003	326	7402					1314	1315		10.1136/bmj.326.7402.1314	http://dx.doi.org/10.1136/bmj.326.7402.1314			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691VK	12805171	Green Published, Bronze			2022-12-24	WOS:000183626500035
J	Mace, GM; Gittleman, JL; Purvis, A				Mace, GM; Gittleman, JL; Purvis, A			Preserving the Tree of Life	SCIENCE			English	Editorial Material							EXTINCTION RISK; HABITAT LOSS; CONSERVATION; HOTSPOTS	Phylogenies provide new ways to measure biodiversity, to assess conservation priorities, and to quantify the evolutionary history in any set of species. Methodological problems and a lack of knowledge about most species have so far hampered their use. In the future, as techniques improve and more data become accessible, we will have an expanded set of conservation options, including ways to prioritize outcomes from evolutionary and ecological processes.	Zool Soc London, Inst Zool, London NW1 4RY, England; Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ascot SL5 7PY, Berks, England	Zoological Society of London; University of Virginia; Imperial College London	Mace, GM (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.		Purvis, Andy/A-7529-2008; Mace, Georgina M/I-3072-2016	Purvis, Andy/0000-0002-8609-6204; Mace, Georgina M/0000-0001-8965-5211				Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Avise JC., 2000, PHYLOGEOGRAPHY; Barraclough TG, 1998, PHILOS T R SOC B, V353, P241, DOI 10.1098/rstb.1998.0206; Bromham L, 1999, TRENDS ECOL EVOL, V14, P113, DOI 10.1016/S0169-5347(98)01507-9; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; COLLAR LNJH, 1994, BIRDS WATCH, V2; Cooper A, 1998, TRENDS ECOL EVOL, V13, P151, DOI 10.1016/S0169-5347(97)01277-9; Cracraft J., 1983, Current Ornithology, V1, P159; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gribaldo S, 2002, THEOR POPUL BIOL, V61, P391, DOI 10.1006/tpbi.2002.1593; Heard SB, 2002, SYST BIOL, V51, P889, DOI 10.1080/10635150290155917; HEYWOOD VH, 1994, NATURE, V368, P105, DOI 10.1038/368105a0; Hilton-Taylor C., 2000, 2000 IUCN RED LIST T; May Robert M., 1995, P1; Meegaskumbura M, 2002, SCIENCE, V298, P379, DOI 10.1126/science.298.5592.379; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Nee Sean, 1996, P230; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Peters SE, 2002, NATURE, V416, P420, DOI 10.1038/416420a; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; RODRIGUES ASL, PHYLOGENY CONSERVATI; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Schwartz MW, 2001, ECOL LETT, V4, P464, DOI 10.1046/j.1461-0248.2001.00241.x; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Soltis PS, 2002, P NATL ACAD SCI USA, V99, P4430, DOI 10.1073/pnas.032087199; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X	30	258	271	1	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1707	1709		10.1126/science.1085510	http://dx.doi.org/10.1126/science.1085510			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805539				2022-12-24	WOS:000183459700040
J	Narita, M; Nunez, S; Heard, E; Narita, M; Lin, AW; Hearn, SA; Spector, DL; Hannon, GJ; Lowe, SW				Narita, M; Nunez, S; Heard, E; Narita, M; Lin, AW; Hearn, SA; Spector, DL; Hannon, GJ; Lowe, SW			Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence	CELL			English	Article							HUMAN-DIPLOID FIBROBLASTS; HISTONE H3; ONCOGENIC RAS; TUMOR-CELLS; X-CHROMOSOME; G(1) CONTROL; LYSINE 9; IN-VIVO; P53; HP1	Cellular senescence is an extremely stable form of cell cycle arrest that limits the proliferation of damaged cells and may act as a natural barrier to cancer progression. In this study, we describe a distinct heterochromatic structure that accumulates in senescent human fibroblasts, which we designated senescence-associated heterochromatic foci (SAHF). SAHF formation coincides with the recruitment of heterochromatin proteins and the retinoblastoma (Rb) tumor suppressor to E2F-responsive promoters and is associated with the stable repression of E2F target genes. Notably, both SAHF formation and the silencing of E2F target genes depend on the integrity of the Rb pathway and do not occur in reversibly arrested cells. These results provide a molecular explanation for the stability of the senescent state, as well as new insights into the action of Rb as a tumor suppressor.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; Inst Curie, CNRS, UMR 218, F-75248 Paris 05, France	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Lowe, SW (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Hannon, Gregory/AAB-3568-2019; Heard, Edith/D-7197-2017	Heard, Edith/0000-0001-8052-7117; Narita, Masako/0000-0002-9774-4908; Narita, Masashi/0000-0001-7764-577X; Hearn, Stephen/0000-0002-2489-2424	NATIONAL CANCER INSTITUTE [P30CA008748, P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016379, R56AG016379] Funding Source: NIH RePORTER; NCI NIH HHS [CA13106, P30 CA008748] Funding Source: Medline; NIA NIH HHS [AG16379] Funding Source: Medline; NIGMS NIH HHS [GM42694, R01 GM042694] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)82148-6; Chang BD, 1999, CANCER RES, V59, P3761; CHENICLET C, 1990, J HISTOCHEM CYTOCHEM, V38, P551, DOI 10.1177/38.4.1690766; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Dai CY, 2000, ONCOGENE, V19, P1613, DOI 10.1038/sj.onc.1203438; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Dimri GP, 1996, BIOL SIGNAL, V5, P154; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DIMRI GP, 1994, J BIOL CHEM, V269, P16180; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Ferbeyre G, 2000, GENE DEV, V14, P2015; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Good LF, 1996, J CELL PHYSIOL, V168, P580, DOI 10.1002/(SICI)1097-4652(199609)168:3<580::AID-JCP10>3.0.CO;2-3; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Henikoff S., 2000, BIOCHIM BIOPHYS ACTA, V1470, P01; Humbert PO, 2000, GENE DEV, V14, P690; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee SW, 2000, P NATL ACAD SCI USA, V97, P8302, DOI 10.1073/pnas.150024397; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; LEUBA SH, 1994, J MOL BIOL, V235, P871, DOI 10.1006/jmbi.1994.1045; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Mathon NE, 2001, NAT REV CANCER, V1, P203, DOI 10.1038/35106045; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Samuelson AV, 1997, P NATL ACAD SCI USA, V94, P12094, DOI 10.1073/pnas.94.22.12094; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Spector DL, 2001, J CELL SCI, V114, P2891; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648; Takahashi Y, 2000, GENE DEV, V14, P804; te Poele RH, 2002, CANCER RES, V62, P1876; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806	52	1620	1685	6	105	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2003	113	6					703	716		10.1016/S0092-8674(03)00401-X	http://dx.doi.org/10.1016/S0092-8674(03)00401-X			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809602	Bronze			2022-12-24	WOS:000183514400006
J	Kmietowicz, Z				Kmietowicz, Z			Commentary: Information for patients: removal of lice and eggs by combing	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ Publishing Grp, BestTreatments, London WC1H 9JR, England	BMJ Publishing Group Ltd	Kmietowicz, Z (corresponding author), BMJ Publishing Grp, BestTreatments, London WC1H 9JR, England.								0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 7	2003	326	7401					1258	1258		10.1136/bmj.326.7401.1258	http://dx.doi.org/10.1136/bmj.326.7401.1258			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689FJ	12791747	Green Published			2022-12-24	WOS:000183480700023
J	Kelly-Welch, AE; Hanson, EM; Boothby, MR; Keegan, AD				Kelly-Welch, AE; Hanson, EM; Boothby, MR; Keegan, AD			Interleukin-4 and interleukin-13 signaling connections maps	SCIENCE			English	Editorial Material							IL-4 RECEPTOR; STAT6	Cytokines are inflammatory mediators important in responding to pathogens and other foreign challenges. Interleukin-4 (IL-4) and IL-13 are two cytokines produced by T helper type 2 cells, mast cells, and basophils. In addition to their physiological roles, these cytokines are also implicated in pathological conditions such as asthma and allergy. IL-4 can stimulate two receptors, type I and type II, whereas IL-13 signaling is mediated only by the type II receptor (see the STKE Connections Maps). These cytokines activate the Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling cascades, which may contribute to allergic responses. In addition, stimulation of the phosphatidylinositol 3-kinase (PI3K) pathway through recruitment of members of the insulin receptor substrate family may contribute to survival and proliferation.	Amer Red Cross, Dept Immunol, Holland Lab, Rockville, MD 20855 USA; George Washington Med Ctr, Inst Biomed Sci, Washington, DC 20037 USA; Vanderbilt Univ, Dept Microbiol, Nashville, TN 37232 USA	American Red Cross; George Washington University; Vanderbilt University	Keegan, AD (corresponding author), Amer Red Cross, Dept Immunol, Holland Lab, Rockville, MD 20855 USA.	keegana@usa.redcross.org			NHLBI NIH HHS [HL61752] Funding Source: Medline; NIAID NIH HHS [AI38985, AI49460, AI45662] Funding Source: Medline; NIGMS NIH HHS [GM42550] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045662, R21AI049460, R01AI049460, R29AI038985, R01AI038985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042550, R29GM042550] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AARONSON DS, 2003, SCI STKE; Andrews RP, 2002, J BIOL CHEM, V277, P36563, DOI 10.1074/jbc.M200986200; Boothby M, 2001, CRIT REV IMMUNOL, V21, P487; CANTLEY LC, 2003, SCI STKE; Chomarat P, 1998, Int Rev Immunol, V17, P1, DOI 10.3109/08830189809084486; Hanson EM, 2003, J BIOL CHEM, V278, P3903, DOI 10.1074/jbc.M211747200; Kashiwada M, 2001, J IMMUNOL, V167, P6382, DOI 10.4049/jimmunol.167.11.6382; KEEGAN AD, 2003, SCI STKE; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Perez-G M, 2002, J IMMUNOL, V168, P1428, DOI 10.4049/jimmunol.168.3.1428; Pernis AB, 2002, J CLIN INVEST, V109, P1279, DOI 10.1172/JCI200215786; Shelburne CP, 2002, CYTOKINE, V19, P218, DOI 10.1006/cyto.2002.1957; Sherman MA, 2002, J IMMUNOL, V169, P3811, DOI 10.4049/jimmunol.169.7.3811; Shirakawa T, 2000, IMMUNOL TODAY, V21, P60, DOI 10.1016/S0167-5699(99)01492-9; Wood N, 2003, J EXP MED, V197, P703, DOI 10.1084/jem.20020906; Wurster AL, 2002, J BIOL CHEM, V277, P27169, DOI 10.1074/jbc.M201207200; Wurster AL, 2002, MOL CELL BIOL, V22, P117, DOI 10.1128/MCB.22.1.117-126.2002; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Zhu JF, 2000, J EXP MED, V192, P1125, DOI 10.1084/jem.192.8.1125; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5	21	304	356	3	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2003	300	5625					1527	1528		10.1126/science.1085458	http://dx.doi.org/10.1126/science.1085458			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791978				2022-12-24	WOS:000183333100038
J	Brakefield, PM; Gates, J; Keys, D; Kesbeke, F; Wijngaarden, PJ; Monteiro, A; French, V; Carroll, SB				Brakefield, PM; Gates, J; Keys, D; Kesbeke, F; Wijngaarden, PJ; Monteiro, A; French, V; Carroll, SB			Development, plasticity and evolution of butterfly eyespot patterns	NATURE			English	Article							WESTERN WHITE BUTTERFLIES; PRECIS-COENIA LEPIDOPTERA; REACTION NORMS; SEASONAL POLYPHENISM; QUANTITATIVE CHARACTER; PHENOTYPIC PLASTICITY; BICYCLUS BUTTERFLIES; WING PATTERNS; GENETICS; NUMBER	The developmental and genetic bases for the formation, plasticity and diversity of eyespot patterns in butterflies are examined. Eyespot pattern mutants, regulatory gene expression, and transplants of the eyespot developmental organizer demonstrate that eyespot position, number, size and colour are determined progressively in a developmental pathway largely uncoupled from those regulating other wing-pattern elements and body structures. Species comparisons and selection experiments suggest that the evolution of eyespot patterns can occur rapidly through modulation of different stages of this pathway, and requires only single, of very few, changes in regulatory genes.	UNIV WISCONSIN, HOWARD HUGHES MED INST, MADISON, WI 53706 USA; UNIV WISCONSIN, MOL BIOL LAB, MADISON, WI 53706 USA; UNIV EDINBURGH, INST CELL ANIM & POPULAT BIOL, EDINBURGH EH9 3JT, MIDLOTHIAN, SCOTLAND	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Edinburgh	Brakefield, PM (corresponding author), LEIDEN UNIV, INST EVOLUTIONARY & ECOL SCI, KAISERSTR 63, POSTBUS 9516, NL-2300 RA LEIDEN, NETHERLANDS.		Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X				BRAKEFIELD PM, 1993, ACTA BIOTHEOR, V41, P447, DOI 10.1007/BF00709376; BRAKEFIELD PM, 1995, J EVOLUTION BIOL, V8, P559, DOI 10.1046/j.1420-9101.1995.8050559.x; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; BRAKEFIELD PM, 1984, BIOL J LINN SOC, V22, P1, DOI 10.1111/j.1095-8312.1984.tb00795.x; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; COCKERHAM CC, 1986, GENETICS, V114, P659; Cott H.B., 1940, ADAPTIVE COLORATION; Endler J.A., 1986, Monographs in Population Biology, pviii; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; FRENCH V, 1995, DEV BIOL, V168, P112, DOI 10.1006/dbio.1995.1065; HOLLOWAY GJ, 1993, HEREDITY, V70, P179, DOI 10.1038/hdy.1993.27; KING RB, 1993, CAN J ZOOL, V71, P1985, DOI 10.1139/z93-282; KINGSOLVER JG, 1995, EVOLUTION, V49, P942, DOI [10.2307/2410416, 10.1111/j.1558-5646.1995.tb02329.x]; KINGSOLVER JG, 1995, EVOLUTION, V49, P932, DOI [10.2307/2410415, 10.1111/j.1558-5646.1995.tb02328.x]; Koch PB, 1996, J INSECT PHYSIOL, V42, P223, DOI 10.1016/0022-1910(95)00103-4; KOOI RE, 1994, PROCEEDINGS OF THE SECTION EXPERIMENTAL AND APPLIED ENTOMOLOGY OF THE NETHERLANDS ENTOMOLOGICAL SOCIETY (N.E.V.), VOL 5, 1994, P47; LANDE R, 1981, GENETICS, V99, P541; MONTEIRO AF, 1994, EVOLUTION, V48, P1147, DOI [10.1111/j.1558-5646.1994.tb05301.x, 10.2307/2410374]; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; Nijhout H.F., 1994, INSECT HORMONES; NIJHOUT HF, 1980, DEV BIOL, V80, P275, DOI 10.1016/0012-1606(80)90404-2; Pigliucci M, 1996, TRENDS ECOL EVOL, V11, P168, DOI 10.1016/0169-5347(96)10008-2; ROUNTREE DB, 1995, J INSECT PHYSIOL, V41, P1141, DOI 10.1016/0022-1910(95)00051-U; ROUNTREE DB, 1995, J INSECT PHYSIOL, V41, P987, DOI 10.1016/0022-1910(95)00046-W; SCHLICHTING CD, 1995, EVOL ECOL, V9, P154, DOI 10.1007/BF01237754; Shapiro A. M., 1976, EVOL BIOL, P259, DOI DOI 10.1007/978-1-4615-6950-3_6; SHEPPARD PM, 1960, NATURAL SELECTION HE; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; VANNOORDWIJK AJ, 1989, BIOSCIENCE, V39, P453, DOI 10.2307/1311137; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; WINDIG JJ, 1994, ECOL ENTOMOL, V19, P285, DOI 10.1111/j.1365-2311.1994.tb00420.x; Wright S., 1968, EVOLUTION GENETICS P, P373; ZENG ZB, 1990, GENETICS, V126, P235; ZWEIFEL RG, 1981, J HERED, V72, P238, DOI 10.1093/oxfordjournals.jhered.a109487	34	365	376	0	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	1996	384	6606					236	242		10.1038/384236a0	http://dx.doi.org/10.1038/384236a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VU381	12809139				2022-12-24	WOS:A1996VU38100042
J	Zschokke, S				Zschokke, S			Spider-web silk from the Early Cretaceous	NATURE			English	Editorial Material							ORB-WEBS		Univ Basel, Dept Integrat Biol, Sect Conservat Biol, CH-4056 Basel, Switzerland	University of Basel	Zschokke, S (corresponding author), Univ Basel, Dept Integrat Biol, Sect Conservat Biol, CH-4056 Basel, Switzerland.		Zschokke, Samuel/B-2583-2009	Zschokke, Samuel/0000-0002-5307-9010				Bachofen-Echt A., 1934, Biologia Generalis Wien Bd, V10, P179; Benjamin SP, 2003, BIOL J LINN SOC, V78, P293, DOI 10.1046/j.1095-8312.2003.00110.x; Coddington J., 1986, P319; ESKOV KY, 1984, NEUES JB GEOLOGIE PA, P645; Opell BD, 2002, J ARACHNOL, V30, P494, DOI 10.1636/0161-8202(2002)030[0494:ETSOIA]2.0.CO;2; Opell BD, 1998, FUNCT ECOL, V12, P613, DOI 10.1046/j.1365-2435.1998.00222.x; Penney D, 2002, J ARACHNOL, V30, P487, DOI 10.1636/0161-8202(2002)030[0487:TOLSIL]2.0.CO;2; SCHLEE D, 1970, NEUES JB GEOLOGIE PA, P40; SELDEN PA, 1989, NATURE, V340, P711, DOI 10.1038/340711a0; SHEAR WA, 1989, SCIENCE, V246, P479, DOI 10.1126/science.246.4929.479; VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0	11	28	31	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					636	637		10.1038/424636a	http://dx.doi.org/10.1038/424636a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904780				2022-12-24	WOS:000184578800032
J	Micheau, O; Tschopp, J				Micheau, O; Tschopp, J			Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes	CELL			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; FLICE-INHIBITORY PROTEINS; DEATH RECEPTORS; C-FLIP; FAS; ACTIVATION; FADD; RECRUITMENT; REQUIREMENT	Apoptosis induced by TNF-receptor I (TNFR1) is thought to proceed via recruitment of the adaptor FADD and caspase-8 to the receptor complex. TNFR1 signaling is also known to activate the transcription factor NF-kappaB and promote survival. The mechanism by which this decision between cell death and survival is arbitrated is not clear. We report that TNFR1-induced apoptosis involves two sequential signaling complexes. The initial plasma membrane bound complex (complex I) consists of TNFR1, the adaptor TRADD, the kinase RIP1, and TRAF2 and rapidly signals activation of NF-kappaB. In a second step, TRADD and RIP1 associate with FADD and caspase-8, forming a cytoplasmic complex (complex II). When NF-kappaB is activated by complex I, complex II harbors the caspase-8 inhibitor FLIPL and the cell survives. Thus, TNFR1-mediated-signal transduction includes a checkpoint, resulting in cell death (via complex II) in instances where the initial signal (via complex I, NF-kappaB) fails to be activated.	Univ Lausanne, Inst Biochem, BIL Biomed Res Ctr, CH-1066 Epalinges, Switzerland	University of Lausanne	Tschopp, J (corresponding author), Univ Lausanne, Inst Biochem, BIL Biomed Res Ctr, Chem Boveresses 155, CH-1066 Epalinges, Switzerland.		micheau, olivier/C-3574-2011	micheau, olivier/0000-0001-8499-7984				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Devin A, 2001, MOL CELL BIOL, V21, P3986, DOI 10.1128/MCB.21.12.3986-3994.2001; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jones SJ, 1999, J IMMUNOL, V162, P1042; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 1999, J BIOL CHEM, V274, P7987, DOI 10.1074/jbc.274.12.7987; Morgan M, 2002, J CELL BIOL, V157, P975, DOI 10.1083/jcb.200204039; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Scaffidi C, 1999, CURR OPIN IMMUNOL, V11, P277, DOI 10.1016/S0952-7915(99)80045-4; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Thomas LR, 2002, J BIOL CHEM, V277, P34343, DOI 10.1074/jbc.M204169200; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Varfolomeev EE, 1996, J EXP MED, V183, P1271, DOI 10.1084/jem.183.3.1271; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	39	1879	1961	2	120	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					181	190		10.1016/S0092-8674(03)00521-X	http://dx.doi.org/10.1016/S0092-8674(03)00521-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887920	Green Submitted, Bronze			2022-12-24	WOS:000184378700008
J	Verburg, P; Hecky, RE; Kling, H				Verburg, P; Hecky, RE; Kling, H			Ecological consequences of a century of warming in Lake Tanganyika	SCIENCE			English	Article							PHYTOPLANKTON; RIVER	Deep tropical lakes are excellent climate monitors because annual mixing is shallow and flushing rates are low, allowing heat to accumulate during climatic warming. We describe effects of warming on Lake Tanganyika: A sharpened density gradient has slowed vertical mixing and reduced primary production. Increased warming rates during the coming century may continue to slow mixing and further reduce productivity in Lake Tanganyika and other deep tropical lakes.	Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; Fisheries & Oceans Canada, Inst Freshwater, Algal Taxon & Ecol, Winnipeg, MB R3T 2N6, Canada	University of Waterloo; Fisheries & Oceans Canada	Verburg, P (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	pverburg@scimail.uwaterloo.ca		verburg, piet/0000-0001-7574-9161				BEAUCHAMP R. S. A., 1939, INTERNAL REV GES HYDROBIOL U HYDROGR, V39, P316, DOI 10.1002/iroh.19390390303; Brooks J. L., 1950, Quarterly Review of Biology, V25, P131, DOI 10.1086/397539; CAPART A, 1952, I R SCI NAT BELG, V1, P3; COULTER GW, 1963, LIMNOL OCEANOGR, V8, P463, DOI 10.4319/lo.1963.8.4.0463; CRAIG H, 1974, LAKE TANGANYIKA GEOC, P1; Davies-Colley R. J, 1993, COLOUR CLARITY NATUR; DUBOIS J. T., 1958, HYDROBIOLOGIA, V10, P215, DOI 10.1007/BF00142188; EDMOND JM, 1993, LIMNOL OCEANOGR, V38, P725, DOI 10.4319/lo.1993.38.4.0725; Hecky R.E., 1991, P90; HECKY RE, 1981, LIMNOL OCEANOGR, V26, P548, DOI 10.4319/lo.1981.26.3.0548; Hutchinson G. E., 1957, TREATISE LIMNOLOGY, VI; Jarvinen M, 1999, HYDROBIOLOGIA, V407, P81, DOI 10.1023/A:1003706002126; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Kimbadi S, 1999, HYDROBIOLOGIA, V407, P75, DOI 10.1023/A:1003749817147; KUFFERATH J, 1952, MILIEU BIOCH, V1, P31; Magnuson JJ, 2000, SCIENCE, V289, P1743, DOI 10.1126/science.289.5485.1743; Millero FJ, 2000, AQUAT GEOCHEM, V6, P1, DOI 10.1023/A:1009626325650; PLISNIER PD, 1996, GCPRAF271FINTD56 FAO; Quayle WC, 2002, SCIENCE, V295, P645, DOI 10.1126/science.1064074; STAPPERS L, 1913, MISSION STAPPERS 191; Vandelannoote A, 1999, HYDROBIOLOGIA, V407, P65, DOI 10.1023/A:1003701901217; VANMEEL L, 1954, PHYTOPLANCTON, V4; Vollmer MK, 2002, ADV GLOB CHANGE RES, V12, P209	23	263	284	5	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					505	507		10.1126/science.1084846	http://dx.doi.org/10.1126/science.1084846			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12829786				2022-12-24	WOS:000184340500039
J	Wellik, DM; Capecchi, MR				Wellik, DM; Capecchi, MR			Hox10 and Hox11 genes are required to globally pattern the mammalian skeleton	SCIENCE			English	Article							AXIAL SKELETON; MICE LACKING; EXPRESSION; COMPLEX; FORELIMB; HOXD-11	Mice in which all members of the Hox10 or Hox11 paralogous group are disrupted provide evidence that these Hox genes are involved in global patterning of the axial and appendicular skeleton. In the absence of Hox10 function, no lumbar vertebrae are formed. Instead, ribs project from all posterior vertebrae, extending caudally from the last thoracic vertebrae to beyond the sacral region. In the absence of Hox11 function, sacral vertebrae are not formed and instead these vertebrae assume a lumbar identity. The redundancy among these paralogous family members is so great that this global aspect of Hox patterning is not apparent in mice that are mutant for five of the six paralogous alleles.	Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Howard Hughes Med Inst, Salt Lake City, UT 84112 USA.							BURKE AC, 1995, DEVELOPMENT, V121, P333; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; DOLLE P, 1991, GENE DEV, V5, P1767, DOI 10.1101/gad.5.10.1767; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; Favier B, 1996, DEVELOPMENT, V122, P449; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Herault Y, 1999, DEV BIOL, V208, P157, DOI 10.1006/dbio.1998.9179; Hildebrand M., 1995, ANAL VERTEBRATE STRU; HORAN GSB, 1995, GENE DEV, V9, P1667, DOI 10.1101/gad.9.13.1667; Hostikka SL, 1998, MECH DEVELOP, V70, P133, DOI 10.1016/S0925-4773(97)00182-2; Kmita M, 2002, DEVELOPMENT, V129, P5521, DOI 10.1242/dev.00151; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Nowicki JL, 2000, DEVELOPMENT, V127, P4265; Suzuki M, 2002, MECH DEVELOP, V118, P241, DOI 10.1016/S0925-4773(02)00257-5; van den Akker E, 2001, DEVELOPMENT, V128, P1911; Wahba GM, 2001, DEV BIOL, V231, P87, DOI 10.1006/dbio.2000.0130	19	388	398	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					363	367		10.1126/science.1085672	http://dx.doi.org/10.1126/science.1085672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869760				2022-12-24	WOS:000184207300043
J	MacCarthy, PA; Kearney, MT; Nolan, J; Lee, AJ; Prescott, RJ; Shah, AM; Brooksby, WP; Fox, KAA				MacCarthy, PA; Kearney, MT; Nolan, J; Lee, AJ; Prescott, RJ; Shah, AM; Brooksby, WP; Fox, KAA			Prognosis in heart failure with preserved left ventricular systolic function: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							VARIABILITY		Guys Kings & St Thomass Sch Med, Dept Cardiol, London SE5 9PJ, England; N Staffordshire Cardiac Ctr, Stoke On Trent ST4 6QG, Staffs, England; Univ Edinburgh, Med Stat Unit, Edinburgh EH3 9YW, Midlothian, Scotland; Pontefract Hosp, Pontefract WF8 1PL, England; Wakefield Hosp, Pontefract WF8 1PL, England; Univ Edinburgh, Dept Cardiol, Edinburgh EH8 9YL, Midlothian, Scotland	University of London; King's College London; University of Edinburgh; University of Edinburgh	Kearney, MT (corresponding author), Guys Kings & St Thomass Sch Med, Dept Cardiol, London SE5 9PJ, England.		Lee, Andrew/GVU-2817-2022; Fox, keith A A/I-3742-2013	Shah, Ajay/0000-0002-6547-0631; Fox, Keith/0000-0002-0140-2752				BIGGER JT, 1995, CIRCULATION, V91, P1936, DOI 10.1161/01.CIR.91.7.1936; Kearney MT, 2002, J AM COLL CARDIOL, V40, P1801, DOI 10.1016/S0735-1097(02)02490-7; Kitzman DW, 2002, JAMA-J AM MED ASSOC, V288, P2144, DOI 10.1001/jama.288.17.2144; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9	5	45	45	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 12	2003	327	7406					78	79		10.1136/bmj.327.7406.78	http://dx.doi.org/10.1136/bmj.327.7406.78			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702NF	12855525	Bronze, Green Published			2022-12-24	WOS:000184229400018
J	Petersson, P; Waldenstrom, A; Fahraeus, C; Schouenborg, J				Petersson, P; Waldenstrom, A; Fahraeus, C; Schouenborg, J			Spontaneous muscle twitches during sleep guide spinal self-organization	NATURE			English	Article							NOCICEPTIVE WITHDRAWAL REFLEXES; SENSORIMOTOR TRANSFORMATION; DEVELOPMENTAL ADAPTATION; SUBSTANTIA-GELATINOSA; POSTNATAL-DEVELOPMENT; DORSAL-HORN; RAT; NEURONS; SYSTEM; NETWORK	During development, information about the three-dimensional shape and mechanical properties of the body is laid down in the synaptic connectivity of sensorimotor systems through unknown adaptive mechanisms. In spinal reflex systems, this enables the fast transformation of complex sensory information into adequate correction of movements. Here we use a computer simulation to show that an unsupervised correlation-based learning mechanism, using spontaneous muscle twitches, can account for the functional adaptation of the withdrawal reflex system. We also show that tactile feedback resulting from spontaneous muscle twitches during sleep(1-3) does indeed modify sensorimotor transformation in young rats in a predictable manner. The results indicate that these twitches, corresponding to human fetal movements(4), are important in spinal self-organization.	Lund Univ, Dept Physiol Sci, Sect Neurophysiol, S-22184 Lund, Sweden	Lund University	Petersson, P (corresponding author), Lund Univ, Dept Physiol Sci, Sect Neurophysiol, BMC F10, S-22184 Lund, Sweden.	per.petersson@mphy.lu.se	Petersson, Per/A-5740-2010; Petersson, Per/P-1878-2019	Petersson, Per/0000-0001-6697-0171; Petersson, Per/0000-0001-6697-0171; Schouenborg, Jens/0000-0002-2815-6918				BLUMBERG MS, 1994, BEHAV NEUROSCI, V108, P1196, DOI 10.1037/0735-7044.108.6.1196; Blumberg MS, 1996, DEV PSYCHOBIOL, V29, P1, DOI 10.1002/(SICI)1098-2302(199601)29:1<1::AID-DEV1>3.0.CO;2-Y; CERVERO F, 1980, BRAIN, V103, P717, DOI 10.1093/brain/103.4.717; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; DELISI L, 1932, RIV PATOL NERV MENT, V29, P481; FITZGERALD M, 1986, DEV BRAIN RES, V24, P261, DOI 10.1016/0165-3806(86)90194-X; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Fregnac Y, 1998, DAHLEM WORK, P113; Gardner R., 1975, ADV SLEEP RES, P67; HADDERSALGRA M, 1993, EARLY HUM DEV, V35, P63, DOI 10.1016/0378-3782(93)90140-P; Holmberg H, 1996, J PHYSIOL-LONDON, V493, P239, DOI 10.1113/jphysiol.1996.sp021379; Holmberg H, 1996, J PHYSIOL-LONDON, V495, P399, DOI 10.1113/jphysiol.1996.sp021602; Holmberg H, 1997, J NEUROSCI, V17, P2071; Johansson R., 1993, SYSTEM MODELING IDEN; Karlsson KAE, 2002, BEHAV NEUROSCI, V116, P912, DOI 10.1037//0735-7044.116.5.912; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Levinsson A, 2002, J NEUROSCI, V22, P8170; Levinsson A, 1999, J NEUROSCI, V19, P10397; LINSKER R, 1986, P NATL ACAD SCI USA, V83, P8779, DOI 10.1073/pnas.83.22.8779; Morisset V, 1998, EUR J NEUROSCI, V10, P3642, DOI 10.1046/j.1460-9568.1998.00370.x; Nakatsuka T, 2000, NEUROSCIENCE, V99, P549, DOI 10.1016/S0306-4522(00)00224-4; Nicolelis MAL, 1996, J NEUROPHYSIOL, V75, P2192, DOI 10.1152/jn.1996.75.5.2192; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; SCHOUENBORG J, 1994, EXP BRAIN RES, V100, P170; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; WALDENSTROM A, 2002, IASP ABSTR, V1558, pP106; WALDENSTROM A, 2001, SOC NEUR ABSTR, V30, P1623	30	133	133	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2003	424	6944					72	75		10.1038/nature01719	http://dx.doi.org/10.1038/nature01719			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840761				2022-12-24	WOS:000183912800042
J	Naleway, AL; Belongia, EA; Greenlee, RT; Kieke, BA; Chen, RT; Shay, DK				Naleway, AL; Belongia, EA; Greenlee, RT; Kieke, BA; Chen, RT; Shay, DK			Eczematous skin disease and recall of past diagnoses: Implications for smallpox vaccination	ANNALS OF INTERNAL MEDICINE			English	Article							ATOPIC-DERMATITIS; PREVALENCE; COMPLICATIONS; UK	Background: Persons with atopic dermatitis or eczema, regardless of disease severity or activity, may develop eczema vaccinatum if they or their close contacts receive the smallpox vaccine. According to current recommendations, a preexposure vaccination program should identify these persons and exclude them from participating. Objective: To determine the prevalence of diagnosed atopic dermatitis and eczema in a defined population and assess the sensitivity of screening questions to identify patients who have received these diagnoses. Design: Population-based prevalence survey and telephone interview. Setting: 14 ZIP code regions in Wisconsin. Patients: Persons given a diagnosis of atopic dermatitis or eczema in 2000 and 2001 were identified from a population-based cohort. Persons with a history of atopic dermatitis diagnosed since 1979 were eligible for the telephone survey. Measurements: Prevalence of diagnosed atopic dermatitis or eczema; proportions of respondents able to recall a past diagnosis of atopic dermatitis, eczema, or recurrent rash. Results: The prevalence of atopic dermatitis or eczema diagnosis in 2000 or 2001 was 0.8%. At least 2.4% of the cohort would be ineligible for smallpox vaccination because of active skin disease in themselves or household members. Among 94 adult respondents with atopic dermatitis, 55 (59%) correctly self-reported skin disease. Seventy-nine (60%) of 133 household contacts of adults with atopic dermatitis correctly reported the presence of skin disease in a household member. Parental recall of skin disease in children with atopic dermatitis was 70% (123 of 177). Conclusions: Identifying dermatologic contraindications to smallpox vaccination by relying only on a self-reported history of rash illnesses is likely to miss a substantial proportion of individuals who should not receive smallpox vaccine in a preexposure vaccination campaign.	Marshfield Med Res Fdn, Epidemiol Res Ctr, Marshfield, WI 54449 USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Belongia, EA (corresponding author), Marshfield Med Res Fdn, Epidemiol Res Ctr, 1000 N Oak Ave,Mailstop ML2, Marshfield, WI 54449 USA.	belongia.edward@mcrf.mfldclin.edu		Shay, David/0000-0001-9619-4820; Belongia, Edward/0000-0001-7478-0415; Naleway, Allison/0000-0001-5747-4643	PHS HHS [200-95-0957] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AM AC DERM, 2003, ECZ AT DERM; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bicknell WJ, 2002, NEW ENGL J MED, V347, P691; Bicknell WJ, 2002, NEW ENGL J MED, V346, P1323, DOI 10.1056/NEJMsb020357; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; Breslow NE., 1987, STAT METHODS CANC RE, P81; *CDCP, 2003, SMALLP VACC REP STAT; [Anonymous], 2001, MMWR Recomm Rep, V50, P1; COPEMAN PWM, 1964, BRIT MED J, V2, P906, DOI 10.1136/bmj.2.5414.906; *DEP DEF, 2003, SMALLP SAF SUMM; DeStefano F, 1996, J CLIN EPIDEMIOL, V49, P643, DOI 10.1016/0895-4356(96)00008-X; Ellis CN, 2002, J AM ACAD DERMATOL, V46, P361, DOI 10.1067/mjd.2002.120528; GOLDSTEIN JA, 1975, PEDIATRICS, V55, P342; GREENBERG M, 1948, AM J DIS CHILD, V76, P492; Hanifin JM., 1980, ACTA DERM-VENEREOL, V92, P44; Hastie TJ., 1990, GEN ADDITIVE MODELS; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Herd RM, 1996, BRIT J DERMATOL, V135, P18; KAY J, 1994, J AM ACAD DERMATOL, V30, P35, DOI 10.1016/S0190-9622(94)70004-4; Kemper Alex R, 2002, Eff Clin Pract, V5, P84; LANE JM, 1970, J INFECT DIS, V122, P303, DOI 10.1093/infdis/122.4.303; LANE JM, 1969, NEW ENGL J MED, V281, P1201, DOI 10.1056/NEJM196911272812201; Lane JM, 2002, NEW ENGL J MED, V347, P691; Larsen FS, 1996, J AM ACAD DERMATOL, V34, P760, DOI 10.1016/S0190-9622(96)90009-2; Laughter D, 2000, J AM ACAD DERMATOL, V43, P649, DOI 10.1067/mjd.2000.107773; McNally NJ, 2000, BRIT J DERMATOL, V142, P712, DOI 10.1046/j.1365-2133.2000.03416.x; NEAME RL, 1995, BRIT J DERMATOL, V132, P772; Neff JM, 2002, JAMA-J AM MED ASSOC, V288, P1901, DOI 10.1001/jama.288.15.1901; WADDINGTON E, 1964, ANN REPORT T LONDON, V50, P22; Williams H, 2001, J AM ACAD DERMATOL, V45, pS33, DOI 10.1067/mjd.2001.117019; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; 2003, MMWR MORB MORTAL WKL, V52, P278; 2003, MMWR DISPATCH, V52, P1	33	33	35	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2003	139	1					1	7		10.7326/0003-4819-139-1-200307010-00006	http://dx.doi.org/10.7326/0003-4819-139-1-200307010-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	695GR	12834312				2022-12-24	WOS:000183823200001
J	Bunch, TJ; White, RD; Gersh, BJ; Meverden, RA; Hodge, DO; Ballman, KV; Hammill, SC; Shen, WK; Packer, DL				Bunch, TJ; White, RD; Gersh, BJ; Meverden, RA; Hodge, DO; Ballman, KV; Hammill, SC; Shen, WK; Packer, DL			Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDICAL-SERVICES SYSTEM; VENTRICULAR-FIBRILLATION; RAPID DEFIBRILLATION; HEALTH-STATUS; PRIMARY-CARE; SURVIVORS; LIFE; RESUSCITATION; TECHNICIANS; PARAMEDICS	BACKGROUND: Mortality after out-of-hospital cardiac arrest from ventricular fibrillation is high. Programs focusing on early defibrillation have improved the rate of survival to hospital discharge. We conducted a population-based analysis of the long-term outcome and quality of life of survivors. METHODS: All patients who had an out-of-hospital cardiac arrest between November 1990 and January 2001 who received early defibrillation for ventricular fibrillation in Olmsted County, Minnesota, were included. The survival rate was compared with that of an age-, sex-, and disease-matched (2:1) control population of residents who had not had an out-of-hospital cardiac arrest and with that of age- and sex-matched controls from the general U.S. population. The quality of life was assessed with use of the Medical Outcomes Study 36-item Short-Form General Health Survey (SF-36) and compared with U.S. population norms. RESULTS: Of 200 patients who presented with an out-of-hospital cardiac arrest with ventricular fibrillation, 145 (72 percent) survived to hospital admission (7 died in the emergency department) and 79 (40 percent) were neurologically intact (good overall capability or moderate overall disability) at discharge. The mean (+/-SD) length of follow-up was 4.8+/-3.0 years. Nineteen patients died after discharge from the hospital. The expected five-year survival rate (79 percent) was identical to that among age-, sex-, and disease-matched controls (P=0.68) but lower than that among the age- and sex-matched U.S. population (86 percent, P=0.02). Fifty patients completed SF-36 surveys at the end of follow-up, and the majority had a nearly normal quality of life, with the exception of reduced vitality. CONCLUSIONS: Long-term survival among patients who have undergone rapid defibrillation after out-of-hospital cardiac arrest is similar to that among age-, sex-, and disease-matched patients who did not have out-of-hospital cardiac arrest. The quality of life among the majority of survivors is similar to that of the general population.	Mayo Clin & Mayo Fdn, Dept Anesthesiol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Div Biostat, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	White, RD (corresponding author), Mayo Clin & Mayo Fdn, Dept Anesthesiol, 200 1St St SW, Rochester, MN 55905 USA.			Ballman, Karla/0000-0002-4492-0357				American Heart Association, 2000, 2001 HEART STROK STA; BERGNER L, 1985, AM J PUBLIC HEALTH, V75, P1321, DOI 10.2105/AJPH.75.11.1321; Bergner L, 1983, Am J Emerg Med, V1, P259, DOI 10.1016/0735-6757(83)90101-8; BERGNER L, 1984, AM J PUBLIC HEALTH, V74, P508, DOI 10.2105/AJPH.74.5.508; BERTINI G, 1990, Journal of Emergency Medicine, V8, P407, DOI 10.1016/0736-4679(90)90166-S; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; EISENBERG MS, 1980, NEW ENGL J MED, V302, P1379, DOI 10.1056/NEJM198006193022502; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; Eisenberg MS, 2001, NEW ENGL J MED, V344, P1304, DOI 10.1056/NEJM200104263441707; Graves JR, 1997, RESUSCITATION, V35, P117; Herbst JH, 1999, PACE, V22, P915, DOI 10.1111/j.1540-8159.1999.tb06816.x; HOLMES DR, 1986, CIRCULATION, V73, P1254, DOI 10.1161/01.CIR.73.6.1254; Hsu JWY, 1996, ANN EMERG MED, V28, P597, DOI 10.1016/S0196-0644(96)70080-X; JENNETT B, 1975, LANCET, V1, P480; KELLERMANN AL, 1993, JAMA-J AM MED ASSOC, V270, P1708, DOI 10.1001/jama.270.14.1708; Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748; Kuilman M, 1999, RESUSCITATION, V41, P25, DOI 10.1016/S0300-9572(99)00016-7; LOMBARDI G, 1994, JAMA-J AM MED ASSOC, V271, P678; MYERBURG RJ, 1992, CIRCULATION, V85, P2; Nichol G, 1999, ACAD EMERG MED, V6, P95, DOI 10.1111/j.1553-2712.1999.tb01044.x; PARADIS NA, 1996, CARDIAC ARREST SCI P, P867; Smith HJ, 2000, HEART, V84, P390, DOI 10.1136/heart.84.4.390; Stratton S, 1998, ANN EMERG MED, V31, P471, DOI 10.1016/S0196-0644(98)70256-2; STULTS KR, 1984, NEW ENGL J MED, V310, P219, DOI 10.1056/NEJM198401263100403; Sunnerhagen KS, 1996, RESUSCITATION, V31, P135, DOI 10.1016/0300-9572(95)00903-5; SWOR RA, 1995, ANN EMERG MED, V25, P780, DOI 10.1016/S0196-0644(95)70207-5; VALENZUELA TD, 1993, ANN EMERG MED, V22, P1678, DOI 10.1016/S0196-0644(05)81305-8; Ware J., 1993, SF 36 HLTH SURVEY MA; White R D, 2001, Curr Opin Crit Care, V7, P145, DOI 10.1097/00075198-200106000-00002; White RD, 1996, ANN EMERG MED, V28, P480, DOI 10.1016/S0196-0644(96)70109-9; White RD, 1998, RESUSCITATION, V39, P145, DOI 10.1016/S0300-9572(98)00135-X; White RD, 2001, RESUSCITATION, V49, P9, DOI 10.1016/S0300-9572(00)00338-5; 1994, JAMA, V271, P984; [No title captured]	35	270	278	0	11	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2003	348	26					2626	2633		10.1056/NEJMoa023053	http://dx.doi.org/10.1056/NEJMoa023053			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	693PN	12826637				2022-12-24	WOS:000183726400006
J	Nishiyama, M; Hoshino, A; Tsai, L; Henley, JR; Goshima, Y; Tessier-Lavigne, M; Poo, MM; Hong, KS				Nishiyama, M; Hoshino, A; Tsai, L; Henley, JR; Goshima, Y; Tessier-Lavigne, M; Poo, MM; Hong, KS			Cyclic AMP/GMP-dependent modulation of Ca2+ channels sets the polarity of nerve growth-cone turning	NATURE			English	Article							ARACHIDONATE 12-LIPOXYGENASE; CALCIUM TRANSIENTS; CANINE BRAIN; NETRIN-1; GUIDANCE; CELLS; ACID; ORIENTATION; SPECIFICITY; ACTIVATION	Signalling by intracellular second messengers such as cyclic nucleotides and Ca2+ is known to regulate attractive and repulsive guidance of axons by extracellular factors(1,2). However, the mechanism of interaction among these second messengers in determining the polarity of the guidance response is largely unknown. Here, we report that the ratio of cyclic AMP to cyclic GMP activities sets the polarity of netrin-1-induced axon guidance: high ratios favour attraction, whereas low ratios favour repulsion. Whole-cell recordings of Ca2+ currents at Xenopus spinal neuron growth cones indicate that cyclic nucleotide signalling directly modulates the activity of L-type Ca2+ channels LCCs) in axonal growth cones. Furthermore, cGMP signalling activated by an arachidonate 12-lipoxygenase metabolite(3) suppresses LCC activity triggered by netrin-1, and is required for growth-cone repulsion mediated by the DCC-UNC5 receptor complex(4). By linking cAMP and cGMP signalling and modulation of Ca2+ channel activity in growth cones, these findings delineate an early membrane-associated event responsible for signal transduction during bi-directional axon guidance.	NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; Univ Calif Berkeley, Dept Cell & Mol Biol, Div Neurobiol, Berkeley, CA 94720 USA; Yokohama City Univ, Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan; Stanford Univ, Dept Biol Sci, Howard Hughes Med Inst, Stanford, CA 94305 USA	New York University; University of California System; University of California Berkeley; Yokohama City University; Howard Hughes Medical Institute; Stanford University	Hong, KS (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.		Henley, John/D-7171-2011	Henley, John/0000-0003-1846-5941				Baldridge WH, 2001, VISUAL NEUROSCI, V18, P849, DOI 10.1017/S0952523801186013; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BRUNE B, 1991, MOL PHARMACOL, V39, P671; Carabelli V, 2002, J PHYSIOL-LONDON, V541, P351, DOI 10.1113/jphysiol.2002.017749; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; Goshima Y, 1997, J NEUROBIOL, V33, P316, DOI 10.1002/(SICI)1097-4695(199709)33:3<316::AID-NEU9>3.0.CO;2-4; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; HAIN J, 1995, J BIOL CHEM, V270, P2074, DOI 10.1074/jbc.270.5.2074; HAWKINS DJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P447, DOI 10.1016/0003-9861(89)90312-3; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; Mikule K, 2002, J NEUROSCI, V22, P4932, DOI 10.1523/JNEUROSCI.22-12-04932.2002; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; NISHIYAMA M, 1993, J HISTOCHEM CYTOCHEM, V41, P111, DOI 10.1177/41.1.8417106; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Nishiyama M, 1998, EUR J PHARMACOL, V341, P57, DOI 10.1016/S0014-2999(97)01353-8; NISHIYAMA M, 1992, J NEUROCHEM, V58, P1395, DOI 10.1111/j.1471-4159.1992.tb11355.x; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; Ruiz-Velasco V, 1998, CIRC RES, V82, P557, DOI 10.1161/01.RES.82.5.557; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Spitzer NC, 2000, BIOESSAYS, V22, P811; Tabti N., 1991, CULTURING NERVE CELL, P137	30	312	324	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					990	995		10.1038/nature01751	http://dx.doi.org/10.1038/nature01751			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827203				2022-12-24	WOS:000183753900051
J	Sinervo, B; Clobert, J				Sinervo, B; Clobert, J			Morphs, dispersal behavior, genetic similarity, and the evolution of cooperation	SCIENCE			English	Article							ALTERNATIVE MALE; CORRELATIONAL SELECTION; KIN SELECTION; ALTRUISM; FITNESS; DRIVEN; CYCLES; GAME	Genetic similarity owing to kin relationship is often invoked to explain the evolution of social cooperation. In this study, male color morphs of side-blotched lizards settle nonrandomly with respect to genetic similarity. Blue morphs tend to settle in close proximity to other blue morphs with high genetic similarity. Blue neighbors have three times the average fitness of blue males lacking such neighbors. Conversely, genetically similar males depress fitness of the orange morph. Moreover, orange males are hyperdispersed with respect to genetic similarity. Pedigree and dispersal data show that genetically similar blue neighbors are not kin. Instead, conditions for the evolution of dispersal and cooperation are promoted by an emergent property of the morph locus that increases genetic similarity within morphs: genome-wide correlational selection links many traits to the morph locus, including settlement behavior.	Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; CNRS, UMR 7625, Ecol Lab, F-75252 Paris 05, France	University of California System; University of California Santa Cruz; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Sinervo, B (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Earth & Marine Sci Bldg,A316, Santa Cruz, CA 95064 USA.	sinervo@biology.ucsc.edu						AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Calsbeek R, 2002, OECOLOGIA, V132, P468, DOI 10.1007/s00442-002-0975-8; Dawkins R, 1976, SELFISH GENE; DOUGHTY P, 1994, J HERPETOL, V28, P485, DOI 10.2307/1564962; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hoglund J, 1999, P ROY SOC B-BIOL SCI, V266, P813; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Koella JC, 2000, P ROY SOC B-BIOL SCI, V267, P1979, DOI 10.1098/rspb.2000.1239; Kokko H, 1996, P ROY SOC B-BIOL SCI, V263, P919, DOI 10.1098/rspb.1996.0136; Komdeur J, 1999, TRENDS ECOL EVOL, V14, P237, DOI 10.1016/S0169-5347(98)01573-0; Le Galliard JF, 2003, EVOLUTION, V57, P1; Petrie M, 1999, NATURE, V401, P155, DOI 10.1038/43651; PFENNIG DW, 1993, NATURE, V362, P836, DOI 10.1038/362836a0; PFENNIG DW, 1993, ANIM BEHAV, V46, P87, DOI 10.1006/anbe.1993.1164; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; SHERMAN PW, 1997, COOPERATIVE BREEDING, P267; Sinervo A, 2001, J HERED, V92, P198, DOI 10.1093/jhered/92.2.198; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sinervo B, 2000, HORM BEHAV, V38, P222, DOI 10.1006/hbeh.2000.1622; Sinervo B, 2001, GENETICA, V112, P417, DOI 10.1023/A:1013360426789; Sinervo B, 2001, EVOLUTION, V55, P2040; Sinervo B, 2000, NATURE, V406, P985, DOI 10.1038/35023149; Sinervo B, 2000, ADAPTIVE GENETIC VARIATION IN THE WILD, P41; Svensson E, 2001, P NATL ACAD SCI USA, V98, P12561, DOI 10.1073/pnas.211071298; Svensson E, 2001, EVOLUTION, V55, P2053; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Zamudio KR, 2000, P NATL ACAD SCI USA, V97, P14427, DOI 10.1073/pnas.011544998	29	123	126	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2003	300	5627					1949	1951		10.1126/science.1083109	http://dx.doi.org/10.1126/science.1083109			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12817150				2022-12-24	WOS:000183619400048
J	Tremblay, S; Shiller, DM; Ostry, DJ				Tremblay, S; Shiller, DM; Ostry, DJ			Somatosensory basis of speech production	NATURE			English	Article							VOWEL-U; PERTURBATION; COMPENSATION; VARIABILITY; ADAPTATION; MODEL	The hypothesis that speech goals are defined acoustically and maintained by auditory feedback is a central idea in speech production research(1-6). An alternative proposal is that speech production is organized in terms of control signals that subserve movements and associated vocal-tract configurations(7-9). Indeed, the capacity for intelligible speech by deaf speakers suggests that somatosensory inputs related to movement play a role in speech production-but studies that might have documented a somatosensory component have been equivocal. For example, mechanical perturbations that have altered somatosensory feedback have simultaneously altered acoustics(10-14). Hence, any adaptation observed under these conditions may have been a consequence of acoustic change. Here we show that somatosensory information on its own is fundamental to the achievement of speech movements. This demonstration involves a dissociation of somatosensory and auditory feedback during speech production. Over time, subjects correct for the effects of a complex mechanical load that alters jaw movements (and hence somatosensory feedback), but which has no measurable or perceptible effect on acoustic output. The findings indicate that the positions of speech articulators and associated somatosensory inputs constitute a goal of speech movements that is wholly separate from the sounds produced.	McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada; Haskins Labs Inc, New Haven, CT 06511 USA	McGill University; Yale University; Haskins Laboratories	Ostry, DJ (corresponding author), McGill Univ, Dept Psychol, 1205 Dr Penfield Ave, Montreal, PQ H3A 1B1, Canada.		Galantucci, Bruno/E-5770-2010					BERNSTEIN LR, 1982, J ACOUST SOC AM, V71, P147, DOI 10.1121/1.387254; BROWMAN CP, 1992, PHONETICA, V49, P155, DOI 10.1159/000261913; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Guenther FH, 1998, PSYCHOL REV, V105, P611, DOI 10.1037/0033-295X.105.4.611-633; GUENTHER FH, 1995, PSYCHOL REV, V102, P594, DOI 10.1037/0033-295X.102.3.594; Guenther FH, 1999, J ACOUST SOC AM, V105, P2854, DOI 10.1121/1.426900; Hamlet S. L, 1976, J PHONETICS, V4, P199; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Jones JA, 2000, J ACOUST SOC AM, V108, P1246, DOI 10.1121/1.1288414; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; LINDBLOM B, 1979, J PHONETICS, V7, P147, DOI 10.1016/S0095-4470(19)31046-0; MCFARLAND DH, 1995, J ACOUST SOC AM, V97, P1865, DOI 10.1121/1.412060; McFarland DH, 1996, J ACOUST SOC AM, V100, P1093, DOI 10.1121/1.416286; PERKELL JS, 1993, J ACOUST SOC AM, V93, P2948, DOI 10.1121/1.405814; PERKELL JS, 1985, J ACOUST SOC AM, V77, P1889, DOI 10.1121/1.391940; Saltzman E., 1989, ECOL PSYCHOL, V1, P333, DOI [10.1207/s15326969eco0104_2, DOI 10.1207/S15326969EC00104_]; SAVARIAUX C, 1995, J ACOUST SOC AM, V98, P2428, DOI 10.1121/1.413277; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588	20	207	210	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					866	869		10.1038/nature01710	http://dx.doi.org/10.1038/nature01710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	691BQ	12815431				2022-12-24	WOS:000183585300045
J	Eisen, JA; Fraser, CM				Eisen, JA; Fraser, CM			Phylogenomics: Intersection of evolution and genomics	SCIENCE			English	Editorial Material							SEQUENCE; GENES; BACTERIAL; PROTEIN	Much has been gained from genomic and evolutionary studies of species. Combining the perspectives of these different approaches suggests that an integrated phylogenomic approach will be beneficial.	Inst Genome Res, Rockville, MD 20850 USA	J. Craig Venter Institute	Eisen, JA (corresponding author), Inst Genome Res, Rockville, MD 20850 USA.	jeisen@tigr.org	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Fraser, Claire/0000-0003-1462-2428				Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Daubin V, 2002, GENOME RES, V12, P1080, DOI 10.1101/gr.187002; DOOLITTLE WF, 1999, TRENDS CELL BIOL, V9, P5, DOI DOI 10.1016/S0168-9525(99)01877-6; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Eisen JA, 2002, NATURE, V415, P845, DOI 10.1038/nature725; Eisen JA, 1998, NUCLEIC ACIDS RES, V26, P4291, DOI 10.1093/nar/26.18.4291; Eisen JA, 1997, NAT MED, V3, P1076, DOI 10.1038/nm1097-1076; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Eisen JA, 2000, GENOME BIOL, V1; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HUENHOLTZ P, 2002, GENOME BIOL, V3; Jordan IK, 2001, GENOME RES, V11, P555, DOI 10.1101/gr.GR-1660R; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837; Roelofs J, 2001, NATURE, V411, P1013, DOI 10.1038/35082627; Rujan T, 2001, TRENDS GENET, V17, P113, DOI 10.1016/S0168-9525(00)02209-5; Salzberg SL, 2001, SCIENCE, V293, P1048; Stanhope MJ, 2001, NATURE, V411, P940, DOI 10.1038/35082058; Suyama M, 2001, TRENDS GENET, V17, P10, DOI 10.1016/S0168-9525(00)02159-4; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	30	212	229	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1706	1707		10.1126/science.1086292	http://dx.doi.org/10.1126/science.1086292			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805538				2022-12-24	WOS:000183459700039
J	Sanfey, AG; Rilling, JK; Aronson, JA; Nystrom, LE; Cohen, JD				Sanfey, AG; Rilling, JK; Aronson, JA; Nystrom, LE; Cohen, JD			The neural basis of economic decision-making in the ultimatum game	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; COMPETITION; COOPERATION; SATIATION; FAIRNESS; DISGUST; PAIN	The nascent field of neuroeconomics seeks to ground economic decision-making in the biological substrate of the brain. We used functional magnetic resonance imaging of Ultimatum Game players to investigate neural substrates of cognitive and emotional processes involved in economic decision-making. In this game, two players split a sum of money; one player proposes a division and the other can accept or reject this. We scanned players as they responded to fair and unfair proposals. Unfair offers elicited activity in brain areas related to both emotion ( anterior insula) and cognition ( dorsolateral prefrontal cortex). Further, significantly heightened activity in anterior insula for rejected unfair offers suggests an important role for emotions in decision-making.	Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Princeton Univ, Ctr Hlth & Well Being, Princeton, NJ 08544 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA	Princeton University; Princeton University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sanfey, AG (corresponding author), Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA.		sarinopoulos, isidoros/B-5453-2010; Sanfey, Alan G/D-2350-2010	Sanfey, Alan/0000-0002-7421-8294				Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; BOLTON GE, 1995, GAME ECON BEHAV, V10, P95, DOI 10.1006/game.1995.1026; Bonetti S, 1998, J ECON PSYCHOL, V19, P377, DOI 10.1016/S0167-4870(98)00012-9; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; CAMERER C, 1995, J ECON PERSPECT, V9, P209, DOI 10.1257/jep.9.2.209; CAMERER C, IN PRESS ADV BEHAV E; Critchley HD, 2000, J NEUROSCI, V20, P3033; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Denton D, 1999, P NATL ACAD SCI USA, V96, P5304, DOI 10.1073/pnas.96.9.5304; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Hertwig R, 2001, BEHAV BRAIN SCI, V24, P383, DOI 10.1017/S0140525X01004149; Iadarola MJ, 1998, BRAIN, V121, P931, DOI 10.1093/brain/121.5.931; Loewenstein G., 2003, HDB AFFECTIVE SCI; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; Roth A.E., 1995, HDB EXPT EC; ROZIN P, 1987, PSYCHOL REV, V94, P23, DOI 10.1037/0033-295X.94.1.23; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; THALER RH, 1988, J ECON PERSPECT, V2, P195, DOI 10.1257/jep.2.4.195; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; [No title captured]	28	1970	2035	21	556	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2003	300	5626					1755	1758		10.1126/science.1082976	http://dx.doi.org/10.1126/science.1082976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805551				2022-12-24	WOS:000183459700054
J	Yamamoto, Y; Verma, UN; Prajapati, S; Kwak, YT; Gaynor, RB				Yamamoto, Y; Verma, UN; Prajapati, S; Kwak, YT; Gaynor, RB			Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression	NATURE			English	Article							NF-KAPPA-B; KINASE COMPLEX; MICE LACKING; P65 SUBUNIT; ACTIVATION; PROTEINS; CBP/P300; GROWTH; ACETYLATION; PATHWAY	Cytokine-induced activation of the IkappaB kinases (IKK) IKK-alpha and IKK-beta is a key step involved in the activation of the NF-kappaB pathway(1-4). Gene-disruption studies of the murine IKK genes have shown that IKK-beta, but not IKK-alpha, is critical for cytokine-induced IkappaB degradation(5-7). Nevertheless, mouse embryo fibroblasts deficient in IKK- a are defective in the induction of NF-kappaB-dependent transcription(7-9). These observations raised the question of whether IKK-alpha might regulate a previously undescribed step to activate the NF-kappaB pathway that is independent of its previously described cytoplasmic role in the phosphorylation of IkappaBalpha. Here we show that IKK-alpha functions in the nucleus to activate the expression of NF-kappaB-responsive genes after stimulation with cytokines. IKK-alpha interacts with CREB-binding protein and in conjunction with Rel A is recruited to NF-kappaB-responsive promoters and mediates the cytokine-induced phosphorylation and subsequent acetylation of specific residues in histone H3. These results define a new nuclear role of IKK-alpha in modifying histone function that is critical for the activation of NF-kappaB-directed gene expression.	Univ Texas, SW Med Ctr, Harold Simmons Canc Ctr, Dept Med,Div Hematol Oncol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Gaynor, RB (corresponding author), Univ Texas, SW Med Ctr, Harold Simmons Canc Ctr, Dept Med,Div Hematol Oncol, Dallas, TX 75390 USA.							Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goodman RH, 2000, GENE DEV, V14, P1553; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; VAN AD, 1996, SCIENCE, V274, P787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Yamamoto Y, 2001, J BIOL CHEM, V276, P36327, DOI 10.1074/jbc.M104090200; Zandi E, 1999, MOL CELL BIOL, V19, P4547; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	29	503	524	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					655	659		10.1038/nature01576	http://dx.doi.org/10.1038/nature01576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789342				2022-12-24	WOS:000183301200044
J	Bassing, CH; Suh, H; Ferguson, DO; Chua, KF; Manis, J; Eckersdorff, M; Gleason, M; Bronson, R; Lee, C; Alt, FW				Bassing, CH; Suh, H; Ferguson, DO; Chua, KF; Manis, J; Eckersdorff, M; Gleason, M; Bronson, R; Lee, C; Alt, FW			Histone H2AX: A dosage-dependent suppressor of oncogenic translocations and tumors	CELL			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE CHECKPOINT; GENOMIC INSTABILITY; V(D)J RECOMBINATION; GENE AMPLIFICATION; THYMIC LYMPHOMA; PATHOGENIC ROLE; MICE; 53BP1; ATM	We employed gene targeting to study H2AX, a histone variant phosphorylated in chromatin surrounding DNA double-strand breaks. Mice deficient for both H2AX and p53 ((HP-/-)-P-Delta/Delta) rapidly developed immature T and B lymphomas and solid tumors. Moreover, H2AX haploinsufficiency caused genomic instability in normal cells and, on a p53-deficient background, early onset of various tumors including more mature B lymphomas. Most H2AX(Delta/Delta)p53(-/-) or H2AX(+/Delta) p53(-/-) B lineage lymphomas harbored chromosome 12 (IgH)/15 (c-myc) translocations with hallmarks of either aberrant V(D)J or class switch recombination. In contrast, H2AX(Delta/Delta)p53(-/-) thymic lymphomas had clonal translocations that did not involve antigen receptor loci and which likely occurred during cellular expansion. Thus, H2AX helps prevent aberrant repair of both programmed and general DNA breakage and, thereby, functions as a dosage-dependent suppressor of genomic instability and tumors in mice. Notably, H2AX maps to a cytogenetic region frequently altered in human cancers, possibily implicating similar functions in man.	Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst,Dept Genet, Boston, MA 02115 USA; Ctr Blood Res, Boston, MA 02115 USA; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cytogenet, Boston, MA 02155 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02155 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Tufts University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Alt, FW (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst,Dept Genet, Boston, MA 02115 USA.				NCI NIH HHS [CA92625] Funding Source: Medline; NHLBI NIH HHS [K08 HL67580-03] Funding Source: Medline; NIAID NIH HHS [AI35714] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL067580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035714] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson G, 1999, IMMUNOL TODAY, V20, P463, DOI 10.1016/S0167-5699(99)01524-8; Bachelier R, 2003, ONCOGENE, V22, P528, DOI 10.1038/sj.onc.1206208; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bosco G, 1998, GENETICS, V150, P1037; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; CHERIF D, 1994, LEUKEMIA, V8, P578; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fodde R, 2002, SCIENCE, V298, P761, DOI 10.1126/science.1077707; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gladdy RA, 2003, CANCER CELL, V3, P37, DOI 10.1016/S1535-6108(02)00236-2; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Jack MT, 2002, P NATL ACAD SCI USA, V99, P9825, DOI 10.1073/pnas.152053599; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Mak TW, 2000, NAT IMMUNOL, V1, P77, DOI 10.1038/76950; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Monteiro ANA, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e51; NOTTENBURG C, 1987, J IMMUNOL, V139, P1718; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schaffner C, 1999, BLOOD, V94, P748, DOI 10.1182/blood.V94.2.748.414k02_748_753; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stilgenbauer S, 1999, BLOOD, V94, P3262, DOI 10.1182/blood.V94.9.3262.421a33_3262_3264; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	53	410	421	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					359	370		10.1016/S0092-8674(03)00566-X	http://dx.doi.org/10.1016/S0092-8674(03)00566-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914700	Bronze			2022-12-24	WOS:000184679200012
J	Li, Z; Hannigan, M; Mo, ZC; Liu, B; Lu, W; Wu, Y; Smrcka, AV; Wu, GQ; Li, L; Liu, MY; Huang, CK; Wu, DQ				Li, Z; Hannigan, M; Mo, ZC; Liu, B; Lu, W; Wu, Y; Smrcka, AV; Wu, GQ; Li, L; Liu, MY; Huang, CK; Wu, DQ			Directional sensing requires G beta gamma-mediated PAK1 and PIX alpha-dependent activation of cdc42	CELL			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ADAPTER PROTEIN NCK; P21-ACTIVATED KINASES; SIGNALING PATHWAYS; MEMBRANE LOCALIZATION; HUMAN NEUTROPHILS; MAMMALIAN-CELLS; LIPID PRODUCTS; RHO-GTPASES; CHEMOTAXIS	Efficient chemotaxis requires directional sensing and cell polarization. We describe a signaling mechanism involving Gbetagamma, PAK-associated guanine nucleotide exchange factor (PIXalpha), Cdc42, and p21-activated kinase (PAK) 1. This pathway is utilized by chemoattractants to regulate directional sensing and directional migration of myeloid cells. Our results suggest that Gbetagamma binds PAKI and, via PAK-associated PIXa, activates Cdc42, which in turn activates PAK1. Thus, in this pathway, PAKII is not only an effector for Cdc42, but it also functions as a scaffold protein required for Cdc42 activation. This Gbetagamma-PAK1/PIXalpha/Cdc42 pathway is essential for the localization of F-actin formation to the leading edge, the exclusion of PTEN from the leading edge, directional sensing, and the persistent directional migration of chemotactic leukocytes. Although ligand-induced production Of PIP3 is not required for activation of this pathway, PIP3 appears to localize the activation of Cdc42 by the pathway.	Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; Texas A&M Univ, Syst Hlth Sci Ctr, Alkek Inst Biosci & Technol, Dept Med Biochem & Genet, Houston, TX 77030 USA; Univ Connecticut, Ctr Hlth, Dept Pathol, Farmington, CT 06030 USA; Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; Vanderbilt Univ, Dept Med Med Genet, Nashville, TN 37232 USA; Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	University of Connecticut; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Connecticut; University of Rochester; Vanderbilt University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wu, DQ (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA.	dwu@neuron.uchc.edu		Liu, Mingyao/0000-0001-7339-5048				Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bokoch GM, 2000, IMMUNOL RES, V21, P139, DOI 10.1385/IR:21:2-3:139; Bourne HR, 2002, NATURE, V419, P21, DOI 10.1038/419021a; Butty AC, 1998, SCIENCE, V282, P1511, DOI 10.1126/science.282.5393.1511; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; Chung CY, 1999, J CELL BIOL, V147, P559, DOI 10.1083/jcb.147.3.559; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; Dharmawardhane S, 1999, J LEUKOCYTE BIOL, V66, P521, DOI 10.1002/jlb.66.3.521; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; HUANG CK, 1991, J LEUKOCYTE BIOL, V49, P158, DOI 10.1002/jlb.49.2.158; Huang RY, 1998, MOL CELL BIOL, V18, P7130, DOI 10.1128/MCB.18.12.7130; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Leeuw T, 1998, NATURE, V391, P191, DOI 10.1038/34448; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Lim L, 1996, EUR J BIOCHEM, V242, P171, DOI 10.1111/j.1432-1033.1996.0171r.x; Lu WG, 1999, ONCOGENE, V18, P797, DOI 10.1038/sj.onc.1202361; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nern A, 1999, J CELL BIOL, V144, P1187, DOI 10.1083/jcb.144.6.1187; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wang J, 1999, J BIOL CHEM, V274, P31641, DOI 10.1074/jbc.274.44.31641; Wang YJ, 2001, CANCER LETT, V164, P69, DOI 10.1016/S0304-3835(00)00723-0; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153; ZIGMOND SH, 1988, METHOD ENZYMOL, V162, P65	50	319	322	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2003	114	2					215	227		10.1016/S0092-8674(03)00559-2	http://dx.doi.org/10.1016/S0092-8674(03)00559-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887923	Bronze			2022-12-24	WOS:000184378700011
J	Xu, JS; Wang, F; Van Keymeulen, A; Herzmark, P; Straight, A; Kelly, K; Takuwa, Y; Sugimoto, N; Mitchison, T; Bourne, HR				Xu, JS; Wang, F; Van Keymeulen, A; Herzmark, P; Straight, A; Kelly, K; Takuwa, Y; Sugimoto, N; Mitchison, T; Bourne, HR			Divergent signals and cytoskeletal assemblies regulate self-organizing polarity in neutrophils	CELL			English	Article							BIOLOGICAL PATTERN FORMATION; BINDING PROTEIN-RHO; CELL POLARITY; LYSOPHOSPHATIDIC ACID; FOCAL ADHESIONS; CULTURED-CELLS; DISTINCT ROLES; LEADING-EDGE; P115 RHOGEF; CHEMOTAXIS	Like neutrophilic leukocytes, differentiated HL-60 cells respond to chemoattractant by adopting a polarized morphology, with F-actin in a protruding pseudopod at the leading edge and contractile actin-myosin complexes at the back and sides. Experiments with pharmacological inhibitors, toxins, and mutant proteins show that this polarity depends on divergent, opposing "frontness" and "backness" signals generated by different receptor-activated trimeric G proteins. Frontness depends upon Gi-mediated production of X-phosphoinositol lipids (PI3Ps), the activated form of Rac, a small GTPase, and F-actin. G12 and G13 trigger backness signals, including activation of a second GTPase (Rho), a Rho-dependent kinase, and myosin If. Functional incompatibility causes the two resulting actin assemblies to aggregate into separate domains, making the leading edge more sensitive to attractant than the back. The latter effect explains both the neutrophil's ability to polarize in uniform concentrations of chemoattractant and its response to reversal of an attractant gradient by performing a U-turn.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Free Univ Brussels, Inst Rech Interdisciplinaire Biol Humaine & Mol, B-1070 Brussels, Belgium; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; NCI, Ctr Canc Res, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA; Kanazawa Univ, Dept Physiol, Kanazawa, Ishikawa 9208640, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kanazawa University	Bourne, HR (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	bourne@cmp.ucsf.edu	Wang, Fei/A-7968-2013; Sugimoto, Naotoshi/C-4739-2015	Sugimoto, Naotoshi/0000-0003-1995-5002; Straight, Aaron/0000-0001-5885-7881	NHLBI NIH HHS [HL07713] Funding Source: Medline; NIGMS NIH HHS [GM 27810] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Cassimeris L, 1990, Semin Cell Biol, V1, P125; Chung CY, 1999, J CELL BIOL, V147, P559, DOI 10.1083/jcb.147.3.559; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; DOWNEY GP, 1994, CURR OPIN IMMUNOL, V6, P113, DOI 10.1016/0952-7915(94)90042-6; Eddy RJ, 2000, J CELL SCI, V113, P1287; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Firtel RA, 2000, CURR OPIN GENET DEV, V10, P421, DOI 10.1016/S0959-437X(00)00107-6; Fishburn CS, 2000, P NATL ACAD SCI USA, V97, P1085, DOI 10.1073/pnas.97.3.1085; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; GOLDMAN DW, 1985, J EXP MED, V162, P145, DOI 10.1084/jem.162.1.145; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hauert AB, 2002, INT J BIOCHEM CELL B, V34, P838, DOI 10.1016/S1357-2725(02)00010-9; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; KELLER HU, 1993, CELL MOTIL CYTOSKEL, V25, P10, DOI 10.1002/cm.970250103; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; KOLEGA J, 1986, J CELL BIOL, V102, P1400, DOI 10.1083/jcb.102.4.1400; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; MAUPIN P, 1994, J CELL SCI, V107, P3077; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; MEINHARDT H, 1974, J CELL SCI, V15, P321; Niggli V, 2000, FEBS LETT, V473, P217, DOI 10.1016/S0014-5793(00)01534-9; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Sah VP, 1996, J BIOL CHEM, V271, P31185, DOI 10.1074/jbc.271.49.31185; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Seveau S, 2001, MOL BIOL CELL, V12, P3550, DOI 10.1091/mbc.12.11.3550; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; SHEFCYK J, 1985, BIOCHEM BIOPH RES CO, V126, P1174, DOI 10.1016/0006-291X(85)90309-2; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sugimoto N, 2003, MOL CELL BIOL, V23, P1534, DOI 10.1128/MCB.23.5.1534-1545.2003; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; VLAHOS CJ, 1995, J IMMUNOL, V154, P2413; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Ward Y, 2002, J CELL BIOL, V157, P291, DOI 10.1083/jcb.200111026; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; WESSELS D, 1988, DEV BIOL, V128, P164, DOI 10.1016/0012-1606(88)90279-5; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585	67	542	550	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2003	114	2					201	214		10.1016/S0092-8674(03)00555-5	http://dx.doi.org/10.1016/S0092-8674(03)00555-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887922	Bronze			2022-12-24	WOS:000184378700010
J	Taylor, JRA; Kier, WM				Taylor, JRA; Kier, WM			Switching skeletons: Hydrostatic support in molting crabs	SCIENCE			English	Article							HOMARUS-AMERICANUS; CYCLE; CRUSTACEAN; LOBSTER; MUSCLE; BEHAVIOR	Skeletal support systems are essential for support, movement, muscular antagonism, and locomotion. Crustaceans shed their rigid exoskeleton at each molt yet are still capable of forceful movement. We hypothesize that the soft water-inflated body of newly molted crabs may rely on a hydrostatic skeleton, similar to that of worms and polyps. We measured internal hydrostatic pressure and the force exerted during claw adduction and observed a strong correlation between force and hydrostatic pressure, consistent with hydrostatic skeletal support. This alternation between the two basic skeletal types may be widespread among arthropods.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Taylor, JRA (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.							ADAMS ES, 1990, ANIM BEHAV, V39, P706, DOI 10.1016/S0003-3472(05)80382-3; Alexander R., 1983, ANIMAL MECH; CHAPMAN G, 1975, J EXP ZOOL, V194, P249, DOI 10.1002/jez.1401940118; CHAPMAN G, 1958, BIOL REV, V33, P338, DOI 10.1111/j.1469-185X.1958.tb01260.x; Clark R. B., 1964, DYNAMICS METAZOAN EV; CLARK RB, 1958, J EXP BIOL, V35, P731; CROMARTY SI, 1991, J EXP BIOL, V158, P565; Drach P., 1939, Ann Inst oceanogr Paris, V19, P103; GUTMANN WF, 1981, AM ZOOL, V21, P63; HARRIS JE, 1957, J EXP BIOL, V34, P116; Kelly DA, 1999, J EXP BIOL, V202, P253; LIPCIUS RN, 1982, MAR BIOL, V68, P241, DOI 10.1007/BF00409591; MYKLES DL, 1981, J ULTRA MOL STRUCT R, V75, P314, DOI 10.1016/S0022-5320(81)80088-3; MYKLES DL, 1980, J EXP BIOL, V84, P89; Olmsted JMD, 1923, J MORPHOL, V38, P279, DOI 10.1002/jmor.1050380203; Passano L., 1960, PHYSIOL CRUSTACEA, P473, DOI DOI 10.1016/B978-0-12-395628-6.50021-X; REAKA ML, 1975, J MORPHOL, V146, P55, DOI 10.1002/jmor.1051460104; Ryer CH, 1997, MAR ECOL PROG SER, V147, P77, DOI 10.3354/meps147077; Schmidt-Nielsen K., 1997, ANIMAL PHYSL; SHAFER GD, 1923, STANFORD U PUBL, V3, P303; SKINNER D M, 1985, P43; SKINNER DM, 1966, J EXP ZOOL, V163, P115, DOI 10.1002/jez.1401630202; SMITH KK, 1989, AM SCI, V77, P29; STEGER R, 1983, SCIENCE, V221, P558, DOI 10.1126/science.221.4610.558; TAMM GR, 1978, SCIENCE, V200, P79, DOI 10.1126/science.200.4337.79; TAYLOR JD, UNPUB; TRAVIS DF, 1954, BIOL BULL, V107, P433, DOI 10.2307/1538591; Trueman E. R., 1975, LOCOMOTION SOFT BODI; Wainwright S.A., 1982, MECH DESIGN ORGANISM; Wainwright SA., 1982, COMPANION ANIMAL PHY, P325	30	42	42	4	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2003	301	5630					209	210		10.1126/science.1085987	http://dx.doi.org/10.1126/science.1085987			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855806				2022-12-24	WOS:000184056200041
J	Gregg, JW; Jones, CG; Dawson, TE				Gregg, JW; Jones, CG; Dawson, TE			Urbanization effects on tree growth in the vicinity of New York City	NATURE			English	Article							ATMOSPHERIC DEPOSITION; RURAL GRADIENT; URBAN; OZONE; POPULUS; FORESTS; AREAS; CO2	Plants in urban ecosystems are exposed to many pollutants and higher temperatures, CO2 and nitrogen deposition than plants in rural areas(1-5). Although each factor has a detrimental or beneficial influence on plant growth(6), the net effect of all factors and the key driving variables are unknown. We grew the same cottonwood clone in urban and rural sites and found that urban plant biomass was double that of rural sites. Using soil transplants, nutrient budgets, chamber experiments and multiple regression analyses, we show that soils, temperature, CO2, nutrient deposition, urban air pollutants and microclimatic variables could not account for increased growth in the city. Rather, higher rural ozone (O-3) exposures reduced growth at rural sites. Urban precursors fuel the reactions of O-3 formation, but NOx scavenging reactions(7) resulted in lower cumulative urban O-3 exposures compared to agricultural and forested sites throughout the northeastern USA. Our study shows the overriding effect of O-3 despite a diversity of altered environmental factors, reveals 'footprints' of lower cumulative urban O-3 exposures amidst a background of higher regional exposures, and shows a greater adverse effect of urban pollutant emissions beyond the urban core.	Cornell Univ, Ithaca, NY 14853 USA; Inst Ecosyst Studies, Millbrook, NY 12545 USA	Cornell University; Cary Institute of Ecosystem Studies	Gregg, JW (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.		Jones, Clive G/I-4603-2014	Jones, Clive G/0000-0001-7630-7285				COLEMAN JS, 1988, OECOLOGIA, V76, P57, DOI 10.1007/BF00379600; *FED LAND MAN AIR, 2000, PHAS 1 REP; Freedman B., 1995, ENV ECOLOGY ECOLOGIC; GATZ DF, 1991, ATMOS ENVIRON B-URB, V25, P1, DOI 10.1016/0957-1272(91)90036-E; GOLDMAN MB, 1995, SOIL BIOL BIOCHEM, V27, P281, DOI 10.1016/0038-0717(94)00185-4; GREGG JW, 1999, THESIS CORNELL U; *I EC STUD, 2002, ENV MON PROGR; Idso CD, 2001, ATMOS ENVIRON, V35, P995, DOI 10.1016/S1352-2310(00)00412-X; ISAKSEN ISA, 1978, ENVIRON SCI TECHNOL, V12, P1279, DOI 10.1021/es60147a011; Jacovides CP, 1997, AGR FOREST METEOROL, V87, P91, DOI 10.1016/S0168-1923(97)00031-2; Jones H, 1996, PLANTS MICROCLIMATE; LEFOHN AS, 1987, JAPCA J AIR WASTE MA, V37, P595, DOI 10.1080/08940630.1987.10466247; Lovett GM, 2000, ENVIRON SCI TECHNOL, V34, P4294, DOI 10.1021/es001077q; LOVETT GM, 1993, CAN J FOREST RES, V23, P1603, DOI 10.1139/x93-200; MAGNUSSEN S, 1985, Forest Tree Improvement, P1; Mooney H.A., 1991, RESPONSE PLANTS MULT, DOI [10.1016/C2009-0-02664-6, DOI 10.1016/C2009-0-02664-6]; *NEW YORK STAT DEP, 1995, DAR951 NYS DEC; PETERSON JT, 1969, NAPCA PUB; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; Potvin C, 1988, FUNCT ECOL, V2, P123, DOI 10.2307/2389472; POUYAT RV, 1995, J ENVIRON QUAL, V24, P516, DOI 10.2134/jeq1995.00472425002400030019x; *US NAT RES COUNC, 1992, RETH OZ PROBL URB RE; *USDA FOR SERV, 1980, A134224C82 USDA FOR; *USDA FOR SERV FIA, 2002, FIELD METH PHAS 3 ME; Wait DA, 1999, OECOLOGIA, V121, P193, DOI 10.1007/s004420050921; Wait DA, 1996, TREE PHYSIOL, V16, P359; WEINSTEIN LH, 1990, USE NATIVE CULTIVATE, P117; Yun SC, 1999, NEW PHYTOL, V141, P411, DOI 10.1046/j.1469-8137.1999.00359.x; [No title captured]	29	275	309	20	260	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2003	424	6945					183	187		10.1038/nature01728	http://dx.doi.org/10.1038/nature01728			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853954				2022-12-24	WOS:000184032700039
J	Chew, MK; Laubichler, MD				Chew, MK; Laubichler, MD			Natural enemies - Metaphor or misconception?	SCIENCE			English	Editorial Material									Arizona State Univ, Sch Life Sci, Biol & Soc Program, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Laubichler, MD (corresponding author), Arizona State Univ, Sch Life Sci, Biol & Soc Program, Tempe, AZ 85287 USA.							Baumer A., 1990, NS BIOL; Huslin Anita, 2002, WASHINGTON POST 0723, pB03; Kevles D., 1985, NAME EUGENICS; Lakof G., 1980, METAPHORS WE LIVE; Lewontin R.C., 1984, NOT OUR GENES BIOL I; Paul Diane B., 1995, CONTROLLING HUMAN HE; Weindling P, 1989, HLTH RACE GERMAN POL; 1935, HORNADAYS AM NATURAL; 2002, NATURE, V418, P267; 2002, SCIENCE, V297, P2175	10	69	69	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2003	301	5629					52	53		10.1126/science.1085274	http://dx.doi.org/10.1126/science.1085274			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12846231				2022-12-24	WOS:000183914700024
J	Polesskaya, A; Seale, P; Rudnicki, MA				Polesskaya, A; Seale, P; Rudnicki, MA			Wnt signaling induces the myogenic specification of resident CD45(+) adult stem cells during muscle regeneration	CELL			English	Article							MURINE SKELETAL-MUSCLE; PARAXIAL MESODERM; PROGENITOR CELLS; SATELLITE CELLS; SONIC HEDGEHOG; BETA-CATENIN; IN-VITRO; EXPRESSION; MYOD; PATHWAY	The observation that CD45(+) stem cells injected into the circulation participate in muscle regeneration raised the question of whether CD45(+) stem cells resident in muscle play a physiological role during regeneration. We found that CD45(+) cells cultured from uninjured muscle were uniformly nonmyogenic. However, CD45(+) cells purified from regenerating muscle readily gave rise to determined myoblasts. The number of CD45(+) cells in muscle rapidly expanded following injury, and a high proportion entered the cell cycle. Investigation of candidate pathways involved in embryonic myogenesis revealed that Wnt signaling was sufficient to induce the myogenic specification of muscle-derived CD45(+) stem cells. Moreover, injection of the Wnt antagonists sFRP2/3 into regenerating muscle markedly reduced CD45(+) stem cell proliferation and myogenic specification. Our data therefore suggest that mobilization of resident CD45(+) stem cells is an important factor in regeneration after injury and highlight the Wnt pathway as a potential therapeutic target for degenerative neuromuscular disease.	Ottawa Hlth Res Inst, Program Mol Med, Ottawa, ON K1H 8L6, Canada; McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada	University of Ottawa; Ottawa Hospital Research Institute; McMaster University	Rudnicki, MA (corresponding author), Ottawa Hlth Res Inst, Program Mol Med, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.			Rudnicki, Michael/0000-0002-3866-5249				Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Baranski M, 2000, DEV BIOL, V217, P25, DOI 10.1006/dbio.1999.9516; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; Borello U, 1999, DEVELOPMENT, V126, P4247; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Davies JA, 2002, EXP NEPHROL, V10, P102; Dell'Agnola C, 2002, EXP HEMATOL, V30, P905, DOI 10.1016/S0301-472X(02)00866-4; Dennis S, 1999, J CELL SCI, V112, P3815; Dierick H, 1999, CURR TOP DEV BIOL, V43, P153, DOI 10.1016/S0070-2153(08)60381-6; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Heslop L, 2000, J CELL SCI, V113, P2299; Hirsinger E, 1997, DEVELOPMENT, V124, P4605; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Howell JC, 2002, EXP HEMATOL, V30, P915, DOI 10.1016/S0301-472X(02)00872-X; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Kablar B, 1997, DEVELOPMENT, V124, P4729; KOPAN R, 1994, DEVELOPMENT, V120, P2385; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Labus Marie B., 1998, Wound Repair and Regeneration, V6, P58, DOI 10.1046/j.1524-475X.1998.60109.x; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Lescher B, 1998, DEV DYNAM, V213, P440, DOI 10.1002/(SICI)1097-0177(199812)213:4<440::AID-AJA9>3.0.CO;2-6; Levin JM, 2001, J MUSCLE RES CELL M, V22, P361, DOI 10.1023/A:1013129209062; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Mahmud N, 2002, EXP HEMATOL, V30, P925, DOI 10.1016/S0301-472X(02)00863-9; Malik TH, 2000, BIOCHEM J, V349, P829, DOI 10.1042/bj3490829; Marcelle C, 1997, DEVELOPMENT, V124, P3955; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; Pagel CN, 1999, J NEUROL SCI, V164, P103, DOI 10.1016/S0022-510X(99)00061-1; Pandur P, 2002, BIOESSAYS, V24, P881, DOI 10.1002/bies.10164; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Reshef R, 1998, GENE DEV, V12, P290, DOI 10.1101/gad.12.3.290; Romero-Ramos M, 2002, J NEUROSCI RES, V69, P894, DOI 10.1002/jnr.10374; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Sasaki T, 2001, INT J BIOCHEM CELL B, V33, P1041, DOI 10.1016/S1357-2725(01)00075-9; Schmidt M, 2000, DEVELOPMENT, V127, P4105; SCHULTZ E, 1986, J MUSCLE RES CELL M, V7, P361, DOI 10.1007/BF01753657; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Tajbakhsh S, 1995, DEVELOPMENT, V121, P4077; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Tang DG, 2001, SCIENCE, V291, P868, DOI 10.1126/science.1056780; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Vainio SJ, 2000, PEDIATR NEPHROL, V15, P151, DOI 10.1007/s004670000404; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; WAKEFORD S, 1991, MUSCLE NERVE, V14, P42, DOI 10.1002/mus.880140108; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zhao P, 2002, J BIOL CHEM, V277, P30091, DOI 10.1074/jbc.M202668200	59	389	415	0	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 27	2003	113	7					841	852		10.1016/S0092-8674(03)00437-9	http://dx.doi.org/10.1016/S0092-8674(03)00437-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	695EJ	12837243	Bronze			2022-12-24	WOS:000183817900009
J	Caulfield, M; Munroe, P; Pembroke, J; Samani, N; Dominiczak, A; Brown, M; Benjamin, N; Webster, J; Ratcliffe, P; O'Shea, S; Papp, J; Taylor, E; Dobson, R; Knight, J; Newhouse, S; Hooper, J; Lee, W; Brain, N; Clayton, D; Lathrop, GM; Farrall, M; Connell, J				Caulfield, M; Munroe, P; Pembroke, J; Samani, N; Dominiczak, A; Brown, M; Benjamin, N; Webster, J; Ratcliffe, P; O'Shea, S; Papp, J; Taylor, E; Dobson, R; Knight, J; Newhouse, S; Hooper, J; Lee, W; Brain, N; Clayton, D; Lathrop, GM; Farrall, M; Connell, J		MRC Brit Genetics Hypertension Stu	Genome-wide mapping of human loci for essential hypertension	LANCET			English	Article							SIB-PAIR LINKAGE; MATERNAL SUSCEPTIBILITY LOCUS; BLOOD-PRESSURE; COMPLEX TRAITS; SCANS; PREECLAMPSIA; CHROMOSOME-2	Background Blood pressure may contribute to 50% of the global cardiovascular disease epidemic. By understanding the genes predisposing to common disorders such as human essential hypertension we may gain insights into novel pathophysiological mechanisms and potential therapeutic targets. In the Medical Research Council BRItish Genetics of HyperTension (BRIGHT) study, we aim to identify these genetic factors by scanning the human genome for susceptibility genes for essential hypertension. We describe the results of a genome scan for hypertension in a large white European population. Methods We phenotyped 2010 affected sibling pairs drawn from 1599 severely hypertensive families, and completed a 10 centimorgan genome-wide scan. After rigorous quality control, we analysed the genotypic data by non-parametric linkage, which tests whether genes are shared in excess among the affected sibling pairs. Lod scores, calculated at regular points along each chromosome, were used to assess the support for linkage, Findings Linkage analysis identified a principle locus on chromosome 6q, with a lod score of 3.21 that attained genome-wide significance (p=0.042). The inclusion of three further loci with lod scores higher than 1.57 (2q, 5q, and 9q) also show genome-wide significance (p=0.017) when assessed under a locus-counting analysis. Interpretation These findings imply that human essential hypertension has an oligogenic element (a few genes may be involved in determination of the trait) possibly superimposed on more minor genetic effects, and that several genes may be tractable to a positional cloning strategy.	Queen Marys Sch Med, Barts & London, William Harvey Res Inst, Barts & London Genome Ctr, London EC1M 6BQ, England; Univ Leicester, Glenfield Hosp, Leicester, Leics, England; Univ Glasgow, Western Infirm, Div Cardiovasc & Med Sci, Glasgow G11 6NT, Lanark, Scotland; Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2QQ, England; Aberdeen Royal Infirm, Aberdeen, Scotland; Univ Oxford, Wellcome Trust Ctr Human Genet, Nuffield Dept Clin Med, Oxford, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford, England; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; Ctr Natl Genotypage, Evry, France	University of London; Queen Mary University London; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Glasgow; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Aberdeen; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; CEA; UDICE-French Research Universities; Universite Paris Saclay	Caulfield, M (corresponding author), Queen Marys Sch Med, Barts & London, William Harvey Res Inst, Barts & London Genome Ctr, Charterhouse Sq, London EC1M 6BQ, England.		Dominiczak, Anna F/P-9390-2017; Dobson, Richard j/C-9269-2011; Brown, Matthew A/E-5749-2010; Knight, Jo/F-4946-2011; Newhouse, Stephen J/C-9330-2011; Dominiczak, Anna F/D-2262-2009	Dominiczak, Anna F/0000-0003-4913-3608; Dobson, Richard j/0000-0003-4224-9245; Brown, Matthew A/0000-0003-0538-8211; Newhouse, Stephen J/0000-0002-1843-9842; Caulfield, Mark/0000-0001-9295-3594; Lee, Wai Kwong/0000-0001-8560-8063; Ratcliffe, Peter/0000-0002-2853-806X; Knight, Joanne/0000-0002-7148-1660; Munroe, Patricia/0000-0002-4176-2947				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Arngrimsson R, 1999, HUM MOL GENET, V8, P1799, DOI 10.1093/hmg/8.9.1799; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Cooper RS, 2002, HYPERTENSION, V40, P629, DOI 10.1161/01.HYP.0000035708.02789.39; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Holmans P, 2002, HUM HERED, V53, P92, DOI 10.1159/000057987; HOLMANS P, 1995, AM J HUM GENET, V57, P1221; Hunt SC, 2002, HYPERTENSION, V40, P1, DOI 10.1161/01.HYP.0000022660.28915.B1; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Kardia SLR, 2003, AM J HYPERTENS, V16, P154, DOI 10.1016/S0895-7061(02)03249-1; Krushkal J, 1999, CIRCULATION, V99, P1407, DOI 10.1161/01.CIR.99.11.1407; Leal SM, 2000, AM J HUM GENET, V66, P567, DOI 10.1086/302748; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Luft FC, 2001, HYPERTENSION, V37, P350, DOI 10.1161/01.HYP.37.2.350; Moses EK, 2000, AM J HUM GENET, V67, P1581, DOI 10.1086/316888; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Perola M, 2000, J HYPERTENS, V18, P1579, DOI 10.1097/00004872-200018110-00008; Province MA, 2003, AM J HYPERTENS, V16, P144, DOI 10.1016/S0895-7061(02)03248-X; Ranade K, 2003, AM J HYPERTENS, V16, P158, DOI 10.1016/S0895-7061(02)03245-4; Rao DC, 2003, AM J HYPERTENS, V16, P148, DOI 10.1016/S0895-7061(02)03247-8; Rice JP, 1999, GENET EPIDEMIOL, V17, pS691; RISCH N, 1990, AM J HUM GENET, V46, P229; Samani NJ, 2003, AM J HYPERTENS, V16, P167, DOI 10.1016/S0895-7061(02)03244-2; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wiltshire S, 2002, AM J HUM GENET, V71, P1175, DOI 10.1086/342976; Zhu DL, 2001, J HYPERTENS, V19, P55, DOI 10.1097/00004872-200101000-00008	27	208	214	0	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 21	2003	361	9375					2118	2123		10.1016/S0140-6736(03)13722-1	http://dx.doi.org/10.1016/S0140-6736(03)13722-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	692GY	12826435				2022-12-24	WOS:000183654200011
J	Irwig, L				Irwig, L			'This added to my multiple myopia'	BRITISH MEDICAL JOURNAL			English	Article									Univ Sydney, Sch Publ Hlth, Ecreening & Test Evaluat Program, Sydney, NSW 2006, Australia	University of Sydney	Irwig, L (corresponding author), Univ Sydney, Sch Publ Hlth, Ecreening & Test Evaluat Program, Sydney, NSW 2006, Australia.								0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2003	326	7402					1336	1336		10.1136/bmj.326.7402.1336	http://dx.doi.org/10.1136/bmj.326.7402.1336			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691VK	12805196	Green Published			2022-12-24	WOS:000183626500061
J	Bailes, E; Gao, F; Bibollet-Ruche, F; Courgnaud, V; Peeters, M; Marx, PA; Hahn, BH; Sharp, PM				Bailes, E; Gao, F; Bibollet-Ruche, F; Courgnaud, V; Peeters, M; Marx, PA; Hahn, BH; Sharp, PM			Hybrid origin of SIV in chimpanzees	SCIENCE			English	Article							TROGLODYTES		Univ Nottingham, Nottingham NG7 2UH, England; Univ Alabama, Birmingham, AL 35294 USA; Duke Univ, Durham, NC 27710 USA; Univ Montpellier 1, F-34032 Montpellier 1, France; Tulane Natl Primate Res Ctr, Covington, LA 70433 USA	University of Nottingham; University of Alabama System; University of Alabama Birmingham; Duke University; Universite de Montpellier; Tulane University	Sharp, PM (corresponding author), Univ Nottingham, Nottingham NG7 2UH, England.	paul@evol.nott.ac.uk	Sharp, Paul/Y-3787-2019; Sharp, Paul M/F-5783-2010; Sharp, Paul M/GPX-1497-2022	Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Hahn, Beatrice/0000-0002-9400-9887	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI085338, R01AI050529, R01AI044596] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI50529, R01 AI44596, N01 AI85338] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beer BE, 2001, J VIROL, V75, P12014, DOI 10.1128/JVI.75.24.12014-12027.2001; Courgnaud V, 2002, J VIROL, V76, P8298, DOI 10.1128/JVI.76.16.8298-8309.2002; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Goldberg TL, 1997, MOL BIOL EVOL, V14, P976, DOI 10.1093/oxfordjournals.molbev.a025841; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Santiago ML, 2002, SCIENCE, V295, P465, DOI 10.1126/science.295.5554.465	6	271	277	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1713	1713		10.1126/science.1080657	http://dx.doi.org/10.1126/science.1080657			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805540				2022-12-24	WOS:000183459700041
J	Burt, D; Pourquie, O				Burt, D; Pourquie, O			Chicken genome - Science nuggets to come soon	SCIENCE			English	Editorial Material									Roslin Inst Edinburgh, Roslin EH25 9PS, Midlothian, Scotland; Stowers Inst Med Res, Kansas City, MO 64110 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; Stowers Institute for Medical Research	Burt, D (corresponding author), Roslin Inst Edinburgh, Roslin EH25 9PS, Midlothian, Scotland.	dave.burt@bbsrc.ac.uk; OLP@Stowers-Institute.org	Pourquié, Olivier/CAJ-5443-2022; Burt, David W/C-7802-2013	Pourquié, Olivier/0000-0001-5189-1227; Burt, David W/0000-0002-9991-1028				Brown WRA, 2003, NAT REV GENET, V4, P87, DOI 10.1038/nrg998; Burt DW, 2003, MOL VIS, V9, P164; Clamp M, 2003, NUCLEIC ACIDS RES, V31, P38, DOI 10.1093/nar/gkg083; de Koning DJ, 2003, J ANIM SCI, V81, P1158; Hu J, 2001, NUCLEIC ACIDS RES, V29, P106, DOI 10.1093/nar/29.1.106; HUBBARD S, COMMUNICATION; MCPHERSON J, COMMUNICATION; Morisson M, 2002, GENET SEL EVOL, V34, P521, DOI [10.1051/gse:2002021, 10.1186/1297-9686-34-4-521]; Neiman PE, 2003, ONCOGENE, V22, P1073, DOI 10.1038/sj.onc.1206070; Pitel F, 2000, GENET SEL EVOL, V32, P73, DOI 10.1051/gse:2000107; Schmid M, 2000, CYTOGENET CELL GENET, V90, P169, DOI 10.1159/000056772; WILSON S, COMMUNICATION	12	41	44	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1669	1669		10.1126/science.1086231	http://dx.doi.org/10.1126/science.1086231			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805524	Green Submitted			2022-12-24	WOS:000183459700025
J	Nishii, I; Ogihara, S; Kirk, DL				Nishii, I; Ogihara, S; Kirk, DL			A kinesin, InvA, plays an essential role in Volvox morphogenesis	CELL			English	Article							CYTOPLASMIC BRIDGE SYSTEM; PROTEIN; CARTERI; INVERSION; PATTERNS; DIFFERENTIATION; MECHANISMS; ENCODES; CELLS; LIGHT	In Volvox carted adults, reproductive cells called gonidia are enclosed within a spherical monolayer of biflagellate somatic cells. Embryos must "invert" (turn inside out) to achieve this configuration, however, because at the end of cleavage the gonidia are on the outside and the flagellar ends of all somatic cells point inward. Generation of a bend region adequate to turn the embryo inside out involves a dramatic change in cell shape, plus cell movements. Here, we cloned a gene called invA that is essential for inversion and found that it codes for a kinesin localized in the cytoplasmic bridges that link all cells to their neighbors. In invA null mutants, cells change shape normally, but are unable to move relative to the cytoplasmic bridges. A normal bend region cannot be formed and inversion stops. We conclude that the InvA kinesin provides the motile force that normally drives inversion to completion.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Osaka Univ, Grad Sch Sci, Dept Biol, Toyonaka, Osaka 560, Japan	Washington University (WUSTL); Osaka University	Kirk, DL (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	kirk@biology.wustl.edu						ADAMS CR, 1990, CURR GENET, V18, P141, DOI 10.1007/BF00312602; Asamiziu E, 2000, DNA RES, V7, P305, DOI 10.1093/dnares/7.5.305; GREEN KJ, 1981, J CELL BIOL, V91, P743, DOI 10.1083/jcb.91.3.743; GREEN KJ, 1981, J CELL BIOL, V91, P756, DOI 10.1083/jcb.91.3.756; Hallmann A, 2000, J CELL SCI, V113, P4605; Hasson T, 2001, CURR OPIN CELL BIOL, V13, P29, DOI 10.1016/S0955-0674(00)00170-8; Jarvik JW, 1998, ANNU REV GENET, V32, P601, DOI 10.1146/annurev.genet.32.1.601; KELLAND JL, 1977, J PHYCOL, V13, P373, DOI 10.1111/j.0022-3646.1977.00373.x; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; KIRK DL, 1983, DEV BIOL, V96, P493, DOI 10.1016/0012-1606(83)90186-0; Kirk DL, 2001, DEV GROWTH DIFFER, V43, P621; Kirk DL, 1982, DEV ORDER ITS ORIGIN, P247; Kirk DL., 1998, VOLVOX MOL GENETIC O; Kirk MM, 1999, DEVELOPMENT, V126, P639; KIRK MM, 1985, CELL, V41, P419, DOI 10.1016/S0092-8674(85)80015-5; KUSCHAKEWITSCH S, 1923, B ACAD SC OUKRAINE, V1, P32; MILLER SM, 1993, PLANT CELL, V5, P1125, DOI 10.1105/tpc.5.9.1125; Miller SM, 1999, DEVELOPMENT, V126, P649; Nishii I, 1999, DEVELOPMENT, V126, P2117; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Sambrook J., 2001, MOL CLONING LAB MANU; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; SESSOMS AH, 1973, P NATL ACAD SCI USA, V70, P1335, DOI 10.1073/pnas.70.5.1335; Starr R C, 1970, Symp Soc Dev Biol, V29, P59; Starr R. C., 1969, Archiv fuer Protistenkunde, V111, P204; Surrey T, 1998, P NATL ACAD SCI USA, V95, P4293, DOI 10.1073/pnas.95.8.4293; TAM LW, 1991, DEVELOPMENT, V112, P571; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIAMONTES GI, 1977, J CELL BIOL, V75, P719, DOI 10.1083/jcb.75.3.719; VIAMONTES GI, 1979, CELL, V17, P537, DOI 10.1016/0092-8674(79)90262-9	31	53	55	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2003	113	6					743	753		10.1016/S0092-8674(03)00431-8	http://dx.doi.org/10.1016/S0092-8674(03)00431-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809605	Bronze			2022-12-24	WOS:000183514400009
J	Luck, S; Torny, M; d'Agapeyeff, K; Pitt, A; Heath, P; Breathnach, A; Russell, AB				Luck, S; Torny, M; d'Agapeyeff, K; Pitt, A; Heath, P; Breathnach, A; Russell, AB			Estimated early-onset group B streptococcal neonatal disease	LANCET			English	Article							INFECTION	Estimates of incidence of early-onset group B streptococcal (EOGBS) infection are based on blood or cerebrospinal fluid culture-proven cases, which can be falsely negative and hence underestimate the true burden of disease. Probable EOGBS infection can be defined as colonisation by group B streptococci accompanied by features of clinical sepsis. Data collected prospectively in the UK over 1 year for neonates who required a septic screen in the first 72 h of life indicated a combined rate of definite and probable EOGBS infection of 3.6 per 1000 livebirths. This estimate Indicates a much greater disease burden in the UK than that suggested by figures of culture-proven sepsis, and lends support to the need for prevention strategies.	Univ London St Georges Hosp, London, England	St Georges University London	Russell, AB (corresponding author), Chelsea & Westminster Hosp, Dept Neonatol, 369 Fulham Rd, London SW10 9NH, England.			Heath, Paul/0000-0002-7540-7433				Ahmet Z, 1999, MOL CELL PROBE, V13, P349, DOI 10.1006/mcpr.1999.0262; Beardsall K, 2001, ARCH DIS CHILD-FETAL, V84, pF77; Nicoll A, 2000, ARCH DIS CHILD-FETAL, V82, pF207; Russell ARB, 2001, ARCH DIS CHILD-FETAL, V84, pF140, DOI 10.1136/fn.84.2.F140b; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103	5	93	99	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 7	2003	361	9373					1953	1954		10.1016/S0140-6736(03)13553-2	http://dx.doi.org/10.1016/S0140-6736(03)13553-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687DB	12801740				2022-12-24	WOS:000183359700012
J	Wolffers, I; van Beelen, N				Wolffers, I; van Beelen, N			Public health and the human rights of sex workers	LANCET			English	Editorial Material							WOMEN		Free Univ Amsterdam, Med Ctr, Dept Hlth Care & Culture, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Wolffers, I (corresponding author), Free Univ Amsterdam, Med Ctr, Dept Hlth Care & Culture, NL-1081 BT Amsterdam, Netherlands.	wolffers.social@med.vu.nl						Ahmad K, 2001, LANCET, V358, P643, DOI 10.1016/S0140-6736(01)05819-6; Day S, 1997, GENITOURIN MED, V73, P161; Liao SS, 2003, AIDS EDUC PREV, V15, P109, DOI 10.1521/aeap.15.3.109.23834; Nairne D, 2000, RES SEX WORK, V3, P3; Sacks V, 1996, SOC SCI MED, V42, P59, DOI 10.1016/0277-9536(95)00079-8; THOMPSON N, 2003, BOSTON GLOBE    0105; Vanwesenbeeck I, 2002, ANN REV SEX RES, V12, P242; Wawer MJ, 1996, SOC SCI MED, V42, P453, DOI 10.1016/0277-9536(95)00150-6	8	38	39	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2003	361	9373					1981	1981		10.1016/S0140-6736(03)13594-5	http://dx.doi.org/10.1016/S0140-6736(03)13594-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	687DB	12801755				2022-12-24	WOS:000183359700026
J	Gentner, TQ; Margoliash, D				Gentner, TQ; Margoliash, D			Neuronal populations and single cells representing learned auditory objects	NATURE			English	Article							INDIVIDUAL VOCAL RECOGNITION; WHITE-CROWNED SPARROW; EUROPEAN STARLINGS; PREFRONTAL CORTEX; SONG SYSTEM; DISCRIMINATION; PLASTICITY; MONKEYS; SOUNDS; ORGANIZATION	The neural representations associated with learned auditory behaviours, such as recognizing individuals based on their vocalizations, are not well described. Higher vertebrates learn to recognize complex conspecific vocalizations that comprise sequences of easily identified, naturally occurring auditory objects(1,2), which should facilitate the analysis of higher auditory pathways. Here we describe the first example of neurons selective for learned conspecific vocalizations in adult animals-in starlings that have been trained operantly to recognize conspecific songs. The neuronal population is found in a non-primary forebrain auditory region, exhibits increased responses to the set of learned songs compared with novel songs, and shows differential responses to categories of learned songs based on recognition training contingencies. Within the population, many cells respond highly selectively to a subset of specific motifs (acoustic objects) present only in the learned songs. Such neuronal selectivity may contribute to song-recognition behaviour, which in starlings is sensitive to motif identity(3,4). In this system, both top-down and bottom-up processes may modify the tuning properties of neurons during recognition learning, giving rise to plastic representations of behaviourally meaningful auditory objects.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago	Gentner, TQ (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1027 E 57th St, Chicago, IL 60637 USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC000389] Funding Source: NIH RePORTER; NIDCD NIH HHS [F32 DC000389, F32 DC000389-03] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; EENS M, 1989, ARDEA, V77, P75; Gentner T. Q., 2002, ACOUSTIC COMMUNICATI, P324; Gentner TQ, 1998, ANIM BEHAV, V56, P579, DOI 10.1006/anbe.1998.0810; Gentner TQ, 2000, J NEUROBIOL, V42, P117, DOI 10.1002/(SICI)1097-4695(200001)42:1<117::AID-NEU11>3.0.CO;2-M; Gentner TQ, 2000, J ACOUST SOC AM, V107, P3369, DOI 10.1121/1.429408; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kilgard MP, 2002, P NATL ACAD SCI USA, V99, P3205, DOI 10.1073/pnas.261705198; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Kroodsma D.E., 1996, ECOLOGY EVOLUTION AC; KROODSMA DE, 1999, DESIGN ANIMAL COMMUN; LEPPELSACK HJ, 1976, J COMP PHYSIOL, V107, P263, DOI 10.1007/BF00656737; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MULLER CM, 1985, EXP BRAIN RES, V59, P587; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; RECANZONE GH, 1993, J NEUROSCI, V13, P87; SCHEICH H, 1979, J COMP PHYSIOL, V132, P257, DOI 10.1007/BF00614497; Sen K, 2001, J NEUROPHYSIOL, V86, P1445, DOI 10.1152/jn.2001.86.3.1445; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Wang XQ, 2001, J NEUROPHYSIOL, V86, P2616, DOI 10.1152/jn.2001.86.5.2616	27	186	187	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					669	674		10.1038/nature01731	http://dx.doi.org/10.1038/nature01731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904792	Green Accepted			2022-12-24	WOS:000184578800044
J	Krekelberg, B; Dannenberg, S; Hoffmann, KP; Bremmer, F; Ross, J				Krekelberg, B; Dannenberg, S; Hoffmann, KP; Bremmer, F; Ross, J			Neural correlates of implied motion	NATURE			English	Article							VISUAL AREA MT; TRANSPARENT MOTION; MACAQUE MONKEY; DIRECTION; PERCEPTION; SIGNALS; NEURONS; SELECTIVITY; ORIENTATION; CORTEX	Current views of the visual system assume that the primate brain analyses form and motion along largely independent pathways(1); they provide no insight into why form is sometimes interpreted as motion. In a series of psychophysical and electrophysiological experiments in humans and macaques, here we show that some form information is processed in the prototypical motion areas of the superior temporal sulcus (STS). First, we show that STS cells respond to dynamic Glass patterns(2),which contain no coherent motion but suggest a path of motion(3). Second, we show that when motion signals conflict with form signals suggesting a different path of motion, both humans and monkeys perceive motion in a compromised direction. This compromise also has a correlate in the responses of STS cells, which alter their direction preferences in the presence of conflicting implied motion information. We conclude that cells in the prototypical motion areas in the dorsal visual cortex process form that implies motion. Estimating motion by combining motion cues with form cues may be a strategy to deal with the complexities of motion perception in our natural environment.	Salk Inst Biol Studies, Vis Ctr Lab, La Jolla, CA 92037 USA; Ruhr Univ Bochum, Dept Neurobiol, D-44780 Bochum, Germany; Univ Marburg, Dept Neurophys, Cognit Neurosci Lab, D-35032 Marburg, Germany; Univ Western Australia, Sch Psychol, Nedlands, WA 6907, Australia	Salk Institute; Ruhr University Bochum; Philipps University Marburg; University of Western Australia	Krekelberg, B (corresponding author), Salk Inst Biol Studies, Vis Ctr Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Bremmer, Frank/F-3268-2012; Krekelberg, Bart/N-7938-2019	Bremmer, Frank/0000-0003-1597-7407; Krekelberg, Bart/0000-0003-1083-6103				ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Batschelet E, 1981, CIRCULAR STAT BIOL; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Burr DC, 2002, J NEUROSCI, V22, P8661; Geisler WS, 1999, NATURE, V400, P65, DOI 10.1038/21886; Geisler WS, 2001, VISUAL NEUROSCI, V18, P501, DOI 10.1017/S0952523801184014; GLASS L, 1969, NATURE, V223, P578, DOI 10.1038/223578a0; Jancke D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-14-j0005.2000; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; QIAN N, 1994, J NEUROSCI, V14, P7367; Ross J, 2000, CURR BIOL, V10, P679, DOI 10.1016/S0960-9822(00)00524-8; Rudolph K, 1999, CEREB CORTEX, V9, P90, DOI 10.1093/cercor/9.1.90; SCHOPPMANN A, 1976, NEUROSCI LETT, V2, P177, DOI 10.1016/0304-3940(76)90011-2; Smith MA, 2002, J NEUROSCI, V22, P8334, DOI 10.1523/jneurosci.22-18-08334.2002; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; Wilson HR, 1997, VISION RES, V37, P2325, DOI 10.1016/S0042-6989(97)00104-1	20	122	125	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					674	677		10.1038/nature01852	http://dx.doi.org/10.1038/nature01852			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904793				2022-12-24	WOS:000184578800045
J	Blackburn, C; Spencer, N; Bonas, S; Coe, C; Dolan, A; Moy, R				Blackburn, C; Spencer, N; Bonas, S; Coe, C; Dolan, A; Moy, R			Effect of strategies to reduce exposure of infants to environmental tobacco smoke in the home: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							URINARY COTININE; PARENTAL SMOKING; CHILDREN; ASTHMA	Objective To examine parents' reported knowledge and use of harm reduction strategies to protect their infants from exposure to tobacco smoke in the home, and the relation between reported use of strategies and urinary cotinine to creatinine ratios in the infants. Design Cross sectional survey. Settings Coventry and Birmingham. Main outcome measures Parents' reported knowledge and use of harm reduction strategies and urinary cotinine to creatinine ratios in their infants. Participants 314 smoking households with infants. Results 86% of parents (264/307) believed that environmental tobacco smoke is harmful, 90% (281/314) believed that infants can be protected from it in the home, and 10% (32/314) were either unaware of measures or reported using none. 65% of parents (205/314) reported using two or more measures, but only 18% (58/314) reported not allowing smoking in the home. No difference was found in mean log e transformed urinary cotinine to creatinine ratio in infants from households that used no measures compared with households that used less strict measures. Mean log cotinine to creatinine ratios were significantly different in households banning smoking in the home compared with those using less strict or no measures. Banning smoking in the home was independently associated with a significant reduction in urinary cotinine to creatinine ratio by a factor of 2.6 (1.6 to 4.2) after adjustment for average household cigarette consumption, tenure, and overcrowding. Conclusions Less than a fifth of parents in smoking households ban smoking in the home. Banning smoking was associated with a small but significant reduction in urinary cotinine to creatinine ratio in infants, whereas less strict measures compared with no measures had no effect on the infants' exposure to environmental tobacco smoke.	Univ Warwick, Sch Hlth & Social Studies, Coventry CV4 7AL, W Midlands, England; Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Birmingham Childrens Hosp, Inst Child Hlth, Birmingham, W Midlands, England	University of Warwick; University of Leicester; University of Birmingham	Blackburn, C (corresponding author), Univ Warwick, Sch Hlth & Social Studies, Coventry CV4 7AL, W Midlands, England.							Bakoula CG, 1997, CANCER CAUSE CONTROL, V8, P73, DOI 10.1023/A:1018487222533; Cook DG, 1999, THORAX, V54, P357, DOI 10.1136/thx.54.4.357; GRAHAM H, 1993, WHEN LIFES DRAG WOME; Haufroid V, 1998, INT ARCH OCC ENV HEA, V71, P162, DOI 10.1007/s004200050266; Jarvis MJ, 2000, BRIT MED J, V321, P343, DOI 10.1136/bmj.321.7257.343; Mascola MA, 1998, AM J PUBLIC HEALTH, V88, P893, DOI 10.2105/AJPH.88.6.893; Peterson EL, 1997, J CLIN EPIDEMIOL, V50, P917, DOI 10.1016/S0895-4356(97)00095-4; Wakefield M, 2000, AM J PREV MED, V19, P188, DOI 10.1016/S0749-3797(00)00197-5; Winkelstein ML, 1997, ANN ALLERG ASTHMA IM, V78, P419, DOI 10.1016/S1081-1206(10)63206-1	9	85	90	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2003	327	7409					257	260		10.1136/bmj.327.7409.257	http://dx.doi.org/10.1136/bmj.327.7409.257			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896936	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000184566300017
J	Sampaolesi, M; Torrente, Y; Innocenzi, A; Tonlorenzi, R; D'Antona, G; Pellegrino, MA; Barresi, R; Bresolin, N; De Angelis, MGC; Campbell, KP; Bottinelli, R; Cossu, G				Sampaolesi, M; Torrente, Y; Innocenzi, A; Tonlorenzi, R; D'Antona, G; Pellegrino, MA; Barresi, R; Bresolin, N; De Angelis, MGC; Campbell, KP; Bottinelli, R; Cossu, G			Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts	SCIENCE			English	Article							SKELETAL-MUSCLE FIBERS; MYOSIN HEAVY-CHAIN; STEM-CELLS; SHORTENING VELOCITY; MUSCULAR-DYSTROPHY; BONE-MARROW; ADENOASSOCIATED VIRUS; MDX MICE; MOUSE; TRANSPLANTATION	Preclinical or clinical trials for muscular dystrophies have met with modest success, mainly because of inefficient delivery of viral vectors or donor cells to dystrophic muscles. We report here that intra-arterial delivery of wildtype mesoangioblasts, a class of vessel-associated stem cells, corrects morphologically and functionally the dystrophic phenotype of virtually all downstream muscles in adult immunocompetent alpha-sarcoglycan (alpha-SG) null mice, a model organism for limb-girdle muscular dystrophy. When mesoangioblasts isolated from juvenile dystrophic mice and transduced with a lentiviral vector expressing alpha-SG were injected into the femoral artery of dystrophic mice, they reconstituted skeletal muscle in a manner similar to that seen in wild-type cells. The success of this protocol was mainly due to widespread distribution of donor stem cells through the capillary network, a distinct advantage of this strategy over previous approaches.	Hosp San Raffaele, Stem Cell Res Inst, I-20132 Milan, Italy; Osped Maggiore Policlin, Ctr Dino Ferrari, IRCCS, Dept Neurol Sci, I-20122 Milan, Italy; Univ Pavia, Dept Expt Med, I-27100 Pavia, Italy; Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Physiol Biophys & Neurol, Iowa City, IA 52242 USA; IRCCS E Medea, I-23842 Bosisio Parini, Lecco, Italy; Univ Roma La Sapienza, Dept Histol & Med Embryol, I-00161 Rome, Italy; Inst Cell Biol & Tissue Engn, I-00128 Rome, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Pavia; Howard Hughes Medical Institute; University of Iowa; IRCCS Eugenio Medea; Sapienza University Rome	Cossu, G (corresponding author), Hosp San Raffaele, Stem Cell Res Inst, Via Olgettina 58, I-20132 Milan, Italy.	cossu.giulio@hsr.it	Tonlorenzi, Rossana/AAN-2241-2020; Barresi, Rita/AAB-9569-2022; Bottinelli, Roberto/AAC-1904-2020; canepari, Monica MC/D-7677-2015; Pellegrino, Maria Antonietta/AAC-4680-2022; Sampaolesi, Maurilio/H-6509-2013; TORRENTE, YVAN/A-2964-2015	Barresi, Rita/0000-0001-7351-959X; Bottinelli, Roberto/0000-0002-4960-7490; Pellegrino, Maria Antonietta/0000-0002-1653-1266; Sampaolesi, Maurilio/0000-0002-2422-3757; TORRENTE, YVAN/0000-0002-2705-3984; Campbell, Kevin/0000-0003-2066-5889; D'Antona, Giuseppe/0000-0002-0683-5565; Bresolin, Nereo/0000-0001-6694-3595; Tonlorenzi, Rossana/0000-0002-6060-8208	Telethon [463/BI, 1322] Funding Source: Medline	Telethon(Fondazione Telethon)		Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; BOTTINELLI R, 1994, J PHYSIOL-LONDON, V478, P341, DOI 10.1113/jphysiol.1994.sp020254; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; Condorelli G, 2001, P NATL ACAD SCI USA, V98, P10733, DOI 10.1073/pnas.191217898; Cossu G, 2000, J CLIN INVEST, V105, P1669, DOI 10.1172/JCI10376; De Angelis FG, 2002, P NATL ACAD SCI USA, V99, P9456, DOI 10.1073/pnas.142302299; DelloRusso C, 2002, P NATL ACAD SCI USA, V99, P12979, DOI 10.1073/pnas.202300099; Dressman D, 2002, HUM GENE THER, V13, P1631, DOI 10.1089/10430340260201725; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Ferrari G, 2001, NATURE, V411, P1014, DOI 10.1038/35082631; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; MacGregor R R, 2001, Hum Gene Ther, V12, P2028; Minasi MG, 2002, DEVELOPMENT, V129, P2773; PALUMBO R, UNPUB; Pansarasa O, 2002, EUR J APPL PHYSIOL, V87, P550, DOI 10.1007/s00421-002-0668-3; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; SAMPAOLESI M, UNPUB; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; Skuk D, 2002, CURR OPIN NEUROL, V15, P563, DOI 10.1097/00019052-200210000-00007; TAGLIAFICO E, UNPUB; Takada T, 1997, NAT BIOTECHNOL, V15, P458, DOI 10.1038/nbt0597-458; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Weiss S, 2001, J BIOL CHEM, V276, P45902, DOI 10.1074/jbc.M107434200; Yuasa K, 2002, GENE THER, V9, P1576, DOI 10.1038/sj.gt.3301829	35	483	514	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					487	492		10.1126/science.1082254	http://dx.doi.org/10.1126/science.1082254			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12855815	Green Accepted			2022-12-24	WOS:000184340500034
J	Sejvar, JJ; Haddad, MB; Tierney, BC; Campbell, GL; Marfin, AA; Van Gerpen, JA; Fleischauer, A; Leis, AA; Stokic, DS; Petersen, LR				Sejvar, JJ; Haddad, MB; Tierney, BC; Campbell, GL; Marfin, AA; Van Gerpen, JA; Fleischauer, A; Leis, AA; Stokic, DS; Petersen, LR			Neurologic manifestations and outcome of West Nile virus infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEW-YORK; JAPANESE ENCEPHALITIS; MOVEMENT-DISORDERS; CLINICAL-FEATURES; OUTBREAK; POLIOMYELITIS; EPIDEMIC	Context The neurologic manifestations, laboratory findings, and outcome of patients with West Nile virus (WNV) infection have not been prospectively characterized. Objective To describe prospectively the clinical and laboratory features and long-term outcome of patients with neurologic manifestations of WNV infection. Design, Setting, and Participants From August 1 to September 2, 2002, a community-based, prospective case series was conducted in St Tammany Parish, La. Standardized clinical data were collected on patients with suspected WNV infection. Confirmed WNV-seropositive patients were reassessed at 8 months. Main Outcome Measures Clinical, neurologic, and laboratory features at initial presentation, and long-term neurologic outcome. Results Sixteen (37%) of 39 suspected cases had antibodies against WNV; 5 had meningitis, 8 had encephalitis, and 3 had poliomyelitis-like acute flaccid paralysis. Movement disorders, including tremor (15 [94%]), myoclonus (5 [31%]) and parkinsonism (11 [69%]), were common among WNV-seropositive patients. One patient died. At 8-month followup, fatigue, headache, and myalgias were persistent symptoms; gait and movement disorders persisted in 6 patients. Patients with WNV meningitis or encephalitis had favorable outcomes, although patients with acute flaccid paralysis did not recover limb strength. Conclusions Movement disorders, including tremor, myoclonus, and parkinsonism, may be present during acute illness with WNV infection. Some patients with WNV infection and meningitis or encephalitis ultimately may have good long-term outcome, although an irreversible poliomyelitis-like syndrome may result.	CDCP, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA 30333 USA; Ochsner Clin & Alton Ochsner Med Fdn, Dept Neurol, New Orleans, LA USA; Methodist Rehabil Ctr, Ctr Neurosci & Neurol Recovery, Jackson, MS USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Ochsner Health System	Sejvar, JJ (corresponding author), CDCP, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,MS A-39, Atlanta, GA 30333 USA.	zea3@cdc.gov		Stokic, Dobrivoje/0000-0002-1891-5730				ALCOCK A, 1985, CMAJ, V130, P1305; Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P825; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P708; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P37; Chowers MY, 2001, EMERG INFECT DIS, V7, P675; Glass JD, 2002, NEW ENGL J MED, V347, P1280, DOI 10.1056/NEJM200210173471616; Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701; GORDON B, 1990, ARCH NEUROL-CHICAGO, V47, P646, DOI 10.1001/archneur.1990.00530060054017; Han LL, 1999, J INFECT DIS, V179, P230, DOI 10.1086/314566; Hokkanen L, 2000, NEUROPSYCHOL REV, V10, P151, DOI 10.1023/A:1009079531196; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Leis AA, 2002, NEW ENGL J MED, V347, P1279, DOI 10.1056/NEJM2002c021587; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; Martin DA, 2002, CLIN DIAGN LAB IMMUN, V9, P544, DOI 10.1128/CDLI.9.3.544-549.2002; Misra UK, 2002, POSTGRAD MED J, V78, P238, DOI 10.1136/pmj.78.918.238; Misra UK, 1997, J NEUROL, V244, P299, DOI 10.1007/s004150050090; Modlin John F., 1997, P57; MONATH T, 1980, ST LOUIS ENCEPHALITI, P503; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Murgod UA, 2001, NEUROLOGY, V57, P2313, DOI 10.1212/WNL.57.12.2313; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; PETROV V, 2001, MOSCOW VOPROSY VIRUS, V45, P22; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Pradhan S, 1999, NEUROLOGY, V53, P1781, DOI 10.1212/WNL.53.8.1781; Sejvar JJ, 2003, EMERG INFECT DIS, V9, P788, DOI 10.3201/eid0907.030129; Shieh WJ, 2000, EMERG INFECT DIS, V6, P370, DOI 10.3201/eid0604.000407; SHOJI H, 1993, J NEUROL, V240, P59, DOI 10.1007/BF00838449; Solomon T, 2002, CURR TOP MICROBIOL, V267, P171; SOUTHERN PM, 1969, ANN INTERN MED, V71, P681, DOI 10.7326/0003-4819-71-4-681; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; TZENG S, 1989, CHINESE MED J, V43, P208; Wasay M, 2000, ARCH NEUROL-CHICAGO, V57, P114, DOI 10.1001/archneur.57.1.114; Weiss D, 2001, EMERG INFECT DIS, V7, P654, DOI 10.3201/eid0704.010409	35	382	396	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2003	290	4					511	515		10.1001/jama.290.4.511	http://dx.doi.org/10.1001/jama.290.4.511			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703JB	12876094				2022-12-24	WOS:000184275300023
J	Wrenger, E; Muller, R; Moesenthin, M; Welte, T; Frolich, JC; Neumann, KH				Wrenger, E; Muller, R; Moesenthin, M; Welte, T; Frolich, JC; Neumann, KH			Lesson of the week - Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases	BRITISH MEDICAL JOURNAL			English	Review							CONGESTIVE-HEART-FAILURE; LIFE-THREATENING HYPERKALEMIA; CONVERTING ENZYME-INHIBITORS; HYPORENINEMIC HYPOALDOSTERONISM; COMBINED THERAPY; RALES		Univ Magdeburg, Div Nephrol, Dept Internal Med, D-39120 Magdeburg, Germany; Univ Magdeburg, Div Cardiol Pulmonol & Angiol, Dept Internal Med, D-39120 Magdeburg, Germany; Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany	Otto von Guericke University; Otto von Guericke University; Hannover Medical School	Wrenger, E (corresponding author), Univ Magdeburg, Div Nephrol, Dept Internal Med, Leipziger Str 44, D-39120 Magdeburg, Germany.							Bauersachs J, 2000, CIRCULATION, V102, P2325, DOI 10.1161/01.CIR.102.19.2325; Berry C, 2001, Heart, V85, pE8, DOI 10.1136/heart.85.4.e8; Blaustein DA, 2002, AM J CARDIOL, V90, P662, DOI 10.1016/S0002-9149(02)02580-8; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; DEFRONZO RA, 1980, KIDNEY INT, V17, P118, DOI 10.1038/ki.1980.14; Evers S, 1998, J NEUROL NEUROSUR PS, V64, P249, DOI 10.1136/jnnp.64.2.249; Georges B, 2000, LANCET, V355, P1369, DOI 10.1016/S0140-6736(05)72606-4; Greenberg A, 2000, AM J MED SCI, V319, P10, DOI 10.1097/00000441-200001000-00002; Hu YW, 2002, ANESTH ANALG, V95, P39, DOI 10.1097/00000539-200207000-00006; JACKSON EK, 1996, GOODMAN GILMANS PHAR, P733; JOHNSTON RT, 1992, INT J CARDIOL, V34, P213, DOI 10.1016/0167-5273(92)90159-Z; LARGE DM, 1984, POSTGRAD MED J, V60, P370, DOI 10.1136/pgmj.60.703.370; Millane T, 2000, BRIT MED J, V320, P559, DOI 10.1136/bmj.320.7234.559; Obialo CI, 2002, AM J CARDIOL, V90, P663, DOI 10.1016/S0002-9149(02)02581-X; Pitt B, 1996, AM J CARDIOL, V78, P902; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Schepkens H, 2001, AM J MED, V110, P438, DOI 10.1016/S0002-9343(01)00642-8; Vanpee D, 2000, AGING-CLIN EXP RES, V12, P315, DOI 10.1007/BF03339853	18	82	87	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2003	327	7407					147	149		10.1136/bmj.327.7407.147	http://dx.doi.org/10.1136/bmj.327.7407.147			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869459	Green Published			2022-12-24	WOS:000184247500022
J	Park, S; Wolanin, PM; Yuzbashyan, EA; Silberzan, P; Stock, JB; Austin, RH				Park, S; Wolanin, PM; Yuzbashyan, EA; Silberzan, P; Stock, JB; Austin, RH			Motion to form a quorum	SCIENCE			English	Article							BACTERIAL CHEMOTAXIS; ESCHERICHIA-COLI		Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Inst Curie, F-75005 Paris, France	Princeton University; Princeton University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Stock, JB (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.		Silberzan, Pascal/L-5934-2016; Park, Sungsu/L-1920-2013; Park, Sungsu/AAF-4792-2020	Silberzan, Pascal/0000-0002-8554-882X; Park, Sungsu/0000-0003-3062-1302	NHGRI NIH HHS [R01 HG001506] Funding Source: Medline; NIGMS NIH HHS [F32 GM064228] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM064228] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER J, 1975, ANNU REV BIOCHEM, V44, P341, DOI 10.1146/annurev.bi.44.070175.002013; Brenner MP, 1998, BIOPHYS J, V74, P1677, DOI 10.1016/S0006-3495(98)77880-4; BUDRENE EO, 1995, NATURE, V376, P49, DOI 10.1038/376049a0; CLARKE S, 1979, J BIOL CHEM, V254, P9695; McClaine JW, 2002, BIOTECHNOL BIOENG, V78, P179, DOI 10.1002/bit.10192; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Swift S, 2001, ADV MICROB PHYSIOL, V45, P199, DOI 10.1016/S0065-2911(01)45005-3	8	115	115	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2003	301	5630					188	188		10.1126/science.1079805	http://dx.doi.org/10.1126/science.1079805			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855801				2022-12-24	WOS:000184056200034
J	Keeling, P; Hughes, D; Price, L; Shaw, S; Barton, A				Keeling, P; Hughes, D; Price, L; Shaw, S; Barton, A			Safety and feasibility of prehospital thrombolysis carried out by paramedics	BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION		S Devon Healthcare Trust, Torquay TQ2 7AA, England; Peninsula Med Sch, Res & Dev Support Unit, Plymouth PL6 8BX, Devon, England; Univ Plymouth, Dept Math & Stat, Plymouth PL4 8AA, Devon, England	University of Plymouth; University of Plymouth	Keeling, P (corresponding author), S Devon Healthcare Trust, Lawes Bridge, Torquay TQ2 7AA, England.			barton, andy/0000-0003-2245-1446				Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; *DEP HLTH, 2001, NAT SERV FRAM COR HE; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; *NAT I CLIN EXC, 2002, GUID US DRUGS EARL T; *ROYAL COLL AMB LI, 2001, TECHN APPR PROC SER, V4	5	27	29	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2003	327	7405					27	28		10.1136/bmj.327.7405.27	http://dx.doi.org/10.1136/bmj.327.7405.27			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699NK	12842952	Bronze, Green Published			2022-12-24	WOS:000184062700022
J	Bouvier, F; Dogbo, O; Camara, B				Bouvier, F; Dogbo, O; Camara, B			Biosynthesis of the food and cosmetic plant pigment bixin (annatto)	SCIENCE			English	Article							CAROTENOIDS; DIOXYGENASE; CLEAVAGE; FLOWERS; COLORS; SEEDS	Bixin, also known as annatto, is a seed-specific pigment widely used in foods and cosmetics since pre-Columbian times. We show that three genes from Bixa orellana, native to tropical America, govern bixin biosynthesis. These genes code for lycopene cleavage dioxygenase, bixin aldehyde dehydrogenase, and norbixin carboxyl methyltransferase, which catalyze the sequential conversion of lycopene into bixin. Introduction of these three genes in Escherichia coli engineered to produce lycopene induced bixin synthesis, thus expanding the supply of this economically important plant product.	Univ Strasbourg, CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; Univ Abobo Adjarne 02, UFR SN, Abidjan 02, Cote Ivoire	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Camara, B (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France.	Bilal.camara@ibmp-ulp.u-strasbg.fr						Bouvier F, 2003, PLANT CELL, V15, P47, DOI 10.1105/tpc.006536; Britton G, 1998, CAROTENOIDS BIOSYNTH, P13; COLLINS P, 1992, FOODS INGRED PROCESS, V13, P23; Dudareva N, 2000, PLANT CELL, V12, P949, DOI 10.1105/tpc.12.6.949; LAURO GJ, 1991, CEREAL FOOD WORLD, V36, P949; Mercadante AZ, 1997, J AGR FOOD CHEM, V45, P1050, DOI 10.1021/jf960412k; Mercadante AZ, 1997, PHYTOCHEMISTRY, V46, P1379, DOI 10.1016/S0031-9422(97)00462-7; MISAWA N, 1995, J BACTERIOL, V177, P6575, DOI 10.1128/jb.177.22.6575-6584.1995; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; Ross JR, 1999, ARCH BIOCHEM BIOPHYS, V367, P9, DOI 10.1006/abbi.1999.1255; Schwartz SH, 2001, J BIOL CHEM, V276, P25208, DOI 10.1074/jbc.M102146200; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; SKIBBE DS, 2002, PLANT MOL BIOL, V88, P751; TIMBERLAKE CF, 1986, ENDEAVOUR, V10, P31, DOI 10.1016/0160-9327(86)90048-7; Watillon B, 1998, PLANT MOL BIOL, V36, P909, DOI 10.1023/A:1005914506110; Zechmeister L, 1962, CIS T ISOMERIC CAROT	16	175	188	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2003	300	5628					2089	2091		10.1126/science.1085162	http://dx.doi.org/10.1126/science.1085162			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12829782				2022-12-24	WOS:000183774900045
J	Newman, JRS; Keating, AE				Newman, JRS; Keating, AE			Comprehensive identification of human bZIP interactions with coiled-coil arrays	SCIENCE			English	Article							DNA-BINDING; TRANSCRIPTION FACTORS; SPECIFICITY; PROTEINS; FOS; JUN; COMPLEXES; PROTEOME; DOMAINS; FAMILY	In eukaryotes, the combinatorial association of sequence-specific DNA binding proteins is essential for transcription. We have used protein arrays to test 49(2) pairings of a nearly complete set of coiled-coil strands from human basic-region leucine zipper ( bZIP) transcription factors. We find considerable partnering selectivity despite the bZIPs' homologous sequences. The interaction data are of high quality, as assessed by their reproducibility, reciprocity, and agreement with previous observations. Biophysical studies in solution support the relative binding strengths observed with the arrays. New associations provide insights into the circadian clock and the unfolded protein response.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Keating, AE (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	keating@mit.edu		Keating, Amy/0000-0003-4074-8980				BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GREENBURY CL, 1965, IMMUNOLOGY, V8, P420; HAAS NB, 1995, MOL CELL BIOL, V15, P1923; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HURST HC, 1995, PROTEIN PROFILE, V2, P105; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kohler JJ, 1999, P NATL ACAD SCI USA, V96, P11735, DOI 10.1073/pnas.96.21.11735; Kohler JJ, 2001, BIOCHEMISTRY-US, V40, P130, DOI 10.1021/bi001881p; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; MacBeath G, 2000, SCIENCE, V289, P1760; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Moll JR, 2000, J BIOL CHEM, V275, P34826, DOI 10.1074/jbc.M004545200; Newman JRS, 2000, P NATL ACAD SCI USA, V97, P13203, DOI 10.1073/pnas.97.24.13203; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; PTASHNE M, 1987, GENETIC SWITCH GENE; SINGH M, 2001, P 5 ANN INT C COMP M, P279; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; VINSON CR, 1993, GENE DEV, V7, P1047, DOI 10.1101/gad.7.6.1047; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wolberger C, 1999, ANNU REV BIOPH BIOM, V28, P29, DOI 10.1146/annurev.biophys.28.1.29; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	33	370	386	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2003	300	5628					2097	2101		10.1126/science.1084648	http://dx.doi.org/10.1126/science.1084648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12805554				2022-12-24	WOS:000183774900048
J	Jiang, H; Stein, BE; McHaffie, JG				Jiang, H; Stein, BE; McHaffie, JG			Opposing basal ganglia processes shape midbrain visuomotor activity bilaterally	NATURE			English	Article							NIGRA PARS RETICULATA; SUPERIOR COLLICULUS; SUBSTANTIA-NIGRA; HORSERADISH-PEROXIDASE; TECTOSPINAL NEURONS; NIGROTECTAL PATHWAY; SUBTHALAMIC NUCLEUS; STRIATAL FUNCTIONS; BASIC PROCESS; CAT	The manner in which the nervous system allocates limited motor resources when confronted with conflicting behavioural demands is a crucial issue in understanding how sensory information is transformed into adaptive motor responses. Understanding this selection process is of particular concern in current models of functions of the basal ganglia(1). Here we report that the basal ganglia use simultaneous enhancing and suppressing processes synergistically to modulate sensory activity in the superior colliculi, which are bilaterally paired midbrain structures involved in the control of visual orientation behaviours(2). These complementary processes presumably ensure accurate gaze shifts mediated by the superior colliculi despite the presence of potential distractors.	Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center	McHaffie, JG (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.							ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; BECKSTEAD RM, 1981, J NEUROSCI, V1, P121; BEHAN M, 1985, J COMP NEUROL, V234, P105, DOI 10.1002/cne.902340108; CHEVALIER G, 1985, BRAIN RES, V334, P215, DOI 10.1016/0006-8993(85)90213-6; CHEVALIER G, 1984, EXP BRAIN RES, V53, P320; CHEVALIER G, 1981, NEUROSCI LETT, V21, P67, DOI 10.1016/0304-3940(81)90059-8; CHEVALIER G, 1990, TRENDS NEUROSCI, V13, P277, DOI 10.1016/0166-2236(90)90109-N; Handel A, 2000, J NEUROPHYSIOL, V83, P3042, DOI 10.1152/jn.2000.83.5.3042; HARTING JK, 1988, J COMP NEUROL, V278, P615, DOI 10.1002/cne.902780412; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1285, DOI 10.1152/jn.1983.49.5.1285; INFANTE C, 1986, BRAIN RES, V381, P390, DOI 10.1016/0006-8993(86)90096-X; JOSEPH JP, 1985, EXP BRAIN RES, V57, P286; Kalesnykas R. P., 1999, Society for Neuroscience Abstracts, V25, P1920; KARABELAS AB, 1985, J COMP NEUROL, V239, P309, DOI 10.1002/cne.902390305; Karnath HO, 2001, NAT REV NEUROSCI, V2, P568, DOI 10.1038/35086057; Kha HT, 2001, J COMP NEUROL, V440, P20, DOI 10.1002/cne.1367; KITA H, 1987, J COMP NEUROL, V260, P435, DOI 10.1002/cne.902600309; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; MAY PJ, 1984, J COMP NEUROL, V226, P357, DOI 10.1002/cne.902260306; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; MIZE RR, 1992, J COMP NEUROL, V320, P243, DOI 10.1002/cne.903200208; MUNOZ DP, 1985, BRAIN RES, V341, P184, DOI 10.1016/0006-8993(85)91487-8; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; RYAN LJ, 1991, EXP BRAIN RES, V86, P641; Sato M, 2002, J NEUROSCI, V22, P2363, DOI 10.1523/JNEUROSCI.22-06-02363.2002; SPRAGUE JM, 1966, SCIENCE, V153, P1544, DOI 10.1126/science.153.3743.1544; Stein BE., 1993, MERGING SENSES; WALLACE SF, 1990, J COMP NEUROL, V296, P222, DOI 10.1002/cne.902960204; WALLACE SF, 1989, J COMP NEUROL, V284, P429, DOI 10.1002/cne.902840309; Wang S, 1997, NEUROSCIENCE, V81, P967, DOI 10.1016/S0306-4522(97)00191-7	30	95	95	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					982	986		10.1038/nature01698	http://dx.doi.org/10.1038/nature01698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827201				2022-12-24	WOS:000183753900049
J	Sisk, JE; Whang, W; Butler, JC; Sneller, VP; Whitney, CG				Sisk, JE; Whang, W; Butler, JC; Sneller, VP; Whitney, CG			Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: Role of comorbid conditions and race	ANNALS OF INTERNAL MEDICINE			English	Article							REVACCINATION; MORTALITY; HEALTH	Background: Guidelines are increasingly recommending preventive services starting at 50 years of age, and policymakers are considering such a recommendation for pneumococcal polysaccharide vaccination. The finding that pneumococcal vaccination is cost-saving for people 65 years of age or older raises the question of the vaccination's implications for other older adults, especially black people, whose disease incidence exceeds that of nonblack people, and those with high-risk conditions. Objective: To assess the implications of vaccinating black and nonblack people 50 through 64 years of age against invasive pneumococcal disease. Design: Cost-effectiveness analysis. Data Sources: Published literature for vaccination effectiveness and cost estimates; data on disease incidence and case-fatality rates from the Centers for Disease Control and Prevention. Target Population: Hypothetical cohort 50 through 64 years of age with the 1995 U.S. age distribution. Time Horizon: Lifetime. Perspective: Societal. Intervention: Pneumococcal polysaccharide vaccination compared with no vaccination. Outcome Measures: Incremental medical costs and health effects, in quality-adjusted life-years per vaccinee. Results of Base-Case Analysis: vaccination saved medical costs and improved health among high-risk black people ($27.55 savings per vaccinee) and nonblack people ($5.92 savings per vaccinee), excluding survivors' future costs. For low-risk black and nonblack people and the overall general population, vaccination cost $2477, $8195, and $3434, respectively, to gain 1 year of healthy life. Results of Sensitivity Analysis: Excluding survivors' future costs, in the general immunocompetent population, cost per quality-adjusted life-year in global worst-case results ranged from $21 513 for black people to $68 871 for nonblack people; in the high-risk population, cost ranged from $11 548 for black people to $39 000 for nonblack people. In the global best case, vaccination was cost-saving for black and nonblack people in the general immunocompetent and high-risk populations, excluding survivors' future costs. The cost-effectiveness range was narrower in probabilistic sensitivity analyses, with 95% probabilistic intervals ranging from cost-saving to $1594 for black people and from cost-saving to $12 273 for nonblack people in the general immunocompetent population. Costs per quality-adjusted life-year for low-risk people with case-fatality rates from 1998 were $2477 for black people and $8195 for nonblack people, excluding survivors' medical costs. Conclusions: These results support the current recommendation to vaccinate high-risk people and provide useful information for considering extending the recommendation to the general population 50 through 64 years of age. Lack of evidence about the effectiveness of revaccination for people 65 years of age or older, when disease risks are higher, argues for further research to guide vaccination policy.	CUNY Mt Sinai Sch Med, Dept Hlth Policy, New York, NY 10029 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Ctr Dis Control & Prevent, Anchorage, AK USA; Ctr Dis Control & Prevent, Atlanta, GA USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Columbia University; Harvard University; Massachusetts General Hospital; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Sisk, JE (corresponding author), CUNY Mt Sinai Sch Med, Dept Hlth Policy, Room 2-34,1425 Madison Ave, New York, NY 10029 USA.	jane.sisk@mssm.edu	Whang, William/AAE-3853-2019					*AG HLTH CAR POL R, 1997, DAT 1987 NMES HOUS S; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; BORGONO JM, 1978, P SOC EXP BIOL MED, V157, P148, DOI 10.3181/00379727-157-40010; Breiman RF, 2000, ARCH INTERN MED, V160, P2633, DOI 10.1001/archinte.160.17.2633; *CDCP, 2001, HLTH PEOPL 2010, V1, P14; CHIANG CL, 1991, ANNU REV PUBL HEALTH, V12, P281, DOI 10.1146/annurev.pu.12.050191.001433; ERICKSON P, 1995, HLTH PEOPLE 2000; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Gold MR, 1996, COST EFFECTIVENESS H; Jackson L, 1999, JAMA-J AM MED ASSOC, V281, P243, DOI 10.1001/jama.281.3.243; LASCHOBER MA, 1997, HLTH HLTH CARE MEDIC; LAUPACIS A, 1993, CAN MED ASSOC J, V148, P927; LAVE JR, 1994, MED CARE, V32, pJS77; MUFSON MA, 1991, VACCINE, V9, P403, DOI 10.1016/0264-410X(91)90126-Q; Nichol KL, 1997, AM J INFECT CONTROL, V25, P223, DOI 10.1016/S0196-6553(97)90008-0; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Singleton J A, 2000, MMWR CDC Surveill Summ, V49, P39; Sisk JE, 1997, JAMA-J AM MED ASSOC, V278, P1333, DOI 10.1001/jama.278.16.1333; Sonnenberg A, 2000, ANN INTERN MED, V133, P573, DOI 10.7326/0003-4819-133-8-200010170-00007; TORRANCE GT, 1995, 7 CDCP NAT CTR HLTH; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; WAGNER JL, 1996, PREVENTION EARLY DET; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304; WINTER WP, 1986, HEMOGLOBIN VARIANTS; 2001, MMWR MORB MORTAL WKL, V50, P532; 1997, MMWR MORB MORTAL WKL, V46, P913	30	103	105	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2003	138	12					960	968		10.7326/0003-4819-138-12-200306170-00007	http://dx.doi.org/10.7326/0003-4819-138-12-200306170-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	690YM	12809452				2022-12-24	WOS:000183578100003
J	Dindo, D; Muller, MK; Weber, M; Clavien, PA				Dindo, D; Muller, MK; Weber, M; Clavien, PA			Obesity in general elective surgery	LANCET			English	Article							BODY-MASS INDEX; QUALITY-OF-LIFE; CARDIAC-SURGERY; MORBID-OBESITY; RISK-FACTORS; MORTALITY; OUTCOMES; CHOLECYSTECTOMY; COMPLICATIONS; OPERATIONS	Background Obese patients are generally believed to be at a higher risk for surgery than those who are not obese, although convincing data are lacking. Methods We prospectively investigated a cohort of 6336 patients undergoing general elective surgery at our institution to assess whether obesity affects the outcome of surgery. Exclusion criteria were emergency, vascular, thoracic, and bariatric operations; transplantation procedures; patients under immunosuppression; and operations done under local anaesthesia. Postoperative morbidity was analysed for nonobese and obese patients (body-mass index <30 kg/m(2) vs &GE;30 kg/m(2)). Obesity was further stratified into mild obesity (30.0-34.9 kg/m(2)) and severe obesity (&GE;35 kg/m(2)). Risk factors were analysed with univariate and multivariate models. Findings The cohort consisted of 6336 patients, of whom 808 (13%) were obese, 569 (9%) were mildly obese, and 239 (4%) had severe obesity. The morbidity rates in patients who were obese compared with those who were not were much the same (122 [15.1%] of 808 vs 901 [16.3%] of 5528; p=0.26), with the exception of an increased incidence of wound infections after open surgery in patients who were obese (17 [4%] of 431 vs 92 [3%] of 3555, p=0.03). Incidence of complications did not differ between patients who were mildly obese (91 [16.0%] of 569), severely obese (36 [15.1%] of 239), and non-obese (901 [16.3%] of 5528; p=0.19). In multivariate regression analyses, obesity was not a risk factor for development of postoperative complications. Of note, the additional medical resource use as estimated by a new classification of complications showed no differences between patients who were and were not obese. Interpretation Obesity alone is not a risk factor for postoperative complications. The regressive attitude towards general surgery in obese patients is no longer justified.	Univ Zurich Hosp, Dept Visceral Surg & Transplantat, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Clavien, PA (corresponding author), Univ Zurich Hosp, Dept Visceral Surg & Transplantat, Ramistr 100, CH-8091 Zurich, Switzerland.							Allison DB, 1999, OBES RES, V7, P342, DOI 10.1002/j.1550-8528.1999.tb00417.x; Benoist S, 2000, AM J SURG, V179, P275, DOI 10.1016/S0002-9610(00)00337-8; Berkalp B, 1995, INT J CARDIOL, V52, P23, DOI 10.1016/0167-5273(95)02431-U; Brandt M, 2001, EUR J CARDIO-THORAC, V19, P662, DOI 10.1016/S1010-7940(01)00647-9; CHAPMAN GW, 1988, J NATL MED ASSOC, V80, P417; CLAVIEN PA, 1992, SURGERY, V111, P518; DeMaria J, 2002, ANN SURG, V235, P640, DOI 10.1097/00000658-200205000-00005; Engelman DT, 1999, J THORAC CARDIOV SUR, V118, P866, DOI 10.1016/S0022-5223(99)70056-5; Fazeli-Matin S, 1999, J UROLOGY, V162, P665, DOI 10.1097/00005392-199909010-00005; Flordal PA, 1996, EUR J SURG, V162, P783; Klotz HP, 1996, BRIT J SURG, V83, P1788, DOI 10.1002/bjs.1800831240; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Livingston EH, 2002, OBES RES, V10, P824, DOI 10.1038/oby.2002.111; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Moulton MJ, 1996, CIRCULATION, V94, P87; Nair S, 2002, HEPATOLOGY, V35, P105, DOI 10.1053/jhep.2002.30318; Nguyen NT, 2001, ANN SURG, V234, P279, DOI 10.1097/00000658-200109000-00002; PASULKA PS, 1986, ANN INTERN MED, V104, P540, DOI 10.7326/0003-4819-104-4-540; PEMBERTON LB, 1971, AM J SURG, V121, P87, DOI 10.1016/0002-9610(71)90081-X; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; POSTLETH.RW, 1972, ARCH SURG-CHICAGO, V105, P438; Schauer PR, 2001, SURG CLIN N AM, V81, P1145, DOI 10.1016/S0039-6109(05)70189-4; Schutz Y, 2002, INT J OBESITY, V26, pS3, DOI 10.1038/sj.ijo.0802122; SHAPIRO M, 1982, NEW ENGL J MED, V307, P1661, DOI 10.1056/NEJM198212303072701; Spicer DDM, 2001, INT ORTHOP, V25, P286, DOI 10.1007/s002640100265; TANAKA S, 1993, INT J OBESITY, V17, P631; WELCH CE, 1986, ANN SURG, V204, P454, DOI 10.1097/00000658-198610000-00014; Westling A, 2002, WORLD J SURG, V26, P470, DOI 10.1007/s00268-001-0251-9; World Health Organization, 1997, OB PREV MAN GLOB EP	30	453	467	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 14	2003	361	9374					2032	2035		10.1016/S0140-6736(03)13640-9	http://dx.doi.org/10.1016/S0140-6736(03)13640-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814714				2022-12-24	WOS:000183488900010
J	Benton, MJ; Ayala, FJ				Benton, MJ; Ayala, FJ			Dating the tree of life	SCIENCE			English	Editorial Material							DIVERGENCE TIMES; MOLECULAR EVIDENCE; FOSSIL RECORD; ORIGIN; BIRDS; PHYLOGENY; SEQUENCES; SYSTEMATICS; EVOLUTION; PATTERNS	The relative merits of molecular and paleontological dates of major branching points in the tree of life are currently debated. In some cases, molecular date estimates are up to twice as old as paleontological dates. However, although it is true that paleontological dates are often too young (missing fossils), molecular dates are often too old (statistical bias). Intense study of the dating of major splits in the tree of mammals has shown rapprochement as fossil dates become older and molecular dates become younger.	Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA	University of Bristol; University of California System; University of California Irvine	Benton, MJ (corresponding author), Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England.	Mike.Benton@bris.ac.uk	Benton, Michael J/A-5639-2008	Benton, Michael J/0000-0002-4323-1824				Adoutte A, 1998, MOL PHYLOGENET EVOL, V9, P331, DOI 10.1006/mpev.1998.0547; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Arnason U, 1996, J MOL EVOL, V43, P650, DOI 10.1007/BF02202113; AYALA FJ, 1995, SCIENCE, V270, P1930, DOI 10.1126/science.270.5244.1930; Ayala FJ, 1998, P NATL ACAD SCI USA, V95, P606, DOI 10.1073/pnas.95.2.606; Benton Michael J., 1996, Historical Biology, V12, P111; Benton MJ, 1998, MOL PHYLOGENET EVOL, V9, P398, DOI 10.1006/mpev.1998.0492; Benton MJ, 2000, NATURE, V403, P534, DOI 10.1038/35000558; BENTON MJ, 1990, J MOL EVOL, V30, P409, DOI 10.1007/BF02101113; BENTON MJ, TELLING EVOLUTIONARY; Bromham L, 1998, P NATL ACAD SCI USA, V95, P12386, DOI 10.1073/pnas.95.21.12386; Bromham LD, 2000, P ROY SOC B-BIOL SCI, V267, P1041, DOI 10.1098/rspb.2000.1108; Cooper A, 1998, TRENDS ECOL EVOL, V13, P151, DOI 10.1016/S0169-5347(97)01277-9; Cooper A, 1997, SCIENCE, V275, P1109, DOI 10.1126/science.275.5303.1109; DARWIN C, 1959, ORIGN SPECIES MEANS; DONOGHUE PJ, IN PRESS TELLING EVO; Dyke GJ, 2001, GEOL J, V36, P305; Easteal S, 1999, BIOESSAYS, V21, P1052, DOI 10.1002/(SICI)1521-1878(199912)22:1<1052::AID-BIES9>3.0.CO;2-6; Easteal S., 1995, MAMMALIAN MOL CLOCK; Eizirik E, 2001, J HERED, V92, P212, DOI 10.1093/jhered/92.2.212; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; GRAUR D, 1993, TRENDS ECOL EVOL, V8, P141, DOI 10.1016/0169-5347(93)90027-M; GRAYBEAL A, 1994, SYST BIOL, V43, P174, DOI 10.2307/2413460; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Hudson RR, 2002, EVOLUTION, V56, P1557, DOI 10.1554/0014-3820(2002)056[1557:MCOTGS]2.0.CO;2; Janke A, 1997, P NATL ACAD SCI USA, V94, P1276, DOI 10.1073/pnas.94.4.1276; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Kenrick P, 1999, NATURE, V402, P358, DOI 10.1038/46437; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lee MSY, 1999, J MOL EVOL, V49, P385, DOI 10.1007/PL00006562; Lynch M, 1999, EVOLUTION, V53, P319, DOI [10.2307/2640769, 10.1111/j.1558-5646.1999.tb03768.x]; Naylor GJP, 1998, SYST BIOL, V47, P61, DOI 10.1080/106351598261030; Nei M, 2001, P NATL ACAD SCI USA, V98, P2497, DOI 10.1073/pnas.051611498; Nikoh N, 1997, J MOL EVOL, V45, P97, DOI 10.1007/PL00006208; NORELL MA, 1992, SCIENCE, V255, P1690, DOI 10.1126/science.255.5052.1690; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Patterson C., 1987, MOL MORPHOLOGY EVOLU; Peters SE, 2002, NATURE, V416, P420, DOI 10.1038/416420a; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; RAUP DM, 1972, SCIENCE, V177, P1065, DOI 10.1126/science.177.4054.1065; Rodriguez-Trelles F, 2002, P NATL ACAD SCI USA, V99, P8112, DOI 10.1073/pnas.122231299; RODRIGUEZTRELLE.F, IN PRESS TELLING EVO; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2001, AM J BOT, V88, P1499, DOI 10.2307/3558458; Schutze J, 1999, P ROY SOC B-BIOL SCI, V266, P63, DOI 10.1098/rspb.1999.0605; Smith AB, 2002, ANNU REV EARTH PL SC, V30, P65, DOI 10.1146/annurev.earth.30.091201.140057; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; Soltis PS, 2002, P NATL ACAD SCI USA, V99, P4430, DOI 10.1073/pnas.032087199; van Tuinen M, 2001, MOL BIOL EVOL, V18, P206, DOI 10.1093/oxfordjournals.molbev.a003794; Waddell PJ, 1999, SYST BIOL, V48, P119; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568; Xun G, 1998, J MOL EVOL, V47, P369, DOI 10.1007/PL00013150; [No title captured]	57	192	204	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1698	1700		10.1126/science.1077795	http://dx.doi.org/10.1126/science.1077795			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805535				2022-12-24	WOS:000183459700036
J	Daniel, RA; Errington, J				Daniel, RA; Errington, J			Control of cell morphogenesis in bacteria: Two distinct ways to make a rod-shaped cell	CELL			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; PEPTIDOGLYCAN SYNTHESIS; MUREIN SACCULUS; STRESS-BEARING; DIVISION SITE; WALL MATERIAL; GROWTH; PROTEIN; CYTOSKELETON	Cell shape in most eubacteria is maintained by a tough external peptidoglycan cell wall. Recently, cell shape determining proteins of the MreB family were shown to form helical, actin-like cables in the cell. We used a fluorescent derivative of the antibiotic vancomycin as a probe for nascent peptidoglycan synthesis in unfixed cells of various Gram-positive bacteria. In the rod-shaped bacterium B. subtilis, synthesis of the cylindrical part of the cell wall occurs in a helical pattern governed by an MreB homolog, Mbl. However, a few rod-shaped bacteria have no MreB system. Here, a rod-like shape can be achieved by a completely different mechanism based on use of polar growth zones derived from the division machinery. These results provide insights into the diverse molecular strategies used by bacteria to control their cellular morphology, as well as suggesting ways in which these strategies may impact on growth rates and cell envelope structure.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Errington, J (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.		Errington, Jeff/G-1832-2011	Errington, Jeff/0000-0002-6977-9388; Daniel, Richard/0000-0002-6483-5897				ABHAYAWARDHANE Y, 1995, J BACTERIOL, V177, P765, DOI 10.1128/jb.177.3.765-773.1995; Archibald A. R., 1993, P381; BURMAN LG, 1983, J BACTERIOL, V155, P983, DOI 10.1128/JB.155.3.983-988.1983; Carballido-Lopez R, 2003, DEV CELL, V4, P19, DOI 10.1016/S1534-5807(02)00403-3; Chatterjee D, 1997, CURR OPIN CHEM BIOL, V1, P579, DOI 10.1016/S1367-5931(97)80055-5; CLARKESTURMAN AJ, 1989, J GEN MICROBIOL, V135, P657; Daniel RA, 2000, MOL MICROBIOL, V35, P299, DOI 10.1046/j.1365-2958.2000.01724.x; DANIEL RA, 1993, J GEN MICROBIOL, V139, P361, DOI 10.1099/00221287-139-2-361; DePedro MA, 1997, J BACTERIOL, V179, P2823, DOI 10.1128/jb.179.9.2823-2834.1997; DOYLE RJ, 1988, MICROBIOL REV, V52, P554, DOI 10.1128/MMBR.52.4.554-567.1988; Errington J, 2003, NAT CELL BIOL, V5, P175, DOI 10.1038/ncb0303-175; Ge M, 1999, SCIENCE, V284, P507, DOI 10.1126/science.284.5413.507; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; GRAY DI, 1990, J GEN MICROBIOL, V136, P1077, DOI 10.1099/00221287-136-6-1077; Harry EJ, 1997, MOL MICROBIOL, V25, P275, DOI 10.1046/j.1365-2958.1997.4581822.x; HENRIQUES AO, 1992, BIOCHIMIE, V74, P735, DOI 10.1016/0300-9084(92)90146-6; Hoch J.A., 2001, BACILLUS SUBTILIS IT, P21, DOI 10.1128/9781555817992.ch4; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; KOCH AL, 1988, MICROBIOL REV, V52, P337, DOI 10.1128/MMBR.52.3.337-353.1988; KOCH AL, 1990, ARCH MICROBIOL, V153, P569, DOI 10.1007/BF00245266; Koch AL, 2000, APPL ENVIRON MICROB, V66, P3657, DOI 10.1128/AEM.66.9.3657-3663.2000; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; MENDELSON NH, 1976, P NATL ACAD SCI USA, V73, P1740, DOI 10.1073/pnas.73.5.1740; MERAD T, 1989, J GEN MICROBIOL, V135, P645; MICHAUD C, 1990, EUR J BIOCHEM, V194, P853, DOI 10.1111/j.1432-1033.1990.tb19479.x; MOBLEY HLT, 1984, J BACTERIOL, V158, P169, DOI 10.1128/JB.158.1.169-179.1984; PARTRIDGE SR, 1993, MOL MICROBIOL, V8, P945, DOI 10.1111/j.1365-2958.1993.tb01639.x; POOLEY HM, 1976, J BACTERIOL, V125, P1127, DOI 10.1128/JB.125.3.1127-1138.1976; POOLEY HM, 1976, J BACTERIOL, V125, P1139, DOI 10.1128/JB.125.3.1139-1147.1976; Prescott L.M., 1999, MICROBIOLOGY; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; SCHLAEPPI JM, 1982, J BACTERIOL, V149, P329, DOI 10.1128/JB.149.1.329-337.1982; Shapiro L, 2000, CELL, V100, P89, DOI 10.1016/S0092-8674(00)81686-4; Sharpe ME, 1998, J BACTERIOL, V180, P547, DOI 10.1128/JB.180.3.547-555.1998; SHELDRICK GM, 1978, NATURE, V271, P223, DOI 10.1038/271223a0; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; Trachtenberg S, 1998, J STRUCT BIOL, V124, P244, DOI 10.1006/jsbi.1998.4063; UMEDA A, 1983, MICROBIOL IMMUNOL, V27, P663, DOI 10.1111/j.1348-0421.1983.tb00629.x; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; VUORIO R, 1992, J BACTERIOL, V174, P7090, DOI 10.1128/jb.174.22.7090-7097.1992; WIENTJES FB, 1989, J BACTERIOL, V171, P3412, DOI 10.1128/jb.171.6.3412-3419.1989; WOLDRINGH CL, 1987, J GEN MICROBIOL, V133, P575	43	579	595	2	68	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 13	2003	113	6					767	776		10.1016/S0092-8674(03)00421-5	http://dx.doi.org/10.1016/S0092-8674(03)00421-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809607	Bronze			2022-12-24	WOS:000183514400011
J	Sharma, J; Dragoi, V; Tenenbaum, JB; Miller, EK; Sur, M				Sharma, J; Dragoi, V; Tenenbaum, JB; Miller, EK; Sur, M			V1 neurons signal acquisition of an internal representation of stimulus location	SCIENCE			English	Article							PRIMARY VISUAL-CORTEX; NEURAL BASIS; PARIETAL CORTEX; EYE-MOVEMENTS; ATTENTION; MONKEY; SACCADES; RESPONSES; DECISION; POSITION	A fundamental aspect of visuomotor behavior is deciding where to look or move next. Under certain conditions, the brain constructs an internal representation of stimulus location on the basis of previous knowledge and uses it to move the eyes or to make other movements. Neuronal responses in primary visual cortex were modulated when such an internal representation was acquired: Responses to a stimulus were affected progressively by sequential presentation of the stimulus at one location but not when the location was varied randomly. Responses of individual neurons were spatially tuned for gaze direction and tracked the Bayesian probability of stimulus appearance. We propose that the representation arises in a distributed cortical network and is associated with systematic changes in response selectivity and dynamics at the earliest stages of cortical visual processing.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, RIKEN MIT Neurosci Ctr, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); RIKEN	Sharma, J (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	jeetu@mit.edu; msur@ai.mit.edu	Miller, Earl K./AAE-8187-2019	Miller, Earl K./0000-0002-0582-6958				ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDERSEN RA, 1997, ANNU REV NEUROSCI, V12, P377; Ben Hamed S, 2002, EXP BRAIN RES, V142, P512, DOI 10.1007/s00221-001-0954-z; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; COLBY CL, 1995, CEREB CORTEX, V5, P470, DOI 10.1093/cercor/5.5.470; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; EDWARDS Anthony William Fairbank, 1972, LIKELIHOOD; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gaymard B, 1998, EXP BRAIN RES, V123, P159, DOI 10.1007/s002210050557; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Glimcher PW, 2001, TRENDS NEUROSCI, V24, P654, DOI 10.1016/S0166-2236(00)01932-9; Goldberg ME, 2002, ANN NY ACAD SCI, V956, P205, DOI 10.1111/j.1749-6632.2002.tb02820.x; Kowler E, 1990, Rev Oculomot Res, V4, P1; Krauzlis RJ, 1999, TRENDS NEUROSCI, V22, P544, DOI 10.1016/S0166-2236(99)01464-2; LAL R, 1989, SCIENCE, V243, P93, DOI 10.1126/science.2911723; LUCE RD, 1986, RESPONSE TIMES THEIR, P253; Lyon DC, 2002, NEURON, V33, P453, DOI 10.1016/S0896-6273(02)00580-9; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Schiller PH, 2001, PROG BRAIN RES, V134, P127; Schlag J, 1998, J NEUROPHYSIOL, V79, P64, DOI 10.1152/jn.1998.79.1.64; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Tootell RBH, 2000, NAT NEUROSCI, V3, P206, DOI 10.1038/72904; TOYAMA K, 1984, J NEUROPHYSIOL, V51, P649, DOI 10.1152/jn.1984.51.4.649; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; WEYAND TG, 1993, J NEUROPHYSIOL, V69, P2258, DOI 10.1152/jn.1993.69.6.2258	35	42	44	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1758	1763		10.1126/science.1081721	http://dx.doi.org/10.1126/science.1081721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805552	Green Submitted			2022-12-24	WOS:000183459700055
J	Tamimi, RM; Lagiou, P; Mucci, LA; Hsieh, CC; Adami, HO; Trichopoulos, D				Tamimi, RM; Lagiou, P; Mucci, LA; Hsieh, CC; Adami, HO; Trichopoulos, D			Average energy intake among pregnant women carrying a boy compared with a girl	BRITISH MEDICAL JOURNAL			English	Article							FOOD FREQUENCY QUESTIONNAIRE		Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-11527 Athens, Greece; Univ Massachusetts, Ctr Canc, Worcester, MA 01655 USA; Karolinska Inst, Dept Med Epidemiol, SE-17177 Stockholm, Sweden	Harvard University; Harvard T.H. Chan School of Public Health; Athens Medical School; National & Kapodistrian University of Athens; University of Massachusetts System; University of Massachusetts Worcester; Karolinska Institutet	Trichopoulos, D (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.				NCI NIH HHS [CA54220] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA054220] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Lipworth L, 1999, BRIT J CANCER, V79, P7, DOI 10.1038/sj.bjc.6690003; ROMIEU I, 1990, AM J EPIDEMIOL, V131, P864, DOI 10.1093/oxfordjournals.aje.a115577; SUSSER M, 1991, AM J CLIN NUTR, V53, P1384, DOI 10.1093/ajcn/53.6.1384; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; YEN SSC, 1999, REPROD ENDOCRINOLOGY	5	106	107	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 7	2003	326	7401					1245	1246		10.1136/bmj.326.7401.1245	http://dx.doi.org/10.1136/bmj.326.7401.1245			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689FJ	12791740	Green Published, Bronze			2022-12-24	WOS:000183480700017
J	Xu, XZS; Sternberg, PW				Xu, XZS; Sternberg, PW			A C-elegans sperm TRP protein required for sperm-egg interactions during fertilization	CELL			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; CA2+ ENTRY; CALCIUM-ENTRY; MOUSE SPERM; CHANNELS; GENE; FUSION; MICE; EXPRESSION; DIFFERENTIATION	Fertilization, a critical step in animal reproduction, is triggered by a series of specialized sperm-egg interactions. However, the molecular mechanisms underlying fertilization are not well understood. Here, we identify a sperm-enriched C. elegans TRPC homolog, TRP-3. Mutations in trp-3 lead to sterility in both hermaphrodites and males due to a defect in their sperm. trp-3 mutant sperm are motile, but fail to fertilize oocytes after gamete contact. TRP-3 is initially localized in intracellular vesicles, and then translocates to the plasma membrane during sperm activation. This translocation coincides with a marked increase in store-operated calcium entry, providing an in vivo mechanism for the regulation of TRP-3 activity. As C. elegans oocytes lack egg coats, our data suggest that some TRPC family channels might function to mediate calcium influx during sperm-egg plasma membrane interactions leading to fertilization.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Sternberg, PW (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.			Sternberg, Paul/0000-0002-7699-0173				Achanzar WE, 1997, J CELL SCI, V110, P1073; Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; Bernheim L, 2002, NEWS PHYSIOL SCI, V17, P22; Browning H, 1996, DEVELOPMENT, V122, P391; Castellano LE, 2003, FEBS LETT, V541, P69, DOI 10.1016/S0014-5793(03)00305-3; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Kelly WG, 1998, DEVELOPMENT, V125, P2451; L'Hernault SW, 1997, C ELEGANS, P271; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; LHERNAULT SW, 1988, GENETICS, V120, P435; Machaca K, 1996, DEV BIOL, V176, P1, DOI 10.1006/dbio.1996.9999; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; OKAMOTO H, 1985, J NEUROSCI, V5, P643; Park JY, 2002, BIOCHEM BIOPH RES CO, V290, P1176, DOI 10.1006/bbrc.2001.6323; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Putney JW, 2001, J CELL SCI, V114, P2223; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; SHAINBERG A, 1969, EXP CELL RES, V58, P163, DOI 10.1016/0014-4827(69)90127-X; Singson A, 1998, CELL, V93, P71, DOI 10.1016/S0092-8674(00)81147-2; Singson A, 2001, DEV BIOL, V230, P101, DOI 10.1006/dbio.2000.0118; Singson A, 1999, GENETICS, V152, P201; SPENCE AM, 1990, CELL, V60, P981, DOI 10.1016/0092-8674(90)90346-G; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; TETI A, 1993, AM J PHYSIOL, V265, pC113, DOI 10.1152/ajpcell.1993.265.1.C113; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Yanagimachi R., 1994, P189; YANAGIMACHI R, 1978, BIOL REPROD, V19, P949, DOI 10.1095/biolreprod19.5.949; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	41	94	106	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					285	297		10.1016/S0092-8674(03)00565-8	http://dx.doi.org/10.1016/S0092-8674(03)00565-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914694	Bronze			2022-12-24	WOS:000184679200006
J	Choe, H; Li, WH; Wright, PL; Vasilieva, N; Venturi, M; Huang, CC; Grundner, C; Dorfman, T; Zwick, MB; Wang, LP; Rosenberg, ES; Kwong, PD; Burton, DR; Robinson, JE; Sodroski, JG; Farzan, M				Choe, H; Li, WH; Wright, PL; Vasilieva, N; Venturi, M; Huang, CC; Grundner, C; Dorfman, T; Zwick, MB; Wang, LP; Rosenberg, ES; Kwong, PD; Burton, DR; Robinson, JE; Sodroski, JG; Farzan, M			Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120	CELL			English	Article							HUMAN MONOCLONAL-ANTIBODY; AMINO-TERMINAL DOMAIN; ENVELOPE GLYCOPROTEIN; CHEMOKINE RECEPTORS; CORECEPTOR USAGE; DISTINCT CCR5; N-TERMINUS; ENTRY; NEUTRALIZATION; MACROPHAGE	Sulfated tyrosines at the amino terminus of the principal HIV-1 coreceptor CCR5 play a critical role in its ability to bind the HIV-1 envelope glycoprotein gp120 and mediate HIV-1 infection. Here, we show that a number of human antibodies directed against gp120 are tyrosine sulfated at their antigen binding sites. Like that of CCR5, antibody association with gp120 is dependent on sulfate moieties, enhanced by CD4, and inhibited by sulfated CCR5-derived peptides. Most of these antibodies preferentially associate with gp120 molecules of CCR5-utilizing (R5) isolates and neutralize primary R5 isolates more efficiently than laboratory-adapted isolates. These studies identify a distinct subset of CD4-induced HIV-1 neutralizing antibodies that closely emulate CCR5 and demonstrate that tyrosine sulfation can contribute to the potency and diversity of the human humoral response.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med Microbiol & Mol Genet,Div AIDS, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA; NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol,Div AIDS, Boston, MA 02115 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA; Tulane Univ, Med Ctr, Dept Pediat, New Orleans, LA 70012 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Tulane University; Harvard University; Harvard T.H. Chan School of Public Health	Farzan, M (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med Microbiol & Mol Genet,Div AIDS, Boston, MA 02115 USA.	farzan@mbcrr.harvard.edu		Farzan, Michael/0000-0002-2990-5319; Li, Wenhui/0000-0003-1305-7404	NIAID NIH HHS [R01 AI043891] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005022, R01AI043891] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; ALZARI PM, 1988, ANNU REV IMMUNOL, V6, P555; Atchison RE, 1996, SCIENCE, V274, P1924, DOI 10.1126/science.274.5294.1924; Beisswanger R, 1998, P NATL ACAD SCI USA, V95, P11134, DOI 10.1073/pnas.95.19.11134; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Blanpain C, 1999, J BIOL CHEM, V274, P34719, DOI 10.1074/jbc.274.49.34719; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Cormier EG, 2000, P NATL ACAD SCI USA, V97, P5762, DOI 10.1073/pnas.97.11.5762; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Doranz BJ, 1997, J VIROL, V71, P6305, DOI 10.1128/JVI.71.9.6305-6314.1997; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; EARL PL, 1990, P NATL ACAD SCI USA, V87, P648, DOI 10.1073/pnas.87.2.648; Farzan M, 2000, J BIOL CHEM, V275, P33516, DOI 10.1074/jbc.M007228200; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200; Farzan M, 2002, J BIOL CHEM, V277, P40397, DOI 10.1074/jbc.M206784200; Farzan M, 1997, J BIOL CHEM, V272, P6854, DOI 10.1074/jbc.272.11.6854; Farzan M, 2001, J EXP MED, V193, P1059, DOI 10.1084/jem.193.9.1059; Farzan M, 1998, J VIROL, V72, P1160, DOI 10.1128/JVI.72.2.1160-1164.1998; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lefranc M-P., 2001, IMMUNOGLOBULIN FACTS; Lu ZH, 1997, P NATL ACAD SCI USA, V94, P6426, DOI 10.1073/pnas.94.12.6426; Montefiori DC, 2001, J VIROL, V75, P10200, DOI 10.1128/JVI.75.21.10200-10207.2001; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ouyang YB, 1998, P NATL ACAD SCI USA, V95, P2896, DOI 10.1073/pnas.95.6.2896; Parren PWHI, 1998, J VIROL, V72, P10270, DOI 10.1128/JVI.72.12.10270-10274.1998; Picard L, 1997, VIROLOGY, V231, P105, DOI 10.1006/viro.1997.8506; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; POSNER MR, 1993, J ACQ IMMUN DEF SYND, V6, P7; POSNER MR, 1991, J IMMUNOL, V146, P4325; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; Preobrazhensky AA, 2000, J IMMUNOL, V165, P5295, DOI 10.4049/jimmunol.165.9.5295; Rabut GEE, 1998, J VIROL, V72, P3464, DOI 10.1128/JVI.72.4.3464-3468.1998; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; ROSENQUIST GL, 1993, PROTEIN SCI, V2, P215; Ross TM, 1998, J VIROL, V72, P1918, DOI 10.1128/JVI.72.3.1918-1924.1998; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; VUJCIC LK, 1995, AIDS RES HUM RETROV, V11, P783, DOI 10.1089/aid.1995.11.783; Wojtowicz WM, 2002, J BIOL CHEM, V277, P35019, DOI 10.1074/jbc.M203518200; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	55	160	172	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2003	114	2					161	170		10.1016/S0092-8674(03)00508-7	http://dx.doi.org/10.1016/S0092-8674(03)00508-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887918	Bronze			2022-12-24	WOS:000184378700006
J	Arnqvist, G; Jones, TM; Elgar, MA				Arnqvist, G; Jones, TM; Elgar, MA			Insect behaviour: Reversal of sex roles in nuptial feeding	NATURE			English	Article							MALES		Uppsala Univ, Evolutionary Biol Ctr, Dept Anim Ecol, S-75236 Uppsala, Sweden; Univ Melbourne, Dept Zool, Parkville, Vic 3010, Australia	Uppsala University; University of Melbourne	Arnqvist, G (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Anim Ecol, S-75236 Uppsala, Sweden.	goran.arnqvist@ebc.uu.se	Jones, Theresa M/B-9124-2009; Arnqvist, Göran/E-6782-2015	Jones, Theresa M/0000-0002-5300-0018; Arnqvist, Göran/0000-0002-3501-3376; Elgar, Mark/0000-0003-0861-6064				Andersen NM, 2001, INVERTEBR TAXON, V15, P217, DOI 10.1071/IT00015; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; GWYNNE DT, 1984, NATURE, V307, P361, DOI 10.1038/307361a0; MARKOW TA, 1984, SCIENCE, V224, P302, DOI 10.1126/science.224.4646.302; PARKER GA, 1989, ETHOLOGY, V82, P3; Polhemus Dan A., 2000, Tijdschrift voor Entomologie, V143, P91; THORNHILL R, 1976, AM NAT, V110, P153, DOI 10.1086/283055; Vahed K, 1998, BIOL REV, V73, P43, DOI 10.1017/S0006323197005112; Vollrath F, 1998, TRENDS ECOL EVOL, V13, P159, DOI 10.1016/S0169-5347(97)01283-4; WEDELL N, 1991, EVOLUTION, V45, P1975, DOI 10.1111/j.1558-5646.1991.tb02704.x	10	23	23	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					387	387		10.1038/424387a	http://dx.doi.org/10.1038/424387a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879056	Bronze			2022-12-24	WOS:000184318400029
J	Xu, K; Evans, DB; Kawabata, K; Zeramdini, R; Klavus, J; Murray, CJL				Xu, K; Evans, DB; Kawabata, K; Zeramdini, R; Klavus, J; Murray, CJL			Household catastrophic health expenditure: a multicountry analysis	LANCET			English	Article							CARE EXPENDITURES; POLICY; POOR	Background Health policy makers have long been concerned with protecting people from the possibility that ill health will lead to catastrophic financial payments and subsequent impoverishment. Yet catastrophic expenditure is not rare. We investigated the extent of catastrophic health expenditure as a first step to developing appropriate policy responses. Methods We used a cross-country analysis design. Data from household surveys in 59 countries were used to explore, by regression analysis, variables associated with catastrophic health expenditure. We defined expenditure as being catastrophic if a household's financial contributions to the health system exceed 40% of income remaining after subsistence needs have been met. Findings The proportion of households facing catastrophic payments from out-of-pocket health expenses varied widely between countries. Catastrophic spending rates were highest in some countries in transition, and in certain Latin American countries. Three key preconditions for catastrophic payments were identified: the availability of health services requiring payment, low capacity to pay, and the lack of prepayment or health insurance. Interpretation People, particularly in poor households, can be protected from catastrophic health expenditures by reducing a health system's reliance on out-of-pocket payments and providing more financial risk protection. Increase in the availability of health services is critical to improving health in poor countries, but this approach could raise the proportion of households facing catastrophic expenditure; risk protection policies would be especially important in this situation.	WHO, EIP, CH-1211 Geneva 27, Switzerland	World Health Organization	Kawabata, K (corresponding author), WHO, EIP, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.				NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG17625-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANAND S, 1994, AM ECON REV, V84, P226; [Anonymous], WORLD HLTH REP 2002; ARHINTENKORANG D, MOBILIZING RESOURCES; BERKI SE, 1986, HEALTH AFFAIR, V5, P139; Bidani B, 1997, J ECONOMETRICS, V77, P125, DOI 10.1016/S0304-4076(95)01809-3; BOVBJERG RR, 2001, COVERING CATASTRO 66; Davison A. C., 1997, BOOTSTRAP METHODS TH; DEATON A., 1980, EC CONSUMER BEHAV; Filmer D, 2002, WORLD BANK RES OBSER, V17, P47, DOI 10.1093/wbro/17.1.47; Frenk J, 2002, B WORLD HEALTH ORGAN, V80, P88; Gilson L, 1997, HEALTH POLICY PLANN, V12, P273, DOI 10.1093/oxfordjournals.heapol.a018882; Kawabata K, 2002, B WORLD HEALTH ORGAN, V80, P612; Kuznets J, 1997, WHOSHSNHP955; MERLIS M, FAMILY OUT OF POCKET; MUSGROVE P, 2000, HLTH POLICY, V53, P61; NAJMAN JM, 1984, SOC SCI MED, V18, P949, DOI 10.1016/0277-9536(84)90265-X; Pannarunothai S, 1997, SOC SCI MED, V44, P1781, DOI 10.1016/S0277-9536(96)00287-0; Pradhan M, 2002, HEALTH ECON, V11, P431, DOI 10.1002/hec.689; Ranson MK, 2002, B WORLD HEALTH ORGAN, V80, P613; RICE T, 1990, HEALTH AFFAIR, V9, P75, DOI 10.1377/hlthaff.9.3.75; Russell S, 1997, INT J HEALTH SERV, V27, P359, DOI 10.2190/YHL2-F0EA-JW1M-DHEJ; Skarbinski J, 2002, JAMA-J AM MED ASSOC, V287, P1043, DOI 10.1001/jama.287.8.1043; TRAPNELL G, 1983, STRATEGIES INSURING; VISARIA P, 1980, 2 LIV STAND MEAS STU; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; World Health Organisation, 2001, MENT DIS AFF ON 4 PE; World Health Organization, 2000, WORLD HLTH REP 2000; WYSZEWIANSKI L, 1986, INQUIRY-J HEALTH CAR, V23, P382; WYSZEWIANSKI L, 1986, HEALTH SERV RES, V21, P617; XU K, IN PRESS HLTH SYSTEM	30	1227	1266	14	143	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 12	2003	362	9378					111	117		10.1016/S0140-6736(03)13861-5	http://dx.doi.org/10.1016/S0140-6736(03)13861-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	699ZY	12867110				2022-12-24	WOS:000184089200009
J	Sorensen, JB; Nagy, G; Varoqueaux, F; Nehring, RB; Brose, N; Wilson, MC; Neher, E				Sorensen, JB; Nagy, G; Varoqueaux, F; Nehring, RB; Brose, N; Wilson, MC; Neher, E			Differential control of the releasable vesicle pools by SNAP-25 splice variants and SNAP-23	CELL			English	Article							SYNAPTOSOME-ASSOCIATED PROTEIN; TRANSMITTER RELEASE; CHROMAFFIN CELLS; MEMBRANE-FUSION; ISOFORMS; SYNAPTOTAGMIN; EXOCYTOSIS; EXPRESSION; BINDING; NEUROTRANSMITTER	The SNARE complex, consisting of synaptobrevin, syntaxin, and SNAP-25, is essential for calcium-triggered exocytosis in neurosecretory cells. Little is known, however, about how developmentally regulated isoforms and other cognate SNARE components regulate vesicular fusion. To address this question, we examined neuroexocytosis from chromaffin cells of Snap25 null mice rescued by the two splice variants SNAP-25a and SNAP-25b and the ubiquitously expressed homolog SNAP-23. In the absence of SNAP25, vesicle docking persisted, but primed vesicle pools were empty and fast calcium-triggered release abolished. Single vesicular fusion events showed normal characteristics, except for a shorter duration of the fusion pore. Overexpression of SNAP-25a, SNAP-25b, and SNAP-23 resulted in three distinct phenotypes; SNAP-25b induced larger primed vesicle pools than SNAP-25a, whereas SNAP-23 did not support a standing pool of primed vesicles. We conclude that three alternative SNARE components support exocytosis, but they differ in their ability to stabilize vesicles in the primed state.	Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; Max Planck Inst Expt Med, D-37075 Gottingen, Germany; Univ New Mexico, Ctr Hlth Sci, Dept Neurosci, Albuquerque, NM 87131 USA	Max Planck Society; Max Planck Society; University of New Mexico	Sorensen, JB (corresponding author), Max Planck Inst Biophys Chem, Am Fassberg 11, D-37077 Gottingen, Germany.	jsoeren@gwdg.de	Varoqueaux, Frederique/AAC-1834-2021; Neher, Erwin/A-2109-2013; Oka, Yoshitaka/C-9670-2010	Varoqueaux, Frederique/0000-0002-3614-3121; Oka, Yoshitaka/0000-0002-3482-3051; Sorensen, Jakob/0000-0001-5465-3769	NIMH NIH HHS [R01 MH048989, MH48989] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048989] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; BARK IC, 1995, P NATL ACAD SCI USA, V92, P1510, DOI 10.1073/pnas.92.5.1510; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chieregatti E, 2002, TRAFFIC, V3, P496, DOI 10.1034/j.1600-0854.2002.30706.x; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Colliver TL, 2000, J NEUROCHEM, V74, P1086; Deitcher DL, 1998, J NEUROSCI, V18, P2028; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gil A, 2002, J BIOL CHEM, V277, P9904, DOI 10.1074/jbc.M110182200; Gonelle-Gispert C, 1999, BIOCHEM J, V339, P159, DOI 10.1042/0264-6021:3390159; Grant NJ, 1999, J NEUROCHEM, V72, P363, DOI 10.1046/j.1471-4159.1999.0720363.x; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hepp R, 2001, NEUROREPORT, V12, P673, DOI 10.1097/00001756-200103260-00011; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Koticha DK, 1999, J BIOL CHEM, V274, P9053, DOI 10.1074/jbc.274.13.9053; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Nagy G, 2002, J NEUROSCI, V22, P9278; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Puffer EB, 2001, BIOCHEMISTRY-US, V40, P9374, DOI 10.1021/bi010362z; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Scales SJ, 2001, SCIENCE, V294, P1015, DOI 10.1126/science.1066728; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Schulte A, 1996, ANAL CHEM, V68, P3054, DOI 10.1021/ac960210n; Shin OH, 2003, NEURON, V37, P99, DOI 10.1016/S0896-6273(02)01145-5; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; Vogel K, 1999, BIOCHEM BIOPH RES CO, V258, P407, DOI 10.1006/bbrc.1999.0652; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Wang GY, 1997, J CELL SCI, V110, P505; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	41	265	275	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2003	114	1					75	86		10.1016/S0092-8674(03)00477-X	http://dx.doi.org/10.1016/S0092-8674(03)00477-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859899	Green Published, Bronze			2022-12-24	WOS:000184219900007
J	Stillman, JH				Stillman, JH			Acclimation capacity underlies susceptibility to climate change	SCIENCE			English	Article							IMPACTS		Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	Stanford University	Stillman, JH (corresponding author), Stanford Univ, Hopkins Marine Stn, Oceanview Blvd, Pacific Grove, CA 93950 USA.			Stillman, Jonathon/0000-0002-4783-3830				Jensen MN, 2003, SCIENCE, V299, P38, DOI 10.1126/science.299.5603.38; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sagarin RD, 1999, ECOL MONOGR, V69, P465, DOI 10.1890/0012-9615(1999)069[0465:CRCIAI]2.0.CO;2; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790	5	578	587	5	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2003	301	5629					65	65		10.1126/science.1083073	http://dx.doi.org/10.1126/science.1083073			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843385				2022-12-24	WOS:000183914700031
J	Royer, DL; Osborne, CP; Beerling, DJ				Royer, DL; Osborne, CP; Beerling, DJ			Carbon loss by deciduous trees in a CO2-rich ancient polar environment	NATURE			English	Article							CLIMATE-CHANGE; FORESTS; ISLAND; FLORAS; CO2; VERTEBRATES; ANTARCTICA; VEGETATION; RESPONSES; TERTIARY	Fossils demonstrate that deciduous forests covered the polar regions for much of the past 250 million years(1) when the climate was warm and atmospheric CO2 high(2). But the evolutionary significance of their deciduous character has remained a matter of conjecture for almost a century(3). The leading hypothesis(1,4-7) argues that it was an adaptation to photoperiod, allowing the avoidance of carbon losses by respiration from a canopy of leaves unable to photosynthesize in the darkness of warm polar winters(8-11). Here we test this proposal with experiments using 'living fossil' tree species grown in a simulated polar climate with and without CO2 enrichment. We show that the quantity of carbon lost annually by shedding a deciduous canopy is significantly greater than that lost by evergreen trees through wintertime respiration and leaf litter production, irrespective of growth CO2 concentration. Scaling up our experimental observations indicates that the greater expense of being deciduous persists in mature forests, even up to latitudes of 83 degreesN, where the duration of the polar winter exceeds five months. We therefore reject the carbon-loss hypothesis as an explanation for the deciduous nature of polar forests.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Beerling, DJ (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.		Beerling, David J/C-2840-2009	Beerling, David J/0000-0003-1869-4314; Royer, Dana/0000-0003-0976-953X				AXELROD DI, 1966, EVOLUTION, V20, P1, DOI [10.2307/2406145, 10.1111/j.1558-5646.1966.tb03339.x]; Beerling DJ, 1998, PHILOS T R SOC B, V353, P131, DOI 10.1098/rstb.1998.0196; Beerling DJ, 2002, ANN BOT-LONDON, V89, P329, DOI 10.1093/aob/mcf045; CHANEY RW, 1947, ECOL MONOGR, V17, P139, DOI 10.2307/1943260; CREBER GT, 1985, PALAEOGEOGR PALAEOCL, V52, P35, DOI 10.1016/0031-0182(85)90030-6; Crowley TJ, 2001, SCIENCE, V292, P870, DOI 10.1126/science.1061664; Dutton AL, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000593; ESTES R, 1980, PALAEOGEOGR PALAEOCL, V30, P325, DOI 10.1016/0031-0182(80)90064-4; Falcon-Lang HJ, 2000, PALAEOGEOGR PALAEOCL, V160, P317, DOI 10.1016/S0031-0182(00)00079-1; Falcon-Lang HJ, 2001, GEOL MAG, V138, P39, DOI 10.1017/S0016756801004927; Givnish TJ, 2002, SILVA FENN, V36, P703, DOI 10.14214/sf.535; HICKEY LJ, 1984, DISCOVERY, V17, P17; MULLER MJ, 1981, SELECTED CLIMATIC DA; Osborne CP, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001467; Parrish JT, 1998, PALAIOS, V13, P149, DOI 10.2307/3515486; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; READ J, 1992, PALAEOGEOGR PALAEOCL, V99, P271, DOI 10.1016/0031-0182(92)90019-2; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; SEWARD A.C., 1914, BR MUS NAT HIST GEOL, V1, P1; Sokal RR., 1995, BIOMETRY, V3; SPICER RA, 1990, TRENDS ECOL EVOL, V5, P279, DOI 10.1016/0169-5347(90)90081-N; Tarduno JA, 1998, SCIENCE, V282, P2241, DOI 10.1126/science.282.5397.2241; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Tripati A, 2001, PALAEOGEOGR PALAEOCL, V170, P101, DOI 10.1016/S0031-0182(01)00230-9; Upchurch G.R., 1990, ANTARCTIC J US, V24, P7; Valdes P.J., 1996, PALAEOCLIMATES, V2, P139, DOI DOI 10.1016/J.ECOLMODEL.2005.03.026; Villar R, 2001, NEW PHYTOL, V151, P213, DOI 10.1046/j.1469-8137.2001.00147.x; Wolfe J.A., 1985, GEOPHYS MONOGR SER, V32, P357, DOI DOI 10.1029/GM032P0357; WOLFE JA, 1987, PALEOBIOLOGY, V13, P215; Yin XW, 2002, GLOBAL CHANGE BIOL, V8, P631, DOI 10.1046/j.1365-2486.2002.00497.x	30	48	51	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					60	62		10.1038/nature01737	http://dx.doi.org/10.1038/nature01737			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840757	Green Accepted			2022-12-24	WOS:000183912800038
J	Nilsson, M; Johnsen, R; Ye, WM; Hveem, K; Lagergren, J				Nilsson, M; Johnsen, R; Ye, WM; Hveem, K; Lagergren, J			Obesity and estrogen as risk factors for gastroesophageal reflux symptoms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOWER ESOPHAGEAL SPHINCTER; NITRIC-OXIDE SYNTHASE; BODY-MASS; GASTRIC CARDIA; DISEASE; PREVALENCE; POPULATION; WOMEN; ADENOCARCINOMAS; PERISTALSIS	Context Gastroesophageal reflux and obesity are both increasing in prevalence. The scientific evidence for an association between these conditions is sparse and contradictory. A difference between sexes concerning this relation has been proposed. Objective To evaluate the relation between body mass and gastroesophageal reflux symptoms and determine how this relation is influenced by female sex hormones. Design Population-based, cross-sectional, case-control study. Setting Two consecutive public health surveys within the county of Nord-Trondelag, Norway, conducted in 1984-1986 and 1995-1997. Participants Among 65363 adult participants in the second survey, 3113 individuals who reported severe heartburn or regurgitation during the last 12 months were defined as cases, whereas 39872 persons without reflux symptoms were defined as controls. Main Outcome Measure Risk of reflux, estimated using multivariate logistic regression, with odds ratios (ORs) and 95% confidence intervals (Cls) as measures of association. Results There was a dose-response association between increasing body mass index (BMI) and reflux symptoms in both sexes (P for trend <.001), with a significantly stronger association in women (P<.001). Compared with those with a BMI less than 25, the risk of reflux was increased significantly among severely obese (BMI >35) men (OR, 3.3; 95% Cl, 2.4-4.7) and women (OR, 6.3; 95% Cl, 4.9-8.0). The association between BMI and reflux symptoms was stronger among premenopausal women compared with postmenopausal women (P<.001), although use of postmenopausal hormone therapy increased the strength of the association (P<.001). Reduction in BMI was associated with decreased risk of reflux symptoms. Conclusions There is a significant association between body mass and symptoms of gastroesophageal reflux. The association is stronger among women, especially premenopausally, and use of hormone therapy strengthens the association, suggesting that estrogens may play an important role in the etiology of reflux disease.	Karolinska Inst, Karolinska Hosp, Dept Surg, SE-17176 Stockholm, Sweden; Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; Norwegian Univ Sci & Technol, Dept Community Med & Gen Practice, N-7034 Trondheim, Norway; Levanger Hosp, Dept Med, Levanger, Norway; HUNT Res Ctr, Verdal, Norway	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Norwegian University of Science & Technology (NTNU)	Nilsson, M (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Surg, SE-17176 Stockholm, Sweden.	magnus.nilsson@ks.se	Hveem, Kristian/AFV-4683-2022; Ye, Weimin/A-5939-2008	Nilsson, Magnus/0000-0002-6215-8132; Lagergren, Jesper/0000-0002-5143-5448				Bray George A., 1997, Human Reproduction (Oxford), V12, P26; CASTRO LDP, 1967, AM J OBSTET GYNECOL, V98, P1; CHOW WH, 1995, JAMA-J AM MED ASSOC, V274, P474, DOI 10.1001/jama.274.6.474; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; DAY JP, 1990, GASTROENTEROL CLIN N, V19, P587; DEMAN JG, 1991, BRIT J PHARMACOL, V103, P1092; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Eloubeidi MA, 2000, AM J GASTROENTEROL, V95, P1881; GARROW JS, 1985, INT J OBESITY, V9, P147; HANSSON LE, 1993, INT J CANCER, V54, P402, DOI 10.1002/ijc.2910540309; Hautanen A, 2000, INT J OBESITY, V24, pS64, DOI 10.1038/sj.ijo.0801281; HEY VMF, 1977, ANAESTHESIA, V32, P372, DOI 10.1111/j.1365-2044.1977.tb11643.x; Hirsch DP, 1998, GASTROENTEROLOGY, V115, P1374, DOI 10.1016/S0016-5085(98)70015-0; ISOLAURI J, 1995, ANN MED, V27, P67, DOI 10.3109/07853899509031939; *JOINT FAO WHO UNU, 1985, WHO TECHN REP SER, P724; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; KLAUSER AG, 1990, LANCET, V335, P205, DOI 10.1016/0140-6736(90)90287-F; Konturek JW, 1997, J PHYSIOL PHARMACOL, V48, P201; KUSKOWSKAWOLK A, 1993, J EPIDEMIOL COMMUN H, V47, P103, DOI 10.1136/jech.47.2.103; KUSZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 1999, ANN INTERN MED, V130, P883, DOI 10.7326/0003-4819-130-11-199906010-00003; Lagergren J, 2000, GUT, V47, P26, DOI 10.1136/gut.47.1.26; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; LOCKE GR, 1994, MAYO CLIN PROC, V69, P539, DOI 10.1016/S0025-6196(12)62245-9; Locke GR, 1999, AM J MED, V106, P642, DOI 10.1016/S0002-9343(99)00121-7; Midthjell K, 1999, DIABETES CARE, V22, P1813, DOI 10.2337/diacare.22.11.1813; Nilsson M, 2002, SCAND J GASTROENTERO, V37, P626, DOI 10.1080/00365520212502; Nuedling S, 1999, CARDIOVASC RES, V43, P666, DOI 10.1016/S0008-6363(99)00093-0; Piccinini F, 2000, GYNECOL ENDOCRINOL, V14, P142, DOI 10.3109/09513590009167673; Revicki DA, 1998, QUAL LIFE RES, V7, P75; Rothacker DQ, 2000, J AM DIET ASSOC, V100, P784, DOI 10.1016/S0002-8223(00)00229-7; Ruhl CE, 1999, ANN EPIDEMIOL, V9, P424, DOI 10.1016/S1047-2797(99)00020-4; RUTH M, 1991, SCAND J GASTROENTERO, V26, P73, DOI 10.3109/00365529108996486; SIITERI PK, 1981, J ENDOCRINOL, V89, pP119; Ter RB, 1997, GASTROENTEROL CLIN N, V26, P549, DOI 10.1016/S0889-8553(05)70313-7; TOTTRUP A, 1991, AM J PHYSIOL, V260, pG385, DOI 10.1152/ajpgi.1991.260.3.G385; VANTHIEL DH, 1976, GASTROENTEROLOGY, V71, P232; VANTHIEL DH, 1977, GASTROENTEROLOGY, V72, P666; Xue SW, 1996, CAN J PHYSIOL PHARM, V74, P1249, DOI 10.1139/cjpp-74-11-1249; Ye WM, 2001, GASTROENTEROLOGY, V121, P1286, DOI 10.1053/gast.2001.29569; Zervou S, 1999, MOL HUM REPROD, V5, P1048, DOI 10.1093/molehr/5.11.1048	42	333	343	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2003	290	1					66	72		10.1001/jama.290.1.66	http://dx.doi.org/10.1001/jama.290.1.66			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696CR	12837713	Bronze			2022-12-24	WOS:000183868600021
J	Schoen, RE; Pinsky, PF; Weissfeld, JL; Bresalier, RS; Church, T; Prorok, P; Gohagan, JK				Schoen, RE; Pinsky, PF; Weissfeld, JL; Bresalier, RS; Church, T; Prorok, P; Gohagan, JK		Prostate Lung Colorectal Ovarian C	Results of repeat sigmoidoscopy 3 years after a negative examination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SCREENING FLEXIBLE SIGMOIDOSCOPY; COLORECTAL-CANCER; ASYMPTOMATIC ADULTS; COLONOSCOPY; RISK; ADENOMAS; YIELD; SURVEILLANCE; PREVENTION; GUIDELINES	Context The necessary frequency of endoscopic colorectal cancer screening after a negative examination is uncertain. Objective To examine the yield of adenomas and cancer in the distal colon found by repeat flexible sigmoidoscopy (FSG) 3 years after a negative examination. Design, Setting, and Participants Participants were drawn from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO), a randomized, controlled community-based study of cancer screening. The mean (SD) age was 65.7 (4.0) years at study entry (1993-1995) and 61.6% were men. individuals underwent screening FSG at baseline and at 3 years as part of the protocol and were referred to their personal physicians for further evaluation of screen-detected abnormalities. Results from subsequent diagnostic evaluations were tracked in a standardized fashion. Of 11583 eligible for repeat screening FSG 3 years after an initial negative examination, 9317 (80.4%) returned. Main Outcome Measures Polyp or mass detection in distal colon at year 3 repeat FSG; incidence of adenoma or cancer in distal colon at year 3 examination; determination of reason for detection (increased depth of insertion or improved preparation at the year 3 examination or detection in a previously examined area). Results A total of 1292 returning participants (13.9%) had a polyp or mass detected by FSG 3 years after the initial examination. In the distal colon, 3.1% (292/ 9317) were found to have an adenoma or cancer. The incidence of advanced adenoma (n=72) or cancer (n=6) in the distal colon was 78 (0.8%)of 9317. Of individuals with advanced distal adenomas detected at the year 3 examination, 80.6% (58/72) had lesions found in a portion of the colon that had been adequately examined at the initial sigmoidoscopy. Conclusions Repeat FSG 3 years after a negative examination will detect advanced adenomas and distal colon cancer. Although the overall percentage with detected abnormalities is modest, these data raise concern about the impact of a prolonged screening interval after a negative examination.	Univ Pittsburgh, Pittsburgh Canc Inst, Pittsburgh, PA USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; NCI, Div Canc Prevent, Bethesda, MD 20892 USA; Univ Texas, MD Anderson Canc Ctr, Div Gastrointestinal Med & Nutr, Houston, TX 77030 USA; Univ Minnesota, Div Environm & Occupat Hlth, Minneapolis, MN USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; University of Minnesota System; University of Minnesota Twin Cities	Schoen, RE (corresponding author), Presbyterian Univ Hosp, Div Gastroenterol & Hepatol, Mezzanine Level,C Wing,200 Lothrop St, Pittsburgh, PA 15213 USA.	rschoen@pitt.edu	Church, Timothy/AAH-7017-2020	Church, Timothy/0000-0003-3292-5035; Bresalier, Robert/0000-0002-9740-281X	NCI NIH HHS [N01-CN2551] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atkin WS, 2001, GASTROENTEROLOGY, V120, pA66; Bresalier RS, 2002, GASTROENTEROLOGY, V122, pA479; BRINT SL, 1993, AM J GASTROENTEROL, V88, P2019; COOPER GS, 1995, CANCER, V75, P775, DOI 10.1002/1097-0142(19950201)75:3<775::AID-CNCR2820750305>3.0.CO;2-D; Dong SM, 2001, J NATL CANCER I, V93, P858, DOI 10.1093/jnci/93.11.858; Fenlon HM, 1999, NEW ENGL J MED, V341, P1496, DOI 10.1056/NEJM199911113412003; HIXSON LJ, 1991, GASTROINTEST ENDOSC, V37, P125, DOI 10.1016/S0016-5107(91)70668-8; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; KREVSKY B, 1994, AM J GASTROENTEROL, V89, P1165; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Marshall JR, 1996, GASTROENTEROLOGY, V111, P1411, DOI 10.1016/S0016-5085(96)70001-X; MAULE WF, 1994, NEW ENGL J MED, V330, P183, DOI 10.1056/NEJM199401203300307; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; NEUGUT AI, 1995, GASTROENTEROLOGY, V108, P402, DOI 10.1016/0016-5085(95)90066-7; Pinsky PF, 2003, CLIN GASTROENTEROL H, V1, P103, DOI 10.1053/cgh.2003.50017; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; REX DK, 1994, GASTROENTEROLOGY, V106, P593, DOI 10.1016/0016-5085(94)90690-4; Rex DK, 1996, GASTROENTEROLOGY, V111, P1178, DOI 10.1053/gast.1996.v111.pm8898630; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; REX DK, 1990, FLEXIBLE SIGMOIDOSCO, P185; RIFF ER, 1990, CLEV CLIN J MED, V57, P131, DOI 10.3949/ccjm.57.2.131; Schoen RE, 2000, ARCH INTERN MED, V160, P1790, DOI 10.1001/archinte.160.12.1790; SCHOEN RE, IN PRESS AM J GASTRO; Schoenfeld P, 1999, GASTROENTEROLOGY, V117, P312, DOI 10.1053/gast.1999.0029900312; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Slattery ML, 1996, CANCER, V78, P1666, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1666::AID-CNCR5>3.0.CO;2-C; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; Smith RA, 2001, CA-CANCER J CLIN, V51, P150; SQUILLACE S, 1994, AM J GASTROENTEROL, V89, P1156; Stallings FL, 2000, CONTROL CLIN TRIALS, V21, p379S, DOI 10.1016/S0197-2456(00)00093-3; Traverso G, 2002, NEW ENGL J MED, V346, P311, DOI 10.1056/NEJMoa012294; Weissfeld JL, 2002, CANCER, V94, P2569, DOI 10.1002/cncr.10538; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044	35	73	75	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2003	290	1					41	48		10.1001/jama.290.1.41	http://dx.doi.org/10.1001/jama.290.1.41			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696CR	12837710	Bronze			2022-12-24	WOS:000183868600018
J	Reimold, WU				Reimold, WU			Impact cratering comes of age	SCIENCE			English	Editorial Material									Univ Witwatersrand, Sch Geosci, Impact Cratering Res Grp, ZA-2050 Johannesburg, South Africa	University of Witwatersrand	Reimold, WU (corresponding author), Univ Witwatersrand, Sch Geosci, Impact Cratering Res Grp, ZA-2050 Johannesburg, South Africa.		Reimold, Wolf Uwe/AAI-6226-2021	Hauser, Natalia/0000-0002-6975-6186				ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Baldwin RB, 1949, THE FACE OF THE MOON; Courtillot V., 2002, EVOLUTIONARY CATASTR; de Pater I., 2015, PLANETARY SCI; French B, 1998, TRACES CATASTROPHE; GIBSON RL, 2001, VREDEFORT IMPACT STR; Hess H.H., 1962, PETROLOGIC STUDIES V, P500, DOI [DOI 10.1130/PETROLOGIC.1962.599, 10.1130/PETROLOGIC.1962.599]; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Milani A, 2003, SCIENCE, V300, P1882, DOI 10.1126/science.1077708; Montanari A., 2000, IMPACT STRATIGRAPHY; NICOLAYSEN LO, 1990, TECTONOPHYSICS, V171; PATRIDGE TC, 1999, INVESTIGATIONS ORIGI; TAYLOR SR, 2001, SOLAR SYSTEM EVOLUTI; Wegener A, 1915, ENTSTEHUNG KONTINENT; Wilson M., 1989, IGNEOUS PETROGENESIS, P342, DOI 10.1007/978-1-4020-6788-4	15	7	8	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2003	300	5627					1889	1890		10.1126/science.1080687	http://dx.doi.org/10.1126/science.1080687			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12817133				2022-12-24	WOS:000183619400028
J	Au, WWL; Benoit-Bird, KJ				Au, WWL; Benoit-Bird, KJ			Automatic gain control in the echolocation system of dolphins	NATURE			English	Article							SIGNALS	In bats(1) and technological sonars(2), the gain of the receiver is progressively increased with time after the transmission of a signal to compensate for acoustic propagation loss. The current understanding of dolphin echolocation indicates that automatic gain control is not a part of their sonar system(3). In order to test this understanding, we have performed field measurements of free-ranging echolocating dolphins. Here we show that dolphins do possess an automatic gain control mechanism, but that it is implemented in the transmission phase rather than the receiving phase of a sonar cycle. We find that the amplitude of the dolphins' echolocation signals are highly range dependent; this amplitude increases with increasing target range, R, in a 20 log(R) fashion to compensate for propagation loss. If the echolocation target is a fish school with many sound scatterers, the echoes from the school will remain nearly constant(4) with range as the dolphin closes in on it. This characteristic has the same effect as time-varying gain in bats and technological sonar when considered from a sonar system perspective.	Univ Hawaii, Hawaii Inst Marine Biol, Kailua, HI 96734 USA	University of Hawaii System	Au, WWL (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, POB 1106, Kailua, HI 96734 USA.	wau@hawaii.edu						Au W. W., 1993, SONAR DOLPHINS; Au WWL, 2003, J ACOUST SOC AM, V113, P598, DOI 10.1121/1.1518980; AU WWL, 2002, J ACOUST SOC AM, V111, P2343; Cranford T. W, 1988, ANIMAL SONAR PROCESS, P67; Cranford TW, 2000, SPR HDB AUD, V12, P109; EVANS WE, 1967, ANIMAL SONAR SYSTEMS, P363; HEITHAUS MR, 2002, ENCY MARINE MAMMALS, P411; HENSON OW, 1965, J PHYSIOL-LONDON, V180, P871, DOI 10.1113/jphysiol.1965.sp007737; Ketten DR, 2000, SPR HDB AUD, V12, P43; Medwin H., 1998, FUNDAMENTALS ACOUSTI; MOROZOV VP, 1972, BIOFIZIKA+, V17, P139; PENNER RH, 1988, ANIMAL SONAR PROCESS, P707; Rasmussen MH, 2002, J ACOUST SOC AM, V111, P1122, DOI 10.1121/1.1433814; Ridgway SH, 2001, J EXP BIOL, V204, P3829; SIMMONS JA, 1992, J ACOUST SOC AM, V91, P1150, DOI 10.1121/1.402641; SUGA N, 1975, J EXP BIOL, V62, P277; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3	17	134	143	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2003	423	6942					861	863		10.1038/nature01727	http://dx.doi.org/10.1038/nature01727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815429				2022-12-24	WOS:000183585300043
J	Bignall, J				Bignall, J			Monkeying with Shakespeare	LANCET			English	Editorial Material																		Bignall J, 1999, LANCET, V353, P610, DOI 10.1016/S0140-6736(99)00058-6; Bignall J, 2002, LANCET, V360, P504, DOI 10.1016/S0140-6736(02)09761-1; HUXLEY TH, 1862, LANCET, V1, P166; LISTER S, 2003, TIMES           0509, P3; SHAPIRO RD, 1986, ORIGINS SKEPTICS GUI, P169	5	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 14	2003	361	9374					2004	2004						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814709				2022-12-24	WOS:000183488900006
J	Ford, N				Ford, N			Public health and company wealth	BRITISH MEDICAL JOURNAL			English	Article									Med Sans Frontieres, London EC1N 8QX, England	Doctors Without Borders	Ford, N (corresponding author), Med Sans Frontieres, London EC1N 8QX, England.								0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2003	326	7402					1296	1296		10.1136/bmj.326.7402.1296	http://dx.doi.org/10.1136/bmj.326.7402.1296			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691VK	12805159	Green Published			2022-12-24	WOS:000183626500023
J	Mann, E				Mann, E			Managing pain	BRITISH MEDICAL JOURNAL			English	Article									Poole Hosp NHS Trust, Poole BH21 2JB, Dorset, England; Bournemouth Univ, IHCS, Poole BH21 2JB, Dorset, England	Bournemouth University	Mann, E (corresponding author), Poole Hosp NHS Trust, Poole BH21 2JB, Dorset, England.								0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2003	326	7402					1320	1321		10.1136/bmj.326.7402.1320	http://dx.doi.org/10.1136/bmj.326.7402.1320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691VK	12805176	Green Published			2022-12-24	WOS:000183626500039
J	Chothia, C; Gough, J; Vogel, C; Teichmann, SA				Chothia, C; Gough, J; Vogel, C; Teichmann, SA			Evolution of the protein repertoire	SCIENCE			English	Editorial Material							ESCHERICHIA-COLI; ENZYMES; PERSPECTIVE; GENOMICS; METABOLISM; BEHAVIOR; FAMILY	Most proteins have been formed by gene duplication, recombination, and divergence. Proteins of known structure can be matched to about 50% of genome sequences, and these data provide a quantitative description and can suggest hypotheses about the origins of these processes.	MRC, Mol Biol Lab, Struct Studies Div, Cambridge CB2 2QH, England; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	MRC Laboratory Molecular Biology; Stanford University	Chothia, C (corresponding author), MRC, Mol Biol Lab, Struct Studies Div, Hills Rd, Cambridge CB2 2QH, England.			Teichmann, Sarah/0000-0002-6294-6366				Alves R, 2002, J MOL BIOL, V320, P751, DOI 10.1016/S0022-2836(02)00546-6; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; APIC G, IN PRESS J STRUCT FU; Bashton M, 2002, J MOL BIOL, V315, P927, DOI 10.1006/jmbi.2001.5288; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; COUGH J, 2001, J MOL BIOL, V313, P903; Dandekar T, 1999, BIOCHEM J, V343, P115, DOI 10.1042/0264-6021:3430115; HOROWITZ N. H., 1965, P15; Huynen MA, 1998, MOL BIOL EVOL, V15, P583, DOI 10.1093/oxfordjournals.molbev.a025959; Jardine O, 2002, GENOME RES, V12, P916, DOI 10.1101/gr.228002; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Koonin EV, 2000, CELL, V101, P573, DOI 10.1016/S0092-8674(00)80867-3; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Koonin EV, 1996, TRENDS GENET, V12, P334, DOI 10.1016/0168-9525(96)20010-1; Koonin EV., 2003, SEQUENCE EVOLUTION F; Kuznetsov VA, 2002, J BIOL SYST, V10, P381, DOI 10.1142/S0218339002000767; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Muller A, 2002, GENOME RES, V12, P1625, DOI 10.1101/gr.221202; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; PERUTZ MF, 1965, J MOL BIOL, V13, P669, DOI 10.1016/S0022-2836(65)80134-6; Qian J, 2001, J MOL BIOL, V313, P673, DOI 10.1006/jmbi.2001.5079; Riley M, 2000, ANNU REV MICROBIOL, V54, P341, DOI 10.1146/annurev.micro.54.1.341; Rison SCG, 2002, J MOL BIOL, V318, P911, DOI 10.1016/S0022-2836(02)00140-7; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Teichmann SA, 1998, P NATL ACAD SCI USA, V95, P14658, DOI 10.1073/pnas.95.25.14658; Teichmann SA, 2001, J MOL BIOL, V311, P693, DOI 10.1006/jmbi.2001.4912; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; VOGEL C, UNPUB; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550; Wolf YI, 1999, GENOME RES, V9, P17; Wuchty S, 2001, MOL BIOL EVOL, V18, P1694, DOI 10.1093/oxfordjournals.molbev.a003957	31	384	402	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2003	300	5626					1701	1703		10.1126/science.1085371	http://dx.doi.org/10.1126/science.1085371			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805536				2022-12-24	WOS:000183459700037
J	Vaudry, D; Falluel-Morel, A; Leuillet, S; Vaudry, H; Gonzalez, BJ				Vaudry, D; Falluel-Morel, A; Leuillet, S; Vaudry, H; Gonzalez, BJ			Regulators of cerebellar granule cell development act through specific signaling pathways	SCIENCE			English	Editorial Material							GROWTH-FACTOR-I; APOPTOSIS; NEURONS; DEATH; DEPOLARIZATION; INVOLVEMENT; INDUCTION; POTASSIUM; SURVIVAL; MANNER	The proper development of the central nervous system depends upon a finely tuned balance between cell proliferation and programmed cell death (PCD). Although PCD was initially believed to depend solely on the inability of certain neurons to obtain access to a limited supply of trophic factors, it has become apparent that the local production of death signals is also critical. In this Viewpoint, we discuss several pathways implicated in the survival of cerebellar granule cells-both pathways that protect from apoptosis and pathways that promote apoptosis-and describe how these disparate pathways converge on the final common mediators of PCD. Information on other important pathways implicated in granule cell survival may be found in the Connections Maps.	Univ Rouen, INSERM,U413, European Inst Peptide Res IFRMP 23, Lab Cellular & Mol Neuroendocrinol, F-76821 Mont St Aignan, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Vaudry, D (corresponding author), Univ Rouen, INSERM,U413, European Inst Peptide Res IFRMP 23, Lab Cellular & Mol Neuroendocrinol, F-76821 Mont St Aignan, France.		VAUDRY, David/M-1454-2018; Gonzalez, Bruno/E-6103-2016	VAUDRY, David/0000-0003-3567-7452; Gonzalez, Bruno/0000-0002-7176-1320; Anthony, FALLUEL-MOREL/0000-0002-4081-6704				ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; Armstrong RC, 1997, J NEUROSCI, V17, P553; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Chen RW, 1999, J NEUROSCI, V19, P9654; Chen RW, 2003, J NEUROCHEM, V84, P566, DOI 10.1046/j.1471-4159.2003.01548.x; Chrysis D, 2001, J NEUROSCI, V21, P1481, DOI 10.1523/JNEUROSCI.21-05-01481.2001; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; deLuca A, 1996, J NEUROSCI, V16, P4174; Hou ST, 2002, J BIOL CHEM, V277, P48764, DOI 10.1074/jbc.M206336200; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lafon-Cazal M, 2002, EUR J NEUROSCI, V16, P575, DOI 10.1046/j.1460-9568.2002.02124.x; LEUILLET S, 2003, SCI STKE; Linseman DA, 2002, J NEUROSCI, V22, P9287; Luo J, 2003, J BIOL CHEM, V278, P4542, DOI 10.1074/jbc.M208295200; Marx J, 2001, SCIENCE, V293, P2192, DOI 10.1126/science.293.5538.2192; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; PEARSON H, 1992, EUR J NEUROSCI, V4, P1369, DOI 10.1111/j.1460-9568.1992.tb00162.x; Persengiev SP, 2001, J STEROID BIOCHEM, V77, P151, DOI 10.1016/S0960-0760(01)00037-1; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Skaper SD, 1998, J NEUROCHEM, V70, P1859, DOI 10.1046/j.1471-4159.1998.70051859.x	20	51	52	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1532	1534		10.1126/science.1085260	http://dx.doi.org/10.1126/science.1085260			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791981				2022-12-24	WOS:000183333100041
J	Canman, JC; Cameron, LA; Maddox, PS; Straight, A; Tirnauer, JS; Mitchison, TJ; Fang, GW; Kapoor, TM; Salmon, ED				Canman, JC; Cameron, LA; Maddox, PS; Straight, A; Tirnauer, JS; Mitchison, TJ; Fang, GW; Kapoor, TM; Salmon, ED			Determining the position of the cell division plane	NATURE			English	Article							SMALL-MOLECULE INHIBITOR; MAMMALIAN-CELLS; CLEAVAGE FURROW; MICROTUBULES; CYTOKINESIS; SPINDLE; ANAPHASE; MECHANISMS; PROTEIN; MAD2	Proper positioning of the cell division plane during mitosis is essential for determining the size and position of the two daughter cells-a critical step during development and cell differentiation(1). A bipolar microtubule array has been proposed to be a minimum requirement for furrow positioning in mammalian cells, with furrows forming at the site of microtubule plus-end overlap between the spindle poles(2-4). Observations in other species have suggested, however, that this may not be true(5,6). Here we show, by inducing mammalian tissue cells with monopolar spindles to enter anaphase(7,8), that furrow formation in cultured mammalian cells does not require a bipolar spindle. Unexpectedly, cytokinesis occurs at high frequency in monopolar cells. Division always occurs at a cortical position distal to the chromosomes. Analysis of microtubules during cytokinesis in cells with monopolar and bipolar spindles shows that a subpopulation of stable microtubules extends past chromosomes and binds to the cell cortex at the site of furrow formation. Our data are consistent with a model in which chromosomes supply microtubules with factors that promote microtubule stability and furrowing.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27699 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA	University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Stanford University; Rockefeller University	Salmon, ED (corresponding author), Univ N Carolina, Dept Biol, 607 Fordham Hall,CB 3280, Chapel Hill, NC 27699 USA.		Canman, Julie C/A-3875-2016	Canman, Julie C/0000-0001-8135-2072; Straight, Aaron/0000-0001-5885-7881	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024364] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; ASNES CF, 1979, EXP CELL RES, V122, P327, DOI 10.1016/0014-4827(79)90309-4; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; Canman JC, 2002, CELL MOTIL CYTOSKEL, V52, P61, DOI 10.1002/cm.10032; Canman JC, 2002, J CELL SCI, V115, P3787, DOI 10.1242/jcs.00057; Dechant R, 2003, DEV CELL, V4, P333, DOI 10.1016/S1534-5807(03)00057-1; Foe VE, 2000, DEVELOPMENT, V127, P1767; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; HARRIS AK, 1989, J CELL BIOL, V109, P2215, DOI 10.1083/jcb.109.5.2215; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; KUBAI DF, 1982, J CELL BIOL, V93, P655, DOI 10.1083/jcb.93.3.655; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Mackay AM, 1998, J CELL BIOL, V140, P991, DOI 10.1083/jcb.140.5.991; Mandato CA, 2000, CELL MOTIL CYTOSKEL, V45, P87, DOI 10.1002/(SICI)1097-0169(200002)45:2<87::AID-CM1>3.0.CO;2-0; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Murata-Hori M, 2002, J CELL BIOL, V159, P45, DOI 10.1083/jcb.200207014; RADLEY JM, 1980, BLOOD, V56, P996; RAPPAPORT R, 1961, J EXP ZOOL, V148, P81, DOI 10.1002/jez.1401480107; RAPPAPORT R, 1997, CYTOKINESIS ANIMALS; Shannon KB, 2002, MOL BIOL CELL, V13, P3706, DOI 10.1091/mbc.E02-03-0137; Wheatley SP, 2001, EXP CELL RES, V262, P122, DOI 10.1006/excr.2000.5088; WHITE JG, 1983, J THEOR BIOL, V101, P289, DOI 10.1016/0022-5193(83)90342-9; Wittmann T, 2001, J CELL SCI, V114, P3795; WOLF N, 1978, J ULTRA MOL STRUCT R, V63, P155, DOI 10.1016/S0022-5320(78)80071-9	25	181	184	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2003	424	6952					1074	1078		10.1038/nature01860	http://dx.doi.org/10.1038/nature01860			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12904818				2022-12-24	WOS:000184984200048
J	Cutforth, T; Moring, L; Mendelsohn, M; Nemes, A; Shah, NM; Kim, MM; Frisen, J; Axel, R				Cutforth, T; Moring, L; Mendelsohn, M; Nemes, A; Shah, NM; Kim, MM; Frisen, J; Axel, R			Axonal ephrin-as and odorant receptors: Coordinate determination of the olfactory sensory map	CELL			English	Article							EXPRESSION PATTERNS; CRYSTAL-STRUCTURE; BRANCH EXTENSION; TOPOGRAPHIC MAP; MULTIPLE ROLES; MESSENGER-RNAS; MICE DEFICIENT; CELL-ADHESION; SYSTEM; LIGANDS	Olfactory sensory neurons expressing a given odorant receptor (OR) project with precision to specific glomeruli in the olfactory bulb, generating a topographic map. In this study, we demonstrate that neurons expressing different ORs express different levels of ephrin-A protein on their axons. Moreover, alterations in the level of ephrin-A alter the glomerular map. Deletion of the ephrin-A5 and ephrin-A3 genes posteriorizes the glomerular locations for neurons expressing either the P2 or SR1 receptor, whereas overexpression of ephrin-A5 in P2 neurons results in an anterior shift in their glomeruli. Thus the ephrin-As are differentially expressed in distinct subpopulations of neurons and are likely to participate, along with the ORs, as one of a complement of guidance receptors governing the targeting of like axons to precise locations in the olfactory bulb.	Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, Coll Phys & Surg, New York, NY 10032 USA; Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Columbia University; Howard Hughes Medical Institute; Columbia University; Karolinska Institutet	Axel, R (corresponding author), Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA.			Axel, Richard/0000-0002-3141-4076	NATIONAL CANCER INSTITUTE [P01CA023767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004209] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA23767] Funding Source: Medline; NIDCD NIH HHS [R01 DC04209] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Cerretti DP, 1998, GENOMICS, V47, P131, DOI 10.1006/geno.1997.5088; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Hennecke M, 2001, NUCLEIC ACIDS RES, V29, P3327, DOI 10.1093/nar/29.16.3327; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Huai JS, 2001, J BIOL CHEM, V276, P6689, DOI 10.1074/jbc.M008127200; KILLACKEY HP, 1995, TRENDS NEUROSCI, V18, P402, DOI 10.1016/0166-2236(95)93937-S; Knoll B, 2001, DEVELOPMENT, V128, P895; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lane RP, 2001, P NATL ACAD SCI USA, V98, P7390, DOI 10.1073/pnas.131215398; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; Prakash N, 2000, J NEUROSCI, V20, P5841, DOI 10.1523/JNEUROSCI.20-15-05841.2000; Puche AC, 1996, DEV BIOL, V179, P274, DOI 10.1006/dbio.1996.0257; Renzi MJ, 2000, NEURON, V28, P437, DOI 10.1016/S0896-6273(00)00123-9; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Schaefer ML, 2001, J COMP NEUROL, V436, P351; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schwarting GA, 2000, J NEUROSCI, V20, P7691; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; St John JA, 2002, DEV BRAIN RES, V138, P1, DOI 10.1016/S0165-3806(02)00454-6; St John JA, 2001, DEV BRAIN RES, V126, P43, DOI 10.1016/S0165-3806(00)00136-X; St John JA, 2000, J COMP NEUROL, V416, P540; Tisay KT, 2000, J COMP NEUROL, V428, P656, DOI 10.1002/1096-9861(20001225)428:4<656::AID-CNE6>3.0.CO;2-7; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; Treloar H, 1997, J NEUROBIOL, V32, P643, DOI 10.1002/(SICI)1097-4695(19970620)32:7<643::AID-NEU1>3.0.CO;2-4; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Walz A, 2002, J NEUROSCI, V22, P4025, DOI 10.1523/JNEUROSCI.22-10-04025.2002; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Zhang JH, 1996, J NEUROSCI, V16, P7182; ZHANG JH, 1990, NEUROSCI LETT, V119, P257, DOI 10.1016/0304-3940(90)90847-3; Zhang JH, 1997, MOL BRAIN RES, V47, P202, DOI 10.1016/S0169-328X(97)00051-X; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	55	175	176	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					311	322		10.1016/S0092-8674(03)00568-3	http://dx.doi.org/10.1016/S0092-8674(03)00568-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914696	Bronze			2022-12-24	WOS:000184679200008
J	Damak, S; Rong, MQ; Yasumatsu, K; Kokrashvili, Z; Varadarajan, V; Zou, SY; Jiang, PH; Ninomiya, Y; Margolskee, RF				Damak, S; Rong, MQ; Yasumatsu, K; Kokrashvili, Z; Varadarajan, V; Zou, SY; Jiang, PH; Ninomiya, Y; Margolskee, RF			Detection of sweet and umami taste in the absence of taste receptor T1r3	SCIENCE			English	Article							SACCHARIN PREFERENCE; GLOSSOPHARYNGEAL NERVES; CHORDA TYMPANI; INBRED STRAINS; MICE; SUBSTANCES; RESPONSES; LOCUS; SAC; IDENTIFICATION	The tastes of sugars ( sweet) and glutamate (umami) are thought to be detected by T1r receptors expressed in taste cells. Molecular genetics and heterologous expression implicate T1r2 plus T1r3 as a sweet-responsive receptor, and T1r1 plus T1r3, as well as a truncated form of the type 4 metabotropic glutamate receptor (taste-mGluR4), as umami-responsive receptors. Here, we show that mice lacking T1r3 showed no preference for artificial sweeteners and had diminished but not abolished behavioral and nerve responses to sugars and umami compounds. These results indicate that T1r3-independent sweet- and umami-responsive receptors and/or pathways exist in taste cells.	CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Howard Hughes Med Inst, New York, NY 10029 USA; Kyushu Univ, Sect Oral Neurosci, Higashi Ku, Fukuoka 8128582, Japan	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Howard Hughes Medical Institute; Icahn School of Medicine at Mount Sinai; Kyushu University	Margolskee, RF (corresponding author), CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, Box 1677,1425 Madison Ave, New York, NY 10029 USA.			Margolskee, Robert/0000-0002-9572-2887				Bachmanov AA, 1997, MAMM GENOME, V8, P545, DOI 10.1007/s003359900500; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; CAPELESS CG, 1995, CHEM SENSES, V20, P291, DOI 10.1093/chemse/20.3.291; CAPRETTA PJ, 1970, PSYCHON SCI, V21, P133; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; FULLER JL, 1974, J HERED, V65, P33, DOI 10.1093/oxfordjournals.jhered.a108452; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; LUSH IE, 1989, GENET RES, V53, P95, DOI 10.1017/S0016672300027968; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ninomiya Y, 2000, J NUTR, V130, p950S, DOI 10.1093/jn/130.4.950S; NINOMIYA Y, 1993, NEUROSCI LETT, V163, P197, DOI 10.1016/0304-3940(93)90381-T; PELZ WE, 1973, PHYSIOL BEHAV, V10, P263, DOI 10.1016/0031-9384(73)90308-9; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Sako N, 2000, PHYSIOL BEHAV, V71, P193, DOI 10.1016/S0031-9384(00)00342-5; SCHIFFMAN SS, 1995, BRAIN RES BULL, V36, P505, DOI 10.1016/0361-9230(94)00225-P; SHINGAI T, 1985, BRAIN RES, V335, P245, DOI 10.1016/0006-8993(85)90476-7	20	453	498	10	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					850	853		10.1126/science.1087155	http://dx.doi.org/10.1126/science.1087155			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12869700				2022-12-24	WOS:000184615700050
J	Sullivan, NJ; Geisbert, TW; Geisbert, JB; Xu, L; Yang, ZY; Roederer, M; Koup, RA; Jahrling, PB; Nabel, GJ				Sullivan, NJ; Geisbert, TW; Geisbert, JB; Xu, L; Yang, ZY; Roederer, M; Koup, RA; Jahrling, PB; Nabel, GJ			Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates	NATURE			English	Article							PASSIVE TRANSFER; INFECTION; GLYCOPROTEINS; CYTOTOXICITY; INJURY; GENE	Containment of highly lethal Ebola virus outbreaks poses a serious public health challenge. Although an experimental vaccine has successfully protected non-human primates against disease(1), more than six months was required to complete the immunizations, making it impractical to limit an acute epidemic. Here, we report the development of accelerated vaccination against Ebola virus in non-human primates. The antibody response to immunization with an adenoviral (ADV) vector encoding the Ebola glycoprotein (GP) was induced more rapidly than with DNA priming and ADV boosting, but it was of lower magnitude. To determine whether this earlier immune response could nonetheless protect against disease, cynomolgus macaques were challenged with Ebola virus after vaccination with ADV-GP and nucleoprotein (NP) vectors. Protection was highly effective and correlated with the generation of Ebola-specific CD8(+) T-cell and antibody responses. Even when animals were immunized once with ADV-GP/NP and challenged 28 days later, they remained resistant to challenge with either low or high doses of virus. This accelerated vaccine provides an intervention that may help to limit the epidemic spread of Ebola, and is applicable to other viruses.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bldg 40,Room 4502,MSC 3005,40 Convent Dr, Bethesda, MD 20892 USA.	gnabel@nih.gov	Roederer, Mario/G-1887-2011		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005004, ZIAAI005073, Z01AI005073] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aoki K, 1999, MOL MED, V5, P224, DOI 10.1007/BF03402119; Chan SY, 2000, J GEN VIROL, V81, P2155, DOI 10.1099/0022-1317-81-9-2155; Gupta M, 2001, J VIROL, V75, P4649, DOI 10.1128/JVI.75.10.4649-4654.2001; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Jahrling PB, 1996, ARCH VIROL, P135; KSIAZEK TG, 1992, J CLIN MICROBIOL, V30, P947, DOI 10.1128/JCM.30.4.947-950.1992; OHNO T, 1994, SCIENCE, V265, P781, DOI 10.1126/science.8047883; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Takada A, 2000, VIROLOGY, V278, P20, DOI 10.1006/viro.2000.0601; Volchkov VE, 2001, SCIENCE, V291, P1965, DOI 10.1126/science.1057269; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; *WHO, 2003, DIS OUTBR EB HAEM FE; Wilson JA, 2001, J VIROL, V75, P2660, DOI 10.1128/JVI.75.6.2660-2664.2001; Xu L, 1998, NAT MED, V4, P37, DOI 10.1038/nm0198-037; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654	17	361	390	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2003	424	6949					681	684		10.1038/nature01876	http://dx.doi.org/10.1038/nature01876			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904795	Green Published, Bronze			2022-12-24	WOS:000184578800047
J	Neumann, CA; Krause, DS; Carman, CV; Das, S; Dubey, DP; Abraham, JL; Bronson, RT; Fujiwara, Y; Orkin, SH; Van Etten, RA				Neumann, CA; Krause, DS; Carman, CV; Das, S; Dubey, DP; Abraham, JL; Bronson, RT; Fujiwara, Y; Orkin, SH; Van Etten, RA			Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression	NATURE			English	Article							ABL TYROSINE KINASE; PAG GENE-PRODUCT; PHYSIOLOGICAL INHIBITOR; STRESS; CLONING; RESISTANCE; PROTEIN; FAMILY; CELLS; MICE	Reactive oxygen species are involved in many cellular metabolic and signalling processes(1) and are thought to have a role in disease, particularly in carcinogenesis and ageing(2). We have generated mice with targeted inactivation of Prdx1, a member of the peroxiredoxin family of antioxidant enzymes(3). Here we show that mice lacking Prdx1 are viable and fertile but have a shortened lifespan owing to the development beginning at about 9 months of severe haemolytic anaemia and several malignant cancers, both of which are also observed at increased frequency in heterozygotes. The haemolytic anaemia is characterized by an increase in erythrocyte reactive oxygen species, leading to protein oxidation, haemoglobin instability, Heinz body formation and decreased erythrocyte lifespan. The malignancies include lymphomas, sarcomas and carcinomas, and are frequently associated with loss of Prdx1 expression in heterozygotes, which suggests that this protein functions as a tumour suppressor. Prdx1-deficient fibroblasts show decreased proliferation and increased sensitivity to oxidative DNA damage, whereas Prdx1-null mice have abnormalities in numbers, phenotype and function of natural killer cells. Our results implicate Prdx1 as an important defence against oxidants in ageing mice.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Tufts University	Van Etten, RA (corresponding author), Tufts Univ New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA.	rvanetten@tufts-nemc.org	Carman, Christopher/L-8108-2016; Carman, Christopher V./AAX-8995-2020	Carman, Christopher/0000-0001-7358-2548; Carman, Christopher V./0000-0001-7358-2548; Neumann, Carola/0000-0003-2801-9531	NIEHS NIH HHS [F32 ES011586] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES011586] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Butterfield LH, 1999, ANTIOXID REDOX SIGN, V1, P385, DOI 10.1089/ars.1999.1.4-385; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chung YM, 2001, ANTICANCER RES, V21, P1129; Dubey DP, 2000, MECH AGEING DEV, V113, P117, DOI 10.1016/S0047-6374(99)00102-5; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Frank J, 2000, HISTOL HISTOPATHOL, V15, P173, DOI 10.14670/HH-15.173; Friedman JS, 2001, J EXP MED, V193, P925, DOI 10.1084/jem.193.8.925; Henderson CJ, 1998, P NATL ACAD SCI USA, V95, P5275, DOI 10.1073/pnas.95.9.5275; HOFFMANNFEZER G, 1993, ANN HEMATOL, V67, P81, DOI 10.1007/BF01788131; ISHII T, 1993, J BIOL CHEM, V268, P18633; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; Johnson RM, 2000, BLOOD, V96, P1985, DOI 10.1182/blood.V96.5.1985.h8001985_1985_1988; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Lyu MS, 1999, MAMM GENOME, V10, P1017, DOI 10.1007/s003359901150; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Noh DY, 2001, ANTICANCER RES, V21, P2085; PROSPERI MT, 1993, J BIOL CHEM, V268, P11050; PROSPERI MT, 1994, GENOMICS, V19, P236, DOI 10.1006/geno.1994.1053; Prosperi MT, 1998, FEBS LETT, V423, P39, DOI 10.1016/S0014-5793(98)00057-X; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Sauri H, 1996, J LEUKOCYTE BIOL, V59, P925, DOI 10.1002/jlb.59.6.925; Shau HY, 1997, FREE RADICAL BIO MED, V22, P497, DOI 10.1016/S0891-5849(96)00372-3; SHAU HY, 1993, CELL IMMUNOL, V147, P1, DOI 10.1006/cimm.1993.1043; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; Takei F, 1997, IMMUNOL REV, V155, P67, DOI 10.1111/j.1600-065X.1997.tb00940.x; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Westphal GH, 1997, CURR BIOL, V7, P530, DOI 10.1016/S0960-9822(06)00224-7	31	614	644	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2003	424	6948					561	565		10.1038/nature01819	http://dx.doi.org/10.1038/nature01819			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891360	Green Published			2022-12-24	WOS:000184454700045
J	Gonzalez-Pastor, JE; Hobbs, EC; Losick, R				Gonzalez-Pastor, JE; Hobbs, EC; Losick, R			Cannibalism by sporulating bacteria	SCIENCE			English	Article							BACILLUS-SUBTILIS; ANTIBIOTICS; EXPRESSION; INITIATION; SIGMA(W); GROWTH; GENES	Spore formation by the bacterium Bacillus subtilis is an elaborate developmental process that is triggered by nutrient limitation. Here we report that cells that have entered the pathway to sporulate produce and export a killing factor and a signaling protein that act cooperatively to block sister cells from sporulating and to cause them to lyse. The sporulating cells feed on the nutrients thereby released, which allows them to keep growing rather than to complete morphogenesis. We propose that sporulation is a stress-response pathway of last resort and that B. subtilis delays a commitment to spore formation by cannibalizing its siblings.	Harvard Univ, Biol Labs, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Losick, R (corresponding author), Harvard Univ, Biol Labs, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.		González-Pastor, José/I-2118-2015	González-Pastor, José/0000-0002-7615-7042	NIGMS NIH HHS [GM18568] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018568, R01GM018568] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Cao M, 2002, MOL MICROBIOL, V45, P1267, DOI 10.1046/j.1365-2958.2002.03050.x; CHUNG JD, 1994, J BACTERIOL, V176, P1977, DOI 10.1128/jb.176.7.1977-1984.1994; COZENS RM, 1986, ANTIMICROB AGENTS CH, V29, P797, DOI 10.1128/AAC.29.5.797; Fawcett P, 2000, P NATL ACAD SCI USA, V97, P8063, DOI 10.1073/pnas.140209597; GONZALEZPASTOR JE, UNPUB; KOLTER R, 1992, ANNU REV MICROBIOL, V46, P141, DOI 10.1146/annurev.mi.46.100192.001041; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lin D, 2001, J APPL MICROBIOL, V91, P1044, DOI 10.1046/j.1365-2672.2001.01475.x; Pei JM, 2001, TRENDS BIOCHEM SCI, V26, P275, DOI 10.1016/S0968-0004(01)01813-8; Piggot P. J., 2002, BACILLUS SUBTILIS IT, P473; PIGGOT PJ, 1976, BACTERIOL REV, V40, P908, DOI 10.1128/MMBR.40.4.908-962.1976; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Siezen RJ, 1996, ANTON LEEUW INT J G, V69, P171, DOI 10.1007/BF00399422; Sonenshein AL, 2000, PROKARYOTIC DEVELOPMENT, P133; Sonenshein AL, 2000, BACTERIAL STRESS RESPONSES, P199; Turner MS, 2000, J BACTERIOL, V182, P5202, DOI 10.1128/JB.182.18.5202-5210.2000; WIREMAN JW, 1975, SCIENCE, V189, P516, DOI 10.1126/science.806967; Zheng GL, 1999, J BACTERIOL, V181, P7346, DOI 10.1128/JB.181.23.7346-7355.1999	21	410	442	6	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					510	513		10.1126/science.1086462	http://dx.doi.org/10.1126/science.1086462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12817086				2022-12-24	WOS:000184340500041
J	Williams, PA; Cosme, J; Ward, A; Angova, HC; Vinkovic, DM; Jhoti, H				Williams, PA; Cosme, J; Ward, A; Angova, HC; Vinkovic, DM; Jhoti, H			Crystal structure of human cytochrome P4502C9 with bound warfarin	NATURE			English	Article								Cytochrome P450 proteins (CYP450s) are membrane-associated haem proteins that metabolize physiologically important compounds in many species of microorganisms, plants and animals. Mammalian CYP450s recognize and metabolize diverse xenobiotics such as drug molecules, environmental compounds and pollutants(1). Human CYP450 proteins CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 are the major drug-metabolizing isoforms, and contribute to the oxidative metabolism of more than 90% of the drugs in current clinical use(2). Polymorphic variants have also been reported for some CYP450 isoforms, which has implications for the efficacy of drugs in individuals, and for the co-administration of drugs. The molecular basis of drug recognition by human CYP450s, however, has remained elusive. Here we describe the crystal structure of a human CYP450, CYP2C9, both unliganded and in complex with the anti-coagulant drug warfarin. The structure defines unanticipated interactions between CYP2C9 and warfarin, and reveals a new binding pocket. The binding mode of warfarin suggests that CYP2C9 may undergo an allosteric mechanism during its function. The newly discovered binding pocket also suggests that CYP2C9 may simultaneously accommodate multiple ligands during its biological function, and provides a possible molecular basis for understanding complex drug-drug interactions.	Astex Technol, Cambridge CB4 0QA, England		Jhoti, H (corresponding author), Astex Technol, 436 Cambridge Sci Pk,Milton Rd, Cambridge CB4 0QA, England.	h.jhoti@astex-technology.com		Williams, Pamela/0000-0002-1257-2351				Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; de Groot MJ, 2002, J MED CHEM, V45, P1983, DOI 10.1021/jm0110791; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Haining RL, 1999, BIOCHEMISTRY-US, V38, P3285, DOI 10.1021/bi982161+; Hemeryck A, 1999, EUR J CLIN PHARMACOL, V54, P947, DOI 10.1007/s002280050580; Hlavica P, 2001, EUR J BIOCHEM, V268, P4817, DOI 10.1046/j.1432-1327.2001.02412.x; Hodgson J, 2001, NAT BIOTECHNOL, V19, P722, DOI 10.1038/90761; Hutzler JM, 2001, DRUG METAB DISPOS, V29, P1029; Hutzler JM, 2003, ARCH BIOCHEM BIOPHYS, V410, P16; Ibeanu GC, 1996, J BIOL CHEM, V271, P12496, DOI 10.1074/jbc.271.21.12496; Jones BC, 1996, DRUG METAB DISPOS, V24, P260; Kaminsky LS, 1997, PHARMACOL THERAPEUT, V73, P67, DOI 10.1016/S0163-7258(96)00140-4; Lewis DFV, 2000, BIOCHEM PHARMACOL, V60, P293, DOI 10.1016/S0006-2952(00)00335-X; Li H, 1996, BIOCHIMIE, V78, P695, DOI 10.1016/S0300-9084(97)82526-6; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; MANCY A, 1995, BIOCHEMISTRY-US, V34, P10365, DOI 10.1021/bi00033a007; Melet A, 2003, ARCH BIOCHEM BIOPHYS, V409, P80, DOI 10.1016/S0003-9861(02)00548-9; Modi S, 1996, NAT STRUCT BIOL, V3, P414, DOI 10.1038/nsb0596-414; Modi S, 1997, BIOCHEMISTRY-US, V36, P4461, DOI 10.1021/bi962633p; MURSHUDOV GN, 1997, ACTA CRYSTALLOGR D, V50, P760; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NAVE C, 1995, RADIAT PHYS CHEM, V45, P483, DOI 10.1016/0969-806X(95)92800-E; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Ridderstrom M, 2000, BIOCHEM BIOPH RES CO, V270, P983, DOI 10.1006/bbrc.2000.2538; Schlichting I, 1997, FEBS LETT, V415, P253, DOI 10.1016/S0014-5793(97)01135-6; STRESSER DM, FLUOROMETRIC CYTOCHR; Takahashi H, 2001, CLIN PHARMACOKINET, V40, P587, DOI 10.2165/00003088-200140080-00003; Tang W, 2001, CURR DRUG METAB, V2, P185, DOI 10.2174/1389200013338658; Williams D, 2000, PERFORM RES, V5, P131	29	696	724	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					464	468		10.1038/nature01862	http://dx.doi.org/10.1038/nature01862			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12861225				2022-12-24	WOS:000184318400052
J	Hotary, KB; Allen, ED; Brooks, PC; Datta, NS; Long, MW; Weiss, SJ				Hotary, KB; Allen, ED; Brooks, PC; Datta, NS; Long, MW; Weiss, SJ			Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix	CELL			English	Article							TISSUE INHIBITOR; COLLAGEN MATRIX; CANCER-THERAPY; UP-REGULATION; ANGIOGENESIS; CELLS; PROLIFERATION; PROGRESSION; EXPRESSION; METASTASIS	Cancer cells are able to proliferate at accelerated rates within the confines of a three-dimensional (313) extracellular matrix (ECM) that is rich in type I collagen. The mechanisms used by tumor cells to circumvent endogenous antigrowth signals have yet to be clearly defined. We find that the matrix metalloproteinase, MT1-MMP, confers tumor cells with a distinct 3D growth advantage in vitro and in vivo. The replicative advantage conferred by MT1-MMP requires pericellular proteolysis of the ECM, as proliferation is fully suppressed when tumor cells are suspended in 3D gels of protease-resistant collagen. In the absence of proteolysis, tumor cells embedded in physiologically relevant ECM matrices are trapped in a compact, spherical configuration and unable to undergo changes in cell shape or cytoskeletal reorganization required for 3D growth. These observations identify MT1-MMP as a tumor-derived growth factor that regulates proliferation by controlling cell geometry within the confines of the 3D ECM.	Univ Michigan, Ctr Comprehens Canc, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Div Hemtol Oncol, Dept Pediat, Ann Arbor, MI 48109 USA; NYU, Sch Med, Dept Radiat Oncol, New York, NY 10016 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; New York University	Weiss, SJ (corresponding author), Univ Michigan, Ctr Comprehens Canc, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA.				NCI NIH HHS [CA88308, CA71699] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA088308, R01CA071699] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Brand K, 2000, CANCER RES, V60, P5723; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Datta NS, 1996, MOL BIOL CELL, V7, P209, DOI 10.1091/mbc.7.2.209; Deryugina EI, 2002, CANCER RES, V62, P580; Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feng XD, 1999, J INVEST DERMATOL, V113, P913, DOI 10.1046/j.1523-1747.1999.00786.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hay E.D., 1991, CELL BIOL EXTRACELLU, DOI 10.1007/978-1-4615-3770-0; Henriet P, 2000, P NATL ACAD SCI USA, V97, P10026, DOI 10.1073/pnas.170290997; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Ingber DE, 2003, P NATL ACAD SCI USA, V100, P1472, DOI 10.1073/pnas.0530201100; Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; LIU X, 1995, J CELL BIOL, V130, P227, DOI 10.1083/jcb.130.1.227; MONTGOMERY AMP, 1994, CANCER RES, V54, P5467; NISHIYAMA T, 1989, MATRIX, V9, P193, DOI 10.1016/S0934-8832(89)80050-2; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Petitclerc E, 1999, CANCER RES, V59, P2724; SELKI M, 2002, CURR OPIN CELL BIOL, V14, P624; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Walpita D, 2002, NAT REV MOL CELL BIO, V3, P137, DOI 10.1038/nrm727; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387	37	560	583	0	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 11	2003	114	1					33	45		10.1016/S0092-8674(03)00513-0	http://dx.doi.org/10.1016/S0092-8674(03)00513-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859896	Bronze			2022-12-24	WOS:000184219900004
J	Chen, J; Larochelle, S; Li, XM; Suter, B				Chen, J; Larochelle, S; Li, XM; Suter, B			Xpd/Ercc2 regulates CAK activity and mitotic progression	NATURE			English	Article							CDK-ACTIVATING KINASE; RNA-POLYMERASE-II; CELL-CYCLE; IN-VIVO; TRANSCRIPTION; TFIIH; EMBRYOS; PHOSPHORYLATION; REPRESSION; MITOSIS	General transcription factor IIH (TFIIH) consists of nine subunits: cyclin-dependent kinase 7 (Cdk7), cyclin H and MAT1 ( forming the Cdk-activating-kinase or CAK complex), the two helicases Xpb/Hay and Xpd, and p34, p44, p52 and p62 (refs 1 - 3). As the kinase subunit of TFIIH, Cdk7 participates in basal transcription by phosphorylating the carboxy-terminal domain of the largest subunit of RNA polymerase II1,4,5. As part of CAK, Cdk7 also phosphorylates other Cdks, an essential step for their activation(6-9). Here we show that the Drosophila TFIIH component Xpd negatively regulates the cell cycle function of Cdk7, the CAK activity. Excess Xpd titrates CAK activity, resulting in decreased Cdk T-loop phosphorylation, mitotic defects and lethality, whereas a decrease in Xpd results in increased CAK activity and cell proliferation. Moreover, Xpd is downregulated at the beginning of mitosis when Cdk1, a cell cycle target of Cdk7, is most active. Downregulation of Xpd thus seems to contribute to the upregulation of mitotic CAK activity and to regulate mitotic progression positively. Simultaneously, the downregulation of Xpd might be a major mechanism of mitotic silencing of basal transcription.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Suter, B (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.		Larochelle, Stephane/D-3662-2012	Larochelle, Stephane/0000-0002-4594-4342				Akoulitchev S, 1998, GENE DEV, V12, P3541, DOI 10.1101/gad.12.22.3541; AKOULITCHEV S, 1995, NATURE, V377, P557, DOI 10.1038/377557a0; Austin RJ, 1996, P NATL ACAD SCI USA, V93, P5788, DOI 10.1073/pnas.93.12.5788; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; Egly JM, 2001, FEBS LETT, V498, P124, DOI 10.1016/S0014-5793(01)02458-9; FISHER RP, 1996, BIOCHIM BIOPHYS ACTA, V1288, P7; FOE VE, 1985, J CELL BIOL, V100, P1623, DOI 10.1083/jcb.100.5.1623; Foe Victoria E., 1993, P149; Frit P, 1999, BIOCHIMIE, V81, P27, DOI 10.1016/S0300-9084(99)80035-2; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Larochelle S, 1998, GENE DEV, V12, P370, DOI 10.1101/gad.12.3.370; Larochelle S, 2001, EMBO J, V20, P3749, DOI 10.1093/emboj/20.14.3749; Long JJ, 1998, MOL CELL BIOL, V18, P1467, DOI 10.1128/MCB.18.3.1467; MAKELA TP, 1995, P NATL ACAD SCI USA, V92, P5174, DOI 10.1073/pnas.92.11.5174; MALDONADOCODINA G, 1993, J CELL SCI, V105, P711; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Sandrock B, 2001, J BIOL CHEM, V276, P35328, DOI 10.1074/jbc.M105570200; Wallenfang MR, 2002, P NATL ACAD SCI USA, V99, P5527, DOI 10.1073/pnas.082618399	21	101	104	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2003	424	6945					228	232		10.1038/nature01746	http://dx.doi.org/10.1038/nature01746			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853965				2022-12-24	WOS:000184032700050
J	Takeda, S; Yamashita, A; Maeda, K; Maeda, Y				Takeda, S; Yamashita, A; Maeda, K; Maeda, Y			Structure of the core domain of human cardiac troponin in the Ca2+-saturated form	NATURE			English	Article							SKELETAL-MUSCLE TROPONIN; SUBFRAGMENT 1 ATPASE; THIN FILAMENT; ACTIN-TROPOMYOSIN; BIOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; CENTRAL HELIX; T FRAGMENTS; 3 STATES; RABBIT	Troponin is essential in Ca2+ regulation of skeletal and cardiac muscle contraction. It consists of three subunits (TnT, TnC and TnI) and, together with tropomyosin, is located on the actin filament. Here we present crystal structures of the core domains (relative molecular mass of 46,000 and 52,000) of human cardiac troponin in the Ca2+-saturated form. Analysis of the four-molecule structures reveals that the core domain is further divided into structurally distinct subdomains that are connected by flexible linkers, making the entire molecule highly flexible. The alpha-helical coiled-coil formed between TnT and TnI is integrated in a rigid and asymmetric structure (about 80 Angstrom long), the IT arm, which bridges putative tropomyosin-anchoring regions. The structures of the troponin ternary complex imply that Ca2+ binding to the regulatory site of TnC removes the carboxy-terminal portion of TnI from actin, thereby altering the mobility and/or flexibility of troponin and tropomyosin on the actin filament.	SPring 8, RIKEN Harima Inst, Lab Struct Biochem, Sayo, Hyogo 6795148, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan	Japan Synchrotron Radiation Research Institute; RIKEN; Japan Science & Technology Agency (JST)	Takeda, S (corresponding author), Natl Cardiovasc Ctr, Res Inst, Dept Cardiac Physiol, 5-7-1 Fujishiro Dai, Osaka 5658565, Japan.		Yamashita, Atsuko/H-5566-2017	Yamashita, Atsuko/0000-0002-8001-4642				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BABU A, 1993, J BIOL CHEM, V268, P19232; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; EBASHI S, 1969, Quarterly Reviews of Biophysics, V2, P351; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; FARAH CS, 1994, J BIOL CHEM, V269, P5230; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; FLICKER PF, 1982, J MOL BIOL, V162, P495, DOI 10.1016/0022-2836(82)90540-X; FUJITABECKER S, 1993, J BIOCHEM, V114, P438, DOI 10.1093/oxfordjournals.jbchem.a124194; Gasmi-Seabrook GMC, 1999, BIOCHEMISTRY-US, V38, P8313, DOI 10.1021/bi9902642; Geeves MA, 2000, BIOCHEMISTRY-US, V39, P9345, DOI 10.1021/bi0002232; Hai H, 2002, J BIOCHEM, V131, P407, DOI 10.1093/oxfordjournals.jbchem.a003116; Haselgrove J. C., 1972, COLD SPRING HARB SYM, V37, P341; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; Houdusse A, 1997, STRUCTURE, V5, P1695, DOI 10.1016/S0969-2126(97)00315-8; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lehrer SS, 1997, BIOCHEMISTRY-US, V36, P13449, DOI 10.1021/bi971568w; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Li ZX, 2001, BIOPHYS J, V81, P321, DOI 10.1016/S0006-3495(01)75702-5; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; Luo Y, 2000, J MOL BIOL, V296, P899, DOI 10.1006/jmbi.1999.3495; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MORRIS EP, 1984, BIOCHEMISTRY-US, V23, P2214, DOI 10.1021/bi00305a018; OHTSUKI I, 1979, J BIOCHEM, V86, P491, DOI 10.1093/oxfordjournals.jbchem.a132549; OHTSUKI I, 1988, J BIOCHEM-TOKYO, V103, P913, DOI 10.1093/oxfordjournals.jbchem.a122387; OHTSUKI I, 1986, ADV PROTEIN CHEM, V38, P1, DOI 10.1016/S0065-3233(08)60525-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; PEARLSTONE JR, 1983, J BIOL CHEM, V258, P2534; PEARLSTONE JR, 1985, CAN J BIOCHEM CELL B, V63, P212, DOI 10.1139/o85-030; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; Ramakrishnan S, 1995, BIOCHEMISTRY-US, V34, P16789, DOI 10.1021/bi00051a029; ROUSSEL A, 1996, TURBO FRODO MANUAL; Schaertl S, 1995, BIOCHEMISTRY-US, V34, P15890, DOI 10.1021/bi00049a003; Slupsky CM, 1995, BIOCHEMISTRY-US, V34, P15953, DOI 10.1021/bi00049a010; Stefancsik R, 1998, P NATL ACAD SCI USA, V95, P957, DOI 10.1073/pnas.95.3.957; SUNDARALINGAM M, 1985, SCIENCE, V227, P945, DOI 10.1126/science.3969570; SYSKA H, 1976, BIOCHEM J, V153, P375, DOI 10.1042/bj1530375; Takeda S, 1997, EUR J BIOCHEM, V246, P611, DOI 10.1111/j.1432-1033.1997.00611.x; TALBOT JA, 1981, J BIOL CHEM, V256, P2798; TANOKURA M, 1983, J BIOCHEM, V93, P331, DOI 10.1093/oxfordjournals.jbchem.a134185; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tripet B, 1997, J MOL BIOL, V271, P728, DOI 10.1006/jmbi.1997.1200; Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847; WHITE SP, 1987, NATURE, V325, P826, DOI 10.1038/325826a0; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	50	612	624	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					35	41		10.1038/nature01780	http://dx.doi.org/10.1038/nature01780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840750				2022-12-24	WOS:000183912800031
J	Ogita, S; Uefuji, H; Yamaguchi, Y; Koizumi, N; Sano, H				Ogita, S; Uefuji, H; Yamaguchi, Y; Koizumi, N; Sano, H			RNA interference - Producing decaffeinated coffee plants	NATURE			English	Editorial Material							CAFFEINE; GENE		Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, Nara 6300192, Japan	Nara Institute of Science & Technology	Ogita, S (corresponding author), Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, Nara 6300192, Japan.		Yamaguchi, Yube/B-9594-2012					Ashihara H, 1996, PLANT PHYSIOL, V111, P747, DOI 10.1104/pp.111.3.747; Ashihara H, 2001, TRENDS PLANT SCI, V6, P407, DOI 10.1016/S1360-1385(01)02055-6; Hatanaka T, 1999, PLANT CELL REP, V19, P106, DOI 10.1007/s002990050719; Ogawa M, 2001, J BIOL CHEM, V276, P8213, DOI 10.1074/jbc.M009480200; OHTA S, 1990, PLANT CELL PHYSIOL, V31, P805; Uefuji H, 2003, PLANT PHYSIOL, V132, P372, DOI 10.1104/pp.102.019679	6	149	196	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					823	823		10.1038/423823a	http://dx.doi.org/10.1038/423823a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815419	Bronze			2022-12-24	WOS:000183585300032
J	Schiermeier, Q				Schiermeier, Q			Researchers rattled as Kyoto Protocol hangs in the balance	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					792	792		10.1038/423792b	http://dx.doi.org/10.1038/423792b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815393	Bronze			2022-12-24	WOS:000183585300010
J	Verghese, J; Lipton, RB; Katz, MJ; Hall, CB; Derby, CA; Kuslansky, G; Ambrose, AF; Sliwinski, M; Buschke, H				Verghese, J; Lipton, RB; Katz, MJ; Hall, CB; Derby, CA; Kuslansky, G; Ambrose, AF; Sliwinski, M; Buschke, H			Leisure activities and the risk of dementia in the elderly	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALZHEIMERS-DISEASE; PHYSICAL-ACTIVITY; COGNITIVE IMPAIRMENT; DIETARY-INTAKE; LATE-LIFE; MEMORY; ASSOCIATION; PREVALENCE; DIAGNOSIS; EDUCATION	BACKGROUND: Participation in leisure activities has been associated with a lower risk of dementia. It is unclear whether increased participation in leisure activities lowers the risk of dementia or participation in leisure activities declines during the preclinical phase of dementia. METHODS: We examined the relation between leisure activities and the risk of dementia in a prospective cohort of 469 subjects older than 75 years of age who resided in the community and did not have dementia at base line. We examined the frequency of participation in leisure activities at enrollment and derived cognitive-activity and physical-activity scales in which the units of measure were activity-days per week. Cox proportional-hazards analysis was used to evaluate the risk of dementia according to the base-line level of participation in leisure activities, with adjustment for age, sex, educational level, presence or absence of chronic medical illnesses, and base-line cognitive status. RESULTS: Over a median follow-up period of 5.1 years, dementia developed in 124 subjects (Alzheimer's disease in 61 subjects, vascular dementia in 30, mixed dementia in 25, and other types of dementia in 8). Among leisure activities, reading, playing board games, playing musical instruments, and dancing were associated with a reduced risk of dementia. A one-point increment in the cognitive-activity score was significantly associated with a reduced risk of dementia (hazard ratio, 0.93 [95 percent confidence interval, 0.90 to 0.97]), but a one-point increment in the physical-activity score was not (hazard ratio, 1.00). The association with the cognitive-activity score persisted after the exclusion of the subjects with possible preclinical dementia at base line. Results were similar for Alzheimer's disease and vascular dementia. In linear mixed models, increased participation in cognitive activities at base line was associated with reduced rates of decline in memory. CONCLUSIONS: Participation in leisure activities is associated with a reduced risk of dementia, even after adjustment for base-line cognitive status and after the exclusion of subjects with possible preclinical dementia. Controlled trials are needed to assess the protective effect of cognitive leisure activities on the risk of dementia.	Albert Einstein Coll Med, Einstein Aging Study, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Phys Med & Rehabil, Bronx, NY 10467 USA; Syracuse Univ, Dept Psychol, Syracuse, NY USA; Syracuse Univ, Ctr Hlth & Behav, Syracuse, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Syracuse University; Syracuse University	Verghese, J (corresponding author), Albert Einstein Coll Med, Einstein Aging Study, 1165 Morris Pk Ave, Bronx, NY 10461 USA.	jverghes@aecom.yu.edu	Lipton, Richard Bruce/AAY-2818-2021; Ambrose, Anne Felicia/ABE-4161-2020; Sliwinski, Martin/HGC-5907-2022; Ambrose, Anne Felicia/AAQ-9668-2021; Lipton, Richard B/B-5060-2011; Hall, Charles B./AAX-8216-2020	Hall, Charles/0000-0001-9982-8120	NATIONAL INSTITUTE ON AGING [P01AG003949] Funding Source: NIH RePORTER; NIA NIH HHS [AGO3949-15] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; ARONSON MK, 1990, NEUROLOGY, V40, P1102, DOI 10.1212/WNL.40.7.1102; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Christmas C, 2000, J AM GERIATR SOC, V48, P318, DOI 10.1111/j.1532-5415.2000.tb02654.x; CHUI HC, 1992, NEUROLOGY, V42, P473, DOI 10.1212/WNL.42.3.473; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; COX DR, 1972, J R STAT SOC B, V34, P187; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; FABRIGOULE C, 1995, J AM GERIATR SOC, V43, P485, DOI 10.1111/j.1532-5415.1995.tb06093.x; Fleiss J, 1981, STAT METHODS RATES P, P38; Fratiglioni L, 1999, DRUG AGING, V15, P365, DOI 10.2165/00002512-199915050-00004; Friedland RP, 2001, P NATL ACAD SCI USA, V98, P3440, DOI 10.1073/pnas.061002998; FULD PA, 1990, J CLIN EXP NEUROPSYC, V12, P520, DOI 10.1080/01688639008400998; Fuld PA., 1978, ALZHEIMERS DIS SENIL, V7, P185; Grober E, 1999, NEUROBIOL AGING, V20, P573, DOI 10.1016/S0197-4580(99)00063-9; Hall CB, 2001, STAT MED, V20, P3695, DOI 10.1002/sim.1113; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; KATZMAN R, 1993, NEUROLOGY, V43, P13, DOI 10.1212/WNL.43.1_Part_1.13; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; KONDO K, 1994, DEMENTIA, V5, P314, DOI 10.1159/000106741; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Mazzeo RS, 1998, MED SCI SPORT EXER, V30, P992, DOI 10.1097/00005768-199806000-00033; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morris MC, 2002, JAMA-J AM MED ASSOC, V287, P3230, DOI 10.1001/jama.287.24.3230; National Collaborative Group for the Revision of the Wechsler Adult Intelligence Scale, 1983, MANUAL WECHSLER ADUL, V03, P362; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; ROGERS RL, 1990, J AM GERIATR SOC, V38, P123, DOI 10.1111/j.1532-5415.1990.tb03472.x; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; Verghese J, 2002, NEW ENGL J MED, V347, P1761, DOI 10.1056/NEJMoa020441; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Wilson RS, 2002, J NEUROL NEUROSUR PS, V73, P672, DOI 10.1136/jnnp.73.6.672; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; ZUNG WWK, 1967, PSYCHOSOMATICS, V8, P287	43	1130	1161	10	329	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2003	348	25					2508	2516		10.1056/NEJMoa022252	http://dx.doi.org/10.1056/NEJMoa022252			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	690YC	12815136				2022-12-24	WOS:000183577200005
J	Enquist, BJ; Economo, EP; Huxman, TE; Allen, AP; Ignace, DD; Gillooly, JF				Enquist, BJ; Economo, EP; Huxman, TE; Allen, AP; Ignace, DD; Gillooly, JF			Scaling metabolism from organisms to ecosystems	NATURE			English	Article							CARBON-DIOXIDE; WATER-VAPOR; TEMPERATURE; RESPIRATION; SIZE; EXCHANGE; ECOLOGY; FLUXES; RATES; SOIL	Understanding energy and material fluxes through ecosystems is central to many questions in global change biology and ecology(1-11). Ecosystem respiration is a critical component of the carbon cycle(1,5-7) and might be important in regulating biosphere response to global climate change(1-3). Here we derive a general model of ecosystem respiration based on the kinetics of metabolic reactions(11-13) and the scaling of resource use by individual organisms(14,15). The model predicts that fluxes of CO2 and energy are invariant of ecosystem biomass, but are strongly influenced by temperature, variation in cellular metabolism and rates of supply of limiting resources (water and/or nutrients). Variation in ecosystem respiration within sites, as calculated from a network of CO2 flux towers(5,7), provides robust support for the model's predictions. However, data indicate that variation in annual flux between sites is not strongly dependent on average site temperature or latitude. This presents an interesting paradox with regard to the expected temperature dependence. Nevertheless, our model provides a basis for quantitatively understanding energy and material flux between the atmosphere and biosphere.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; Ctr Appl Biodivers Sci, Washington, DC 20036 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of Arizona; University of New Mexico	Enquist, BJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	benquist@u.arizona.edu	Enquist, Brian J/B-6436-2008; Allen, Andrew/B-8045-2011	Enquist, Brian J/0000-0002-6124-7096; Allen, Andrew/0000-0003-0304-7544				Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; BALDOCCHI DD, 1988, ECOLOGY, V69, P1331, DOI 10.2307/1941631; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; EARNSHAW MJ, 1981, ARCTIC ALPINE RES, V13, P425, DOI 10.2307/1551053; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; ENQUIST BJ, IN PRESS MACROECOLOG; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; HEMMINGSEN AXEL M., 1960, REPTS STENO HOSP COPENHAGEN, V9, P7; Huxman TE, 2003, OECOLOGIA, V134, P537, DOI 10.1007/s00442-002-1131-1; JORDAN CF, 1971, AM SCI, V59, P425; Keeling C.D., 1994, TRENDS 93 COMPENDIUM, P16; Law BE, 2002, AGR FOREST METEOROL, V113, P97, DOI 10.1016/S0168-1923(02)00104-1; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; MOONEY HA, 1961, ECOL MONOGR, V31, P1, DOI 10.2307/1950744; Nelson DL, 2000, LEHNINGER PRINCIPLES; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; NOBEL PS, 1999, PHYSIOCHEMICAL ENV P; PEARCY RW, 1977, PLANT PHYSIOL, V59, P795, DOI 10.1104/pp.59.5.795; RAISON J K, 1976, Australian Journal of Plant Physiology, V3, P291; RAVEN JA, 1988, NEW PHYTOL, V110, P441, DOI 10.1111/j.1469-8137.1988.tb00282.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Running SW, 1999, REMOTE SENS ENVIRON, V70, P108, DOI 10.1016/S0034-4257(99)00061-9; SCHULZE ED, 1994, ANNU REV ECOL SYST, V25, P629, DOI 10.1146/annurev.es.25.110194.003213; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; VETTER RAH, 1995, J COMP PHYSIOL B, V165, P46, DOI 10.1007/BF00264685; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799	33	272	289	6	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2003	423	6940					639	642		10.1038/nature01671	http://dx.doi.org/10.1038/nature01671			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789338	Bronze			2022-12-24	WOS:000183301200040
J	Cinatl, J; Morgenstern, B; Bauer, G; Chandra, P; Rabenau, H; Doerr, HW				Cinatl, J; Morgenstern, B; Bauer, G; Chandra, P; Rabenau, H; Doerr, HW			Treatment of SARS with human interferons	LANCET			English	Article							IDENTIFICATION; CORONAVIRUS; VIRUS	Effective antiviral agents are needed to treat severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infection. We assessed the antiviral potential of recombinant interferons against two clinical isolates of SARS-CoV-FFM-1, from Frankfurt patients, and Hong Kong-replicated in Vero and Caco2 cells. Interferon beta was five to ten times more effective in Caco2 cells. Interferon alpha effectively inhibited SARS-CoV replication, but with a selectivity index 50-90 times lower than that for interferon beta. Interferon gamma was slightly better than interferon alpha in Vero cell cultures, but was completely ineffective in Caco2 cell cultures. Interferon beta could be useful alone or in combination with other antiviral drugs for the treatment of SARS.	Univ Frankfurt, Sch Med, Inst Med Virol, D-60596 Frankfurt, Germany	Goethe University Frankfurt	Cinatl, J (corresponding author), Univ Frankfurt, Sch Med, Inst Med Virol, Paul Ehrlich Str 40, D-60596 Frankfurt, Germany.	cinatl@em.uni-frankfurt.de						Cinatl J, 2003, LANCET, V361, P2045, DOI 10.1016/S0140-6736(03)13615-X; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Garcia S, 2001, J CLIN MICROBIOL, V39, P4456, DOI 10.1128/JCM.39.12.4456-4461.2001; Pitkaranta A, 1999, J CLIN VIROL, V14, P199, DOI 10.1016/S1386-6532(99)00056-6	5	317	361	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					293	294		10.1016/S0140-6736(03)13973-6	http://dx.doi.org/10.1016/S0140-6736(03)13973-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892961	Bronze, Green Published			2022-12-24	WOS:000184413400013
J	Kim, M; McCormick, S; Timmermans, M; Sinha, N				Kim, M; McCormick, S; Timmermans, M; Sinha, N			The expression domain of PHANTASTICA determines leaflet placement in compound leaves	NATURE			English	Article								Diverse leaf forms in nature can be categorized as simple or compound. Simple leaves, such as those of petunia, have a single unit of blade, whereas compound leaves, such as those of tomato, have several units of blades called leaflets. Compound leaves can be pinnate, with leaflets arranged in succession on a rachis, or palmate, with leaflets clustered together at the leaf tip. The mechanisms that generate these various leaf forms are largely unknown. The upper (adaxial) surface is usually different from the bottom (abaxial) surface in both simple and compound leaves. In species with simple leaves, the specification of adaxial and abaxial cells is important for formation of the leaf blade(1,2), and the MYB transcription factor gene PHANTASTICA (PHAN) is involved in maintaining the leaf adaxial (upper) domain(3,4). Here we show that downregulation of PHAN is sufficient to reduce the adaxial domain of leaf primordia and to change pinnate compound leaves into palmate compound leaves. Furthermore, this mechanism seems to be shared among compound leaves that arose independently.	Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA; USDA ARS, Ctr Plant Gene Express, Albany, CA 94710 USA; Univ Calif Berkeley, Albany, CA 94710 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of California System; University of California Davis; United States Department of Agriculture (USDA); University of California System; University of California Berkeley; Cold Spring Harbor Laboratory	Sinha, N (corresponding author), Univ Calif Davis, Plant Biol Sect, 1 Shields Ave, Davis, CA 95616 USA.	nrsinha@ucdavis.edu		Sinha, Neelima/0000-0002-1494-7065; McCormick, Sheila/0000-0001-9106-9385				Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Gellon G, 1998, BIOESSAYS, V20, P116, DOI 10.1002/(SICI)1521-1878(199802)20:2<116::AID-BIES4>3.3.CO;2-N; Gleissberg S, 1999, INT J PLANT SCI, V160, P787, DOI 10.1086/314165; JACKSON D, 1994, DEVELOPMENT, V120, P405; Kessler S, 2001, INT J PLANT SCI, V162, P475, DOI 10.1086/320136; Koltai H, 2000, PLANT J, V22, P455, DOI 10.1046/j.1365-313X.2000.00754.x; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; MCCORMICK S, 1991, PLANT TISSUE CULTU B, V6, P1; Pien S, 2001, PLANT J, V25, P663, DOI 10.1046/j.1365-313x.2001.01002.x; Ruiz-Medrano R, 1999, DEVELOPMENT, V126, P4405; Sun Y, 2002, PLANTA, V214, P694, DOI 10.1007/s004250100673; Timmermans MCP, 1999, SCIENCE, V284, P151, DOI 10.1126/science.284.5411.151; Tsiantis M, 1999, SCIENCE, V284, P154, DOI 10.1126/science.284.5411.154; WAITES R, 1995, DEVELOPMENT, V121, P2143; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7	19	109	116	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					438	443		10.1038/nature01820	http://dx.doi.org/10.1038/nature01820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879073				2022-12-24	WOS:000184318400046
J	Shergill, SS; Bays, PM; Frith, CD; Wolpert, DM				Shergill, SS; Bays, PM; Frith, CD; Wolpert, DM			Two eyes for an eye: The neuroscience of force escalation	SCIENCE			English	Article							MOVEMENT		UCL, Inst Neurol, London WC1N 3BG, England; Inst Psychiat, London, England	University of London; University College London; University of London; King's College London	Wolpert, DM (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.	wolpert@hera.ucl.ac.uk	Bays, Paul/B-3999-2009; Shergill, Sukhi S/G-7725-2011; Frith, Chris/A-2171-2009	Frith, Chris/0000-0002-8665-0690; Bays, Paul/0000-0003-4684-4893; shergill, sukhi/0000-0003-4928-9100				ANGEL RW, 1982, EXP NEUROL, V77, P266, DOI 10.1016/0014-4886(82)90244-8; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 1998, J NEUROSCI, V18, P7511; CHAPMAN CE, 1987, EXP BRAIN RES, V68, P516; CLAXTON G, 1975, PERCEPT MOTOR SKILL, V41, P335, DOI 10.2466/pms.1975.41.1.335; Curio G, 2000, HUM BRAIN MAPP, V9, P183, DOI 10.1002/(SICI)1097-0193(200004)9:4<183::AID-HBM1>3.0.CO;2-Z; MILNE RJ, 1988, EXP BRAIN RES, V70, P569; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; von Holst E, 1954, BRIT J ANIM BEHAV, V2, P89, DOI DOI 10.1016/S0950-5601(54)80044-X; WEISKRANTZ L, 1971, NATURE, V230, P598, DOI 10.1038/230598a0; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	11	260	260	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2003	301	5630					187	187		10.1126/science.1085327	http://dx.doi.org/10.1126/science.1085327			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855800	Green Submitted			2022-12-24	WOS:000184056200033
J	Nieuwenhuizen, WF; Pieters, RHH; Knippels, LMJ; Jansen, MCJF; Koppelman, SJ				Nieuwenhuizen, WF; Pieters, RHH; Knippels, LMJ; Jansen, MCJF; Koppelman, SJ			Is Candida albicans a trigger in the onset of coeliac disease?	LANCET			English	Article							CELIAC-DISEASE; TISSUE TRANSGLUTAMINASE; DERMATITIS-HERPETIFORMIS; MICE; GLIADIN; COLONIZATION; AUTOANTIGEN; SUBSTRATE; PROTEINS; PEPTIDES	Coeliac disease is a T-cell-mediated autoimmune disease of the small intestine that is induced by ingestion of gluten proteins from wheat, barley, or rye. We postulate that Candida albicans is a trigger in the onset of coeliac disease. The virulence factor of C albicans-hyphal wall protein 1 (HWP1)-contains aminoacid sequences that are identical or highly homologous to known coeliac disease-related a-gliadin and gamma-gliadin T-cell epitopes. HWP1 is a transglutaminase substrate, and is used by C albicans to adhere to the intestinal epithelium. Furthermore, tissue transglutaminase and endomysium components could become covalently linked to the yeast. Subsequently, C albicans might function as an adjuvant that stimulates antibody formation against HWP1 and gluten, and formation of autoreactive antibodies against tissue transglutaminase and endomysium.	TNO, NL-3700 AJ Zeist, Netherlands; Univ Utrecht, Dept Immunotoxicol, Inst Risk Assessment Sci, NL-3508 TD Utrecht, Netherlands	Netherlands Organization Applied Science Research; Utrecht University	Nieuwenhuizen, WF (corresponding author), TNO, POB 360, NL-3700 AJ Zeist, Netherlands.							Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; ARRESE JE, 1995, DERMATOLOGY, V190, P119, DOI 10.1159/000246659; Black KE, 2002, J IMMUNOL, V169, P5595, DOI 10.4049/jimmunol.169.10.5595; BRADWAY SD, 1993, CRIT REV ORAL BIOL M, V4, P293, DOI 10.1177/10454411930040030601; DEREPENTIGNY L, 1992, INFECT IMMUN, V60, P4907, DOI 10.1128/IAI.60.11.4907-4914.1992; Hervonen K, 2002, SCAND J GASTROENTERO, V37, P51, DOI 10.1080/003655202753387356; KAGNOFF MF, 1984, J EXP MED, V160, P1544, DOI 10.1084/jem.160.5.1544; Lacour M, 2002, INT J HYG ENVIR HEAL, V205, P257, DOI 10.1078/1438-4639-00159; Piper JL, 2002, BIOCHEMISTRY-US, V41, P386, DOI 10.1021/bi011715x; Sardy M, 2002, J EXP MED, V195, P747, DOI 10.1084/jem.20011299; Seissler J, 2001, CLIN EXP IMMUNOL, V125, P216, DOI 10.1046/j.1365-2249.2001.01584.x; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Stern M, 2000, J PEDIATR GASTR NUTR, V31, P513, DOI 10.1097/00005176-200011000-00012; Sundstrom P, 2002, J INFECT DIS, V185, P521, DOI 10.1086/338836; TlaskalovaHogenova H, 1997, ANN NY ACAD SCI, V815, P503, DOI 10.1111/j.1749-6632.1997.tb52115.x; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; VESY CJ, 1993, MODERN PATHOL, V6, P61	20	43	44	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 21	2003	361	9375					2152	2154		10.1016/S0140-6736(03)13695-1	http://dx.doi.org/10.1016/S0140-6736(03)13695-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	692GY	12826451				2022-12-24	WOS:000183654200026
J	Elf, J; Nilsson, D; Tenson, T; Ehrenberg, M				Elf, J; Nilsson, D; Tenson, T; Ehrenberg, M			Selective charging of tRNA isoacceptors explains patterns of codon usage	SCIENCE			English	Article							TRANSFER-RNA ABUNDANCE; ESCHERICHIA-COLI; SEQUENCE; TRANSLATION; ADAPTATION; ACCURACY; PPGPP	We modeled how the charged levels of different transfer RNAs (tRNAs) that carry the same amino acid ( isoacceptors) respond when this amino acid becomes growth-limiting. The charged levels will approach zero for some isoacceptors (such as tRNA(2)(Leu)) and remain high for others (such as tRNA(4)(Leu)), as determined by the concentrations of isoacceptors and how often their codons occur in protein synthesis. The theory accounts for ( synonymous) codons for the same amino acid that are used in ribosome-mediated transcriptional attenuation, the choices of synonymous codons in trans-translating transfer-messenger RNA, and the overrepresentation of rare codons in messenger RNAs for amino acid biosynthetic enzymes.	Uppsala Univ, Ctr Biomed, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; Karolinska Inst, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden; Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	Uppsala University; Karolinska Institutet; University of Tartu	Ehrenberg, M (corresponding author), Uppsala Univ, Ctr Biomed, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden.	ehrenberg@xray.bmc.uu.se	Nilsson, Daniel/B-8365-2009; Tenson, Tanel/I-6431-2015	Nilsson, Daniel/0000-0001-5831-385X; Tenson, Tanel/0000-0002-0260-3601; elf, johan/0000-0001-5522-1810				Barak Z, 1996, J MOL BIOL, V256, P676, DOI 10.1006/jmbi.1996.0117; BJORK GR, 1996, CELLULAR MOL BIOL, P861; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOCK A, 1966, J BACTERIOL, V92, P1076; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; CASHEL M, 1996, CELLULAR MOL BIOL, P1458; CRICK FH, 1961, NATURE, V192, P1227, DOI 10.1038/1921227a0; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; EHRENBERG M, 1984, Q REV BIOPHYS, V17, P45, DOI 10.1017/S0033583500005254; EHRENBERG M, UNPUB; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; LANDICK R, 1987, CELLULAR MOL BIOL, P1276; MORRIS DW, 1965, J BACTERIOL, V90, P1624, DOI 10.1128/JB.90.6.1624-1631.1965; Nakamura Y, 1996, NUCLEIC ACIDS RES, V24, P214, DOI 10.1093/nar/24.1.214; NEIDHARDT FC, 1996, CELLULAR MOL BIOL; OFARRELL PH, 1978, CELL, V14, P545, DOI 10.1016/0092-8674(78)90241-6; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; POST LE, 1979, P NATL ACAD SCI USA, V76, P1697, DOI 10.1073/pnas.76.4.1697; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sorensen MA, 2001, J MOL BIOL, V307, P785, DOI 10.1006/jmbi.2001.4525; Withey JH, 2002, CURR OPIN MICROBIOL, V5, P154, DOI 10.1016/S1369-5274(02)00299-0; YANOFSKY C, 1981, NATURE, V289, P751, DOI 10.1038/289751a0; YEGIAN CD, 1969, J MOL BIOL, V39, P45, DOI 10.1016/0022-2836(69)90332-5	27	182	187	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2003	300	5626					1718	1722		10.1126/science.1083811	http://dx.doi.org/10.1126/science.1083811			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805541				2022-12-24	WOS:000183459700043
J	Le Roch, KG; Zhou, YY; Blair, PL; Grainger, M; Moch, JK; Haynes, JD; De la Vega, P; Holder, AA; Batalov, S; Carucci, DJ; Winzeler, EA				Le Roch, KG; Zhou, YY; Blair, PL; Grainger, M; Moch, JK; Haynes, JD; De la Vega, P; Holder, AA; Batalov, S; Carucci, DJ; Winzeler, EA			Discovery of gene function by expression profiling of the malaria parasite life cycle	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; STABLE TRANSFECTION; ANTIGENIC VARIATION; EBL FAMILY; SEQUENCE; PROTEIN; SPOROZOITE; CHROMOSOME-2; SURFACE; KINASE	The completion of the genome sequence for Plasmodium falciparum, the species responsible for most malaria human deaths, has the potential to reveal hundreds of new drug targets and proteins involved in pathogenesis. However, only similar to35% of the genes code for proteins with an identifiable function. The absence of routine genetic tools for studying Plasmodium parasites suggests that this number is unlikely to change quickly if conventional serial methods are used to characterize encoded proteins. Here, we use a high-density oligonucleotide array to generate expression profiles of human and mosquito stages of the malaria parasite's life cycle. Genes with highly correlated levels and temporal patterns of expression were often involved in similar functions or cellular processes.	Scripps Res Inst, Dept Cell Biol ICND202, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; USN, Med Res Ctr, Malaria Program, Silver Spring, MD 20910 USA; Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; Walter Reed Army Inst Res, Dept Immunol, Silver Spring, MD 20910 USA	Scripps Research Institute; Novartis; United States Department of Defense; United States Navy; MRC National Institute for Medical Research; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Le Roch, KG (corresponding author), Scripps Res Inst, Dept Cell Biol ICND202, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Winzeler, Elizabeth/AAP-6752-2020; Holder, Anthony A/A-7554-2013	Winzeler, Elizabeth/0000-0002-4049-2113; Holder, Anthony A/0000-0002-8490-6058; Batalov, Sergey/0000-0002-0925-0554	MRC [MC_U117532067] Funding Source: UKRI; Medical Research Council [MC_U117532067] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Birago C, 2003, MOL BIOCHEM PARASIT, V126, P209, DOI 10.1016/S0166-6851(02)00275-X; Blair PL, 2002, MOL BIOCHEM PARASIT, V122, P35, DOI 10.1016/S0166-6851(02)00067-1; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Doerig CM, 1996, GENE, V177, P1, DOI 10.1016/0378-1119(96)00281-8; Dorin D, 1999, J BIOL CHEM, V274, P29912, DOI 10.1074/jbc.274.42.29912; Dorin D, 2001, EUR J BIOCHEM, V268, P2600, DOI 10.1046/j.1432-1327.2001.02151.x; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Fidock DA, 1997, EUR J IMMUNOL, V27, P2502, DOI 10.1002/eji.1830271007; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Gatton ML, 2003, TRENDS PARASITOL, V19, P202, DOI 10.1016/S1471-4922(03)00067-9; Ghai M, 2002, MOL BIOCHEM PARASIT, V123, P35, DOI 10.1016/S0166-6851(02)00123-8; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Haynes J David, 2002, Methods Mol Med, V72, P489, DOI 10.1385/1-59259-271-6:489; Hyman RW, 2002, NATURE, V419, P534, DOI 10.1038/nature01102; Kappe SHI, 2001, P NATL ACAD SCI USA, V98, P9895, DOI 10.1073/pnas.171185198; Kaviratne M, 2002, EUKARYOT CELL, V1, P926, DOI 10.1128/EC.1.6.926-935.2002; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2002, AM J TROP MED HYG, V67, P233, DOI 10.4269/ajtmh.2002.67.233; LEROCH KG, UNPUB; Ling, UNPUB; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; Rathod PK, 2002, TRENDS PARASITOL, V18, P39, DOI 10.1016/S1471-4922(01)02153-5; SHERMAN IW, 1979, MICROBIOL REV, V43, P453, DOI 10.1128/MMBR.43.4.453-495.1979; Spielmann T, 2003, MOL BIOL CELL, V14, P1529, DOI 10.1091/mbc.E02-04-0240; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tachibana M, 2001, MOL BIOCHEM PARASIT, V113, P341, DOI 10.1016/S0166-6851(01)00231-6; Trenholme KR, 2000, P NATL ACAD SCI USA, V97, P4029, DOI 10.1073/pnas.040561197; VANDIJK MR, 1995, SCIENCE, V268, P1358, DOI 10.1126/science.7761856; Winter G, 2003, MOL BIOCHEM PARASIT, V127, P179, DOI 10.1016/S0166-6851(03)00004-5; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; Zhou YY, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-3	44	963	980	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2003	301	5639					1503	1508		10.1126/science.1087025	http://dx.doi.org/10.1126/science.1087025			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	720HL	12893887				2022-12-24	WOS:000185255300040
J	Daubin, V; Moran, NA; Ochman, H				Daubin, V; Moran, NA; Ochman, H			Phylogenetics and the cohesion of bacterial genomes	SCIENCE			English	Article							MAXIMUM-LIKELIHOOD METHOD; ESCHERICHIA-COLI; SEQUENCE DATA; GENE-TRANSFER; RECOMBINATION; TOPOLOGIES; EVOLUTION; BLAST	Gene acquisition is an ongoing process in many bacterial genomes, contributing to adaptation and ecological diversification. Lateral gene transfer is considered the primary explanation for discordance among gene phylogenies and as an obstacle to reconstructing the tree of life. We measured the extent of phylogenetic conflict and alien-gene acquisition within quartets of sequenced genomes. Although comparisons of complete gene inventories indicate appreciable gain and loss of genes, orthologs available for phylogenetic reconstruction are consistent with a single tree.	Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Ochman, H (corresponding author), Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA.	hochman@email.arizona.edu	chen, qi/C-8585-2011; Moran, Nancy A/G-1591-2010	Daubin, Vincent/0000-0001-8269-9430				Adachi J, 1996, MOL PHYLOGENET EVOL, V6, P72, DOI 10.1006/mpev.1996.0059; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; DOOLITTLE WF, 1999, TRENDS CELL BIOL, V9, P5, DOI DOI 10.1016/S0168-9525(99)01877-6; DYKHUIZEN DE, 1991, J BACTERIOL, V173, P7257, DOI 10.1128/jb.173.22.7257-7268.1991; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; GRAUR D, 1991, NATURE, V351, P649, DOI 10.1038/351649a0; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; Hedges SB, 1999, SCIENCE, V283, P998, DOI 10.1126/science.283.5404.998; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Hughes S, 2001, J MOL EVOL, V53, P70, DOI 10.1007/s002390010194; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Millman KL, 2001, J BACTERIOL, V183, P5997, DOI 10.1128/JB.183.20.5997-6008.2001; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nesbo CL, 2001, J MOL EVOL, V53, P340, DOI 10.1007/s002390010224; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Philippe Herve, 1994, Journal of Mammalian Evolution, V2, P133, DOI 10.1007/BF01464365; Raymond J, 2002, SCIENCE, V298, P1616, DOI 10.1126/science.1075558; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Zhaxybayeva O, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-4	27	192	203	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					829	832		10.1126/science.1086568	http://dx.doi.org/10.1126/science.1086568			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907801				2022-12-24	WOS:000184615700044
J	Wiedemann, N; Kozjak, V; Chacinska, A; Schonfisch, B; Rospert, S; Ryan, MT; Pfanner, N; Meisinger, C				Wiedemann, N; Kozjak, V; Chacinska, A; Schonfisch, B; Rospert, S; Ryan, MT; Pfanner, N; Meisinger, C			Machinery for protein sorting and assembly in the mitochondrial outer membrane	NATURE			English	Article							GENERAL IMPORT PORE; TOM COMPLEX; RECEPTORS; PREPROTEINS; BIOGENESIS; CHANNEL; TRANSLOCATION	Mitochondria contain translocases for the transport of precursor proteins across their outer and inner membranes(1-5). It has been assumed that the translocases also mediate the sorting of proteins to their submitochondrial destination(1,2,5-10). Here we show that the mitochondrial outer membrane contains a separate sorting and assembly machinery (SAM) that operates after the translocase of the outer membrane (TOM). Mas37 forms a constituent of the SAM complex. The central role of the SAM complex in the sorting and assembly pathway of outer membrane proteins explains the various pleiotropic functions that have been ascribed to Mas37 (refs 4, 11-15). These results suggest that the TOM complex, which can transport all kinds of mitochondrial precursor proteins, is not sufficient for the correct integration of outer membrane proteins with a complicated topology, and instead transfers precursor proteins to the SAM complex.	Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle Saale, Germany	University of Freiburg; University of Freiburg; Max Planck Society	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Hermann Herder Str 7, D-79104 Freiburg, Germany.		Pfanner, Nikolaus/AAV-7878-2021; Kozjak-Pavlovic, Vera/E-1494-2013; Ryan, Michael/X-2152-2019; Meisinger, Chris/J-1110-2014; Ryan, Michael T/C-6673-2011	Kozjak-Pavlovic, Vera/0000-0001-9658-7018; Ryan, Michael/0000-0003-2586-8829; Meisinger, Chris/0000-0002-8326-3548; Ryan, Michael T/0000-0003-2586-8829; Wiedemann, Nils/0000-0001-8305-6728; Chacinska, Agnieszka/0000-0002-2832-2568; Rospert, Sabine/0000-0002-3089-9614				Abdul KM, 2000, BIOCHEM BIOPH RES CO, V276, P1028, DOI 10.1006/bbrc.2000.3589; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Dietmeier K, 1997, NATURE, V388, P195, DOI 10.1038/40663; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; GRATZER S, 1995, J CELL BIOL, V129, P25, DOI 10.1083/jcb.129.1.25; HACHIYA N, 1995, NATURE, V376, P705, DOI 10.1038/376705a0; Herrmann JM, 2000, CURR OPIN MICROBIOL, V3, P210, DOI 10.1016/S1369-5274(00)00077-1; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; Koehler CM, 1999, TRENDS BIOCHEM SCI, V24, P428, DOI 10.1016/S0968-0004(99)01462-0; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973; Martelli Pier Luigi, 2002, Bioinformatics, V18 Suppl 1, pS46; Matouschek A, 2001, NAT STRUCT BIOL, V8, P284, DOI 10.1038/86140; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Rapaport D, 1999, J CELL BIOL, V146, P321, DOI 10.1083/jcb.146.2.321; Rapaport D, 2002, TRENDS BIOCHEM SCI, V27, P191, DOI 10.1016/S0968-0004(02)02065-0; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361; Taylor RD, 2003, J BIOL CHEM, V278, P765, DOI 10.1074/jbc.M208083200; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802	24	288	302	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					565	571		10.1038/nature01753	http://dx.doi.org/10.1038/nature01753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891361				2022-12-24	WOS:000184454700046
J	Johansson, L; Rytkonen, A; Bergman, P; Albiger, B; Kallstrom, H; Hokfelt, T; Agerberth, B; Cattaneo, R; Jonsson, AB				Johansson, L; Rytkonen, A; Bergman, P; Albiger, B; Kallstrom, H; Hokfelt, T; Agerberth, B; Cattaneo, R; Jonsson, AB			CD46 in meningococcal disease	SCIENCE			English	Article							MEMBRANE COFACTOR PROTEIN; MEASLES-VIRUS; PATHOGENIC NEISSERIA; MULTIPLE ISOFORMS; CELLULAR RECEPTOR; EXPRESSION; COMPLEMENT; MCP; MENINGITIDIS; CELLS	The human-specific bacterial pathogen Neisseria meningitidis is a major cause of sepsis and/or meningitis. The pili of N. meningitidis interact with CD46, a human cell-surface protein involved in regulation of complement activation. Transgenic mice expressing human CD46 were susceptible to meningococcal disease, because bacteria crossed the blood-brain barrier in these mice. Development of disease was more efficient with piliated bacteria after intranasal, but not intraperitoneal, challenge of CD46 transgenic mice, suggesting that human CD46 facilitates pilus-dependent interactions at the epithelial mucosa. Hence, the human CD46 transgenic mice model is a potentially useful tool for studying pathogenesis and for vaccine development against meningococcal disease.	Ctr Microbiol & Tumor Biol, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden; Swedish Inst Infect Dis Control, SE-17182 Solna, Sweden; Mayo Clin & Mayo Fdn, Program Mol Med, Rochester, MN 55905 USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Mayo Clinic	Jonsson, AB (corresponding author), Ctr Microbiol & Tumor Biol, Nobels Vag 16,Box 280, SE-17177 Stockholm, Sweden.			Bergman, Peter/0000-0003-3306-3713				ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457, DOI 10.1177/40.10.1527370; Albiger B, 2003, INFECT IMMUN, V71, P155, DOI 10.1128/IAI.71.1.155-162.2003; Ayala BP, 2001, CELL MICROBIOL, V3, P265, DOI 10.1046/j.1462-5822.2001.00112.x; Brumovsky PR, 2002, EXP NEUROL, V174, P1, DOI 10.1006/exnr.2001.7845; Danielii J.F., 1958, GENERAL CYTOCHEMICAL, P399; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; DYER DW, 1987, MICROB PATHOGENESIS, V3, P351, DOI 10.1016/0882-4010(87)90005-2; JOHANSSON LS, UNPUB; JONSSON AB, 1991, EMBO J, V10, P477, DOI 10.1002/j.1460-2075.1991.tb07970.x; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kallstrom H, 1998, J BIOL CHEM, V273, P21777, DOI 10.1074/jbc.273.34.21777; Kemper C, 2001, CLIN EXP IMMUNOL, V124, P180, DOI 10.1046/j.1365-2249.2001.01458.x; Lee SW, 2002, J CELL BIOL, V156, P951, DOI 10.1083/jcb.200109005; Liszewski MK, 1996, J IMMUNOL, V156, P4415; MANCHESTER M, 1994, P NATL ACAD SCI USA, V91, P2161, DOI 10.1073/pnas.91.6.2161; Marie JC, 2002, NAT IMMUNOL, V3, P659, DOI 10.1038/ni810; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; Mrkic B, 1998, J VIROL, V72, P7420, DOI 10.1128/JVI.72.9.7420-7427.1998; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Nassif X, 1999, MOL MICROBIOL, V32, P1124, DOI 10.1046/j.1365-2958.1999.01416.x; OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489; POST TW, 1991, J EXP MED, V174, P93, DOI 10.1084/jem.174.1.93; PURCELL DFJ, 1991, IMMUNOGENETICS, V33, P335, DOI 10.1007/BF00216692; Rahman M, 1997, MOL MICROBIOL, V25, P11, DOI 10.1046/j.1365-2958.1997.4601823.x; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; Shusta EV, 2002, J NEUROPATH EXP NEUR, V61, P597, DOI 10.1093/jnen/61.7.597; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2	27	131	140	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					373	375		10.1126/science.1086476	http://dx.doi.org/10.1126/science.1086476			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869763				2022-12-24	WOS:000184207300046
J	Kelley, SP; Dunlop, JI; Kirkness, EF; Lambert, JJ; Peters, JA				Kelley, SP; Dunlop, JI; Kirkness, EF; Lambert, JJ; Peters, JA			A cytoplasmic region determines single-channel conductance in 5-HT3 receptors	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; STRUCTURAL BASIS; GATING KINETICS; ION PERMEATION; SUBUNIT; SELECTIVITY; EXPRESSION; PORE	5-Hydroxytryptamine type 3 (5-HT3) receptors are cation-selective transmitter-gated ion channels of the Cys-loop superfamily(1-9). The single-channel conductance of human recombinant 5-HT3 receptors assembled as homomers of 5-HT3A subunits, or heteromers of 5-HT3A and 5-HT3B subunits, are markedly different, being 0.4 pS (refs 6, 9) and 16 pS (ref. 7), respectively. Paradoxically, the channel-lining M2 domain of the 5-HT3A subunit would be predicted to promote cation conduction, whereas that of the 5-HT3B subunit would not(7). Here we describe a determinant of single-channel conductance that can explain these observations. By constructing chimaeric 5-HT3A and 5-HT3B subunits we identified a region (the 'HA-stretch')(10) within the large cytoplasmic loop of the receptor that markedly influences channel conductance. Replacement of three arginine residues unique to the HA-stretch of the 5-HT3A subunit by their 5-HT3B subunit counterparts increased single-channel conductance 28-fold. Significantly, ultrastructural studies of the Torpedo nicotinic acetylcholine receptor(11) indicate that the key residues might frame narrow openings that contribute to the permeation pathway. Our findings solve the conundrum of the anomalously low conductance of homomeric 5-HT3A receptors and indicate an important function for the HA-stretch in Cys-loop transmitter-gated ion channels.	Univ Dundee, Ninewells Hosp & Med Sch, Inst Neurosci, Dept Pharmacol & Neurosci, Dundee DD1 9SY, Scotland; Inst Genom Res, Rockville, MD 20850 USA	University of Dundee; J. Craig Venter Institute	Peters, JA (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Inst Neurosci, Dept Pharmacol & Neurosci, Dundee DD1 9SY, Scotland.	j.a.peters@dundee.ac.uk						Akk G, 2000, J PHYSIOL-LONDON, V527, P405, DOI 10.1111/j.1469-7793.2000.t01-2-00405.x; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Boyd GW, 2002, MOL CELL NEUROSCI, V21, P38, DOI 10.1006/mcne.2002.1160; Brown AM, 1998, J PHYSIOL-LONDON, V507, P653, DOI 10.1111/j.1469-7793.1998.653bs.x; Davies PA, 2003, J BIOL CHEM, V278, P712, DOI 10.1074/jbc.M208814200; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; DERKACH V, 1989, NATURE, V339, P706, DOI 10.1038/339706a0; Dubin AE, 1999, J BIOL CHEM, V274, P30799, DOI 10.1074/jbc.274.43.30799; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; GILL CH, 1995, BRIT J PHARMACOL, V114, P1211, DOI 10.1111/j.1476-5381.1995.tb13335.x; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Hanna MC, 2000, J NEUROCHEM, V75, P240, DOI 10.1046/j.1471-4159.2000.0750240.x; Higgins MK, 2002, EMBO J, V21, P2087, DOI 10.1093/emboj/21.9.2087; HUSSY N, 1994, J PHYSIOL-LONDON, V481, P311, DOI 10.1113/jphysiol.1994.sp020441; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Reeves DC, 2001, J BIOL CHEM, V276, P42035, DOI 10.1074/jbc.M106066200; Sambrook JFE, 1989, MOL CLONING LAB MANU; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Unwin N, 2000, PHILOS T R SOC B, V355, P1813, DOI 10.1098/rstb.2000.0737; YAKEL JL, 1988, NEURON, V1, P615, DOI 10.1016/0896-6273(88)90111-0; YAKEL JL, 1990, BRAIN RES, V533, P46, DOI 10.1016/0006-8993(90)91793-G; YANG J, 1990, J GEN PHYSIOL, V96, P1177, DOI 10.1085/jgp.96.6.1177; YU XM, 1994, NEURON, V13, P247, DOI 10.1016/0896-6273(94)90473-1	29	227	238	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					321	324		10.1038/nature01788	http://dx.doi.org/10.1038/nature01788			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867984	Green Accepted			2022-12-24	WOS:000184183900044
J	Wilson, JE				Wilson, JE			Building African AIDS care from the ground up	ANNALS OF INTERNAL MEDICINE			English	Editorial Material													Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136					0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2003	139	2					157	160		10.7326/0003-4819-139-2-200307150-00028	http://dx.doi.org/10.7326/0003-4819-139-2-200307150-00028			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701HX	12859173				2022-12-24	WOS:000184163100017
J	Calarese, DA; Scanlan, CN; Zwick, MB; Deechongkit, S; Mimura, Y; Kunert, R; Zhu, P; Wormald, MR; Stanfield, RL; Roux, KH; Kelly, JW; Rudd, PM; Dwek, RA; Katinger, H; Burton, DR; Wilson, IA				Calarese, DA; Scanlan, CN; Zwick, MB; Deechongkit, S; Mimura, Y; Kunert, R; Zhu, P; Wormald, MR; Stanfield, RL; Roux, KH; Kelly, JW; Rudd, PM; Dwek, RA; Katinger, H; Burton, DR; Wilson, IA			Antibody domain exchange is an immunological solution to carbohydrate cluster recognition	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; HIV-INACTIVATING PROTEIN; CD4 BINDING-SITE; CYANOVIRIN-N; CRYSTAL-STRUCTURE; DC-SIGN; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEINS; STRUCTURAL BASIS	Human antibody 2G12 neutralizes a broad range of human immunodeficiency virus type 1( HIV-1) isolates by binding an unusually dense cluster of carbohydrate moieties on the "silent" face of the gp120 envelope glycoprotein. Crystal structures of Fab 2G12 and its complexes with the disaccharide Manalpha1-2Man and with the oligosaccharide Man 9 GlcNAc 2 revealed that two Fabs assemble into an interlocked V-H domain-swapped dimer. Further biochemical, biophysical, and mutagenesis data strongly support a Fab-dimerized antibody as the prevalent form that recognizes gp120. The extraordinary configuration of this antibody provides an extended surface, with newly described binding sites, for multivalent interaction with a conserved cluster of oligomannose type sugars on the surface of gp120. The unique interdigitation of Fab domains within an antibody uncovers a previously unappreciated mechanism for high-affinity recognition of carbohydrate or other repeating epitopes on cell or microbial surfaces.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Oxford, Dept Biochem, Glycobiol Inst, Oxford OX1 3QU, England; Univ Bodenkultur Wien, Inst Appl Microbiol, A-1180 Vienna, Austria; Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Oxford; University of Natural Resources & Life Sciences, Vienna; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	burton@scripps.edu; wilson@scripps.edu	Stanfield, Robyn/AAH-3190-2019; Wormald, Mark R/G-2785-2011; Kunert, Renate E/B-9185-2018	Wormald, Mark R/0000-0002-4853-2773; Kunert, Renate E/0000-0002-3397-3621	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033292, R01AI033292] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33292] Funding Source: Medline; NIGMS NIH HHS [GM46192] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrientos LG, 2002, BIOCHEM BIOPH RES CO, V298, P598, DOI 10.1016/S0006-291X(02)02489-0; Bergdoll M, 1997, STRUCTURE, V5, P391, DOI 10.1016/S0969-2126(97)00196-2; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Carrasco B, 2001, BIOPHYS CHEM, V93, P181, DOI 10.1016/S0301-4622(01)00220-4; Chang LC, 2002, J MOL BIOL, V318, P1, DOI 10.1016/S0022-2836(02)00045-1; CONLEY AJ, 1994, P NATL ACAD SCI USA, V91, P3348, DOI 10.1073/pnas.91.8.3348; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Esser MT, 1999, J VIROL, V73, P4360, DOI 10.1128/JVI.73.5.4360-4371.1999; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Ferrantelli F, 2002, CURR OPIN IMMUNOL, V14, P495, DOI 10.1016/S0952-7915(02)00362-X; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; GELIN BR, 1979, BIOCHEMISTRY-US, V18, P1256, DOI 10.1021/bi00574a022; Hong PWP, 2002, J VIROL, V76, P12855, DOI 10.1128/JVI.76.24.12855-12865.2002; Kabat EA, 1991, SEQUENCES PROTEINS I; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LESK AM, 1988, NATURE, V335, P188, DOI 10.1038/335188a0; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; O'Keefe BR, 2000, MOL PHARMACOL, V58, P982, DOI 10.1124/mol.58.5.982; Parker CE, 2001, J VIROL, V75, P10906, DOI 10.1128/JVI.75.22.10906-10911.2001; Pei XY, 1997, P NATL ACAD SCI USA, V94, P9637, DOI 10.1073/pnas.94.18.9637; PERISIC O, 1994, STRUCTURE, V2, P1217, DOI 10.1016/S0969-2126(94)00123-5; PETRESCU AJ, UNPUB; PHILLIPS ML, 1994, MOL IMMUNOL, V31, P1201, DOI 10.1016/0161-5890(94)90034-5; Ragupathi G, 2002, P NATL ACAD SCI USA, V99, P13699, DOI 10.1073/pnas.202427599; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; SCANLON CN, UNPUB; Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Thomas R, 2002, J BIOL CHEM, V277, P2059, DOI 10.1074/jbc.M104364200; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Ultsch MH, 1999, J MOL BIOL, V290, P149, DOI 10.1006/jmbi.1999.2816; Weis WI, 1997, CURR OPIN STRUC BIOL, V7, P624, DOI 10.1016/S0959-440X(97)80070-X; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; WILSON IA, 1995, NAT STRUCT BIOL, V2, P433, DOI 10.1038/nsb0695-433; Woods RJ, 1998, EUR J BIOCHEM, V258, P372, DOI 10.1046/j.1432-1327.1998.2580372.x; Wormald MR, 2002, CHEM REV, V102, P371, DOI 10.1021/cr990368i; Yang F, 1999, J MOL BIOL, V288, P403, DOI 10.1006/jmbi.1999.2693; Zinkernagel RM, 2001, ADV IMMUNOL, V79, P1, DOI 10.1016/S0065-2776(01)79001-3; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	58	639	725	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2003	300	5628					2065	2071		10.1126/science.1083182	http://dx.doi.org/10.1126/science.1083182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12829775				2022-12-24	WOS:000183774900038
J	Mitrofanov, IG; Zuber, MT; Litvak, ML; Boynton, WV; Smith, DE; Drake, D; Hamara, D; Kozyrev, AS; Sanin, AB; Shinohara, C; Saunders, RS; Tretyakov, V				Mitrofanov, IG; Zuber, MT; Litvak, ML; Boynton, WV; Smith, DE; Drake, D; Hamara, D; Kozyrev, AS; Sanin, AB; Shinohara, C; Saunders, RS; Tretyakov, V			CO2 snow depth and subsurface water-ice abundance in the northern hemisphere of Mars	SCIENCE			English	Article							SUMMER TEMPERATURES; ORBITER CAMERA; POLAR-CAP; EVOLUTION; FROST; HYDROGEN; NEUTRONS; BEHAVIOR; DETECTOR; SURFACE	Observations of seasonal variations of neutron flux from the high-energy neutron detector (HEND) on Mars Odyssey combined with direct measurements of the thickness of condensed carbon dioxide by the Mars Orbiter Laser Altimeter (MOLA) on Mars Global Surveyor show a latitudinal dependence of northern winter deposition of carbon dioxide. The observations are also consistent with a shallow substrate consisting of a layer with water ice overlain by a layer of drier soil. The lower ice-rich layer contains between 50 and 75 weight % water, indicating that the shallow subsurface at northern polar latitudes on Mars is even more water rich than that in the south.	Russian Acad Sci, Space Res Inst, Moscow 117997, Russia; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; NASA, Terr Phys Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Tech Source, Santa Fe, NM 87505 USA; NASA Headquarters, Washington, DC 20514 USA	Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Massachusetts Institute of Technology (MIT); University of Arizona; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA)	Mitrofanov, IG (corresponding author), Russian Acad Sci, Space Res Inst, Moscow 117997, Russia.		Litvak, Maxim/C-6453-2017; Sanin, Anton/T-9393-2017	Mitrofanov, Igor/0000-0001-7204-2101				BIEMANN K, 1979, J MOL EVOL, V14, P65, DOI 10.1007/BF01732368; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; BOYNTON WV, IN PRESS SPACE SCI R; Carr M.H, 1996, WATER MARS; Clifford SM, 2001, ICARUS, V154, P40, DOI 10.1006/icar.2001.6671; DRAKE DM, 1988, J GEOPHYS RES-SOLID, V93, P6353, DOI 10.1029/JB093iB06p06353; FARMER CB, 1979, J GEOPHYS RES, V84, P2881, DOI 10.1029/JB084iB06p02881; FELDMAN WC, 1993, J GEOPHYS RES-PLANET, V98, P20855, DOI 10.1029/93JE02325; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; Jakosky B. M., 1992, MARS, P969; JAKOSKY BM, 1982, J GEOPHYS RES, V87, P2999, DOI 10.1029/JB087iB04p02999; James PB, 2001, ICARUS, V154, P131, DOI 10.1006/icar.2001.6653; JAMES PB, 1992, MARS, P934; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; Kieffer HH, 2000, J GEOPHYS RES-PLANET, V105, P9653, DOI 10.1029/1999JE001136; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Masarik J, 1996, J GEOPHYS RES-PLANET, V101, P18891, DOI 10.1029/96JE01563; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; PAIGE DA, 1990, J GEOPHYS RES-SOLID, V95, P1319, DOI 10.1029/JB095iB02p01319; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Smith DE, 2001, SCIENCE, V294, P2141, DOI 10.1126/science.1066556; Squyres S. W., 1992, MARS, P523; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; WATERS L, 1999, LAUR996058 LOS AL NA; ZUBER MT, 1992, J GEOPHYS RES-PLANET, V97, P7781, DOI 10.1029/92JE00341	28	60	60	4	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2003	300	5628					2081	2084		10.1126/science.1084350	http://dx.doi.org/10.1126/science.1084350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12829779				2022-12-24	WOS:000183774900042
J	Noh, B; Bandyopadhyay, A; Peer, WA; Spalding, EP; Murphy, AS				Noh, B; Bandyopadhyay, A; Peer, WA; Spalding, EP; Murphy, AS			Enhanced gravi- and phototropism in plant mdr mutants mislocalizing the auxin efflux protein PIN1	NATURE			English	Article							ARABIDOPSIS; TRANSPORT; LIGHT	Many aspects of plant growth and development are dependent on the flow of the hormone auxin down the plant from the growing shoot tip where it is synthesized(1,2). The direction of auxin transport in stems is believed to result from the basal localization within cells of the PIN1 membrane protein, which controls the efflux of the auxin anion(3). Mutations in two genes homologous to those encoding the P-glycoprotein ABC transporters that are especially abundant in multidrug-resistant tumour cells in animals(4) were recently shown to block polar auxin transport in the hypocotyls of Arabidopsis seedlings(5). Here we show that the mdr mutants display faster and greater gravitropism and enhanced phototropism instead of the impaired curvature development expected in mutants lacking polar auxin transport. We find that these phenotypes result from a disruption of the normal accumulation of PIN1 protein along the basal end of hypocotyl cells associated with basipetal auxin flow. Lateral auxin conductance becomes relatively larger as a result, enhancing the growth differentials responsible for tropic responses.	Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	University of Wisconsin System; University of Wisconsin Madison; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Spalding, EP (corresponding author), Univ Wisconsin, Dept Bot, 430 Lincoln Dr, Madison, WI 53706 USA.		Peer, Wendy/H-2970-2013; Spalding, Edgar P/GWC-1811-2022; Spalding, Edgar P/A-9034-2008; Spalding, Edgar P/ABF-3253-2021	Peer, Wendy/0000-0003-0046-7324; Spalding, Edgar P/0000-0002-6890-4765; Spalding, Edgar P/0000-0002-6890-4765; 				Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Folta KM, 2001, PLANT J, V26, P471, DOI 10.1046/j.1365-313x.2001.01038.x; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, PLANT MOL BIOL, V49, P273, DOI 10.1023/A:1015248926412; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Harper JDI, 1996, CYTOBIOS, V87, P71; Muday GK, 2001, J PLANT GROWTH REGUL, V20, P226, DOI 10.1007/s003440010027; Muday GK, 2001, TRENDS PLANT SCI, V6, P535, DOI 10.1016/S1360-1385(01)02101-X; Murphy AS, 2002, PLANT PHYSIOL, V128, P935, DOI 10.1104/pp.010519; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Sidler M, 1998, PLANT CELL, V10, P1623, DOI 10.1105/tpc.10.10.1623	14	204	223	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					999	1002		10.1038/nature01716	http://dx.doi.org/10.1038/nature01716			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827205				2022-12-24	WOS:000183753900053
J	Kovalchuk, I; Kovalchuk, O; Kalck, V; Boyko, V; Filkowski, J; Heinlein, M; Hohn, B				Kovalchuk, I; Kovalchuk, O; Kalck, V; Boyko, V; Filkowski, J; Heinlein, M; Hohn, B			Pathogen-induced systemic plant signal triggers DNA rearrangements	NATURE			English	Article							TOBACCO MOSAIC-VIRUS; HOMOLOGOUS RECOMBINATION; TRANSPOSABLE ELEMENTS; MAIZE; ARABIDOPSIS; RESISTANCE; INFECTION; INDUCTION; RADIATION	Plant genome stability is known to be affected by various abiotic environmental conditions(1-7), but little is known about the effect of pathogens. For example, exposure of maize plants to barley stripe mosaic virus seems to activate transposable elements(8,9) and to cause mutations in the non-infected progeny of infected plants(10). The induction by barley stripe mosaic virus of an inherited effect may mean that the virus has a non-cell-autonomous influence on genome stability. Infection with Peronospora parasitica results in an increase in the frequency of somatic recombination in Arabidopsis thaliana(11); however, it is unclear whether effects on recombination require the presence of the pathogen or represent a systemic plant response. It is also not clear whether the changes in the frequency of somatic recombination can be inherited. Here we report a threefold increase in homologous recombination frequency in both infected and noninfected tissue of tobacco plants infected with either tobacco mosaic virus(12) or oilseed rape mosaic virus(13). These results indicate the existence of a systemic recombination signal that also results in an increased frequency of meiotic and/or inherited late somatic recombination.	Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland	University of Lethbridge; Friedrich Miescher Institute for Biomedical Research	Kovalchuk, I (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada.							Aguilar I, 1996, PLANT MOL BIOL, V30, P191, DOI 10.1007/BF00017814; Boyko V, 2000, NAT CELL BIOL, V2, P826, DOI 10.1038/35041072; BRAKKE MK, 1984, ANNU REV PHYTOPATHOL, V22, P77, DOI 10.1146/annurev.py.22.090184.000453; BURK L. G., 1964, TOBACCO SCI, V8, P101; DELLAPORTA SL, 1984, COLD SPRING HARB SYM, V49, P321, DOI 10.1101/SQB.1984.049.01.038; Dempsey DA, 1999, CRIT REV PLANT SCI, V18, P547, DOI 10.1080/07352689991309397; Dong XN, 2001, CURR OPIN PLANT BIOL, V4, P309, DOI 10.1016/S1369-5266(00)00178-3; Gorbunova V, 2000, PLANT J, V24, P601, DOI 10.1046/j.1365-313x.2000.00905.x; Harrison BD, 1999, PHILOS T ROY SOC B, V354, P521, DOI 10.1098/rstb.1999.0403; JOHNS MA, 1985, EMBO J, V4, P1093, DOI 10.1002/j.1460-2075.1985.tb03745.x; Karpinski S, 1999, SCIENCE, V284, P654, DOI 10.1126/science.284.5414.654; Kovalchuk I, 1998, NAT BIOTECHNOL, V16, P1054, DOI 10.1038/3505; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Lucht JM, 2002, NAT GENET, V30, P311, DOI 10.1038/ng846; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; PUCHTA H, 1995, PLANT J, V7, P203, DOI 10.1046/j.1365-313X.1995.7020203.x; Ries G, 2000, P NATL ACAD SCI USA, V97, P13425, DOI 10.1073/pnas.230251897; Ries G, 2000, NATURE, V406, P98, DOI 10.1038/35017595; Shalev G, 1999, P NATL ACAD SCI USA, V96, P7398, DOI 10.1073/pnas.96.13.7398; WALBOT V, 1992, MOL GEN GENET, V234, P353, DOI 10.1007/BF00538694; Walbot V, 1999, NATURE, V397, P398, DOI 10.1038/17043; Waterhouse PM, 2001, TRENDS PLANT SCI, V6, P297, DOI 10.1016/S1360-1385(01)01989-6; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6	23	209	227	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2003	423	6941					760	762		10.1038/nature01683	http://dx.doi.org/10.1038/nature01683			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802336				2022-12-24	WOS:000183443400045
J	Yamauchi, T; Kamon, J; Ito, Y; Tsuchida, A; Yokomizo, T; Kita, S; Sugiyama, T; Miyagishi, M; Hara, K; Tsunoda, M; Murakami, K; Ohteki, T; Uchida, S; Takekawa, S; Waki, H; Tsuno, NH; Shibata, Y; Terauchi, Y; Froguel, P; Tobe, K; Koyasu, S; Taira, K; Kitamura, T; Shimizu, T; Nagai, R; Kadowaki, T				Yamauchi, T; Kamon, J; Ito, Y; Tsuchida, A; Yokomizo, T; Kita, S; Sugiyama, T; Miyagishi, M; Hara, K; Tsunoda, M; Murakami, K; Ohteki, T; Uchida, S; Takekawa, S; Waki, H; Tsuno, NH; Shibata, Y; Terauchi, Y; Froguel, P; Tobe, K; Koyasu, S; Taira, K; Kitamura, T; Shimizu, T; Nagai, R; Kadowaki, T			Cloning of adiponectin receptors that mediate antidiabetic metabolic effects	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; EXPRESSION; EFFICIENT; ADIPOSE; OBESITY; MICE	Adiponectin (also known as 30-kDa adipocyte complement-related protein; Acrp30)(1-4) is a hormone secreted by adipocytes that acts as an antidiabetic(5-12) and anti-atherogenic(8,12,13) adipokine. Levels of adiponectin in the blood are decreased under conditions of obesity, insulin resistance and type 2 diabetes(2). Administration of adiponectin causes glucose-lowering effects and ameliorates insulin resistance in mice(5-7). Conversely, adiponectin-deficient mice exhibit insulin resistance and diabetes(8,9). This insulin-sensitizing effect of adiponectin seems to be mediated by an increase in fatty-acid oxidation through activation of AMP kinase(10,11) and PPAR-alpha(5,6,12). Here we report the cloning of complementary DNAs encoding adiponectin receptors 1 and 2 (AdipoR1 and AdipoR2) by expression cloning(14-16). AdipoR1 is abundantly expressed in skeletal muscle, whereas AdipoR2 is predominantly expressed in the liver. These two adiponectin receptors are predicted to contain seven transmembrane domains, but to be structurally and functionally distinct from G-protein-coupled receptors(17-19). Expression of AdipoR1/R2 or suppression of AdipoR1/R2 expression by small-interfering RNA 20 supports our conclusion that they serve as receptors for globular and full-length adiponectin, and that they mediate increased AMP kinase(10,11) and PPAR-alpha ligand activities(12), as well as fatty-acid oxidation and glucose uptake by adiponectin.	Univ Tokyo, Grad Sch Med, Dept Internal Med, Tokyo 1138655, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan; Nissan Chem Ind Co Ltd, Biol Res Labs, Saitama 3490294, Japan; Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 1130033, Japan; JST, PRESTO, Kawaguchi, Japan; Univ Tokyo, Inst Med Sci, Div Hematopoiet Factors, Tokyo 1088639, Japan; Univ Tokyo, Sch English, Dept Chem & Biotechnol, Tokyo 1138656, Japan; Natl Inst AIST, Gene Funct Res Ctr, Tsukuba, Ibaraki 3058562, Japan; Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; Univ Tokyo, Grad Sch Med, Dept Transfus Med, Tokyo 1138655, Japan; Inst Pasteur, CNRS, Inst Biol, UPRES A8090, F-59000 Lille, France	University of Tokyo; Japan Science & Technology Agency (JST); Nissan Chemical Corporation; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Keio University; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Kadowaki, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Internal Med, Tokyo 1138655, Japan.		Adiels, Martin/C-9278-2011; sheng, jian/E-9474-2012; Miyagishi, Makoto/L-8174-2016; Waki, Hironori/AAE-3942-2020; FROGUEL, Philippe/O-6799-2017; Yokomizo, Takehiko/P-5673-2016; Koyasu, Shigeo/J-5583-2015; Terauchi, Yasuo/AAO-4347-2020	Miyagishi, Makoto/0000-0001-7654-3616; Waki, Hironori/0000-0002-5302-9793; FROGUEL, Philippe/0000-0003-2972-0784; Yokomizo, Takehiko/0000-0002-5219-1553; Koyasu, Shigeo/0000-0001-9585-3038; 	Medical Research Council [G0000477] Funding Source: Medline; MRC [G0000477] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barger PM, 2001, J BIOL CHEM, V276, P44495, DOI 10.1074/jbc.M105945200; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Karpichev IV, 2002, J BIOL CHEM, V277, P19609, DOI 10.1074/jbc.M202045200; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Michael I, 1998, EUR MASS SPECTROM, V4, P1; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P802; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Scheer A, 1996, EMBO J, V15, P3566, DOI 10.1002/j.1460-2075.1996.tb00726.x; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	27	2426	2699	5	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2003	423	6941					762	769		10.1038/nature01705	http://dx.doi.org/10.1038/nature01705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802337				2022-12-24	WOS:000183443400046
J	Riddler, SA; Smit, E; Cole, SR; Li, R; Chmiel, JS; Dobs, A; Palella, F; Visscher, B; Evans, R; Kingsley, LA				Riddler, SA; Smit, E; Cole, SR; Li, R; Chmiel, JS; Dobs, A; Palella, F; Visscher, B; Evans, R; Kingsley, LA			Impact of HIV infection and HAART on serum lipids in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	10th Conference on Retroviruses and Opportunistic Infections	FEB 10-14, 2003	BOSTON, MA				INSULIN-RESISTANCE; PROTEASE; HYPERLIPIDEMIA; THERAPY; LIPODYSTROPHY; LIPOPROTEINS	Context Alterations in serum lipid values have been widely reported among persons infected with human immunodeficiency virus (HIV) type 1 treated with highly active antiretroviral therapy (HAART), but no data have yet been reported on changes from preseroconversion lipid values. Objective To describe changes in serum cholesterol levels associated with HIV infection and antiretroviral medication exposure, and 1-time assessment of triglyceride levels post-HAART initiation. Design, Setting, and Participants The Multicenter AIDS Cohort Study, a prospective study in which homosexual and bisexual men were enrolled and from which 50 of 517 HIV seroconverters were drawn for the analysis herein, who later initiated HAART, involving measurements of stored serum samples obtained between 1984 and 2002. Main Outcome Measures Changes in levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) at 6 time points during an average of 12 years; 1-time assessment of triglyceride levels from the third post-HAART clinic visit. Results Among the 50 men, notable declines in mean serum TC (-30 mg/dL [-0.78 mmol/L]) HDL-C (-12 mg/dL [-0.31 mmol/L]), and LDL-C values (-22 mg/dL [-0.57 mmol/L]) were observed after HIV infection. Following HAART initiation, there were large increases in mean TC and LDL-C values (50 and 21 mg/dL [1.30 and 0.54 mmol/L], respectively); however, the mean changes from the preseroconversion values were 20 mg/dL (0.52 mmol/L) (95% confidence interval [CI], -1 to 41) and -1 mg/dL <LF>(-0.03 mmol/L) (95% Cl, -25 to 22), respectively. Mean HDL-C remained below baseline levels throughout follow-up. The median value (interquartile range) of triglycerides was 225 mg/dL (2.54 mmol/L) (147-331 mg/dL). Conclusions Before treatment, HIV infection results in substantial decreases in serum TC, HDL-C, and LDL-C levels. Subsequent HAART initiation is associated with increases in TC and LDL-C but little change in HDL-C. Increases in TC and LDL-C observed after about 3 years of HAART possibly represent a return to preinfection serum lipid levels after accounting for expected age-related changes.	Univ Pittsburgh, Pittsburgh, PA USA; SUNY Buffalo, Buffalo, NY 14260 USA; Johns Hopkins Univ, Baltimore, MD USA; Northwestern Univ, Chicago, IL 60611 USA; Univ Calif Los Angeles, Los Angeles, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Johns Hopkins University; Northwestern University; University of California System; University of California Los Angeles	Riddler, SA (corresponding author), 613 Falk Bldg,3601 5th Ave, Pittsburgh, PA 15213 USA.	riddler@msx.dept-med.pitt.edu		Kingsley, Lawrence/0000-0002-7000-8556	NIAID NIH HHS [U01 AI 46383, P01 AI 43664, U01 AI 35041, U01-AI-35039] Funding Source: Medline; NIDCR NIH HHS [DE 15166] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046383, U01AI035039, P01AI043664, U01AI035041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE015166] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALLAIN CC, 1974, CLIN CHEM, V20, P470; Behrens G, 1999, AIDS, V13, pF63, DOI 10.1097/00002030-199907090-00001; Berthold HK, 1999, J INTERN MED, V246, P567, DOI 10.1046/j.1365-2796.1999.00615.x; Bonnet F, 2000, J ACQ IMMUN DEF SYND, V25, P199, DOI 10.1097/00126334-200010010-00017; Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dong KL, 1999, J ACQ IMMUN DEF SYND, V21, P107; FRIISMOLLER F, 2003, 10 C RETR OPP INF FE; GIORGI JV, 1990, CLIN IMMUNOL IMMUNOP, V55, P173, DOI 10.1016/0090-1229(90)90096-9; GRUNFELD C, 1992, J CLIN ENDOCR METAB, V74, P1045, DOI 10.1210/jc.74.5.1045; GRUNFELD C, 1991, AM J MED, V90, P154, DOI 10.1016/0002-9343(91)80154-E; GRUNFELD C, 1992, NEW ENGL J MED, V327, P329, DOI 10.1056/NEJM199207303270506; Henry K, 1998, LANCET, V351, P1328, DOI 10.1016/S0140-6736(05)79053-X; Henry K, 1998, LANCET, V352, P1031, DOI 10.1016/S0140-6736(98)00022-1; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Mulligan K, 2000, J ACQ IMMUN DEF SYND, V23, P35, DOI 10.1097/00042560-200001010-00005; Periard D, 1999, CIRCULATION, V100, P700, DOI 10.1161/01.CIR.100.7.700; Rifai N, 1998, CLIN CHEM, V44, P1242; Roberts AD, 1999, CLIN INFECT DIS, V29, P441, DOI 10.1086/520231; SHORPOSNER G, 1993, AM J MED, V94, P515, DOI 10.1016/0002-9343(93)90087-6; STASZEWSKI S, 2003, 10 C RETR OPP INF FE; *US DEP HHS, 1996, 3RD NAT HLTH NUTR EX; WARNICK GR, 1978, J LIPID RES, V19, P65	25	435	447	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2003	289	22					2978	2982		10.1001/jama.289.22.2978	http://dx.doi.org/10.1001/jama.289.22.2978			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	687XZ	12799406	Bronze, Green Published			2022-12-24	WOS:000183403400021
J	Barton, GM; Medzhitov, R				Barton, GM; Medzhitov, R			Toll-like receptor signaling pathways	SCIENCE			English	Editorial Material							TIRAP	Members of the Toll-like receptor (TLR) family recognize conserved microbial structures, such as bacterial lipopolysaccharide and viral double-stranded RNA, and activate signaling pathways that result in immune responses against microbial infections. All TLRs activate MyD88-dependent pathways to induce a core set of stereotyped responses, such as inflammation. However, individual TLRs can also induce immune responses that are tailored to a given microbial infection. Thus, these receptors are involved in both innate and adaptive immune responses. The mechanisms and components of these varied responses are only partly understood. Given the importance of TLRs in host defense, dissection of the pathways they activate has become an important emerging research focus. TLRs and their pathways are numerous; Science's Signal Transduction Knowledge Environment's TLR Connections Map provides an immediate, clear overview of the known components and relations of this complex system.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, 300 Cedar St,CAB S660, New Haven, CT 06520 USA.			Barton, Gregory/0000-0002-3793-0100				BARTON G, 2003, SCI STKE; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	9	1019	1083	4	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1524	1525		10.1126/science.1085536	http://dx.doi.org/10.1126/science.1085536			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791976				2022-12-24	WOS:000183333100036
J	Anest, V; Hanson, JL; Cogswell, PC; Steinbrecher, KA; Strahl, BD; Baldwin, AS				Anest, V; Hanson, JL; Cogswell, PC; Steinbrecher, KA; Strahl, BD; Baldwin, AS			A nucleosomal function for I kappa B kinase-alpha in NF-kappa B-dependent gene expression	NATURE			English	Article							HISTONE H3; NEMO/IKK-GAMMA; IKK-ALPHA; PHOSPHORYLATION; ACETYLATION; INDUCTION; ACTIVATION; PATHWAY; BETA	NF-kappaB is a principal transcriptional regulator of diverse cytokine-mediated processes and is tightly controlled by the IkappaB kinase complex (IKK-alpha/beta/gamma). IKK-beta and IKK-gamma are critical for cytokine-induced NF-kappaB function, whereas IKK-alpha is thought to be involved in other regulatory pathways(1-4). However, recent data suggest a role for IKK-alpha in NF-kappaB-dependent gene expression in response to cytokine treatment(1,5-7). Here we demonstrate nuclear accumulation of IKK-alpha after cytokine exposure, suggesting a nuclear function for this protein. Consistent with this, chromatin immunoprecipitation (ChIP) assays reveal that IKK-alpha was recruited to the promoter regions of NF-kappaB-regulated genes on stimulation with tumour-necrosis factor-alpha. Notably, NF-kappaB-regulated gene expression is suppressed by the loss of IKK-alpha and this correlates with a complete loss of gene-specific phosphorylation of histone H3 on serine 10, a modification previously associated with positive gene expression. Furthermore, we show that IKK-alpha can directly phosphorylate histone H3 in vitro, suggesting a new substrate for this kinase. We propose that IKK-alpha is an essential regulator of NF-kappaB-dependent gene expression through control of promoter-associated histone phosphorylation after cytokine exposure. These findings provide additional insight into the role of the IKK complex in NF-kappaB-regulated gene expression.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Baldwin, AS (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.		Strahl, Brian/C-7601-2012	Strahl, Brian/0000-0002-4947-6259				Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; Berger SL, 2001, ONCOGENE, V20, P3007, DOI 10.1038/sj.onc.1204324; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Courtois G, 2001, TRENDS MOL MED, V7, P427, DOI 10.1016/S1471-4914(01)02154-2; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Prajapati S, 2002, J BIOL CHEM, V277, P24331, DOI 10.1074/jbc.M201393200; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Thomson S, 2001, MOL CELL, V8, P1231, DOI 10.1016/S1097-2765(01)00404-X; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576	22	454	476	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					659	663		10.1038/nature01648	http://dx.doi.org/10.1038/nature01648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789343	Green Submitted			2022-12-24	WOS:000183301200045
J	Opalka, N; Chlenov, M; Chacon, P; Rice, WJ; Wriggers, W; Darst, SA				Opalka, N; Chlenov, M; Chacon, P; Rice, WJ; Wriggers, W; Darst, SA			Structure and function of the transcription elongation factor GreB bound to bacterial RNA polymerase	CELL			English	Article							CLEAVAGE FACTORS GREA; CRYSTAL-STRUCTURE; FACTOR TFIIS; II ELONGATION; NASCENT TRANSCRIPT; IN-VIVO; SUBUNIT; BINDING; DOMAIN; MECHANISM	Bacterial GreA and GreB promote transcription elongation by stimulating an endogenous, endonucleolytic transcript cleavage activity of the RNA polymerase. The structure of Escherichia coli core RNA polymerase bound to GreB was determined by cryo-electron microscopy and image processing of helical crystals to a nominal resolution of 15 Angstrom, allowing fitting of high-resolution RNA polymerase and GreB structures. In the resulting model, the GreB N-terminal coiled-coil domain extends 45 Angstrom through a channel directly to the RNA polymerase active site. The model leads to detailed insights into the mechanism of Gre factor activity that explains a wide range of experimental observations and points to a key role for conserved acidic residues at the tip of the Gre factor coiled coil in modifying the RNA polymerase active site to catalyze the cleavage reaction. Mutational studies confirm that these positions are critical for Gre factor function.	Rockefeller Univ, New York, NY 10021 USA; Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA; NYU, Med Ctr, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Med Ctr, Dept Cell Biol, New York, NY 10016 USA	Rockefeller University; Scripps Research Institute; New York University; New York University	Darst, SA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	darst@rockefeller.edu	Chacon, Pablo/B-4211-2014	Chacon, Pablo/0000-0002-3168-4826; Rice, William/0000-0002-5187-255X; Wriggers, Willy/0000-0001-5326-3152	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062968, R01GM061898, R01GM058020] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGARWAL K, 1991, BIOCHEMISTRY-US, V30, P7842, DOI 10.1021/bi00245a026; ARCHAMBAULT J, 1992, MOL CELL BIOL, V12, P4142, DOI 10.1128/MCB.12.9.4142; ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; BORUKHOV S, 1991, J BIOL CHEM, V266, P23921; Borukhov S, 1996, METHOD ENZYMOL, V274, P315; BORUKHOV S, 1992, P NATL ACAD SCI USA, V89, P8899, DOI 10.1073/pnas.89.19.8899; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; BORUKHOV S, 1991, J BIOL CHEM, V266, P23932; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; CIPRESPALACIN G, 1995, BIOCHEMISTRY-US, V34, P15375, DOI 10.1021/bi00046a046; Cramer P, 2001, SCIENCE, V292, P1863, DOI 10.1126/science.1059493; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; DeRosier D, 1999, J MOL BIOL, V289, P159, DOI 10.1006/jmbi.1999.2677; Epshtein V, 2002, MOL CELL, V10, P623, DOI 10.1016/S1097-2765(02)00640-8; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; FENG GH, 1994, J BIOL CHEM, V269, P22282; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Fu JH, 1999, CELL, V98, P799, DOI 10.1016/S0092-8674(00)81514-7; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Hogan BP, 2002, J BIOL CHEM, V277, P967, DOI 10.1074/jbc.M108737200; HSU LM, 1995, P NATL ACAD SCI USA, V92, P11588, DOI 10.1073/pnas.92.25.11588; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; Juo ZS, 2003, NATURE, V422, P534, DOI 10.1038/nature01534; Kamada K, 2001, P NATL ACAD SCI USA, V98, P3115, DOI 10.1073/pnas.051631098; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kornberg Roger D., 1999, Trends in Cell Biology, V9, pM46, DOI 10.1016/S0962-8924(99)01679-7; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Koulich D, 1998, J MOL BIOL, V276, P379, DOI 10.1006/jmbi.1997.1545; Koulich D, 1997, J BIOL CHEM, V272, P7201, DOI 10.1074/jbc.272.11.7201; Kulish D, 2000, J BIOL CHEM, V275, P12789, DOI 10.1074/jbc.275.17.12789; Loizos N, 1999, J BIOL CHEM, V274, P23378, DOI 10.1074/jbc.274.33.23378; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Morin PE, 1996, P NATL ACAD SCI USA, V93, P10604, DOI 10.1073/pnas.93.20.10604; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Mustaev A, 1997, P NATL ACAD SCI USA, V94, P6641, DOI 10.1073/pnas.94.13.6641; NAKANISHI T, 1995, J BIOL CHEM, V270, P8991, DOI 10.1074/jbc.270.15.8991; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Olmsted VK, 1998, J BIOL CHEM, V273, P22589, DOI 10.1074/jbc.273.35.22589; Opalka N, 2000, P NATL ACAD SCI USA, V97, P617, DOI 10.1073/pnas.97.2.617; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; POLYAKOV A, 1995, CELL, V83, P365, DOI 10.1016/0092-8674(95)90114-0; Polyakov A, 1998, J MOL BIOL, V281, P465, DOI 10.1006/jmbi.1998.1958; QIAN XQ, 1993, NATURE, V365, P277, DOI 10.1038/365277a0; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; REINES D, 1992, J BIOL CHEM, V267, P3795; REINES D, 1989, J BIOL CHEM, V264, P10799; Rice WJ, 2001, BIOPHYS J, V80, P2187, DOI 10.1016/S0006-3495(01)76191-7; RUDD MD, 1994, P NATL ACAD SCI USA, V91, P8057, DOI 10.1073/pnas.91.17.8057; SEVERINOV K, 1994, J BIOL CHEM, V269, P14254; SLUDER AE, 1989, J BIOL CHEM, V264, P8963; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; SURRATT CK, 1991, P NATL ACAD SCI USA, V88, P7983, DOI 10.1073/pnas.88.18.7983; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Toulme F, 2000, EMBO J, V19, P6853, DOI 10.1093/emboj/19.24.6853; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WANG DG, 1993, P NATL ACAD SCI USA, V90, P843, DOI 10.1073/pnas.90.3.843; Wriggers W, 2001, STRUCTURE, V9, P779, DOI 10.1016/S0969-2126(01)00648-7; Wu JS, 1996, P NATL ACAD SCI USA, V93, P11552, DOI 10.1073/pnas.93.21.11552; YEE D, 1979, BIOCHEMISTRY-US, V18, P4116, DOI 10.1021/bi00586a009; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262	81	165	173	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2003	114	3					335	345		10.1016/S0092-8674(03)00600-7	http://dx.doi.org/10.1016/S0092-8674(03)00600-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914698	Bronze			2022-12-24	WOS:000184679200010
J	Bivona, TG; Perez de Castro, I; Ahearn, IM; Grana, TM; Chiu, VK; Lockyer, PJ; Cullen, PJ; Pellicer, A; Cox, AD; Philips, MR				Bivona, TG; Perez de Castro, I; Ahearn, IM; Grana, TM; Chiu, VK; Lockyer, PJ; Cullen, PJ; Pellicer, A; Cox, AD; Philips, MR			Phospholipase C gamma activates Ras on the Golgi apparatus by means of RasGRP1	NATURE			English	Article							CALCIUM; DIACYLGLYCEROL; RECRUITMENT; PROTEIN	Ras proteins regulate cellular growth and differentiation, and are mutated in 30% of cancers. We have shown recently that Ras is activated on and transmits signals from the Golgi apparatus as well as the plasma membrane(1,2) but the mechanism of compartmentalized signalling was not determined. Here we show that, in response to Src-dependent activation of phospholipase Cgamma1, the Ras guanine nucleotide exchange factor RasGRP1 translocated to the Golgi where it activated Ras. Whereas Ca2+ positively regulated Ras on the Golgi apparatus through RasGRP1, the same second messenger negatively regulated Ras on the plasma membrane by means of the Ras GTPase-activating protein CAPRI(3). Ras activation after T-cell receptor stimulation in Jurkat cells, rich in RasGRP1, was limited to the Golgi apparatus through the action of CAPRI, demonstrating unambiguously a physiological role for Ras on Golgi. Activation of Ras on Golgi also induced differentiation of PC12 cells, transformed fibroblasts and mediated radioresistance. Thus, activation of Ras on Golgi has important biological consequences and proceeds through a pathway distinct from the one that activates Ras on the plasma membrane.	NYU, Sch Med, Dept Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; Babraham Inst, Cambridge CB2 4AT, England; Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England	New York University; New York University; New York University; New York University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Bristol	Philips, MR (corresponding author), NYU, Sch Med, Dept Med, 550 1st Ave, New York, NY 10016 USA.	philim01@med.nyu.edu	MARTINEZ, ANTONIO PELLICER/C-4832-2015; de Castro, Ignacio Pérez/A-6260-2012	de Castro, Ignacio Pérez/0000-0002-8822-8274; Ahearn, Ian/0000-0002-2275-137X; Pellicer, Angel/0000-0002-5062-0692; Cullen, Peter/0000-0002-9070-8349; Mark, Philips/0000-0002-1179-8156; Cox, Adrienne D./0000-0002-4901-2454				Bankaitis VA, 2002, SCIENCE, V295, P290, DOI 10.1126/science.1068446; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Ji GS, 1998, MOL BIOL CELL, V9, P749, DOI 10.1091/mbc.9.4.749; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Lockyer PJ, 2001, CURR BIOL, V11, P981, DOI 10.1016/S0960-9822(01)00261-5; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Park WM, 1997, ONCOGENE, V14, P831, DOI 10.1038/sj.onc.1200893; Peppelenbosch MP, 1996, J BIOL CHEM, V271, P7883, DOI 10.1074/jbc.271.14.7883; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596	19	346	362	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2003	424	6949					694	698		10.1038/nature01806	http://dx.doi.org/10.1038/nature01806			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12845332				2022-12-24	WOS:000184578800050
J	Stern, SA				Stern, SA			The evolution of comets in the Oort cloud and Kuiper belt	NATURE			English	Article							EROSION	Comets are remnants from the time when the outer planets formed, similar to4-4.5 billion years ago. They have been in storage since then in the Oort cloud and Kuiper belt-distant regions that are so cold and sparsely populated that it was long thought that comets approaching the Sun were pristine samples from the time of Solar System formation. It is now recognized, however, that a variety of subtle but important evolutionary mechanisms operate on comets during their long storage, so they can no longer be regarded as wholly pristine.	SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA		Stern, SA (corresponding author), SW Res Inst, Dept Space Studies, 1050 Walnut St,Suite 400, Boulder, CO 80302 USA.	astern@swri.edu						Asphaug E, 1996, ICARUS, V121, P225, DOI 10.1006/icar.1996.0083; BELTON M, 2002, NEW FRONTIERS SOLAR, P457; DELSEMME AH, 1977, COMETS ASTEROIDS MET, P3; DONES L, UNPUB ICARUS; DUNCAN M, 1988, ASTROPHYS J, V328, pL69, DOI 10.1086/185162; Durda DD, 2000, ICARUS, V145, P220, DOI 10.1006/icar.1999.6333; FARINELLA P, 2000, PROTOSTARS PLANETS, V4, P125; Gerakines PA, 2001, J GEOPHYS RES-PLANET, V106, P33381, DOI 10.1029/2000JE001320; GERAKINES PA, 2001, J GEOPHYS RES, V106, P33275; Greenberg J., 1982, COMETS, P131; JEWITT D, 1993, NATURE, V362, P730, DOI 10.1038/362730a0; Johnson R. E., 1990, ENERGETIC CHARGED PA, P232; KLINGER J, 1985, ICES SOLAR SYSTEM, P407; KOUCHI A, 1992, ASTROPHYS J, V388, pL73, DOI 10.1086/186333; Kuiper G.P., 1951, ASTROPHYSICS TOPICAL, P357; LEVISON HF, 1994, ICARUS, V108, P18, DOI 10.1006/icar.1994.1039; LISSAUER JJ, 1989, ASTROPHYS J, V340, P468, DOI 10.1086/167409; Mumma M. J., 1997, Astronomical Society of the Pacific Conference Series, V122, P369; Mumma M. J., 1993, PROTOSTARS PLANETS, P1177; ODELL CR, 1973, ICARUS, V19, P137; Oort J., 1950, BAIN, V11, P91; Prialnik D, 1999, SPACE SCI REV, V90, P169, DOI 10.1023/A:1005202215579; SAFRONOV VS, 1987, EVOLUTION SMALL BODI, P217; Schwadron NA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015829; STERN SA, 1988, ICARUS, V73, P499, DOI 10.1016/0019-1035(88)90059-0; STERN SA, 1990, ICARUS, V84, P447, DOI 10.1016/0019-1035(90)90048-E; STERN SA, 1986, ICARUS, V68, P276, DOI 10.1016/0019-1035(86)90024-2; Stern SA, 2001, NATURE, V409, P589, DOI 10.1038/35054508; STERN SA, 1988, NATURE, V332, P407, DOI 10.1038/332407a0; STRAZZULA G, 1999, COMPOSITION ORIGIN C, P269; THOMPSON WR, 1987, J GEOPHYS RES, V92, P14933, DOI 10.1029/JA092iA13p14933; THROOP HB, 2000, THESIS U COLORADO, P1; Weaver HA, 2002, ASTROPHYS J, V576, pL95, DOI 10.1086/343087; WEISSMAN PR, 1990, NATURE, V344, P825, DOI 10.1038/344825a0; Weissman PR, 1996, ASTR SOC P, V107, P265; WEISSMAN PR, IN PRESS COMETS, V2; WHIPPLE FL, 1950, ASTROPHYS J, V111, P375, DOI 10.1086/145272; WHIPPLE FL, 1964, P NATL ACAD SCI USA, V51, P711, DOI 10.1073/pnas.51.5.711; WHIPPLE FL, 1977, COMETS ASTEROIDS MET, P25; Wilkening L. L, 1982, IAU C 61 COMET DISCO, P85; [No title captured]	41	83	86	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2003	424	6949					639	642		10.1038/nature01725	http://dx.doi.org/10.1038/nature01725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904784				2022-12-24	WOS:000184578800036
J	Winston, FK; Kassam-Adams, N; Garcia-Espana, F; Ittenbach, R; Cnaan, A				Winston, FK; Kassam-Adams, N; Garcia-Espana, F; Ittenbach, R; Cnaan, A			Screening for risk of persistent posttraumatic stress in injured children and their parents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL INJURY; SEVERITY SCORE; DISORDER; SYMPTOMS; EPIDEMIOLOGY; DISASTER; TRAUMA; IMPACT; ADOLESCENTS; PREDICTORS	Context Injury, a leading health threat to children, is also a common cause of posttraumatic stress disorder (PTSD) in childhood. Most injured children with PTSD are not diagnosed or treated. Objective To develop a stand-alone screening tool for use by clinicians during acute trauma care to identify injured children and their parents who are at risk of significant, persistent posttraumatic stress symptoms. Design The Screening Tool for Early Predictors of PTSD (STEPP) was derived from a 50-item risk factor survey administered within 1 month of injury as part of a prospective cohort study of posttraumatic stress in injured children and their parents. Symptoms of PTSD were assessed at least 3 months after injury. Setting Urban, pediatric level I trauma center. Participants A sample of 269 children aged 8 to 17 years admitted for treatment of traffic-related injuries between July 1999 and October 2001, and one parent per child, completed a risk factor survey assessing potential predictors of PTSD outcome. One hundred seventy-one families (63%) completed a follow-up assessment. Main Outcome Measures The Clinician-Administered PTSD Scale for Children and Adolescents and the PTSD Checklist served as criterion standards for child and parent outcomes, respectively. Positive cases were defined as those meeting criteria for at least subsyndromal PTSD with continuing impairment ("persistent traumatic stress"). Results The STEPP contains 4 dichotomous questions asked of the child, 4 asked of one parent, and 4 items obtained easily from the emergency medical record. STEPP sensitivity in predicting posttraumatic stress was 0.88 for children and 0.96 for parents, with negative predictive values of 0.95 for children and 0.99 for parents. The odds ratio for prediction of persistent traumatic stress was 6.5 (95% confidence interval [CI], 1.8-22.8) in children and 26.6 (95% CI, 3.5-202.1) in parents. Conclusions The STEPP represents a new method to guide clinicians in making evidence-based decisions for the allocation of scarce mental health resources for traumatic stress. Its brevity and simple scoring rule suggest that it can be easily administered in the acute care setting.	Childrens Hosp Philadelphia, Traumalink Pediat Interdisciplinary Injury Contro, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Div Gen Pediat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Ctr Pediat Traumat Stress, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Biostat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Winston, FK (corresponding author), Childrens Hosp Philadelphia, Traumalink Pediat Interdisciplinary Injury Contro, 34th St & Civic Ctr Blvd,3535 TraumaLink,10th Flo, Philadelphia, PA 19104 USA.	flaura@mail.med.upenn.edu	Kassam-Adams, Nancy/C-4091-2009; Ittenbach, Richard F/Q-1806-2015	Kassam-Adams, Nancy/0000-0001-7412-1428	PHS HHS [R40 MC 00138] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aaron J, 1999, J PEDIATR PSYCHOL, V24, P335, DOI 10.1093/jpepsy/24.4.335; American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Athey JL, 1997, PROF PSYCHOL-RES PR, V28, P464, DOI 10.1037/0735-7028.28.5.464; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baker SP, 1992, THE INJURY FACT BOOK, V2nd; Breslau N, 2001, J CLIN PSYCHIAT, V62, P16; BRETON JJ, 1993, J AM ACAD CHILD PSY, V32, P438, DOI 10.1097/00004583-199303000-00028; BULL JP, 1975, ACCIDENT ANAL PREV, V7, P249, DOI 10.1016/0001-4575(75)90026-3; Daviss WB, 2000, J AM ACAD CHILD PSY, V39, P576, DOI 10.1097/00004583-200005000-00011; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; DiGallo A, 1997, BRIT J PSYCHIAT, V170, P358, DOI 10.1192/bjp.170.4.358; Fletcher Kenneth E., 1996, P242; Foy D., 1994, J SCH PSYCHOL, V34, P133; Gavin LA, 1997, PEDIATR EMERG CARE, V13, P222, DOI 10.1097/00006565-199706000-00013; GREEN BL, 1991, J AM ACAD CHILD PSY, V30, P945, DOI 10.1097/00004583-199111000-00012; HAINES C, 1995, J ADV NURS, V21, P350, DOI 10.1111/j.1365-2648.1995.tb02533.x; *I MED, 1999, RED BURD INJ ADV PRE; KOCH WJ, 1995, COGN BEHAV PRACT, V2, P327, DOI 10.1016/S1077-7229(95)80016-6; KOOPMAN C, 1994, AM J PSYCHIAT, V151, P888; Kovacs M., 1992, CHILDRENS DEPRESSION; Kuch K, 1996, CAN J PSYCHIAT, V41, P429, DOI 10.1177/070674379604100707; Litz BT, 2002, CLIN PSYCHOL-SCI PR, V9, P112, DOI 10.1093/clipsy/9.2.112; March JS, 1998, J AM ACAD CHILD PSY, V37, P585, DOI 10.1097/00004583-199806000-00008; March JS., 2013, MULTIDIMENSIONAL ANX, V2nd; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Mirza KAH, 1998, BRIT J PSYCHIAT, V172, P443, DOI 10.1192/bjp.172.5.443; National Institute of Mental Health, 1998, NIH PUBL, V98-4321; NEWMAN E, 1996, MEASUREMENT STRESS T, P108; NORRIS FH, 1992, J CONSULT CLIN PSYCH, V60, P409, DOI 10.1037/0022-006X.60.3.409; Pfefferbaum B, 2000, PSYCHIATRY, V63, P358, DOI 10.1080/00332747.2000.11024929; PTACEK JT, 1995, J PAIN SYMPTOM MANAG, V10, P446, DOI 10.1016/0885-3924(95)00083-B; PYNOOS RS, 1991, POSTTRAUMATIC STRESS, P65; Richmond TS, 1998, J TRAUMA, V44, P635, DOI 10.1097/00005373-199804000-00012; SAXE G, 1998, J BURN CARE REHABIL, V19, pS206; SCHREIBER S, 1993, PAIN, V54, P107, DOI 10.1016/0304-3959(93)90105-X; SHANNON MP, 1994, J AM ACAD CHILD PSY, V33, P80, DOI 10.1097/00004583-199401000-00012; Stallard P, 1998, BRIT MED J, V317, P1619, DOI 10.1136/bmj.317.7173.1619; Stuber J, 2002, PSYCHIAT SERV, V53, P815, DOI 10.1176/appi.ps.53.7.815; U.S. Public Health Service, 2000, SURG GEN C CHILDR ME; Vernberg EM, 1996, J ABNORM PSYCHOL, V105, P237, DOI 10.1037/0021-843X.105.2.237; Weathers F.W., 1996, MEASUREMENT STRESS T, P250; Winje D, 1996, J CONSULT CLIN PSYCH, V64, P1037, DOI 10.1037/0022-006X.64.5.1037; Winston FK, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e90; Yehuda R, 1998, BIOL PSYCHIAT, V44, P1305, DOI 10.1016/S0006-3223(98)00276-5; 1997, INT CLASSIFICATION D	48	128	130	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2003	290	5					643	649		10.1001/jama.290.5.643	http://dx.doi.org/10.1001/jama.290.5.643			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708GH	12902368	Bronze			2022-12-24	WOS:000184558500019
J	Burrows, M				Burrows, M			Biomechanics: Froghopper insects leap to new heights - An innovative leaping action propels these bugs to the top of the insect athletic league.	NATURE			English	Editorial Material							JUMP; ENERGETICS; MECHANISM		Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Burrows, M (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.							ALEXANDER RM, 1995, PHILOS T R SOC B, V347, P235, DOI 10.1098/rstb.1995.0024; Bennet-Clark H.C., 1976, P467; BENNETCLARK HC, 1967, J EXP BIOL, V47, P59; BENNETCLARK HC, 1975, J EXP BIOL, V63, P53; Burrows M, 2003, J EXP BIOL, V206, P1035, DOI 10.1242/jeb.00214; DOWLING JJ, 1993, J APPL BIOMECH, V9, P95, DOI 10.1123/jab.9.2.95; EVANS MEG, 1973, J ZOOL, V169, P181; ROTHSCHILD M, 1975, PHILOS T ROY SOC B, V271, P499, DOI 10.1098/rstb.1975.0064; Sander K., 1956, Zoologische Jahrbuecher Jena Anatomie, V75, P383; WEISFOGH T, 1956, J EXP BIOL, V33, P668	10	169	175	11	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					509	509		10.1038/424509a	http://dx.doi.org/10.1038/424509a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891345	Bronze			2022-12-24	WOS:000184454700029
J	Matsushita, T; Mochizuki, N; Nagatani, A				Matsushita, T; Mochizuki, N; Nagatani, A			Dimers of the N-terminal domain of phytochrome B are functional in the nucleus	NATURE			English	Article							SIGNAL-TRANSDUCTION; LIGHT; PROTEIN; REVEALS; ENCODES; REGION; PIF3	A plant modulates its developmental processes in response to light by several informational photoreceptors such as phytochrome. Phytochrome is a dimeric chromoprotein which regulates various aspects of plant development from seed germination to flowering(1). Upon absorption of red light, phytochrome translocates from the cytoplasm to the nucleus(2-4), and regulates gene expression through interaction with transcription factors such as PIF3 (refs 5-7). The phytochrome polypeptide has two domains(1,8) : the amino-terminal photosensory domain with a chromophore and the carboxy-terminal domain which contains signalling motifs such as a kinase domain(9). The latter is widely believed to transduce the signal to downstream components(1,5,810). Here we show that the C-terminal domain of Arabidopsis phytochrome B (phyB), which is known as the most important member of the phytochrome family(1), is not directly involved in signal transduction. The N-terminal domain isolated from phyB, when dimerized and localized in the nucleus, triggered full phyB responses with much higher photosensitivity than the full-length phyB. These findings indicate that the C-terminal domain attenuates the activity of phyB rather than positively transducing the signal.	Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Nagatani, A (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan.	nagatani@physiol.bot.kyoto-u.ac.jp						CHERRY JR, 1993, PLANT CELL, V5, P565, DOI 10.1105/tpc.5.5.565; Clough RC, 1999, PLANT J, V17, P155, DOI 10.1046/j.1365-313X.1999.00360.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Grebenok RJ, 1997, PLANT J, V11, P573, DOI 10.1046/j.1365-313X.1997.11030573.x; Jarillo JA, 2001, NATURE, V410, P487, DOI 10.1038/35068589; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kato A, 1999, PLANT CELL PHYSIOL, V40, P586, DOI 10.1093/oxfordjournals.pcp.a029581; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Liu XL, 2001, PLANT CELL, V13, P1293, DOI 10.1105/tpc.13.6.1293; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Nagy F, 2000, SEMIN CELL DEV BIOL, V11, P505, DOI 10.1006/scdb.2000.0202; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Park CM, 2000, SEMIN CELL DEV BIOL, V11, P449, DOI 10.1006/scdb.2000.0200; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Sakamoto K, 1996, PLANT J, V10, P859, DOI 10.1046/j.1365-313X.1996.10050859.x; SHACKLOCK PS, 1992, NATURE, V358, P753, DOI 10.1038/358753a0; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Shinomura T, 1996, P NATL ACAD SCI USA, V93, P8129, DOI 10.1073/pnas.93.15.8129; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; STOCKHAUS J, 1992, GENE DEV, V6, P2364, DOI 10.1101/gad.6.12a.2364; Wagner D, 1996, P NATL ACAD SCI USA, V93, P4011, DOI 10.1073/pnas.93.9.4011; Wagner D, 1996, PLANT CELL, V8, P859, DOI 10.1105/tpc.8.5.859; WAGNER D, 1995, P NATL ACAD SCI USA, V92, P8596, DOI 10.1073/pnas.92.19.8596; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	30	227	245	3	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2003	424	6948					571	574		10.1038/nature01837	http://dx.doi.org/10.1038/nature01837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891362				2022-12-24	WOS:000184454700047
J	Mitchell, K; Owens, RG				Mitchell, K; Owens, RG			National survey of medical decisions at end of life made by New Zealand general practitioners	BRITISH MEDICAL JOURNAL			English	Article									Univ Auckland, Dept Psychol, Auckland, New Zealand; Univ Wales, Bangor LL57 2AS, Gwynedd, Wales	University of Auckland; Bangor University	Mitchell, K (corresponding author), Univ Auckland, Dept Psychol, Private Bag 92019, Auckland, New Zealand.							Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; GILLETT GR, 1991, NZ LAW J         APR; Kuhse H, 1997, MED J AUSTRALIA, V166, P191, DOI 10.5694/j.1326-5377.1997.tb140074.x; van der Maas PJ, 1992, HEALTH POLICY, V22, P1; Zylicz Z, 2000, PATIENT EDUC COUNS, V41, P47, DOI 10.1016/S0738-3991(00)00114-2	5	32	32	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2003	327	7408					202	203		10.1136/bmj.327.7408.202	http://dx.doi.org/10.1136/bmj.327.7408.202			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	706DL	12881263	Bronze, Green Published			2022-12-24	WOS:000184437300019
J	Dudley, CA; Erbel-Sieler, C; Estill, SJ; Reick, M; Franken, P; Pitts, S; McKnight, SL				Dudley, CA; Erbel-Sieler, C; Estill, SJ; Reick, M; Franken, P; Pitts, S; McKnight, SL			Altered patterns of sleep and behavioral adaptability in NPAS2-defficient mice	SCIENCE			English	Article							CIRCADIAN CLOCK; SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; PHASE-SHIFT; RHYTHM; MOUSE; PERIOD; LIGHT; LOOP; PHOTORECEPTION	Animal behavior is synchronized to the 24-hour light:dark (LD) cycle by regulatory programs that produce circadian fluctuations in gene expression throughout the body. In mammals, the transcription factor CLOCK controls circadian oscillation in the suprachiasmatic nucleus of the brain; its paralog, neuronal PAS domain protein 2 (NPAS2), performs a similar function in other forebrain sites. To investigate the role of NPAS2 in behavioral manifestations of circadian rhythm, we studied locomotor activity, sleep patterns, and adaptability to both light- and restricted food-driven entrainment in NPAS2-deficient mice. Our results indicate that NPAS2 plays a substantive role in maintaining circadian behaviors in normal LD and feeding conditions and that NPAS2 is critical for adaptability to food restriction.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Columbia Univ, Dept Psychol, New York, NY 10027 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Stanford University; Columbia University	McKnight, SL (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	smckni@biochem.swmed.edu	Jansen, Heiko T./A-5770-2008; Franken, Paul/A-9633-2018	Jansen, Heiko T./0000-0003-0178-396X; Franken, Paul/0000-0002-2500-2921	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059388] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 64148] Funding Source: Medline; NIDDK NIH HHS [5T3DK07328] Funding Source: Medline; NIMH NIH HHS [4R37 MH59388] Funding Source: Medline; PHS HHS [37919] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abe H, 2001, EUR J NEUROSCI, V14, P1121, DOI 10.1046/j.0953-816x.2001.01732.x; Abe H, 2001, MOL BRAIN RES, V87, P92, DOI 10.1016/S0169-328X(00)00295-3; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Challet E, 2001, BRAIN RES, V909, P81, DOI 10.1016/S0006-8993(01)02625-7; DAAN S, 1975, P NATL ACAD SCI USA, V72, P3744, DOI 10.1073/pnas.72.9.3744; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Franken P, 1999, SLEEP, V22, P155; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Golden SS, 1997, ANNU REV PLANT PHYS, V48, P327, DOI 10.1146/annurev.arplant.48.1.327; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Herzog ED, 1997, BRAIN RES, V757, P285, DOI 10.1016/S0006-8993(97)00337-5; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; Marchant EG, 1997, BRAIN RES, V765, P273, DOI 10.1016/S0006-8993(97)00571-4; Mayeda AR, 1999, BEHAV GENET, V29, P171, DOI 10.1023/A:1021639901679; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; NELSON RJ, 1981, COMP BIOCHEM PHYS A, V69, P145, DOI 10.1016/0300-9629(81)90651-4; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Pitts SN, 2003, AM J PHYSIOL-REG I, V285, pR57, DOI 10.1152/ajpregu.00023.2003; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; SCHWARTZ WJ, 1980, J COMP NEUROL, V189, P157, DOI 10.1002/cne.901890109; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Tankersley CG, 2002, J APPL PHYSIOL, V92, P870, DOI 10.1152/japplphysiol.00904.2001; Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	48	304	314	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					379	383		10.1126/science.1082795	http://dx.doi.org/10.1126/science.1082795			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12843397				2022-12-24	WOS:000184207300048
J	Wolfe, JT; Wang, HG; Howard, J; Garrison, JC; Barrett, PQ				Wolfe, JT; Wang, HG; Howard, J; Garrison, JC; Barrett, PQ			T-type calcium channel regulation by specific G-protein beta gamma subunits	NATURE			English	Article							CA2+ CHANNEL; DOPAMINE-RECEPTORS; INHIBITION; CURRENTS; MODULATION; EXPRESSION; BINDING; CELLS; K+	Low-voltage-activated (LVA) T-type calcium channels have a wide tissue distribution and have well-documented roles in the control of action potential burst generation and hormone secretion(1). In neurons of the central nervous system and secretory cells of the adrenal and pituitary, LVA channels are inhibited by activation of G-protein-coupled receptors that generate membrane-delimited signals(2-5), yet these signals have not been identified. Here we show that the inhibition of alpha(1H) (Ca(v)3.2), but not alpha(1G) (Ca(v)3.1) LVA Ca2+ channels is mediated selectively by beta(2)gamma(2) subunits that bind to the intracellular loop connecting channel transmembrane domains II and III. This region of the alpha(1H) channel is crucial for inhibition, because its replacement abrogates inhibition and its transfer to non-modulated alpha(1G) channels confers beta(2)gamma(2)-dependent inhibition. betagamma reduces channel activity independent of voltage, a mechanism distinct from the established betagamma-dependent inhibition of non-L-type high-voltage-activated channels of the Ca(v)2 family(6,7). These studies identify the alpha(1H) channel as a new effector for G-protein betagamma subunits, and highlight the selective signalling roles available for particular betagamma combinations.	Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia	Barrett, PQ (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.	pqb4b@virginia.edu	Wolfe, Joshua/H-3821-2013; Barrett, Paula/AAY-1056-2021		NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; BIRD IM, 1993, ENDOCRINOLOGY, V133, P1555, DOI 10.1210/en.133.4.1555; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; Cooper CB, 2000, J BIOL CHEM, V275, P40777, DOI 10.1074/jbc.C000673200; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; Downes GB, 1999, GENOMICS, V62, P544, DOI 10.1006/geno.1999.5992; Drolet P, 1997, MOL ENDOCRINOL, V11, P503, DOI 10.1210/me.11.4.503; FISHMAN MC, 1981, P NATL ACAD SCI-BIOL, V78, P5245, DOI 10.1073/pnas.78.8.5245; GRABER SG, 1996, METH NEUROSCI, V29, P207; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jarvis SE, 2001, TRENDS PHARMACOL SCI, V22, P519, DOI 10.1016/S0165-6147(00)01800-9; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KOZASA T, 1999, CRC METH SIG TRANS, P23; Lei QB, 2000, P NATL ACAD SCI USA, V97, P9771, DOI 10.1073/pnas.97.17.9771; LLEDO PM, 1992, NEURON, V8, P455, DOI 10.1016/0896-6273(92)90273-G; LLEDO PM, 1990, ENDOCRINOLOGY, V127, P990, DOI 10.1210/endo-127-3-990; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; Safa P, 2001, J BIOL CHEM, V276, P38727, DOI 10.1074/jbc.M103724200; Schrier AD, 2001, AM J PHYSIOL-CELL PH, V280, pC265, DOI 10.1152/ajpcell.2001.280.2.C265; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; WILLIAMS PJ, 1990, J NEUROSCI, V10, P757; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhang JF, 1996, NEURON, V17, P991, DOI 10.1016/S0896-6273(00)80229-9	30	113	120	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					209	213		10.1038/nature01772	http://dx.doi.org/10.1038/nature01772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853961				2022-12-24	WOS:000184032700046
J	Heintz, N				Heintz, N			Ataxin-1 regulators in the spotlight	SCIENCE			English	Editorial Material							BULBAR MUSCULAR-ATROPHY; TRANSGENIC MOUSE MODEL; 14-3-3 PROTEINS; DISEASE BRAINS		Rockefeller Univ, Dept Mol Biol, New York, NY 10021 USA	Rockefeller University	Heintz, N (corresponding author), Rockefeller Univ, Dept Mol Biol, 1230 York Ave, New York, NY 10021 USA.							Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Kawamoto Y, 2002, J NEUROPATH EXP NEUR, V61, P245, DOI 10.1093/jnen/61.3.245; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401	8	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2003	301	5629					59	60		10.1126/science.1086311	http://dx.doi.org/10.1126/science.1086311			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843383				2022-12-24	WOS:000183914700029
J	Pinyopich, A; Ditta, GS; Savidge, B; Liljegren, SJ; Baumann, E; Wisman, E; Yanofsky, MF				Pinyopich, A; Ditta, GS; Savidge, B; Liljegren, SJ; Baumann, E; Wisman, E; Yanofsky, MF			Assessing the redundancy of MADS-box genes during carpel and ovule development	NATURE			English	Article							FLORAL ORGAN IDENTITY; ARABIDOPSIS-THALIANA; EXPRESSION; TRANSCRIPTION; DETERMINES; SPATULA; PETUNIA; PROTEIN; PLANTS	Carpels are essential for sexual plant reproduction because they house the ovules and subsequently develop into fruits that protect, nourish and ultimately disperse the seeds. The AGAMOUS (AG) gene is necessary for plant sexual reproduction because stamens and carpels are absent from ag mutant flowers(1),(2). However, the fact that sepals are converted into carpelloid organs in certain mutant backgrounds even in the absence of AG activity indicates that an AG-independent carpel-development pathway exists(2). AG is a member of a monophyletic clade of MADS-box genes that includes SHATTERPROOF1 (SHP1), SHP2 and SEEDSTICK (STK)(3), indicating that these four genes might share partly redundant activities. Here we show that the SHP genes are responsible for AG-independent carpel development. We also show that the STK gene is required for normal development of the funiculus, an umbilical-cord-like structure that connects the developing seed to the fruit, and for dispersal of the seeds when the fruit matures. We further show that all four members of the AG clade are required for specifying the identity of ovules, the landmark invention during the course of vascular plant evolution that enabled seed plants to become the most successful group of land plants(4).	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Max Planck Inst Zuchtungsforsch, D-50829 Cologne, Germany	University of California System; University of California San Diego; Max Planck Society	Yanofsky, MF (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.							Alvarez J, 1999, DEVELOPMENT, V126, P2377; ANGENENT GC, 1995, PLANT CELL, V7, P1569, DOI 10.1105/tpc.7.10.1569; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; COLOMBO L, 1995, PLANT CELL, V7, P1859, DOI 10.1105/tpc.7.11.1859; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; Flanagan CA, 1996, PLANT J, V10, P343, DOI 10.1046/j.1365-313X.1996.10020343.x; Heisler MGB, 2001, DEVELOPMENT, V128, P1089; Kempin SA, 1997, NATURE, V389, P802, DOI 10.1038/39770; KUNST L, 1989, PLANT CELL, V1, P1195, DOI 10.1105/tpc.1.12.1195; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; ROUNSLEY SD, 1995, PLANT CELL, V7, P1259, DOI 10.1105/tpc.7.8.1259; SAVIDGE B, 1995, PLANT CELL, V7, P721, DOI 10.1105/tpc.7.6.721; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; Stewart W.N., 1993, PALEOBOTANY EVOLUTIO; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Western TL, 1999, PLANT J, V18, P329, DOI 10.1046/j.1365-313X.1999.00448.x; Wisman E, 1998, PLANT MOL BIOL, V37, P989, DOI 10.1023/A:1006082009151; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	22	533	611	11	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					85	88		10.1038/nature01741	http://dx.doi.org/10.1038/nature01741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840762				2022-12-24	WOS:000183912800045
J	Potts, M; Walsh, J				Potts, M; Walsh, J			Tackling India's HIV epidemic: lessons from Africa	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MALE CIRCUMCISION; INTERVENTIONS; TRANSMISSION; IMPACT; CORE	India stands on the brink of a major HIV epidemic. However, by examining where public health initiatives went wrong in Africa, die international community may be able to help India avoid the devastating effects seen in Africa.	Univ Calif Berkeley, Sch Publ Hlth, Bay Area Int Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Inst Human Dev, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Potts, M (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Bay Area Int Grp, Berkeley, CA 94720 USA.	pottsmalcolm@yahoo.com						Attaran A, 2001, LANCET, V357, P57, DOI 10.1016/S0140-6736(00)03576-5; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Chen SY, 2002, AM J PUBLIC HEALTH, V92, P1387, DOI 10.2105/AJPH.92.9.1387-a; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; GREEN R, 2001, INT HLTH EC ASS 3 IN; Hawkes S, 2002, SEX TRANSM INFECT, V78, pI31, DOI 10.1136/sti.78.suppl_1.i31; *INT LESB GAY ASS, SIT HOM IND REP SWED; Jha P, 2002, SCIENCE, V295, P2036, DOI 10.1126/science.295.5562.2036; LAZARO FD, AIDS CHALLENGE THAIL; Lowndes CM, 2002, SEX TRANSM INFECT, V78, pI69, DOI 10.1136/sti.78.suppl_1.i69; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; MASAKI E, COST EFFECTIVENESS H; MCNEIL D, 2002, NY TIMES        1009; Nagelkerke NJD, 2002, B WORLD HEALTH ORGAN, V80, P89; National Intelligence Council, 2002, NEXT WAV HIV AIDS NI; Parkhurst JO, 2002, LANCET, V360, P78, DOI 10.1016/S0140-6736(02)09340-6; *ROCK FDN, 2002, MICR IN MOB MICR DEC; Shelton JD, 2001, BRIT MED J, V323, P139, DOI 10.1136/bmj.323.7305.139; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; Szabo R, 2000, BRIT MED J, V320, P1592, DOI 10.1136/bmj.320.7249.1592; *UN POP FUND, 2003, SEC ESS SUPPL; *UNAIDS, 2000, REP GLOB HIV AIDS EP; LEMONAIDS	24	11	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2003	326	7403					1389	1392		10.1136/bmj.326.7403.1389	http://dx.doi.org/10.1136/bmj.326.7403.1389			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694CN	12816832	Green Published			2022-12-24	WOS:000183756400030
J	Wong, RSM; Wu, A; To, KF; Lee, N; Lam, CWK; Wong, CK; Chan, PKS; Ng, MHL; Yu, LM; Hui, DS; Tam, JS; Cheng, G; Sung, JJY				Wong, RSM; Wu, A; To, KF; Lee, N; Lam, CWK; Wong, CK; Chan, PKS; Ng, MHL; Yu, LM; Hui, DS; Tam, JS; Cheng, G; Sung, JJY			Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis	BRITISH MEDICAL JOURNAL			English	Article							CYTOMEGALOVIRUS-INDUCED THROMBOCYTOPENIA; IMMUNODEFICIENCY-VIRUS INFECTION; IMMUNOCOMPETENT ADULT; MEGAKARYOCYTES	Objectives To evaluate the haematological findings of patients with severe acute respiratory syndrome (SARS). Design Analysis of the demographic, clinical, and laboratory characteristics of patients with SARS. Setting Prince of Wales Hospital, Hong Kong. Subjects All patients with a diagnosis of SARS between 11 March and 29 March 2003 who had no pre-existing haematological disorders. Main outcome measures Clinical end points included the need for intensive care and death. Univariate and multivariate analyses were performed to examine factors associated with adverse outcome. Results 64 male and 93 female patients were included in this study. The most common findings included lymphopenia in 153 (98%) of the 157 patients, neutrophilia in 129 (82% thrombocytopenia in 87 patients (55%), followed by thrombocytosis in 77 (49%), and isolated prolonged activated partial thromboplastin time in 96 patients (63%). The haemoglobin count dropped by more than 20 g/l from baseline in 95 (61%) patients. Four patients (2.5%) developed disseminated intravascular coagulation. Lymphopenia was shown in haemato-lymphoid organs at postmortem examination. Multivariate analysis showed that advanced age and a high concentration of lactate dehydrogenase at presentation were independent predictors of an adverse outcome. Subsets of peripheral blood lymphocytes were analysed in 31 patients. The counts of CD4 positive and CD8 positive T cells fell early in the course of illness. Low counts of CD4 and CD8 cells at presentation were associated with adverse outcomes. Conclusions Abnormal haematological variables were common among patients with SARS. Lymphopenia and the depletion of T lymphocyte subsets may be associated with disease activity.	Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Ctr Clin Trials & Epidemiol Res, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Sung, JJY (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.		Sung, Joseph J. Y./R-3203-2018; Chan, Paul KS/J-9360-2013; Wong, Raymond S. M./H-9644-2016; Wong, CK/H-3256-2016; Hui, David Shu-Cheong/O-2754-2015; Lee, Nelson/B-6418-2008	Sung, Joseph J. Y./0000-0003-3125-5199; Chan, Paul KS/0000-0002-6360-4608; Wong, Raymond S. M./0000-0002-9011-4268; Wong, CK/0000-0002-5637-8331; Hui, David Shu-Cheong/0000-0003-4382-2445; Lee, Nelson/0000-0002-0783-6607; Yu, Ly-Mee/0000-0003-0331-7364				[Anonymous], 2003, MMWR MORB MORTAL WKL, V52, P226; BALLEM PJ, 1992, NEW ENGL J MED, V327, P1779, DOI 10.1056/NEJM199212173272503; CHESNEY PJ, 1978, J PEDIATR-US, V92, P957, DOI 10.1016/S0022-3476(78)80375-8; EISENBERG MJ, 1993, WESTERN J MED, V158, P525; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; MAURY CPJ, 1990, J INTERN MED, V227, P253, DOI 10.1111/j.1365-2796.1990.tb00154.x; MCCROMICK JB, 1986, NEW ENGL J MED, V314, P20; NINOMIYA N, 1977, HELV PAEDIATR ACTA, V32, P87; OSKI FA, 1966, NEW ENGL J MED, V275, P352, DOI 10.1056/NEJM196608182750703; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; ROBERTS RB, 1987, CLIN PHARMACOL THER, V42, P365, DOI 10.1038/clpt.1987.165; VANCAMPEN H, 1989, J GEN VIROL, V70, P467, DOI 10.1099/0022-1317-70-2-467; vanSpronsen DJ, 1996, BRIT J HAEMATOL, V92, P218; ZUCKERFRANKLIN D, 1994, SEMIN HEMATOL, V31, P329	16	397	430	0	16	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 21	2003	326	7403					1358	1362		10.1136/bmj.326.7403.1358	http://dx.doi.org/10.1136/bmj.326.7403.1358			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694CN	12816821	Bronze, Green Published			2022-12-24	WOS:000183756400017
J	Stollewerk, A; Schoppmeier, M; Damen, WGM				Stollewerk, A; Schoppmeier, M; Damen, WGM			Involvement of Notch and Delta genes in spider segmentation	NATURE			English	Article							SIGNALING PATHWAY; CUPIENNIUS-SALEI; EXPRESSION; OSCILLATOR; SOMITE; HAIRY; PATTERN; FRINGE; HER1	It is currently debated whether segmentation in different animal phyla has a common origin and shares a common genetic mechanism(1,2). The apparent use of different genetic networks in arthropods and vertebrates has become a strong argument against a common origin of segmentation. Our knowledge of arthropod segmentation is based mainly on the insect Drosophila, in which a hierarchical cascade of transcription factors controls segmentation(3,4). The function of some of these genes seems to be conserved among arthropods, including spiders(5,6), but not vertebrates(1,6-8). The Notch pathway has a key role in vertebrate segmentation (somitogenesis) but is not involved in Drosophila body segmentation(1,7,9). Here we show that Notch and Delta genes are involved in segmentation of another arthropod, the spider Cupiennius salei. Expression patterns of Notch and Delta, coupled with RNA interference experiments, identify many similarities between spider segmentation and vertebrate somitogenesis. Our data indicate that formation of the segments in arthropods and vertebrates may have shared a genetic programme in a common ancestor and that parts of this programme have been lost in particular descendant lineages.	Univ Cologne, Inst Genet Evolutionary Genet, D-50931 Cologne, Germany	University of Cologne	Damen, WGM (corresponding author), Univ Cologne, Inst Genet Evolutionary Genet, Weyertal 121, D-50931 Cologne, Germany.	damen@uni-koeln.de						Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Anderson D. T., 1973, EMBRYOLOGY PHYLOGENY, P365, DOI [10.1016/B978-0-08-017069-5.50014-7, DOI 10.1016/B978-0-08-017069-5.50014-7]; Baonza A, 2001, DEVELOPMENT, V128, P3889; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Brook WJ, 1996, ANNU REV CELL DEV BI, V12, P161, DOI 10.1146/annurev.cellbio.12.1.161; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; Damen WGM, 2000, P NATL ACAD SCI USA, V97, P4515, DOI 10.1073/pnas.97.9.4515; Damen WGM, 2002, DEVELOPMENT, V129, P1239; Davis G.K., 1999, TRENDS GENET, V9, pM68; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; de Celis JF, 1998, DEVELOPMENT, V125, P4617; Dearden P, 2000, DEV GENES EVOL, V210, P329, DOI 10.1007/s004270000072; DeRobertis EM, 1997, NATURE, V387, P25, DOI 10.1038/387025a0; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jouve C, 2000, DEVELOPMENT, V127, P1421; Oates AC, 2002, DEVELOPMENT, V129, P2929; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pankratz Michael J., 1993, P467; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; Pourquie O, 1999, CURR OPIN GENET DEV, V9, P559, DOI 10.1016/S0959-437X(99)00011-8; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Schoppmeier M, 2001, DEV GENES EVOL, V211, P76, DOI 10.1007/s004270000121; Seitz K. H., 1966, Zoologische Jahrbuecher (Anatomie), V83, P327; STJOHNSTON D, 1992, CELL, V68, P201; Stollewerk A, 2002, DEVELOPMENT, V129, P5339, DOI 10.1242/dev.00109; Wiellette EL, 1999, DEVELOPMENT, V126, P1985	30	174	184	1	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2003	423	6942					863	865		10.1038/nature01682	http://dx.doi.org/10.1038/nature01682			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815430				2022-12-24	WOS:000183585300044
J	Reddy, MM; Quinton, PM				Reddy, MM; Quinton, PM			Control of dynamic CFTR selectivity by glutamate and ATP in epithelial cells	NATURE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; DEPENDENT HCO3 TRANSPORT; CYSTIC-FIBROSIS; CHLORIDE CONDUCTANCE; CHANNEL; RECEPTORS; DELTA-F508; ACTIVATION; MUTATIONS; BINDING	Cystic fibrosis is caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR), an anion channel(1). Phosphorylation and ATP hydrolysis are generally believed to be indispensable for activating CFTR2. Here we report phosphorylation- and ATP-independent activation of CFTR by cytoplasmic glutamate that exclusively elicits Cl-, but not HCO3-, conductance in the human sweat duct. We also report that the anion selectivity of glutamate-activated CFTR is not intrinsically fixed, but can undergo a dynamic shift to conduct HCO3- by a process involving ATP hydrolysis. Duct cells from patients with DeltaF508 mutant CFTR showed no glutamate/ATP activated Cl- or HCO3- conductance. In contrast, duct cells from heterozygous patients with R117H/DeltaF508 mutant CFTR also lost most of the Cl- conductance, yet retained significant HCO3- conductance. Hence, not only does glutamate control neuronal ion channels, as is well known, but it can also regulate anion conductance and selectivity of CFTR in native epithelial cells. The loss of this uniquely regulated HCO3- conductance is most probably responsible for the more severe forms of cystic fibrosis pathology.	Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA	University of California System; University of California San Diego; University of California System; University of California Riverside	Reddy, MM (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA.							ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Cavalheiro EA, 2001, P NATL ACAD SCI USA, V98, P5947, DOI 10.1073/pnas.121179198; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Choi JY, 2001, NATURE, V410, P94, DOI 10.1038/35065099; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; DalL'Asta V, 1999, AM J PHYSIOL-CELL PH, V276, pC865, DOI 10.1152/ajpcell.1999.276.4.C865; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Duan SM, 2000, J NEUROPHYSIOL, V83, P31, DOI 10.1152/jn.2000.83.1.31; Durie PR, 1999, CYSTIC FIBROSIS IN ADULTS, P261; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; LEW TS, 1991, PEDIATR PULM, V6, P251; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Linsdell P, 1998, J GEN PHYSIOL, V111, P601, DOI 10.1085/jgp.111.4.601; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; QUINTON PM, 1992, NATURE, V360, P79, DOI 10.1038/360079a0; QUINTON PM, 1999, PHYSIOL REV, V79, P3; RAJ D, 2001, AM J PHYSIOL-RENAL, V280, pF214; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; Reddy MM, 2001, AM J PHYSIOL-CELL PH, V280, pC604, DOI 10.1152/ajpcell.2001.280.3.C604; Reddy MM, 1996, SCIENCE, V271, P1876, DOI 10.1126/science.271.5257.1876; RIORDAN JR, 1989, SCIENCE, V245, P1066; Santana LF, 1998, SCIENCE, V279, P1027, DOI 10.1126/science.279.5353.1027; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Skerry TM, 2001, TRENDS PHARMACOL SCI, V22, P174, DOI 10.1016/S0165-6147(00)01642-4; Sohma Y, 2000, J MEMBRANE BIOL, V176, P77, DOI 10.1007/s002320001077; Welbourne T, 2001, AM J PHYSIOL-CELL PH, V280, pC1151, DOI 10.1152/ajpcell.2001.280.5.C1151; WOLLHEIM C, 2002, DIABETOLOGIA, V43, P265	30	88	91	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2003	423	6941					756	760		10.1038/nature01694	http://dx.doi.org/10.1038/nature01694			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802335				2022-12-24	WOS:000183443400044
J	Gutmann, S; Haebel, PW; Metzinger, L; Sutter, M; Felden, B; Ban, N				Gutmann, S; Haebel, PW; Metzinger, L; Sutter, M; Felden, B; Ban, N			Crystal structure of the transfer-RNA domain of transfer-messenger RNA in complex with SmpB	NATURE			English	Article							PHENYLALANINE TRANSFER-RNA; ESCHERICHIA-COLI; ANGSTROM RESOLUTION; RIBOSOME RESCUE; BINDING PROTEIN; TAGGING SYSTEM; 10SA RNA; TMRNA; DEGRADATION; IDENTITY	Accurate translation of genetic information into protein sequence depends on complete messenger RNA molecules. Truncated mRNAs cause synthesis of defective proteins, and arrest ribosomes at the end of their incomplete message. In bacteria, a hybrid RNA molecule that combines the functions of both transfer and messenger RNAs (called tmRNA) rescues stalled ribosomes, and targets aberrant, partially synthesized, proteins for proteolytic degradation(1,2). Here we report the 3.2-Angstrom-resolution structure of the tRNA-like domain of tmRNA (tmRNA(Delta)) in complex with small protein B (SmpB), a protein essential for biological functions of tmRNA. We find that the flexible RNA molecule adopts an open L-shaped conformation and SmpB binds to its elbow region, stabilizing the single-stranded D-loop in an extended conformation. The most striking feature of the structure of tmRNA(Delta) is a 90degrees rotation of the TPsiC-arm around the helical axis. Owing to this unusual conformation, the SmpB-tmRNA(Delta) complex positioned into the A-site of the ribosome orients SmpB towards the small ribosomal subunit, and directs tmRNA towards the elongation-factor binding region of the ribosome. On the basis of this structure, we propose a model for the binding of tmRNA on the ribosome.	ETH, Inst Mol Biol & Biophys, HPK Gebaude, CH-8093 Zurich, Switzerland; Univ Rennes 1, UPRES JE2311, F-35043 Rennes, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Universite de Rennes	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, HPK Gebaude, CH-8093 Zurich, Switzerland.		Metzinger, Laurent/B-1426-2016; metzinger, laurent/AAY-4634-2021; felden, brice/L-4825-2015	Metzinger, Laurent/0000-0002-7636-8480; metzinger, laurent/0000-0002-7636-8480; Gutmann, Sascha/0000-0002-4242-8510; Sutter, Markus/0000-0001-6290-4820				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Barends S, 2001, J MOL BIOL, V314, P9, DOI 10.1006/jmbi.2001.5114; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Corvaisier S, 2003, J BIOL CHEM, V278, P14788, DOI 10.1074/jbc.M212830200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong G, 2002, EMBO J, V21, P1845, DOI 10.1093/emboj/21.7.1845; Felden B, 1997, RNA, V3, P89; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hanawa-Suetsugu K, 2001, NUCLEIC ACIDS RES, V29, P4663, DOI 10.1093/nar/29.22.4663; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 2000, P NATL ACAD SCI USA, V97, P7778, DOI 10.1073/pnas.97.14.7778; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; KIM SH, 1973, SCIENCE, V179, P285, DOI 10.1126/science.179.4070.285; Komine Y, 1996, J BIOCHEM-TOKYO, V119, P463; MCCLAIN WH, 1991, P NATL ACAD SCI USA, V88, P9272, DOI 10.1073/pnas.88.20.9272; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Rudinger-Thirion J, 1999, RNA, V5, P989, DOI 10.1017/S135583829999101X; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Someya T, 2003, FEBS LETT, V535, P94, DOI 10.1016/S0014-5793(02)03880-2; Stagg SM, 2001, J MOL BIOL, V309, P727, DOI 10.1006/jmbi.2001.4632; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; USHIDA C, 1994, NUCLEIC ACIDS RES, V22, P3392, DOI 10.1093/nar/22.16.3392; Valle M, 2003, SCIENCE, V300, P127, DOI 10.1126/science.1081798; Williams KP, 1996, RNA, V2, P1306; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	30	100	103	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					699	703		10.1038/nature01831	http://dx.doi.org/10.1038/nature01831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904796				2022-12-24	WOS:000184578800051
J	Abramson, J; Smirnova, I; Kasho, V; Verner, G; Kaback, HR; Iwata, S				Abramson, J; Smirnova, I; Kasho, V; Verner, G; Kaback, HR; Iwata, S			Structure and mechanism of the lactose permease of Escherichia coli	SCIENCE			English	Article								Membrane transport proteins that transduce free energy stored in electrochemical ion gradients into a concentration gradient are a major class of membrane proteins. We report the crystal structure at 3.5 angstroms of the Escherichia coli lactose permease, an intensively studied member of the major facilitator superfamily of transporters. The molecule is composed of N- and C-terminal domains, each with six transmembrane helices, symmetrically positioned within the permease. A large internal hydrophilic cavity open to the cytoplasmic side represents the inward-facing conformation of the transporter. The structure with a bound lactose homolog, beta-D-galactopyranosyl-1-thio-beta-D-galactopyranoside, reveals the sugar-binding site in the cavity, and residues that play major roles in substrate recognition and proton translocation are identified. We propose a possible mechanism for lactose/proton symport (cotransport) consistent with both the structure and a large body of experimental data.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England; Univ Calif Los Angeles, Inst Mol Biol, Howard Hughes Med Inst, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Howard Hughes Med Inst, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	Imperial College London; Imperial College London; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Kaback, HR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England.	ronaldk@hhmi.ucla.edu; s.iwata@imperial.ac.uk			NIDDK NIH HHS [DK51131: 08] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051131] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CALAMIA J, 1990, P NATL ACAD SCI USA, V87, P4937, DOI 10.1073/pnas.87.13.4937; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; FOSTER DL, 1983, J BIOL CHEM, V258, P31; FRANCO PJ, 1994, J BIOL CHEM, V269, P7379; Frillingos S, 1997, PROTEIN SCI, V6, P438; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Guan L, 2003, BIOCHEMISTRY-US, V42, P1377, DOI 10.1021/bi027152m; Guan L, 2002, P NATL ACAD SCI USA, V99, P3475, DOI 10.1073/pnas.052703699; Guan L, 2002, P NATL ACAD SCI USA, V99, P6613, DOI 10.1073/pnas.102178299; HENDERSON PJF, 1990, J BIOENERG BIOMEMBR, V22, P525, DOI 10.1007/BF00762961; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; JUNG K, 1995, BIOCHEMISTRY-US, V34, P6272, DOI 10.1021/bi00019a003; JUNG K, 1993, BIOCHEMISTRY-US, V32, P12273, DOI 10.1021/bi00097a001; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; le Coutre J, 1998, P NATL ACAD SCI USA, V95, P6114, DOI 10.1073/pnas.95.11.6114; M_uller-Hill B., 1996, LAC OPERON SHORT HIS; Merritt EA, 1997, STRUCTURE, V5, P1485, DOI 10.1016/S0969-2126(97)00298-0; Miller C, 2000, CURR OPIN CHEM BIOL, V4, P148, DOI 10.1016/S1367-5931(99)00068-X; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Patzlaff JS, 1998, BIOCHEMISTRY-US, V37, P15363, DOI 10.1021/bi981142x; ROEPE PD, 1989, BIOCHEMISTRY-US, V28, P6127, DOI 10.1021/bi00440a060; Sahin-Toth M, 2000, BIOCHEMISTRY-US, V39, P5097, DOI 10.1021/bi0000263; Sahin-Toth M, 2001, BIOCHEMISTRY-US, V40, P13015, DOI 10.1021/bi011233l; Sahin-Toth M, 2001, P NATL ACAD SCI USA, V98, P6068, DOI 10.1073/pnas.111139698; SAHINTOTH M, 1992, P NATL ACAD SCI USA, V89, P10547, DOI 10.1073/pnas.89.21.10547; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Smirnova IN, 2003, BIOCHEMISTRY-US, V42, P3025, DOI 10.1021/bi027329c; Sorgen PL, 2002, P NATL ACAD SCI USA, V99, P14037, DOI 10.1073/pnas.182552199; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; UJWAL ML, 1994, MOL MEMBR BIOL, V11, P9, DOI 10.3109/09687689409161024; Venkatesan P, 1998, P NATL ACAD SCI USA, V95, P9802, DOI 10.1073/pnas.95.17.9802; Weinglass AB, 2002, J MOL BIOL, V315, P561, DOI 10.1006/jmbi.2001.5289; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Wolin CD, 2000, BIOCHEMISTRY-US, V39, P6130, DOI 10.1021/bi0001269; Wolin CD, 2001, BIOCHEMISTRY-US, V40, P1996, DOI 10.1021/bi0025767; Zhao M, 1999, BIOCHEMISTRY-US, V38, P7407, DOI 10.1021/bi9906524	37	1180	1205	1	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2003	301	5633					610	615		10.1126/science.1088196	http://dx.doi.org/10.1126/science.1088196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893935				2022-12-24	WOS:000184473600030
J	Thomson, RE; Mihaly, SF; Rabinovich, AB; McDuff, RE; Veirs, SR; Stahr, FR				Thomson, RE; Mihaly, SF; Rabinovich, AB; McDuff, RE; Veirs, SR; Stahr, FR			Constrained circulation at Endeavour ridge facilitates colonization by vent larvae	NATURE			English	Article							DE-FUCA RIDGE; MID-ATLANTIC RIDGE; HYDROTHERMAL PLUMES; NORTHEAST PACIFIC; HEAT-FLUX; BIOLOGY; EVOLUTION; OCEAN	Understanding how larvae from extant hydrothermal vent fields colonize neighbouring regions of the mid-ocean ridge system remains a major challenge in oceanic research(1,2). Among the factors considered important in the recruitment of deep-sea larvae are metabolic lifespan, the connectivity of the seafloor topography, and the characteristics of the currents(3). Here we use current velocity measurements from Endeavour ridge to examine the role of topographically constrained circulation on larval transport along-ridge. We show that the dominant tidal and wind-generated currents in the region are strongly attenuated within the rift valley that splits the ridge crest, and that hydrothermal plumes rising from vent fields in the valley drive a steady near-bottom inflow within the valley. Extrapolation of these findings suggests that the suppression of oscillatory currents within rift valleys of mid-ocean ridges shields larvae from cross-axis dispersal into the inhospitable deep ocean. This effect, augmented by plume-driven circulation within rift valleys having active hydrothermal venting, helps retain larvae near their source. Larvae are then exported preferentially down-ridge during regional flow events that intermittently over-ride the currents within the valley.	Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; PP Shirshov Oceanol Inst, Moscow 117851, Russia; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	Russian Academy of Sciences; Shirshov Institute of Oceanology; University of Washington; University of Washington Seattle	Thomson, RE (corresponding author), Inst Ocean Sci, 9860 W Saanich Rd, Sidney, BC V8L 4B2, Canada.		Rabinovich, Alexander/ABD-5745-2020	Veirs, Scott/0000-0001-7395-9085				BAKER ET, 1987, EARTH PLANET SC LETT, V85, P59, DOI 10.1016/0012-821X(87)90021-5; BEMIS KG, 1993, J GEOPHYS RES-SOL EA, V98, P6351, DOI 10.1029/92JB02273; Cannon GA, 1996, GEOPHYS RES LETT, V23, P1613, DOI 10.1029/96GL01370; GERMAN CR, 1993, EARTH PLANET SC LETT, V116, P129, DOI 10.1016/0012-821X(93)90049-F; GINSTER U, 1994, J GEOPHYS RES-SOL EA, V99, P4937, DOI 10.1029/93JB02800; Kelley D. S., 2001, EOS T AGU, V82, pF612; Lavelle JW, 2001, J GEOPHYS RES-OCEANS, V106, P31099, DOI 10.1029/2001JC000865; LUPTON JE, 1985, NATURE, V316, P621, DOI 10.1038/316621a0; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; Mcduff R.E., 1995, PHYSICAL CHEM BIOL G, P357; Mihaly SF, 1998, GEOPHYS RES LETT, V25, P1205, DOI 10.1029/98GL00722; Murton BJ, 1999, EARTH PLANET SC LETT, V171, P301, DOI 10.1016/S0012-821X(99)00157-0; ROSENBERG ND, 1988, NATURE, V334, P604, DOI 10.1038/334604a0; STAHR FR, 2000, EOS T AGU S, V81; THOMSON RE, 1992, EARTH PLANET SC LETT, V111, P141, DOI 10.1016/0012-821X(92)90175-U; Thurnherr AM, 2002, J PHYS OCEANOGR, V32, P1763, DOI 10.1175/1520-0485(2002)032<1763:FAMITR>2.0.CO;2; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; VEIRS SR, 2003, THESIS U WASHINGTON	19	81	83	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					545	549		10.1038/nature01824	http://dx.doi.org/10.1038/nature01824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891356				2022-12-24	WOS:000184454700041
J	Webster, AJ; Payne, RJH; Pagel, M				Webster, AJ; Payne, RJH; Pagel, M			Molecular Phylogenies link rates of evolution and speciation	SCIENCE			English	Article							DIVERSITY		Univ Reading, Sch Anim & Microbial Sci, Reading RG6 2AH, Berks, England	University of Reading	Pagel, M (corresponding author), Univ Reading, Sch Anim & Microbial Sci, Reading RG6 2AH, Berks, England.							Barraclough TG, 2001, EVOLUTION, V55, P677, DOI 10.1554/0014-3820(2001)055[0677:ERASDI]2.0.CO;2; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Mayr E., 1954, EVOLUTION PROCESS, P157; MINDELL DP, 1990, J EVOLUTION BIOL, V3, P125, DOI 10.1046/j.1420-9101.1990.3010125.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Weller SG, 1996, EVOLUTION, V50, P23, DOI 10.1111/j.1558-5646.1996.tb04469.x	7	122	125	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					478	478		10.1126/science.1083202	http://dx.doi.org/10.1126/science.1083202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881561				2022-12-24	WOS:000184340500031
J	Cobb, KM; Charles, CD; Cheng, H; Edwards, RL				Cobb, KM; Charles, CD; Cheng, H; Edwards, RL			El Nino/Southern Oscillation and tropical Pacific climate during the last millennium	NATURE			English	Article							SOUTHERN-OSCILLATION; SOLAR IRRADIANCE; NINO; VARIABILITY; ENSO; CORAL; DROUGHT; MODEL; STABILITY; FREQUENCY	Any assessment of future climate change requires knowledge of the full range of natural variability in the El Nino/Southern Oscillation (ENSO) phenomenon. Here we splice together fossil-coral oxygen isotopic records from Palmyra Island in the tropical Pacific Ocean to provide 30-150-year windows of tropical Pacific climate variability within the last 1,100 years. The records indicate mean climate conditions in the central tropical Pacific ranging from relatively cool and dry during the tenth century to increasingly warmer and wetter climate in the twentieth century. But the corals also document a broad range of ENSO behaviour that correlates poorly with these estimates of mean climate. The most intense ENSO activity within the reconstruction occurred during the mid-seventeenth century. Taken together, the coral data imply that the majority of ENSO variability over the last millennium may have arisen from dynamics internal to the ENSO system itself.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Minnesota, Dept Geol & Geophys, Minnesota Isotope Lab, Minneapolis, MN 55455 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Minnesota System; University of Minnesota Twin Cities	Cobb, KM (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	kcobb@gps.caltech.edu	CHENG, HAI/H-3413-2017; Edwards, R. Lawrence/I-3124-2014	CHENG, HAI/0000-0002-5305-9458; Edwards, R. Lawrence/0000-0002-7027-5881; Cobb, Kim/0000-0002-2125-9164				Bard E, 2000, TELLUS B, V52, P985, DOI 10.1034/j.1600-0889.2000.d01-7.x; Black DE, 1999, SCIENCE, V286, P1709, DOI 10.1126/science.286.5445.1709; Cane M. A., 1995, NATURAL CLIMATE VARI, P442; Cobb KM, 2003, EARTH PLANET SC LETT, V210, P91, DOI 10.1016/S0012-821X(03)00138-9; Cobb KM, 2001, GEOPHYS RES LETT, V28, P2209, DOI 10.1029/2001GL012919; COLE JE, 1993, SCIENCE, V260, P1790, DOI 10.1126/science.260.5115.1790; Correge T, 2001, GEOPHYS RES LETT, V28, P3477, DOI 10.1029/2001GL013216; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; Dai A, 2000, GEOPHYS RES LETT, V27, P1283, DOI 10.1029/1999GL011140; Evans M., 2001, INTERHEMISPHERIC CLI, DOI [10.1016/b978-012472670-3/50007-0, DOI 10.1016/B978-012472670-3/50007-0]; Evans MN, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000590; Evans MN, 1999, J GEOPHYS RES-OCEANS, V104, P13409, DOI 10.1029/1999JC900001; Fedorov AV, 2001, J CLIMATE, V14, P3086, DOI 10.1175/1520-0442(2001)014<3086:ASAOTO>2.0.CO;2; GRAHAM NE, 1988, SCIENCE, V240, P1293, DOI 10.1126/science.240.4857.1293; Gu DF, 1997, SCIENCE, V275, P805, DOI 10.1126/science.275.5301.805; Harrison DE, 1997, GEOPHYS RES LETT, V24, P1779, DOI 10.1029/97GL01789; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hendy EJ, 2002, SCIENCE, V295, P1511, DOI 10.1126/science.1067693; Hodell DA, 2001, SCIENCE, V292, P1367, DOI 10.1126/science.1057759; HODELL DA, 1995, NATURE, V375, P391, DOI 10.1038/375391a0; Hughen KA, 1999, GEOPHYS RES LETT, V26, P3129, DOI 10.1029/1999GL006062; JIN FF, 1994, SCIENCE, V264, P70, DOI 10.1126/science.264.5155.70; Jin FF, 1997, J ATMOS SCI, V54, P811, DOI 10.1175/1520-0469(1997)054<0811:AEORPF>2.0.CO;2; JONES PD, 1986, J CLIM APPL METEOROL, V25, P161, DOI 10.1175/1520-0450(1986)025<0161:NHSATV>2.0.CO;2; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; KEEMAN R, 1994, TELLUS A, V46, P529, DOI 10.1034/j.1600-0870.1994.00014.x; Knutson TR, 1997, J CLIMATE, V10, P138, DOI 10.1175/1520-0442(1997)010<0138:SEIAGC>2.0.CO;2; Latif M, 1997, J CLIMATE, V10, P2221, DOI 10.1175/1520-0442(1997)010<2221:GWDVOE>2.0.CO;2; LEAN J, 1995, GEOPHYS RES LETT, V22, P3195, DOI 10.1029/95GL03093; Linsley BK, 1999, CORAL REEFS, V18, P13, DOI 10.1007/s003380050148; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Mann ME, 2000, EL NINO SO OSCILLATI, P357, DOI 10.1017/CBO9780511573125.011; McCulloch M, 1996, EARTH PLANET SC LETT, V138, P169, DOI 10.1016/0012-821X(95)00230-A; McPhaden MJ, 2002, NATURE, V415, P603, DOI 10.1038/415603a; Neelin JD, 1998, J GEOPHYS RES-OCEANS, V103, P14261, DOI 10.1029/97JC03424; Parker DE, 1995, CLIMATIC CHANGE, V31, P559, DOI 10.1007/BF01095162; Rajagopalan B, 1997, J CLIMATE, V10, P2351, DOI 10.1175/1520-0442(1997)010<2351:AEOAAV>2.0.CO;2; Robock A, 2000, REV GEOPHYS, V38, P191, DOI 10.1029/1998RG000054; SCOFFIN TP, 1993, CORAL REEFS, V12, P203, DOI 10.1007/BF00334480; STINE S, 1994, NATURE, V369, P546, DOI 10.1038/369546a0; TETT S, 1995, J CLIMATE, V8, P1473, DOI 10.1175/1520-0442(1995)008<1473:SOENSO>2.0.CO;2; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Timmermann A, 2001, GEOPHYS RES LETT, V28, P2061, DOI 10.1029/2001GL012879; Trenberth KE, 1996, GEOPHYS RES LETT, V23, P57, DOI 10.1029/95GL03602; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; TZIPERMAN E, 1994, SCIENCE, V264, P72, DOI 10.1126/science.264.5155.72; Urban FE, 2000, NATURE, V407, P989, DOI 10.1038/35039597; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Zhang Y, 1997, J CLIMATE, V10, P1004, DOI 10.1175/1520-0442(1997)010<1004:ELIV>2.0.CO;2	50	649	676	6	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					271	276		10.1038/nature01779	http://dx.doi.org/10.1038/nature01779			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867972				2022-12-24	WOS:000184183900031
J	Jiang, GY; Giannone, G; Critchley, DR; Fukumoto, E; Sheetz, MP				Jiang, GY; Giannone, G; Critchley, DR; Fukumoto, E; Sheetz, MP			Two-piconewton slip bond between fibronectin and the cytoskeleton depends on talin	NATURE			English	Article								Mechanical forces on matrix-integrin-cytoskeleton linkages are crucial for cell viability, morphology and organ function(1). The production of force depends on the molecular connections from extracellular-matrix-integrin complexes to the cytoskeleton(2,3). The minimal matrix complex causing integrin-cytoskeleton connections is a trimer of fibronectin's integrin-binding domain FNIII7-10 (ref. 4). Here we report a specific, molecular slip bond that was broken repeatedly by a force of 2 pN at the cellular loading rate of 60 nm s(-1); this occurred with single trimer beads but not with monomer. Talin1, which binds to both integrins and actin filaments in vitro, is required for the 2-pN slip bond and rapid cytoskeleton binding. Further, inhibition of fibronectin binding to alpha(v)beta(3) and deletion of beta(3) markedly decreases the 2-pN force peak. We suggest that talin1 initially forms a molecular slip bond between closely packed fibronectin-integrin complexes and the actin cytoskeleton, which can apply a low level of force to fibronectin until many bonds form or a signal is received to activate a force response.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; NIH, Natl Inst Dent & Craniofacial Res, Bethesda, MD 20892 USA	Columbia University; University of Leicester; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Sheetz, MP (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.			Giannone, Gregory/0000-0002-0932-1690	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000524] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Coussen F, 2002, J CELL SCI, V115, P2581; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Felsenfeld DP, 1996, NATURE, V383, P438, DOI 10.1038/383438a0; FINER JT, 1995, BIOPHYS J, V68, P291; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; GIANNONE G, UNPUB J CELL BIOL; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; NISHIZAKA T, 1995, NATURE, V377, P251, DOI 10.1038/377251a0; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Sonnenberg A, 1993, Curr Top Microbiol Immunol, V184, P7; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Suzuki K, 2001, BIOPHYS J, V81, P2181, DOI 10.1016/S0006-3495(01)75866-3; Thoumine O, 2000, EUR BIOPHYS J BIOPHY, V29, P398, DOI 10.1007/s002490000087; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Watanabe K, 2002, J BIOL CHEM, V277, P11549, DOI 10.1074/jbc.M200356200; Xing BD, 2001, J BIOL CHEM, V276, P44373, DOI 10.1074/jbc.M108587200	30	348	368	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					334	337		10.1038/nature01805	http://dx.doi.org/10.1038/nature01805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867986				2022-12-24	WOS:000184183900047
J	Slabbekoorn, H; Peet, M				Slabbekoorn, H; Peet, M			Ecology: Birds sing at a higher pitch in urban noise - Great tits hit the high notes to ensure that their mating calls are heard above the city's din.	NATURE			English	Editorial Material							PARUS-MAJOR; SONG; HYPOTHESIS; SELECTION; ROADS		Leiden Univ, Inst Biol Leiden, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Slabbekoorn, H (corresponding author), Leiden Univ, Inst Biol Leiden, NL-2300 RA Leiden, Netherlands.							Catterall CP, 1998, BIOL CONSERV, V84, P65, DOI 10.1016/S0006-3207(97)00076-1; Clergeau P, 1998, CONDOR, V100, P413, DOI 10.2307/1369707; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; HANSEN P, 1979, ANIM BEHAV, V27, P1270, DOI 10.1016/0003-3472(79)90073-3; HUNTER ML, 1979, J ANIM ECOL, V48, P759, DOI 10.2307/4194; Junker-Bornholdt R, 1998, J ORNITHOL, V139, P131, DOI 10.1007/BF01651222; Klump Georg M., 1996, P321; MCGREGOR PK, 1989, BEHAVIOUR, V108, P139, DOI 10.1163/156853989X00105; Rabin LA, 2002, J COMP PSYCHOL, V116, P137, DOI 10.1037//0735-7036.116.2.137; REIJNEN R, 1995, J APPL ECOL, V32, P187, DOI 10.2307/2404428; Skiba R, 2000, J ORNITHOL, V141, P160, DOI 10.1046/j.1439-0361.2000.00071.x; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Slabbekoorn H, 2002, EVOLUTION, V56, P1849	13	673	710	7	456	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					267	267		10.1038/424267a	http://dx.doi.org/10.1038/424267a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867967				2022-12-24	WOS:000184183900026
J	Tseng, CW; Brook, RH; Keeler, E; Mangione, CM				Tseng, CW; Brook, RH; Keeler, E; Mangione, CM			Impact of an annual dollar limit or "cap" on prescription drug benefits for medicare patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BENEFICIARIES; COVERAGE; COST	Context Annual dollar limits, or "caps," on drug benefits are common in Medicare managed care (Medicare + Choice) and have been part of several proposals for a national Medicare drug benefit. Objectives To determine how cap levels affect the percentage of patients exceeding the cap and their out-of-pocket drug costs and to identify the medications that contribute most to prescription costs. Design and Setting Cross-sectional analysis of 2001 pharmacy claims data from a large Medicare + Choice plan in a mature market with caps of $750 to $2000 per year applied to the plan's share of prescription costs. Participants Patients who filled at least 1 prescription in 2001 (n=438802). Main Outcome Measures Percentages of patients exceeding caps, identified from prescription claims; out-of-pocket patient costs before exceeding caps, calculated from patients' co-payments; and out-of-pocket patient costs after exceeding caps, estimated from total prescription costs before exceeding the cap. Each unique drug was ranked by total expenditures, which included spending by patients who exceeded caps and by the plan for that drug. Results A total of 22%, 14%, and 4% of Medicare patients exceeded caps of $750, $1000, and $2000, respectively. Across caps, patients faced a potential 2- to 3-fold increase in median out-of-pocket costs after exceeding caps ($179-$305/mo) to continue the same prescription use as before exceeding caps ($794100/mo). For patients who exceeded a cap of $750, yearly out-of-pocket drug costs ranged from $564 to $4201 (5th-95th percentiles). Fifteen of the 20 medications with the highest total prescription expenditures for patients who exceeded the cap were for chronic conditions. Seven had lower-cost generic versions or a generic medication available in the same treatment class. Conclusions At lower caps, a substantial proportion of Medicare patients exceeded their annual drug benefit. To continue the same medication use as before exceeding caps, these patients faced potentially high increases in out-of-pocket costs for medications used primarily to treat chronic conditions. Generic options were not available for many of these drugs.	Univ Hawaii, Dept Family Practice & Community Hlth, Honolulu, HI 96822 USA; Pacific Hlth Res Inst, Honolulu, HI USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, Los Angeles, CA USA; RAND Corp, Hlth, Santa Monica, CA USA	University of Hawaii System; Pacific Health Research & Education Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Robert Wood Johnson Foundation (RWJF); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RAND Corporation	Tseng, CW (corresponding author), 846 S Hotel St,Suite 303, Honolulu, HI 96813 USA.				NIA NIH HHS [AG-02-004] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams AS, 2001, HEALTH AFFAIR, V20, P276, DOI 10.1377/hlthaff.20.1.276; *C BUDG OFF, 2002, ISS DES PRESCR DRUG; *COMM FUND, 1999, TRENDS MED PLUS CHOI; Cox ER, 2001, MED CARE, V39, P296, DOI 10.1097/00005650-200103000-00009; Federman AD, 2001, JAMA-J AM MED ASSOC, V286, P1732, DOI 10.1001/jama.286.14.1732; *HJ KAIS FAM FDN C, SEN PRESCR DRUGS FIN; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P1733, DOI 10.1001/jama.288.14.1733; LASCHOBER MA, 1996, TRENDS MEDICARE S IN; Lichtenberg FR, 2001, HEALTH AFFAIR, V20, P241, DOI 10.1377/hlthaff.20.5.241; McClellan M, 2000, HEALTH AFFAIR, V19, P26, DOI 10.1377/hlthaff.19.2.26; Poisal JA, 2001, HEALTH AFFAIR, V20, P74, DOI 10.1377/hlthaff.20.2.74; Rector TS, 2000, JAMA-J AM MED ASSOC, V283, P2163, DOI 10.1001/jama.283.16.2163; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; Steinman MA, 2001, J GEN INTERN MED, V16, P793, DOI 10.1046/j.1525-1497.2001.10412.x; Stuart B, 1998, MED CARE, V36, P202, DOI 10.1097/00005650-199802000-00009; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; 2002, HJ KAISER FAMILY FDN	18	42	42	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2003	290	2					222	227		10.1001/jama.290.2.222	http://dx.doi.org/10.1001/jama.290.2.222			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	698GH	12851277	Bronze, Green Submitted			2022-12-24	WOS:000183989800027
J	Seo, HS; Yang, JY; Ishikawa, M; Bolle, C; Ballesteros, ML; Chua, NH				Seo, HS; Yang, JY; Ishikawa, M; Bolle, C; Ballesteros, ML; Chua, NH			LAF1 ubiquitination by COP1 controls photomorphogenesis and is stimulated by SPA1	NATURE			English	Article							RING FINGER MOTIF; PHYTOCHROME-A; SIGNAL-TRANSDUCTION; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; LIGHT CONTROL; PROTEIN; REPRESSOR; INTERACTS; DEFINES	Far-red light regulates many aspects of seedling development, such as inhibition of hypocotyl elongation and the promotion of greening(1), acting in part through phytochrome A ( phyA). The RING motif protein COP1 is also important because cop1 mutants exhibit constitutive photomorphogenesis in darkness(2,3). COP1 is present in the nucleus in darkness but is gradually relocated to the cytoplasm upon illumination(4). Here we show that COP1 functions as an E3 ligase ubiquitinating both itself and the myb transcription activator LAF1, which is required for complete phyA responses(5). In transgenic plants, inducible COP1 overexpression leads to a decrease in LAF1 concentrations, but is blocked by the proteasome inhibitor MG132. The coiled-coil domain of SPA1, a negative regulator of phyA signalling(6), has no effect on COP1 auto-ubiquitination but facilitates LAF1 ubiquitination at low COP1 concentrations. These results indicate that, in darkness, COP1 functions as a repressor of photomorphogenesis by promoting the ubiquitin-mediated proteolysis of a subset of positive regulators, including LAF1. After the activation of phyA, SPA1 stimulates the E3 activity of residual nuclear COP1 to ubiquitinate LAF1, thereby desensitizing phyA signals.	Rockefeller Univ, Plant Mol Biol Lab, New York, NY 10021 USA	Rockefeller University	Chua, NH (corresponding author), Rockefeller Univ, Plant Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.		Yang, Jun-Yi/ABA-2044-2021; Ishikawa, Masaki/Q-7598-2018; Ishikawa, Masaki/AAC-8162-2022; Bolle, Cordelia/C-5569-2011	Yang, Jun-Yi/0000-0002-6332-6265; Ishikawa, Masaki/0000-0002-6491-5539; Ishikawa, Masaki/0000-0002-6491-5539; Bolle, Cordelia/0000-0002-4399-0070				Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Ballesteros ML, 2001, GENE DEV, V15, P2613, DOI 10.1101/gad.915001; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DENG XW, 1991, GENE DEV, V5, P1172, DOI 10.1101/gad.5.7.1172; Dieterle M, 2001, GENE DEV, V15, P939, DOI 10.1101/gad.197201; Hardtke CS, 2002, PLANT J, V30, P385, DOI 10.1046/j.1365-313X.2002.01298.x; Hardtke CS, 2000, PLANT PHYSIOL, V124, P1548, DOI 10.1104/pp.124.4.1548; Hoecker U, 1998, PLANT CELL, V10, P19, DOI 10.1105/tpc.10.1.19; Hoecker U, 2001, J BIOL CHEM, V276, P38173; Hoecker U, 1999, SCIENCE, V284, P496, DOI 10.1126/science.284.5413.496; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Nagy F, 2002, ANNU REV PLANT BIOL, V53, P329, DOI 10.1146/annurev.arplant.53.100301.135302; Neff MM, 2000, GENE DEV, V14, P257; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Stacey MG, 1999, J BIOL CHEM, V274, P27231, DOI 10.1074/jbc.274.38.27231; Torii KU, 1999, J BIOL CHEM, V274, P27674, DOI 10.1074/jbc.274.39.27674; Torii KU, 1998, EMBO J, V17, P5577, DOI 10.1093/emboj/17.19.5577; VONARNIM AG, 1993, J BIOL CHEM, V268, P19626; vonArnim AG, 1997, PLANT PHYSIOL, V114, P779, DOI 10.1104/pp.114.3.779; Wilson JF, 2002, LANCET NEUROL, V1, P4, DOI 10.1016/S1474-4422(02)00025-X; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	30	374	409	6	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					995	999		10.1038/nature01696	http://dx.doi.org/10.1038/nature01696			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827204				2022-12-24	WOS:000183753900052
J	Li, CI; Malone, KE; Porter, PL; Weiss, NS; Tang, MTC; Cushing-Haugen, KL; Daling, JR				Li, CI; Malone, KE; Porter, PL; Weiss, NS; Tang, MTC; Cushing-Haugen, KL; Daling, JR			Relationship between long durations and different regimens of hormone therapy and risk of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; RECEPTOR STATUS; ESTROGEN USE; CARCINOMA; PROGESTIN; HEALTH; METAANALYSIS; INFORMATION; RELIABILITY	Context Women using combined estrogen and progestin hormone replacement therapy (CHRT) have an increased risk of breast cancer; however, data on use for long durations and on risk associated with patterns of use are lacking. Objective To evaluate relationships between durations and patterns of CHRT use and risk of breast cancer by histological type and hormone receptor status. Design Population-based case-control study. Setting Three counties in western Washington State. Participants Nine hundred seventy-five women 65-79 years of age diagnosed with invasive breast cancer from April 1, 1997, through May 31, 1999 (histology: 196 lobular cases, 656 ductal cases, 114 cases with other histological type, and 9 cases with an unspecified histological type; estrogen receptor (ER)/progesterone receptor (PR) status: 646 ER+/PR+ cases, 147 ER+/PR- cases, and 101 ER-/PR- cases [6 ER-/PR+ cases and 75 cases with unknown ER/PR status were not included in the analyses herein]) and 1007 population controls. Main Outcome Measures Risks of invasive lobular, ductal, ER+/PR+, ER+/PR-, and ER-/PR- breast carcinomas. Results Women using unopposed estrogen replacement therapy (ERT) (exclusive ERT use), even for 25 years or longer, had no appreciable increase in risk of breast cancer, although the associated odds ratios were not inconsistent with a possible small effect. Ever users of CHRT (includes CHRT users who also had used ERT) had a 1.7-fold (95% confidence interval (01, 1.3-2.2) increased risk of breast cancer, including a 2.7-fold (95% Cl, 1.7-4.3) increased risk of invasive lobular carcinoma, a 1.5-fold (95% Cl, 1.1-2.0) increased risk of invasive ductal carcinoma, and a 2.0-fold (95% Cl, 1.5-2.7) increased risk of ER+/PR+ breast cancers. The increase in risk was greatest in those using CHRT for longer durations (users for 5-14.9 years and 15 years had 1.5-fold [95% Cl, 1.0-2.3] and 1.6-fold [95% Cl, 1.0-2.6] increases in risk of invasive ductal carcinoma, respectively, and 3.7-fold [95% Cl, 2.0-6.6] and 2.6-fold [95% Cl, 1.3-5.3] increases in risk of invasive lobular carcinoma, respectively. Associations of similar magnitudes were seen among users of both sequential and continuous CHRT. Risks of ER+/PR- and ER-/ PR- tumors were not increased by use of any form of hormone replacement therapy; however,,small numbers of these tumors limited power to detect possible associations. Conclusion These data suggest that use of CHRT is associated with an increased risk of breast cancer, particularly invasive lobular tumors, whether the progestin component was taken in a sequential or in a continuous manner.	Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Li, CI (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave N,MP 381,POB 19024, Seattle, WA 98109 USA.				NCI NIH HHS [R01 CA072787] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072787] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEGG CB, 1984, BIOMETRIKA, V71, P11, DOI 10.2307/2336391; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Breslow NE, 1980, ANAL CASE CONTROL ST; Chen CL, 2002, JAMA-J AM MED ASSOC, V287, P734, DOI 10.1001/jama.287.6.734; Cobleigh MA, 1999, JAMA-J AM MED ASSOC, V281, P1528, DOI 10.1001/jama.281.16.1528; COLDITZ GA, 1990, JAMA-J AM MED ASSOC, V264, P2648, DOI 10.1001/jama.264.20.2648; COLDITZ GA, 1992, CANCER CAUSE CONTROL, V3, P433, DOI 10.1007/BF00051356; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Daling JR, 2002, CANCER-AM CANCER SOC, V95, P2455, DOI 10.1002/cncr.10984; DIXON JM, 1982, HISTOPATHOLOGY, V6, P149, DOI 10.1111/j.1365-2559.1982.tb02712.x; DUTOIT RS, 1991, EUR J SURG ONCOL, V17, P251; *F HUTCH CANC RES, CSS REP PUBL FAQS; GOODMAN MT, 1990, AM J EPIDEMIOL, V131, P815, DOI 10.1093/oxfordjournals.aje.a115572; GRADY D, 1995, OBSTET GYNECOL, V85, P304, DOI 10.1016/0029-7844(94)00383-O; Jain MG, 1999, EPIDEMIOLOGY, V10, P260, DOI 10.1097/00001648-199905000-00012; Kirsh V, 2002, CANCER CAUSE CONTROL, V13, P583, DOI 10.1023/A:1016330024268; Li CI, 2000, CANCER, V88, P2561, DOI 10.1002/1097-0142(20000601)88:11<2561::AID-CNCR19>3.3.CO;2-O; Li CI, 2003, JAMA-J AM MED ASSOC, V289, P1421, DOI 10.1001/jama.289.11.1421; Li CI, 2000, CANCER, V88, P2570, DOI 10.1002/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O; Lower EE, 1999, BREAST CANCER RES TR, V58, P205, DOI 10.1023/A:1006315607241; *NCI, 2003, SEER; Newcomb PA, 2002, CANCER EPIDEM BIOMAR, V11, P593; Newcomer LM, 1999, AM J EPIDEMIOL, V149, pS79; PAGANINIHILL A, 1982, AM J EPIDEMIOL, V116, P114; PERSSON I, 1987, INT J EPIDEMIOL, V16, P222, DOI 10.1093/ije/16.2.222; POTTER JD, 1995, CANCER EPIDEM BIOMAR, V4, P319; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; STEINBERG KK, 1994, EPIDEMIOLOGY, V5, P415, DOI 10.1097/00001648-199407000-00007; STIERER M, 1993, ANN SURG, V218, P13, DOI 10.1097/00000658-199307000-00004; WHO, 2000, INT CLASSIFICATION D, V3rd	31	296	313	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2003	289	24					3254	3263		10.1001/jama.289.24.3254	http://dx.doi.org/10.1001/jama.289.24.3254			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	693EX	12824206	Bronze			2022-12-24	WOS:000183704600018
J	Hunt, GM; Oakeshott, P				Hunt, GM; Oakeshott, P			Outcome in people with open spina bifida at age 35: prospective community based cohort study	BRITISH MEDICAL JOURNAL			English	Article									Addenbrookes Hosp, Cambridge CB2 2QQ, England; St George Hosp, Sch Med, Dept Community Hlth, London SW17 0RE, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; St Georges University London	Hunt, GM (corresponding author), 65 Grantchester St, Cambridge CB3 9HZ, England.			Oakeshott, Pippa/0000-0003-2568-8211				HUNT G, 1973, BRIT MED J, V4, P197, DOI 10.1136/bmj.4.5886.197; HUNT GM, 1995, DEV MED CHILD NEUROL, V37, P19; Hunt GM, 1999, J NEUROL NEUROSUR PS, V67, P591, DOI 10.1136/jnnp.67.5.591; LAURENCE KM, 1974, LANCET, V1, P301; SMITH GK, 1973, BRIT MED J, V4, P189, DOI 10.1136/bmj.4.5886.189	5	72	74	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 21	2003	326	7403					1365	1366		10.1136/bmj.326.7403.1365	http://dx.doi.org/10.1136/bmj.326.7403.1365			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694CN	12816823	Bronze, Green Published			2022-12-24	WOS:000183756400021
J	Baldwin, E				Baldwin, E			Time for a fresh look at complementary medicine	BRITISH MEDICAL JOURNAL			English	Article									House Lords, London SW1A 0PW, England		Baldwin, E (corresponding author), House Lords, London SW1A 0PW, England.								0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2003	326	7402					1322	1322		10.1136/bmj.326.7402.1322	http://dx.doi.org/10.1136/bmj.326.7402.1322			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691VK	12805177	Green Published			2022-12-24	WOS:000183626500041
J	Gold, ER				Gold, ER			SARS genome patent: symptom or disease?	LANCET			English	Editorial Material									McGill Univ, Fac Law, Ctr Intellectual Property Policy, Montreal, PQ H3A 1W9, Canada	McGill University	Gold, ER (corresponding author), McGill Univ, Fac Law, Ctr Intellectual Property Policy, Montreal, PQ H3A 1W9, Canada.	Richard.Gold2@McGill.ca		Gold, E. Richard/0000-0002-3789-9238				BRICKLEY P, 2003, SCIENTIST       0509; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; Gold ER, 2002, NAT GENET, V30, P359, DOI 10.1038/ng0402-359; Gold ER, 2002, LANCET, V359, P2268, DOI 10.1016/S0140-6736(02)09298-X; GOLD ER, 2002, DEBATING BIOTECHNOLO, P163; Gold ER, 1999, COMMERCIALIZATION GE, P63; Gold R, 2002, CAN MED ASSOC J, V167, P256; Merz JF, 2002, NATURE, V415, P577, DOI 10.1038/415577a; *MIN HLTH LONG TER, 2002, GEN TEST GEN PAT CHA; *ORG EC COOP DEV, 2002, GEN INV INT PROP RIT	10	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2003	361	9374					2002	2003		10.1016/S0140-6736(03)13674-4	http://dx.doi.org/10.1016/S0140-6736(03)13674-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814707	Green Published, hybrid			2022-12-24	WOS:000183488900004
J	Wu, XL; Li, Y; Crise, B; Burgess, SM				Wu, XL; Li, Y; Crise, B; Burgess, SM			Transcription start regions in the human genome are favored targets for MLV integration	SCIENCE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; RETROVIRAL INTEGRATION; GENE-THERAPY; DIRECTS INTEGRATION; DNA; MINICHROMOSOMES; ISLANDS; SITES	Factors contributing to retroviral integration have been intractable because past studies have not precisely located genomic sites of proviruses in sufficient numbers for significant analysis. In this study, 903 murine leukemia virus (MLV) and 379 human immunodeficiency virus-1 (HIV-1) integrations in the human genome were mapped. The data showed that MLV preferred integration near the start of transcriptional units ( either upstream or downstream) whereas HIV-1 preferred integration anywhere in the transcriptional unit but not upstream of the transcriptional start. Defining different integration site preferences for retroviruses will have important rami. cations for gene therapy and may aid in our understanding of the factors directing the integration process.	NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Sci Applicat Int Corp, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Science Applications International Corporation (SAIC)	Burgess, SM (corresponding author), NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA.	burgess@mail.nih.gov	Wilson, Matthew H/K-3193-2013	Burgess, Shawn/0000-0003-1147-0596	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000183] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-12400] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BUSHMAN FD, 1994, P NATL ACAD SCI USA, V91, P9233, DOI 10.1073/pnas.91.20.9233; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Check E, 2002, NATURE, V420, P116, DOI 10.1038/420116a; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Kaiser J, 2003, SCIENCE, V299, P495, DOI 10.1126/science.299.5606.495; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; MOOSLEHNER K, 1990, J VIROL, V64, P3056, DOI 10.1128/JVI.64.6.3056-3058.1990; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; PRUSS D, 1994, J BIOL CHEM, V269, P25031; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, P NATL ACAD SCI USA, V89, P9237, DOI 10.1073/pnas.89.19.9237; PRYCIAK PM, 1992, EMBO J, V11, P291, DOI 10.1002/j.1460-2075.1992.tb05052.x; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; SCATCHERI P, COMMUNICATION; SCHERDIN U, 1990, J VIROL, V64, P907, DOI 10.1128/JVI.64.2.907-912.1990; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Weidhaas JB, 2000, J VIROL, V74, P8382, DOI 10.1128/JVI.74.18.8382-8389.2000	18	1033	1101	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2003	300	5626					1749	1751		10.1126/science.1083413	http://dx.doi.org/10.1126/science.1083413			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805549				2022-12-24	WOS:000183459700052
J	Dore, JE; Lukas, R; Sadler, DW; Karl, DM				Dore, JE; Lukas, R; Sadler, DW; Karl, DM			Climate-driven changes to the atmospheric CO2 sink in the subtropical North Pacific Ocean	NATURE			English	Article							INORGANIC CARBON; ATLANTIC OCEAN; SEAWATER; GYRE; DISSOCIATION; VARIABILITY; EQUILIBRIUM; CONSTANTS; EXCHANGE; DIOXIDE	The oceans represent a significant sink for atmospheric carbon dioxide(1). Variability in the strength of this sink occurs on interannual timescales, as a result of regional and basin-scale changes in the physical and biological parameters that control the flux of this greenhouse gas into and out of the surface mixed layer(2,3). Here we analyse a 13-year time series of oceanic carbon dioxide measurements from station ALOHA in the subtropical North Pacific Ocean near Hawaii(4), and find a significant decrease in the strength of the carbon dioxide sink over the period 1989-2001. We show that much of this reduction in sink strength can be attributed to an increase in the partial pressure of surface ocean carbon dioxide caused by excess evaporation and the accompanying concentration of solutes in the water mass. Our results suggest that carbon dioxide uptake by ocean waters can be strongly influenced by changes in regional precipitation and evaporation patterns brought on by climate variability.	Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA	University of Hawaii System	Dore, JE (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, 1000 Pope Rd, Honolulu, HI 96822 USA.		Lukas, Roger B/B-3715-2009; Karl, David/AFP-3837-2022	Karl, David/0000-0002-6660-6721				Bates NR, 2002, NATURE, V420, P489, DOI 10.1038/nature01253; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Dickson A.G., 2001, OCEANOGRAPHY, V14, P21; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; *DOE, 1994, HDB METH AN VAR PAR; Dore JE, 2002, LIMNOL OCEANOGR, V47, P1595, DOI 10.4319/lo.2002.47.6.1595; Gruber N, 2002, SCIENCE, V298, P2374, DOI 10.1126/science.1077077; Hoerling M, 2003, SCIENCE, V299, P691, DOI 10.1126/science.1079053; Houghton J.T., 1990, CLIMATE CHANGE IPCC; Ishii M, 2001, MAR CHEM, V75, P17, DOI 10.1016/S0304-4203(01)00023-8; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; Keeling CD., 2002, TRENDS COMPENDIUM DA; KEELING CD, 1993, NATO ASI SERIES, V115; Lee K, 2000, GEOPHYS RES LETT, V27, P229, DOI 10.1029/1999GL002345; Lewis E., 1998, ORNLCDIAC105 US DEP; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; Lukas R, 2001, GEOPHYS RES LETT, V28, P3485, DOI 10.1029/2001GL013116; MERBACH C, 1973, LIMNOL OCEANOGR, V18, P897; Minobe S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014447; SIEGENTHALER U, 1993, NATURE, V365, P119, DOI 10.1038/365119a0; TUPAS L, 1993, 9314 SOEST U HAW; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Waple AM, 2002, B AM METEOROL SOC, V83, pS1; WEISS RF, 1982, NATURE, V300, P511, DOI 10.1038/300511a0; WINN CD, 1994, GLOBAL BIOGEOCHEM CY, V8, P157, DOI 10.1029/94GB00387	25	114	121	5	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2003	424	6950					754	757		10.1038/nature01885	http://dx.doi.org/10.1038/nature01885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917678				2022-12-24	WOS:000184733900033
J	Mann, NH; Cook, A; Millard, A; Bailey, S; Clokie, M				Mann, NH; Cook, A; Millard, A; Bailey, S; Clokie, M			Marine ecosystems: Bacterial photosynthesis genes in a virus	NATURE			English	Editorial Material									Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Mann, NH (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	n.h.mann@warwick.ac.uk	millard, andrew D/B-3893-2011; chen, qi/C-8585-2011	Millard, Andrew/0000-0002-3895-2854; Clokie, Martha/0000-0002-6069-8936				ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Deshpande NN, 1997, RNA, V3, P37; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Hambly E, 2001, P NATL ACAD SCI USA, V98, P11411, DOI 10.1073/pnas.191174498; Partensky F., 1999, B I OCEANOGRAPHIQUE, V19, P457; Piazena H, 2002, DEEP-SEA RES PT II, V49, P3513, DOI 10.1016/S0967-0645(02)00093-0; Seaton GGR, 1996, FEBS LETT, V389, P319, DOI 10.1016/0014-5793(96)00615-1; WILSON WH, 1993, APPL ENVIRON MICROB, V59, P3736, DOI 10.1128/AEM.59.11.3736-3743.1993	8	303	335	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2003	424	6950					741	741		10.1038/424741a	http://dx.doi.org/10.1038/424741a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917674	Bronze			2022-12-24	WOS:000184733900027
J	Kaspar, BK; Llado, J; Sherkat, N; Rothstein, JD; Gage, FH				Kaspar, BK; Llado, J; Sherkat, N; Rothstein, JD; Gage, FH			Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; SUSTAINED EXPRESSION; SUPEROXIDE-DISMUTASE; DISEASE PROGRESSION; LENTIVIRAL VECTORS; NERVOUS-SYSTEM; GENE DELIVERY; MICE; GDNF	Amyotrophic lateral sclerosis (ALS) is a progressive, lethal neuromuscular disease that is associated with the degeneration of spinal and brainstem motor neurons, leading to atrophy of limb, axial, and respiratory muscles. The cause of ALS is unknown, and there is no effective therapy. Neurotrophic factors are candidates for therapeutic evaluation in ALS. Although chronic delivery of molecules to the central nervous system has proven difficult, we recently discovered that adeno-associated virus can be retrogradely transported efficiently from muscle to motor neurons of the spinal cord. We report that insulin-like growth factor 1 prolongs life and delays disease progression, even when delivered at the time of overt disease symptoms.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21287 USA	Salk Institute; Johns Hopkins University; Johns Hopkins University	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Kaspar, Brian/E-6490-2010; Lladó, Jerònia/A-2633-2011; rothstein, jeffrey d/C-9470-2013; Kaspar, Brian/E-3349-2011	Lladó, Jerònia/0000-0002-8489-427X; 	NIA NIH HHS [AG21876, AG12992] Funding Source: Medline; NINDS NIH HHS [NS33958] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021876, P01AG012992] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Acsadi G, 2002, HUM GENE THER, V13, P1047, DOI 10.1089/104303402753812458; Azzouz M, 2000, HUM MOL GENET, V9, P803, DOI 10.1093/hmg/9.5.803; Bilak MM, 2001, AMYOTROPH LATERAL SC, V2, P83; Boulis NM, 2003, NEUROSURGERY, V52, P381, DOI 10.1227/01.NEU.0000044459.24519.3E; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Corse AM, 1999, NEUROBIOL DIS, V6, P335, DOI 10.1006/nbdi.1999.0253; Davidson BL, 2000, P NATL ACAD SCI USA, V97, P3428, DOI 10.1073/pnas.050581197; Drachman DB, 2000, ANN NEUROL, V48, P792, DOI 10.1002/1531-8249(200011)48:5<792::AID-ANA14>3.3.CO;2-X; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Kafri T, 1997, NAT GENET, V17, P314, DOI 10.1038/ng1197-314; Kaspar BK, 2002, MOL THER, V5, P50, DOI 10.1006/mthe.2001.0520; KASPAR BK, UNPUB; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Levine JB, 1999, GLIA, V28, P215; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Lu YY, 2003, NEUROSCI RES, V45, P33, DOI 10.1016/S0168-0102(02)00195-5; Manabe Y, 2003, NEUROL RES, V25, P195, DOI 10.1179/016164103101201193; Manabe Y, 2002, APOPTOSIS, V7, P329, DOI 10.1023/A:1016123413038; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; MILLER RG, 2001, COCHRANE DB SYST REV, V4, P1447; MITCHELL JD, 2002, COCHRANE DB SYST REV, V3; Mohajeri MH, 1999, HUM GENE THER, V10, P1853, DOI 10.1089/10430349950017536; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Vincent AM, 2002, GROWTH HORM IGF RES, V12, P193, DOI 10.1016/S1096-6374(02)00017-5; Wang LJ, 2002, J NEUROSCI, V22, P6920; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Yoshihara T, 2002, J NEUROCHEM, V80, P158, DOI 10.1046/j.0022-3042.2001.00683.x; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	33	672	761	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					839	842		10.1126/science.1086137	http://dx.doi.org/10.1126/science.1086137			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907804				2022-12-24	WOS:000184615700047
J	DeRenzo, C; Reese, KJ; Seydoux, G				DeRenzo, C; Reese, KJ; Seydoux, G			Exclusion of germ plasm proteins from somatic lineages by cullin-dependent degradation	NATURE			English	Article							CAENORHABDITIS-ELEGANS EMBRYOS; ZINC-FINGER PROTEINS; C-ELEGANS; GENE-EXPRESSION; PIE-1 PROTEIN; SOCS-BOX; LOCALIZATION; RNA; UBIQUITINATION; SPECIFICATION	In many animals, establishment of the germ line depends on segregation of a specialized cytoplasm, or 'germplasm', to a small number of germline precursor cells during early embryogenesis(1). Germ plasm asymmetry involves targeting of RNAs and proteins to a specific region of the oocyte and/or embryo(2). Here we demonstrate that germ plasm asymmetry also depends on degradation of germline proteins in non-germline (somatic) cells. We show that five CCCH finger proteins, components of the Caenorhabditis elegans germ plasm, are targeted for degradation by the novel CCCH-finger-binding protein ZIF-1. ZIF-1 is a SOCS-box protein that interacts with the E3 ubiquitin ligase subunit elongin C. Elongin C, the cullin CUL-2, the ring finger protein RBX-1 and the E2 ubiquitin conjugation enzyme UBC5 (also known as LET-70) are all required in vivo for CCCH finger protein degradation. Degradation is activated in somatic cells by the redundant CCCH finger proteins MEX-5 and MEX-6, which are counteracted in the germ line by the PAR-1 kinase. We propose that segregation of the germ plasm involves both stabilization of germline proteins in the germ line and cullin-dependent degradation in the soma.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Seydoux, G (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.		SEYDOUX, Geraldine/AAA-2005-2020	Seydoux, Geraldine/0000-0001-8257-0493	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037047] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD037047] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Detwiler MR, 2001, DEV CELL, V1, P187, DOI 10.1016/S1534-5807(01)00026-0; Feng H, 1999, NAT CELL BIOL, V1, P486, DOI 10.1038/70272; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Guedes S, 1997, DEVELOPMENT, V124, P731; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hird SN, 1996, DEVELOPMENT, V122, P1303; Houston DW, 2000, CURR TOP DEV BIOL, V50, P155, DOI 10.1016/S0070-2153(00)50008-8; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kloc M, 2001, INT REV CYTOL, V203, P63; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Riechmann V, 2002, NAT CELL BIOL, V4, P337, DOI 10.1038/ncb782; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Seydoux G, 1995, METHOD CELL BIOL, V48, P323; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Styhler S, 2002, DEV CELL, V3, P865, DOI 10.1016/S1534-5807(02)00361-1; Tabara H, 1999, DEVELOPMENT, V126, P1; Tenenhaus C, 1998, DEV BIOL, V200, P212, DOI 10.1006/dbio.1998.8940; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	28	135	149	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					685	689		10.1038/nature01887	http://dx.doi.org/10.1038/nature01887			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12894212	Green Accepted			2022-12-24	WOS:000184578800048
J	Li, Y; Brown, JH; Reshetnikova, L; Blazsek, A; Farkas, L; Nyitray, L; Cohen, C				Li, Y; Brown, JH; Reshetnikova, L; Blazsek, A; Farkas, L; Nyitray, L; Cohen, C			Visualization of an unstable coiled coil from the scallop myosin rod	NATURE			English	Article							SMOOTH-MUSCLE MYOSIN; JUNCTION; DESIGN; STABILITY; FEATURES; CALCIUM; BINDING; DOMAIN; MODEL	alpha-Helical coiled coils in muscle exemplify simplicity and economy of protein design: small variations in sequence lead to remarkable diversity in cellular functions(1,2). Myosin II is the key protein in muscle contraction, and the molecule's two-chain alpha-helical coiled-coil rod region-towards the carboxy terminus of the heavy chain-has unusual structural and dynamic features. The amino-terminal subfragment-2 (S2) domains of the rods can swing out from the thick filament backbone at a hinge in the coiled coil, allowing the two myosin 'heads' and their motor domains to interact with actin and generate tension(3). Most of the S2 rod appears to be a flexible coiled coil, but studies suggest that the structure at the N-terminal region is unstable(4-6), and unwinding or bending of the alpha-helices near the head-rod junction seems necessary for many of myosin's functional properties(7,8). Here we show the physical basis of a particularly weak coiled-coil segment by determining the 2.5-Angstrom-resolution crystal structure of a leucine-zipper-stabilized fragment of the scallop striated-muscle myosin rod adjacent to the head-rod junction. The N-terminal 14 residues are poorly ordered; the rest of the S2 segment forms a flexible coiled coil with poorly packed core residues. The unusual absence of inter-helical salt bridges here exposes apolar core atoms to solvent.	Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; Brandeis Univ, Biophys & Struct Biol Program, Waltham, MA 02454 USA; Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary	Brandeis University; Brandeis University; Eotvos Lorand University	Cohen, C (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA.	ccohen@brandeis.edu	Nyitray, László/AAE-5910-2020	Nyitray, László/0000-0003-4717-5994				ADELSTEIN RS, 1980, ANNU REV BIOCHEM, V49, P921, DOI 10.1146/annurev.bi.49.070180.004421; Arndt KM, 2002, STRUCTURE, V10, P1235, DOI 10.1016/S0969-2126(02)00838-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Burgess S, 2002, BIOPHYS J, V82, p356A; Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3; Burkhard P, 2002, J MOL BIOL, V318, P901, DOI 10.1016/S0022-2836(02)00114-6; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Buss F, 2001, FEBS LETT, V508, P295, DOI 10.1016/S0014-5793(01)03065-4; Chakrabarty T, 2002, P NATL ACAD SCI USA, V99, P6011, DOI 10.1073/pnas.082024299; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; CONWAY JF, 1990, INT J BIOL MACROMOL, V12, P328, DOI 10.1016/0141-8130(90)90023-4; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; Knight PJ, 1996, J MOL BIOL, V255, P269, DOI 10.1006/jmbi.1996.0022; Lauzon AM, 2001, BIOPHYS J, V80, P1900, DOI 10.1016/S0006-3495(01)76159-0; Li Y, 2002, P NATL ACAD SCI USA, V99, P7378, DOI 10.1073/pnas.102179999; Liu J, 2003, J MOL BIOL, V329, P963, DOI 10.1016/S0022-2836(03)00516-3; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)90126-7; Malnasi-Csizmadia A, 1998, BIOCHEM BIOPH RES CO, V252, P595, DOI 10.1006/bbrc.1998.9603; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; MCLACHLAN AD, 1983, J MOL BIOL, V164, P605, DOI 10.1016/0022-2836(83)90053-0; Meier M, 2002, J STRUCT BIOL, V137, P65, DOI 10.1006/jsbi.2002.4467; Nyitrai M, 2002, BIOCHEM J, V365, P19, DOI 10.1042/BJ20020099; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Stafford WF, 2001, J MOL BIOL, V307, P137, DOI 10.1006/jmbi.2000.4490; Tomishige M, 2000, J CELL BIOL, V151, P1081, DOI 10.1083/jcb.151.5.1081; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818	31	72	72	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					341	345		10.1038/nature01801	http://dx.doi.org/10.1038/nature01801			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867988				2022-12-24	WOS:000184183900049
J	Yoshida, T; Jones, LE; Ellner, SP; Fussmann, GF; Hairston, NG				Yoshida, T; Jones, LE; Ellner, SP; Fussmann, GF; Hairston, NG			Rapid evolution drives ecological dynamics in a predator-prey system	NATURE			English	Article							CYCLES	Ecological and evolutionary dynamics can occur on similar timescales(1-7). However, theoretical predictions of how rapid evolution can affect ecological dynamics(8) are inconclusive and often depend on untested model assumptions(8). Here we report that rapid prey evolution in response to oscillating predator density affects predator-prey (rotifer-algal) cycles in laboratory microcosms. Our experiments tested explicit predictions from a model for our system that allows prey evolution(9). We verified the predicted existence of an evolutionary tradeoff between algal competitive ability and defence against consumption, and examined its effects on cycle dynamics by manipulating the evolutionary potential of the prey population. Single-clone algal cultures (lacking genetic variability) produced short cycle periods and typical quarter-period phase lags between prey and predator densities, whereas multi-clonal (genetically variable) algal cultures produced long cycles with prey and predator densities nearly out of phase, exactly as predicted. These results confirm that prey evolution can substantially alter predator-prey dynamics, and therefore that attempts to understand population oscillations in nature(10,11) cannot neglect potential effects from ongoing rapid evolution.	Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	Cornell University	Hairston, NG (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	NGH1@cornell.edu	Yoshida, Takehito/O-9983-2014; Yoshida, Takehito/ABB-2490-2020	Yoshida, Takehito/0000-0001-9178-3634; Yoshida, Takehito/0000-0001-9178-3634; Fussmann, Gregor/0000-0001-9576-0122				Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Berryman, 2002, POPULATION CYCLES CA, DOI 10.1093/oso/9780195140989.001.0001; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731; HALBACH U, 1974, ARCH HYDROBIOL, V73, P273; Hendry AP, 2000, SCIENCE, V290, P516, DOI 10.1126/science.290.5491.516; Hillborn R., 1997, ECOLOGICAL DETECTIVE; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; Lambin X, 2002, POPULATION CYCLES: THE CASE FOR TROPHIC INTERACTIONS, P155; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; Palumbi Stephen R., 2001, EVOLUTION EXPLOSION; Pickett-Heaps J. D., 1975, GREEN ALGAE STRUCTUR; Rothhaupt KO, 1995, LIMNOL OCEANOGR, V40, P1201, DOI 10.4319/lo.1995.40.7.1201; Shertzer KW, 2002, J ANIM ECOL, V71, P802, DOI 10.1046/j.1365-2656.2002.00645.x; Sinervo B, 2000, NATURE, V406, P985, DOI 10.1038/35023149; Thompson JN, 2001, BIOSCIENCE, V51, P15, DOI 10.1641/0006-3568(2001)051[0015:FOE]2.0.CO;2; Tollrian R., 1999, ECOLOGY EVOLUTION IN; TURCHIN P, IN PRESS ECOLOGY; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Vermeij G.J., 1987, EVOLUTION ESCALATION; VERMEIJ GJ, 1994, ANNU REV ECOL SYST, V25, P219, DOI 10.1146/annurev.es.25.110194.001251	25	740	749	8	406	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					303	306		10.1038/nature01767	http://dx.doi.org/10.1038/nature01767			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867979				2022-12-24	WOS:000184183900039
J	Radermacher, J; Mengel, M; Ellis, S; Stuht, S; Hiss, M; Schwarz, A; Eisenberger, U; Burg, M; Luft, FC; Gwinner, W; Haller, H				Radermacher, J; Mengel, M; Ellis, S; Stuht, S; Hiss, M; Schwarz, A; Eisenberger, U; Burg, M; Luft, FC; Gwinner, W; Haller, H			The renal arterial resistance index and renal allograft survival	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLOR DOPPLER SONOGRAPHY; RESISTIVE INDEX; KIDNEY-TRANSPLANTATION; HYPERTENSIVE PATIENTS; VASCULAR-RESISTANCE; CYCLOSPORINE-A; GRAFT FUNCTION; FOLLOW-UP; FAILURE; ULTRASONOGRAPHY	BACKGROUND: Most renal transplants fail because of chronic allograft nephropathy or because the recipient dies, but no reliable factor predicting long-term outcome has been identified. We tested whether a renal arterial resistance index of less than 80 was predictive of long-term allograft survival. METHODS: The renal segmental arterial resistance index (the percentage reduction of the end-diastolic flow as compared with the systolic flow) was measured by Doppler ultrasonography in 601 patients at least three months after transplantation between August 1997 and November 1998. All patients were followed for three or more years. The combined end point was a decrease of 50 percent or more in the creatinine clearance rate, allograft failure (indicated by the need for dialysis), or death. RESULTS: A total of 122 patients (20 percent) had a resistance index of 80 or higher. Eighty-four of these patients (69 percent) had a decrease of 50 percent or more in creatinine clearance, as compared with 56 of the 479 patients with a resistance index of less than 80 (12 percent); 57 patients with a higher resistance index (47 percent) required dialysis, as compared with 43 patients with a lower resistance index (9 percent); and 36 patients with a higher resistance index (30 percent) died, as compared with 33 patients with a lower resistance index (7 percent) (P<0.001 for all comparisons). A total of 107 patients with a higher resistance index (88 percent) reached the combined end point, as compared with 83 of those with a lower resistance index (17 percent, P<0.001). The multivariate relative risk of graft loss among patients with a higher resistance index was 9.1 (95 percent confidence interval, 6.6 to 12.7). Proteinuria (protein excretion, 1 g per day or more), symptomatic cytomegalovirus infection, and a creatinine clearance rate of less than 30 ml per minute per 1.73 m(2) of body-surface area after transplantation also increased the risk. CONCLUSIONS: A renal arterial resistance index of 80 or higher measured at least three months after transplantation is associated with poor subsequent allograft performance and death.	Hannover Med Sch, Dept Nephrol, D-30625 Hannover, Germany; Hannover Med Sch, Dept Pathol, Hannover, Germany; Humboldt Univ, HELIOS Klinikum Berlin, Franz Volhard Clin, Berlin, Germany	Hannover Medical School; Hannover Medical School; Franz-Volhard Clinical Research Center; Helios Kliniken; Humboldt University of Berlin	Radermacher, J (corresponding author), Hannover Med Sch, Dept Nephrol, POB 610180, D-30625 Hannover, Germany.			Luft, Friedrich/0000-0002-8635-1199; Eisenberger, Ute/0000-0003-3862-6933				Alterini B, 1996, Ann Ital Med Int, V11, P107; BITTARD H, 1991, J UROLOGY, V146, P1; Boddi M, 1996, AM J HYPERTENS, V9, P461, DOI 10.1016/0895-7061(96)00027-1; BREITENSEHER M, 1994, ULTRASCHALL MED, V15, P24, DOI 10.1055/s-2007-1004000; DON S, 1989, RADIOLOGY, V171, P709, DOI 10.1148/radiology.171.3.2655003; Drudi F M, 2001, Radiol Med, V101, P243; GAULT MH, 1992, NEPHRON, V62, P249, DOI 10.1159/000187054; Gerhardt U, 1999, INT J CARDIOL, V68, P203, DOI 10.1016/S0167-5273(98)00368-4; Giral-Classe M, 1998, KIDNEY INT, V54, P972, DOI 10.1046/j.1523-1755.1998.00071.x; HENNIGE M, 1986, TRANSPLANTATION, V42, P491, DOI 10.1097/00007890-198611000-00009; Howard RJ, 2002, TRANSPLANTATION, V73, P1923, DOI 10.1097/00007890-200206270-00013; Kosch M, 2002, J HYPERTENS, V20, P501, DOI 10.1097/00004872-200203000-00026; Kreis HA, 2001, TRANSPLANTATION, V71, pSS5; Krumme B, 1997, J AM SOC NEPHROL, V8, P813; Leoncini G, 2002, NEPHRON, V90, P169, DOI 10.1159/000049038; Mange KC, 2000, JAMA-J AM MED ASSOC, V283, P633, DOI 10.1001/jama.283.5.633; Martinoli C, 1998, EUR RADIOL, V8, P765, DOI 10.1007/s003300050469; OPELZ G, 1978, TRANSPLANTATION, V25, P212, DOI 10.1097/00007890-197804000-00011; Petersen LJ, 1997, NEPHROL DIAL TRANSPL, V12, P1376, DOI 10.1093/ndt/12.7.1376; Ponticelli C, 2002, KIDNEY INT, V62, P1848, DOI 10.1046/j.1523-1755.2002.00612.x; Pontremoli R, 1999, NEPHROL DIAL TRANSPL, V14, P360, DOI 10.1093/ndt/14.2.360; POZNIAK MA, 1988, INVEST RADIOL, V23, P899, DOI 10.1097/00004424-198812000-00004; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Radermacher J, 2001, NEW ENGL J MED, V344, P410, DOI 10.1056/NEJM200102083440603; Radermacher J, 1998, TRANSPLANT INT, V11, P3, DOI 10.1111/j.1432-2277.1998.tb00948.x; Radermacher J, 2000, CLIN NEPHROL, V53, P333; Radermacher J, 2002, HYPERTENSION, V39, P699, DOI 10.1161/hy0202.103782; RADERMACHER J, 2002, IMAGING DECIS, V6, P15; Restrepo-Schafer IK, 1999, ULTRASCHALL MED, V20, P87, DOI 10.1055/s-1999-14242; SCHWERK WB, 1993, ULTRASCHALL MED, V14, P117, DOI 10.1055/s-2007-1005230; Scorza R, 1997, J RHEUMATOL, V24, P1944; Shimizu Y, 2001, HYPERTENS RES, V24, P13, DOI 10.1291/hypres.24.13; SKOTNICKI SH, 1989, TRANSPLANT INT, V2, P16; Takano R, 2001, J CLIN ULTRASOUND, V29, P384; Takemoto SK, 2000, NEW ENGL J MED, V343, P1078, DOI 10.1056/NEJM200010123431504; Trillaud H, 1998, AM J ROENTGENOL, V171, P1611, DOI 10.2214/ajr.171.6.9843297	36	288	303	2	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2003	349	2					115	124		10.1056/NEJMoa022602	http://dx.doi.org/10.1056/NEJMoa022602			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	698XH	12853584	Green Accepted, Bronze			2022-12-24	WOS:000184024400004
J	Maiuri, L; Ciacci, C; Ricciardelli, I; Vacca, L; Raia, V; Auricchio, S; Picard, J; Osman, M; Quaratino, S; Londei, M				Maiuri, L; Ciacci, C; Ricciardelli, I; Vacca, L; Raia, V; Auricchio, S; Picard, J; Osman, M; Quaratino, S; Londei, M			Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease	LANCET			English	Article							BLOOD MONOCYTES; DENDRITIC CELLS; ORGAN-CULTURE; MESSENGER-RNA; GLUTEN; CHALLENGE; MACROPHAGES; EXPRESSION; PEPTIDES; TOXICITY	Background The adaptive immune system is central to the development of coeliac disease. Adaptive immune responses are, however, controlled by a preceding activation of the innate immune system. We investigated whether gliadin, a protein present in wheat flour, could activate an innate as well as an adaptive immune response in patients with coeliac disease. Methods Duodenal biopsy samples from 42 patients with untreated coeliac disease, 37 treated patients, and 18 controls, were cultured in vitro for 3 h or 24 h, in the presence of either immunodominant gliadin epitopes (palpha-2 and palpha-9) or a non-immunodominant peptide.(p31-43) known to induce small intestine damage in coeliac disease. We also incubated biopsy samples from nine untreated and six treated patients with a non-immunodominant peptide for 3 h, before incubation with immunodominant gliadin epitopes. Different combinations of interleukin-15 or signal transduction inhibitors were added to selected incubations. Findings Only the non-immunodominant peptide induced rapid expression of interleukin-15, CD83, cyclo-oxygenase (COX)-2, and CD25 by CD3- cells (p=0.005 vs medium alone) and enterocyte apoptosis (p<0.0001). Only the non-immunodominant peptide induced p38 MAP kinase activation in CD3- cells. Pre-incubation with the non-immunodominant peptide enabled immunodominant epitopes to induce T-cell activation (p=0.001) and enterocyte apoptosis. Inhibition of interleukin-15 or of p38 MAP kinase controlled such activity. Interpretation A gliadin fragment can activate the innate immune system, affecting the in situ T-cell recognition of dominant gliadin epitopes. Although our findings emphasise the key role of gliadin-specific T cells, they suggest a complex pathogenic situation; and show that inhibition of interleukin-15 or p38 MAP kinase might have the potential to control coeliac disease.	UCL, Inst Child Hlth, London WC1N 1EH, England; Univ Naples Federico 2, Dept Paediat, Naples, Italy; Univ Naples Federico 2, Dept Gastroenterol, Naples, Italy; European Lab Invest Food Induced Dis, Naples, Italy; Hammersmith Hosp, MRC, Ctr Clin Sci, London, England; Univ Southampton, Southampton Gen Hosp, Canc Res UK Canc Sci Div, Southampton, Hants, England	University of London; University College London; University of Naples Federico II; University of Naples Federico II; Imperial College London; University of Southampton	Londei, M (corresponding author), UCL, Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.	m.londei@ich.ucl.ac.uk	Raia, Valeria/AAC-3029-2022; carolina, ciacci/A-2594-2012	carolina, ciacci/0000-0002-7426-1145				Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Cammarota G, 2000, LANCET, V356, P1494, DOI 10.1016/S0140-6736(00)02880-4; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DERITIS G, 1988, GASTROENTEROLOGY, V94, P41, DOI 10.1016/0016-5085(88)90607-5; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Greco L, 2002, GUT, V50, P624, DOI 10.1136/gut.50.5.624; HALSTENSEN TS, 1993, SCAND J IMMUNOL, V38, P581, DOI 10.1111/j.1365-3083.1993.tb03245.x; HEMPEL SL, 1994, J CLIN INVEST, V93, P391, DOI 10.1172/JCI116971; Hmama Z, 1998, J IMMUNOL, V161, P4882; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Lohmann T, 2000, LANCET, V356, P31, DOI 10.1016/S0140-6736(00)02431-4; Maiuri L, 2000, GASTROENTEROLOGY, V119, P996, DOI 10.1053/gast.2000.18149; Maiuri L, 1998, GASTROENTEROLOGY, V115, P564, DOI 10.1016/S0016-5085(98)70135-0; Maiuri L, 1996, GASTROENTEROLOGY, V110, P1368, DOI 10.1053/gast.1996.v110.pm8613040; Maiuri L, 2001, GUT, V48, P418, DOI 10.1136/gut.48.3.418; MARSH MN, 1995, GASTROENTEROLOGY, V108, pA871; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McAdam SN, 2000, GUT, V47, P743, DOI 10.1136/gut.47.6.743; MEAGHER L, 1994, J IMMUNOL METHODS, V175, P237, DOI 10.1016/0022-1759(94)90366-2; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Quaratino S, 2000, P NATL ACAD SCI USA, V97, P10911, DOI 10.1073/pnas.190204697; Schuppan D, 2000, GASTROENTEROLOGY, V119, P234, DOI 10.1053/gast.2000.8521; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; SHIDRAWI RG, 1995, SCAND J GASTROENTERO, V30, P758, DOI 10.3109/00365529509096324; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; STURGESS R, 1994, LANCET, V343, P758, DOI 10.1016/S0140-6736(94)91837-6; Subbarayan V, 2001, CANCER RES, V61, P2720; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	30	465	483	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 5	2003	362	9377					30	37		10.1016/S0140-6736(03)13803-2	http://dx.doi.org/10.1016/S0140-6736(03)13803-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699KW	12853196				2022-12-24	WOS:000184056900010
J	Peng, WT; Robinson, MD; Mnaimneh, S; Krogan, NJ; Cagney, G; Morris, Q; Davierwala, AP; Grigull, J; Yang, XQ; Zhang, W; Mitsakakis, N; Ryan, OW; Datta, N; Jojic, V; Pal, C; Canadien, V; Richards, D; Beattie, B; Wu, LF; Altschuler, SJ; Roweis, S; Frey, BJ; Emili, A; Greenblatt, JF; Hughes, TR				Peng, WT; Robinson, MD; Mnaimneh, S; Krogan, NJ; Cagney, G; Morris, Q; Davierwala, AP; Grigull, J; Yang, XQ; Zhang, W; Mitsakakis, N; Ryan, OW; Datta, N; Jojic, V; Pal, C; Canadien, V; Richards, D; Beattie, B; Wu, LF; Altschuler, SJ; Roweis, S; Frey, BJ; Emili, A; Greenblatt, JF; Hughes, TR			Panoramic view of yeast noncoding RNA processing	CELL			English	Article							PRE-RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; PROTEIN; BIOGENESIS; MATURATION; SNORNA; IDENTIFICATION; MULTIPLE; HOMOLOG	Predictive analysis using publicly available yeast functional genomics and proteomics data suggests that many more proteins may be involved in biogenesis of ribonucleoproteins than are currently known. Using a microarray that monitors abundance and processing of noncoding RNAs, we analyzed 468 yeast strains carrying mutations in protein-coding genes, most of which have not previously been associated with RNA or RNP synthesis. Many strains mutated in uncharacterized genes displayed aberrant noncoding RNA profiles. Ten factors involved in noncoding RNA biogenesis were verified by further experimentation, including a protein required for 20S pre-rRNA processing (Tsr2p), a protein associated with the nuclear exosome (Lrp1p), and a factor required for box C/D snoRNA accumulation (Bcd1p). These data present a global View of yeast noncoding RNA processing and confirm that many currently uncharacterized yeast proteins are involved in biogenesis of noncoding RNA.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Elect & Comp Engn, Probabilist & Stat Inference Grp, Toronto, ON M5S 3G4, Canada; Univ Toronto, Dept Comp Sci, Probabilist & Stat Inference Grp, Toronto, ON M5S 3G4, Canada; Affinium Pharmaceut, Toronto, ON M5J 1V6, Canada; Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA	University of Toronto; University of Toronto; University of Toronto; Harvard University	Hughes, TR (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.	t.hughes@utoronto.ca	Robinson, Mark D/A-6432-2015; Cagney, Gerard/A-4648-2009; Robinson, Mark D./O-2254-2019; Morris, Quaid/ABE-8343-2020	Robinson, Mark D/0000-0002-3048-5518; Robinson, Mark D./0000-0002-3048-5518; Cagney, Gerard/0000-0001-7189-9496; Morris, Quaid/0000-0002-2760-6999				AbouElela S, 1996, CELL, V85, P115, DOI 10.1016/S0092-8674(00)81087-9; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; BISHOP C, 1995, NEURAL NETOWRKS PATT; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Chanfreau G, 1998, J MOL BIOL, V284, P975, DOI 10.1006/jmbi.1998.2237; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Duda R.O., 2001, PATTERN CLASSIFICATI; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erdemir T, 2002, MOL MICROBIOL, V46, P947, DOI 10.1046/j.1365-2958.2002.03224.x; Fatica A, 2002, RNA, V8, P1502, DOI 10.1017/S1355838202022094; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Fatica A, 2000, EMBO J, V19, P6218, DOI 10.1093/emboj/19.22.6218; Galardi S, 2002, MOL CELL BIOL, V22, P6663, DOI 10.1128/MCB.22.19.6663-6668.2002; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Gromadka R, 2000, ACTA BIOCHIM POL, V47, P993, DOI 10.18388/abp.2000_3953; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HOPPER AK, 1990, J CELL BIOL, V111, P309, DOI 10.1083/jcb.111.2.309; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; Juhnke H, 2000, MOL MICROBIOL, V35, P936, DOI 10.1046/j.1365-2958.2000.01768.x; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Kufel J, 1999, RNA, V5, P909, DOI 10.1017/S135583829999026X; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; LEE WC, 1992, MOL CELL BIOL, V12, P3865, DOI 10.1128/MCB.12.9.3865; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Milkereit P, 2003, NUCLEIC ACIDS RES, V31, P799, DOI 10.1093/nar/gkg165; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Morl M, 2001, EMBO REP, V2, P17, DOI 10.1093/embo-reports/kve006; Nguyen Allen, 2002, BMC Biotechnol, V2, P14, DOI 10.1186/1472-6750-2-14; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; Pestov DG, 2001, NUCLEIC ACIDS RES, V29, P3621, DOI 10.1093/nar/29.17.3621; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Sasaki T, 2000, MOL CELL BIOL, V20, P7971, DOI 10.1128/MCB.20.21.7971-7979.2000; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Tone Y, 2002, GENE DEV, V16, P3142, DOI 10.1101/gad.1025602; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; van Hoof A, 2000, EMBO J, V19, P1357, DOI 10.1093/emboj/19.6.1357; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Verheggen C, 2001, EMBO J, V20, P5480, DOI 10.1093/emboj/20.19.5480; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Xing F, 2002, RNA, V8, P370, DOI 10.1017/S1355838202029825; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	69	203	217	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2003	113	7					919	933		10.1016/S0092-8674(03)00466-5	http://dx.doi.org/10.1016/S0092-8674(03)00466-5			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	695EJ	12837249	Green Submitted, Bronze			2022-12-24	WOS:000183817900015
J	Choi, KH; Liu, H; Guo, YQ; Han, L; Mandel, JS; Rutherford, GW				Choi, KH; Liu, H; Guo, YQ; Han, L; Mandel, JS; Rutherford, GW			Emerging HIV-1 epidemic in China in men who have sex with men	LANCET			English	Article								China is currently undergoing a serious HIV-1 epidemic in intravenous drug users, sex workers, and former plasma donors. Little is known, however, about HIV-1 risk in Chinese men who have sex with men. In this study of seroprevalence in such men in Beijing, we recorded 15 (3.1%, 95% Cl 1.8-5.1) of 481 men infected with HIV-1. Overall, 238 (49%) of participants reported unprotected anal intercourse during the previous 6 months. HIV-1 seropositivtty was independently associated with being older than 39 years and having had more than 20 male sexual partners. Most men older than 39 years had been married. Our findings suggest the potential for spread of HIV-1 between men who have sex with men and to their heterosexual partners.	Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94105 USA; Beijing Municipal STD Clin, Beijing, Peoples R China; Beijing Tongzhi Hotline Programme, Beijing, Peoples R China	University of California System; University of California San Francisco	Choi, KH (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, 74 New Montgomery,Suite 600, San Francisco, CA 94105 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH042459] Funding Source: NIH RePORTER; NIMH NIH HHS [MH42459] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Beach M, 2001, LANCET, V358, P1792, DOI 10.1016/S0140-6736(01)06856-8; KUMTA S, 2002, 14 INT C AIDS BARC S; United Nations Theme Group on HIV/AIDS in China, 2002, HIV AIDS CHIN TIT PE; Zhang BC, 2000, AM J PUBLIC HEALTH, V90, P1949, DOI 10.2105/AJPH.90.12.1949; Zhang KL, 2002, BMJ-BRIT MED J, V324, P803, DOI 10.1136/bmj.324.7341.803	5	117	138	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 21	2003	361	9375					2125	2126		10.1016/S0140-6736(03)13690-2	http://dx.doi.org/10.1016/S0140-6736(03)13690-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	692GY	12826438				2022-12-24	WOS:000183654200014
J	Dillingham, MS; Spies, M; Kowalczykowski, SC				Dillingham, MS; Spies, M; Kowalczykowski, SC			RecBCD enzyme is a bipolar DNA helicase	NATURE			English	Article							SINGLE-STRANDED-DNA; RECOMBINATION HOTSPOT-CHI; ESCHERICHIA-COLI; NUCLEASE ACTIVITY; ATP HYDROLYSIS; PCRA HELICASE; STEP-SIZE; PROTEIN; TRANSLOCATION; SEQUENCE	Escherichia coli RecBCD is a heterotrimeric helicase/nuclease that catalyses a complex reaction in which double-strand breaks in DNA are processed for repair by homologous recombination(1). For some time it has been clear that the RecB subunit possesses a 3'-->5' DNA helicase activity(2-4), which was thought to drive DNA translocation and unwinding in the RecBCD holoenzyme. Here we show that purified RecD protein is also a DNA helicase, but one that possesses a 5'-->3' polarity. We also show that the RecB and RecD helicases are both active in intact RecBCD, because the enzyme remains capable of processive DNA unwinding when either of these subunits is inactivated by mutation. These findings point to a bipolar translocation model for RecBCD in which the two DNA helicases are complementary, travelling with opposite polarities, but in the same direction, on each strand of the antiparallel DNA duplex. This bipolar motor organization helps to explain various biochemical properties of RecBCD, notably its exceptionally high speed and processivity, and offers a mechanistic insight into aspects of RecBCD function.	Univ Calif Davis, Ctr Genet & Dev, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Ctr Genet & Dev, Microbiol Sect, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Spies, Maria/0000-0002-7375-8037; Dillingham, Mark/0000-0002-4612-7141				Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Arnold DA, 1998, J BIOL CHEM, V273, P16476, DOI 10.1074/jbc.273.26.16476; ARNOLD DA, 1999, ENCY LIFE SCI; Bianco PR, 1997, P NATL ACAD SCI USA, V94, P6706, DOI 10.1073/pnas.94.13.6706; Bianco PR, 2000, NATURE, V405, P368, DOI 10.1038/35012652; BOEHMER PE, 1991, GENE, V102, P1, DOI 10.1016/0378-1119(91)90529-K; Chen HW, 1997, J BIOL CHEM, V272, P10072; Chen HW, 1998, J MOL BIOL, V278, P89, DOI 10.1006/jmbi.1998.1694; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; GANESAN S, 1993, J MOL BIOL, V229, P67, DOI 10.1006/jmbi.1993.1008; HSIEH S, 1992, NUCLEIC ACIDS RES, V20, P5647, DOI 10.1093/nar/20.21.5647; JONGENEEL CV, 1984, J BIOL CHEM, V259, P2925; KORANGY F, 1993, BIOCHEMISTRY-US, V32, P4873, DOI 10.1021/bi00069a024; KORANGY F, 1992, J BIOL CHEM, V267, P1727; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; LAHUE EE, 1988, J BIOL CHEM, V263, P3208; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Phillips RJ, 1997, MOL GEN GENET, V254, P319, DOI 10.1007/PL00008605; ROMAN LJ, 1992, J BIOL CHEM, V267, P4207; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; TAYLOR A, 1980, CELL, V22, P447, DOI 10.1016/0092-8674(80)90355-4; TAYLOR AF, 2003, NATURE; van Brabant AJ, 2000, ANNU REV GENOM HUM G, V1, P409, DOI 10.1146/annurev.genom.1.1.409; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981; Zhang XJJ, 1999, NUCLEIC ACIDS RES, V27, P4200, DOI 10.1093/nar/27.21.4200	30	162	171	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2003	423	6942					893	897		10.1038/nature01673	http://dx.doi.org/10.1038/nature01673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815438				2022-12-24	WOS:000183585300052
J	Itoh, S; Yurimoto, H				Itoh, S; Yurimoto, H			Contemporaneous formation of chondrules and refractory inclusions in the early Solar System	NATURE			English	Article							ALUMINUM-RICH INCLUSIONS; CRYSTALLIZATION SEQUENCES; OXYGEN ISOTOPES; ALLENDE; NEBULA; CHONDRITES; METEORITES; MELILITE; ORIGIN; RAYS	Chondrules and calcium-aluminium-rich inclusions (CAIs) are preserved materials from the early history of the Solar System, where they resulted from thermal processing of pre-existing solids during various flash heating episodes which lasted for several million years(1). CAIs are believed to have formed about two million years before the chondrules(2-5). Here we report the discovery of a chondrule fragment embedded in a CAI. The chondrule's composition is poor in O-16, while the CAI has a O-16-poor melilite (Ca, Mg, Al-Silicate) core surrounded by a O-16-rich igneous mantle. These observations, when combined with the previously reported CAI-bearing chondrules(6-9),strongly suggest that the formation of chondrules and CAIs overlapped in time and space, and that there were large fluctuations in the oxygen isotopic compositions in the solar nebula probably synchronizing astrophysical pulses.	Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan	Tokyo Institute of Technology	Yurimoto, H (corresponding author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan.		Yurimoto, Hisayoshi/S-9938-2018	Yurimoto, Hisayoshi/0000-0003-0702-0533; Itoh, Shoichi/0000-0001-9431-0525				Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; BISCHOFF A, 1984, GEOCHIM COSMOCHIM AC, V48, P693, DOI 10.1016/0016-7037(84)90096-6; CAMERON AGW, 1995, METEORITICS, V30, P133, DOI 10.1111/j.1945-5100.1995.tb01110.x; CHEN JH, 1976, GEOCHIM COSMOCHIM AC, V40, P635, DOI 10.1016/0016-7037(76)90109-5; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Gounelle M, 2001, ASTROPHYS J, V548, P1051, DOI 10.1086/319019; Hewins R., 1996, CHONDRULES PROTOPLAN, P55; ITOH S, 2000, LUNAR PLANET SCI, V31, P1323; ITOH S, IN PRESS GEOCHIM COS; Jones RH, 2000, METEORIT PLANET SCI, V35, P849, DOI 10.1111/j.1945-5100.2000.tb01468.x; Kojima T., 1995, PROC NIPR S ANTARCT, V8, P79; Krot AN, 2002, SCIENCE, V295, P1051, DOI 10.1126/science.1068200; Krot AN, 2001, METEORIT PLANET SCI, V36, P1189, DOI 10.1111/j.1945-5100.2001.tb01954.x; Krot AN, 1999, METEORIT PLANET SCI, V34, pA68; LASAGA AC, 1983, KINETICS EQUILIBRIUM, P81; MacPherson G.J., 1988, METEORITES EARLY SOL, P746; Maruyama S, 1999, EARTH PLANET SC LETT, V169, P165, DOI 10.1016/S0012-821X(99)00075-8; Noguchi T., 1989, P NIPR S ANT MET, V2, P169; Russell SS, 1996, SCIENCE, V273, P757, DOI 10.1126/science.273.5276.757; Shu FH, 1997, SCIENCE, V277, P1475, DOI 10.1126/science.277.5331.1475; Shu FH, 2001, ASTROPHYS J, V548, P1029, DOI 10.1086/319018; Srinivasan G, 1998, METEORIT PLANET SCI, V33, pA148; STOLPER E, 1986, GEOCHIM COSMOCHIM AC, V50, P1785, DOI 10.1016/0016-7037(86)90139-0; STOLPER E, 1982, GEOCHIM COSMOCHIM AC, V46, P2159, DOI 10.1016/0016-7037(82)90192-2; TATSUMOTO M, 1976, GEOCHIM COSMOCHIM AC, V40, P617, DOI 10.1016/0016-7037(76)90108-3; Wasson JT, 2000, METEORIT PLANET SCI, V35, pA166; Wasson JT, 2001, GEOCHIM COSMOCHIM AC, V65, P4539, DOI 10.1016/S0016-7037(01)00738-4; Yurimoto H, 1998, SCIENCE, V282, P1874, DOI 10.1126/science.282.5395.1874; YURIMOTO H, 1989, GEOCHIM COSMOCHIM AC, V53, P2387, DOI 10.1016/0016-7037(89)90360-8; YURIMOTO H, 2001, METEORIT PLANET SCI, V36, pA230	30	95	96	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2003	423	6941					728	731		10.1038/nature01699	http://dx.doi.org/10.1038/nature01699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802328				2022-12-24	WOS:000183443400037
J	Andersen, JH; Thomsen, JF; Overgaard, E; Lassen, CF; Brandt, LPA; Vilstrup, I; Kryger, AI; Mikkelsen, S				Andersen, JH; Thomsen, JF; Overgaard, E; Lassen, CF; Brandt, LPA; Vilstrup, I; Kryger, AI; Mikkelsen, S			Computer use and carpal tunnel syndrome - A 1-year follow-up study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MUSCULOSKELETAL DISORDERS; GENERAL-POPULATION; RISK-FACTORS; WORK; PREVALENCE; SYMPTOMS	Context Computer use is increasingly common among many working populations, and concern exists about possible adverse effects of computer use, such as carpal tunnel syndrome (CTS). Objectives To estimate the prevalence and incidence of possible CTS and to evaluate the contribution of use of mouse devices and keyboards to the risk of possible CTS. Design and Setting A 1-year follow-up study with questionnaires conducted in 2000 and 2001 at 3500 workplaces in Denmark, followed on each of the 2 occasions by a clinical interview on symptom distribution and frequency. Participants The questionnaire was sent to 9480 members of a trade union, with an initial response rate of 73% (n=6943), and 82% (n=5658) at follow-up. Main Outcome Measures At baseline, there were 3 outcome measures: tingling/numbness in the right hand once a week or more as reported in the questionnaire; tingling, numbness, and pain in the median nerve in the right hand confirmed by clinical interview; and tingling, numbness, and pain in the median nerve in the right hand at night confirmed by clinical interview. At 1 year of follow-up the main outcome of interest was onset of symptoms among participants who had no or minor symptoms at baseline. Results The overall self-reported prevalence of tingling/numbness in the right hand at baseline was 10.9%. The interview confirmed that prevalence of tingling/numbness in the median nerve was 4.8%, of which about one third, corresponding to a prevalence of 1.4%, experienced symptoms at night. Onset of new symptoms in the 1-year follow-up was 5.5%. In the cross-sectional comparisons and in the follow-up analyses, there was an association between use of a mouse device for more than 20 h/wk and risk of possible CTS but no statistically significant association with keyboard use. Conclusions The occurrence of possible CTS in the right hand was low. The study emphasizes that computer use does riot pose a severe occupational hazard for developing symptoms of CTS.	Herning Hosp, Dept Occupat Med, DK-7400 Herning, Denmark; Copenhagen Univ Hosp, Dept Occupat Med, Glostrup, Denmark; Odense Univ Hosp, Dept Occupat & Environm Med, DK-5000 Odense, Denmark	Aarhus University; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Andersen, JH (corresponding author), Herning Hosp, Dept Occupat Med, DK-7400 Herning, Denmark.	hecjha@ringamt.dk	Andersen, Johan Hviid/AAI-2086-2019	Andersen, Johan Hviid/0000-0003-1638-8276				Abbas M A, 1998, Int J Occup Environ Health, V4, P160; Atcheson SG, 1998, ARCH INTERN MED, V158, P1506, DOI 10.1001/archinte.158.14.1506; Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; BERNARD B, 1994, SCAND J WORK ENV HEA, V20, P417, DOI 10.5271/sjweh.1379; DEKROM MCTFM, 1992, J CLIN EPIDEMIOL, V45, P373, DOI 10.1016/0895-4356(92)90038-O; DEMBE A, 1996, OCCUPATION DIS SOCIA; Frost P, 1998, SCAND J WORK ENV HEA, V24, P285, DOI 10.5271/sjweh.322; Gerr F, 2002, AM J IND MED, V41, P221, DOI 10.1002/ajim.10066; HALES TR, 1994, ERGONOMICS, V37, P1603, DOI 10.1080/00140139408964940; Kristensen TS, 2002, SCAND J PUBLIC HEALT, V30, P41, DOI 10.1177/14034948020300032401; National Research Council Institute of Medicine, 2001, MUSC DIS WORKPL LOW; Nordstrom DL, 1998, EPIDEMIOLOGY, V9, P342, DOI 10.1097/00001648-199805000-00021; Palmer KT, 2001, OCCUP MED-OXFORD, V51, P392, DOI 10.1093/occmed/51.6.392; Rossignol M, 1997, OCCUP ENVIRON MED, V54, P519, DOI 10.1136/oem.54.7.519; STEVENS JC, 1988, NEUROLOGY, V38, P134, DOI 10.1212/WNL.38.1.134; Stevens JC, 2001, NEUROLOGY, V56, P1568; Thomsen JF, 2002, AM J IND MED, V42, P344, DOI 10.1002/ajim.10115; Tittiranonda P, 1999, OCCUP MED, V14, P17	18	146	147	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2003	289	22					2963	2969		10.1001/jama.289.22.2963	http://dx.doi.org/10.1001/jama.289.22.2963			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687XZ	12799404	Bronze			2022-12-24	WOS:000183403400019
J	Gambacorti-Passerini, C; Tornaghi, L; Cavagnini, F; Rossi, P; Pecori-Giraldi, F; Mariani, L; Cambiaghi, N; Pogliani, E; Corneo, G; Gnessi, L				Gambacorti-Passerini, C; Tornaghi, L; Cavagnini, F; Rossi, P; Pecori-Giraldi, F; Mariani, L; Cambiaghi, N; Pogliani, E; Corneo, G; Gnessi, L			Gynaecomastia in men with chronic myeloid leukaemia after imatinib	LANCET			English	Article							STEM-CELL FACTOR; GROWTH	cKit and platelet-derived growth-factor receptor (PDGFR) are receptor tyrosine kinases expressed in the testis, are involved in testosterone production, and are inhibited by imatinib. We measured hormone concentrations in 38 men receiving imatinib for chronic myeloid leukaemia at baseline and during treatment. Mean follow-up was 23-6 months (SD 7.5). We noted seven cases of gynaecomastia (18%, 95% CI 6-30%). A comparison of hormone concentrations in 21 patients before and during treatment showed that patients who developed gynaecomastia had a reduction in free testosterone concentrations of 29.53 pmol/L (95% Cl 11.63-47.43), while patients who did not had a decrease of 6.36 pmol/L (-1.02 to 13.74). In most men with chronic myeloid leukaemia studied here, imatinib was associated with a reduction in the production of testicular hormones and in some, with the development of gynaecomastia.	Ist Nazl Tumori, I-20133 Milan, Italy; Univ Milano Bicocca, Monza, Italy; Univ Milan, Ist Auxol Italiano, Milan, Italy; Univ Roma Tor Vergata, Rome, Italy; Univ Roma La Sapienza, Rome, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milano-Bicocca; IRCCS Istituto Auxologico Italiano; University of Milan; University of Rome Tor Vergata; Sapienza University Rome	Gambacorti-Passerini, C (corresponding author), Ist Nazl Tumori, Via Venezian 1, I-20133 Milan, Italy.		Rossi, Pellegrino/AAA-7072-2019; Giraldi, Francesca Pecori/F-5081-2011; Mariani, Luigi/AAB-9464-2019; Gnessi, Lucio/K-8025-2016; Mariani, Luigi/C-2580-2017	Giraldi, Francesca Pecori/0000-0001-6065-7803; Gnessi, Lucio/0000-0001-8217-2372; Mariani, Luigi/0000-0001-6208-4084; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; ROSSI, PELLEGRINO/0000-0003-4796-327X				Basciani S, 2002, J CLIN ENDOCR METAB, V87, P2310, DOI 10.1210/jc.87.5.2310; Griffin J, 2001, SEMIN ONCOL, V28, P3, DOI 10.1016/S0093-7754(01)90097-1; Huang CTF, 2001, BIOL REPROD, V64, P451, DOI 10.1095/biolreprod64.2.451; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Sette C, 2000, INT J DEV BIOL, V44, P599	5	72	76	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 7	2003	361	9373					1954	1956		10.1016/S0140-6736(03)13554-4	http://dx.doi.org/10.1016/S0140-6736(03)13554-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687DB	12801741	Green Submitted			2022-12-24	WOS:000183359700013
J	Du, KY; Herzig, S; Kulkarni, RN; Montminy, M				Du, KY; Herzig, S; Kulkarni, RN; Montminy, M			TRB3: A tribbles homolog that inhibits Akt/PKB activation by insulin in liver	SCIENCE			English	Article							PROTEIN-KINASE-B; GLYCOGEN-SYNTHASE KINASE-3; NEGATIVE REGULATOR; DROSOPHILA; MORPHOGENESIS; INACTIVATION; GLUCOSE; CELLS; PKB; RESISTANCE	Insulin resistance is a major hallmark in the development of type II diabetes, which is characterized by the failure of insulin to promote glucose uptake in muscle and to suppress glucose production in liver. The serine-threonine kinase Akt (PKB) is a principal target of insulin signaling that inhibits hepatic glucose output when glucose is available from food. Here we show that TRB3, a mammalian homolog of Drosophila tribbles, functions as a negative modulator of Akt. TRB3 expression is induced in liver under fasting conditions, and TRB3 disrupts insulin signaling by binding directly to Akt and blocking activation of the kinase. Amounts of TRB3 RNA and protein were increased in livers of db/db diabetic mice compared with those in wild-type mice. Hepatic overexpression of TRB3 in amounts comparable to those in db/db mice promoted hyperglycemia and glucose intolerance. Our results suggest that, by interfering with Akt activation, TRB3 contributes to insulin resistance in individuals with susceptibility to type II diabetes.	Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Med, Joslin Diabet Ctr, Boston, MA 02215 USA	Salk Institute; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Montminy, M (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Herzig, Stephan/0000-0003-3950-3652				Aman MJ, 1998, J BIOL CHEM, V273, P33922, DOI 10.1074/jbc.273.51.33922; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Brady MJ, 1998, J BIOL CHEM, V273, P14063, DOI 10.1074/jbc.273.23.14063; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Buren J, 2002, EUR J ENDOCRINOL, V146, P419, DOI 10.1530/eje.0.1460419; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dirlewanger M, 2000, CLIN NUTR, V19, P29, DOI 10.1054/clnu.1999.0064; DU K, UNPUB; GANNON MC, 1984, J NUTR, V114, P2147, DOI 10.1093/jn/114.11.2147; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Maira SM, 2001, SCIENCE, V294, P374, DOI 10.1126/science.1062030; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Mayumi-Matsuda K, 1999, BIOCHEM BIOPH RES CO, V258, P260, DOI 10.1006/bbrc.1999.0576; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Mitsuuchi Y, 1998, J CELL BIOCHEM, V70, P433, DOI 10.1002/(SICI)1097-4644(19980915)70:4<433::AID-JCB1>3.0.CO;2-K; Paez-Espinosa EV, 1999, MOL CELL ENDOCRINOL, V156, P121, DOI 10.1016/S0303-7207(99)00137-9; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; RAO RH, 1995, METABOLISM, V44, P817, DOI 10.1016/0026-0495(95)90199-X; Rorth P, 2000, MOL CELL, V6, P23; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150	24	687	722	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1574	1577		10.1126/science.1079817	http://dx.doi.org/10.1126/science.1079817			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791994				2022-12-24	WOS:000183333100056
J	Pardo, M; Nurse, P				Pardo, M; Nurse, P			Equatorial retention of the contractile actin ring by microtubules during cytokinesis	SCIENCE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; CELL-DIVISION; SPINDLE FORMATION; F-ACTIN; GENE; CHECKPOINT; CYCLE; EUKARYOTES; PLACEMENT	In most eukaryotes cytokinesis is brought about by a contractile actin ring located at the division plane. Here, in fission yeast the actin ring was found to be required to generate late-mitotic microtubular structures located at the division plane, and these in turn maintained the medial position of the actin ring. When these microtubular structures were disrupted, the actin ring migrated away from the cell middle in a membrane traffic-dependent manner, resulting in asymmetrical cell divisions that led to genomic instability. We propose that these microtubular structures contribute to a checkpoint control that retains the equatorial position of the ring when progression through cytokinesis is delayed.	Canc Res UK London Res Inst, Cell Cycle Lab, London WC2A 3PX, England	Cancer Research UK	Pardo, M (corresponding author), Canc Res UK London Res Inst, Cell Cycle Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.			Pardo, Mercedes/0000-0002-3477-9695				Arai R, 2002, J CELL SCI, V115, P887; Ayscough K, 1998, METHOD ENZYMOL, V298, P18, DOI 10.1016/S0076-6879(98)98004-1; Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603; Balasubramanian MK, 2000, J CELL SCI, V113, P1503; Chang F, 1996, J CELL SCI, V109, P131; Ding DQ, 1998, J CELL SCI, V111, P701; DRABIKOWSKI W, 1973, BIOCHIM BIOPHYS ACTA, V291, P61, DOI 10.1016/0005-2736(73)90060-6; Field C, 1999, CURR OPIN CELL BIOL, V11, P68, DOI 10.1016/S0955-0674(99)80009-X; Finger FP, 2002, CELL, V108, P727, DOI 10.1016/S0092-8674(02)00668-2; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Gachet Y, 2001, NATURE, V412, P352, DOI 10.1038/35085604; Gatti M, 2000, MICROSC RES TECHNIQ, V49, P202, DOI 10.1002/(SICI)1097-0029(20000415)49:2<202::AID-JEMT13>3.0.CO;2-8; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Hagan IM, 1998, J CELL SCI, V111, P1603; Heitz MJ, 2001, J CELL SCI, V114, P4521; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Le Goff X, 1999, MOL GEN GENET, V262, P163; Liu JH, 1999, GENETICS, V153, P1193; Liu JH, 2000, J CELL SCI, V113, P1223; MARKS J, 1985, EUR J CELL BIOL, V39, P27; Paoletti A, 2000, MOL BIOL CELL, V11, P2757, DOI 10.1091/mbc.11.8.2757; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sohrmann M, 1996, GENE DEV, V10, P2707, DOI 10.1101/gad.10.21.2707; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; TURI TG, 1994, J BIOL CHEM, V269, P24229; Vardy L, 2000, EMBO J, V19, P6098, DOI 10.1093/emboj/19.22.6098; Wachtler V, 2003, J CELL SCI, V116, P867, DOI 10.1242/jcs.00299; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839	31	62	62	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1569	1574		10.1126/science.1084671	http://dx.doi.org/10.1126/science.1084671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791993				2022-12-24	WOS:000183333100055
J	Shen, Y; Knoll, AH; Walter, MR				Shen, Y; Knoll, AH; Walter, MR			Evidence for low sulphate and anoxia in a mid-Proterozoic marine basin	NATURE			English	Article							PROTEROZOIC OCEAN CHEMISTRY; VELKERRI FORMATION; BELT SUPERGROUP; MCARTHUR BASIN; SULFUR-ISOTOPE; EVOLUTION; IRON; GEOCHEMISTRY; CONSTRAINTS; SEDIMENTS	Many independent lines of evidence document a large increase in the Earth's surface oxidation state 2,400 to 2,200 million years ago(1-4), and a second biospheric oxygenation 800 to 580 million years ago, just before large animals appear in the fossil record(5,6). Such a two-staged oxidation implies a unique ocean chemistry for much of the Proterozoic eon, which would have been neither completely anoxic and iron-rich as hypothesized for Archaean seas, nor fully oxic as supposed for most of the Phanerozoic eon(7). The redox chemistry of Proterozoic oceans has important implications for evolution(8), but empirical constraints on competing environmental models are scarce. Here we present an analysis of the iron chemistry of shales deposited in the marine Roper Basin, Australia, between about 1,500 and 1,400 million years ago, which record deep-water anoxia beneath oxidized surface water. The sulphur isotopic compositions of pyrites in the shales show strong variations along a palaeodepth gradient, indicating low sulphate concentrations in mid-Proterozoic oceans. Our data help to integrate a growing body of evidence favouring a long-lived intermediate state of the oceans, generated by the early Proterozoic oxygen revolution and terminated by the environmental transformation late in the Proterozoic eon.	Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; Macquarie Univ, Australian Ctr Astrobiol, N Ryde, NSW 2109, Australia	Harvard University; Macquarie University	Shen, Y (corresponding author), Harvard Univ, Bot Museum, 26 Oxford St, Cambridge, MA 02138 USA.	yshen@oeb.harvard.edu	Shen, Yanan/L-3724-2018	Shen, Yanan/0000-0001-8343-6763				Abbott ST, 2000, AUST J EARTH SCI, V47, P637, DOI 10.1046/j.1440-0952.2000.00795.x; Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; BAKER PA, 1981, SCIENCE, V213, P214, DOI 10.1126/science.213.4504.214; Canfield DE, 1999, AM J SCI, V299, P697, DOI 10.2475/ajs.299.7-9.697; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; DERRY LA, 1992, GEOCHIM COSMOCHIM AC, V56, P1317, DOI 10.1016/0016-7037(92)90064-P; DONNELLY TH, 1988, PRECAMBRIAN RES, V42, P165, DOI 10.1016/0301-9268(88)90015-0; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; GAUTIER DL, 1986, GEOLOGY, V14, P225, DOI 10.1130/0091-7613(1986)14<225:CSFTWI>2.0.CO;2; Hayes J.M., 1992, PROTEROZOIC BIOSPHER, P129; Holland H. D., 1994, EARLY LIFE EARTH, V84, P237; Hurtgen MT, 2002, EARTH PLANET SC LETT, V203, P413, DOI 10.1016/S0012-821X(02)00804-X; JACKSON MJ, 1991, PRECAMBRIAN RES, V54, P81, DOI 10.1016/0301-9268(91)90070-Q; Kah LC, 2001, PRECAMBRIAN RES, V111, P203, DOI 10.1016/S0301-9268(01)00161-9; Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129; LOGAN GA, 1995, NATURE, V376, P53, DOI 10.1038/376053a0; Lyons TW, 1997, GEOCHIM COSMOCHIM AC, V61, P3367, DOI 10.1016/S0016-7037(97)00174-9; Lyons TW, 2000, GEOCHIM COSMOCHIM AC, V64, P427, DOI 10.1016/S0016-7037(99)00323-3; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; MUIR MD, 1985, AUST J EARTH SCI, V32, P239, DOI 10.1080/08120098508729328; Pavlov AA, 2003, GEOLOGY, V31, P87, DOI 10.1130/0091-7613(2003)031<0087:MRPA>2.0.CO;2; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; Raiswell R, 2001, J SEDIMENT RES, V71, P286, DOI 10.1306/070300710286; ROSS GM, 1995, PRECAMBRIAN RES, V73, P71, DOI 10.1016/0301-9268(94)00072-Y; Shen YN, 2002, AM J SCI, V302, P81, DOI 10.2475/ajs.302.2.81; STRAUSS H, 1990, GEOCHIM COSMOCHIM AC, V54, P197, DOI 10.1016/0016-7037(90)90207-2; Wijsman JWM, 2001, MAR CHEM, V74, P261, DOI 10.1016/S0304-4203(01)00019-6; ZABACK DA, 1993, GEOLOGY, V21, P141, DOI 10.1130/0091-7613(1993)021<0141:TAROSA>2.3.CO;2	30	213	233	4	68	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 5	2003	423	6940					632	635		10.1038/nature01651	http://dx.doi.org/10.1038/nature01651			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789336				2022-12-24	WOS:000183301200038
J	Galli, C; Lagutina, I; Crotti, G; Colleoni, S; Turini, P; Ponderato, N; Duchi, R; Lazzari, G				Galli, C; Lagutina, I; Crotti, G; Colleoni, S; Turini, P; Ponderato, N; Duchi, R; Lazzari, G			A cloned horse born to its dam twin - A birth announcement calls for a rethink on the immunological demands of pregnancy.	NATURE			English	Editorial Material									CIZ Srl, Ist Sperimentale Italiano Lazzaro Spallanzani, Lab Tecnol Riproduz, I-26100 Cremona, Italy	IRCCS Lazzaro Spallanzani	Galli, C (corresponding author), CIZ Srl, Ist Sperimentale Italiano Lazzaro Spallanzani, Lab Tecnol Riproduz, I-26100 Cremona, Italy.		王, 士勇/B-5170-2012					[Anonymous], 2003, CLONING STEM CELLS, V5, P1, DOI 10.1089/153623003321512102; Galli C, 2002, THERIOGENOLOGY, V58, P705; Lagutina I., 2003, Theriogenology, V59, P269; Lazzari G, 2002, J REPROD FERTIL ABST, V28, P73; Szekeres-Bartho Julia, 2002, Int Rev Immunol, V21, P471, DOI 10.1080/08830180215017; WOODS GL, 2003, SCIENCE	6	312	370	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					635	635		10.1038/424635a	http://dx.doi.org/10.1038/424635a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904778				2022-12-24	WOS:000184578800030
J	Ono, M; Terabe, H; Hori, H; Sasaki, M				Ono, M; Terabe, H; Hori, H; Sasaki, M			Components of giant hornet alarm pheromone	NATURE			English	Editorial Material							VOLATILES		Tamagawa Univ, Res Inst, Ctr Excellence Integrat Human Sci Program, Tokyo 1948610, Japan; Tamagawa Univ, Grad Sch Agr, Tokyo 1948610, Japan; Tamagawa Univ, Dept Appl Biol Chem, Tokyo 1948610, Japan		Ono, M (corresponding author), Tamagawa Univ, Res Inst, Ctr Excellence Integrat Human Sci Program, Tokyo 1948610, Japan.							Dani FR, 2000, PHYSIOL ENTOMOL, V25, P363, DOI 10.1046/j.1365-3032.2000.00205.x; HEATH RR, 1988, EXPERIENTIA, V44, P82, DOI 10.1007/BF01960257; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; Ono M., 1997, SCI JAPANESE HORNETS; Rossiter K. J., 1996, PERFUM FLAVOR, V21, P33; SHIOTA H, 1993, J AGR FOOD CHEM, V41, P2056, DOI 10.1021/jf00035a046; VEITH HJ, 1984, NATURWISSENSCHAFTEN, V71, P328, DOI 10.1007/BF00396622	7	68	71	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					637	638		10.1038/424637a	http://dx.doi.org/10.1038/424637a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904781				2022-12-24	WOS:000184578800033
J	Tei, S; Kitajima, N; Takahashi, K; Mishiro, S				Tei, S; Kitajima, N; Takahashi, K; Mishiro, S			Zoonotic transmission of hepatitis E virus from deer to human beings	LANCET			English	Article								Zoonosis has been suggested for hepatitis E virus (HEV) infection, but so far is based only on indirect evidence. We experienced a series of cases of HEV infection among people who had eaten uncooked deer meat 6-7 weeks before. On testing, a left over portion of the deer meat, kept frozen to eat in the future, was positive for HEV RNA, whose nucleotide sequence was identical to those from the patients. Patients' family members who ate none or very little of the deer meat remained uninfected. These findings provide direct evidence for HEV infection to be a zoonosis.	Toshiba Gen Hosp, Dept Med Sci, Shinagawa Ku, Tokyo 1408522, Japan; Kasai City Hosp, Dept Internal Med, Kasai, Hyogo, Japan	Toshiba Corporation	Mishiro, S (corresponding author), Toshiba Gen Hosp, Dept Med Sci, Shinagawa Ku, 6-3-22 Higashi Oh I, Tokyo 1408522, Japan.	shunji.mishiro@po.toshiba.co.jp		Mishiro, Shunji/0000-0001-9618-6468				MENG XJ, 2000, INFECT DIS REV, V2, P35; Schlauder GG, 1998, J GEN VIROL, V79, P447, DOI 10.1099/0022-1317-79-3-447; Schlauder GG, 1999, J MED VIROL, V57, P243, DOI 10.1002/(SICI)1096-9071(199903)57:3&lt;243::AID-JMV6&gt;3.0.CO;2-R; Takahashi K, 2002, J INFECT DIS, V185, P1342, DOI 10.1086/340023; Takahashi K, 2001, VIROLOGY, V287, P9, DOI 10.1006/viro.2001.1017	5	728	771	4	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2003	362	9381					371	373		10.1016/S0140-6736(03)14025-1	http://dx.doi.org/10.1016/S0140-6736(03)14025-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907011				2022-12-24	WOS:000184498700011
J	Kanold, PO; Kara, P; Reid, RC; Shatz, CJ				Kanold, PO; Kara, P; Reid, RC; Shatz, CJ			Role of subplate neurons in functional maturation of visual cortical columns	SCIENCE			English	Article							OCULAR DOMINANCE COLUMNS; LATERAL GENICULATE-NUCLEUS; THALAMOCORTICAL SYNAPSES; CORTEX; CONNECTIONS; EXPRESSION; PLASTICITY; ABSENCE; SYSTEM; INPUT	The subplate forms a transient circuit required for development of connections between the thalamus and the cerebral cortex. When subplate neurons are ablated, ocular dominance columns do not form in the visual cortex despite the robust presence of thalamic axons in layer 4. We show that subplate ablation also prevents formation of orientation columns. Visual responses are weak and poorly tuned to orientation. Furthermore, thalamocortical synaptic transmission fails to strengthen, whereas intracortical synapses are unaffected. Thus, subplate circuits are essential not only for the anatomical segregation of thalamic inputs but also for key steps in synaptic remodeling and maturation needed to establish the functional architecture of visual cortex.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shatz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.			Kanold, Patrick/0000-0002-7529-5435	NEI NIH HHS [P30 EY12196, R01 EY02858, F32 EY013526, R01 EY10115, F32 EY013526-01, F32 EY1352] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010115, R01EY002858, P30EY012196, F32EY013526] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; ANTONINI A, 1993, J NEUROSCI, V13, P3549; Cai DQ, 1997, J NEUROPHYSIOL, V78, P1045, DOI 10.1152/jn.1997.78.2.1045; Chapman B, 1996, J NEUROSCI, V16, P6443; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Fine A, 1997, NEUROSCIENCE, V81, P331, DOI 10.1016/S0306-4522(97)00208-X; Finney EM, 1998, J COMP NEUROL, V398, P105; FRIAUF E, 1991, J NEUROPHYSIOL, V66, P2059, DOI 10.1152/jn.1991.66.6.2059; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; KANOLD PO, UNPUB; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Lein ES, 1999, P NATL ACAD SCI USA, V96, P13491, DOI 10.1073/pnas.96.23.13491; Lein ES, 2000, J COMP NEUROL, V420, P1, DOI 10.1002/(SICI)1096-9861(20000424)420:1<1::AID-CNE1>3.0.CO;2-H; Mrzljak L, 1998, J COMP NEUROL, V390, P112; PIORO EP, 1990, NEUROSCIENCE, V34, P57, DOI 10.1016/0306-4522(90)90304-M; SHATZ CJ, 1986, J NEUROSCI, V6, P3655; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599	26	222	225	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					521	525		10.1126/science.1084152	http://dx.doi.org/10.1126/science.1084152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881571				2022-12-24	WOS:000184340500044
J	Wang, X; Huong, SM; Chiu, ML; Raab-Traub, N; Huang, ES				Wang, X; Huong, SM; Chiu, ML; Raab-Traub, N; Huang, ES			Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus	NATURE			English	Article								Human cytomegalovirus (HCMV) is a widespread opportunistic herpesvirus that causes severe and fatal diseases in immune-compromised individuals, including organ transplant recipients and individuals with AIDS(1). It is also a leading cause of virus-associated birth defects and is associated with atherosclerosis and letters to nature and coronary restenosis(1-3). HCMV initiates infection and intracellular signalling by binding to its cognate cellular receptors 4,5 and by activating several signalling pathways including those mediated by mitogen-activated protein kinase(5-7), phosphatidylinositol-3-OH kinase(8), interferons(5,9), and G proteins(10). But a cellular receptor responsible for viral entry and HCMV-induced signalling has yet to be identified. Here we show that HCMV infects cells by interacting with epidermal growth factor receptor (EGFR) and inducing signalling. Transfecting EGFR-negative cells with an EGFR complementary DNA renders non-susceptible cells susceptible to HCMV. Ligand displacement and crosslinking analyses show that HCMV interacts with EGFR through gB, its principal envelope glycoprotein. gB preferentially binds EGFR and EGFR-ErbB3 oligomeric molecules in Chinese hamster ovary cells transfected with erbB family cDNAs. Taken together, these data indicate that EGFR is a necessary component for HCMV-triggered signalling and viral entry.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Huang, ES (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	eshuang@med.unc.edu						Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Baulida J, 1996, J BIOL CHEM, V271, P5251; Boyle KA, 1999, MOL CELL BIOL, V19, P3607; COMPTON T, 1992, VIROLOGY, V191, P387, DOI 10.1016/0042-6822(92)90200-9; EARP HS, 1995, BREAST CANCER RES TR, V35, P115, DOI 10.1007/BF00694752; Fairley JA, 2002, J GEN VIROL, V83, P2803, DOI 10.1099/0022-1317-83-11-2803; Huang ES, 1993, MOL ASPECTS HUMAN CY, P1; Johnson RA, 2000, J VIROL, V74, P1158, DOI 10.1128/JVI.74.3.1158-1167.2000; Johnson RA, 2001, J VIROL, V75, P6022, DOI 10.1128/JVI.75.13.6022-6032.2001; Johnson RA, 2001, J GEN VIROL, V82, P493, DOI 10.1099/0022-1317-82-3-493; Kanda S, 1997, J BIOL CHEM, V272, P23347, DOI 10.1074/jbc.272.37.23347; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; MELNICK JL, 1993, EUR HEART J, V14, P30; Miyazawa N, 1999, J VIROL, V73, P6056, DOI 10.1128/JVI.73.7.6056-6065.1999; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; PELES E, 1993, BIOESSAYS, V15, P815, DOI 10.1002/bies.950151207; Pietropaolo RL, 1997, J VIROL, V71, P9803, DOI 10.1128/JVI.71.12.9803-9807.1997; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sexl V, 1997, J BIOL CHEM, V272, P5792, DOI 10.1074/jbc.272.9.5792; Shibutani T, 1997, J CLIN INVEST, V100, P2054, DOI 10.1172/JCI119738; Simmen KA, 2001, P NATL ACAD SCI USA, V98, P7140, DOI 10.1073/pnas.121177598; SPEIR E, 1994, SCIENCE, V265, P391, DOI 10.1126/science.8023160; Tvorogov D, 2002, EXP CELL RES, V277, P86, DOI 10.1006/excr.2002.5545; Tzahar E, 1998, EMBO J, V17, P5948, DOI 10.1093/emboj/17.20.5948; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; Yurochko AD, 1997, J VIROL, V71, P5051, DOI 10.1128/JVI.71.7.5051-5059.1997	30	309	336	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					456	461		10.1038/nature01818	http://dx.doi.org/10.1038/nature01818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879076				2022-12-24	WOS:000184318400050
J	Watanabe, H; Vriens, J; Prenen, J; Droogmans, G; Voets, T; Nilius, B				Watanabe, H; Vriens, J; Prenen, J; Droogmans, G; Voets, T; Nilius, B			Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels	NATURE			English	Article								TRPV4 is a widely expressed cation channel of the 'transient receptor potential' (TRP) family(1) that is related to the vanilloid receptor VR1 (TRPV1). It functions as a Ca2+ entry channel(2) and displays remarkable gating promiscuity by responding to both physical stimuli (cell swelling, innoxious heat(2-7)) and the synthetic ligand 4alphaPDD(8). An endogenous ligand for this channel has not yet been identified. Here we show that the endocannabinoid anandamide and its metabolite arachidonic acid activate TRPV4 in an indirect way involving the cytochrome P450 epoxygenase-dependent formation of epoxyeicosatrienoic acids. Application of 5',6'-epoxyeicosatrienoic acid at submicromolar concentrations activates TRPV4 in a membrane-delimited manner and causes Ca2+ influx through TRPV4- like channels in vascular endothelial cells. Activation of TRPV4 in vascular endothelial cells might therefore contribute to the relaxant effects of endocannabinoids and their P450 epoxygenase-dependent metabolites on vascular tone(9-12).	Katholieke Univ Leuven, Dept Physiol, B-3000 Louvain, Belgium	KU Leuven	Nilius, B (corresponding author), Katholieke Univ Leuven, Dept Physiol, Campus Gasthuisberg, B-3000 Louvain, Belgium.	bernd.nilius@med.kuleuven.ac.be	Voets, Thomas/AAD-4389-2019; Vriens, Joris/G-9966-2018; Voets, Thomas/E-2466-2012	Voets, Thomas/0000-0001-5526-5821; Vriens, Joris/0000-0002-2502-0409; Voets, Thomas/0000-0001-5526-5821				Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Fleming I, 2001, CIRC RES, V89, P753, DOI 10.1161/hh2101.099268; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Fuloria M, 2002, AM J PHYSIOL-LUNG C, V283, pL383, DOI 10.1152/ajplung.00444.2001; GRAIER WF, 1995, J PHYSIOL-LONDON, V482, P259, DOI 10.1113/jphysiol.1995.sp020515; Grainger J, 2001, BRIT J PHARMACOL, V134, P1003, DOI 10.1038/sj.bjp.0704340; Guler AD, 2002, J NEUROSCI, V22, P6408; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Randall MD, 1998, EUR J PHARMACOL, V346, P51, DOI 10.1016/S0014-2999(98)00003-X; Randall MD, 1998, TRENDS PHARMACOL SCI, V19, P55, DOI 10.1016/S0165-6147(97)01161-9; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Rzigalinski BA, 1999, J BIOL CHEM, V274, P175, DOI 10.1074/jbc.274.1.175; Seegers HC, 2002, J PHARMACOL EXP THER, V302, P918, DOI 10.1124/jpet.302.3.918; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suh SH, 1999, PFLUG ARCH EUR J PHY, V438, P612, DOI 10.1007/s004240051084; Tan JZ, 1997, ADV EXP MED BIOL, V407, P561; Ueda N, 2002, PROSTAG OTH LIPID M, V68-9, P521, DOI 10.1016/S0090-6980(02)00053-9; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; WILLAN RL, 1990, MULTIPURPOSE TREE SP, V2, P11; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Xie Q, 2002, J BIOL CHEM, V277, P16559, DOI 10.1074/jbc.M109518200; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	27	731	767	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					434	438		10.1038/nature01807	http://dx.doi.org/10.1038/nature01807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879072				2022-12-24	WOS:000184318400045
J	Yamazaki, D; Suetsugu, S; Miki, H; Kataoka, Y; Nishikawa, SI; Fujiwara, T; Yoshida, N; Takenawa, T				Yamazaki, D; Suetsugu, S; Miki, H; Kataoka, Y; Nishikawa, SI; Fujiwara, T; Yoshida, N; Takenawa, T			WAVE2 is required for directed cell migration and cardiovascular development	NATURE			English	Article								WAVE2, a protein related to Wiskott-Aldrich syndrome protein, is crucial for Rac-induced membrane ruffling, which is important in cell motility(1-4). Cell movement is essential for morphogenesis, but it is unclear how cell movement is regulated or related to morphogenesis. Here we show the physiological functions of WAVE2 by disruption of the WAVE2 gene in mice. WAVE2 was expressed predominantly in vascular endothelial cells during embryogenesis. WAVE2(-/-) embryos showed haemorrhages and died at about embryonic day 10. Deficiency in WAVE2 had no significant effect on vasculogenesis, but it decreased sprouting and branching of endothelial cells from existing vessels during angiogenesis. In WAVE2(-/-) endothelial cells, cell polarity formed in response to vascular endothelial growth factor, but the formation of lamellipodia at leading edges and capillaries was severely impaired. These findings indicate that WAVE2-regulated actin reorganization might be required for proper cell movement and that a lack of functional WAVE2 impairs angiogenesis in vivo.	Univ Tokyo, Dept Biochem, Mianato Ku, Tokyo 1088639, Japan; Univ Tokyo, Div Canc Genom, Mianato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Div Gene Express & Regulat, Mianato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, CREST, Tokyo, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Japan; Kyoto Univ, Grad Sch Med, Dept Mol Genet, Sakyo Ku, Kyoto 6068509, Japan; Ehime Univ, Sch Med, Lab Anim Ctr, Shigenobu, Ehime 7910295, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Kyoto University; Ehime University	Takenawa, T (corresponding author), Univ Tokyo, Dept Biochem, Mianato Ku, 4-6-1 Shirokanedai, Mianato ku, Tokyo 1088639, Japan.	takenawa@ims.u-tokyo.ac.jp	Suetsugu, Shiro/B-3300-2010; Suetsugu, Shiro/AAF-4427-2019; Suetsugu, Shiro/ABB-6033-2020	Suetsugu, Shiro/0000-0002-4612-0628; Suetsugu, Shiro/0000-0002-4612-0628; 				Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Hashi H, 2001, J IMMUNOL, V166, P3702, DOI 10.4049/jimmunol.166.6.3702; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miki H, 2002, BIOCHEM BIOPH RES CO, V293, P93, DOI 10.1016/S0006-291X(02)00218-8; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SHIMADA T, 1983, J ELECTRON MICROSC, V32, P187; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Takenawa T, 2001, J CELL SCI, V114, P1801; Yamaguchi H, 2002, CANCER RES, V62, P2503	16	182	184	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					452	456		10.1038/nature01770	http://dx.doi.org/10.1038/nature01770			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879075				2022-12-24	WOS:000184318400049
J	Jasmin, L; Rabkin, SD; Granato, A; Boudah, A; Ohara, PT				Jasmin, L; Rabkin, SD; Granato, A; Boudah, A; Ohara, PT			Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex	NATURE			English	Article								It is known that pain perception can be altered by mood, attention and cognition, or by direct stimulation of the cerebral cortex(1), but we know little of the neural mechanisms underlying the cortical modulation of pain. One of the few cortical areas consistently activated by painful stimuli is the rostral agranular insular cortex (RAIC) where, as in other parts of the cortex, the neurotransmitter gamma-aminobutyric acid (GABA) robustly inhibits neuronal activity. Here we show that changes in GABA neurotransmission in the RAIC can raise or lower the pain threshold-producing analgesia or hyperalgesia, respectively-in freely moving rats. Locally increasing GABA, by using an enzyme inhibitor or gene transfer mediated by a viral vector, produces lasting analgesia by enhancing the descending inhibition of spinal nociceptive neurons. Selectively activating GABA(B)-receptor-bearing RAIC neurons produces hyperalgesia through projections to the amygdala, an area involved in pain and fear. Whereas most studies focus on the role of the cerebral cortex as the end point of nociceptive processing, we suggest that cerebral cortex activity can change the set-point of pain threshold in a top-down manner.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA 02129 USA; Catholic Univ, Dept Psychol, I-20123 Milan, Italy	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Massachusetts General Hospital; Catholic University of the Sacred Heart	Jasmin, L (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.		rabkin, samuel/C-2443-2012	rabkin, samuel/0000-0003-2344-2795; GRANATO, Alberto/0000-0003-3755-1036				BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; BERTHIER M, 1988, ANN NEUROL, V24, P41, DOI 10.1002/ana.410240109; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Burkey AR, 1999, J NEUROSCI, V19, P4169; Calejesan AA, 2000, EUR J PAIN, V4, P83, DOI 10.1053/eujp.1999.0158; EVERITT B J, 1992, P401; Fields HL, 2000, PROG BRAIN RES, V122, P245; GREENSPAN JD, 1992, PAIN, V50, P29, DOI 10.1016/0304-3959(92)90109-O; Helmstetter FJ, 1998, BRAIN RES, V779, P104, DOI 10.1016/S0006-8993(97)01104-9; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Jasmin L, 2003, J COMP NEUROL, V460, P38, DOI 10.1002/cne.10633; Jasmin L, 2001, J NEUROSCI METH, V110, P81, DOI 10.1016/S0165-0270(01)00420-4; JUNG MJ, 1977, J NEUROCHEM, V29, P797, DOI 10.1111/j.1471-4159.1977.tb10721.x; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; LeDoux JE., 2000, AMYGDALA FUNCTIONAL, P289; Lopantsev V, 1999, J NEUROPHYSIOL, V82, P1218, DOI 10.1152/jn.1999.82.3.1218; Manning BH, 1998, J NEUROSCI, V18, P9453; Margeta-Mitrovic M, 1999, J COMP NEUROL, V405, P299, DOI 10.1002/(SICI)1096-9861(19990315)405:3<299::AID-CNE2>3.0.CO;2-6; Nandigama P, 2003, BRAIN RES, V959, P343, DOI 10.1016/S0006-8993(02)03884-2; New KC, 1996, MOL BRAIN RES, V37, P317, DOI 10.1016/0169-328X(95)00262-Q; New KC, 1998, MOL BRAIN RES, V61, P121, DOI 10.1016/S0169-328X(98)00203-4; New KC, 1998, J NEUROCHEM, V71, P2304; Ostrowsky K, 2002, CEREB CORTEX, V12, P376, DOI 10.1093/cercor/12.4.376; Pitkanen A., 2000, AMYGDALA FUNCTIONAL, V2; PROUDFIT HK, 1991, PROG BRAIN RES, V88, P123; SAGEN J, 1984, BRAIN RES, V310, P295, DOI 10.1016/0006-8993(84)90152-5; Somogyi J, 2001, EUR J NEUROSCI, V14, P219, DOI 10.1046/j.0953-816x.2001.01638.x; Suzuki R, 2002, NAT NEUROSCI, V5, P1319, DOI 10.1038/nn966; Watkins LR, 1998, BEHAV NEUROSCI, V112, P360; Zhang S, 1997, NEUROSCI LETT, V224, P142, DOI 10.1016/S0304-3940(97)13478-4	30	255	264	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					316	320		10.1038/nature01808	http://dx.doi.org/10.1038/nature01808			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867983				2022-12-24	WOS:000184183900043
J	Courchesne, E; Carper, R; Akshoomoff, N				Courchesne, E; Carper, R; Akshoomoff, N			Evidence of brain overgrowth in the first year of life in autism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEAD CIRCUMFERENCE; YOUNG-CHILDREN; ABNORMALITIES; CORTEX; WEIGHT; VOLUME; AGE; CEREBELLAR; PATTERNS	Context Autism most commonly appears by 2 to 3 years of life, at which time the brain is already abnormally large. This raises the possibility that brain overgrowth begins much earlier, perhaps before the first clinically noticeable behavioral symptoms. Objectives To determine whether pathological brain overgrowth precedes the first clinical signs of autism spectrum disorder (ASD) and whether the rate of overgrowth during the first year is related to neuroanatomical and clinical outcome in early childhood. Design, Setting, and Participants Head circumference (HQ, body length, and body weight measurements during the first year were obtained from the medical records of 48 children with ASD aged 2 to 5 years who had participated in magnetic resonance imaging studies. Of these children, 15 (longitudinal group) had measurement at 4 periods during infancy: birth, 1 to 2 months, 3 to months, and 6 to 14 months; and 33 (partial HC data group) had measurements at birth and 6 to 14 months (n=7), and at birth only (n=28). Main Outcome Measures Age-related changes in infants with ASD who had multiple-age measurements, and the relationship of these changes to brain anatomy and clinical and diagnostic outcome at 2 to 5 years were evaluated by using 2 nationally recognized normative databases: cross-sectional normative data from a national survey and longitudinal data of individual growth. Results Compared with normative data of healthy infants, birth HC in infants with ASD was significantly smaller (z= -0.66, P<.001); after birth, HC increased 1.67 SDS and mean HC was at the 84th percentile by 6 to 14 months. Birth HC was related to cerebellar gray matter volume at 2 to 5 years, although the excessive increase in HC between birth and 6 to 14 months was related to greater cerebral cortex volume at 2 to 5 years. Within the ASD group, every child with autistic disorder had a greater increase in HC between birth and 6 to 14 months (mean [SD], 2.19 [0.98]) than infants with pervasive developmental disorder-not otherwise specified (0.58 [0.35]). Only 6% of the individual healthy infants in the longitudinal data showed accelerated HC growth trajectories (>2.0 SDs) from birth to 6 to 14 months; 59% of infants with autistic disorder showed these accelerated growth trajectories. Conclusions The clinical onset of autism appears to be preceded by 2 phases of brain growth abnormality: a reduced head size at birth and a sudden and excessive increase in head size between 1 to 2 months and 6 to 14 months. Abnormally accelerated rate of growth may serve as an early warning signal of risk for autism.	Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; Childrens Hosp Res Ctr, Ctr Autism Res, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Courchesne, E (corresponding author), Ctr Autism Res, 8110 La Jolla Shores Dr, La Jolla, CA 92037 USA.	ecourchesne@ucsd.edu	Warfield, Simon/B-3352-2009	Warfield, Simon/0000-0002-7659-3880	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019855] Funding Source: NIH RePORTER; NINDS NIH HHS [2-RO1-NS-19855] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akshoomoff N, 2002, DEV PSYCHOPATHOL, V14, P613, DOI 10.1017/S0954579402003115; American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; ARTHUR G, 1980, ARTHUR ADAPTATION LE; Aylward EH, 2002, NEUROLOGY, V59, P175, DOI 10.1212/WNL.59.2.175; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; BARONCOHEN S, 1992, BRIT J PSYCHIAT, V161, P839, DOI 10.1192/bjp.161.6.839; Bartholomeusz HH, 2002, NEUROPEDIATRICS, V33, P239, DOI 10.1055/s-2002-36735; Blinkov SM., 1968, HUMAN BRAIN FIGURES; Carper RA, 2000, BRAIN, V123, P836, DOI 10.1093/brain/123.4.836; Carper RA, 2002, NEUROIMAGE, V16, P1038, DOI 10.1006/nimg.2002.1099; Casanova MF, 2002, NEUROLOGY, V58, P428, DOI 10.1212/WNL.58.3.428; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; COOKE RWI, 1977, EARLY HUM DEV, V1, P145, DOI 10.1016/0378-3782(77)90015-9; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Courchesne E, 1997, CURR OPIN NEUROBIOL, V7, P269, DOI 10.1016/S0959-4388(97)80016-5; Courchesne E, 1999, NEUROLOGY, V52, P1057, DOI 10.1212/WNL.52.5.1057; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; COURCHESNE E, 1994, MANUAL DEV PSYCHOPAT, P195; COURCHESNE E, IN PRESS BIOL PSYCHI; DAHLGREN SO, 1989, EUR ARCH PSY CLIN N, V238, P169; De Giacomo A, 1998, EUR CHILD ADOLES PSY, V7, P131, DOI 10.1007/s007870050058; Durston S, 2001, J AM ACAD CHILD PSY, V40, P1012, DOI 10.1097/00004583-200109000-00009; Fatemi SH, 2001, NEUROREPORT, V12, P929, DOI 10.1097/00001756-200104170-00013; FRIEDLANDER MJ, 1991, J NEUROSCI, V11, P3268; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; GUO S, 1988, J PEDIATR-US, V113, P490, DOI 10.1016/S0022-3476(88)80634-6; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kemper TL, 1998, J NEUROPATH EXP NEUR, V57, P645, DOI 10.1097/00005072-199807000-00001; Kuczmarski RJ., 2000, VITAL HLTH STAT, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Lainhart JE, 1997, J AM ACAD CHILD PSY, V36, P282, DOI 10.1097/00004583-199702000-00019; Lamb JA, 2000, HUM MOL GENET, V9, P861, DOI 10.1093/hmg/9.6.861; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; Lee M, 2002, BRAIN, V125, P1483, DOI 10.1093/brain/awf160; LEMONS JA, 1981, HUM BIOL, V53, P351; Lord C, 2001, AM J MED GENET, V105, P36, DOI 10.1002/1096-8628(20010108)105:1<36::AID-AJMG1053>3.3.CO;2-W; LORD C, 2000, AUTISM SPECTRUM DISO, P167; LORD C, 1998, AUTISM DIAGNOSTIC OB; Mercado E, 2001, NEUROREPORT, V12, P2283, DOI 10.1097/00001756-200107200-00047; Mullen E., 1995, MULLEN SCALES EARLY; Nelson KB, 2001, ANN NEUROL, V49, P597, DOI 10.1002/ana.1024.abs; Orstavik KH, 1997, J MED GENET, V34, P849, DOI 10.1136/jmg.34.10.849; Penn AA, 1999, PEDIATR RES, V45, P447, DOI 10.1203/00006450-199904010-00001; Perry EK, 2001, AM J PSYCHIAT, V158, P1058, DOI 10.1176/appi.ajp.158.7.1058; Quartz SR, 1997, BEHAV BRAIN SCI, V20, P537; Rodier PM, 1996, J COMP NEUROL, V370, P247, DOI 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2; ROGERS SJ, 1990, J AM ACAD CHILD PSY, V29, P863, DOI 10.1097/00004583-199011000-00004; Rutter M., 1995, AUTISM DIAGNOSTIC IN; SANES DH, 1983, SCIENCE, V221, P1183, DOI 10.1126/science.6612332; Sattler, 1986, STANFORD BINET INTEL; Schopler E., 1988, CHILDHOOD AUTISM RAT; Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184; Stevenson RE, 1997, LANCET, V349, P1744, DOI 10.1016/S0140-6736(05)62956-X; Wechsler D., 1991, WISC 3 WECHSLER INTE; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398	55	705	727	1	65	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2003	290	3					337	344		10.1001/jama.290.3.337	http://dx.doi.org/10.1001/jama.290.3.337			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	699WK	12865374				2022-12-24	WOS:000184078800027
J	Sanders, J; Evans, M; Premawardhana, LDKE; Depraetere, H; Jeffreys, J; Richards, T; Furmaniak, J; Smith, BR				Sanders, J; Evans, M; Premawardhana, LDKE; Depraetere, H; Jeffreys, J; Richards, T; Furmaniak, J; Smith, BR			Human monoclonal thyroid stimulating autoantibody	LANCET			English	Article								A monoclonal autoantibody (MAb) with powerful thyroid stimulating activity has been produced from lymphocytes from a patient with Graves' disease. The autoantibody and its Fab fragment bind to the thyroid stimulating hormone (TSH) receptor (TSHR) with high affinity, inhibit labelled TSH binding to the receptor and stimulate cyclic AMP production in Chinese hamster ovary cells transfected with TSHR. TSHR autoantibodies with TSH agonist or antagonist activities from patients' serum samples are effective inhibitors of labelled monoclonal autoantibody binding to TSHR. Thus, the human monoclonal autoantilbody has all the characteristics of serum TSHR autoantibodies. Its availability has important implications for new studies on the pathogenesis of Graves' disease.	RSR Ltd, FIRS Labs, Cardiff CF14 5DU, S Glam, Wales; Caerphilly Dist Miners Hosp, Dept Adult Med, Caerphilly, Wales	RSR LTD	Smith, BR (corresponding author), RSR Ltd, FIRS Labs, Parc Ty Glas, Cardiff CF14 5DU, S Glam, Wales.	firs.rsrltd@virgin.net	Premawardhana, Lakdasa/L-4031-2019	Premawardhana, Lakdasa/0000-0003-0931-3700; Depraetere, Hilde/0000-0001-7196-7911				Ando T, 2002, J CLIN INVEST, V110, P1667, DOI 10.1172/JCI200216991; Hayakawa N, 2002, AUTOIMMUNITY, V35, P343, DOI 10.1080/0891693021000003206; McLachlan SM, 1996, J CLIN ENDOCR METAB, V81, P3152, DOI 10.1210/jc.81.9.3152; Sanders J, 2002, THYROID, V12, P1043, DOI 10.1089/105072502321085135; SMITH BR, 1988, ENDOCR REV, V9, P106, DOI 10.1210/edrv-9-1-106	5	133	136	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2003	362	9378					126	128		10.1016/S0140-6736(03)13866-4	http://dx.doi.org/10.1016/S0140-6736(03)13866-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699ZY	12867115				2022-12-24	WOS:000184089200014
J	Dumas, JJ; Kumar, R; Seehra, J; Somers, WS; Mosyak, L				Dumas, JJ; Kumar, R; Seehra, J; Somers, WS; Mosyak, L			Crystal structure of the GpIb alpha-thrombin complex essential for platelet aggregation	SCIENCE			English	Article							GLYCOPROTEIN-IB-ALPHA; VON-WILLEBRAND-FACTOR; BINDING-SITE; IDENTIFICATION; RECEPTOR; ADHESION; GLYCOCALICIN; RESIDUES; DOMAIN; LOCALIZATION	Direct interaction between platelet receptor glycoprotein Ibalpha (GpIbalpha) and thrombin is required for platelet aggregation and activation at sites of vascular injury. Abnormal GpIbalpha-thrombin binding is associated with many pathological conditions, including occlusive arterial thrombosis and bleeding disorders. The crystal structure of the GpIbalpha-thrombin complex at 2.6 angstrom resolution reveals simultaneous interactions of GpIbalpha with exosite I of one thrombin molecule, and with exosite II of a second thrombin molecule. In the crystal lattice, the periodic arrangement of GpIbalpha-thrombin complexes mirrors a scaffold that could serve as a driving force for tight platelet adhesion. The details of these interactions reconcile GpIbalpha-thrombin binding modes that are presently controversial, highlighting two distinct interfaces that are potential targets for development of novel antithrombotic drugs.	Wyeth, Dept Chem & Screening Sci, Cambridge, MA 02140 USA	Pfizer	Mosyak, L (corresponding author), Wyeth, Dept Chem & Screening Sci, 200 Cambridge Pk Dr, Cambridge, MA 02140 USA.	wsomers@wyeth.com; lmosyak@wyeth.com						Andrews RK, 1997, INT J BIOCHEM CELL B, V29, P91, DOI 10.1016/S1357-2725(96)00122-7; Andrews RK, 1999, THROMB HAEMOSTASIS, V82, P357, DOI 10.1055/s-0037-1615854; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berndt MC, 2001, THROMB HAEMOSTASIS, V86, P178; Bouton MC, 1998, THROMB HAEMOSTASIS, V80, P310, DOI 10.1055/s-0037-1615193; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; de Cristofaro R, 1998, BIOCHEM J, V332, P643, DOI 10.1042/bj3320643; De Cristofaro R, 2000, J BIOL CHEM, V275, P3887, DOI 10.1074/jbc.275.6.3887; De Cristofaro R, 2001, BIOCHEMISTRY-US, V40, P13268, DOI 10.1021/bi010491f; DeCandia E, 1997, THROMB HAEMOSTASIS, V77, P735; DEMARCO L, 1991, J BIOL CHEM, V266, P23776; DEMARCO L, 1994, J BIOL CHEM, V269, P6478; DONG JF, 1994, BIOCHEMISTRY-US, V33, P13946, DOI 10.1021/bi00250a050; Dormann D, 2000, BLOOD, V96, P2469, DOI 10.1182/blood.V96.7.2469.h8002469_2469_2478; DUMAS JC, UNPUB; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; GAN ZR, 1994, J BIOL CHEM, V269, P1301; GRALNICK HR, 1994, P NATL ACAD SCI USA, V91, P6334, DOI 10.1073/pnas.91.14.6334; HARMON JT, 1986, J BIOL CHEM, V261, P3224; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; JANDROTPERRUS M, 1992, BLOOD, V80, P2781; JANDROTPERRUS M, 1991, THROMB HAEMOSTASIS, V66, P300; JANDROTPERRUS M, 1992, SEMIN THROMB HEMOST, V18, P261, DOI 10.1055/s-2007-1002433; KATAGIRI Y, 1990, THROMB HAEMOSTASIS, V63, P122; Li CQ, 2001, J BIOL CHEM, V276, P6161, DOI 10.1074/jbc.M004164200; MARCHESE P, 1995, J BIOL CHEM, V270, P9571, DOI 10.1074/jbc.270.16.9571; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; NICHOLLS A, 1993, GRASP; NURDEN AT, 1975, NATURE, V255, P720, DOI 10.1038/255720a0; OKUMURA T, 1978, J BIOL CHEM, V253, P3435; Ramakrishnan V, 2001, P NATL ACAD SCI USA, V98, P1823, DOI 10.1073/pnas.98.4.1823; Ravanat C, 2000, THROMB HAEMOSTASIS, V83, P327; Ruggeri ZM, 2003, CURR OPIN HEMATOL, V10, P142, DOI 10.1097/00062752-200303000-00008; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Soslau G, 2001, J BIOL CHEM, V276, P21173, DOI 10.1074/jbc.M008249200; Uff S, 2002, J BIOL CHEM, V277, P35657, DOI 10.1074/jbc.M205271200; Wang JH, 2002, TRENDS BIOCHEM SCI, V27, P122, DOI 10.1016/S0968-0004(01)02038-2; Ward CM, 1996, BIOCHEMISTRY-US, V35, P4929, DOI 10.1021/bi952456c; WORKMAN EF, 1977, J BIOL CHEM, V252, P7118	42	134	137	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2003	301	5630					222	226		10.1126/science.1083917	http://dx.doi.org/10.1126/science.1083917			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855811				2022-12-24	WOS:000184056200046
J	Matsumoto, K; Suzuki, W; Tanaka, K				Matsumoto, K; Suzuki, W; Tanaka, K			Neuronal correlates of goal-based motor selection in the prefrontal cortex	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; ORBITOFRONTAL CORTEX; REWARD EXPECTANCY; COGNITIVE CONTROL; UNIT-ACTIVITY; HUMAN BRAIN; BEHAVIOR; SIGNALS; MACAQUE; MONKEY	Choosing an action that leads to a desired goal requires an understanding of the linkages between actions and their outcomes. We investigated neural mechanisms of such goal-based action selection. We trained monkeys on a task in which the relation between visual cues, action types, and reward conditions changed regularly, such that the monkeys selected their actions based on anticipated reward conditions. A significant number of neurons in the medial prefrontal cortex were activated, after cue presentation and before motor execution, only by particular action-reward combinations. This prefrontal activity is likely to underlie goal-based action selection.	RIKEN, Brain Sci Inst, Cognit Brain Mapping Lab, Wako, Saitama 3510198, Japan	RIKEN	Matsumoto, K (corresponding author), RIKEN, Brain Sci Inst, Cognit Brain Mapping Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsumot@postman.riken.go.jp	Tanaka, Keiji/N-5917-2015	Tanaka, Keiji/0000-0002-1910-3427; Matsumoto, Kenji/0000-0003-0883-4280				Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Duncan John, 1995, P721; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Hadland KA, 2003, J NEUROPHYSIOL, V89, P1161, DOI 10.1152/jn.00634.2002; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Overmier JB, 2001, INTEGR PHYS BEH SCI, V36, P173, DOI 10.1007/BF02734091; PETERSON GB, 1980, LEARN MOTIV, V11, P267, DOI 10.1016/0023-9690(80)90001-6; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; Savage LM, 2001, INTEGR PHYS BEH SCI, V36, P182, DOI 10.1007/BF02734092; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Watanabe M, 2002, J NEUROSCI, V22, P2391, DOI 10.1523/JNEUROSCI.22-06-02391.2002; WATANABE M, 1990, EXP BRAIN RES, V80, P296; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0	28	302	306	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2003	301	5630					229	232		10.1126/science.1084204	http://dx.doi.org/10.1126/science.1084204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	699KN	12855813				2022-12-24	WOS:000184056200048
J	Valle, M; Zavialov, A; Sengupta, J; Rawat, U; Ehrenberg, M; Frank, J				Valle, M; Zavialov, A; Sengupta, J; Rawat, U; Ehrenberg, M; Frank, J			Locking and unlocking of ribosomal motions	CELL			English	Article							ELONGATION-FACTOR-G; COLI 70S RIBOSOME; 3-DIMENSIONAL CRYOELECTRON MICROSCOPY; TRANSFER-RNA TRANSLOCATION; AMINOACYL-TRANSFER-RNA; ESCHERICHIA-COLI; ANGSTROM RESOLUTION; PROTEIN-SYNTHESIS; GTPASE ACTIVITY; PROMOTES TRANSLOCATION	During the ribosomal translocation, the binding of elongation factor G (EF-G) to the pretranslocational ribosome leads to a ratchet-like rotation of the 30S subunit relative to the 50S subunit in the direction of the mRNA movement. By means of cryo-electron microscopy we observe that this rotation is accompanied by a 20 Angstrom movement of the L1 stalk of the 50S subunit, implying that this region is involved in the translocation of deacylated tRNAs from the P to the E site. These ribosomal motions can occur only when the P-site tRNA is deacylated. Prior to peptidyl-transfer to the A-site tRNA or peptide removal, the presence of the charged P-site tRNA locks the ribosome and prohibits both of these motions.	SUNY Albany, Howard Hughes Med Inst, Albany, NY 12201 USA; SUNY Albany, Htlh Res Inc, Wadsworth Ctr, Albany, NY 12201 USA; SUNY Albany, Htlh Res Inc, Dept Biomed Sci, Albany, NY 12201 USA; Biomed Ctr, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden	Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Frank, J (corresponding author), SUNY Albany, Howard Hughes Med Inst, Empire State Plaza, Albany, NY 12201 USA.		Valle, Mikel/F-7598-2011	Valle, Mikel/0000-0001-8268-6912; Zavialov, Andrey/0000-0001-6420-0368	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029169, R01GM055440] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM55440, R37 GM29169] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P53; Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Borowski C, 1996, P NATL ACAD SCI USA, V93, P4202, DOI 10.1073/pnas.93.9.4202; BRETSCHER MS, 1968, NATURE, V218, P675, DOI 10.1038/218675a0; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2000, METHOD ENZYMOL, V317, P276; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; HIGHLAND JH, 1975, J BIOL CHEM, V250, P1141; Hirokawa G, 2002, EMBO J, V21, P2272, DOI 10.1093/emboj/21.9.2272; ISHITSUKA H, 1970, J BIOL CHEM, V245, P3346; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joseph S, 1998, EMBO J, V17, P3478, DOI 10.1093/emboj/17.12.3478; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; Marquez V, 2002, BIOCHEM SOC T, V30, P133, DOI 10.1042/BST0300133; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Noller HF, 2002, FEBS LETT, V514, P11, DOI 10.1016/S0014-5793(02)02327-X; Peske F, 2000, MOL CELL, V6, P501, DOI 10.1016/S1097-2765(00)00049-6; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Rodnina MV, 2001, MOL BIOL+, V35, P559, DOI 10.1023/A:1010523026531; Savelsbergh A, 2000, J BIOL CHEM, V275, P890, DOI 10.1074/jbc.275.2.890; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; SUBRAMANIAN AR, 1980, EUR J BIOCHEM, V112, P425, DOI 10.1111/j.1432-1033.1980.tb07222.x; TRAUT RR, 1964, J MOL BIOL, V10, P63, DOI 10.1016/S0022-2836(64)80028-0; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; VanLoock MS, 2000, J MOL BIOL, V304, P507, DOI 10.1006/jmbi.2000.4213; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wower J, 2000, J BIOL CHEM, V275, P37887, DOI 10.1074/jbc.M005031200; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6	48	485	507	0	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 11	2003	114	1					123	134		10.1016/S0092-8674(03)00476-8	http://dx.doi.org/10.1016/S0092-8674(03)00476-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859903	Bronze			2022-12-24	WOS:000184219900011
J	Anderson, GG; Palermo, JJ; Schilling, JD; Roth, R; Heuser, J; Hultgren, SJ				Anderson, GG; Palermo, JJ; Schilling, JD; Roth, R; Heuser, J; Hultgren, SJ			Intracellular bacterial biofilm-like pods in urinary tract infections	SCIENCE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; COMPLETE GENOME SEQUENCE; HOST DEFENSES; OUTER-MEMBRANE; BLADDER; PROTEIN; RESISTANCE; INVASION; CELLS; MICE	Escherichia coli entry into the bladder is met with potent innate defenses, including neutrophil influx and epithelial exfoliation. Bacterial subversion of innate responses involves invasion into bladder superficial cells. We discovered that the intracellular bacteria matured into biofilms, creating pod-like bulges on the bladder surface. Pods contained bacteria encased in a polysaccharide-rich matrix surrounded by a protective shell of uroplakin. Within the biofilm, bacterial structures interacted extensively with the surrounding matrix, and biofilm associated factors had regional variation in expression. The discovery of intracellular biofilm-like pods explains how bladder infections can persist in the face of robust host defenses.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Hultgren, SJ (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	hultgren@borcim.wustl.edu			NIAID NIH HHS [AI48689, AI29549] Funding Source: Medline; NIDDK NIH HHS [DK51406, DK64540] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048689, R37AI029549, R01AI029549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064540, R01DK051406] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Danese PN, 2000, MOL MICROBIOL, V37, P424, DOI 10.1046/j.1365-2958.2000.02008.x; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Foxman B, 2002, AM J MED, V113, p5S; Fulcher TP, 2001, OPHTHALMOLOGY, V108, P1088, DOI 10.1016/S0161-6420(01)00561-9; Haraoka M, 1999, J INFECT DIS, V180, P1220, DOI 10.1086/315006; HEUSER JE, 1987, J MUSCLE RES CELL M, V8, P303, DOI 10.1007/BF01568887; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Hooton TM, 1997, INFECT DIS CLIN N AM, V11, P551, DOI 10.1016/S0891-5520(05)70373-1; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; JUSTICE S, UNPUB; Lewis SA, 2000, AM J PHYSIOL-RENAL, V278, pF867; Manges AR, 2001, NEW ENGL J MED, V345, P1007, DOI 10.1056/NEJMoa011265; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Mysorekar IU, 2002, J BIOL CHEM, V277, P7412, DOI 10.1074/jbc.M110560200; Olsson LE, 1998, J PHARMACOL EXP THER, V284, P1203; Otto G, 1999, J INFECT DIS, V179, P172, DOI 10.1086/314534; OWEN P, 1987, J BACTERIOL, V169, P3770, DOI 10.1128/jb.169.8.3770-3777.1987; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Schilling JD, 2003, P NATL ACAD SCI USA, V100, P4203, DOI 10.1073/pnas.0736473100; Schilling JD, 2002, INFECT IMMUN, V70, P7042, DOI 10.1128/IAI.70.12.7042-7049.2002; Schilling JD, 2001, J IMMUNOL, V166, P1148, DOI 10.4049/jimmunol.166.2.1148; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; WU XR, 1990, J BIOL CHEM, V265, P19170	31	736	772	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2003	301	5629					105	107		10.1126/science.1084550	http://dx.doi.org/10.1126/science.1084550			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843396				2022-12-24	WOS:000183914700044
J	Ashraf, H				Ashraf, H			UK ethicists say GM foods could help poor - Group back the controversial crops as government warily tests public opinion	LANCET			English	News Item																			0	2	2	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 14	2003	361	9374					2051	2051						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814720				2022-12-24	WOS:000183488900016
J	van Montfort, RLM; Congreve, M; Tisi, D; Carr, R; Jhoti, H				van Montfort, RLM; Congreve, M; Tisi, D; Carr, R; Jhoti, H			Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B	NATURE			English	Article							REVERSIBLE INACTIVATION; SUBSTRATE-SPECIFICITY; INSULIN SENSITIVITY; HYDROGEN-PEROXIDE; ENZYME CATALYSIS; INTERMEDIATE; ROLES	Protein tyrosine phosphatases regulate signal transduction pathways involving tyrosine phosphorylation(1) and have been implicated in the development of cancer, diabetes, rheumatoid arthritis and hypertension(2). Increasing evidence suggests that the cellular redox state is involved in regulating tyrosine phosphatase activity through the reversible oxidization of the catalytic cysteine to sulphenic acid (Cys-SOH)(3-6). But how further oxidation to the irreversible sulphinic (Cys-SO2H) and sulphonic (Cys-SO3H) forms is prevented remains unclear. Here we report the crystal structures of the regulatory sulphenic and irreversible sulphinic and sulphonic acids of protein tyrosine phosphatase 1B (PTP1B), an important enzyme in the negative regulation of the insulin receptor(7,8) and a therapeutic target in type II diabetes and obesity(9). We also identify a sulphenyl-amide species that is formed through oxidation of its catalytic cysteine. Formation of the sulphenyl-amide causes large changes in the PTP1B active site, which are reversible by reduction with the cellular reducing agent glutathione. The sulphenyl-amide is a protective intermediate in the oxidative inhibition of PTP1B. In addition, it may facilitate reactivation of PTP1B by biological thiols and signal a unique state of the protein.	Astex Technol Ltd, Cambridge CB4 0QA, England		Jhoti, H (corresponding author), Astex Technol Ltd, 436 Cambridge Sci Pk,Milton Rd, Cambridge CB4 0QA, England.	h.jhoti@astex-technology.com	van Montfort, Rob/D-3248-2009					BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barford D, 1995, CURR OPIN STRUC BIOL, V5, P728, DOI 10.1016/0959-440X(95)80004-2; BARFORD D, 1994, J MOL BIOL, V239, P726, DOI 10.1006/jmbi.1994.1409; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; CLAIBORNE A, 1993, FASEB J, V7, P1483, DOI 10.1096/fasebj.7.15.8262333; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Goldstein Barry J., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P265, DOI 10.2174/1568008013341163; HARTSHORN MJ, IN PRESS J COMPUT AI; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lohse DL, 1997, BIOCHEMISTRY-US, V36, P4568, DOI 10.1021/bi963094r; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Sarmiento M, 1998, J BIOL CHEM, V273, P26368, DOI 10.1074/jbc.273.41.26368; Scapin G, 2001, PROTEIN SCI, V10, P1596, DOI 10.1110/ps.11001; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616	23	492	505	3	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2003	423	6941					773	777		10.1038/nature01681	http://dx.doi.org/10.1038/nature01681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802339				2022-12-24	WOS:000183443400048
J	Wikelski, M; Tarlow, EM; Raim, A; Diehl, RH; Larkin, RP; Visser, GH				Wikelski, M; Tarlow, EM; Raim, A; Diehl, RH; Larkin, RP; Visser, GH			Costs of migration in free-flying songbirds	NATURE			English	Article							BIRD MIGRATION		Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; Illinois Nat Hist Survey, Champaign, IL 61820 USA; Univ Groningen, Ctr Isotope Res, NL-9747 AG Groningen, Netherlands; Univ Groningen, Zool Lab, NL-9750 AA Haren, Netherlands	Princeton University; University of Illinois System; University of Illinois Urbana-Champaign; Illinois Natural History Survey; University of Groningen; University of Groningen	Wikelski, M (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.							Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; BENNETT PM, 1987, J ZOOL, V213, P327, DOI 10.1111/j.1469-7998.1987.tb03708.x; COCHRAN WW, 1987, ANIM BEHAV, V35, P927, DOI 10.1016/S0003-3472(87)80132-X; Cochran WW, 1972, ANIMAL ORIENTATION N, P39; Faaborg John, 1995, P357; GRABER RR, 1971, BIOL NOTES ILLINOIS, V75; Hedenstrom A, 1997, J THEOR BIOL, V189, P227, DOI 10.1006/jtbi.1997.0505; Klaassen M, 1996, J EXP BIOL, V199, P57; MASMAN D, 1987, AUK, V104, P603, DOI 10.1093/auk/104.4.603; Pennycuick CJ, 1998, J THEOR BIOL, V191, P47, DOI 10.1006/jtbi.1997.0572; RICHARDSON WJ, 1978, OIKOS, V30, P224, DOI 10.2307/3543482; Speakman JR, 1997, DOUBLY LABELED WATER; [No title captured]	13	317	328	0	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2003	423	6941					704	704		10.1038/423704a	http://dx.doi.org/10.1038/423704a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802324	Bronze			2022-12-24	WOS:000183443400032
J	Hansen, L				Hansen, L			Commentary: We need to determine who benefits most from flu treatments	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Edinburgh, Edinburgh EH9 1QH, Midlothian, Scotland	University of Edinburgh	Hansen, L (corresponding author), Univ Edinburgh, Edinburgh EH9 1QH, Midlothian, Scotland.							*ADV COMM IMM PRAC, 2002, MMWR, V51; *APPR COMM NAT I C, 2003, FULL GUID US ZAN OS; Peters PH, 2001, J AM GERIATR SOC, V49, P1025, DOI 10.1046/j.1532-5415.2001.49204.x	3	1	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 7	2003	326	7401					1239	1240		10.1136/bmj.326.7401.1239	http://dx.doi.org/10.1136/bmj.326.7401.1239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689FJ	12791736	Green Published			2022-12-24	WOS:000183480700013
J	Tian, PF; Keusters, D; Suzaki, Y; Warren, WS				Tian, PF; Keusters, D; Suzaki, Y; Warren, WS			Femtosecond phase-coherent two-dimensional spectroscopy	SCIENCE			English	Article							PEPTIDES; SEQUENCES; DYNAMICS; ECHO	Femtosecond phase-coherent two-dimensional (2D) spectroscopy has been experimentally demonstrated as the direct optical analog of 2D nuclear magnetic resonance. An acousto-optic pulse shaper created a collinear three-pulse sequence with well-controlled and variable interpulse delays and phases, which interacted with a model atomic system of rubidium vapor. The desired nonlinear polarization was selected by phase cycling (coadding experimental results obtained with different interpulse phases). This method may enhance our ability to probe the femtosecond structural dynamics of macromolecules.	Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; Princeton Univ, Ctr Ultrafast Laser Applicat, Dept Chem, Princeton, NJ 08544 USA; Kagawa Univ, Fac Engn, Dept Adv Mat Sci, Kagawa 7610396, Japan	Princeton University; Princeton University; Kagawa University	Tian, PF (corresponding author), Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA.							Asplund MC, 2000, P NATL ACAD SCI USA, V97, P8219, DOI 10.1073/pnas.140227997; AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; de Boeij WP, 1998, CHEM PHYS, V233, P287, DOI 10.1016/S0301-0104(98)00084-6; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; Ge NH, 2002, PHYSCHEMCOMM, V5, P17, DOI 10.1039/b109935c; Golonzka O, 2001, PHYS REV LETT, V86, P2154, DOI 10.1103/PhysRevLett.86.2154; Hamm P, 1998, J PHYS CHEM B, V102, P6123, DOI 10.1021/jp9813286; Hybl JD, 2001, J CHEM PHYS, V115, P6606, DOI 10.1063/1.1398579; Keusters D, 2001, SPRINGER SERIES CHEM, V66, P165; Keusters D, 1999, J PHYS CHEM A, V103, P10369, DOI 10.1021/jp99235b; KHALIL M, IN PRESS J PHYS CH A; Merchant KA, 2001, PHYS REV LETT, V86, P3899, DOI 10.1103/PhysRevLett.86.3899; Mukamel S, 2000, ANNU REV PHYS CHEM, V51, P691, DOI 10.1146/annurev.physchem.51.1.691; Mukamel S., 1995, PRINCIPLES NONLINEAR; SCHERER NF, 1991, J CHEM PHYS, V95, P1487, DOI 10.1063/1.461064; Scheurer C, 2001, J CHEM PHYS, V115, P4989, DOI 10.1063/1.1391266; TAN HS, UNPUB; TAN HW, COMMUNICATION, P37401; WARREN WS, 1981, J CHEM PHYS, V75, P5956, DOI 10.1063/1.442051; Weiner AM, 2000, REV SCI INSTRUM, V71, P1929, DOI 10.1063/1.1150614; Woutersen S, 2002, J PHYS-CONDENS MAT, V14, pR1035, DOI 10.1088/0953-8984/14/39/202; Woutersen S, 2001, P NATL ACAD SCI USA, V98, P11254, DOI 10.1073/pnas.201169498; Yang WG, 1998, OPT LETT, V23, P1843, DOI 10.1364/OL.23.001843; Zanni MT, 2001, P NATL ACAD SCI USA, V98, P11265, DOI 10.1073/pnas.201412998; 2001, CHEM PHYS, V266, P135	25	372	390	0	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2003	300	5625					1553	1555		10.1126/science.1083433	http://dx.doi.org/10.1126/science.1083433			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791987	Green Submitted			2022-12-24	WOS:000183333100049
J	Wirth, S; Yanike, M; Frank, LM; Smith, AC; Brown, EN; Suzuki, WA				Wirth, S; Yanike, M; Frank, LM; Smith, AC; Brown, EN; Suzuki, WA			Single neurons in the monkey hippocampus and learning of new associations	SCIENCE			English	Article							CONDITIONAL OCULOMOTOR ASSOCIATIONS; SUPPLEMENTARY EYE FIELD; PERIRHINAL NEURONS; CORTEX; MEMORY; ACQUISITION; RESPONSES; TASK	The medial temporal lobe is crucial for the ability to learn and retain new declarative memories. This form of memory includes the ability to quickly establish novel associations between unrelated items. To better understand the patterns of neural activity during associative memory formation, we recorded the activity of hippocampal neurons of macaque monkeys as they learned new associations. Hippocampal neurons signaled learning by changing their stimulus-selective response properties. This change in the pattern of selective neural activity occurred before, at the same time as, or after learning, which suggests that these neurons are involved in the initial formation of new associative memories.	NYU, Ctr Neural Sci, New York, NY 10003 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med,Dept Anesthesia & Crit Care, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02114 USA	New York University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Suzuki, WA (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.		Wirth, Sylvia/M-4752-2017	Frank, Loren/0000-0002-1752-5677; Wirth, Sylvia/0000-0001-7002-329X				Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; BERGER TW, 1976, SCIENCE, V192, P483, DOI 10.1126/science.1257783; CAHUSAC PMB, 1993, HIPPOCAMPUS, V3, P29, DOI 10.1002/hipo.450030104; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1122, DOI 10.1152/jn.1995.73.3.1122; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Erickson CA, 1999, J NEUROSCI, V19, P10404; Erickson CA, 2000, NAT NEUROSCI, V3, P1143, DOI 10.1038/80664; Frank LM, 2001, J NEUROPHYSIOL, V86, P2029, DOI 10.1152/jn.2001.86.4.2029; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; McEchron MD, 1999, HIPPOCAMPUS, V9, P385, DOI 10.1002/(SICI)1098-1063(1999)9:4<385::AID-HIPO5>3.0.CO;2-K; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MITZ AR, 1991, J NEUROSCI, V11, P1855; Moody SL, 1998, J NEUROSCI, V18, P399; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515	18	251	255	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1578	1581		10.1126/science.1084324	http://dx.doi.org/10.1126/science.1084324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791995				2022-12-24	WOS:000183333100057
J	Wang, YJ; Wang, J; Sun, HQ; Martinez, M; Sun, YX; Macia, E; Kirchhausen, T; Albanesi, JP; Roth, MG; Yin, HL				Wang, YJ; Wang, J; Sun, HQ; Martinez, M; Sun, YX; Macia, E; Kirchhausen, T; Albanesi, JP; Roth, MG; Yin, HL			Phosphatidylinositol 4 phosphate regulates targeting of clathrin adaptor AP-1 complexes to the golgi	CELL			English	Article							PLASMA-MEMBRANE; SORTING SIGNALS; 4,5-BISPHOSPHATE; 4-KINASE; PROTEIN; DOMAIN; YEAST; PHOSPHOINOSITIDES; RECRUITMENT; SECRETION	Phosphatidylinositol 4 phosphate [PI(4)P] is essential for secretion in yeast, but its role in mammalian cells is unclear. Current paradigms propose that PI(4)P acts primarily as a precursor to phosphatidylinositol 4,5 bisphosphate (PIP2), an important plasma membrane regulator. We found that PI(4)P is enriched in the mammalian Golgi, and used RNA interference (RNAi) of PI4KIIalpha, a Golgi resident phosphatidylinositol 4 kinase, to determine whether PI(4)P directly regulates the Golgi. PI4KIIalpha RNAi decreases Golgi PI(4)P, blocks the recruitment of clathrin adaptor AP-1 complexes to the Golgi, and inhibits AP-1-dependent functions. This AP-1 binding defect is rescued by adding back PI(4)P. In addition, purified AP-1 binds PI(4)P, and anti-PI(4)P inhibits the in vitro recruitment of cytosolic AP-1 to normal cellular membranes. We propose that PI4KIIalpha establishes the Golgi's unique lipid-defined organelle identity by generating PI(4)P-rich domains that specify the docking of the AP-1 coat machinery.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Yin, HL (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA.	helen.yin@utsouthwestern.edu	Macia, Eric/AAW-2964-2021	Roth, Michael/0000-0002-9056-332X; macia, eric/0000-0003-3686-2000	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036548, P50GM021681, R01GM055562, R01GM037547, R01GM051112] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM21681, GM37547, R01 GM55562, GM36548, R01 GM51112] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Barylko B, 2002, J BIOL CHEM, V277, P44366, DOI 10.1074/jbc.M203241200; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Cockcroft S, 2001, J MEMBRANE BIOL, V180, P187, DOI 10.1007/s002320010069; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Cremona O, 2001, J CELL SCI, V114, P1041; Crottet P, 2002, MOL BIOL CELL, V13, P3672, DOI 10.1091/mbc.E02-05-0309; De Matteis MA, 2002, CURR OPIN CELL BIOL, V14, P434, DOI 10.1016/S0955-0674(02)00357-5; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Guo J, 2003, P NATL ACAD SCI USA, V100, P3995, DOI 10.1073/pnas.0230488100; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Han P, 2002, CYTOTHERAPY, V4, P277, DOI 10.1080/146532402320219790; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lin S, 1997, J BIOL CHEM, V272, P26300, DOI 10.1074/jbc.272.42.26300; Lin SS, 1998, J CELL BIOL, V142, P51, DOI 10.1083/jcb.142.1.51; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Meyer C, 2001, J CELL SCI, V114, P4469; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Minogue S, 2001, J BIOL CHEM, V276, P16635, DOI 10.1074/jbc.M100982200; Munro S, 2002, CURR OPIN CELL BIOL, V14, P506, DOI 10.1016/S0955-0674(02)00350-2; Ozaki S, 2000, P NATL ACAD SCI USA, V97, P11286, DOI 10.1073/pnas.210197897; Panaretou C, 2002, BIOCHEM J, V363, P289, DOI 10.1042/0264-6021:3630289; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Shelton SN, 2003, BIOCHEM J, V371, P533, DOI 10.1042/BJ20021407; Siddhanta A, 2000, J BIOL CHEM, V275, P12023, DOI 10.1074/jbc.275.16.12023; Skippen A, 2002, J BIOL CHEM, V277, P5823, DOI 10.1074/jbc.M110274200; Tran D, 1999, J HISTOCHEM CYTOCHEM, V47, P601, DOI 10.1177/002215549904700503; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Wei YJ, 2002, J BIOL CHEM, V277, P46586, DOI 10.1074/jbc.M206860200; Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhu Y.-P., 1998, J SURFACTANTS DETERG, V1, P1; Zhu YX, 1999, P NATL ACAD SCI USA, V96, P5013, DOI 10.1073/pnas.96.9.5013	51	388	398	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2003	114	3					299	310		10.1016/S0092-8674(03)00603-2	http://dx.doi.org/10.1016/S0092-8674(03)00603-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914695	Bronze			2022-12-24	WOS:000184679200007
J	Lyss, SB; Kamb, ML; Peterman, TA; Moran, JS; Newman, DR; Bolan, G; Douglas, JM; Iatesta, M; Malotte, CK; Zenilman, JM; Ehret, J; Gaydos, C; Newhall, WJ				Lyss, SB; Kamb, ML; Peterman, TA; Moran, JS; Newman, DR; Bolan, G; Douglas, JM; Iatesta, M; Malotte, CK; Zenilman, JM; Ehret, J; Gaydos, C; Newhall, WJ		RESPECT Study Grp	Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							NONGONOCOCCAL URETHRITIS; GENITAL INFECTIONS; ADOLESCENT WOMEN; VENEREAL-DISEASE; PREVALENCE; MEN; COINFECTION; URINE; TRACT; INTERVENTION	Background: For two decades, treatment guidelines for sexually transmitted diseases (STDs) have recommended empirical co-treatment for chlamydia when patients are treated for gonorrhea. Because the epidemiology of and diagnostic testing for STDs have changed over time, co-treatment may no longer be needed as a clinical or public health strategy. Objective: To assess the prevalence of chlamydia among patients at STD clinics who are infected with and treated for Neisseria gonorrhoeae and to determine whether co-treatment recommendations are still justified. Design: Cross-sectional analysis of data from a multisite study. Setting: Five public STD clinics (Baltimore, Maryland; Denver, Colorado; Long Beach, California; Newark, New Jersey; and San Francisco, California), July 1993 through October 1995. Patients: 3885 heterosexual patients (2184 men and 1701 women) who agreed to participate in a trial of counseling interventions and had conclusive results from diagnostic tests for gonorrhea and chlamydia performed routinely as part of the trial. Measurements: infection with Chlamydia trachomatis as determined by polymerase chain reaction. Results: Chlamydia trachomatis was detected in 20% (95% CI, 16% to 24%) of 411 men and 42% (CI, 35% to 50%) of 151 women with laboratory-confirmed N. gonorrhoeae. Chlamydia trachomatis was detected in 19% (CI, 15% to 22%) of 410 men and 35% (CI, 28% to 43%) of 154 women with treatment indications for gonorrhea who would not otherwise have been treated for chlamydia: chlamydia prevalence among these patients was significantly higher than among patients without treatment indications for either gonorrhea or chlamydia: 7% in men and 9% in women (relative risk, 2.58 [CI, 1.92 to 3.47] and 4.12 [CI, 3.05 to 5.57], respectively). Conclusion: The frequent presence of chlamydia among patients at STD clinics who received treatment for gonorrhea, including sex partners of gonorrhea-infected patients, supports continuing current recommendations for co-treatment.	Ctr Dis Control & Prevent, Off Commun, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; San Francisco Hlth Dept, San Francisco, CA USA; Denver Publ Hlth, Denver, CO USA; New Jersey State Dept Hlth, Newark, NJ USA; Calif State Univ Long Beach, Long Beach, CA 90840 USA; Baltimore City Dept Hlth, Baltimore, MD USA; Johns Hopkins Univ, Baltimore, MD 21218 USA	Centers for Disease Control & Prevention - USA; New Jersey Department of Health & Senior Services; California State University System; California State University Long Beach; Johns Hopkins University	Lyss, SB (corresponding author), Ctr Dis Control & Prevent, Off Commun, Natl Ctr HIV STD & TB Prevent, 1600 Clifton Rd NE,Mailstop E-07, Atlanta, GA 30333 USA.		Gaydos, Charlotte A./E-9937-2010					ALANI MD, 1977, BRIT J VENER DIS, V53, P88; [Anonymous], 2002, MMWR MORB MORTAL WKL, V51; ARYA OP, 1981, BRIT J VENER DIS, V57, P118; BIRO FM, 1995, CLIN PEDIATR, V34, P419, DOI 10.1177/000992289503400804; Black CM, 1997, CLIN MICROBIOL REV, V10, P160, DOI 10.1128/CMR.10.1.160; BOWIE WR, 1981, CAN MED ASSOC J, V124, P1477; BRUNHAM R, 1981, CLIN RES, V29, pA47; BURNS DCM, 1975, BRIT J VENER DIS, V51, P314; Carroll KC, 1998, J CLIN MICROBIOL, V36, P1630, DOI 10.1128/JCM.36.6.1630-1633.1998; *CDCP, 2000, TRACK HIDD EP TRENDS; *CDCP, 2002, SEX TRANS DIS SURV 2; Chernesky M, 1999, SEX TRANSM DIS, V26, pS8, DOI 10.1097/00007435-199904001-00003; CHOW JM, 2001, INT C SEX TRANSM INF; CHRISTMAS JT, 1989, OBSTET GYNECOL, V74, P295; Ciemins EL, 2000, SEX TRANSM DIS, V27, P249, DOI 10.1097/00007435-200005000-00002; Creighton S, 2003, INT J STD AIDS, V14, P109, DOI 10.1258/095646203321156872; David LM, 1997, INT J STD AIDS, V8, P311, DOI 10.1258/0956462971920154; DEVORE JL, 1991, PROBABILITY STAT ENG, P266; Dicker LW, 2003, SEX TRANSM DIS, V30, P472, DOI 10.1097/00007435-200305000-00016; Embling ML, 2000, ANN EMERG MED, V36, P28, DOI 10.1067/mem.2000.105930; GREYDANUS DE, 1980, J FAM PRACTICE, V10, P611; HANDSFIELD HH, 1997, INT C SEX TRANSM DIS; Hijazi L, 2002, SEX TRANSM INFECT, V78, P387, DOI 10.1136/sti.78.5.387; HILTON AL, 1974, BRIT J VENER DIS, V50, P1; HOLMES KK, 1975, NEW ENGL J MED, V292, P1199, DOI 10.1056/NEJM197506052922301; Hook Er., 1999, SEX TRANSM DIS; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Lin JSL, 1998, J INFECT DIS, V178, P1707, DOI 10.1086/314485; LYCKE E, 1980, SEX TRANSM DIS, V7, P6, DOI 10.1097/00007435-198001000-00002; MARDH PA, 1980, BRIT J VENER DIS, V56, P327; Mehta SD, 2001, SEX TRANSM DIS, V28, P33, DOI 10.1097/00007435-200101000-00008; Mertz KJ, 1997, SEX TRANSM DIS, V24, P169, DOI 10.1097/00007435-199703000-00009; METCALF CA, 2002, 14 INT AIDS C BARC S; NAYYAR KC, 1976, BRIT J VENER DIS, V52, P396; Oh MK, 1998, ARCH PEDIAT ADOL MED, V152, P52; ORIEL JD, 1974, BRIT J VENER DIS, V50, P11; ORIEL JD, 1976, J INFECT DIS, V133, P568, DOI 10.1093/infdis/133.5.568; ORIEL JD, 1975, J INFECT DIS, V131, P376, DOI 10.1093/infdis/131.4.376; PERROUD HM, 1978, BRIT J VENER DIS, V54, P45; RICHMOND SJ, 1972, BRIT J VENER DIS, V48, P437; RUDEN AK, 1986, ACTA DERM-VENEREOL, V66, P453; SCHACHTER J, 1975, JAMA-J AM MED ASSOC, V231, P1252, DOI 10.1001/jama.231.12.1252; SMITH TF, 1978, AM J CLIN PATHOL, V70, P333; STAMM WE, 1984, NEW ENGL J MED, V310, P545, DOI 10.1056/NEJM198403013100901; SVENSSON L, 1981, BRIT J VENER DIS, V57, P259; TERHO P, 1978, BRIT J VENER DIS, V54, P326; WONG JL, 1977, SEX TRANSM DIS, V4, P4, DOI 10.1097/00007435-197701000-00002; WOOLFITT JMG, 1977, BRIT J VENER DIS, V53, P93; Xu KY, 1998, SEX TRANSM DIS, V25, P533, DOI 10.1097/00007435-199811000-00007; 2002, MMWR MORB MORTAL WKL, V51, P36; 1985, MMWR MORB MORTAL S3, V34, pS53; 1982, MMWR MORB MORTAL  S2, V31, pS33	53	58	63	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2003	139	3					178	185		10.7326/0003-4819-139-3-200308050-00007	http://dx.doi.org/10.7326/0003-4819-139-3-200308050-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707RH	12899585				2022-12-24	WOS:000184523300003
J	Liou, YC; Sun, A; Ryo, A; Zhou, XZ; Yu, ZX; Huang, HK; Uchida, T; Bronson, R; Bing, GY; Li, XJ; Hunter, T; Lu, KP				Liou, YC; Sun, A; Ryo, A; Zhou, XZ; Yu, ZX; Huang, HK; Uchida, T; Bronson, R; Bing, GY; Li, XJ; Hunter, T; Lu, KP			Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration	NATURE			English	Article							PAIRED HELICAL FILAMENTS; PROLINE-DIRECTED PHOSPHORYLATION; ALZHEIMERS-DISEASE; TRANSGENIC MICE; TAU-PROTEIN; NEUROFIBRILLARY TANGLES; P301L TAU; ISOMERIZATION; HYPERPHOSPHORYLATION; DEPHOSPHORYLATION	The neuropathological hallmarks of Alzheimer's disease and other tauopathies include senile plaques and/or neurofibrillary tangles(1-4). Although mouse models have been created by overexpressing specific proteins including beta-amyloid precursor protein, presenilin and tau(1-10), no model has been generated by gene knockout. Phosphorylation of tau and other proteins on serine or threonine residues preceding proline seems to precede tangle formation and neurodegeneration in Alzheimer's disease(11-14). Notably, these phospho(Ser/Thr)-Pro motifs exist in two distinct conformations, whose conversion in some proteins is catalysed by the Pin1 prolyl isomerase(15-17). Pin1 activity can directly restore the conformation and function of phosphorylated tau or it can do so indirectly by promoting its dephosphorylation, which suggests that Pin1 is involved in neurodegeneration(14,18,19); however, genetic evidence is lacking. Here we show that Pin1 expression is inversely correlated with predicted neuronal vulnerability and actual neurofibrillary degeneration in Alzheimer's disease. Pin1 knockout in mice causes progressive age-dependent neuropathy characterized by motor and behavioural deficits, tau hyperphosphorylation, tau filament formation and neuronal degeneration. Thus, Pin1 is pivotal in protecting against age-dependent neurodegeneration, providing insight into the pathogenesis and treatment of Alzheimer's disease and other tauopathies.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Canc Biol Program, Boston, MA 02215 USA; Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; Tohoku Univ, Dept Pathol, Sendai, Miyagi 9808575, Japan; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Kentucky; Emory University; Salk Institute; Tohoku University; Tufts University	Lu, KP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Canc Biol Program, Boston, MA 02215 USA.		bing, guoying/F-7084-2012	Uchida, Takafumi/0000-0003-3665-4906; Bing, Guoying/0000-0003-0609-8152				Allen B, 2002, J NEUROSCI, V22, P9340; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; DAVIES DC, 1992, ACTA NEUROPATHOL, V83, P510, DOI 10.1007/BF00310028; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Gordon-Krajcer W, 2000, BRAIN RES, V856, P163, DOI 10.1016/S0006-8993(99)02391-4; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Holzer M, 2002, ACTA NEUROPATHOL, V104, P471, DOI 10.1007/s00401-002-0581-1; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Kins S, 2001, J BIOL CHEM, V276, P38193; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2003, BIOESSAYS, V25, P174, DOI 10.1002/bies.10223; Lu PJ, 1999, NATURE, V399, P784; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mandelkow EM, 1998, TRENDS CELL BIOL, V8, P425, DOI 10.1016/S0962-8924(98)01368-3; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Preuss U, 1998, EUR J CELL BIOL, V76, P176, DOI 10.1016/S0171-9335(98)80032-0; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Vincent I, 1998, NEUROBIOL AGING, V19, P287, DOI 10.1016/S0197-4580(98)00071-2; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; Wong PC, 2002, NAT NEUROSCI, V5, P633, DOI 10.1038/nn0702-633; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	30	354	373	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					556	561		10.1038/nature01832	http://dx.doi.org/10.1038/nature01832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891359				2022-12-24	WOS:000184454700044
J	Okada, Y; Higuchi, H; Hirokawa, N				Okada, Y; Higuchi, H; Hirokawa, N			Processivity of the single-headed kinesin KIF1A through biased binding to tubulin	NATURE			English	Article							SUPERFAMILY PROTEIN KIF1A; MOTOR PROTEIN; MECHANISM; MOLECULES; MICROTUBULES; TRANSPORT; MOVEMENT; ATPASE; MUTANT; STEPS	Conventional isoforms of the motor protein kinesin behave functionally not as 'single molecules' but as 'two molecules' paired. This dimeric structure poses a barrier to solving its mechanism(1-4). To overcome this problem, we used an unconventional kinesin KIF1A (refs 5, 6) as a model molecule. KIF1A moves processively as an independent monomer(7,8), and can also work synergistically as a functional dimer(9). Here we show, by measuring its movement with an optical trapping system(10), that a single ATP hydrolysis triggers a single stepping movement of a single KIF1A monomer. The step size is distributed stochastically around multiples of 8 nm with a gaussian-like envelope and a standard deviation of 15 nm. On average, the step is directional to the microtubule's plus-end against a load force of up to 0.15 pN. As the source for this directional movement, we show that KIF1A moves to the microtubule's plus-end by similar to3 nm on average on binding to the microtubule, presumably by preferential binding to tubulin on the plus-end side. We propose a simple physical formulation to explain the movement of KIF1A.	Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Tohoku Univ, Grad Sch Engn, Dept Met, Sendai, Miyagi 9808579, Japan; Tohoku Univ, Interdisciplinary Res Ctr, Sendai, Miyagi 9808579, Japan	University of Tokyo; Tohoku University; Tohoku University	Hirokawa, N (corresponding author), Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan.		Okada, Yasushi/N-5067-2015	Okada, Yasushi/0000-0003-2601-3689				Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; deCastro MJ, 2000, NAT CELL BIOL, V2, P724, DOI 10.1038/35036357; Endow SA, 2000, NATURE, V406, P913, DOI 10.1038/35022617; Farrell CM, 2002, J BIOL CHEM, V277, P17079, DOI 10.1074/jbc.M108793200; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Hackney DD, 2002, BIOCHEMISTRY-US, V41, P4437, DOI 10.1021/bi0159229; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HOWARD J, 1993, METHOD CELL BIOL, V39, P105, DOI 10.1016/S0091-679X(08)60164-8; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Inoue Y, 1997, P NATL ACAD SCI USA, V94, P7275, DOI 10.1073/pnas.94.14.7275; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; Kaseda K, 2002, P NATL ACAD SCI USA, V99, P16058, DOI 10.1073/pnas.252409199; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104	25	137	142	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					574	577		10.1038/nature01804	http://dx.doi.org/10.1038/nature01804			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891363				2022-12-24	WOS:000184454700048
J	Schmitz, C; Perraud, AL; Johnson, CO; Inabe, K; Smith, MK; Penner, R; Kurosaki, T; Fleig, A; Scharenberg, AM				Schmitz, C; Perraud, AL; Johnson, CO; Inabe, K; Smith, MK; Penner, R; Kurosaki, T; Fleig, A; Scharenberg, AM			Regulation of vertebrate cellular Mg2+ Homeostasis by TRPM7	CELL			English	Article							MAGNESIUM TRANSPORT; ADP-RIBOSE; CHANNEL; PROTEIN; ION; MEMBRANE; LTRPC2; FAMILY; KINASE; YEAST	TRPM7 is a polypeptide with intrinsic ion channel and protein kinase domains whose targeted deletion causes cells to experience growth arrest within 24 hr and eventually die. Here, we show that while TRPM7's kinase domain is not essential for activation of its channel, a functional coupling exists such that structural alterations of the kinase domain alter the sensitivity of channel activation to Mg2+. Investigation of the relationship between Mg2+ and the cell biological role of TRPM7 revealed that TRPM7-deficient cells become Mg2+ deficient, that both the viability and proliferation of TRPM7-deficient cells are rescued by supplementation of extracellular Mg2+, and that the capacity of heterologously expressed TRPM7 mutants to complement TRPM7 deficiency correlates with their sensitivity to Mg2+. Overall, our results indicate that TRPM7 has a central role in Mg2+ homeostasis as a Mg2+ uptake pathway regulated through a functional coupling between its channel and kinase domains.	Univ Washington, Dept Immunol, Dept Pediat, Seattle, WA 98195 USA; Childrens Hosp & Reg Med Ctr, Seattle, WA 98195 USA; Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA; Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Osaka 5708506, Japan; RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Osaka, Japan; Univ Hawaii, Queens Med Ctr, Ctr Biomed Res, Lab Cell & Mol Signaling, Honolulu, HI 96813 USA; Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; National Jewish Health; Kansai Medical University; RIKEN; The Queen's Medical Center; University of Hawaii System; University of Hawaii System	Scharenberg, AM (corresponding author), Univ Washington, Dept Immunol, Dept Pediat, Seattle, WA 98195 USA.		Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X; Penner, Reinhold/0000-0002-5366-1537; Fleig, Andrea/0000-0001-8396-7249	NIAID NIH HHS [R01-AI64316] Funding Source: Medline; NIGMS NIH HHS [R01-GM065360] Funding Source: Medline; NINDS NIH HHS [R01-NS040927] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040927] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Elliott AC, 2001, CELL CALCIUM, V30, P73, DOI 10.1054/ceca.2001.0215; Graschopf A, 2001, J BIOL CHEM, V276, P16216, DOI 10.1074/jbc.M101504200; Gregan J, 2001, MOL GEN GENET, V264, P773, DOI 10.1007/s004380000366; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; Li LG, 2001, PLANT CELL, V13, P2761, DOI 10.1105/tpc.13.12.2761; MacDiarmid CW, 1998, J BIOL CHEM, V273, P1727, DOI 10.1074/jbc.273.3.1727; MONTEILHZOLLER MK, 2003, J PHYSL, V121, P1; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; PERRAUD AL, 2003, CELL CALCIUM, V382, P1; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Smith RL, 1998, MOL MICROBIOL, V28, P217, DOI 10.1046/j.1365-2958.1998.00810.x; Vennekens R, 2002, CELL CALCIUM, V31, P253, DOI 10.1016/S0143-4160(02)00055-6; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Zhang Y, 1998, EMBO J, V17, P7304, DOI 10.1093/emboj/17.24.7304	26	570	594	1	36	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					191	200		10.1016/S0092-8674(03)00556-7	http://dx.doi.org/10.1016/S0092-8674(03)00556-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887921	Bronze			2022-12-24	WOS:000184378700009
J	Gozani, O; Karuman, P; Jones, DR; Ivanov, D; Cha, J; Lugovskoy, AA; Baird, CL; Zhu, H; Field, SJ; Lessnick, SL; Villasenor, J; Mehrotra, B; Chen, J; Rao, VR; Brugge, JS; Ferguson, CG; Payrastre, B; Myszka, DG; Cantley, LC; Wagner, G; Divecha, N; Prestwich, GD; Yuan, JY				Gozani, O; Karuman, P; Jones, DR; Ivanov, D; Cha, J; Lugovskoy, AA; Baird, CL; Zhu, H; Field, SJ; Lessnick, SL; Villasenor, J; Mehrotra, B; Chen, J; Rao, VR; Brugge, JS; Ferguson, CG; Payrastre, B; Myszka, DG; Cantley, LC; Wagner, G; Divecha, N; Prestwich, GD; Yuan, JY			The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor	CELL			English	Article							PLECKSTRIN-HOMOLOGY-DOMAIN; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; ZINC-FINGER; CELL-CYCLE; BINDING; DNA; COMPLEX; PTDINS(4,5)P-2; IDENTIFICATION; TRANSCRIPTION	Phosphoinositides (PtdInsPs) play critical roles in cytoplasmic signal transduction pathways. However, their functions in the nucleus are unclear, as specific nuclear receptors for PtdInsPs have not been identified. Here, we show that ING2, a candidate tumor suppressor protein, is a nuclear PtdInsP receptor. ING2 contains a plant homeodomain (PHD) finger, a motif common to many chromatin-regulatory proteins. We find that the PHD fingers of ING2 and other diverse nuclear proteins bind in vitro to PtdInsPs, including the rare PtdInsP species, phosphatidylinositol 5-phosphate (PtdIns(5)P). Further, we demonstrate that the ING2 PHD finger interacts with PtdIns(5)P in vivo and provide evidence that this interaction regulates the ability of ING2 to activate p53 and p53-dependent apoptotic pathways. Together, our data identify the PHD finger as a phosphoinositide binding module and a nuclear PtdInsP receptor, and suggest that PHD-phosphoinositide interactions directly regulate nuclear responses to DNA damage.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Utah, Ctr Biomol Interact Anal, Salt Lake City, UT 84132 USA; Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Echelon Biosci Inc, Salt Lake City, UT 84108 USA; Hop Purpan, INSERM, U563, Dept Oncogenesis,IFR30, F-31059 Toulouse, France	Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Netherlands Cancer Institute; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Yuan, JY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	jyuan@hms.harvard.edu	Baird, Cheryl L/F-6569-2011; Ivanov, Dmitri/B-4600-2011; Ferguson, Colin/AAY-2524-2021; Gozani, Or P/I-6157-2013; Cantley, Lewis C/D-1800-2014; Baird, Cheryl/AGM-0065-2022	Ferguson, Colin/0000-0002-9021-4533; Cantley, Lewis C/0000-0002-1298-7653; Zhu, Hong/0000-0002-2575-4031; , Bernard/0000-0002-8693-0190; Gozani, Or/0000-0002-1365-4463; Field, Seth/0000-0002-8893-4806; divecha, nullin/0000-0001-9695-6039	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R41GM057705, R42GM057705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG019245, R01AG016674] Funding Source: NIH RePORTER; NIA NIH HHS [AG16674, KO8AG19245] Funding Source: Medline; NIGMS NIH HHS [GM36624, GM57705] Funding Source: Medline; NINDS NIH HHS [NS29632] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Aravind L, 2003, CELL CYCLE, V2, P123, DOI 10.4161/cc.2.2.335; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Chen RY, 2002, J HISTOCHEM CYTOCHEM, V50, P697, DOI 10.1177/002215540205000511; Clarke JH, 2001, BIOCHEM J, V357, P905, DOI 10.1042/0264-6021:3570905; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Degterev A, 2001, NAT CELL BIOL, V3, P173, DOI 10.1038/35055085; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; DOWLER S, 2002, PROTEIN LIPID OVERLA; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Feng XL, 2002, TRENDS CELL BIOL, V12, P532, DOI 10.1016/S0962-8924(02)02391-7; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fyodorov DV, 2002, MOL CELL BIOL, V22, P6344, DOI 10.1128/MCB.22.18.6344-6353.2002; Garkavtsev I, 1998, NATURE, V391, P295, DOI 10.1038/34675; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hanakahi LA, 2002, EMBO J, V21, P2038, DOI 10.1093/emboj/21.8.2038; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; IRVINE R, 2000, NUCL LIPID SIGNALING; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; Kalkhoven E, 2002, MOL CELL BIOL, V22, P1961, DOI 10.1128/MCB.22.7.1961-1970.2002; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kutateladze T, 2001, SCIENCE, V291, P1793, DOI 10.1126/science.291.5509.1793; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Lau WTW, 1998, GENETICS, V150, P1349; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Ma YM, 2002, J BIOL CHEM, V277, P10756, DOI 10.1074/jbc.C200030200; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Misra S, 2001, CELL, V107, P559, DOI 10.1016/S0092-8674(01)00594-3; Morris JB, 2000, FEBS LETT, V475, P57, DOI 10.1016/S0014-5793(00)01625-2; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522; Osborne SL, 2001, J CELL SCI, V114, P2501; Pascual J, 2000, J MOL BIOL, V304, P723, DOI 10.1006/jmbi.2000.4308; Payrastre B, 2001, CELL SIGNAL, V13, P377, DOI 10.1016/S0898-6568(01)00158-9; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rao VR, 1999, J BIOL CHEM, V274, P37893, DOI 10.1074/jbc.274.53.37893; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Shimada Y, 1998, CYTOGENET CELL GENET, V83, P232, DOI 10.1159/000015188; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Stenmark H, 2002, FEBS LETT, V513, P77, DOI 10.1016/S0014-5793(01)03308-7; Tanaka K, 1999, J BIOL CHEM, V274, P3919, DOI 10.1074/jbc.274.7.3919; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Yokogawa T, 2000, FEBS LETT, V473, P222, DOI 10.1016/S0014-5793(00)01535-0; York JD, 2001, ADV ENZYME REGUL, V41, P57, DOI 10.1016/S0065-2571(00)00025-X; Zhang XL, 1997, J BIOL CHEM, V272, P17756, DOI 10.1074/jbc.272.28.17756; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	56	399	414	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2003	114	1					99	111		10.1016/S0092-8674(03)00480-X	http://dx.doi.org/10.1016/S0092-8674(03)00480-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859901	Bronze			2022-12-24	WOS:000184219900009
J	Manzke, T; Guenther, U; Ponimaskin, EG; Haller, M; Dutschmann, M; Schwarzacher, S; Richter, DW				Manzke, T; Guenther, U; Ponimaskin, EG; Haller, M; Dutschmann, M; Schwarzacher, S; Richter, DW			5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia	SCIENCE			English	Article							5-HYDROXYTRYPTAMINE 4(A) RECEPTOR; ISOLATED RESPIRATORY NETWORK; PREBOTZINGER COMPLEX; RAT-BRAIN; NEURONS; PHARMACOLOGY; SEROTONIN; CLONING; RHYTHM	Opiates are widely used analgesics in anesthesiology, but they have serious adverse effects such as depression of breathing. This is caused by direct inhibition of rhythm-generating respiratory neurons in the Pre-Boetzinger complex (PBC) of the brainstem. We report that serotonin 4(a) [5-HT4(a)] receptors are strongly expressed in respiratory PBC neurons and that their selective activation protects spontaneous respiratory activity. Treatment of rats with a 5-HT4 receptor specific agonist overcame fentanyl-induced respiratory depression and reestablished stable respiratory rhythm without loss of fentanyl's analgesic effect. These findings imply the prospect of a fine-tuned recovery from opioid-induced respiratory depression, through adjustment of intracellular adenosine 3', 5'-monophosphate levels through the convergent signaling pathways in neurons.	Univ Gottingen, Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany; Univ Gottingen, Ctr Anesthesiol, D-37075 Gottingen, Germany; Dept Anat, D-37075 Gottingen, Germany	University of Gottingen; University of Gottingen	Richter, DW (corresponding author), Univ Gottingen, Dept Neuro & Sensory Physiol, Humboldtallee 23, D-37073 Gottingen, Germany.			Ponimaskin, evgeni/0000-0002-4570-5130; Dutschmann, Mathias/0000-0002-0692-746X				Ballanyi K, 1997, J PHYSIOL-LONDON, V504, P127, DOI 10.1111/j.1469-7793.1997.127bf.x; BOCKAERT J, 1990, MOL PHARMACOL, V37, P408; Claeysen S, 1996, FEBS LETT, V398, P19, DOI 10.1016/S0014-5793(96)01132-5; Compan V, 1996, EUR J NEUROSCI, V8, P2591, DOI 10.1111/j.1460-9568.1996.tb01553.x; DENAVITSAUBIE M, 1978, BRAIN RES, V155, P55, DOI 10.1016/0006-8993(78)90305-0; Dunn EB, 2000, VET HUM TOXICOL, V42, P36; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Guyenet PG, 2001, J NEUROPHYSIOL, V86, P438, DOI 10.1152/jn.2001.86.1.438; Heine M, 2002, PFLUG ARCH EUR J PHY, V443, P418, DOI 10.1007/s004240100690; HOYER D, 1994, PHARMACOL REV, V46, P157; Hynie S, 1995, Cesk Fysiol, V44, P135; LI YW, 1997, AM J PHYSIOL, V273, P805; MANZKE T, 2002, FENS FOR ABSTR, V1, P77; MORIN D, 1990, BRAIN RES, V535, P281, DOI 10.1016/0006-8993(90)91611-J; PATON JF, 1996, J NEUROSCI METH, V65, P6; Ponimaskin EG, 2002, J BIOL CHEM, V277, P20812, DOI 10.1074/jbc.M112216200; Ponimaskin EG, 2001, BIOCHEM J, V353, P627, DOI 10.1042/0264-6021:3530627; Richter DW, 1997, RESP PHYSIOL, V110, P113, DOI 10.1016/S0034-5687(97)00077-7; Richter DW, 2000, NEUROSCIENTIST, V6, P181, DOI 10.1177/107385840000600309; SMITH JC, 1992, NEUROSCI LETT, V134, P153, DOI 10.1016/0304-3940(92)90504-Z; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Takeda S, 2001, ANESTHESIOLOGY, V95, P740, DOI 10.1097/00000542-200109000-00029; Vilaro MT, 2002, NEUROPHARMACOLOGY, V42, P60, DOI 10.1016/S0028-3908(01)00154-X; Vilaro MT, 1996, MOL BRAIN RES, V43, P356, DOI 10.1016/S0169-328X(96)00248-3	25	204	230	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2003	301	5630					226	229		10.1126/science.1084674	http://dx.doi.org/10.1126/science.1084674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855812				2022-12-24	WOS:000184056200047
J	Zavialov, AV; Ehrenberg, M				Zavialov, AV; Ehrenberg, M			Peptidyl-tRNA regulates the GTPase activity of translation factors	CELL			English	Article							ELONGATION-FACTOR-G; RIBOSOME RECYCLING FACTOR; ESCHERICHIA-COLI RIBOSOME; INITIATION-FACTOR IF2; RELEASE FACTORS; 70S RIBOSOME; TERMINATION COMPLEX; PROTEIN-SYNTHESIS; BINDING-SITES; GGQ MOTIF	Rapid protein synthesis in bacteria requires the G proteins IF2, EF-Tu, EF-G, and RF3. These factors catalyze all major steps of mRNA translation in a GTP-dependent manner. Here, it is shown how the position of peptidyl-tRNA in the ribosome and presence of its peptide control the binding and GTPase activity of these translation factors. The results explain how idling GTPase activity and negative interference between different translation factors are avoided and suggest that hybrid sites for tRNA on the ribosome play essential roles in translocation of tRNAs, recycling of class 1 release factors by RF3, and recycling of ribosomes back to a new round of initiation. We also propose a model for translocation of tRNAs in two separate steps, which clarifies the roles of EF-G(.)GTP and GTP hydrolysis in this process.	Uppsala Univ, BMC, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden	Uppsala University	Zavialov, AV (corresponding author), Uppsala Univ, BMC, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden.			Zavialov, Andrey/0000-0001-6420-0368				Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Borowski C, 1996, P NATL ACAD SCI USA, V93, P4202, DOI 10.1073/pnas.93.9.4202; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRETSCHER MS, 1968, NATURE, V218, P675, DOI 10.1038/218675a0; BURNS K, 1974, FEBS LETT, V40, P219, DOI 10.1016/0014-5793(74)80932-4; Cameron DM, 2002, J MOL BIOL, V319, P27, DOI 10.1016/S0022-2836(02)00235-8; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Hirokawa G, 2002, EMBO J, V21, P2272, DOI 10.1093/emboj/21.9.2272; INOUEYOKOSAWA N, 1974, J BIOL CHEM, V249, P4321; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Katunin VI, 2002, BIOCHEMISTRY-US, V41, P12806, DOI 10.1021/bi0264871; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; LAALAMI S, 1991, BIOCHIMIE, V73, P1557, DOI 10.1016/0300-9084(91)90191-3; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; LILL R, 1986, BIOCHEMISTRY-US, V25, P3245, DOI 10.1021/bi00359a025; Marquez V, 2002, BIOCHEM SOC T, V30, P133, DOI 10.1042/BST0300133; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Mora L, 2003, MOL MICROBIOL, V47, P267, DOI 10.1046/j.1365-2958.2003.03301.x; Noller HF, 2002, FEBS LETT, V514, P11, DOI 10.1016/S0014-5793(02)02327-X; Pavlov MY, 1997, EMBO J, V16, P4134, DOI 10.1093/emboj/16.13.4134; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; RUUSALA T, 1982, EMBO J, V1, P741, DOI 10.1002/j.1460-2075.1982.tb01240.x; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; THOMPSON RC, 1977, P NATL ACAD SCI USA, V74, P198, DOI 10.1073/pnas.74.1.198; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Wower J, 2000, J BIOL CHEM, V275, P37887, DOI 10.1074/jbc.M005031200; Wu XQ, 1997, J BIOL CHEM, V272, P1891, DOI 10.1074/jbc.272.3.1891; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6	34	112	117	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 11	2003	114	1					113	122		10.1016/S0092-8674(03)00478-1	http://dx.doi.org/10.1016/S0092-8674(03)00478-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859902	Bronze			2022-12-24	WOS:000184219900010
J	Wehrens, XHT; Lehnart, SE; Huang, F; Vest, JA; Reiken, SR; Mohler, PJ; Sun, J; Guatimosim, S; Song, LS; Rosemblit, N; D'Armiento, JM; Napolitano, C; Memmi, M; Priori, SG; Lederer, WJ; Marks, AR				Wehrens, XHT; Lehnart, SE; Huang, F; Vest, JA; Reiken, SR; Mohler, PJ; Sun, J; Guatimosim, S; Song, LS; Rosemblit, N; D'Armiento, JM; Napolitano, C; Memmi, M; Priori, SG; Lederer, WJ; Marks, AR			FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death	CELL			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; FAILING HEARTS; PHOSPHORYLATION; PROTEIN; ARRHYTHMIAS; MECHANISMS; GENE; AFTERDEPOLARIZATIONS; MUTATIONS; FAILURE	Arrhythmias, a common cause of sudden cardiac death, can occur in structurally normal hearts, although the mechanism is not known. In cardiac muscle, the ryanodine receptor (RyR2) on the sarcoplasmic reticulum releases the calcium required for muscle contraction. The FK506 binding protein (FKBP12.6) stabilizes RyR2, preventing aberrant activation of the channel during the resting phase of the cardiac cycle. We show that during exercise, RyR2 phosphorylation by cAMP-dependent protein kinase A (PKA) partially dissociates FKBP12.6 from the channel, increasing intracellular Ca2+ release and cardiac contractility. FKBP12.6(-/-) mice consistently exhibited exercise-induced cardiac ventricular arrhythmias that cause sudden cardiac death. Mutations in RyR2 linked to exercise-induced arrhythmias (in patients with catecholaminergic polymorphic ventricular tachycardia [CPVT]) reduced the affinity of FKBP12.6 for RyR2 and increased single-channel activity under conditions that simulate exercise. These data suggest that "leaky" RyR2 channels can trigger fatal cardiac arrhythmias, providing a possible explanation for CPVT.	Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Dept Med, Ctr Mol Cardiol, New York, NY 10032 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Cell Biol, Durham, NC 27710 USA; Univ Maryland, Sch Med, Dept Physiol, Biotechnol Inst,Med Biotechnol Ctr, Baltimore, MD 21201 USA; Univ Pavia, IRCCS, I-27100 Pavia, Italy	Columbia University; Duke University; Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore; University of Pavia	Marks, AR (corresponding author), Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Dept Med, Ctr Mol Cardiol, 630 W 168th St, New York, NY 10032 USA.		napolitano, carlo/ABI-4608-2020; Priori, Silvia G/ABH-6894-2020; Priori, Silvia G G/A-6116-2014; Song, Long-Sheng/D-5899-2012; memmi, mirella/AAB-9428-2020; Guatimosim, Silvia/AAN-7441-2021; Napolitano, Carlo/K-4760-2016; Lederer, William/B-1285-2010; Wehrens, Xander/AAQ-9574-2020	napolitano, carlo/0000-0002-7643-4628; Priori, Silvia G/0000-0001-6877-0288; Priori, Silvia G G/0000-0001-6877-0288; memmi, mirella/0000-0003-4006-5661; Guatimosim, Silvia/0000-0001-8386-3722; Napolitano, Carlo/0000-0002-7643-4628; Wehrens, Xander/0000-0001-5044-672X; Song, Long-Sheng/0000-0002-6035-8106	Telethon [GP0227Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Bennett JA, 1998, MAMM GENOME, V9, P1069, DOI 10.1007/s003359900928; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; Fisher JD, 1999, J AM COLL CARDIOL, V34, P2015, DOI 10.1016/S0735-1097(99)00438-6; FOZZARD HA, 1992, BASIC RES CARDIOL, V87, P105; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; Jiang DW, 2002, CIRC RES, V91, P218, DOI 10.1161/01.RES.0000028455.36940.5E; Kaftan E, 1996, CIRC RES, V78, P990, DOI 10.1161/01.RES.78.6.990; Laitinen PJ, 2001, CIRCULATION, V103, P485, DOI 10.1161/01.CIR.103.4.485; LEENHARDT A, 1995, CIRCULATION, V91, P1512, DOI 10.1161/01.CIR.91.5.1512; MARBAN E, 1986, J CLIN INVEST, V78, P1185, DOI 10.1172/JCI112701; Marks AR, 2000, CIRC RES, V87, P8, DOI 10.1161/01.RES.87.1.8; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; NABAUER M, 1989, SCIENCE, V244, P800, DOI 10.1126/science.2543067; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Pogwizd SM, 1998, CIRCULATION, V98, P2404, DOI 10.1161/01.CIR.98.22.2404; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Priori SG, 2001, CIRCULATION, V103, P196; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; SONG YJ, 1994, AM J PHYSIOL-HEART C, V267, pH2005, DOI 10.1152/ajpheart.1994.267.5.H2005; Swan H, 1999, J AM COLL CARDIOL, V34, P2035, DOI 10.1016/S0735-1097(99)00461-1; VALDIVIA HH, 1995, SCIENCE, V267, P1997, DOI 10.1126/science.7701323; WIT AL, 1983, AM HEART J, V106, P798, DOI 10.1016/0002-8703(83)90003-0; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a	29	552	587	1	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 27	2003	113	7					829	840		10.1016/S0092-8674(03)00434-3	http://dx.doi.org/10.1016/S0092-8674(03)00434-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	695EJ	12837242	Bronze			2022-12-24	WOS:000183817900008
J	Basole, A; White, LE; Fitzpatrick, D				Basole, A; White, LE; Fitzpatrick, D			Mapping multiple features in the population response of visual cortex	NATURE			English	Article							CATS STRIATE CORTEX; COMPLEX CELLS; SPATIAL-FREQUENCY; DOT PATTERNS; DIRECTION; MOTION; MAPS; ORIENTATION; ORGANIZATION; SELECTIVITY	Stimulus features such as edge orientation, motion direction and spatial frequency are thought to be encoded in the primary visual cortex by overlapping feature maps arranged so that the location of neurons activated by a particular combination of stimulus features can be predicted from the intersections of these maps(1-8). This view is based on the use of grating stimuli, which limit the range of stimulus combinations that can be examined. We used optical imaging of intrinsic signals(9) in ferrets to assess patterns of population activity evoked by the motion of a texture ( a field of iso-oriented bars). Here we show that the same neural population can be activated by multiple combinations of orientation, length, motion axis and speed. Rather than reflecting the intersection of multiple maps, our results indicate that population activity in primary visual cortex is better described as a single map of spatiotemporal energy.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA	Duke University; Duke University	Fitzpatrick, D (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.							ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Bonhoeffer Tobias, 1996, P55; Carandini M., 1999, CEREB CORTEX, V13, P401, DOI DOI 10.1007/978-1-4615-4903-1_7; DEVALOIS KK, 1979, J PHYSIOL-LONDON, V291, P483, DOI 10.1113/jphysiol.1979.sp012827; DeValois RL, 1988, SPATIAL VISION; Everson RM, 1998, P NATL ACAD SCI USA, V95, P8334, DOI 10.1073/pnas.95.14.8334; GALUSKE RAW, 2001, SOC NEUR ABSTR, V27; Geisler WS, 2001, VISUAL NEUROSCI, V18, P501, DOI 10.1017/S0952523801184014; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GIZZI MS, 1990, J NEUROPHYSIOL, V63, P1529, DOI 10.1152/jn.1990.63.6.1529; HAMMOND P, 1983, J PHYSIOL-LONDON, V342, P35, DOI 10.1113/jphysiol.1983.sp014838; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Hubener M, 1997, J NEUROSCI, V17, P9270; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; LORENCEAU J, 1993, VISION RES, V33, P1207, DOI 10.1016/0042-6989(93)90209-F; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Shmuel A, 1996, J NEUROSCI, V16, P6945; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; SKOTTUN BC, 1988, J NEUROPHYSIOL, V59, P1719, DOI 10.1152/jn.1988.59.6.1719; SKOTTUN BC, 1994, VISUAL NEUROSCI, V11, P885, DOI 10.1017/S0952523800003849; Swindale NV, 2000, CEREB CORTEX, V10, P633, DOI 10.1093/cercor/10.7.633; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; White LE, 1999, J NEUROSCI, V19, P7089, DOI 10.1523/JNEUROSCI.19-16-07089.1999; Wuerger S, 1996, PERCEPTION, V25, P1317, DOI 10.1068/p251317	29	128	131	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					986	990		10.1038/nature01721	http://dx.doi.org/10.1038/nature01721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827202				2022-12-24	WOS:000183753900050
J	Kramer, HJ; Nguyen, QD; Curhan, G; Hsu, CY				Kramer, HJ; Nguyen, QD; Curhan, G; Hsu, CY			Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ARTERIAL-HYPERTENSION; NEPHROPATHY; PREVALENCE; MICROALBUMINURIA; DISEASE; CREATININE; PREDICTION; HEALTH; STAGE	Context Kidney disease in type 2 diabetes mellitus (DM) is more heterogeneous than in type 1 DM. Reduced glomerular-filtration rate (GFR) among individuals with type 2 DM may not always be due to classic diabetic glomerulosclerosis, which is associated with albuminuria and retinopathy. Objective To determine the prevalence of chronic renal insufficiency (CRI), defined as a GFR less than 60 mL/min per 1.73 m(2) body surface area (BSA) in the absence of microalbuminuria or macroalbuminuria and diabetic retinopathy among adults with type 2 DM. Design, Setting, and Participants Cross-sectional analysis of adults aged 40 years or older with type 2 DM in the Third National Health and Nutrition Examination Survey, a probability sample of the total civilian US non institutionalized population conducted from 1988-1994. Main Outcome Measures The GFR per 1.73 m(2) BSA, calculated with serum creatinine, urea nitrogen, and serum albumin levels using the Modification of Diet in Renal Disease Study prediction equation; albuminuria, assessed using spot urine albumin/ creatinine ratio; and presence of retinopathy, determined with fundus photography. Results Overall, 13% (sampled n=171) of adults with type 2 DM (n=1197) had CRI with a population estimate of 1.1 million. Among these adults with CRI, diabetic retinopathy was noted in 28% (n=58), while the frequencies of microalbuminuria and macroalbuminuria were 45% (n=64) and 19% (n=47), respectively. Retinopathy and albuminuria (microalbuminuria or macroalbuminuria) were both absent in 30% (n=51) of adults with type 2 DM and CRI. The population estimate of adults with type 2 DM and CRI in the absence of diabetic retinopathy or albuminuria was approximately 0.3 million. Conclusions A substantial burden of CRI among persons with type 2 DM in the United States is likely due to renal parenchymal disease other than classic diabetic glomerulosclerosis. Approaches to screening renal disease in the type 2 DM population should incorporate assessment of GFR in addition to monitoring urine albumin excretion and funduscopic changes to ensure that individuals with type 2 DM and CRI not due to diabetic glomerulosclerosis will receive appropriate intervention.	Loyola Univ, Med Ctr, Dept Epidemiol & Prevent Med, Div Nephrol, Maywood, IL 60153 USA; Loyola Univ, Med Ctr, Dept Med, Div Nephrol, Maywood, IL 60153 USA; Johns Hopkins Med Inst, Wilmer Ophthalmol Inst, Baltimore, MD 21205 USA; Massachusetts Gen Hosp, Gen Med Unit, Boston, MA 02114 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Univ Calif San Francisco, Div Nephrol, San Francisco, CA 94143 USA	Loyola University Chicago; Loyola University Chicago; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco	Kramer, HJ (corresponding author), Loyola Univ, Med Ctr, Dept Epidemiol & Prevent Med, Div Nephrol, 2160 S 1st Ave, Maywood, IL 60153 USA.	hkramer@lumc.edu		Hsu, Chi-yuan/0000-0001-8182-1238; Kramer, Holly/0000-0002-6374-837X	NATIONAL EYE INSTITUTE [K23EY013552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052866, K23DK061520] Funding Source: NIH RePORTER; NEI NIH HHS [EY13552] Funding Source: Medline; NIDDK NIH HHS [DK61520, DK52866] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 1981, INVEST OPHTH VIS SCI, V21, P210; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; GALL MA, 1991, DIABETOLOGIA, V34, P655, DOI 10.1007/BF00400995; Gavin JR, 1997, DIABETES CARE, V20, P1183; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; MATHIESEN ER, 1984, DIABETOLOGIA, V26, P406; Mattix HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341034; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; MOGENSEN CE, 1983, DIABETES, V32, P64, DOI 10.2337/diab.32.2.S64; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; National Center for Health Statistics, 1996, 3 NAT HLTH NUTR EX S; *NIH NAT I DIAB DI, 2002, USRDS 2002 ANN DAT R; OLSON JL, 1998, HEPTINSTALLS PATHOLO, P1247; PARVING HH, 1988, BMJ-BRIT MED J, V296, P156, DOI 10.1136/bmj.296.6616.156; RAVID M, 1993, ANN INTERN MED, V118, P577, DOI 10.7326/0003-4819-118-8-199304150-00001; Remuzzi G, 2002, NEW ENGL J MED, V346, P1145, DOI 10.1056/NEJMcp011773; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; Ritz E, 1996, AM J KIDNEY DIS, V27, P167, DOI 10.1016/S0272-6386(96)90538-7; Rychlik I., 1999, NEPHROPATHY TYPE 2 D, P7; VIBERTI GC, 1982, LANCET, V1, P1430; Warram JH, 1996, J AM SOC NEPHROL, V7, P930; Wilmer WA, 1999, AM J KIDNEY DIS, V34, P308, DOI 10.1016/S0272-6386(99)70360-4; Xue JL, 2001, J AM SOC NEPHROL, V12, P2753, DOI 10.1681/ASN.V12122753	26	433	470	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2003	289	24					3273	3277		10.1001/jama.289.24.3273	http://dx.doi.org/10.1001/jama.289.24.3273			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	693EX	12824208	Bronze			2022-12-24	WOS:000183704600020
J	Zhou, Q; Tao, HZW; Poo, MM				Zhou, Q; Tao, HZW; Poo, MM			Reversal and stabilization of synaptic modifications in a developing visual system	SCIENCE			English	Article							LONG-TERM POTENTIATION; DEVELOPING RETINOTECTAL SYNAPSES; LOW-FREQUENCY STIMULATION; NMDA RECEPTOR; IN-VIVO; PLASTICITY; MEMORY; INPUT; LTP; HIPPOCAMPUS	Persistent synaptic modi. cations are essential for experience-dependent refinement of developing circuits. However, in the developing Xenopus retinotectal system, activity-induced synaptic modi. cations were quickly reversed either by subsequent spontaneous activity in the tectum or by exposure to random visual inputs. This reversal depended on the burst spiking and activation of the N-methyl-D-aspartate subtype of glutamate receptors. Stabilization of synaptic modi. cations can be achieved by an appropriately spaced pattern of induction stimuli. These findings underscore the vulnerable nature of activity-induced synaptic modi. cations in vivo and suggest a temporal constraint on the pattern of visual inputs for effective induction of stable synaptic modifications.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.		Tao, Huizhong W/HDM-9767-2022		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 36999] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Huang CC, 1999, J NEUROSCI, V19, P9728; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LARSON J, 1993, BRAIN RES, V600, P97, DOI 10.1016/0006-8993(93)90406-D; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; O'Dell T J, 1994, Learn Mem, V1, P129; Penn AA, 1999, PEDIATR RES, V45, P447, DOI 10.1203/00006450-199904010-00001; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Staubli U, 1996, J NEUROSCI, V16, P853; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2; Udin SB, 1999, PROG NEUROBIOL, V59, P81, DOI 10.1016/S0301-0082(98)00096-3; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	24	115	117	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2003	300	5627					1953	1957		10.1126/science.1082212	http://dx.doi.org/10.1126/science.1082212			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12817152				2022-12-24	WOS:000183619400050
J	Zhong, WW; Feng, H; Santiago, FE; Kipreos, ET				Zhong, WW; Feng, H; Santiago, FE; Kipreos, ET			CUL-4 ubiquitin ligase maintains genome stability by restraining DNA-replication licensing	NATURE			English	Article							MITOTIC CHROMOSOME CONDENSATION; CAENORHABDITIS-ELEGANS; C-ELEGANS; CELL-CYCLE; S-PHASE; PROTEIN; CDT1; PROLIFERATION; INTERFERENCE; EXPRESSION	To maintain genome stability, DNA replication is strictly regulated to occur only once per cell cycle. In eukaryotes, the presence of 'licensing proteins' at replication origins during the G1 cell-cycle phase allows the formation of the pre-replicative complex(1). The removal of licensing proteins from chromatin during the S phase ensures that origins fire only once per cell cycle(1). Here we show that the CUL-4 ubiquitin ligase temporally restricts DNA-replication licensing in Caenorhabditis elegans. Inactivation of CUL-4 causes massive DNA re-replication, producing cells with up to 100C DNA content. The C. elegans orthologue of the replication-licensing factor Cdt1 (refs 2, 3) is required for DNA replication. C. elegans CDT-1 is present in G1-phase nuclei but disappears as cells enter S phase. In cells lacking CUL-4, CDT-1 levels fail to decrease during S phase and instead remain constant in the re-replicating cells. Removal of one genomic copy of cdt-1 suppresses the cul-4 re-replication phenotype. We propose that CUL-4 prevents aberrant re-initiation of DNA replication, at least in part, by facilitating the degradation of CDT-1.	Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Kipreos, ET (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.		Feng, Hui/D-4423-2019; Santiago, Fernando Enrique/GLS-9127-2022; Feng, Hui/L-4343-2019	Feng, Hui/0000-0003-1318-821X; Santiago, Fernando/0000-0001-9514-3722				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Cimbora DM, 2001, CELL, V104, P643, DOI 10.1016/S0092-8674(01)00260-4; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; EDGAR LG, 1988, CELL, V53, P589, DOI 10.1016/0092-8674(88)90575-2; Feng H, 1999, NAT CELL BIOL, V1, P486, DOI 10.1038/70272; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hong Y, 1998, DEVELOPMENT, V125, P3585; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Lorson MA, 2000, J CELL BIOL, V148, P73, DOI 10.1083/jcb.148.1.73; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; MILLER DM, 1995, CAENORHABDITIS ELEGA, P365; Nayak S, 2002, CURR BIOL, V12, P277, DOI 10.1016/S0960-9822(02)00682-6; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Praitis V, 2001, GENETICS, V157, P1217; Seydoux G, 2001, INT REV CYTOL, V203, P139; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; Whittaker AJ, 2000, GENE DEV, V14, P1765; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yanow SK, 2001, EMBO J, V20, P4648, DOI 10.1093/emboj/20.17.4648	30	251	260	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					885	889		10.1038/nature01747	http://dx.doi.org/10.1038/nature01747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815436				2022-12-24	WOS:000183585300050
J	Burgess, I				Burgess, I			Commentary: How to advise a patient when over the counter products have failed	BRITISH MEDICAL JOURNAL			English	Editorial Material									Insect Res & Dev Ltd, Cambridge CB1 5EL, England		Burgess, I (corresponding author), Insect Res & Dev Ltd, Cambridge CB1 5EL, England.		Burgess, Ian/E-4049-2016; Burgess, Ian/N-2977-2013	Burgess, Ian/0000-0001-9348-2915; Burgess, Ian/0000-0003-0747-3938					0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 7	2003	326	7401					1257	1257		10.1136/bmj.326.7401.1257	http://dx.doi.org/10.1136/bmj.326.7401.1257			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689FJ	12791745	Green Published			2022-12-24	WOS:000183480700022
J	Spiro, D				Spiro, D			A little bit longer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2003	290	6					716	716		10.1001/jama.290.6.716	http://dx.doi.org/10.1001/jama.290.6.716			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709VU	12915408				2022-12-24	WOS:000184647700001
J	MacQueen, KM; Karim, QA; Sugarman, J				MacQueen, KM; Karim, QA; Sugarman, J		Ethics Working Grp HIV Prevention	Ethics guidance for HIV prevention trials	BRITISH MEDICAL JOURNAL			English	Article									Family Hlth Int, Res Triangle Pk, NC 27709 USA; Univ Natal, Ctr AIDS Program Res S Africa, ZA-4001 Durban, South Africa; Duke Univ, Ctr Study Med Eth & Humanities, Durham, NC USA	University of Kwazulu Natal; Duke University	MacQueen, KM (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.		Abdool Karim, Quarraisha/GVS-1160-2022	Abdool Karim, Quarraisha/0000-0002-0985-477X; Sugarman, Jeremy/0000-0001-7022-8332	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068619] Funding Source: NIH RePORTER; NIAID NIH HHS [UM1 AI068619] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*HIV PREV TRIALS N, ETH GUID RES; MacQueen Kathleen M, 2003, IRB, V25, P11, DOI 10.2307/3563635	2	6	6	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2003	327	7410					340	340		10.1136/bmj.327.7410.340	http://dx.doi.org/10.1136/bmj.327.7410.340			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	710JE	12907494	Green Published			2022-12-24	WOS:000184676400030
J	Hu, DL; Chan, B; Bush, JWM				Hu, DL; Chan, B; Bush, JWM			The hydrodynamics of water strider locomotion	NATURE			English	Article							GERRIS-REMIGIS; SURFACE; FLIGHT	Water striders Gerridae are insects of characteristic length 1 cm and weight 10 dynes that reside on the surface of ponds, rivers, and the open ocean(1-4). Their weight is supported by the surface tension force generated by curvature of the free surface(5,6), and they propel themselves by driving their central pair of hydrophobic legs in a sculling motion(7,8). Previous investigators have assumed that the hydrodynamic propulsion of the water strider relies on momentum transfer by surface waves(1,9,10). This assumption leads to Denny's paradox(11): infant water striders, whose legs are too slow to generate waves, should be incapable of propelling themselves along the surface. We here resolve this paradox through reporting the results of high-speed video and particle-tracking studies. Experiments reveal that the strider transfers momentum to the underlying fluid not primarily through capillary waves, but rather through hemispherical vortices shed by its driving legs. This insight guided us in constructing a self-contained mechanical water strider whose means of propulsion is analogous to that of its natural counterpart.	MIT, Dept Math, Cambridge, MA 02139 USA; MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bush, JWM (corresponding author), MIT, Dept Math, Cambridge, MA 02139 USA.							Andersen N.M., 1976, Videnskabelige Meddr dansk naturh Foren, V139, P337; Andersen NM, 1982, SEMIAQUATIC BUGS HEM; Baudoin R, 1955, B BIOL FR BELG, V89, P16; BOWDAN E, 1978, J COMP PHYSIOL, V123, P43, DOI 10.1007/BF00657342; Brinkhurst R. O., 1960, Proceedings of the Zoological Society of London, V133, P531; Chen Y Y, 2010, HYDRODYNAMICS, V42, P1; Childress S., 1981, MECH SWIMMING FLYING; COBBEN RH, 1960, STUD FAUNA CURACAO, V11, P1; Darnhofer-Demar, 1969, ZOOL ANZ S, V32, P430; DEGENNES PG, 2002, GOUTTES BOULES PERLE; DENNY MW, 1993, AIR WATER BIOL PHYSI; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; ELLINGTON CP, 1990, NATURE, V347, P472, DOI 10.1038/347472a0; Glasheen JW, 1996, NATURE, V380, P340, DOI 10.1038/380340a0; Henry T. J., 1998, CATALOG HETEROPTERA; HUNGERFORD HB, 1960, KANS U SCI B, V41; Keller JB, 1998, PHYS FLUIDS, V10, P3009, DOI 10.1063/1.869820; MATSUDA K, 1985, APPL OPTICS, V24, P4443, DOI 10.1364/AO.24.004443; MURPHEY RK, 1971, Z VERGL PHYSIOL, V72, P150, DOI 10.1007/BF00297819; RAYNER JMV, 1986, NATURE, V321, P162, DOI 10.1038/321162a0; SCHOOLEY AH, 1958, J MAR RES, V16, P100; SCRIVEN LE, 1960, NATURE, V187, P186, DOI 10.1038/187186a0; STARR VP, 1947, J MAR RES, V6, P175; Sun SM, 2001, PHYS FLUIDS, V13, P2146, DOI 10.1063/1.1384889; Suter RB, 1997, J EXP BIOL, V200, P2523; Suter RB, 1999, J EXP BIOL, V202, P2771; Tseng M, 1999, CAN J ZOOL, V77, P923, DOI 10.1139/cjz-77-6-923; Vogel S, 1994, LIFE MOVING FLUIDS; VOGEL S, 1988, LIFES DEVICES; WILCOX RS, 1979, SCIENCE, V206, P1325, DOI 10.1126/science.206.4424.1325	30	510	536	17	346	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					663	666		10.1038/nature01793	http://dx.doi.org/10.1038/nature01793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904790				2022-12-24	WOS:000184578800042
J	Walther, TC; Askjaer, P; Gentzel, M; Habermann, A; Griffiths, G; Wilm, M; Mattaj, IW; Hetzer, M				Walther, TC; Askjaer, P; Gentzel, M; Habermann, A; Griffiths, G; Wilm, M; Mattaj, IW; Hetzer, M			RanGTP mediates nuclear pore complex assembly	NATURE			English	Article							IMPORTIN-BETA; GTPASE CYCLE; CHROMATIN; SUBCOMPLEX; PROTEINS; YEAST	In metazoa, the nuclear envelope breaks down and reforms during each cell cycle. Nuclear pore complexes (NPCs), which serve as channels for transport between the nucleus and cytoplasm(1), assemble into the reforming nuclear envelope in a sequential process involving association of a subset of NPC proteins, nucleoporins, with chromatin followed by the formation of a closed nuclear envelope fenestrated by NPCs2-7. How chromatin recruitment of nucleoporins and NPC assembly are regulated is unknown. Here we demonstrate that RanGTP production is required to dissociate nucleoporins Nup107, Nup153 and Nup358 from Importin beta, to target them to chromatin and to induce association between separate NPC subcomplexes. Additionally, either an excess of RanGTP or removal of Importin beta induces formation of NPC-containing membrane structures-annulate lamellae-both in vitro in the absence of chromatin and in vivo. Annulate lamellae formation is strongly and specifically inhibited by an excess of Importin beta. The data demonstrate that RanGTP triggers distinct steps of NPC assembly, and suggest a mechanism for the spatial restriction of NPC assembly to the surface of chromatin.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Mattaj, IW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Askjaer, Peter/I-3316-2012	Askjaer, Peter/0000-0003-3192-4428; Wilm, Matthias/0000-0002-5461-6834; Mattaj, Iain/0000-0002-5537-8284; Walther, Tobias/0000-0003-1442-1327; Habermann, Anja/0000-0003-3686-9050; Gentzel, Marc/0000-0002-4482-6010				Askjaer P, 2002, MOL BIOL CELL, V13, P4355, DOI 10.1091/mbc.E02-06-0346; Bamba C, 2002, CURR BIOL, V12, P503, DOI 10.1016/S0960-9822(02)00741-8; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Bodoor K, 1999, J CELL SCI, V112, P2253; DABAUVALLE MC, 1991, J CELL BIOL, V112, P1073, DOI 10.1083/jcb.112.6.1073; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; DEMETER J, 1995, P NATL ACAD SCI USA, V92, P1436, DOI 10.1073/pnas.92.5.1436; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN, P137; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hinkle B, 2002, J CELL SCI, V115, P4685, DOI 10.1242/jcs.00136; KESSEL RG, 1992, INT REV CYTOL, V133, P43, DOI 10.1016/S0074-7696(08)61858-6; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lusk CP, 2002, J CELL BIOL, V159, P267, DOI 10.1083/jcb.200203079; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; MURRAY AW, 1991, CELL CYCLE EXTRACTS, P581; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; Ryan KJ, 2003, J CELL BIOL, V160, P1041, DOI 10.1083/jcb.200209116; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Vasu SK, 2001, CURR OPIN CELL BIOL, V13, P363, DOI 10.1016/S0955-0674(00)00221-0; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zhang CM, 2002, EUR J CELL BIOL, V81, P623, DOI 10.1078/0171-9335-00288; Zhang CM, 2002, CURR BIOL, V12, P498, DOI 10.1016/S0960-9822(02)00714-5	30	166	173	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					689	694		10.1038/nature01898	http://dx.doi.org/10.1038/nature01898			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12894213				2022-12-24	WOS:000184578800049
J	Dowsett, M; Ashworth, A				Dowsett, M; Ashworth, A			New biology of the oestrogen receptor	LANCET			English	Editorial Material							BREAST-CANCER		Royal Marsden Hosp, Dept Biochem, London SW3 6JJ, England; Inst Canc Res, Breakthrough Breast Canc Ctr, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Dowsett, M (corresponding author), Royal Marsden Hosp, Dept Biochem, London SW3 6JJ, England.	mitch@icr.ac.uk						CLARK JH, 1979, FEMALE SEX STEROIDS, P70; Gruvberger S, 2001, CANCER RES, V61, P5979; McDonnell DP, 2002, RECENT PROG HORM RES, V57, P295, DOI 10.1210/rp.57.1.295; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Peto R, 2000, LANCET, V356, P593, DOI 10.1016/S0140-6736(05)73970-2; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998	10	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					260	262		10.1016/S0140-6736(03)14005-6	http://dx.doi.org/10.1016/S0140-6736(03)14005-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892953				2022-12-24	WOS:000184413400005
J	Crampton, JS; Beu, AG; Cooper, RA; Jones, CM; Marshall, B; Maxwell, PA				Crampton, JS; Beu, AG; Cooper, RA; Jones, CM; Marshall, B; Maxwell, PA			Estimating the rock volume bias in paleobiodiversity studies	SCIENCE			English	Article							FOSSIL RECORD; BIODIVERSITY; EXTINCTION; DIVERSITY	To interpret changes in biodiversity through geological time, it is necessary first to correct for biases in sampling effort related to variations in the exposure of rocks and recovery of fossils with age. Data from New Zealand indicate that outcrop area is likely to be a reliable proxy of rock volume in both stable cratonic regions, where the paleobiodiversity record is strongly correlated with relative sea level, and on tectonically active margins. In contrast, another potential proxy, the number of rock formations, is a poor predictor of outcrop area or sampling effort in the New Zealand case.	Inst Geol & Nucl Sci, Lower Hutt, New Zealand; Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand	GNS Science - New Zealand	Crampton, JS (corresponding author), Inst Geol & Nucl Sci, POB 30-368, Lower Hutt, New Zealand.	j.crampton@gns.cri.nz	Crampton, James/G-1381-2012; Jones, Craig/C-9693-2011	Crampton, James/0000-0003-3270-9981; Jones, Craig/0000-0002-1495-9293				Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; CARTER RM, 1991, SPEC PUBL INT ASS SE, V12, P41; COOPER RA, IN PRESS I GEOLOGICA; Edbrooke PR., 1999, I GEOLOGICAL NUCL SC, V1; Jackson JBC, 2001, SCIENCE, V293, P2401, DOI 10.1126/science.1063789; Miller AI, 2000, PALEOBIOLOGY, V26, P53, DOI 10.1666/0094-8373(2000)26[53:CAPGD]2.0.CO;2; Peters SE, 2002, NATURE, V416, P420, DOI 10.1038/416420a; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; RAUP D M, 1976, Paleobiology, V2, P289; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; Smith AB, 2001, PALEOBIOLOGY, V27, P241, DOI 10.1666/0094-8373(2001)027<0241:SLCARR>2.0.CO;2; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; Wignall PB, 1999, J GEOL SOC LONDON, V156, P453, DOI 10.1144/gsjgs.156.3.0453	13	132	134	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					358	360		10.1126/science.1085075	http://dx.doi.org/10.1126/science.1085075			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12805555				2022-12-24	WOS:000184207300041
J	Stephan, KE; Marshall, JC; Friston, KJ; Rowe, JB; Ritzl, A; Zilles, K; Fink, GR				Stephan, KE; Marshall, JC; Friston, KJ; Rowe, JB; Ritzl, A; Zilles, K; Fink, GR			Lateralized cognitive processes and lateralized task control in the human brain	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; HEMISPHERIC-SPECIALIZATION; VISUAL-ATTENTION; WORKING-MEMORY; RHESUS-MONKEY; DISSOCIATION; CONNECTIONS; ASYMMETRY; CONFLICT; PATHWAYS	The principles underlying human hemispheric specialization are poorly understood. We used functional magnetic resonance imaging of letter and visuospatial decision tasks with identical word stimuli to address two unresolved problems. First, hemispheric specialization depended on the nature of the task rather than on the nature of the stimulus. Second, analysis of frontal candidate regions for cognitive control showed increased coupling between left anterior cingulate cortex (ACC) and left inferior frontal gyrus during letter decisions, whereas right ACC showed enhanced coupling with right parietal areas during visuospatial decisions. Cognitive control is thus localized in the same hemisphere as task execution.	Res Ctr Julich, Inst Med, D-52425 Julich, Germany; Univ Aachen, Dept Neurol, D-52074 Aachen, Germany; UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCL, Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Neuropsychol Unit, Oxford OX2 6HE, England; Univ Dusseldorf, C&O Vogt Brain Res Inst, D-40225 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Radcliffe Infirmary; University of Oxford; Heinrich Heine University Dusseldorf	Fink, GR (corresponding author), Res Ctr Julich, Inst Med, D-52425 Julich, Germany.	g.fink@fz-juelich.de	Friston, Karl/D-9230-2011; rowe, james B/C-3661-2013; Zilles, Karl/Y-3784-2019; Fink, Gereon R./AFW-9377-2022; Zilles, Karl/J-9704-2013; Fink, Gereon R./E-1616-2012; Tick, Beata/ABA-1728-2020	Friston, Karl/0000-0001-7984-8909; rowe, james B/0000-0001-7216-8679; Zilles, Karl/0000-0002-4705-4175; Fink, Gereon R./0000-0002-8230-1856; Zilles, Karl/0000-0001-9296-9959; Fink, Gereon R./0000-0002-8230-1856; Stephan, Klaas Enno/0000-0002-8594-9092	Wellcome Trust [077029] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BRADSHAW JL, 1981, BEHAV BRAIN SCI, V4, P51, DOI 10.1017/S0140525X00007548; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; CHIARELLO C, 1986, NEUROPSYCHOLOGIA, V24, P521, DOI 10.1016/0028-3932(86)90096-5; Corballis PM, 1999, NEUROREPORT, V10, P2183, DOI 10.1097/00001756-199907130-00033; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; HELLIGE JB, 1990, ANNU REV PSYCHOL, V41, P55, DOI 10.1146/annurev.ps.41.020190.000415; HUGDAHL K, 2003, ASYMMETRICAL BRAIN; LEVY J, 1976, J EXP PSYCHOL HUMAN, V2, P299, DOI 10.1037/0096-1523.2.3.299; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MARSHALL JC, 1981, BEHAV BRAIN SCI, V4, P72, DOI 10.1017/S0140525X00007664; MCINTOSH AR, 1994, J NEUROSCI, V14, P655; Nystrom LE, 2000, NEUROIMAGE, V11, P424, DOI 10.1006/nimg.2000.0572; PANDYA DN, 1981, EXP BRAIN RES, V42, P319, DOI 10.1007/BF00237497; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.neuro.13.1.25; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; SERGENT J, 1983, PSYCHOL BULL, V93, P481, DOI 10.1037/0033-2909.93.3.481; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45	27	223	229	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					384	386		10.1126/science.1086025	http://dx.doi.org/10.1126/science.1086025			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869765				2022-12-24	WOS:000184207300049
J	Agrawal, A; Lingappa, J; Leppla, SH; Agrawal, S; Jabbar, A; Quinn, C; Pulendran, B				Agrawal, A; Lingappa, J; Leppla, SH; Agrawal, S; Jabbar, A; Quinn, C; Pulendran, B			Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin	NATURE			English	Article								Anthrax poses a clear and present danger as an agent of biological terrorism(1-3). Infection with Bacillus anthracis, the causative agent of anthrax, if untreated can result in rampant bacteraemia, multisystem dysfunction and death(4-8). Anthrax lethal toxin (LT) is a critical virulence factor of B. anthracis, which occurs as a complex of protective antigen and lethal factor. Here we demonstrate that LT severely impairs the function of dendritic cells-which are pivotal to the establishment of immunity against pathogens- and host immune responses by disrupting the mitogen-activated protein (MAP) kinase intracellular signalling network. Dendritic cells exposed to LT and then stimulated with lipopolysaccharide do not upregulate co-stimulatory molecules, secrete greatly diminished amounts of proinflammatory cytokines, and do not effectively stimulate antigen-specific T cells in vivo. Furthermore, injections of LT induce a profound impairment of antigen-specific T- and B-cell immunity. These data suggest a role for LT in suppressing host immunity during B. anthracis infections, and represent an immune evasion strategy, where a microbe targets MAP kinases in dendritic cells to disarm the immune response.	Emory Vaccine Res Ctr, Atlanta, GA 30329 USA; CDCP, Meningitis & Special Pathogens Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; NIAID, Microbial Pathogenesis Sect, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pulendran, B (corresponding author), Emory Vaccine Res Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.		Lingappa, Jairam/N-7760-2017; Pulendran, Bali/AAW-9550-2021	Pulendran, Bali/0000-0001-6517-4333	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000929, ZIAAI000929] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brossier F, 2001, TOXICON, V39, P1747, DOI 10.1016/S0041-0101(01)00161-1; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Hanna PC, 1999, TRENDS MICROBIOL, V7, P180, DOI 10.1016/S0966-842X(99)01507-3; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Lane HC, 2001, NAT MED, V7, P1271, DOI 10.1038/nm1201-1271; Little SF, 1999, MICROBES INFECT, V1, P131, DOI 10.1016/S1286-4579(99)80004-5; Liu LZ, 2002, NAT MED, V8, P185, DOI 10.1038/nm0202-185; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Mourez M, 2002, TRENDS MICROBIOL, V10, P287, DOI 10.1016/S0966-842X(02)02369-7; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Pulendran B, 1997, J IMMUNOL, V159, P2222; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Sailaja G, 2003, J IMMUNOL, V170, P2496, DOI 10.4049/jimmunol.170.5.2496; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Smith H, 2000, TRENDS MICROBIOL, V8, P199, DOI 10.1016/S0966-842X(00)01755-8; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Yi AK, 2001, INT IMMUNOL, V13, P1391, DOI 10.1093/intimm/13.11.1391; Yi AK, 2002, J IMMUNOL, V168, P4711, DOI 10.4049/jimmunol.168.9.4711	30	238	250	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					329	334		10.1038/nature01794	http://dx.doi.org/10.1038/nature01794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867985				2022-12-24	WOS:000184183900046
J	Chen, GN; Yanofsky, C				Chen, GN; Yanofsky, C			Tandem transcription and translation regulatory sensing of uncharged tryptophan tRNA	SCIENCE			English	Article							BINDING ATTENUATION PROTEIN; BACILLUS-SUBTILIS; LEADER RNA; TRAP; EXPRESSION; TRPG; REPEATS; GENES	The Bacillus subtilis AT (anti-TRAP) protein inhibits the regulatory protein TRAP (trp RNA-binding attenuation protein), thereby eliminating transcription termination in the leader region of the trp operon. Transcription of the AT operon is activated by uncharged tryptophan transfer RNA (tRNA(Trp)). Here we show that translation of AT also is regulated by uncharged tRNATrp. A 10-residue coding region containing three consecutive tryptophan codons is located immediately preceding the AT structural gene. Completion of translation of this coding region inhibits AT synthesis, whereas incomplete translation increases AT production. Tandem sensing of uncharged tRNATrp therefore regulates synthesis of AT, which in turn regulates TRAP's ability to inhibit trp operon expression.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Yanofsky, C (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	yanofsky@cmgm.stanford.edu						Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; ANTSON AA, 1995, NATURE, V374, P693, DOI 10.1038/374693a0; BABITZKE P, 1995, P NATL ACAD SCI USA, V92, P7916, DOI 10.1073/pnas.92.17.7916; BABITZKE P, 1993, P NATL ACAD SCI USA, V90, P133, DOI 10.1073/pnas.90.1.133; BABITZKE P, 1994, J BIOL CHEM, V269, P16597; Babitzke P, 2001, J BACTERIOL, V183, P5795, DOI 10.1128/JB.183.20.5795-5802.2001; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CREIGHTON TE, 1970, METHODS ENZYMOLOGY A, V17, P365, DOI DOI 10.1021/ACS.BIOCHEM.8B00167; Du HS, 1997, J BACTERIOL, V179, P2582, DOI 10.1128/jb.179.8.2582-2586.1997; Du HS, 1998, J BIOL CHEM, V273, P20494, DOI 10.1074/jbc.273.32.20494; GOLLNICK P, 2001, BACILLUS SUBTILIS IT, P233; Henkin TM, 2000, CURR OPIN MICROBIOL, V3, P149, DOI 10.1016/S1369-5274(00)00067-9; Henner Dennis, 1993, P269; Lee AI, 1996, J BACTERIOL, V178, P6518, DOI 10.1128/jb.178.22.6518-6524.1996; MERINO E, 1995, J BACTERIOL, V177, P6362, DOI 10.1128/jb.177.22.6362-6370.1995; OTRIDGE J, 1993, P NATL ACAD SCI USA, V90, P128, DOI 10.1073/pnas.90.1.128; Sarsero JP, 2000, P NATL ACAD SCI USA, V97, P2656, DOI 10.1073/pnas.050578997; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SEKIGUCHI J, 1975, J BACTERIOL, V121, P688, DOI 10.1128/JB.121.2.688-694.1975; SHIMOTSU H, 1986, J BACTERIOL, V166, P461, DOI 10.1128/jb.166.2.461-471.1986; STEINBERG W, 1974, J BACTERIOL, V117, P1023, DOI 10.1128/JB.117.3.1023-1034.1974; Sudershana S, 1999, J BACTERIOL, V181, P5742, DOI 10.1128/JB.181.18.5742-5749.1999; Valbuzzi A, 2001, SCIENCE, V293, P2057, DOI 10.1126/science.1062187; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; YANG M, 1995, J BACTERIOL, V177, P4272, DOI 10.1128/jb.177.15.4272-4278.1995	25	26	27	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2003	301	5630					211	213		10.1126/science.1084902	http://dx.doi.org/10.1126/science.1084902			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855807				2022-12-24	WOS:000184056200042
J	Orofino, MG; Argiolu, F; Sanna, MA; Rosatelli, MC; Tuveri, T; Scalas, MT; Badiali, M; Cossu, P; Puddu, R; Lai, ME; Cao, A				Orofino, MG; Argiolu, F; Sanna, MA; Rosatelli, MC; Tuveri, T; Scalas, MT; Badiali, M; Cossu, P; Puddu, R; Lai, ME; Cao, A			Fetal HLA typing in beta thalassaemia: implications for haemopoietic stem-cell transplantation	LANCET			English	Article								Stem-cell transplantation can cure beta thalassaemia. We aimed to assess whether fetal HLA typing done early in the-pregnancy of couples who were at risk of beta thalassaemia could provide an alternative to pregnancy termination if the prospect of a bone-marrow transplantation from a family member was available. In our clinic in Sardinia, we did fetal HLA typing for 49 couples at risk of having a baby with beta thalassaemia. Two affected children were born and successfully received a transplantation from a family donor. Five non-affected fetuses were HLA compatible with an affected sibling and their cord blood was harvested for a future transplantation.	Univ Cagliari, Dept Biomed Sci & Biotechnol, Paediat Clin Bone Marrow Transplant Ctr, Cagliari, Italy	University of Cagliari	Argiolu, F (corresponding author), Univ Cagliari, Dept Biomed Sci & Biotechnol, Paediat Clin Bone Marrow Transplant Ctr, Cagliari, Italy.			ROSATELLI, MARIA CRISTINA/0000-0001-6821-3190				ARGIOLU F, 2000, HAEMATOLOGICA, V85, P37; Bugert P, 2001, TISSUE ANTIGENS, V58, P103, DOI 10.1034/j.1399-0039.2001.580208.x; DYER C, 2002, BRIT MED J, V321, P503; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; van den Berg H, 2000, BONE MARROW TRANSPL, V25, P579, DOI 10.1038/sj.bmt.1702219	5	16	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 5	2003	362	9377					41	42		10.1016/S0140-6736(03)13806-8	http://dx.doi.org/10.1016/S0140-6736(03)13806-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699KW	12853199				2022-12-24	WOS:000184056900013
J	Pedley, DK; Bissett, K; Connolly, EM; Goodman, CG; Golding, I; Pringle, TH; McNeill, GP; Pringle, SD; Jones, MC				Pedley, DK; Bissett, K; Connolly, EM; Goodman, CG; Golding, I; Pringle, TH; McNeill, GP; Pringle, SD; Jones, MC			Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedics	BRITISH MEDICAL JOURNAL			English	Article							EARLY ANISTREPLASE TRIAL; NEEDLE TIMES; THERAPY; MORTALITY; CALL	Objectives To evaluate a system of prehospital thrombolysis, delivered by paramedics, in meeting the national service framework's targets for the management of acute myocardial infarction. Design Prospective observational cohort study comparing patients with suspected acute myocardial infarction considered for thrombolysis in the prehospital environment With patients treated in hospital. Setting The catchment area of a large teaching hospital, including urban and rural areas. Participants 201 patients presenting concurrently over a 12 month period who had changes to the electrocardiogram that were diagnostic of acute myocardial infarction or who received thrombolysis for suspected acute myocardial infarction. Main outcome measures Time from first medical contact to initiation of thrombolysis (call to needle time), number of patients given thrombolysis appropriately, and all cause mortality in hospital. Results The median call to needle time for patients treated before arriving in hospital (n=28) was 52 (95% confidence interval 41 to 62) minutes. Patients from similar rural areas who were treated in hospital (n=43) had a median time of 125 (104 to 140) minutes. This represents a median time saved of 73 minutes (P < 0.001). Sixty minutes after medical contact 64% of, patients (18/28) treated before arrival in hospital had received thrombolysis; this compares with 4% of patients (2/43) in a cohort from similar areas. Median call to needle time for patients from urban areas (n=107) was 80 (78 to 93) minutes. Myocardial infarction was confirmed in 89% of patients (25/28) who had received prehospital thrombolysis; this compares with 92% (138/150) in the two groups of patients receiving thrombolysis in hospital. Conclusions Thrombolysis delivered by paramedics with support from the base hospital can meet the national targets for early thrombolysis. The system has been shown to work well and can be introduced without delay.	Univ Dundee, Ninewells Hosp & Med Sch, Chest Pain Serv, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Med & Cardiovasc Grp, Dundee DD1 9SY, Scotland; Scottish Ambulance Serv, Dundee DD3 8PQ, Scotland	University of Dundee; University of Dundee	Pedley, DK (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Chest Pain Serv, Dundee DD1 9SY, Scotland.							[Anonymous], 1988, LANCET, V332, P349; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; *DEP HLTH, 2000, NAT SERV FRAM COR HE; GATENBY R, 1992, BMJ-BRIT MED J, V305, P548; LEIZOROVICZ A, 1993, NEW ENGL J MED, V329, P383; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; Rawles J, 1998, BRIT MED J, V317, P576, DOI 10.1136/bmj.317.7158.576; Rawles J, 1999, BRIT MED J, V318, P1554; Rawles JM, 1997, J AM COLL CARDIOL, V30, P1181, DOI 10.1016/S0735-1097(97)00299-4; WEAVER WD, 1993, JAMA-J AM MED ASSOC, V270, P1211, DOI 10.1001/jama.270.10.1211; WESTON CFM, 1994, BMJ-BRIT MED J, V308, P767, DOI 10.1136/bmj.308.6931.767; 2002, J AM COLL CARDIOL, V3, P71	13	53	54	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2003	327	7405					22	26		10.1136/bmj.327.7405.22	http://dx.doi.org/10.1136/bmj.327.7405.22			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699NK	12842951	Green Published, Bronze			2022-12-24	WOS:000184062700018
J	Dacke, M; Nilsson, DE; Scholtz, CH; Byrne, M; Warrant, EJ				Dacke, M; Nilsson, DE; Scholtz, CH; Byrne, M; Warrant, EJ			Insect orientation to polarized moonlight	NATURE			English	Article									Lund Univ, Dept Cell & Organism Biol, S-22362 Lund, Sweden; Univ Witwatersrand, Dept Anim Plant & Environm Sci, Ecophysiol Studies Res Grp, ZA-2050 Johannesburg, South Africa; Univ Pretoria, Dept Zool & Entomol, ZA-0001 Pretoria, South Africa	Lund University; University of Witwatersrand; University of Pretoria	Dacke, M (corresponding author), Lund Univ, Dept Cell & Organism Biol, S-22362 Lund, Sweden.	marie.dacke@cob.lu.se	Byrne, Marcus/AAF-9789-2021; Scholtz, Clarke/E-7121-2010	Byrne, Marcus/0000-0002-5155-2599; Warrant, Eric/0000-0001-7480-7016				Dacke M, 2003, J EXP BIOL, V206, P1535, DOI 10.1242/jeb.00289; Gal J, 2001, J GEOPHYS RES-ATMOS, V106, P22647, DOI 10.1029/2000JD000085; Strutt J. W., 1871, PHILOS MAG, V41, P107, DOI DOI 10.1080/14786447108640452; Waterman T.H., 1981, HDB SENSORY PHYSL, P281; Wehner R, 2001, J EXP BIOL, V204, P2589	5	178	196	2	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2003	424	6944					33	33		10.1038/424033a	http://dx.doi.org/10.1038/424033a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840748				2022-12-24	WOS:000183912800029
J	Baglione, V; Canestrari, D; Marcos, JM; Ekman, J				Baglione, V; Canestrari, D; Marcos, JM; Ekman, J			Kin selection in cooperative alliances of carrion crows	SCIENCE			English	Article							DISPERSAL; BEHAVIOR	In most cooperative vertebrates, delayed natal dispersal is the mechanism that leads to the formation of kin societies. Under this condition, the possibility that kin-based cooperative breeding is an unselected consequence of dispersal patterns can never be ruled out because helpers can only help their relatives. Here we show that a population of carrion crows (Corvus corone corone) fully fits the central prediction of kin selection theory that cooperative breeding should arise among relatives. On their territory, resident breeders are aided not only by nonbreeding retained offspring but also by immigrants ( mainly males), with whom they share matings. Philopatry cannot account, however, for the high degree of genetic relatedness found between breeders and immigrants of the same sex that cooperate at a nest, indicating that crows actively choose to breed cooperatively with their relatives.	Uppsala Univ, Populat Biol Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; Univ Seville, Seville 41071, Spain	Uppsala University; University of Sevilla	Baglione, V (corresponding author), Uppsala Univ, Populat Biol Evolutionary Biol Ctr, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	vittorio.baglione@ebc.uu.se	Baglione, Vittorio/D-6456-2014; Canestrari, Daniela/F-9696-2016	Canestrari, Daniela/0000-0001-9112-0208; Baglione, Vittorio/0000-0001-8464-7861				Baglione V, 2002, ANIM BEHAV, V64, P887, DOI 10.1006/anbe.2002.2007; Baglione V, 2002, AUK, V119, P790, DOI 10.1642/0004-8038(2002)119[0790:CBGOCC]2.0.CO;2; Baglione V, 2002, P ROY SOC B-BIOL SCI, V269, P1247, DOI 10.1098/rspb.2002.2016; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; EKMAN J, 1994, BEHAV ECOL, V5, P245, DOI 10.1093/beheco/5.3.245; EMLEN ST, 1988, BEHAV ECOL SOCIOBIOL, V23, P305, DOI 10.1007/BF00300577; EMLEN ST, 1995, P NATL ACAD SCI USA, V92, P8092, DOI 10.1073/pnas.92.18.8092; Griffin AS, 2002, TRENDS ECOL EVOL, V17, P15, DOI 10.1016/S0169-5347(01)02355-2; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; Koenig WD, 2000, CONDOR, V102, P492, DOI 10.1650/0010-5422(2000)102[0492:NDITCB]2.0.CO;2; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; QUELLER DC, 1992, TRENDS ECOL EVOL, V7, P322, DOI 10.1016/0169-5347(92)90120-Z; Russell AF, 2001, P ROY SOC B-BIOL SCI, V268, P2169, DOI 10.1098/rspb.2001.1790; Spong G, 2001, P ROY SOC B-BIOL SCI, V268, P2571, DOI 10.1098/rspb.2001.1835; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; Zar JH, 1999, BIOSTATISTICAL ANAL; [No title captured]	20	82	83	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2003	300	5627					1947	1949		10.1126/science.1082429	http://dx.doi.org/10.1126/science.1082429			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12817149				2022-12-24	WOS:000183619400047
J	Garsin, DA; Villanueva, JM; Begun, J; Kim, DH; Sifri, CD; Calderwood, SB; Ruvkun, G; Ausubel, FM				Garsin, DA; Villanueva, JM; Begun, J; Kim, DH; Sifri, CD; Calderwood, SB; Ruvkun, G; Ausubel, FM			Long-lived C-elegans daf-2 mutants are resistant to bacterial pathogens	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; HOST		Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Ausubel, FM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.	Ausubel@molbio.mgh.harvard.edu	Begun, Jakob/J-6793-2014	Begun, Jakob/0000-0001-5256-7672; Sifri, Costi/0000-0001-6033-2515	NIGMS NIH HHS [GM48707] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048707, R37GM048707] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aballay A, 2002, CURR OPIN MICROBIOL, V5, P97, DOI 10.1016/S1369-5274(02)00293-X; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	7	415	430	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2003	300	5627					1921	1921		10.1126/science.1080147	http://dx.doi.org/10.1126/science.1080147			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12817143				2022-12-24	WOS:000183619400038
J	Taylor, AF; Smith, GR				Taylor, AF; Smith, GR			RecBCD enzyme is a DNA helicase with fast and slow motors of opposite polarity	NATURE			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; ATP-BINDING; HOMOLOGOUS RECOMBINATION; PURIFIED SUBUNITS; RECD SUBUNIT; TRANSLOCATION; SEQUENCE; PROTEIN; CHI	Helicases are molecular motors that move along and unwind double-stranded nucleic acids(1). RecBCD enzyme is a complex helicase and nuclease, essential for the major pathway of homologous recombination and DNA repair in Escherichia coli(2). It has sets of helicase motifs(1) in both RecB and RecD, two of its three subunits. This rapid, highly processive enzyme unwinds DNA in an unusual manner: the 5'-ended strand forms a long single-stranded tail, whereas the 3'-ended strand forms an ever-growing single-stranded loop and short single-stranded tail. Here we show by electron microscopy of individual molecules that RecD is a fast helicase acting on the 5'-ended strand and RecB is a slow helicase acting on the 3'-ended strand on which the single-stranded loop accumulates. Mutational inactivation of the helicase domain in RecB or in RecD, or removal of the RecD subunit, altered the rates of unwinding or the types of structure produced, or both. This dual-helicase mechanism explains how the looped recombination intermediates are generated and may serve as a general model for highly processive travelling machines with two active motors, such as other helicases and kinesins.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Smith, GR (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.			Smith, Gerald/0000-0002-8747-1352				Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Berneburg M, 2001, ADV GENET, V43, P71, DOI 10.1016/S0065-2660(01)43004-5; Bianco PR, 1997, P NATL ACAD SCI USA, V94, P6706, DOI 10.1073/pnas.94.13.6706; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; BOEHMER PE, 1991, GENE, V102, P1, DOI 10.1016/0378-1119(91)90529-K; BRAEDT G, 1989, P NATL ACAD SCI USA, V86, P871, DOI 10.1073/pnas.86.3.871; CHAUDHURY AM, 1984, P NATL ACAD SCI-BIOL, V81, P7850, DOI 10.1073/pnas.81.24.7850; Chen HW, 1997, J BIOL CHEM, V272, P10072; Chen HW, 1998, J MOL BIOL, V278, P89, DOI 10.1006/jmbi.1998.1694; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; GANESAN S, 1993, J MOL BIOL, V229, P67, DOI 10.1006/jmbi.1993.1008; GEORGE JW, 1994, J MOL BIOL, V229, P67; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; HSIEH S, 1992, NUCLEIC ACIDS RES, V20, P5647, DOI 10.1093/nar/20.21.5647; KORANGY F, 1994, BIOCHEMISTRY-US, V33, P9552, DOI 10.1021/bi00198a022; KORANGY F, 1992, J BIOL CHEM, V267, P1733; LEE MS, 1990, J BIOL CHEM, V265, P17078; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MASTERSON C, 1992, J BIOL CHEM, V267, P13564; Phillips RJ, 1997, MOL GEN GENET, V254, P319, DOI 10.1007/PL00008605; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Smith GR, 2001, ANNU REV GENET, V35, P243, DOI 10.1146/annurev.genet.35.102401.090509; TAYLOR A, 1980, CELL, V22, P447, DOI 10.1016/0092-8674(80)90355-4; TAYLOR AF, 1995, J BIOL CHEM, V270, P24451, DOI 10.1074/jbc.270.41.24451; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Yu M, 1998, J MOL BIOL, V283, P797, DOI 10.1006/jmbi.1998.2127	30	158	167	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					889	893		10.1038/nature01674	http://dx.doi.org/10.1038/nature01674			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815437				2022-12-24	WOS:000183585300051
J	Berman, B				Berman, B			Integrative approaches to pain management: how to get the best of both worlds	BRITISH MEDICAL JOURNAL			English	Article									Univ Maryland, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Berman, B (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.				NCCIH NIH HHS [N0 5-P50-AT00084-02] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT000084] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)			0	9	10	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2003	326	7402					1320	+		10.1136/bmj.326.7402.1320-a	http://dx.doi.org/10.1136/bmj.326.7402.1320-a			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691VK	12805175	Green Published			2022-12-24	WOS:000183626500040
J	Donaldson, L				Donaldson, L			Expert patients usher in a new era of opportunity for the NHS	BRITISH MEDICAL JOURNAL			English	Editorial Material									Dept Hlth, London SW1A 2NS, England		Donaldson, L (corresponding author), Dept Hlth, London SW1A 2NS, England.								0	94	94	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2003	326	7402					1279	1279		10.1136/bmj.326.7402.1279	http://dx.doi.org/10.1136/bmj.326.7402.1279			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691VK	12805129	Green Published			2022-12-24	WOS:000183626500005
J	Hayes, EB; Piesman, J				Hayes, EB; Piesman, J			Current concepts - How can we prevent Lyme disease?	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							IXODES-SCAPULARIS ACARI; DEER-TICK BITES; DAMMINI ACARI; IXODIDAE NYMPHS; SOUTHEASTERN CONNECTICUT; ANTIBIOTIC-TREATMENT; REDUCED ABUNDANCE; RESIDENTIAL AREA; NEW-YORK; RISK		Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO 80522 USA	Centers for Disease Control & Prevention - USA	Piesman, J (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, POB 2087,Rampart Rd, Ft Collins, CO 80522 USA.	jfp2@cdc.gov						*ADV COMM IMM PRAC, 1999, MMWR-MORBID MORTAL W, V48, P833; AGRE F, 1993, AM J DIS CHILD, V147, P945, DOI 10.1001/archpedi.1993.02160330035013; Allan SA, 1998, MED VET ENTOMOL, V12, P141, DOI 10.1046/j.1365-2915.1998.00080.x; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; BERGER BW, 1989, REV INFECT DIS, V11, pS1475; CDC, 1999, MMWR-MORBID MORTAL W, V48, P1; Costello C M, 1989, Conn Med, V53, P338; Crippa M, 2002, VECTOR-BORNE ZOONOT, V2, P3, DOI 10.1089/153036602760260724; CURRAN KL, 1993, J MED ENTOMOL, V30, P107, DOI 10.1093/jmedent/30.1.107; DANIELS TJ, 1995, J MED ENTOMOL, V32, P5, DOI 10.1093/jmedent/32.1.5; DANIELS TJ, 1991, J MED ENTOMOL, V28, P537, DOI 10.1093/jmedent/28.4.537; DEBLINGER RD, 1991, J MED ENTOMOL, V28, P708, DOI 10.1093/jmedent/28.5.708; DELBINGER RD, 1993, J MED ENTOMOL, V30, P144; Gresikova M, 1997, ACTA VIROL, V41, P115; HASSLER D, 1990, INFECTION, V18, P16, DOI 10.1007/BF01644175; Hayes E B, 1999, J Public Health Manag Pract, V5, P84; Herrington JE, 1997, AM J PUBLIC HEALTH, V87, P2035, DOI 10.2105/AJPH.87.12.2035; Kahl O, 1998, ZBL BAKT-INT J MED M, V287, P41; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Lathrop SL, 2002, VACCINE, V20, P1603, DOI 10.1016/S0264-410X(01)00500-X; LEY C, 1995, AM J EPIDEMIOL, V142, pS39, DOI 10.1093/aje/142.Supplement_9.S39; Logigian EL, 1999, J INFECT DIS, V180, P377, DOI 10.1086/314860; MALOUIN R, IN PRESS AM J EPIDEM; MAUPIN GO, 1991, AM J EPIDEMIOL, V133, P1105, DOI 10.1093/oxfordjournals.aje.a115823; Meltzer MI, 1999, EMERG INFECT DIS, V5, P321, DOI 10.3201/eid0503.990302; Nadelman RB, 1996, AM J MED, V100, P502, DOI 10.1016/S0002-9343(95)99915-9; Nadelman RB, 2001, NEW ENGL J MED, V345, P79, DOI 10.1056/NEJM200107123450201; O'Connell S, 1998, ZBL BAKT-INT J MED M, V287, P229, DOI 10.1016/S0934-8840(98)80124-2; Orloski K A, 2000, MMWR CDC Surveill Summ, V49, P1; Orloski KA, 1998, AM J EPIDEMIOL, V147, P391; Panella NA, 1997, J MED ENTOMOL, V34, P340, DOI 10.1093/jmedent/34.3.340; Parola P, 2001, CLIN INFECT DIS, V33, P749; PATRICAN LA, 1995, J MED ENTOMOL, V32, P859, DOI 10.1093/jmedent/32.6.859; PFISTER HW, 1991, J INFECT DIS, V163, P311, DOI 10.1093/infdis/163.2.311; PIESMAN J, 1993, J INFECT DIS, V167, P1082, DOI 10.1093/infdis/167.5.1082; Poland GA, 2001, MAYO CLIN PROC, V76, P713, DOI 10.4065/76.7.713; Pound JM, 2000, J MED ENTOMOL, V37, P588, DOI 10.1603/0022-2585-37.4.588; Rothermel H, 2001, PEDIATRICS, V108, P477, DOI 10.1542/peds.108.2.477; SCHULZE TL, 1995, J MED ENTOMOL, V32, P730, DOI 10.1093/jmedent/32.5.730; Schulze TL, 2001, J ECON ENTOMOL, V94, P123, DOI 10.1603/0022-0493-94.1.123; Schulze TL, 2001, J MED ENTOMOL, V38, P344, DOI 10.1603/0022-2585-38.2.344; Shapiro ED, 2001, NEW ENGL J MED, V345, P133, DOI 10.1056/NEJM200107123450210; SHAPIRO ED, 1992, NEW ENGL J MED, V327, P1769, DOI 10.1056/NEJM199212173272501; Sood SK, 1997, J INFECT DIS, V175, P996, DOI 10.1086/514009; STAFFORD KC, 1991, J MED ENTOMOL, V28, P32, DOI 10.1093/jmedent/28.1.32; Stafford KC, 1998, J MED ENTOMOL, V35, P510, DOI 10.1093/jmedent/35.4.510; STAFFORD KC, 1993, J MED ENTOMOL, V30, P762, DOI 10.1093/jmedent/30.4.762; STAFFORD KC, 1992, J MED ENTOMOL, V29, P717, DOI 10.1093/jmedent/29.4.717; Stafford KC, 1996, J MED ENTOMOL, V33, P183, DOI 10.1093/jmedent/33.1.183; Steere AC, 1998, NEW ENGL J MED, V339, P1638; Steere AC, 2001, J AUTOIMMUN, V16, P263, DOI 10.1006/jaut.2000.0495; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; STEERE AC, 1994, ARTHRITIS RHEUM-US, V37, P878, DOI 10.1002/art.1780370616; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; WILSON ML, 1986, J ECON ENTOMOL, V79, P693, DOI 10.1093/jee/79.3.693; WILSON ML, 1988, J MED ENTOMOL, V25, P224, DOI 10.1093/jmedent/25.4.224; Wormser GP, 2000, CLIN INFECT DIS, V31, pS1, DOI 10.1086/314053; Wormser GP, 1997, NEW ENGL J MED, V336, P1107; Zhioua E, 1997, J PARASITOL, V83, P815, DOI 10.2307/3284273; ZHIOUA E, 1995, J MED ENTOMOL, V32, P900, DOI 10.1093/jmedent/32.6.900; 2001, MMWR MORB MORTAL WKL, V50, P92	61	159	168	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2003	348	24					2424	2430		10.1056/NEJMra021397	http://dx.doi.org/10.1056/NEJMra021397			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688HU	12802029				2022-12-24	WOS:000183428900009
J	Chin-Dusting, JPF; Dart, AM				Chin-Dusting, JPF; Dart, AM			Age and the treatment gap in the use of statins	LANCET			English	Editorial Material							DISEASE; INTERVENTION; THERAPY		Baker Heart Res Inst, Alfred & Baker Med Unit, Melbourne, Vic 3004, Australia; Alfred Hosp, Melbourne, Vic 3004, Australia	Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health	Chin-Dusting, JPF (corresponding author), Baker Heart Res Inst, Alfred & Baker Med Unit, Wynn Domain, Melbourne, Vic 3004, Australia.	j.chin@alfred.org.au	Dart, Anthony M/E-7461-2010	Dart, Anthony M/0000-0003-1360-3778				*AM HEART ASS, 2003, CHOL LOW DRUGS; Bartlett C, 2003, HEART, V89, P327, DOI 10.1136/heart.89.3.327; Bowker TJ, 1996, HEART, V75, P334, DOI 10.1136/hrt.75.4.334; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; DeWilde S, 2003, HEART, V89, P417, DOI 10.1136/heart.89.4.417; Hilleman DE, 2001, PHARMACOTHERAPY, V21, P1415, DOI 10.1592/phco.21.17.1415.34422; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Julian DG, 1997, EUR HEART J, V18, P394; *NAT HEART FDN AUS, 2003, RED RISK HEART DIS G; *NAT SERV FRAM COR, 1998, EM FIND REP; PEDERSEN TR, 1994, LANCET, V344, P1383; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; VALE MJ, IN PRESS ARCH INTERN; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9	14	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2003	361	9373					1925	1926		10.1016/S0140-6736(03)13601-X	http://dx.doi.org/10.1016/S0140-6736(03)13601-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687DB	12801733				2022-12-24	WOS:000183359700005
J	Yao, MC; Fuller, P; Xi, XH				Yao, MC; Fuller, P; Xi, XH			Programmed DNA deletion as an RNA-guided system of genome defense	SCIENCE			English	Article							TETRAHYMENA-THERMOPHILA; DEVELOPMENTAL EXCISION; PARAMECIUM-TETRAURELIA; HISTONE H3; GENE; METHYLATION; REARRANGEMENTS; ELIMINATION; EXPRESSION; SEQUENCES	Genomewide DNA rearrangements occur in many eukaryotes during development, but their functions and mechanisms are poorly understood. Previous studies have implicated a sequence-recognition mechanism based on RNA-mediated interactions between nuclei in ciliated protozoa. In this study, we found that the process recognized and deleted a foreign gene integrated in a Tetrahymena chromosome, suggesting an unusual mechanism of genome surveillance. We further found that injection of double-stranded RNA into the cell at specific developmental stages triggers efficient deletion of the targeted genomic regions. Together the results indicate an RNA-based mechanism that directs genomewide DNA rearrangements and serves to disable invading genetic agents.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Yao, MC (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N,POB 19024, Seattle, WA 98109 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026210] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM26210] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aufsatz W, 2002, EMBO J, V21, P6832, DOI 10.1093/emboj/cdf663; CASSIDYHANLEY D, 1994, GENETICS, V137, P95; Chalker DL, 1996, MOL CELL BIOL, V16, P3658; Chalker DL, 2001, GENE DEV, V15, P1287, DOI 10.1101/gad.884601; CHALKER DL, UNPUB; COYNE R, UNPUB; Coyne RS, 1999, MOL CELL, V4, P865, DOI 10.1016/S1097-2765(00)80396-2; Duharcourt S, 1998, MOL CELL BIOL, V18, P7075, DOI 10.1128/MCB.18.12.7075; DUHARCOURT S, 1995, GENE DEV, V9, P2065, DOI 10.1101/gad.9.16.2065; Duharcourt S, 2002, EUKARYOT CELL, V1, P293, DOI 10.1128/EC.1.2.293-303.2002; GAERTIG J, 1994, NUCLEIC ACIDS RES, V22, P5391, DOI 10.1093/nar/22.24.5391; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; MARCZYNSKI GT, 1985, NUCLEIC ACIDS RES, V13, P8487, DOI 10.1093/nar/13.23.8487; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Matzke MA, 1996, TRENDS PLANT SCI, V1, P382, DOI 10.1016/S1360-1385(96)80313-X; MCGRATH KE, 1994, CELL MOTIL CYTOSKEL, V27, P272, DOI 10.1002/cm.970270308; Meyer E, 1996, CELL, V87, P9, DOI 10.1016/S0092-8674(00)81317-3; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Selker EU, 1999, CELL, V97, P157, DOI 10.1016/S0092-8674(00)80725-4; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; YAO MC, UNPUB; Yao MC, 2002, MOBILE DNA, P730; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	27	154	159	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1581	1584		10.1126/science.1084737	http://dx.doi.org/10.1126/science.1084737			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791996				2022-12-24	WOS:000183333100058
J	Whitaker, RJ; Grogan, DW; Taylor, JW				Whitaker, RJ; Grogan, DW; Taylor, JW			Geographic barriers isolate endemic populations of hyperthermophilic archaea	SCIENCE			English	Article							DIFFERENT OCEANIC PROVINCES; BACTERIA; SULFOLOBUS; DIVERSITY; BIOGEOGRAPHY; TEMPERATURE; VIRUSES; SOIL; SEA	Barriers to dispersal between populations allow them to diverge through local adaptation or random genetic drift. High-resolution multilocus sequence analysis revealed that, on a global scale, populations of hyperthermophilic microorganisms are isolated from one another by geographic barriers and have diverged over the course of their recent evolutionary history. The identification of a biogeographic pattern in the archaeon Sulfolobus challenges the current model of microbial biodiversity in which unrestricted dispersal constrains the development of global species richness.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA	University of California System; University of California Berkeley; University System of Ohio; University of Cincinnati	Whitaker, RJ (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.							Beja O, 2002, APPL ENVIRON MICROB, V68, P335, DOI 10.1128/AEM.68.1.335-345.2002; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Casamayor EO, 2002, APPL ENVIRON MICROB, V68, P1706, DOI 10.1128/AEM.68.4.1706-1714.2002; Castenholz R. W., 1996, NOVA HEDWIGIA, V112, P33; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fulthorpe RR, 1998, APPL ENVIRON MICROB, V64, P1620; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Hjort K, 1999, J BACTERIOL, V181, P5669, DOI 10.1128/JB.181.18.5669-5675.1999; Massana R, 2000, APPL ENVIRON MICROB, V66, P1777, DOI 10.1128/AEM.66.5.1777-1787.2000; MUSSER JM, 1990, REV INFECT DIS, V12, P75; Oda Y, 2002, APPL ENVIRON MICROB, V68, P3467, DOI 10.1128/AEM.68.7.3467-3477.2002; Palys T, 1997, INT J SYST BACTERIOL, V47, P1145, DOI 10.1099/00207713-47-4-1145; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Petursdottir SK, 2000, EXTREMOPHILES, V4, P267, DOI 10.1007/s007920070012; Rice G, 2001, P NATL ACAD SCI USA, V98, P13341, DOI 10.1073/pnas.231170198; Roberts MS, 1995, EVOLUTION, V49, P1081, DOI 10.1111/j.1558-5646.1995.tb04435.x; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; SMITH JM, 1991, NATURE, V349, P29, DOI 10.1038/349029a0; Staley JT, 1999, ANNU REV MICROBIOL, V53, P189, DOI 10.1146/annurev.micro.53.1.189; STETTER KO, 1993, NATURE, V365, P743, DOI 10.1038/365743a0; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; ZILLIG W, 1994, SYST APPL MICROBIOL, V16, P609	25	605	637	6	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2003	301	5635					976	978		10.1126/science.1086909	http://dx.doi.org/10.1126/science.1086909			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711RY	12881573				2022-12-24	WOS:000184755900043
J	Smith, GCS; Pell, JP; Dobbie, R				Smith, GCS; Pell, JP; Dobbie, R			Interpregnancy interval and risk of preterm birth and neonatal death: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							PERINATAL OUTCOMES; PREGNANCY INTERVAL; GESTATIONAL-AGE; BLACK-WOMEN; WEIGHT; ASSOCIATION; DELIVERY; LABOR; WHITE	Objective To determine whether a short interval between pregnancies is an independent risk factor for adverse obstetric outcome. Design Retrospective cohort study. Setting Scotland. Subjects 89 143 women having second births in 1992-8 who conceived within five years of their first birth. Main outcome measures Intrauterine growth restriction (birth weight less than the 5th centile for gestational acre), extremely preterm birth (24-32 weeks), moderately preterm birth (33-36 weeks), and perinatal death. Results Women whose subsequent interpregnancy interval was less than six months were more likely than other women to have had a first birth complicated by 4-itrauterine growth restriction (odds ratio 1.3, 95% confidence interval 1.1 to 1.5), extremely preterm birth (4.1, 3.2 to 5.3), moderately preterm birth (1.5, 1.3 to 1.7), or perinatal death (24.4, 18.9 to 31.5). They were also shorter, less likely to be married, mid more likely to be aged less than 20 years at the time of the second birth, to smoke, and to live in an area of high socioeconomic deprivation. When the outcome of die second birth was analysed in relation to the preceding interpregnancy interval and the analysis confined to women whose first birth was a term live birth (n = 69 055), no significant association occurred (adjusted for age, marital status, height, socioeconomic deprivation, smoking, previous birth weight vigesimal, and previous caesarean delivery) between interpregnancy interval and intrauterine growth restriction or stillbirth. However, a short interpregnancy interval (< 6 months) was an independent risk factor for extremely preterm birth (adjusted odds ratio 2.2, 1.3 to 3.6), moderately preterm birth (1.6,1.3 to 2.0), and neonatal death unrelated to congenital abnormality (3.6, 1.2 to 10.7). The adjusted attributable fractions for these associations were 6.1%,3.9%, and 13.8%. The associations were very similar when the analysis was confined to married non-smokers aged 25 and above. Conclusions A short interpregnancy interval is an independent risk factor for preterm delivery and neonatal death in the second birth.	Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Cambridge CB2 2QQ, England; Greater Glasgow NHS Board, Dept Publ Hlth, Glasgow, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh, Midlothian, Scotland	University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Box 223, Cambridge CB2 2QQ, England.		Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997; Pell, Jill/0000-0002-8898-7035				Adams MM, 1997, PAEDIATR PERINAT EP, V11, P48, DOI 10.1046/j.1365-3016.11.s1.8.x; Adams MM, 1997, PAEDIATR PERINAT EP, V11, P1; Basso O, 1998, AM J OBSTET GYNECOL, V178, P259, DOI 10.1016/S0002-9378(98)80010-0; BRODY DJ, 1987, AM J PERINAT, V4, P50, DOI 10.1055/s-2007-999736; Campbell S., 1993, ULTRASOUND OBSTET GY, P1432; COLE SK, 1986, BRIT J OBSTET GYNAEC, V93, P1204, DOI 10.1111/j.1471-0528.1986.tb07853.x; COLE SK, 1980, PERINATAL AUDIT SURV, P39; ERICKSON JD, 1978, J EPIDEMIOL COMMUN H, V32, P124, DOI 10.1136/jech.32.2.124; Fuentes-Afflick E, 2000, OBSTET GYNECOL, V95, P383, DOI 10.1016/S0029-7844(99)00583-9; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; *INF STAT DIV NHS, 2002, SCOTT PER INF MORT M; Kaharuza FM, 2001, ACTA OBSTET GYN SCAN, V80, P532, DOI 10.1034/j.1600-0412.2001.080006532.x; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Khoshnood B, 1998, AM J EPIDEMIOL, V148, P798; KLEBANOFF MA, 1988, AM J PUBLIC HEALTH, V78, P667, DOI 10.2105/AJPH.78.6.667; LIEBERMAN E, 1989, OBSTET GYNECOL, V74, P1; MCILWAINE GM, 1985, BRIT J OBSTET GYNAEC, V92, P9, DOI 10.1111/j.1471-0528.1985.tb01041.x; Norwitz ER, 1999, NEW ENGL J MED, V341, P660, DOI 10.1056/NEJM199908263410906; RAWLINGS JS, 1995, NEW ENGL J MED, V332, P69, DOI 10.1056/NEJM199501123320201; Shults RA, 1999, EPIDEMIOLOGY, V10, P250, DOI 10.1097/00001648-199905000-00010; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; Smith GCS, 2001, BRIT MED J, V323, P476, DOI 10.1136/bmj.323.7311.476; Zhu BP, 2001, AM J OBSTET GYNECOL, V185, P1403, DOI 10.1067/mob.2001.118307; Zhu BP, 1999, NEW ENGL J MED, V340, P589, DOI 10.1056/NEJM199902253400801	25	184	191	0	13	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2003	327	7410					313	316		10.1136/bmj.327.7410.313	http://dx.doi.org/10.1136/bmj.327.7410.313			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	710JE	12907483	Bronze, Green Published			2022-12-24	WOS:000184676400015
J	Hacker, J; Hentschel, U; Dobrindt, U				Hacker, J; Hentschel, U; Dobrindt, U			Prokaryotic chromosomes and disease	SCIENCE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; BACTERIAL PATHOGENICITY; HORIZONTAL TRANSFER; GENOME SEQUENCE; MISMATCH REPAIR; YERSINIA-PESTIS; HIGH-FREQUENCY; VIRULENCE; RESISTANCE; EVOLUTION	Recent insights into bacterial genome organization and function have improved our understanding of the nature of pathogenic bacteria and their ability to cause disease. It is becoming increasingly clear that the bacterial chromosome constantly undergoes structural changes due to gene acquisition and loss, recombination, and mutational events that have an impact on the pathogenic potential of the bacterium. Even though the bacterial genome includes additional genetic elements, the chromosome represents the most important entity in this context. Here, we will show that various processes of genomic instability have an influence on the many manifestations of infectious disease.	Univ Wurzburg, Inst Mol Infekt Biol, D-97070 Wurzburg, Germany	University of Wurzburg	Hacker, J (corresponding author), Univ Wurzburg, Inst Mol Infekt Biol, Rontgenring 11, D-97070 Wurzburg, Germany.	j.hacker@mail.uni-wuerzburg.de	Hentschel, Ute/ABD-6624-2021; Hentschel, Ute/H-8343-2013; Dobrindt, Ulrich/AEU-2378-2022	Hentschel, Ute/0000-0003-0596-790X; Hentschel, Ute/0000-0003-0596-790X; Dobrindt, Ulrich/0000-0001-9949-1898				Boddicker JD, 2002, MOL MICROBIOL, V45, P1255, DOI 10.1046/j.1365-2958.2002.03121.x; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Brown EW, 2001, J BACTERIOL, V183, P1631, DOI 10.1128/JB.183.5.1631-1644.2001; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; de Boer P, 2002, MOL MICROBIOL, V44, P351, DOI 10.1046/j.1365-2958.2002.02930.x; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; Dobrindt U, 2003, J BACTERIOL, V185, P1831, DOI 10.1128/JB.185.6.1831-1840.2003; Dobrindt U, 2002, MOL GENET GENOMICS, V267, P370, DOI 10.1007/s00438-002-0668-3; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gross Roy, 2003, Molecular Microbiology, V47, P1749, DOI 10.1046/j.1365-2958.2003.03443.x; Gunther NW, 2001, INFECT IMMUN, V69, P2838, DOI 10.1128/IAI.69.5.2838-2846.2001; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Hentschel U, 2000, TRENDS MICROBIOL, V8, P226, DOI 10.1016/S0966-842X(00)01758-3; Hinnebusch BJ, 2002, MOL MICROBIOL, V46, P349, DOI 10.1046/j.1365-2958.2002.03159.x; Ho TD, 2002, J BACTERIOL, V184, P5234, DOI 10.1128/JB.184.19.5234-5239.2002; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Loessner I, 2002, J BACTERIOL, V184, P4709, DOI 10.1128/JB.184.17.4709-4714.2002; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oelschlaeger TA, 2003, J BACTERIOL, V185, P1107, DOI 10.1128/JB.185.3.1107-1111.2003; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Picard B, 2001, INFECT IMMUN, V69, P9, DOI 10.1128/IAI.69.1.9-14.2001; Prunier AL, 2003, J INFECT DIS, V187, P1709, DOI 10.1086/374937; Richardson AR, 2001, MOL MICROBIOL, V40, P645, DOI 10.1046/j.1365-2958.2001.02408.x; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Umeda A, 2002, J ANTIMICROB CHEMOTH, V50, P253, DOI 10.1093/jac/dkf105; Weissman SJ, 2003, TRENDS MICROBIOL, V11, P115, DOI 10.1016/S0966-842X(03)00010-6	35	87	92	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					790	793		10.1126/science.1086802	http://dx.doi.org/10.1126/science.1086802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907788				2022-12-24	WOS:000184615700031
J	Lamb, J; Ramaswamy, S; Ford, HL; Contreras, B; Martinez, RV; Kittrell, FS; Zahnow, CA; Patterson, N; Golub, TR; Ewen, ME				Lamb, J; Ramaswamy, S; Ford, HL; Contreras, B; Martinez, RV; Kittrell, FS; Zahnow, CA; Patterson, N; Golub, TR; Ewen, ME			A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer	CELL			English	Article							BINDING-PROTEIN-BETA; MESSENGER-RNA; TRANSCRIPTION FACTOR; ESTROGEN-RECEPTOR; BREAST-CANCER; MOLECULAR CLASSIFICATION; RETINOBLASTOMA PROTEIN; INHIBITORY PROTEIN; CDK INHIBITORS; IN-SITU	Here we describe how patterns of gene expression in human tumors have been deconvoluted to reveal a mechanism of action for the cyclin D1 oncogene. Computational analysis of the expression patterns of thousands of genes across hundreds of tumor specimens suggested that a transcription factor, C/EBPbeta/Nf-II6, participates in the consequences of cyclin Di overexpression. Functional analyses confirmed the involvement of C/EBPbeta in the regulation of genes affected by cyclin D1 and established this protein as an indispensable effector of a potentially important facet of cyclin D1 biology. This work demonstrates that tumor gene expression databases can be used to study the function of a human oncogene in situ.	Harvard Univ, Sch Med, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biochem, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21231 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Baylor College of Medicine; Johns Hopkins University; Johns Hopkins Medicine	Ewen, ME (corresponding author), Harvard Univ, Sch Med, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.		Villena, Rodolfo/HDM-2742-2022		NCI NIH HHS [CA88843, F32-CA79197, P01-CA80111, R01-CA61253, R01-CA65842] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA088843, P01CA080111, R01CA065842, F32CA079197] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Desprez Pierre-Yves, 1993, Molecular and Cellular Differentiation, V1, P99; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; GAUGITSCH HW, 1992, J BIOL CHEM, V267, P11267; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; Hollander M., 1973, NONPARAMETRIC STAT M; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Kamano H, 1997, ONCOGENE, V14, P1223, DOI 10.1038/sj.onc.1200945; KITTRELL FS, 1992, CANCER RES, V52, P1924; Knudsen KE, 1999, CANCER RES, V59, P2297; Lamb J, 2000, MOL CELL BIOL, V20, P8667, DOI 10.1128/MCB.20.23.8667-8675.2000; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Oyama T, 1998, CANCER RES, V58, P2876; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Ratineau C, 2002, J BIOL CHEM, V277, P8847, DOI 10.1074/jbc.M110747200; RAUGHT B, 1995, MOL ENDOCRINOL, V9, P1223, DOI 10.1210/me.9.9.1223; Raught B, 1996, CANCER RES, V56, P4382; ROSENBERG CL, 1991, P NATL ACAD SCI USA, V88, P9638, DOI 10.1073/pnas.88.21.9638; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Su AI, 2001, CANCER RES, V61, P7388; TSUKADA J, 1994, MOL CELL BIOL, V14, P7285, DOI 10.1128/MCB.14.11.7285; Ubeda M, 1999, BIOCHEM BIOPH RES CO, V262, P31, DOI 10.1006/bbrc.1999.1140; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vos CBJ, 1999, J PATHOL, V187, P279; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WEINSTATSASLOW D, 1995, NAT MED, V1, P1257, DOI 10.1038/nm1295-1257; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887; Zahnow CA, 2001, CANCER RES, V61, P261; ZUKERBERG LR, 1995, MODERN PATHOL, V8, P560; Zukerberg LR, 1996, BLOOD, V88, P268, DOI 10.1182/blood.V88.1.268.bloodjournal881268; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	48	337	352	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					323	334		10.1016/S0092-8674(03)00570-1	http://dx.doi.org/10.1016/S0092-8674(03)00570-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914697	Bronze			2022-12-24	WOS:000184679200009
J	Chittka, L; Dyer, AG; Bock, F; Dornhaus, A				Chittka, L; Dyer, AG; Bock, F; Dornhaus, A			Psychophysics - Bees trade off foraging speed for accuracy	NATURE			English	Article									Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany; Univ London, Queen Mary, London E1 4NS, England; La Trobe Univ, Fac Hlth Sci, Sch Orthopt, Bundoora, Vic 3086, Australia; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Wurzburg; University of London; La Trobe University; University of Bristol	Chittka, L (corresponding author), Univ Wurzburg, Biozentrum, Hubland, D-97074 Wurzburg, Germany.	l.chittka@qmul.ac.uk	Chittka, Lars/C-3110-2012	Chittka, Lars/0000-0001-8153-1732				CHITTKA L, 1995, ANIM BEHAV, V49, P159, DOI 10.1016/0003-3472(95)80163-4; DUKAS R, 1994, ANIM BEHAV, V48, P1001, DOI 10.1006/anbe.1994.1332; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Maleszka R, 2000, BEHAV BRAIN RES, V115, P49, DOI 10.1016/S0166-4328(00)00235-7; Menzel R., 1990, NEUROBIOLOGY COMP CO, P237; Rival C, 2003, NEUROSCI LETT, V336, P65, DOI 10.1016/S0304-3940(02)01246-6; SMITH BH, 1991, J COMP PSYCHOL, V105, P345, DOI 10.1037/0735-7036.105.4.345; Thomson JD, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P191, DOI 10.1017/CBO9780511542268.011; Zenger B, 1997, J EXP PSYCHOL HUMAN, V23, P1783, DOI 10.1037/0096-1523.23.6.1783	9	277	278	4	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					388	388		10.1038/424388a	http://dx.doi.org/10.1038/424388a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879057				2022-12-24	WOS:000184318400030
J	Bauch, D; Darling, K; Simstich, J; Bauch, HA; Erlenkeuser, H; Kroon, D				Bauch, D; Darling, K; Simstich, J; Bauch, HA; Erlenkeuser, H; Kroon, D			Palaeoceanographic implications of genetic variation in living North Atlantic Neogloboquadrina pachyderma	NATURE			English	Article								The shells of the planktonic foraminifer Neogloboquadrina pachyderma have become a classical tool for reconstructing glacial-interglacial climate conditions in the North Atlantic Ocean(1-3). Palaeoceanographers utilize its left- and right-coiling variants, which exhibit a distinctive reciprocal temperature and water mass related shift in faunal abundance both at present and in late Quaternary sediments(1,2,4,5). Recently discovered cryptic genetic diversity in planktonic foraminifers(6-8) now poses significant questions for these studies. Here we report genetic evidence demonstrating that the apparent 'single species' shell-based records of right-coiling N. pachyderma used in palaeoceanographic reconstructions contain an alternation in species as environmental factors change. This is reflected in a species-dependent incremental shift in right-coiling N. pachyderma shell calcite delta(18)O between the Last Glacial Maximum and full Holocene conditions. Guided by the percentage dextral coiling ratio, our findings enhance the use of delta(18)O records of right-coiling N. pachyderma for future study. They also highlight the need to genetically investigate other important morphospecies to refine their accuracy and reliability as palaeoceanographic proxies.	GEOMAR, D-24148 Kiel, Germany; Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JG, Midlothian, Scotland; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JG, Midlothian, Scotland; Mainz Acad Sci Human & Lit, D-55131 Mainz, Germany; Univ Kiel, Leibniz Lab, D-24118 Kiel, Germany; Vrije Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Edinburgh; University of Edinburgh; University of Kiel; Vrije Universiteit Amsterdam	Bauch, D (corresponding author), GEOMAR, Wischhofstr 1-3, D-24148 Kiel, Germany.			Bauch, Dorothea/0000-0002-1419-9714	Natural Environment Research Council [NER/J/S/2000/00860] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		BANDY O L, 1972, Micropaleontology (New York), V18, P294, DOI 10.2307/1485010; Bauch D, 2002, MAR MICROPALEONTOL, V45, P83, DOI 10.1016/S0377-8398(02)00038-5; Bauch H. A., 1999, LAND OCEAN SYSTEMS S, DOI [10.1007/978- 3, DOI 10.1007/978-3-642-60134-7_46, 10.1007/978-3-642-60134-7_46]; Bauch HA, 2001, QUATERNARY SCI REV, V20, P659, DOI 10.1016/S0277-3791(00)00098-6; Be A.W.H., 1971, MICROPALEONTOLOGY OC, P105; Bemis BE, 2002, MAR MICROPALEONTOL, V46, P405, DOI 10.1016/S0377-8398(02)00083-X; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; CIFELLI R, 1973, Journal of Foraminiferal Research, V3, P157; CLIMAP PM, 1976, SCIENCE, V191, P1131, DOI DOI 10.1126/SCIENCE.191.4232.1131; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darling KF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000723; de Vargas C, 2001, PALEOBIOLOGY, V27, P104, DOI 10.1666/0094-8373(2001)027<0104:PARIGT>2.0.CO;2; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; EMILIANI C, 1955, J GEOL, V63, P538, DOI 10.1086/626295; ERICSON DB, 1959, SCIENCE, V130, P219, DOI 10.1126/science.130.3369.219; HEALYWILLIAMS N, 1984, ANTARCT J US, V18, P138; Huber R, 2000, PALAEOGEOGR PALAEOCL, V160, P193, DOI 10.1016/S0031-0182(00)00066-3; Jansen E., 1989, Quaternary International, V1, P151, DOI 10.1016/1040-6182(89)90013-X; Kandiano ES, 2002, J FORAMIN RES, V32, P245, DOI 10.2113/32.3.245; KELLOGG TB, 1978, BOREAS, V7, P61, DOI 10.1111/j.1502-3885.1978.tb00051.x; KIPP NG, 1976, GEOL SOC AM MEM, V145, P3, DOI DOI 10.1130/MEM145-P3; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Oppo DW, 1998, SCIENCE, V279, P1335, DOI 10.1126/science.279.5355.1335; Oppo DW, 2001, PALEOCEANOGRAPHY, V16, P280, DOI 10.1029/2000PA000527; Pflaumann U, 1996, PALEOCEANOGRAPHY, V11, P15, DOI 10.1029/95PA01743; SIMSTICH J, 1999, BER REP I GEOWISS U, V2, P1; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; Stewart IA, 2001, MAR MICROPALEONTOL, V43, P143, DOI 10.1016/S0377-8398(01)00024-X; WILLIAMS DF, 1988, PALAEOGEOGR PALAEOCL, V64, P153, DOI 10.1016/0031-0182(88)90004-1	29	65	70	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					299	302		10.1038/nature01778	http://dx.doi.org/10.1038/nature01778			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867978	Green Published			2022-12-24	WOS:000184183900038
J	Mao, YH; Abrieu, A; Cleveland, DW				Mao, YH; Abrieu, A; Cleveland, DW			Activating and silencing the mitotic checkpoint through CENP-E-dependent activation/inactivation of BubR1	CELL			English	Article							SPINDLE ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING COMPLEX; PUTATIVE KINETOCHORE MOTOR; SACCHAROMYCES-CEREVISIAE; UNATTACHED KINETOCHORES; CHROMOSOME ALIGNMENT; CHROMATID SEPARATION; KINASE-ACTIVITY; PROTEIN BUBR1; MAD2	The mitotic checkpoint prevents advance to anaphase prior to successful attachment of every centromere/ kinetochore to mitotic spindle microtubules. Using purified components and Xenopus egg extracts, the kinetochore-associated microtubule motor CENP-E is now shown to be the activator of the essential checkpoint kinase BubR1. Since kinase activity and the checkpoint are silenced following CENP-E-dependent microtubule attachment in extracts or binding of CENP-E antibodies that do not disrupt CENP-E association with BubR1, CENP-E mediates silencing of BubR1 signaling. Checkpoint signaling requires the normal level of BubR1 containing a functional Mad3 domain implicated in Cdc20 binding, but only a small fraction need be kinase competent. This supports bifunctional roles for BubR1 in the checkpoint: an enzymatic one requiring CENP-E-dependent activation of its kinase activity at kinetochores and a stoichiometric one as a direct inhibitor of Cdc20.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.		Abrieu, Ariane/P-3307-2019; Cleveland, Don/AAN-9783-2021; Abrieu, Ariane/G-6336-2013	Abrieu, Ariane/0000-0002-0942-8877; Mao, Yinghui/0000-0002-4078-129X; Cleveland, Don/0000-0002-1934-3682				Abrieu A, 2000, CELL, V102, P817, DOI 10.1016/S0092-8674(00)00070-2; Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; BROWN KD, 1994, J CELL BIOL, V125, P1303, DOI 10.1083/jcb.125.6.1303; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Chen RH, 2002, J CELL BIOL, V158, P487, DOI 10.1083/jcb.200204048; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Farr KA, 1998, MOL CELL BIOL, V18, P2738, DOI 10.1128/MCB.18.5.2738; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; ROBERTS BT, 1994, MOL CELL BIOL, V14, P8282, DOI 10.1128/MCB.14.12.8282; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Sharp-Baker H, 2001, J CELL BIOL, V153, P1239, DOI 10.1083/jcb.153.6.1239; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 2001, J CELL SCI, V114, P4385; Taylor TE, 1998, TROP MED INT HEALTH, V3, P3, DOI 10.1046/j.1365-3156.1998.00166.x; Wassmann K, 2003, EMBO J, V22, P797, DOI 10.1093/emboj/cdg071; WEAVER BAA, 2003, IN PRESS J CELL BIOL; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Wu HY, 2000, ONCOGENE, V19, P4557, DOI 10.1038/sj.onc.1203803; Yamaguchi S, 2003, EMBO J, V22, P1075, DOI 10.1093/emboj/cdg100; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	42	190	196	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 11	2003	114	1					87	98		10.1016/S0092-8674(03)00475-6	http://dx.doi.org/10.1016/S0092-8674(03)00475-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859900	Bronze			2022-12-24	WOS:000184219900008
J	Lin, SY; Elledge, SJ				Lin, SY; Elledge, SJ			Multiple tumor suppressor pathways negatively regulate telomerase	CELL			English	Article							REVERSE-TRANSCRIPTASE; CATALYTIC SUBUNIT; CELLULAR SENESCENCE; MENIN INTERACTS; DOWN-REGULATION; IMMORTAL CELLS; CANCER-CELLS; LIFE-SPAN; EXPRESSION; P53	Telomerase expression is repressed in most somatic cells but is observed in stem cells and a high percentage of human cancers and has been hypothesized to contribute to tumorigenesis and maintenance of stem cell states. To explore telomerase regulation, we employed a general genetic screen to identify negative regulators of hTERT. We discovered three tumor suppressor/oncogene pathways involved in hTERT repression. One, the Mad1/c-Myc pathway, had been previously implicated in hTERT regulation. The second, SIPI, a transcriptional target of the TGF-beta pathway, mediates the TGF-beta regulated repression of hTERT. The third, the tumor suppressor Menin, is a direct repressor of hTERT. Depleting Menin immortalizes primary human fibroblasts and causes a transformation phenotype when coupled with expression of SV40 Large and Small T antigen and oncogenic ras. These studies suggest that multiple tumor suppressor/oncogene pathways coordinately repress hTERT expression and imply that telomerase is reactivated in human tumors through oncogenic mutations.	Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Elledge, SJ (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	selledge@bcm.tmc.edu			NCI NIH HHS [1 F32 CA93943] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agarwal SK, 1999, CELL, V96, P143, DOI 10.1016/S0092-8674(00)80967-8; Aisner DL, 2002, CURR OPIN GENET DEV, V12, P80, DOI 10.1016/S0959-437X(01)00268-4; Artandi SE, 2000, NAT MED, V6, P852, DOI 10.1038/78595; Ayer DE, 1996, MOL CELL BIOL, V16, P5772; AYER DE, 1996, MOL CELL BIOL, V38, P2222; Blasco MA, 2002, EUR J CANCER, V38, P2222, DOI 10.1016/S0959-8049(02)00450-1; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; CRAVEN RJ, 1995, CANCER RES, V55, P3969; DELANGE T, 1994, P NATL ACAD SCI USA, V91, P2882, DOI 10.1073/pnas.91.8.2882; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ducrest AL, 2002, ONCOGENE, V21, P541, DOI 10.1038/sj.onc.1205081; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; Greider CW, 1996, SCI AM, V274, P92, DOI 10.1038/scientificamerican0296-92; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Greider CW, 1998, P NATL ACAD SCI USA, V95, P90, DOI 10.1073/pnas.95.1.90; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hahn WC, 2001, ANN MED, V33, P123, DOI 10.3109/07853890109002067; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heppner C, 2001, ONCOGENE, V20, P4917, DOI 10.1038/sj.onc.1204529; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Kanaya T, 2000, CLIN CANCER RES, V6, P1239; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kyo S, 2002, ONCOGENE, V21, P688, DOI 10.1038/sj.onc.1205163; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Liu D, 2000, ONCOGENE, V19, P5964, DOI 10.1038/sj.onc.1203992; LUSKY M, 1981, NATURE, V293, P79, DOI 10.1038/293079a0; Marx S, 1998, ANN INTERN MED, V129, P484, DOI 10.7326/0003-4819-129-6-199809150-00011; Mason PJ, 2003, BIOESSAYS, V25, P126, DOI 10.1002/bies.10229; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Minamino T, 2001, MOL CELL BIOL, V21, P3336, DOI 10.1128/MCB.21.10.3336-3342.2001; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Oh S, 2000, ONCOGENE, V19, P1485, DOI 10.1038/sj.onc.1203439; Oshimura M, 1997, EUR J CANCER, V33, P710, DOI 10.1016/S0959-8049(97)00090-7; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; REARDON DB, 1993, J BIOL CHEM, V268, P18136; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rufer N, 2001, BLOOD, V98, P597, DOI 10.1182/blood.V98.3.597; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Sood AK, 2002, CANCER BIOL THER, V1, P511, DOI 10.4161/cbt.1.5.167; Stampfer MR, 2001, P NATL ACAD SCI USA, V98, P4498, DOI 10.1073/pnas.071483998; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Stewart SA, 2002, ONCOGENE, V21, P627, DOI 10.1038/sj.onc.1205062; Stewart SA, 2000, SEMIN CANCER BIOL, V10, P399, DOI 10.1006/scbi.2000.0339; Takakura M, 1999, CANCER RES, V59, P551; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; WRIGHT WE, 1989, MOL CELL BIOL, V9, P3088, DOI 10.1128/MCB.9.7.3088; Xu DW, 2000, ONCOGENE, V19, P5123, DOI 10.1038/sj.onc.1203890; Xu DW, 2001, P NATL ACAD SCI USA, V98, P3826, DOI 10.1073/pnas.071043198; Yang H, 2001, CELL GROWTH DIFFER, V12, P119; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723	68	349	371	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2003	113	7					881	889		10.1016/S0092-8674(03)00430-6	http://dx.doi.org/10.1016/S0092-8674(03)00430-6			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	695EJ	12837246	Bronze			2022-12-24	WOS:000183817900012
J	Miyazawa, A; Fujiyoshi, Y; Unwin, N				Miyazawa, A; Fujiyoshi, Y; Unwin, N			Structure and gating mechanism of the acetylcholine receptor pore	NATURE			English	Article							ION-CHANNEL; M2 DOMAIN; TUBULAR CRYSTALS; LIGAND-BINDING; DELTA-SUBUNIT; ALPHA-SUBUNIT; PROTEIN; RESOLUTION; LOCATION; SEGMENT	The nicotinic acetylcholine receptor controls electrical signalling between nerve and muscle cells by opening and closing a gated, membrane-spanning pore. Here we present an atomic model of the closed pore, obtained by electron microscopy of crystalline postsynaptic membranes. The pore is shaped by an inner ring of 5 alpha-helices, which curve radially to create a tapering path for the ions, and an outer ring of 15 alpha-helices, which coil around each other and shield the inner ring from the lipids. The gate is a constricting hydrophobic girdle at the middle of the lipid bilayer, formed by weak interactions between neighbouring inner helices. When acetylcholine enters the ligand-binding domain, it triggers rotations of the protein chains on opposite sides of the entrance to the pore. These rotations are communicated through the inner helices, and open the pore by breaking the girdle apart.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; RIKEN, Harima Inst, Sayo, Hyogo 6795148, Japan; Kyoto Univ, Fac Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan	MRC Laboratory Molecular Biology; RIKEN; Kyoto University	Unwin, N (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	mas@mrc-lmb.cam.ac.uk	Fujiyoshi, Yoshinori/E-5989-2012	Fujiyoshi, Yoshinori/0000-0002-8070-1493				AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; Beckstein O, 2001, J PHYS CHEM B, V105, P12902, DOI 10.1021/jp012233y; Beroukhim R, 1997, ULTRAMICROSCOPY, V70, P57, DOI 10.1016/S0304-3991(97)00070-3; Blanton MP, 1998, J BIOL CHEM, V273, P8659, DOI 10.1074/jbc.273.15.8659; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BRISSON A, 1984, J CELL BIOL, V99, P1202, DOI 10.1083/jcb.99.4.1202; CHARNET P, 1990, NEURON, V4, P87, DOI 10.1016/0896-6273(90)90445-L; Colquhoun D., 2003, BURGERS MED CHEM DRU, P357; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Croxen R, 1997, HUM MOL GENET, V6, P767, DOI 10.1093/hmg/6.5.767; DeRosier DJ, 2000, ULTRAMICROSCOPY, V81, P83, DOI 10.1016/S0304-3991(99)00120-5; DEROSIER DJ, 1970, J MOL BIOL, V52, P355, DOI 10.1016/0022-2836(70)90036-7; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; FUJIYOSHI Y, 1991, ULTRAMICROSCOPY, V38, P241, DOI 10.1016/0304-3991(91)90159-4; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; HENDERSON R, 1992, ULTRAMICROSCOPY, V46, P1, DOI 10.1016/0304-3991(92)90003-3; HEUSER JE, 1979, J CELL BIOL, V82, P150, DOI 10.1083/jcb.82.1.150; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HUCHO F, 1986, FEBS LETT, V205, P137, DOI 10.1016/0014-5793(86)80881-X; IMOTO K, 1986, NATURE, V324, P670, DOI 10.1038/324670a0; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; KLUG A, 1958, ACTA CRYSTALLOGR, V11, P199, DOI 10.1107/S0365110X58000517; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; TOYOSHIMA C, 1988, NATURE, V336, P247, DOI 10.1038/336247a0; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; VILLARROEL A, 1991, P ROY SOC B-BIOL SCI, V243, P69, DOI 10.1098/rspb.1991.0012; Wang HL, 1999, NAT NEUROSCI, V2, P226, DOI 10.1038/6326; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Wick MJ, 1998, P NATL ACAD SCI USA, V95, P6504, DOI 10.1073/pnas.95.11.6504; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; Zhang H, 1998, BIOCHEMISTRY-US, V37, P7952, DOI 10.1021/bi980143m	48	1020	1058	4	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2003	423	6943					949	955		10.1038/nature01748	http://dx.doi.org/10.1038/nature01748			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827192				2022-12-24	WOS:000183753900040
J	Grabenstein, JD; Winkenwerder, W				Grabenstein, JD; Winkenwerder, W			US military smallpox vaccination program experience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPLICATIONS; VACCINIA; RISKS	Context The United States recently implemented smallpox vaccination of selected military personnel in a national program of preparedness against use of smallpox as a biological. weapon. The resumption of smallpox vaccinations raises important questions regarding implementation and safety. Objective To describe the US military smallpox vaccination program. Design Descriptive study of the vaccination program from its inception on December 13, 2002, through May 28, 2003. Setting US Department of Defense (DoD) fixed and field medical treatment facilities on multiple continents and ships at sea. Subjects US service members and DoD civilian workers eligible for smallpox vaccination. Main Outcome Measures Numbers of vaccinations and rates of vaccination exemptions, symptoms, and adverse events. Data were collected via reports to headquarters and rigorous surveillance for sentinel events. Results In 5.5 months, the DoD administered 450293 smallpox vaccinations (70.5% primary vaccinees and 29.5% revaccinees). In 2 settings, 0.5% and 3.0% of vaccine recipients needed short-term sick leave. Most adverse events occurred at rates below historical rates. One case of encephalitis and 37 cases of acute myopericarditis developed after vaccination; all cases recovered. Among 19461 worker-months of clinical contact, there were no cases of transmission of vaccinia from worker to patient, no cases of eczema vaccinatum or progressive vaccinia, and no attributed deaths. Conclusions Mass smallpox vaccinations can be conducted safely with very low rates of serious adverse events. Program implementation emphasized human factors: careful staff training, contraindication screening, recipient education, and attention to bandaging. Our experience suggests that broad smallpox vaccination programs may be implemented with fewer serious adverse events than previously believed.	USA, Mil Vaccine Agcy, Med Command, Falls Church, VA 22041 USA; Pentagon, Washington, DC USA		Grabenstein, JD (corresponding author), USA, Mil Vaccine Agcy, Med Command, 5111 Leesburg Pike,Suite 401, Falls Church, VA 22041 USA.	john.grabenstein@us.army.mil	Grabenstein, John/Y-7322-2019					*ADV COMM IMM PRAC, 2003, MMWR RECOMM REP, V52, P1; [Anonymous], 2001, MMWR-MORBID MORTAL W, V50, P1; *ARM FORC EP BOARD, 1977, REP AD HOC SUBC SMAL; *ARM FORC EP BOARD, 1981, MIN JUN 11 1981 M; CDC Center for Disease Control and Prevention, 1985, MMWR-MORBID MORTAL W, V34, P182; *CDCP, 1982, MMWR-MORBID MORTAL W, V31, P682; *CDCP, 1984, MMWR-MORBID MORTAL W, V33, P37; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P419; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P191; *CDCP, 2002, SMALL POX RESP PLAN; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P180; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P256; *CDCP, 1983, MMWR-MORBID MORTAL W, V32, P403; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P386; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P278; COATES JB, 1964, MED DEP US ARMY WORL, V7, P17; COATES JB, 1955, MED DEP US ARMY WORL, V3, P280; DUNCAN LC, 1932, MIL SURG, V71, P439; Fenner F., 1989, SMALLPOX ITS ERADICA, VVolume 43; GILLETT MC, 1981, ARMY MED DEP 1775 18, P56; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; *I MED, 2003, 1 I MED NAT AC SCI; KARJALAINEN J, 1983, ACTA MED SCAND, V213, P65; LANE JM, 1970, J INFECT DIS, V122, P303, DOI 10.1093/infdis/122.4.303; LANE JM, 1969, NEW ENGL J MED, V281, P1201, DOI 10.1056/NEJM196911272812201; Lane JM, 2003, ANN INTERN MED, V138, P488, DOI 10.7326/0003-4819-138-6-200303180-00014; LANE JM, 1971, AM J EPIDEMIOL, V93, P238, DOI 10.1093/oxfordjournals.aje.a121252; LANE JM, 1971, ANNU REV MED, V22, P251, DOI 10.1146/annurev.me.22.020171.001343; REDFIELD RR, 1987, NEW ENGL J MED, V316, P673, DOI 10.1056/NEJM198703123161106; *WYETH LAB, 2002, SMALLP VACC DRIED CA; 1995, US DEP DEFENSE SMALL	32	153	157	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2003	289	24					3278	3282		10.1001/jama.289.24.3278	http://dx.doi.org/10.1001/jama.289.24.3278			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	693EX	12824209	Bronze			2022-12-24	WOS:000183704600021
J	Ackermann, M; Stearns, SC; Jenal, U				Ackermann, M; Stearns, SC; Jenal, U			Senescence in a bacterium with asymmetric division	SCIENCE			English	Article									Univ Basel, Bioctr, Div Mol Microbiol, CH-4056 Basel, Switzerland; Yale Univ, Osborn Mem Labs, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	University of Basel; Yale University	Ackermann, M (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	MKAckerm@ucsd.edu	Ackermann, Martin/V-4554-2017	Ackermann, Martin/0000-0003-0087-4819; Stearns, Stephen/0000-0002-6621-4373				Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; MEDAWAR PB, 2002, UNSOLVED PROBLEM BIO; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; Rose M.R., 1991, EVOLUTIONARY BIOL AG; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	8	183	188	3	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2003	300	5627					1920	1920		10.1126/science.1083532	http://dx.doi.org/10.1126/science.1083532			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12817142				2022-12-24	WOS:000183619400037
J	Sakai, T; Larsen, M; Yamada, KM				Sakai, T; Larsen, M; Yamada, KM			Fibronectin requirement in branching morphogenesis	NATURE			English	Article							CELL-MATRIX ADHESIONS; SALIVARY-GLAND; SUBMANDIBULAR-GLAND; EPITHELIUM; CADHERIN; SURFACE; LUNG	Many organs, including salivary glands, lung and kidney, are formed during embryonic development by epithelial branching. In branching morphogenesis, repetitive epithelial cleft and bud formation create the complex three-dimensional branching structures characteristic of many organs(1-3). Although the mechanisms are poorly understood, one might involve the site-specific accumulation of some regulatory protein. Here we show that the extracellular matrix protein fibronectin(4,5) is essential for cleft formation during the initiation of epithelial branching. Fibronectin messenger RNA and fibrils appeared transiently and focally in forming cleft regions of submandibular salivary-gland epithelia, accompanied by an adjacent loss of cadherin localization. Decreasing the fibronectin concentration by using small interfering RNA and inhibition by anti-fibronectin or anti-integrin antibodies blocked cleft formation and branching. Exogenous fibronectin accelerated cleft formation and branching. Similar effects of fibronectin suppression and augmentation were observed in developing lung and kidney. Mechanistic studies revealed that fibrillar fibronectin can induce cell-matrix adhesions on cultured human salivary epithelial cells with a local loss of cadherins at cell-cell junctions. Thus, fibronectin expression is required for cleft formation in branching morphogenesis associated with the conversion of cell-cell adhesions to cell-matrix adhesions.	Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Yamada, KM (corresponding author), Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA.		Sakai, Takayoshi/L-1456-2019	Sakai, Takayoshi/0000-0003-4348-4896; Larsen, Melinda/0000-0002-5026-2012; Yamada, Kenneth/0000-0003-1512-6805	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000525, ZIADE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000524, Z01DE000525] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BERNFIELD MR, 1972, J CELL BIOL, V52, P674, DOI 10.1083/jcb.52.3.674; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Davies JA, 2002, BIOESSAYS, V24, P937, DOI 10.1002/bies.10161; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; GILBERT SF, 1997, DEV BIOL, P683; GROBSTEIN C, 1953, NATURE, V172, P869, DOI 10.1038/172869a0; GROBSTEIN C, 1965, SCIENCE, V150, P626, DOI 10.1126/science.150.3696.626; HARDMAN P, 1992, ANAT REC, V234, P452, DOI 10.1002/ar.1092340315; Hay E.D., 1991, CELL BIOL EXTRACELLU, DOI 10.1007/978-1-4615-3770-0; Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172; Hogan BLM, 1998, CURR OPIN GENET DEV, V8, P481, DOI 10.1016/S0959-437X(98)80121-4; Hynes RO, 1990, FIBRONECTINS; Jiang ST, 2000, KIDNEY INT, V57, P1860, DOI 10.1046/j.1523-1755.2000.00035.x; KADOYA Y, 1995, J CELL BIOL, V129, P521, DOI 10.1083/jcb.129.2.521; Kashimata M, 2000, DEV BIOL, V220, P183, DOI 10.1006/dbio.2000.9639; Levenberg S, 1998, J CELL SCI, V111, P347; Menko AS, 2002, DEV DYNAM, V224, P321, DOI 10.1002/dvdy.10111; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; Mosher DF, 1989, FIBRONECTIN; NAKANISHI Y, 1986, DEV BIOL, V113, P201, DOI 10.1016/0012-1606(86)90122-3; NAKANISHI Y, 1988, DEVELOPMENT, V104, P51; NOGAWA H, 1991, DEVELOPMENT, V112, P855; Roman J, 1997, EXP LUNG RES, V23, P147, DOI 10.3109/01902149709074027; SAKAI T, 2002, CURRENT PROTOCOLS CE; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; SPOONER BS, 1972, DEV BIOL, V27, P38, DOI 10.1016/0012-1606(72)90111-X; Spooner BS, 1986, DEV BIOL COMPREHENSI, V3, P225; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; YAMADA KM, 1978, NATURE, V275, P179, DOI 10.1038/275179a0	30	387	394	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					876	881		10.1038/nature01712	http://dx.doi.org/10.1038/nature01712			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815434				2022-12-24	WOS:000183585300048
J	Whitney, D; Westwood, DA; Goodale, MA				Whitney, D; Westwood, DA; Goodale, MA			The influence of visual motion on fast reaching movements to a stationary object	NATURE			English	Article							PERCEIVED POSITION; SPACE; PERCEPTION; TARGET; HAND; DISPLACEMENT; INFORMATION; LOCATION; SYSTEMS; VISION	One of the most important functions of vision is to direct actions to objects(1). However, every time that vision is used to guide an action, retinal motion signals are produced by the movement of the eye and head as the person looks at the object or by the motion of other objects in the scene. To reach for the object accurately, the visuomotor system must separate information about the position of the stationary target from background retinal motion signals-a long-standing problem that is poorly understood(2-7). Here we show that the visuomotor system does not distinguish between these two information sources: when observers made fast reaching movements to a briefly presented stationary target, their hand shifted in a direction consistent with the motion of a distant and unrelated stimulus, a result contrary to most other findings(8,9). This can be seen early in the hand's trajectory (similar to120 ms) and occurs continuously from programming of the movement through to its execution. The visuomotor system might make use of the motion signals arising from eye and head movements to update the positions of targets rapidly and redirect the hand to compensate for body movements.	Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6A 5C2, Canada; Dalhousie Univ, Sch Hlth & Human Performance, Halifax, NS B3H 3J5, Canada	Western University (University of Western Ontario); Dalhousie University	Whitney, D (corresponding author), Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6A 5C2, Canada.		Goodale, Melvyn A/M-5907-2013	Goodale, Melvyn A/0000-0001-6748-0561; Westwood, David/0000-0003-3317-0447	NATIONAL EYE INSTITUTE [F32EY013899] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY013899-03, F32 EY013899, F32 EY013899-02, F32 EY013899-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABRAMS RA, 1990, PERCEPT PSYCHOPHYS, V47, P349, DOI 10.3758/BF03210875; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; [Anonymous], EYE MOVEMENTS THEIR; BACON JH, 1982, PERCEPT PSYCHOPHYS, V32, P353, DOI 10.3758/BF03206241; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; BLOUIN J, 1995, NEUROREPORT, V6, P1165, DOI 10.1097/00001756-199505300-00023; Brenner E, 1997, J MOTOR BEHAV, V29, P297, DOI 10.1080/00222899709600017; BRIDGEMAN B, 1979, J EXP PSYCHOL HUMAN, V5, P692, DOI 10.1037/0096-1523.5.4.692; Bridgeman B, 1997, PERCEPT PSYCHOPHYS, V59, P456, DOI 10.3758/BF03211912; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; Hayes A, 2000, P ROY SOC B-BIOL SCI, V267, P1341, DOI 10.1098/rspb.2000.1148; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; LEPECQ JC, 1993, PERCEPTION, V22, P49, DOI 10.1068/p220049; MASSON G, 1995, VISION RES, V35, P837, DOI 10.1016/0042-6989(94)00185-O; Nishida S, 1999, NATURE, V397, P610, DOI 10.1038/17600; PAULIGNAN Y, 1990, EXP BRAIN RES, V79, P431, DOI 10.1007/BF00608255; PELISSON D, 1986, EXP BRAIN RES, V62, P303; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; Sheth BR, 2000, PERCEPTION, V29, P1279, DOI 10.1068/p3114; SMEETS JBJ, 1995, J EXP PSYCHOL HUMAN, V21, P19, DOI 10.1037/0096-1523.21.1.19; Snowden RJ, 1998, CURR BIOL, V8, P1343, DOI 10.1016/S0960-9822(07)00567-2; Whitaker D, 1999, VISION RES, V39, P2999, DOI 10.1016/S0042-6989(99)00010-3; Whitney D, 2000, NAT NEUROSCI, V3, P954, DOI 10.1038/78878; WONG E, 1981, ACTA PSYCHOL, V48, P123, DOI 10.1016/0001-6918(81)90054-8; Yamagishi N, 2001, P ROY SOC B-BIOL SCI, V268, P973, DOI 10.1098/rspb.2001.1603	30	93	93	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					869	873		10.1038/nature01693	http://dx.doi.org/10.1038/nature01693			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	691BQ	12815432	Green Accepted			2022-12-24	WOS:000183585300046
J	Ellwood, BB; Benoist, SL; El Hassani, A; Wheeler, C; Crick, RE				Ellwood, BB; Benoist, SL; El Hassani, A; Wheeler, C; Crick, RE			Impact ejecta layer from the mid-Devonian: Possible connection to global mass extinctions	SCIENCE			English	Article							MAGNETOSUSCEPTIBILITY EVENT; CYCLOSTRATIGRAPHY MSEC; ANTI-ATLAS; BOUNDARY; MOROCCO; MOUNDS; ROCKS	We have found evidence for a bolide impacting Earth in the mid-Devonian (similar to380 million years ago), including high concentrations of shocked quartz, Ni, Cr, As, V, and Co anomalies; a large negative carbon isotope shift (-9 per mil); and microspherules and microcrysts at Jebel Mech Irdane in the Anti Atlas desert near Rissani, Morocco. This impact is important because it is coincident with a major global extinction event (Kacak/otomari event), suggesting a possible cause-and-effect relation between the impact and the extinction. The result may represent the extinction of as many as 40% of all living marine animal genera.	Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA; Inst Sci, Dept Geol, Rabat, Morocco; Univ Texas, Dept Geol, Arlington, TX 76019 USA	Louisiana State University System; Louisiana State University; Mohammed V University in Rabat; University of Texas System; University of Texas Arlington	Ellwood, BB (corresponding author), Louisiana State Univ, Dept Geol & Geophys, E235 Howe Russell Geosci Complex, Baton Rouge, LA 70803 USA.			EL HASSANI, Ahmed/0000-0002-2272-817X				Crick RE, 1997, EPISODES, V20, P167, DOI 10.18814/epiiugs/1997/v20i3/004; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Ellwood BB, 2003, EARTH PLANET SC LETT, V206, P529, DOI 10.1016/S0012-821X(02)01124-X; Ellwood BB, 2000, GEOLOGY, V28, P1135, DOI 10.1130/0091-7613(2000)028<1135:MEACMA>2.3.CO;2; Ellwood BB, 1999, AAPG BULL, V83, P1119; FRENCH BM, 1998, LUNAR PLANET I CONTR, V954; GRIEVE RAF, 1988, CAN J EARTH SCI, V25, P1530, DOI 10.1139/e88-144; HLADIL J, 2002, CORAL RES B, V7, P65; HOUSE MR, 1985, NATURE, V313, P17, DOI 10.1038/313017a0; HSU KJ, 1985, NATURE, V316, P809, DOI 10.1038/316809a0; IRWIN H, 1977, NATURE, V269, P209, DOI 10.1038/269209a0; JOHNSON JG, 1985, GEOL SOC AM BULL, V96, P567, DOI 10.1130/0016-7606(1985)96<567:DEFIE>2.0.CO;2; Kaufmann B, 1997, J SEDIMENT RES, V67, P945; KUMP LR, 1991, GEOLOGY, V19, P299, DOI 10.1130/0091-7613(1991)019<0299:ICIESO>2.3.CO;2; KVENVOLDEN KA, 1993, REV GEOPHYS, V31, P173, DOI 10.1029/93RG00268; Salvador A, 1994, INT STRATIGRAPHIC GU; SMIT J, 1997, MICROPALEONTOLOGY, V29, P65; SMIT J, 1982, CRETACEOUS RES, V3, P307, DOI DOI 10.1016/0195-6671(82)90031-3; SPEKOSKI JJ, 1996, GLOBAL EVENTS EVENT, P35; TALENT JA, 1993, PALAEOGEOGR PALAEOCL, V104, P139, DOI 10.1016/0031-0182(93)90126-4; Walliser OH, 1995, EPISODES, V18, P107, DOI 10.18814/epiiugs/1995/v18i3/002; Wendt J, 1997, J SEDIMENT RES, V67, P424	22	39	42	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2003	300	5626					1734	1737		10.1126/science.1081544	http://dx.doi.org/10.1126/science.1081544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805544				2022-12-24	WOS:000183459700047
J	Zhao, J; Kilman, VL; Keegan, KP; Peng, Y; Emery, P; Rosbash, M; Allada, R				Zhao, J; Kilman, VL; Keegan, KP; Peng, Y; Emery, P; Rosbash, M; Allada, R			Drosophila clock can generate ectopic circadian clocks	CELL			English	Article							PER-TIM COMPLEX; MUSHROOM BODIES; TIMELESS GENES; EXPRESSION; TRANSCRIPTION; RHYTHMS; PROTEIN; VRILLE; FLIES; PHOTORECEPTORS	Circadian rhythms of behavior, physiology, and gene expression are present in diverse tissues and organisms. The function of the transcriptional activator, Clock, is necessary in both Drosophila and mammals for the expression of many core clock components. We demonstrate in Drosophila that Clock misexpression in naive brain regions induces circadian gene expression. This includes major components of the pacemaker program, as Clock also activates the rhythmic expression of cryptochrome, a gene that CLOCK normally represses. Moreover, this ectopic clock expression has potent effects on behavior, radically altering locomotor activity patterns. We propose that Clock is uniquely able to induce and organize the core elements of interdependent feedback loops necessary for circadian rhythms.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA	Northwestern University; Brandeis University; Howard Hughes Medical Institute	Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.							Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Bae K, 2000, J NEUROSCI, V20, P1746; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Bonini NM, 1997, DEVELOPMENT, V124, P4819; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 1997, J NEUROSCI, V17, P6745; Kaneko M, 1998, CURR OPIN NEUROBIOL, V8, P652, DOI 10.1016/S0959-4388(98)80095-0; Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Moreau-Fauvarque C, 1998, MECH DEVELOP, V78, P47, DOI 10.1016/S0925-4773(98)00147-6; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; YANG MY, 1995, NEURON, V15, P45	36	101	102	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 13	2003	113	6					755	766		10.1016/S0092-8674(03)00400-8	http://dx.doi.org/10.1016/S0092-8674(03)00400-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809606	Bronze			2022-12-24	WOS:000183514400010
J	Hannan, EL; Racz, MJ; Walford, G; Ryan, TJ; Isom, OW; Bennett, E; Jones, RH				Hannan, EL; Racz, MJ; Walford, G; Ryan, TJ; Isom, OW; Bennett, E; Jones, RH			Predictors of readmission for complications of coronary artery bypass graft surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEW-YORK-STATE; HOSPITAL READMISSION; OUTCOMES; QUALITY; MORTALITY; CHOICE; RATES; CARE	Context Risk factors for perioperative mortality after coronary artery bypass graft (CABG) surgery have been extensively studied. However, which factors are associated with early readmissions following CABG surgery are less clear. Objective To identify significant predictors of readmission within 30 days following CABG surgery. Design, Setting, and Patients Causes for readmission within 30 days were investigated for all patients discharged after CABG surgery in the state of New York from January 1, 1999, through December 31, 1999. A variety of patient demographics, preoperative risk factors, complications, operative and postoperative factors, and provider characteristics were considered as potential predictors of readmissions. Main Outcome Measure Hospital readmissions within 30 days of discharge following CABG surgery. Results Of 16325 total patients, 2111 (12.9%) were readmitted within 30 days for reasons related to CABG surgery. The most common causes of readmission were postsurgical infection (n=598 [28%]) and heart failure (n=331 [16%]). Eleven risk factors were found to be independently associated with higher readmission rates: older age, female sex, African American race, greater body surface area, previous myocardial infarction within 1 week, and 6 comorbidities. After controlling for these preoperative patient-level risk factors, 2 provider characteristics (annual surgeon CABG volume <100, hospital risk-adjusted mortality rate in the highest decile) and 2 postoperative factors (discharge to nursing home or rehabilitation/acute care facility, length of stay during index CABG admission of &GE;5 days) were also related to higher readmission rates. Conclusions Readmission within 30 days following discharge is an important adverse outcome of CABG surgery. Continued attempts should be made to explore the potential of readmission as a supplement to mortality in assessing provider quality.	SUNY Albany, Sch Publ Hlth, Dept Hlth Policy Management & Behav, Rensselaer, NY 12144 USA; St Josephs Hosp, Cardiac Catheterizat Lab, Syracuse, NY USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; New York Hosp Cornell, Dept Cardiothorac Surg, New York, NY USA; St Peters Hosp, Dept Cardiac Surg, Albany, NY USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Boston University; NewYork-Presbyterian Hospital; Duke University	Hannan, EL (corresponding author), SUNY Albany, Sch Publ Hlth, Dept Hlth Policy Management & Behav, 1 Univ Pl, Rensselaer, NY 12144 USA.							*AM HEART ASS, 2002, 2002 HEART STROK STA; Cowper PA, 1997, J AM COLL CARDIOL, V30, P908, DOI 10.1016/S0735-1097(97)00243-X; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HANNAN EL, 1990, JAMA-J AM MED ASSOC, V264, P2768, DOI 10.1001/jama.264.21.2768; HANNAN EL, 1995, JAMA-J AM MED ASSOC, V273, P209, DOI 10.1001/jama.273.3.209; HANNAN EL, 1994, ANN THORAC SURG, V58, P1852, DOI 10.1016/0003-4975(94)91726-4; HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; Kiefe C, 1999, MED CARE, V37, P621, DOI 10.1097/00005650-199907000-00001; *NJ DEP HLTH SEN S, 1997, COR ART BYP GRAFT SU; *NY STAT DEP HLTH, 2002, COR ART BYP SURG NEW; OCONNOR GT, 1992, CIRCULATION, V85, P2110, DOI 10.1161/01.CIR.85.6.2110; *PA HLTH CAR COST, 2002, PENNS GUID COR ART B; *PAC BUS GROUP HLT, 2001, CAL REP COR ART BYP; *PENNS HLTH CAR CO, 2001, HOSP READM FOLL COR; RILEY G, 1993, MED CARE, V31, P921, DOI 10.1097/00005650-199310000-00005; ROSENTHAL GE, 1994, JOINT COMM J QUAL IM, V20, P425, DOI 10.1016/S1070-3241(16)30088-8; Silber JH, 1997, INT J QUAL HEALTH C, V9, P193, DOI 10.1093/intqhc/9.3.193; SILBER JH, 1995, JAMA-J AM MED ASSOC, V274, P317, DOI 10.1001/jama.274.4.317; STANTON BA, 1985, JAMA-J AM MED ASSOC, V253, P3568; Steuer J, 2002, ANN THORAC SURG, V73, P1380, DOI 10.1016/S0003-4975(02)03467-7; Stewart RD, 2000, ANN THORAC SURG, V70, P169, DOI 10.1016/S0003-4975(00)01386-2; Thomas JW, 1996, INQUIRY-J HEALTH CAR, V33, P258; Tu JV, 1998, CAN MED ASSOC J, V159, P221; *US DEP HHS, 1998, INT CLASS DIS; Zitser-Gurevich Y, 1999, MED CARE, V37, P625, DOI 10.1097/00005650-199907000-00002	26	190	193	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2003	290	6					773	780		10.1001/jama.290.6.773	http://dx.doi.org/10.1001/jama.290.6.773			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	709VU	12915430	Bronze			2022-12-24	WOS:000184647700028
J	Seidenbecher, T; Laxmi, TR; Stork, O; Pape, HC				Seidenbecher, T; Laxmi, TR; Stork, O; Pape, HC			Amygdalar and hippocampal theta rhythm synchronization during fear memory retrieval	SCIENCE			English	Article							LONG-TERM POTENTIATION; BASOLATERAL AMYGDALA; IN-VIVO; SYNAPTIC PLASTICITY; PERIRHINAL CORTEX; LATERAL AMYGDALA; CONSCIOUS CATS; DENTATE GYRUS; STIMULATION; OSCILLATIONS	The amygdalohippocampal circuit plays a pivotal role in Pavlovian fear memory. We simultaneously recorded electrical activity in the lateral amygdala (LA) and the CA1 area of the hippocampus in freely behaving fear-conditioned mice. Patterns of activity were related to fear behavior evoked by conditioned and indifferent sensory stimuli and contexts. Rhythmically synchronized activity at theta frequencies increased between the LA and the CA1 after fear conditioning and became significant during confrontation with conditioned fear stimuli and expression of freezing behavior. Synchronization of theta activities in the amygdalohippocampal network represents a neuronal correlate of conditioned fear, apt to improve neuronal communication during memory retrieval.	Otto Von Guericke Univ, Inst Physiol, D-39120 Magdeburg, Germany	Otto von Guericke University	Pape, HC (corresponding author), Otto Von Guericke Univ, Inst Physiol, Leipziger Str 44, D-39120 Magdeburg, Germany.		Laxmi, T. R./T-9769-2019	Laxmi, T. R./0000-0001-8147-9559; Stork, Oliver/0000-0003-4285-7507				Akirav I, 1999, J NEUROSCI, V19, P10530; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 2000, PROG BRAIN RES, V126, P29; CAHILL L, 2001, AMYGDALA FUNCTIONAL, P425; Collins DR, 1999, NEUROSCIENCE, V89, P1025, DOI 10.1016/S0306-4522(98)00396-0; Frey S, 2001, J NEUROSCI, V21, P3697, DOI 10.1523/JNEUROSCI.21-10-03697.2001; Heinbockel T, 2000, J NEUROSCI, V20; IKEGAYA Y, 1994, BRAIN RES, V656, P157, DOI 10.1016/0006-8993(94)91377-3; IKEGAYA Y, 1995, J NEUROPHYSIOL, V74, P2201, DOI 10.1152/jn.1995.74.5.2201; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; MAREN S, 1995, J NEUROSCI, V15, P7548; Maren S, 2001, NEUROBIOL LEARN MEM, V76, P268, DOI 10.1006/nlme.2001.4042; PACKARD MG, 1994, P NATL ACAD SCI USA, V91, P8477, DOI 10.1073/pnas.91.18.8477; Pape HC, 1998, J NEUROPHYSIOL, V79, P205, DOI 10.1152/jn.1998.79.1.205; PARE D, 1995, J NEUROPHYSIOL, V74, P1179, DOI 10.1152/jn.1995.74.3.1179; Pare D, 1996, J NEUROSCI, V16, P3334; Pare D, 2000, J NEUROSCI, V20, P2701; Pare D, 2002, TRENDS COGN SCI, V6, P306, DOI 10.1016/S1364-6613(02)01924-1; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Vertes RP, 2001, NEUROSCIENCE, V104, P619, DOI 10.1016/S0306-4522(01)00131-2; Vertes RP, 1997, NEUROSCIENCE, V81, P893; Willingham DB, 1997, NEURON, V18, P5, DOI 10.1016/S0896-6273(01)80040-4	28	525	534	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					846	850		10.1126/science.1085818	http://dx.doi.org/10.1126/science.1085818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907806				2022-12-24	WOS:000184615700049
J	Goriely, A; McVean, GAT; Rojmyr, M; Ingemarsson, B; Wilkie, AOM				Goriely, A; McVean, GAT; Rojmyr, M; Ingemarsson, B; Wilkie, AOM			Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line	SCIENCE			English	Article								Observed mutation rates in humans appear higher in male than female gametes and often increase with paternal age. This bias, usually attributed to the accumulation of replication errors or inefficient repair processes, has been difficult to study directly. Here, we describe a sensitive method to quantify substitutions at nucleotide 755 of the fibroblast growth factor receptor 2 (FGFR2) gene in sperm. Although substitution levels increase with age, we show that even high levels originate from infrequent mutational events. We propose that these FGFR2 mutations, although harmful to embryonic development, are paradoxically enriched because they confer a selective advantage to the spermatogonial cells in which they arise.	Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DS, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Pyrosequencing AB, SE-75228 Uppsala, Sweden	University of Oxford; University of Oxford; University of Oxford	Wilkie, AOM (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.		Wilkie, Andrew/AAC-3820-2020; Goriely, Anne/AAR-1133-2020	Wilkie, Andrew/0000-0002-2972-5481; Goriely, Anne/0000-0001-9229-7216				Anderson J, 1998, HUM MOL GENET, V7, P1475, DOI 10.1093/hmg/7.9.1475; COHEN MM, 1992, AM J MED GENET, V42, P655, DOI 10.1002/ajmg.1320420505; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Ibrahimi OA, 2001, P NATL ACAD SCI USA, V98, P7182, DOI 10.1073/pnas.121183798; Jang JH, 2001, CANCER RES, V61, P3541; Kan S, 2002, AM J HUM GENET, V70, P472, DOI 10.1086/338758; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Lajeunie E, 1999, J NEUROSURG, V90, P443, DOI 10.3171/jns.1999.90.3.0443; Li WH, 2002, CURR OPIN GENET DEV, V12, P650, DOI 10.1016/S0959-437X(02)00354-4; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; MUENKE M, 2001, METABOLIC MOL BASES, P6117; Nachman MW, 2000, GENETICS, V156, P297; Oldridge M, 1997, HUM MOL GENET, V6, P137, DOI 10.1093/hmg/6.1.137; OROURKE AW, UNPUB; Otto SP, 1998, GENETICA, V102-3, P507, DOI 10.1023/A:1017074823337; RISCH N, 1987, AM J HUM GENET, V41, P218; Tiemann-Boege I, 2002, P NATL ACAD SCI USA, V99, P14952, DOI 10.1073/pnas.232568699; Tolarova MM, 1997, AM J MED GENET, V72, P394, DOI 10.1002/(SICI)1096-8628(19971112)72:4<394::AID-AJMG4>3.0.CO;2-R; Tomlinson IPM, 1996, P NATL ACAD SCI USA, V93, P14800, DOI 10.1073/pnas.93.25.14800; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Wilkie AOM, 2002, AM J MED GENET, V112, P266, DOI 10.1002/ajmg.10775; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536	24	203	215	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					643	646		10.1126/science.1085710	http://dx.doi.org/10.1126/science.1085710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893942				2022-12-24	WOS:000184473600039
J	Gu, C; Jan, YN; Jan, LY				Gu, C; Jan, YN; Jan, LY			A conserved domain in axonal targeting of Kv1 (shaker) voltage-gated potassium channels	SCIENCE			English	Article							BETA-SUBUNIT; K+ CHANNEL; SURFACE; RELEASE; MICE; GENE	Axonal voltage-gated potassium (Kv1) channels regulate action-potential invasion and hence transmitter release. Although evolutionarily conserved, what mediates their axonal targeting is not known. We found that Kv1 axonal targeting required its T1 tetramerization domain. When fused to unpolarized CD4 or dendritic transferrin receptor, T1 promoted their axonal surface expression. Moreover, T1 mutations eliminating Kvbeta association compromised axonal targeting, but not surface expression, of CD4-T1 fusion proteins. Thus, proper association of Kvbeta with the Kv1 T1 domain is essential for axonal targeting.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.		Gu, Chen/E-3163-2011	Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498				Baccus SA, 2000, J NEUROPHYSIOL, V83, P1693, DOI 10.1152/jn.2000.83.3.1693; Brody DL, 2000, J NEUROSCI, V20, P2480; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Campomanes CR, 2002, J BIOL CHEM, V277, P8298, DOI 10.1074/jbc.M110276200; Debanne D, 1997, NATURE, V390, P536, DOI 10.1038/37406; Fili O, 2001, J NEUROSCI, V21, P1964, DOI 10.1523/JNEUROSCI.21-06-01964.2001; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hattan D, 2002, J BIOL CHEM, V277, P38596, DOI 10.1074/jbc.M205005200; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; Kosolapov A, 2003, J BIOL CHEM, V278, P4305, DOI 10.1074/jbc.M209422200; Lambe EK, 2001, J NEUROSCI, V21, P9955, DOI 10.1523/JNEUROSCI.21-24-09955.2001; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Zhou L, 1998, J NEUROSCI, V18, P7200	23	126	130	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					646	649		10.1126/science.1086998	http://dx.doi.org/10.1126/science.1086998			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893943				2022-12-24	WOS:000184473600040
J	de Lemos, JA; McGuire, DK; Drazner, MH				de Lemos, JA; McGuire, DK; Drazner, MH			B-type natriuretic peptide in cardiovascular disease	LANCET			English	Review							CHRONIC HEART-FAILURE; N-TERMINAL PROATRIAL; LEFT-VENTRICULAR DYSFUNCTION; BETA-BLOCKER THERAPY; NEUROHORMONAL ACTIVATION; DIASTOLIC DYSFUNCTION; PROGNOSTIC VALUE; GENE-EXPRESSION; PLASMA-LEVELS; DOUBLE-BLIND	Natriuretic peptide hormones, a family of vasoactive peptides with many favourable physiological properties, have emerged as important candidates for development of diagnostic tools and therapeutic agents in cardiovascular disease. The rapid incorporation into clinical practice of bioassays to measure natriuretic peptide concentrations, and drugs that augment the biological actions of this system, show the potential for translational research to improve patient care. Here, we focus on the physiology of the natriuretic peptide system, measurement of circulating concentrations of B-type natriuretic peptide (BNP) and the N-terminal fragment of its prohormone (N-terminal SNP) to diagnose heart failure and left ventricular dysfunction, measurement of BNP and N-terminal BNP to assess prognosis in patients with cardiac abnormalities, and use of recombinant human BNP (nesiritide) and vasopeptidase inhibitors to treat heart failure.	Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	de Lemos, JA (corresponding author), Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA.	james.delemos@utsouthwestern.edu	de Lemos, James/ABD-6669-2021					Abraham W T, 1998, J Card Fail, V4, P37, DOI 10.1016/S1071-9164(98)90506-1; ATARASHI K, 1985, J CLIN INVEST, V76, P1807, DOI 10.1172/JCI112172; Bando M, 1999, RESP MED, V93, P507, DOI 10.1016/S0954-6111(99)90094-X; Berger R, 2002, CIRCULATION, V105, P2392, DOI 10.1161/01.CIR.0000016642.15031.34; Bolger AP, 2002, CIRCULATION, V106, P92, DOI 10.1161/01.CIR.0000020009.30736.3F; Bruneau BG, 1997, AM J PHYSIOL-HEART C, V273, pH2678, DOI 10.1152/ajpheart.1997.273.6.H2678; Brunner-La Rocca HP, 2001, J AM COLL CARDIOL, V37, P1221, DOI 10.1016/S0735-1097(01)01172-X; Burger AJ, 2001, AM J CARDIOL, V88, P35, DOI 10.1016/S0002-9149(01)01581-8; BURNETT JC, 1984, AM J PHYSIOL, V247, pF863, DOI 10.1152/ajprenal.1984.247.5.F863; CAO L, 1995, HYPERTENSION, V25, P227, DOI 10.1161/01.HYP.25.2.227; CHARLES CJ, 1995, PEPTIDES, V16, P129, DOI 10.1016/0196-9781(94)00160-8; Cheng V, 2001, J AM COLL CARDIOL, V37, P386, DOI 10.1016/S0735-1097(00)01157-8; CHRISTENSEN G, 1991, CIRC RES, V68, P638, DOI 10.1161/01.RES.68.3.638; Cirillo W, 2000, CIRCULATION, V101, P378, DOI 10.1161/01.CIR.101.4.378; CLARKSON PBM, 1995, CLIN SCI, V88, P159, DOI 10.1042/cs0880159; Colucci WS, 2000, NEW ENGL J MED, V343, P246, DOI 10.1056/NEJM200007273430403; Corti R, 2001, CIRCULATION, V104, P1856, DOI 10.1161/hc4001.097191; Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5; Dao Q, 2001, J AM COLL CARDIOL, V37, P379, DOI 10.1016/S0735-1097(00)01156-6; DAVIS M, 1994, LANCET, V343, P440, DOI 10.1016/S0140-6736(94)92690-5; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; Doyama K, 1998, J AM COLL CARDIOL, V32, P1832, DOI 10.1016/S0735-1097(98)00494-X; EDWARDS BS, 1988, CIRC RES, V62, P191, DOI 10.1161/01.RES.62.2.191; FLORAS JS, 1990, CIRCULATION, V81, P1860, DOI 10.1161/01.CIR.81.6.1860; HAMA N, 1995, CIRCULATION, V92, P1558, DOI 10.1161/01.CIR.92.6.1558; Hammerer-Lercher A, 2001, CLIN CHIM ACTA, V310, P193, DOI 10.1016/S0009-8981(01)00578-2; Harrison A, 2002, ANN EMERG MED, V39, P131, DOI 10.1067/mem.2002.121483; HENRY JP, 1956, J PHYSIOL-LONDON, V131, P572, DOI 10.1113/jphysiol.1956.sp005483; Hobbs RE, 1996, AM J CARDIOL, V78, P896, DOI 10.1016/S0002-9149(96)00464-X; HOLMES SJ, 1993, J CLIN ENDOCR METAB, V76, P91, DOI 10.1210/jc.76.1.91; HOSODA K, 1991, HYPERTENSION, V17, P1152, DOI 10.1161/01.HYP.17.6.1152; HUNT PJ, 1994, J CLIN ENDOCR METAB, V78, P1428, DOI 10.1210/jc.78.6.1428; Ishii J, 2000, CLIN CHIM ACTA, V301, P19, DOI 10.1016/S0009-8981(00)00312-0; Isnard R, 2000, AM J CARDIOL, V86, P417, DOI 10.1016/S0002-9149(00)00957-7; ITOH H, 1990, J CLIN INVEST, V86, P1690, DOI 10.1172/JCI114893; Jernberg T, 2002, J AM COLL CARDIOL, V40, P437, DOI 10.1016/S0735-1097(02)01986-1; Johnson W, 2002, J AM COLL CARDIOL, V39, P1623, DOI 10.1016/S0735-1097(02)01814-4; KANGAWA K, 1984, BIOCHEM BIOPH RES CO, V119, P933, DOI 10.1016/0006-291X(84)90863-5; Kawai K, 2001, AM HEART J, V141, P925, DOI 10.1067/mhj.2001.115435; Kazanegra R, 2001, J CARD FAIL, V7, P21, DOI 10.1054/jcaf.2001.23355; KISCH B, 1956, Exp Med Surg, V14, P99; Klapholz M, 2001, AM J CARDIOL, V88, P657, DOI 10.1016/S0002-9149(01)01809-4; Koglin J, 2001, J AM COLL CARDIOL, V38, P1934, DOI 10.1016/S0735-1097(01)01672-2; LADENSON PW, 1988, ENDOCRINOLOGY, V123, P652, DOI 10.1210/endo-123-1-652; Lainchbury JG, 1997, HYPERTENSION, V30, P398, DOI 10.1161/01.HYP.30.3.398; Latini R, 2002, CIRCULATION, V106, P2454, DOI 10.1161/01.CIR.0000036747.68104.AC; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; Luchner A, 2000, J HYPERTENS, V18, P1121, DOI 10.1097/00004872-200018080-00018; Maeda K, 2000, J AM COLL CARDIOL, V36, P1587, DOI 10.1016/S0735-1097(00)00912-8; Maisel AS, 2001, AM HEART J, V141, P367, DOI 10.1067/mhj.2001.113215; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Mallamaci F, 2001, KIDNEY INT, V59, P1559, DOI 10.1046/j.1523-1755.2001.0590041559.x; Marcus LS, 1996, CIRCULATION, V94, P3184, DOI 10.1161/01.CIR.94.12.3184; MARGULIES KB, 1995, CIRCULATION, V91, P2036, DOI 10.1161/01.CIR.91.7.2036; MARINGREZ M, 1986, NATURE, V324, P473, DOI 10.1038/324473a0; Matsuo K, 1998, CIRCULATION, V98, P2433, DOI 10.1161/01.CIR.98.22.2433; McClean DR, 2000, J AM COLL CARDIOL, V36, P479, DOI 10.1016/S0735-1097(00)00741-5; McCullough PA, 2002, CIRCULATION, V106, P416, DOI 10.1161/01.CIR.0000025242.79963.4C; McDonagh TA, 2001, HEART, V86, P21, DOI 10.1136/heart.86.1.21; Messerli FH, 2000, LANCET, V356, P608, DOI 10.1016/S0140-6736(00)02596-4; MINAMINO N, 1991, BIOCHEM BIOPH RES CO, V179, P535, DOI 10.1016/0006-291X(91)91404-Z; Mitchell GF, 2002, CIRCULATION, V105, P2955, DOI 10.1161/01.CIR.0000020500.77568.3C; Mizuno Y, 2000, AM J CARDIOL, V86, P1036, DOI 10.1016/S0002-9149(00)01147-4; Morrison LK, 2002, J AM COLL CARDIOL, V39, P202, DOI 10.1016/S0735-1097(01)01744-2; MOTWANI JG, 1993, LANCET, V341, P1109, DOI 10.1016/0140-6736(93)93126-L; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; Murdoch DR, 1999, AM HEART J, V138, P1126, DOI 10.1016/S0002-8703(99)70079-7; Nagaya N, 1998, AM HEART J, V135, P21, DOI 10.1016/S0002-8703(98)70338-2; Nagaya N, 1998, J AM COLL CARDIOL, V31, P202, DOI 10.1016/S0735-1097(97)00452-X; Nagaya N, 2000, CIRCULATION, V102, P865; NAKAMURA S, 1991, AM J HYPERTENS, V4, P909, DOI 10.1093/ajh/4.11.909; NAKAO K, 1991, CAN J PHYSIOL PHARM, V69, P1500, DOI 10.1139/y91-225; Nishimori T, 1997, J MOL CELL CARDIOL, V29, P2125, DOI 10.1006/jmcc.1997.0460; Okumura H, 2000, ACTA HAEMATOL-BASEL, V104, P158, DOI 10.1159/000046508; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; Omland T, 1996, HEART, V76, P232, DOI 10.1136/hrt.76.3.232; Omland T, 2002, AM J CARDIOL, V89, P463, DOI 10.1016/S0002-9149(01)02271-8; Onuoha GN, 1998, NEUROPEPTIDES, V32, P319, DOI 10.1016/S0143-4179(98)90054-3; Osca JQ, 2001, CIRCULATION, V104, P501; Packer M, 2002, CIRCULATION, V106, P920, DOI 10.1161/01.CIR.0000029801.86489.50; PUCCI A, 1992, INT J CARDIOL, V34, P237, DOI 10.1016/0167-5273(92)90020-4; Qi W, 2001, AM HEART J, V142, P725, DOI 10.1067/mhj.2001.117131; Rame JE, 2001, AM HEART J, V142, P714, DOI 10.1067/mhj.2001.118473; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; RICHARDS AM, 1988, J CLIN ENDOCR METAB, V67, P1134, DOI 10.1210/jcem-67-6-1134; Richards AM, 1998, CIRCULATION, V97, P1921, DOI 10.1161/01.CIR.97.19.1921; Richards AM, 1999, HEART, V81, P114, DOI 10.1136/hrt.81.2.114; Richards AM, 1999, CIRCULATION, V99, P786, DOI 10.1161/01.CIR.99.6.786; Richards AM, 2001, J AM COLL CARDIOL, V37, P1781, DOI 10.1016/S0735-1097(01)01269-4; RICHARDS AM, 1993, BRIT HEART J, V69, P414; RIDDERVOLD F, 1991, AM J PHYSIOL, V260, pH1953, DOI 10.1152/ajpheart.1991.260.6.H1953; Rouleau JL, 2000, LANCET, V356, P615, DOI 10.1016/S0140-6736(00)02602-7; SANDERSON JE, 1995, BRIT HEART J, V74, P502; SONNENBERG JL, 1988, PEPTIDES, V9, P173, DOI 10.1016/0196-9781(88)90024-1; Stanek B, 2001, J AM COLL CARDIOL, V38, P436, DOI 10.1016/S0735-1097(01)01383-3; Struthers AD, 2002, LANCET, V359, P1430, DOI 10.1016/S0140-6736(02)08358-7; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; SUGA S, 1992, J CLIN INVEST, V90, P1145, DOI 10.1172/JCI115933; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; SUMIDA H, 1995, J AM COLL CARDIOL, V25, P1105, DOI 10.1016/0735-1097(94)00525-U; Takemura G, 1998, J AM COLL CARDIOL, V31, P754, DOI 10.1016/S0735-1097(98)00045-X; TONOLO G, 1989, CIRCULATION, V80, P893, DOI 10.1161/01.CIR.80.4.893; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; Tsutamoto T, 2001, J AM COLL CARDIOL, V37, P1228, DOI 10.1016/S0735-1097(01)01116-0; *UMAC INV, 2002, JAMA-J AM MED ASSOC, V287, P1531; van Veldhuisen DJ, 1998, J AM COLL CARDIOL, V32, P1811, DOI 10.1016/S0735-1097(98)00464-1; Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252; Wallen T, 1997, HEART, V77, P264, DOI 10.1136/hrt.77.3.264; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5; Wiese S, 2000, CIRCULATION, V102, P3074; Williams ES, 2002, J AM COLL CARDIOL, V40, P1; Yamamoto K, 1996, HYPERTENSION, V28, P988, DOI 10.1161/01.HYP.28.6.988; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195; YOSHIMURA M, 1993, CIRCULATION, V87, P464, DOI 10.1161/01.CIR.87.2.464; Yu CM, 1996, EUR HEART J, V17, P1694	117	793	811	0	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					316	322		10.1016/S0140-6736(03)13976-1	http://dx.doi.org/10.1016/S0140-6736(03)13976-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892964				2022-12-24	WOS:000184413400025
J	Kikule, E				Kikule, E			A good death in Uganda: survey of needs for palliative care for terminally ill people in urban areas	BRITISH MEDICAL JOURNAL			English	Article								Objective To identify the palliative care needs of terminally ill people in Uganda. Design Descriptive cross sectional study. Setting Home care programmes in and around Kampala that look after terminally ill people in their homes. Participants 173 terminally ill patients registered with the home care programmes. Results Most of the participants had either HIV/AIDS or cancer or both; 145 were aged under 50 years, and 107 were women. Three main needs were identified: the control or relief of pain and other symptoms; counselling; and financial assistance for basic needs such as food, shelter, and school fees for their children. The preferred site of care was the home, though all these people lived in urban areas with access to healthcare services within 5 kin of their homes. Conclusion A "good death" in a developing country occurs when the dying person is being cared for at home, is free from pain or other distressing symptoms, feels no stigma, is at peace, and has their basic needs met without feeling dependent on others.	Hospice Africa Uganda, Kampala, Uganda		Kikule, E (corresponding author), Hospice Africa Uganda, POB 7757, Kampala, Uganda.							KATABIRA E, 1998, WORLD HLTH, P16; Kish L, 1965, SURVEY SAMPLING; *MIN ENV, 1999, POLL CHECK RES 98 EV, P10; Murray SA, 2003, BRIT MED J, V326, P368, DOI 10.1136/bmj.326.7385.368; OKUONZI SA, 2003, UGANDA HLTH B J  JAN, P9; REGNARD FBC, 1998, GUIDE SYMPTOM RELIEF; SIMS R, 1995, TERMINAL CARE PEOPLE, P1; *UN DEV PROGR, 2000, UG HUM DEV REP; *UNAIDS WHO, 1998, AIDS EP UPD DEC, P1; 1990, WHO TECH REP SER, V804, P1	10	72	73	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2003	327	7408					192	194		10.1136/bmj.327.7408.192	http://dx.doi.org/10.1136/bmj.327.7408.192			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706DL	12881259	Green Published, Bronze			2022-12-24	WOS:000184437300015
J	Swingler, S; Brichacek, B; Jacque, JM; Ulich, C; Zhou, J; Stevenson, M				Swingler, S; Brichacek, B; Jacque, JM; Ulich, C; Zhou, J; Stevenson, M			HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection	NATURE			English	Article							T-CELLS; ACTIVATION; REPLICATION; VIRUS; LYMPHOCYTES; INHIBITION; EVASION; THERAPY	All primate lentiviruses (HIV-1, HIV-2, SIV) encode Nef proteins, which are important for viral replication and pathogenicity in vivo(1-3). It is not known how Nef regulates these processes. It has been suggested that Nef protects infected cells from apoptosis and recognition by cytotoxic T lymphocytes(4-6). Other studies suggest that Nef influences the activation state of the infected cell, thereby enhancing the ability of that cell to support viral replication(7-10). Here we show that macrophages that express Nef or are stimulated through the CD40 receptor release a paracrine factor that renders T lymphocytes permissive to HIV-1 infection. This activity requires the upregulation of B-cell receptors involved in the alternative pathway of T-lymphocyte stimulation. T lymphocytes stimulated through this pathway become susceptible to viral infection without progressing through the cell cycle. We identify two proteins, soluble CD23 and soluble ICAM, that are induced from macrophages by Nef and CD40L, and which mediate their effects on lymphocyte permissivity. Our results reveal a mechanism by which Nef expands the cellular reservoir of HIV-1 by permitting the infection of resting T lymphocytes.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Stevenson, M (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.		Jacque, Jean-Marc/B-6875-2008		NIAID NIH HHS [R01 AI032890, R01 AI037475] Funding Source: Medline; NIMH NIH HHS [R01 MH093306, R01 MH064411] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Chambers CA, 2001, TRENDS IMMUNOL, V22, P217, DOI 10.1016/S1471-4906(01)01868-3; Collins KL, 1999, IMMUNOL REV, V168, P65, DOI 10.1111/j.1600-065X.1999.tb01283.x; Davis SJ, 1996, SCIENCE, V273, P1241, DOI 10.1126/science.273.5279.1241; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Eckstein DA, 2001, J EXP MED, V194, P1407, DOI 10.1084/jem.194.10.1407; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Fackler OT, 1999, MOL CELL, V3, P729, DOI 10.1016/S1097-2765(01)80005-8; Frauwirth KA, 2002, J CLIN INVEST, V109, P295, DOI 10.1172/JCI14941; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; GRUBER MF, 1995, J IMMUNOL, V154, P5528; Jamieson BD, 1998, J VIROL, V72, P6520, DOI 10.1128/JVI.72.8.6520-6526.1998; Johnson WE, 2002, ANNU REV MED, V53, P499, DOI 10.1146/annurev.med.53.082901.104053; KALTER DC, 1991, J IMMUNOL, V146, P298; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Lisignoli G, 1996, EUR J IMMUNOL, V26, P17, DOI 10.1002/eji.1830260104; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	28	190	195	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2003	424	6945					213	219		10.1038/nature01749	http://dx.doi.org/10.1038/nature01749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853962	Green Accepted			2022-12-24	WOS:000184032700047
J	Hajjar, I; Kotchen, TA				Hajjar, I; Kotchen, TA			Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; BLOOD-PRESSURE; NATIONAL-HEALTH; POPULATION	Context Prior analyses of National Health and Nutrition Examination Survey (NHANES) data through 1991 have suggested that hypertension prevalence is declining, but more recent self-reported rates of hypertension suggest that the rate is increasing. Objective To describe trends in the prevalence, awareness, treatment, and control of hypertension in the United States using NHANES data. Design, Setting, and Participants Survey using a stratified multistage probability sample of the civilian noninstitutionalized population. The most recent NHANES survey, conducted in 1999-2000 (n=5448), was compared with the 2 phases of NHANES III conducted in 1988-1991 (n=9901) and 1991-1994 (n =9717). Individuals aged 18 years or older were included in this analysis. Main Outcome Measures Hypertension, defined as a measured blood pressure of 140/90 mm Hg or greater or reported use of anti hypertensive medications. Hypertension awareness and treatment were assessed with standardized questions. Hypertension control was defined as treatment with anti hypertensive medication and a measured blood pressure of less than 140/90 mm Hg. Results In 1999-2000, 28.7% of NHANES participants had hypertension, an increase of 3.7% (95% confidence interval [CI], 0%-8.3%) from 1988-1991. Hypertension prevalence was highest in non-Hispanic blacks (33.5%), increased with age (65.4% among those aged greater than or equal to60 years), and tended to be higher in women (30.1%). In a multiple regression analysis, increasing age, increasing body mass index, and non-Hispanic black race/ethnicity were independently associated with increased rates of hypertension. Overall, in 1999-2000, 68.9% were aware of their hypertension (nonsignificant decline of -0.3%; 95% CI, -4.2% to 3.6%), 58.4% were treated (increase of 6.0%; 95% Cl, 1.2%-10.8%), and hypertension was controlled in 31.0% (increase of 6.4%; 95% Cl, 1.6%-11.2%). Women, Mexican Americans, and those aged 60 years or older had significantly lower rates of control compared with men, younger individuals, and non-Hispanic whites. Conclusions Contrary to earlier reports, hypertension prevalence is increasing in the United States. Hypertension control rates, although improving, continue to be low. Programs targeting hypertension prevention and treatment are of utmost importance.	Univ S Carolina, Palmetto Hlth Alliance, Dept Med, Div Geriatr, Columbia, SC 29203 USA; Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Epidemiol, Milwaukee, WI 53226 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical College of Wisconsin; Medical College of Wisconsin	Hajjar, I (corresponding author), Univ S Carolina, Palmetto Hlth Alliance, Dept Med, Div Geriatr, 9 Med Pk,Suite 230, Columbia, SC 29203 USA.	ihab.hajjar@palmettohealth.org						[Anonymous], 1991, JAMA, V265, P3255; [Anonymous], VITAL HLTH STAT; [Anonymous], 1996, ANAL REPORTING GUIDE; AYLA C, 2002, MMWR-MORBID MORTAL W, V51, P456; Baines LA, 2001, DIABETES, V50, P843; Barker WH, 1998, HYPERTENSION, V31, P552, DOI 10.1161/01.HYP.31.1.552; BERGLUND PA, 2002, P 27 ANN SAS US GROU; Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Goff DC, 2001, ANN EPIDEMIOL, V11, P271, DOI 10.1016/S1047-2797(00)00224-6; Hansson L, 1999, BLOOD PRESSURE, V8, P196; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Kannel W B, 1995, Hypertens Res, V18, P181, DOI 10.1291/hypres.18.181; KANNEL WB, 1993, J CARDIOVASC PHARM, V21, pS27, DOI 10.1097/00005344-199321002-00006; Klein RJ, 2001, HLTH PEOPLE 2010 STA, P1, DOI DOI 10.1037/E583772012-001; Kotchen JM, 1998, AM J PUBLIC HEALTH, V88, P1696, DOI 10.2105/AJPH.88.11.1696; Lloyd-Jones DM, 2000, HYPERTENSION, V36, P594, DOI 10.1161/01.HYP.36.4.594; Lloyd-Jones DM, 2002, HYPERTENSION, V40, P640, DOI 10.1161/01.HYP.0000035855.44620.DA; *NAT AC AG SOC, 2000, HYP COMM COND OLD AM; *NAT HLTH NUTR EX, 1989, CYCL 2 BLOOD PRESS Q; Neal B, 2000, LANCET, V356, P1955; *NHANES, 2002, BLOOD PRESS SECT PHY; Rust K., 1985, J OFF STAT, V1, P381; Rust K F, 1996, Stat Methods Med Res, V5, P283, DOI 10.1177/096228029600500305; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; Vargas CM, 1997, PREV MED, V26, P678, DOI 10.1006/pmed.1997.0190; Wassertheil-Smoller S, 2000, HYPERTENSION, V36, P780, DOI 10.1161/01.HYP.36.5.780; *WEST INC, 1996, NAT HLTH NUTR EX SUR; 1992, VITAL HLTH STAT, V2, P1; 1997, ARCH INTERN MED, V157, P2413; 1995, HLTH PEOPLE 2000 MID	36	1689	1832	3	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2003	290	2					199	206		10.1001/jama.290.2.199	http://dx.doi.org/10.1001/jama.290.2.199			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	698GH	12851274	Bronze			2022-12-24	WOS:000183989800024
J	Masoudi, FA; Wang, YF; Inzucchi, SE; Setaro, JF; Havranek, EP; Foody, JM; Krumholz, HM				Masoudi, FA; Wang, YF; Inzucchi, SE; Setaro, JF; Havranek, EP; Foody, JM; Krumholz, HM			Metformin and thiazolidinedione use in medicare patients with heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LACTIC-ACIDOSIS; THERAPY; CONTRAINDICATIONS	Context According to package inserts, metformin is contraindicated in diabetic patients receiving drug treatment for heart failure therapy, and thiazolidinediones are not recommended in diabetic patients with symptoms of advanced heart failure. Little is known about patterns of use of these anti hyperglycemic drugs in diabetic patients with heart failure. Objective To determine the proportions of patients hospitalized with heart failure and concomitant diabetes treated with metformin or thiazolidinediones. Design Serial cross-sectional measurements using data from retrospective medical record abstraction. Setting Nongovernmental acute care hospitals in the United States. Patients Two nationally representative samples of Medicare beneficiaries hospitalized with the primary diagnosis of heart failure and concomitant diabetes between April 1998 and March 1999 and between July 2000 and June 2001. Main Outcome Measures The prescription of either metformin or a thiazolidinedione at hospital discharge. Results In the 1998-1999 sample (n=12505), 7.1% of patients were discharged with a prescription for metformin, 7.2% with a prescription for a thiazolidinedione, and 13.5% with a prescription for either drug. In the 2000-2001 sample (n=13158), metformin use increased to 11.2%, thiazolidinedione use to 16.1%, And use of either drug to 24.4% (P<.001 for all comparisons). Similar increases were seen among patients of all age groups, all races, and both sexes. Conclusions The use of metformin and thiazolidinediones is common and has increased rapidly in Medicare beneficiaries with diabetes and heart failure in direct contrast with explicit warnings against this practice by the Food and Drug Administration. Further studies to establish the safety and effectiveness of this practice are needed to ensure optimal care of patients with diabetes and heart failure.	Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, Endocrinol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Cardiol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Geriatr Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Denver Hlth Med Ctr, Dept Med,Div Cardiol, Denver, CO USA; Colorado Fdn Med Care, Aurora, CO USA	Yale University; Yale University; Yale University; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, 333 Cedar St,Room I-456 SHM,POB 208088, New Haven, CT 06520 USA.	harlan.krumholz@yale.edu	Inzucchi, Silvio/ABF-4121-2021; Masoudi, Frederick/Q-7467-2019; , Harlan/AAI-2875-2020		NCI NIH HHS [500-02-CO 01] Funding Source: Medline; NIA NIH HHS [K08-AG01011] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG001011] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amer Diabet Assoc, 2002, DIABETES CARE, V25, P213; *BRIST MYERS SQUIB, GLUC GLUC XR PRESCR; CAMPBELL IW, 1985, HORM METAB RES, V15, P105; Emslie-Smith AM, 2001, DIABETIC MED, V18, P483, DOI 10.1046/j.1464-5491.2001.00509.x; Ghazzi MN, 1997, DIABETES, V46, P433, DOI 10.2337/diabetes.46.3.433; *GLAX PHARM, 2002, AV PRESCR INF; Goff DC, 2000, ARCH INTERN MED, V160, P197, DOI 10.1001/archinte.160.2.197; Holstein A, 1999, DIABETIC MED, V16, P692, DOI 10.1046/j.1464-5491.1999.00115.x; Horlen C, 2002, JAMA-J AM MED ASSOC, V287, P2504, DOI 10.1001/jama.287.19.2504-a; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; INZUCCHI SE, 2002, PRACT DIABETOL, V21, P7; LUFT D, 1978, DIABETOLOGIA, V14, P75, DOI 10.1007/BF01263444; *MED EC CO INC, 1998, PHYS DESK REF; *MED EC CO INC, 1999, PHYS DESK REF; Misbin RI, 1998, NEW ENGL J MED, V338, P265, DOI 10.1056/NEJM199801223380415; Parulkar AA, 2001, ANN INTERN MED, V134, P61, DOI 10.7326/0003-4819-134-1-200101020-00014; SALPETER S, 2002, COCHRANE DB SYST REV, V2, P2967; Stang M, 1999, DIABETES CARE, V22, P925, DOI 10.2337/diacare.22.6.925; *TAK PHARM, 2002, ACT PRESCR INF; Tang WHW, 2003, J AM COLL CARDIOL, V41, P1394, DOI 10.1016/S0735-1097(03)00159-1; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; *US FDA, SUMM ACT AV; WIHOLM BE, 1993, EUR J CLIN PHARMACOL, V44, P589, DOI 10.1007/BF02440866	23	96	97	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2003	290	1					81	85		10.1001/jama.290.1.81	http://dx.doi.org/10.1001/jama.290.1.81			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696CR	12837715	Bronze			2022-12-24	WOS:000183868600023
J	Klausner, RD; Fauci, AS; Corey, L; Nabel, GJ; Gayle, H; Berkley, S; Haynes, BF; Baltimore, D; Collins, C; Douglas, RG; Esparza, J; Francis, DP; Ganguly, NK; Gerberding, JL; Johnston, MI; Kazatchkine, MD; McMichael, AJ; Makgoba, MW; Pantaleo, G; Piot, P; Shao, YM; Tramont, E; Varmus, H; Wasserheit, JN				Klausner, RD; Fauci, AS; Corey, L; Nabel, GJ; Gayle, H; Berkley, S; Haynes, BF; Baltimore, D; Collins, C; Douglas, RG; Esparza, J; Francis, DP; Ganguly, NK; Gerberding, JL; Johnston, MI; Kazatchkine, MD; McMichael, AJ; Makgoba, MW; Pantaleo, G; Piot, P; Shao, YM; Tramont, E; Varmus, H; Wasserheit, JN			The need for a global HIV vaccine enterprise	SCIENCE			English	Editorial Material									Bill & Melinda Gates Fdn, Seattle, WA 98102 USA; NIAID, Div AIDS, NIH, Vaccine & Prevent Res Program, Bethesda, MD 20892 USA; NIAID, Vaccine Res Ctr, Bethesda, MD 20892 USA; Fred Hutchinson Canc Res Ctr, HIV Vaccine Trials Network, Program Infect Dis, Seattle, WA 98109 USA; Univ Washington, Dept Lab Med, Seattle, WA 98109 USA; Int AIDS Vaccine Initiat, New York, NY 10038 USA; Duke Univ, Sch Med, Durham, NC 27710 USA; CALTECH, Pasadena, CA 91125 USA; AIDS Vaccine Advocacy Coalit, New York, NY 10011 USA; Sequella Global TB Fdn, Rockville, MD 20850 USA; WHO, UNAIDS, Joint UN Programme HIV AIDS, HIV Vaccine Initiat, Geneva 27, Switzerland; VaxGen Inc, Brisbane, CA 94005 USA; Indian Council Med Res, New Delhi 110029, India; Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; ANRS, F-75013 Paris, France; Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Univ Natal, ZA-4041 Durban, South Africa; Univ Lausanne, CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Bill & Melinda Gates Foundation; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; International AIDS Vaccine Initiative; Duke University; California Institute of Technology; UNAIDS; World Health Organization; Indian Council of Medical Research (ICMR); Centers for Disease Control & Prevention - USA; University of Oxford; University of Kwazulu Natal; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Memorial Sloan Kettering Cancer Center	Klausner, RD (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98102 USA.		Pantaleo, Giuseppe/K-6163-2016; Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436				FRANCIS DW, COMMUNICATION; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X	2	156	167	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2003	300	5628					2036	2039		10.1126/science.1086916	http://dx.doi.org/10.1126/science.1086916			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12829768				2022-12-24	WOS:000183774900028
J	Paratcha, G; Ledda, F; Ibanez, CF				Paratcha, G; Ledda, F; Ibanez, CF			The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family Ligands	CELL			English	Article							MICE LACKING GDNF; C-RET PROTOONCOGENE; TYROSINE KINASE; N-CAM; SYNAPTIC PLASTICITY; FGF RECEPTOR; NERVOUS-SYSTEM; LIPID RAFTS; NEURONAL SURVIVAL; AXONAL GROWTH	Intercellular communication involves either direct cell-cell contact or release and uptake of diffusible signals, two strategies mediated by distinct and largely non-overlapping sets of molecules. Here, we show that the neural cell adhesion molecule NCAM can function as a signaling receptor for members of the GDNF ligand family. Association of NCAM with GFRalpha1, a GPI-anchored receptor for GDNF, downregulates NCAM-mediated cell adhesion and promotes high-affinity binding of GDNF to p140(NCAM), resulting in rapid activation of cytoplasmic protein tyrosine kinases Fyn and FAK in cells lacking RET, a known GDNF signaling receptor. GDNF stimulates Schwann cell migration and axonal growth in hippocampal and cortical neurons via binding to NCAM and activation of Fyn, but independently of RET. These results uncover an unexpected intersection between short- and long-range mechanisms of intercellular communication and reveal a pathway for GDNF signaling that does not require the RET receptor.	Karolinska Inst, Div Mol Neurobiol, Dept Neurosci, S-17177 Stockholm, Sweden	Karolinska Institutet	Ibanez, CF (corresponding author), Karolinska Inst, Div Mol Neurobiol, Dept Neurosci, Retzius Vag 8,A2-2, S-17177 Stockholm, Sweden.			Paratcha, Gustavo/0000-0002-0804-4433				Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Chao CC, 2003, NEUROBIOL AGING, V24, P105, DOI 10.1016/S0197-4580(02)00047-7; Chazal G, 2000, J NEUROSCI, V20, P1446; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 2000, INT J DEV NEUROSCI, V18, P213, DOI 10.1016/S0736-5748(99)00090-8; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; DOHERTY P, 1995, J NEUROBIOL, V26, P437, DOI 10.1002/neu.480260315; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; Doherty Patrick, 1994, Current Opinion in Neurobiology, V4, P49, DOI 10.1016/0959-4388(94)90031-0; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Gerlai R, 2001, EUR J NEUROSCI, V14, P1153, DOI 10.1046/j.0953-816x.2001.01724.x; Holst BD, 1998, P NATL ACAD SCI USA, V95, P2597, DOI 10.1073/pnas.95.5.2597; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; KLINZ SG, 1995, J NEUROCHEM, V65, P84; Kokaia Z, 1999, EUR J NEUROSCI, V11, P1202, DOI 10.1046/j.1460-9568.1999.00513.x; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Maness PF, 1996, PERSPECT DEV NEUROBI, V4, P169; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Nanobashvili A, 2000, P NATL ACAD SCI USA, V97, P12312, DOI 10.1073/pnas.97.22.12312; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Poteryaev D, 1999, FEBS LETT, V463, P63, DOI 10.1016/S0014-5793(99)01590-2; Ronn LCB, 2000, INT J DEV NEUROSCI, V18, P193, DOI 10.1016/S0736-5748(99)00088-X; Saffell JL, 1995, MOL CELL NEUROSCI, V6, P521, DOI 10.1006/mcne.1995.0004; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Stork O, 1997, EUR J NEUROSCI, V9, P1117, DOI 10.1111/j.1460-9568.1997.tb01464.x; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; Thomaidou D, 2001, J NEUROCHEM, V78, P767, DOI 10.1046/j.1471-4159.2001.00454.x; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1999, J BIOL CHEM, V274, P20885, DOI 10.1074/jbc.274.30.20885; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Trupp M, 1997, J NEUROSCI, V17, P3554; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Yu T, 1998, J NEUROSCI, V18, P4684	50	449	481	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 27	2003	113	7					867	879		10.1016/S0092-8674(03)00435-5	http://dx.doi.org/10.1016/S0092-8674(03)00435-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	695EJ	12837245	Bronze			2022-12-24	WOS:000183817900011
J	Missler, M; Zhang, WQ; Rohlmann, A; Kattenstroth, G; Hammer, RE; Gottmann, K; Sudhof, TC				Missler, M; Zhang, WQ; Rohlmann, A; Kattenstroth, G; Hammer, RE; Gottmann, K; Sudhof, TC			alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis	NATURE			English	Article							CALCIUM CHANNELS; TRANSMITTER RELEASE; MICE LACKING; NEOCORTICAL NEURONS; LATROTOXIN RECEPTOR; GABAERGIC SYNAPSES; NERVE-TERMINALS; PYRAMIDAL CELLS; RAT NEOCORTEX; BRAIN	Synapses are specialized intercellular junctions in which cell adhesion molecules connect the presynaptic machinery for neurotransmitter release to the postsynaptic machinery for receptor signalling. Neurotransmitter release requires the presynaptic co-assembly of Ca2+ channels with the secretory apparatus, but little is known about how synaptic components are organized. alpha-Neurexins, a family of > 1,000 presynaptic cell-surface proteins encoded by three genes, link the pre- and postsynaptic compartments of synapses by binding extracellularly to postsynaptic cell adhesion molecules and intracellularly to presynaptic PDZ domain proteins. Using triple-knockout mice, we show that alpha-neurexins are not required for synapse formation, but are essential for Ca2+-triggered neurotransmitter release. Neurotransmitter release is impaired because synaptic Ca2+ channel function is markedly reduced, although the number of cell-surface Ca2+ channels appears normal. These data suggest that alpha-neurexins organize presynaptic terminals by functionally coupling Ca2+ channels to the presynaptic machinery.	Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA; Ctr Basic Neurosci, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Gottingen, Zentrum Physiol & Pathophysiol, D-37073 Gottingen, Germany; Ruhr Univ Bochum, Lehrstuhl Zellphysiol, D-44780 Bochum, Germany	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Gottingen; Ruhr University Bochum	Missler, M (corresponding author), Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA.			Missler, Markus/0000-0001-8008-984X; Rohlmann, Astrid/0000-0003-0869-6893; Hammer, Robert E./0000-0001-5487-7551				Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Bergsman JB, 2000, J NEUROSCI, V20, P4368, DOI 10.1523/JNEUROSCI.20-12-04368.2000; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; Geppert M, 1998, J BIOL CHEM, V273, P1705, DOI 10.1074/jbc.273.3.1705; Hata Y, 1996, J NEUROSCI, V16, P2488; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Ino M, 2001, P NATL ACAD SCI USA, V98, P5323, DOI 10.1073/pnas.081089398; Iwasaki S, 2000, J NEUROSCI, V20, P59, DOI 10.1523/JNEUROSCI.20-01-00059.2000; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Katz B., 1969, RELEASE NEURAL TRANS; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002; Ludwig A, 1997, J NEUROSCI, V17, P1339; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Mohrmann R, 1999, J NEUROSCI, V19, P10004; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Muth JN, 2001, TRENDS PHARMACOL SCI, V22, P526, DOI 10.1016/S0165-6147(00)01797-1; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; Plitzko D, 2001, EUR J NEUROSCI, V14, P1412, DOI 10.1046/j.0953-816x.2001.01740.x; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Saegusa H, 2000, P NATL ACAD SCI USA, V97, P6132, DOI 10.1073/pnas.100124197; Sakmann B., 1995, SINGLE CHANNEL RECOR; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Singer JH, 1996, J NEUROPHYSIOL, V76, P799, DOI 10.1152/jn.1996.76.2.799; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; Zhang W, 1999, EUR J NEUROSCI, V11, P2332, DOI 10.1046/j.1460-9568.1999.00655.x	50	480	494	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					939	948		10.1038/nature01755	http://dx.doi.org/10.1038/nature01755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827191				2022-12-24	WOS:000183753900039
J	Harrap, SB				Harrap, SB			Where are all the blood-pressure genes?	LANCET			English	Review							COMPLEX HUMAN-DISEASES; WIDE LINKAGE ANALYSIS; GENOME SCAN; SUSCEPTIBILITY; DISEQUILIBRIUM; HYPERTENSION; PATTERNS; FAMILY; TRAITS	Context The potential for discovery of underlying genetic causes for common conditions, such as hypertension, is a major justification for the human genome project. Hopes have been raised that personalised molecular prognostic and therapeutic strategies will result from genomic studies. Starting point The largest and most recent searches of the genome (Mark Caulfield and colleagues, Lancet 2003; 361: 2118-23; Michael Province and colleagues, Am J Hypertens 2003; 16: 144-47) have found limited evidence of genes that determine hypertension, and even less evidence for the existence of causative DNA variants (alleles) within these genes. Previous genomic studies did not reach a consensus on the likely location of blood-pressure genes. The difficulty in identifying genetic causes for common conditions might be because the causative alleles are numerous, with small individual impact, and are distributed unevenly between populations. Where next? Without comprehensive and reliable description of the alleles associated with hypertension, using genetics for diagnosis remains tenuous. However, the discovery of a single allele proven to be associated with control of blood pressure could lead to the discovery of relevant and hovel physiological targets for the prevention and treatment of hypertension.	Univ Melbourne, Dept Physiol, Parkville, Vic 3010, Australia	University of Melbourne	Harrap, SB (corresponding author), Univ Melbourne, Dept Physiol, Parkville, Vic 3010, Australia.			Harrap, Stephen/0000-0003-2907-6714				Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Bashyam MD, 2003, J HUM GENET, V48, P55, DOI 10.1007/s100380300007; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Cooper RS, 2002, HYPERTENSION, V40, P629, DOI 10.1161/01.HYP.0000035708.02789.39; Cui JSS, 2003, HYPERTENSION, V41, P207, DOI 10.1161/01.HYP.0000044938.94050.E3; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Harrap SB, 2000, AM J EPIDEMIOL, V152, P704, DOI 10.1093/aje/152.8.704; Harrap SB, 2002, PHYSIOL GENOMICS, V8, P99, DOI 10.1152/physiolgenomics.00069.2001; HARRAP SB, 1986, HYPERTENSION, V8, P572, DOI 10.1161/01.HYP.8.7.572; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kaplan N, 2001, GENET EPIDEMIOL, V20, P432, DOI 10.1002/gepi.1012; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Perola M, 2000, J HYPERTENS, V18, P1579, DOI 10.1097/00004872-200018110-00008; Phillips PC, 1999, TRENDS GENET, V15, P6, DOI 10.1016/S0168-9525(98)01622-9; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Province MA, 2003, AM J HYPERTENS, V16, P144, DOI 10.1016/S0895-7061(02)03248-X; Ranade K, 2003, AM J HYPERTENS, V16, P158, DOI 10.1016/S0895-7061(02)03245-4; Rapp JP, 2000, PHYSIOL REV, V80, P135, DOI 10.1152/physrev.2000.80.1.135; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rice T, 2000, CIRCULATION, V102, P1956, DOI 10.1161/01.CIR.102.16.1956; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Thiel BA, 2003, AM J HYPERTENS, V16, P151, DOI 10.1016/S0895-7061(02)03246-6; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Xu XP, 1999, AM J HUM GENET, V64, P1694, DOI 10.1086/302405; Zhu DL, 2001, J HYPERTENS, V19, P55, DOI 10.1097/00004872-200101000-00008	30	56	65	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 21	2003	361	9375					2149	2151		10.1016/S0140-6736(03)13694-X	http://dx.doi.org/10.1016/S0140-6736(03)13694-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	692GY	12826450				2022-12-24	WOS:000183654200025
J	Abbott, A				Abbott, A			British panel bans use of antidepressant to treat children	NATURE			English	News Item																			0	11	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					792	792		10.1038/423792a	http://dx.doi.org/10.1038/423792a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815392	Bronze			2022-12-24	WOS:000183585300009
J	Fitzmaurice, DA				Fitzmaurice, DA			Commentary: The faults of expert reviews are already well known	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Fitzmaurice, DA (corresponding author), Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.								0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2003	327	7409					269	269		10.1136/bmj.327.7409.269	http://dx.doi.org/10.1136/bmj.327.7409.269			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896941	Green Published			2022-12-24	WOS:000184566300022
J	Swarte, NB; van der Lee, ML; van der Bom, JG; van den Bout, J; Heintz, APM				Swarte, NB; van der Lee, ML; van der Bom, JG; van den Bout, J; Heintz, APM			Effects of euthanasia on the bereaved family and friends: a cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICIAN-ASSISTED SUICIDE; NATIONWIDE; LIFE; END	Objective To assess how euthanasia in terminally ill cancer patients affects the grief response of bereaved family and friends. Design Cross sectional study Setting Tertiary referral centre for oncology patients in Utrecht, the Netherlands. Participants 189 bereaved family members and close friends of terminally ill cancer patients who died by euthanasia and 316 bereaved family members and close friends of comparable cancer patients who died a natural death between 1992 and 1999. Main outcome measures Symptoms of traumatic grief assessed by the inventory of traumatic grief, current feelings of grief assessed by the Texas revised inventory of grief, and post-traumatic stress reactions assessed by the impact of event scale. Results The bereaved family and friends of cancer patients who died by euthanasia had less traumatic grief symptoms (adjusted difference - 5.29 (95% confidence interval - 8.44 to - 2.15)), less current feeling of grief (adjusted difference 2.93 (0.85 to 5.01)); and less post-traumatic stress reactions (adjusted difference - 2.79 (- 5.33 to - 0.25)) than the family and friends of patients who died of natural causes. These differences were independent of other risk factors. Conclusions The bereaved family and friends of cancer patients who died by euthanasia coped better with respect to grief symptoms and post-traumatic stress reactions than the bereaved of comparable cancer patients who died a natural death. These results should not be interpreted as a plea for euthanasia, but as a plea for the same level of care and openness in all patients who are terminally ill.	Univ Med Ctr Utrecht, Dept Gynaecol, NL-3508 GA Utrecht, Netherlands; Univ Utrecht, Dept Clin Psychol, NL-3508 TC Utrecht, Netherlands; Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University; Utrecht University Medical Center	Swarte, NB (corresponding author), Univ Med Ctr Utrecht, Dept Gynaecol, F05-829,POB 85500, NL-3508 GA Utrecht, Netherlands.	n.swarte@azu.nl	van der Bom, Johanna G./G-1965-2018	van der Bom, Johanna G./0000-0001-9095-2475				Arrindell WA, 1986, SCL 90 MANUAL MULTID; Boelen PA, 2003, DEATH STUD, V27, P227, DOI 10.1080/07481180302889; BrintzenhofeSzoc KM, 1999, CANCER PRACT, V7, P233, DOI 10.1046/j.1523-5394.1999.75006.x; Chochinov HM, 2000, PSYCHOSOMATICS, V41, P500, DOI 10.1176/appi.psy.41.6.500; Emanuel EJ, 2002, ARCH INTERN MED, V162, P142, DOI 10.1001/archinte.162.2.142; FASCHINGBAUER RRZ, 1987, BIOPSYCHOSOCIAL ASPE, P127; Goldstein H., 1998, USERS GUIDE MLWIN; Groenewoud JH, 2000, NEW ENGL J MED, V342, P551, DOI 10.1056/NEJM200002243420805; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Jacobs S, 2000, DEATH STUD, V24, P185, DOI 10.1080/074811800200531; Kelly BJ, 1996, AUST NZ J PSYCHIAT, V30, P3, DOI 10.3109/00048679609076068; Koop P M, 1997, Can J Nurs Res, V29, P33; LUBIN B, 1965, ARCH GEN PSYCHIAT, V12, P57; PIJNENBORG L, 1994, BMJ-BRIT MED J, V309, P1209, DOI 10.1136/bmj.309.6963.1209; SANDERMAN R, 1995, EYSENCK PERSONALITY; STROEBE MS, 1989, OMEGA-J DEATH DYING, V20, P1, DOI 10.2190/C3JE-C9L1-5R91-DWDU; STROEBE W, 2001, HDB BEREAVEMENT RES, P613; Swarte NB, 2001, BEST PRACT RES CL OB, V15, P313, DOI 10.1053/beog.2000.0171; Swarte NB, 1999, ANN MED, V31, P364, DOI 10.3109/07853899908998793; SWARTE NB, 2000, BAILLIERE CLIN OB GY, V15, P313; Valdimarsdottir U, 2002, BRIT J CANCER, V86, P1540, DOI 10.1038/sj.bjc.6600271; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; vandenBoom F, 1995, AIDS CARE, V7, pS175; VANDERWAL G, 1994, BRIT MED J, V308, P1346, DOI 10.1136/bmj.308.6940.1346; WEGNER M, 1993, MEASUREMENT PERCEIVE	25	64	64	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2003	327	7408					189	192		10.1136/bmj.327.7408.189	http://dx.doi.org/10.1136/bmj.327.7408.189			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	706DL	12881258	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000184437300014
J	Katoh, H; Negishi, M				Katoh, H; Negishi, M			RhoG activates Rac1 by direct interaction with the Dock180-binding protein Elmo	NATURE			English	Article								The small GTPase Rac has a central role in regulating the actin cytoskeleton during cell migration and axon guidance(1). Elmo has been identified as an upstream regulator of Rac1 that binds to and functionally cooperates with Dock180 (refs 2-4). Dock180 does not contain a conventional catalytic domain for guanine nucleotide exchange on Rac, but possesses a domain that directly binds to and specifically activates Rac1 (refs 5, 6). The small GTPase RhoG mediates several cellular morphological processes, such as neurite outgrowth in neuronal cells, through a signalling cascade that activates Rac1 (refs 7-12); however, the downstream target of RhoG and the mechanism by which RhoG regulates Rac1 activity remain unclear. Here we show that RhoG interacts directly with Elmo in a GTP-dependent manner and forms a ternary complex with Dock180 to induce activation of Rac1. The RhoG-Elmo-Dock180 pathway is required for activation of Rac1 and cell spreading mediated by integrin, as well as for neurite outgrowth induced by nerve growth factor. We conclude that RhoG activates Rac1 through Elmo and Dock180 to control cell morphology.	Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Katoh, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068502, Japan.	hirokato@pharm.kyoto-u.ac.jp		Katoh, Hironori/0000-0002-8191-8117				Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Blangy A, 2000, J CELL SCI, V113, P729; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gauthier-Rouviere C, 1998, MOL BIOL CELL, V9, P1379, DOI 10.1091/mbc.9.6.1379; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; May V, 2002, J NEUROSCI, V22, P6980; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Vigorito E, 2003, ONCOGENE, V22, P330, DOI 10.1038/sj.onc.1206116; Wu YC, 2002, DEV BIOL, V250, P145, DOI 10.1006/dbio.2002.0785; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Zhou WS, 2001, J VIS COMMUN IMAGE R, V12, P1, DOI 10.1006/jvci.2000.0459	25	272	276	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					461	464		10.1038/nature01817	http://dx.doi.org/10.1038/nature01817			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879077				2022-12-24	WOS:000184318400051
J	Johansson, LC; Norberg, RA				Johansson, LC; Norberg, RA			Delta-wing function of webbed feet gives hydrodynamic lift for swimming propulsion in birds	NATURE			English	Article							LEADING-EDGE; FLIGHT	Most foot-propelled swimming birds sweep their webbed feet backwards in a curved path that lies in a plane aligned with the swimming direction. When the foot passes the most outward position, near the beginning of the power stroke, a tangent to the foot trajectory is parallel with the line of swimming and the foot web is perpendicular to it. But later in the stroke the foot takes an increasingly transverse direction, swinging towards the longitudinal axis of the body. Here we show that, early in the power stroke, propulsion is achieved mostly by hydrodynamic drag on the foot, whereas there is a gradual transition into lift-based propulsion later in the stroke. At the shift to lift mode, the attached vortices of the drag-based phase turn into a starting vortex, shed at the trailing edge, and into spiralling leading-edge vortices along the sides of the foot. Because of their delta shape, webbed feet can generate propulsive forces continuously through two successive modes, from drag at the beginning of the stroke, all the way through the transition to predominantly lift later in the stroke.	Univ Gothenburg, Dept Zool, SE-40530 Gothenburg, Sweden; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of Gothenburg; Harvard University	Norberg, RA (corresponding author), Univ Gothenburg, Dept Zool, Box 463, SE-40530 Gothenburg, Sweden.		Johansson, Christoffer/B-2189-2013	Johansson, Christoffer/0000-0002-1851-3635				Blake R. W., 1981, S ZOOL SOC LONDON, V48, P29; Braun J., 1985, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V169, P307; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; Johansson LC, 2000, NATURE, V407, P582, DOI 10.1038/35036689; Johansson LC, 2001, J EXP BIOL, V204, P1687; Katz J., 1991, LOW SPEED AERODYNAMI; Lee M., 1990, APPL MECH REV, V43, P209, DOI [10.1115/1.3119169, DOI 10.1115/1.3119169]; NORBERG RA, 1994, P ROY SOC B-BIOL SCI, V257, P227, DOI 10.1098/rspb.1994.0119; THOMAS ALR, 1993, PHILOS T ROY SOC B, V340, P361, DOI 10.1098/rstb.1993.0079; WALKER JA, 1997, QUICKSAND QUICK SMOO	10	42	43	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					65	68		10.1038/nature01695	http://dx.doi.org/10.1038/nature01695			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840759				2022-12-24	WOS:000183912800040
J	Mitchell, SL; Teno, JM; Roy, J; Kabumoto, G; Mor, V				Mitchell, SL; Teno, JM; Roy, J; Kabumoto, G; Mor, V			Clinical and organizational factors associated with feeding tube use among nursing home residents with advanced cognitive impairment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVANCED DEMENTIA; PREFERENCES; DIRECTIVES; ATTITUDES; FACILITY; RISK	Context Empiric data and expert opinion suggest that use of feeding tubes is not beneficial for older persons with advanced dementia. Previous research has shown a 10-fold variation in this practice across the United States. Objective To identify the facility and resident characteristics associated with feeding tube use among US nursing homes residents with severe cognitive impairment. Design, Setting, and Participants Cross-sectional study of all residents with advanced cognitive impairment who had Minimum Data Set assessments within 60 days of April 1, 1999, (N = 186835) and who resided in Medicare- or Medicaid-certified US nursing homes. Main Outcomes Measures Facility and resident characteristics described in the 1999 On-line Survey Certification of Automated Records and the 1999 Minimum Data Set. Multivariate analysis using generalized estimating equations determined the facility and resident factors independently associated with feeding tube use. Results Thirty-four percent of residents with advanced cognitive impairment had feeding tubes (N = 63 101). Resident characteristics associated with a greater likelihood of feeding tube use included younger age, nonwhite race, male sex, divorced marital status, lack of advance directives, a recent decline in functional status, and no diagnosis of Alzheimer disease. Controlling for these patient factors, residents living in facilities that were for profit (adjusted odds ratio (OR], 1.09; 95% confidence interval [Cl], 1.06-1.12); located in an urban area (OR, 1.14; 95% Cl, 1.11-1.16); having more than 100 beds (OR, 1.04; 95% Cl, 1.01-1.07); and lacking a special dementia care unit (OR, 1.11; 95% Cl, 1.07-1.15) had a higher likelihood of having a feeding tube. Additionally, feeding tube use was more likely among residents living in facilities that had a smaller proportion of residents with do-not-resuscitate orders, had a higher prevalence of non-white residents, and lacked a nurse practitioner or physician assistant on staff. Conclusions More than one third of severely cognitively impaired residents in US nursing homes have feeding tubes. Feeding tube use is independently associated with both the residents' clinical characteristics and the nursing homes' fiscal, organizational, and demographic features.	Beth Israel Deaconess Med Ctr, Hebrew Rehabil Ctr Aged, Res & Training Inst, Dept Med, Boston, MA 02131 USA; Harvard Univ, Sch Med, Div Aging, Boston, MA 02115 USA; Brown Univ, Sch Med, Dept Community Hlth, Ctr Gerontol & Hlth Care Res, Providence, RI 02912 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Brown University	Mitchell, SL (corresponding author), Beth Israel Deaconess Med Ctr, Hebrew Rehabil Ctr Aged, Res & Training Inst, Dept Med, 1200 Ctr St, Boston, MA 02131 USA.				NATIONAL INSTITUTE ON AGING [K23AG020054, R37AG011624] Funding Source: NIH RePORTER; NIA NIH HHS [AG-11624, K23AG20054-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahronheim JC, 2001, J AM GERIATR SOC, V49, P148, DOI 10.1046/j.1532-5415.2001.49035.x; BATCHELOR AJ, 1992, J AM GERIATR SOC, V40, P679, DOI 10.1111/j.1532-5415.1992.tb01959.x; Blackhall LJ, 1999, SOC SCI MED, V48, P1779, DOI 10.1016/S0277-9536(99)00077-5; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; FRIES BE, 1994, MED CARE, V32, P668, DOI 10.1097/00005650-199407000-00002; Gessert CE, 2000, J AM GERIATR SOC, V48, P1593, DOI 10.1111/j.1532-5415.2000.tb03869.x; Gillick MR, 2000, NEW ENGL J MED, V342, P206, DOI 10.1056/NEJM200001203420312; GRADY D, 2000, NY TIMES        0120, pA13; HARTMAIER SL, 1995, J GERONTOL A-BIOL, V50, pM128, DOI 10.1093/gerona/50A.2.M128; Intrator O, 1999, MED CARE, V37, P228, DOI 10.1097/00005650-199903000-00003; Kayser-Jones J, 1999, J AM GERIATR SOC, V47, P1187, DOI 10.1111/j.1532-5415.1999.tb05198.x; Kiely DK, 2001, J AM GERIATR SOC, V49, P1346, DOI 10.1046/j.1532-5415.2001.49263.x; Mebane EW, 1999, J AM GERIATR SOC, V47, P579, DOI 10.1111/j.1532-5415.1999.tb02573.x; Meier DE, 2002, NEW ENGL J MED, V346, P1087, DOI 10.1056/NEJM200204043461413; Meier DE, 2001, ARCH INTERN MED, V161, P594, DOI 10.1001/archinte.161.4.594; Mitchell S L, 2001, J Am Med Dir Assoc, V2, P10, DOI 10.1097/00130535-200101000-00003; Mitchell SL, 1997, ARCH INTERN MED, V157, P327, DOI 10.1001/archinte.157.3.327; Mitchell SL, 2003, J AM GERIATR SOC, V51, P75, DOI 10.1034/j.1601-5215.2002.51021.x; Mitchell SL, 2003, J AM GERIATR SOC, V51, P129, DOI 10.1034/j.1601-5215.2002.51021.x; Mitchell Susan L, 2003, J Am Med Dir Assoc, V4, P27, DOI 10.1097/00130535-200301000-00005; MORRIS JN, 1990, GERONTOLOGIST, V30, P293, DOI 10.1093/geront/30.3.293; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Pritchard RS, 1998, J AM GERIATR SOC, V46, P1242, DOI 10.1111/j.1532-5415.1998.tb04540.x; SAS Institute Inc, 1997, SAS STAT SOFTW CHANG; Teno JM, 2002, JAMA-J AM MED ASSOC, V287, P3211, DOI 10.1001/jama.287.24.3211; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	26	236	240	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2003	290	1					73	80		10.1001/jama.290.1.73	http://dx.doi.org/10.1001/jama.290.1.73			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696CR	12837714	Bronze			2022-12-24	WOS:000183868600022
J	Lowe, CJ; Wu, M; Salic, A; Evans, L; Lander, E; Stange-Thomann, N; Gruber, CE; Gerhart, J; Kirschner, M				Lowe, CJ; Wu, M; Salic, A; Evans, L; Lander, E; Stange-Thomann, N; Gruber, CE; Gerhart, J; Kirschner, M			Anteroposterior patterning in hemichordates and the origins of the chordate nervous system	CELL			English	Article							HOMEOBOX GENES; DEVELOPMENTAL EXPRESSION; ANIMAL PHYLOGENY; NEURAL PLATE; HOX CLUSTER; SEA-URCHIN; BODY PLAN; DROSOPHILA; EVOLUTION; BRAIN	The chordate central nervous system has been hypothesized to originate from either a dorsal centralized, or a ventral centralized, or a noncentralized nervous system of a deuterostome ancestor. In an effort to resolve these issues, we examined the hemichordate Saccoglossus kowalevskii and studied the expression of orthologs of genes that are involved in patterning the chordate central nervous system. All 22 orthologs studied are expressed in the ectoderm in an anteroposterior arrangement nearly identical to that found in chordates. Domain topography is conserved between hemichordates and chordates despite the fact that hemichordates have a diffuse nerve net, whereas chordates have a centralized system. We propose that the deuterostome ancestor may have had a diffuse nervous system, which was later centralized during the evolution of the chordate lineage.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; MIT, Ctr Genome Res, Whitehead Inst, Cambridge, MA 02142 USA; Express Genom Inc, Frederick, MD 21701 USA	University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute	Lowe, CJ (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	clowe@uclink4.berkeley.edu	Salic, Adrian/GXG-1611-2022	Lowe, Christopher/0000-0002-7789-8643	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042724] Funding Source: NIH RePORTER; NICHD NIH HHS [1-R01-HD42724] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Arenas-Mena C, 2000, DEVELOPMENT, V127, P4631; Arendt D, 1996, BIOESSAYS, V18, P255, DOI 10.1002/bies.950180314; BALSER EJ, 1990, ACTA ZOOL-STOCKHOLM, V71, P235, DOI 10.1111/j.1463-6395.1990.tb01082.x; Bateson W., 1886, Q J MICROSC SCI, V26, P511; Bateson W, 1884, Q J MICROSC SCI, V24, P208; Bateson W, 1885, Q J MICROSC SCI, V25, P81; Bateson W, 1886, Q J MICROSC SCI, V26, P535; Brusca R.C., 1990, INVERTEBRATES; BULLOCK TH, 1945, Q J MICROSC SCI, V86, P55; Bullock TH, 1965, STRUCTURE FUNCTION N, P1567; BURDONJONES C, 1952, PHILOS T ROY SOC B, V236, P553, DOI 10.1098/rstb.1952.0010; Cameron CB, 1996, CAN J ZOOL, V74, P15, DOI 10.1139/z96-003; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Carpenter EM, 2002, DEV NEUROSCI-BASEL, V24, P24, DOI 10.1159/000064943; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; COLWIN AL, 1950, J EXP ZOOL, V115, P263, DOI 10.1002/jez.1401150204; COLWIN AL, 1953, J MORPHOL, V92, P401, DOI 10.1002/jmor.1050920302; COLWIN LH, 1962, BIOL BULL, V123, P493; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; GARSTANG W, 1894, ZOOL ANT, V17, P122; GARSTANG WALTER, 1928, QUART JOUR MICROS SCI, V72, P51; Gee H., 1996, BACKBONE VIEWS ORIGI; Geoffroy Saint-Hilaire E., 1822, MEM HIST NAT, V9, P89; Glavic A, 2002, DEVELOPMENT, V129, P1609; Gomez-Skarmeta JL, 2002, CURR OPIN GENET DEV, V12, P403, DOI 10.1016/S0959-437X(02)00317-9; Hirth F, 2003, DEVELOPMENT, V130, P2365, DOI 10.1242/dev.00438; Jan Yuh Nung, 1993, P1207; Jefferies RPS, 1996, ACTA ZOOL-STOCKHOLM, V77, P101, DOI 10.1111/j.1463-6395.1996.tb01256.x; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; KARR TL, 1989, DEVELOPMENT, V105, P605; KIM YJ, 1993, J NEUROSCI, V13, P1045; KNIGHTJONES EW, 1952, PHILOS T ROY SOC B, V236, P315, DOI 10.1098/rstb.1952.0004; KRUMLAUF R, 1993, J NEUROBIOL, V24, P1328, DOI 10.1002/neu.480241006; LACALLI TC, 1994, AM ZOOL, V34, P533; Lilly B, 1999, MECH DEVELOP, V88, P195, DOI 10.1016/S0925-4773(99)00189-6; LOWE CJ, IN PRESS METHODS CEL; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Mendez AT, 2000, MAR BIOTECHNOL, V2, P231, DOI 10.1007/s101269900027; Morgan T, 1894, J MORPHOL, V9, P1, DOI DOI 10.1002/JMOR.1050090102; NEUBUSER A, 1995, DEV BIOL, V170, P701, DOI 10.1006/dbio.1995.1248; Nielsen C, 1999, DEV GENES EVOL, V209, P198, DOI 10.1007/s004270050244; Nubler-Jung K, 1999, J ZOOL SYST EVOL RES, V37, P93; Ogasawara M, 1999, DEVELOPMENT, V126, P2539; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Papillon D, 2003, DEV GENES EVOL, V213, P142, DOI 10.1007/s00427-003-0306-z; PENDLETON JW, 1993, P NATL ACAD SCI USA, V90, P6300, DOI 10.1073/pnas.90.13.6300; Peterson KJ, 2001, EVOL DEV, V3, P170, DOI 10.1046/j.1525-142x.2001.003003170.x; Popodi E, 1996, MOL BIOL EVOL, V13, P1078, DOI 10.1093/oxfordjournals.molbev.a025670; Raikova OI, 2000, ZOOMORPHOLOGY, V120, P107, DOI 10.1007/s004350000028; Reichert H, 2001, PHILOS T R SOC B, V356, P1533, DOI 10.1098/rstb.2001.0972; Reuter M, 1998, TISSUE CELL, V30, P57, DOI 10.1016/S0040-8166(98)80006-2; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; Rubenstein JLR, 1997, MOL CELLULAR APPROAC, P356; Ruiz-Trillo I, 2002, P NATL ACAD SCI USA, V99, P11246, DOI 10.1073/pnas.172390199; Salic AN, 1997, DEVELOPMENT, V124, P4739; Sasai Y, 2001, INT J DEV BIOL, V45, P321; SCHMIDTOTT U, 1992, DEVELOPMENT, V116, P111; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; SIMEONE A, 1994, NEURON, V13, P83, DOI 10.1016/0896-6273(94)90461-8; SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0; Suda Y, 1999, DEVELOPMENT, V126, P743; Sussel L, 1999, DEVELOPMENT, V126, P3359; Takacs CM, 2002, EVOL DEV, V4, P405, DOI 10.1046/j.1525-142X.2002.02029.x; Tallafuss A, 2002, GENE, V287, P23, DOI 10.1016/S0378-1119(01)00829-0	67	355	362	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2003	113	7					853	865		10.1016/S0092-8674(03)00469-0	http://dx.doi.org/10.1016/S0092-8674(03)00469-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	695EJ	12837244	Bronze			2022-12-24	WOS:000183817900010
J	Tyree, MT				Tyree, MT			The ascent of water	NATURE			English	Article									US Forest Serv, USDA, NE Expt Stn, Burlington, VT 05402 USA	United States Department of Agriculture (USDA); United States Forest Service	Tyree, MT (corresponding author), US Forest Serv, USDA, NE Expt Stn, POB 968, Burlington, VT 05402 USA.							Tyree MT, 2003, TREES-STRUCT FUNCT, V17, P95, DOI 10.1007/s00468-002-0227-x; Tyree MT, 2002, XYLEM STRUCTURE ASCE; Wei CF, 1999, PLANT PHYSIOL, V121, P1191, DOI 10.1104/pp.121.4.1191	3	107	115	5	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					923	923		10.1038/423923a	http://dx.doi.org/10.1038/423923a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827177	Bronze			2022-12-24	WOS:000183753900026
J	Halsell, JS; Riddle, JR; Atwood, JE; Gardner, P; Shope, R; Poland, GA; Gray, GC; Ostroff, S; Eckart, RE; Hospenthal, DR; Gibson, RL; Grabenstein, JD; Arness, MK; Tornberg, DN				Halsell, JS; Riddle, JR; Atwood, JE; Gardner, P; Shope, R; Poland, GA; Gray, GC; Ostroff, S; Eckart, RE; Hospenthal, DR; Gibson, RL; Grabenstein, JD; Arness, MK; Tornberg, DN		Dept Def Smallpox Vaccination Clin	Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPLICATIONS; MYOCARDITIS; PERICARDITIS; SURVEILLANCE	Context In the United States, the annual incidence of myocarditis is estimated at 1 to 10 per 100000 population. As many as 1% to 5% of patients with acute viral infections involve the myocardium. Although many viruses have been reported to cause myopencarditis, it has been a rare or unrecognized event after vaccination with the currently used strain of vaccinia virus (New York City Board of Health). Objective To describe a series of probable cases of myopericarditis following smallpox vaccination among US military service members reported since the reintroduction of vaccinia vaccine. Design, Setting, Participants Surveillance case definitions are presented. The cases were identified either through sentinel reporting to US military headquarters surveillance using the Defense Medical Surveillance System or reports to the Vaccine Adverse Event Reporting System using International Classification of Diseases, Ninth Revision. The cases occurred among individuals vaccinated from mid-December 2002 to March 14, 2003. Main Outcome Measure Elevated serum levels of creatine kinase (MB isoenzyme), troponin 1, and troponin T, usually in the presence of ST-segment elevation on electrocardiogram and wall motion abnormalities on echocardiogram. Results Among 230734 primary, vaccinees, 18 cases of probable myopericarditis after smallpox vaccination were reported (an incidence of 7.8 per 100000 over 30 days). No cases of myopericarditis following smallpox vaccination were reported among 95 622 vaccinees who were previously vaccinated. All cases were white men aged 21 years to 33 years (mean age, 26.5 years), who presented with acute myopericarditis 7 to 19 days following vaccination. A causal relationship is supported by the close temporal clustering (7-19 days; mean, 10.5 days following vaccination), wide geographic and temporal distribution, occurrence in only primary vaccinees, and lack of evidence for alternative etiologies or other diseases associated with myopericarditis. Additional supporting evidence is the observation that the observed rate of myopericarditis among primary vaccinees is 3.6-fold (95% confidence interval, 3.33-4.11) higher than the expected rate among personnel who were not vaccinated. The background incidence of myopericarditis did not show statistical significance when stratified by age (20-34 years: 2.18 expected cases per 100000; 95% confidence interval [CI], 1.90-2.34), race (whites: 1.82 per 100000; 95% Cl, 1.50-2.01), and sex (males: 2.28 per 100000; 95% Cl, 2.04-2.54). Conclusion Among US military personnel vaccinated against smallpox, myopericarditis occurred at a rate of 1 per 12819 primary vaccinees. Myopericarditis should be considered an expected adverse event associated with smallpox vaccination. Clinicians should consider myopericarditis in the differential diagnosis of patients presenting with chest pain 4 to 30 days following smallpox vaccination and be aware of the implications as well as the need to report this potential adverse advent.	Armed Forces Epidemiol Board, Falls Church, VA 22041 USA		Riddle, JR (corresponding author), Armed Forces Epidemiol Board, Skyline 6,Suite 682,5111 Leesburg Pike, Falls Church, VA 22041 USA.	James.Riddle@otsg.amedd.army.mil	Gray, Gregory C./ABF-1298-2020; Grabenstein, John/Y-7322-2019	Gray, Gregory/0000-0002-4628-5908				AHLBORG B, 1966, ACTA MED SCAND, VS, P127; BENGTSSON ELIAS, 1966, ACTA MED SCAND SUPPL, V464, P113; BENGTSSON ELLAS, 1957, CARDIOLOGIA, V30, P1, DOI 10.1159/000165631; CANGEMI VF, 1958, NEW ENGL J MED, V258, P1257, DOI 10.1056/NEJM195806192582507; *CDCP, TEMP DEF REC HEART P; *CDCP, INT SMALLP FACT SHEE; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P278; DOLGOPOL VB, 1955, ARCH NEURO PSYCHIATR, V73, P216, DOI 10.1001/archneurpsyc.1955.02330080094018; DONADON W, 1974, MINERVA CARDIOANGIOL, V22, P642; Drucker N A, 1997, Adv Pediatr, V44, P141; FEERY BJ, 1977, MED J AUSTRALIA, V2, P180, DOI 10.5694/j.1326-5377.1977.tb114544.x; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Fenner F., 1989, SMALLPOX ITS ERADICA, VVolume 43; FINLAYJONES LR, 1964, NEW ENGL J MED, V270, P41, DOI 10.1056/NEJM196401022700108; Grabenstein JD, 2003, JAMA-J AM MED ASSOC, V289, P3278, DOI 10.1001/jama.289.24.3278; HALLETT P, 1969, MED J AUSTRALIA, V1, P898, DOI 10.5694/j.1326-5377.1969.tb49779.x; HEIKKILA J, 1982, BRIT HEART J, V47, P381; HELLE EPJ, 1978, ANN CLIN RES, V10, P280; *INF MED CLIN GREN, 1974, PEDIATRIE, V29, P179; KARJALAINEN J, 1983, ACTA MED SCAND, V213, P65; Karjalainen J, 1999, EUR HEART J, V20, P1120, DOI 10.1053/euhj.1998.1444; Klein RM, 1998, AM HEART J, V136, P389, DOI 10.1016/S0002-8703(98)70211-X; LANE JM, 1970, J INFECT DIS, V122, P303, DOI 10.1093/infdis/122.4.303; LANE JM, 1969, NEW ENGL J MED, V281, P1201, DOI 10.1056/NEJM196911272812201; MACADAM D, 1962, BRIT MED J, V2, P1099; MARTINO TA, 1994, CIRC RES, V74, P182, DOI 10.1161/01.RES.74.2.182; MATHIEU L, 1953, ARCH MAL COEUR VAISS, V48, P802; MATTHEWS AW, 1974, BRIT HEART J, V36, P1043; MEAD J, 1966, J AM GERIATR SOC, V14, P754, DOI 10.1111/j.1532-5415.1966.tb02902.x; NEFF JM, 1967, NEW ENGL J MED, V276, P125, DOI 10.1056/NEJM196701192760301; NEFF JM, 1967, PEDIATRICS, V39, P916; PHILLIPS M, 1986, JAMA-J AM MED ASSOC, V256, P2696, DOI 10.1001/jama.256.19.2696; PRICE M. A., 1968, Papua New Guinea Medical Journal, V11, P30; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; SOLE MJ, 1993, J AM COLL CARDIOL, V22, pA99, DOI 10.1016/0735-1097(93)90470-L; Towbin J A, 2001, Adolesc Med, V12, P47; WOODRUFF JF, 1980, AM J PATHOL, V101, P425; World Health Organisation, 1977, INT CLASS DIS 9 REV; WYNNE J, 2001, CARDIOMYOPATHIES MYO, P1783; 2003, MORB MORTAL WKLY REP, V52, P492	40	202	212	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2003	289	24					3283	3289		10.1001/jama.289.24.3283	http://dx.doi.org/10.1001/jama.289.24.3283			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	693EX	12824210	Bronze			2022-12-24	WOS:000183704600022
J	Schmidt, R; Enzinger, C; Ropele, S; Schmidt, H; Fazekas, F				Schmidt, R; Enzinger, C; Ropele, S; Schmidt, H; Fazekas, F			Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study	LANCET			English	Article							HYPERINTENSITIES; MRI	More than half of all elderly people have some degree of cerebral white matter lesions. However, the rate of progression of these lesions is uncertain. We aimed to assess the progression of lesions in community-dwelling volunteers aged 50-75 years without neuropsychiatric disease. We used MRI to grade and measure the total volume of white matter lesions in 296 volunteers at baseline, 3 years, and 6 years. 58 participants with no lesions and 123 with punctate abnormalities at baseline had a low tendency for lesion progression, whereas 14 participants with early confluent and nine with confluent lesions underwent median increases of 2.7 cm(3) (IQR 0.5-5.9) and 9.3 cm(3) (7.1-21.0), respectively, in lesion volume at 6 years. Lesion grade at baseline was the only significant predictor of lesion progression (p<0.0001). Punctate white matter lesions are not progressive and are thus benign, whereas early confluent and confluent white matter abnormalities are progressive, and thus malignant.	Karl Franzens Univ Graz, Dept Neurol, A-8036 Graz, Austria; Karl Franzens Univ Graz, MRI Ctr, A-8036 Graz, Austria; Karl Franzens Univ Graz, Inst Med Biochem & Med Mol Biol, A-8036 Graz, Austria	University of Graz; University of Graz; University of Graz	Schmidt, R (corresponding author), Karl Franzens Univ Graz, Dept Neurol, A-8036 Graz, Austria.							FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Schmidt R, 1999, NEUROLOGY, V53, P132, DOI 10.1212/WNL.53.1.132; van Gijn J, 2000, LANCET, V356, P612, DOI 10.1016/S0140-6736(00)02599-X; Veldink JH, 1998, NEUROLOGY, V51, P319, DOI 10.1212/WNL.51.1.319; Whitman GT, 2001, NEUROLOGY, V57, P990, DOI 10.1212/WNL.57.6.990	5	225	234	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 14	2003	361	9374					2046	2048		10.1016/S0140-6736(03)13616-1	http://dx.doi.org/10.1016/S0140-6736(03)13616-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814718				2022-12-24	WOS:000183488900014
J	Wandinger, KP; Lunemann, JD; Wengert, O; Bellmann-Strobl, J; Aktas, O; Weber, A; Grundstrom, E; Ehrlich, S; Wernecke, KD; Volk, HD; Zipp, F				Wandinger, KP; Lunemann, JD; Wengert, O; Bellmann-Strobl, J; Aktas, O; Weber, A; Grundstrom, E; Ehrlich, S; Wernecke, KD; Volk, HD; Zipp, F			TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis	LANCET			English	Article							BLOOD MONONUCLEAR-CELLS; HUMAN T-CELLS; I INTERFERONS; MS PATIENTS; GUIDELINES; LYMPHOCYTE; MECHANISM; LINES	Background Many patients with multiple sclerosis do not respond to interferon beta, which is widely used as an immunomodulatory treatment in this disease. We aimed to assess the functional relevance of tumour necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL), which is upregulated on incubation with interferon beta, for clinical treatment response. Methods We quantified gene expression longitudinally by realtime-PCR of the peripheral immune cells of 82 patients with multiple sclerosis. In a first cohort of 62 patients, 20 were classified as first-year responders since they did not have relapses during treatment with interferon beta la; 19 were classified as first-year non-responders; and 23 developed neutralising antibodies to interferon beta. A second cohort, also characterised by MRI, consisted of 11 patients on interferon beta la and nine patients who,were not treated. Concentrations of soluble TRAIL were determined by ELISA in serum samples of nine non-treated patients, 49 patients before treatment (29 responders, 20 non-responders), as well as longitudinally in a subset of 23 patients. Findings In both patient cohorts, drug-responders could be distinguished from non-responders by early and sustained induction of TRAIL (p<0.0001, each). In the presence of neutralising antibodies, initial upregulation of TRAIL expression was subsequently abrogated. Raised concentrations of soluble TRAIL in patients' serum samples before the start of treatment allowed prediction of the treatment response in the first year (ROC analysis with area under the curve 0.879 [0.785-0.974]). Interpretation Our data suggest that TRAIL expression is a candidate for pretreatment assessment and might thus be used as a prognostic marker of treatment response to interferon beta in multiple sclerosis. Furthermore, our observations have implications for the development of future immunoregulatory strategies in multiple sclerosis therapy.	Charite Univ Hosp, Neurosci Res Ctr, Inst Neuroimmunol, NWFZ 2680, D-10117 Berlin, Germany; Charite Univ Hosp, Dept Neurol, D-10117 Berlin, Germany; Charite Univ Hosp, Inst Med Biometry, D-10117 Berlin, Germany; Charite Univ Hosp, Inst Med Immunol, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Zipp, F (corresponding author), Charite Univ Hosp, Neurosci Res Ctr, Inst Neuroimmunol, NWFZ 2680, Schumannstr 20-21, D-10117 Berlin, Germany.		Zipp, Frauke/C-9968-2015; Ehrlich, Stefan/ABB-4650-2020; Aktas, Orhan/B-7623-2009; Lunemann, Jan D/G-8729-2011; volk, hans-dieter/AAV-8053-2021	Zipp, Frauke/0000-0002-1231-1928; Ehrlich, Stefan/0000-0003-2132-4445; Aktas, Orhan/0000-0002-2020-9210; Lunemann, Jan D/0000-0002-3007-708X; volk, hans-dieter/0000-0002-7743-6668; Bellmann-Strobl, Judith/0000-0003-2615-1643				Brunner E., 2002, NONPARAMETRIC ANAL L; Chawla-Sarkar M, 2001, CLIN CANCER RES, V7, P1821; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Deisenhammer F, 1999, NEUROLOGY, V52, P1239, DOI 10.1212/WNL.52.6.1239; Duquette P, 1996, NEUROLOGY, V47, P889; Ebers G, 1999, NEUROLOGY, V53, P679; Francis G, 2001, NEUROLOGY, V56, P1628; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; Hilliard B, 2001, J IMMUNOL, V166, P1314, DOI 10.4049/jimmunol.166.2.1314; Huang WX, 2000, NEUROLOGY, V55, P928, DOI 10.1212/WNL.55.7.928; Jo M, 2000, NAT MED, V6, P564, DOI 10.1038/75045; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; Kracke A, 2000, NEUROLOGY, V54, P193, DOI 10.1212/WNL.54.1.193; Kumar-Sinha C, 2002, J BIOL CHEM, V277, P575, DOI 10.1074/jbc.M107795200; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lunemann JD, 2002, J IMMUNOL, V168, P4881, DOI 10.4049/jimmunol.168.10.4881; Mariani SM, 1998, EUR J IMMUNOL, V28, P973, DOI 10.1002/(SICI)1521-4141(199803)28:03<973::AID-IMMU973>3.0.CO;2-T; Markovic-Plese S, 2001, J CLIN INVEST, V108, P1185, DOI 10.1172/JCI200112516; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; Martinez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274; Nitsch R, 2000, LANCET, V356, P827, DOI 10.1016/S0140-6736(00)02659-3; PETTE M, 1990, NEUROLOGY, V40, P1770, DOI 10.1212/WNL.40.11.1770; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; STONE LA, 1995, ANN NEUROL, V37, P611, DOI 10.1002/ana.410370511; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wandinger KP, 2001, ANN NEUROL, V50, P349, DOI 10.1002/ana.1096; Wandinger KP, 1997, J NEUROL SCI, V149, P87, DOI 10.1016/S0022-510X(97)05383-5; Wang X, 2000, J IMMUNOL, V165, P548, DOI 10.4049/jimmunol.165.1.548; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8	30	173	186	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 14	2003	361	9374					2036	2043		10.1016/S0140-6736(03)13641-0	http://dx.doi.org/10.1016/S0140-6736(03)13641-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814715				2022-12-24	WOS:000183488900011
J	Baldauf, SL				Baldauf, SL			The deep roots of eukaryotes	SCIENCE			English	Editorial Material							OSTREOCOCCUS-TAURI CHLOROPHYTA; UNIVERSAL TREE; DIVERSITY; EVOLUTION; GENOME; SEQUENCES; PLASTIDS; ANCIENT; ORIGIN	Most cultivated and characterized eukaryotes can be confidently assigned to one of eight major groups. After a few false starts, we are beginning to resolve relationships among these major groups as well. However, recent developments are radically revising this picture again, particularly (i) the discovery of the likely antiquity and taxonomic diversity of ultrasmall eukaryotes, and (ii) a fundamental rethinking of the position of the root. Together these data suggest major gaps in our understanding simply of what eukaryotes are or, when it comes to the tree, even which end is up.	Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England	University of York - UK	Baldauf, SL (corresponding author), Univ York, Dept Biol, Box 373, York YO10 5YW, N Yorkshire, England.	slb14@york.ac.uk		Baldauf, Sandra/0000-0003-4485-6671				Amaral Zettler Linda A., 2002, Nature (London), V417, P137, DOI 10.1038/417137a; AMARALZETTLER LA, 2001, J EUKARYOT MICROBIOL, V48, P293; Archibald JM, 2002, TRENDS GENET, V18, P577, DOI 10.1016/S0168-9525(02)02777-4; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Baldauf SL, 1996, P NATL ACAD SCI USA, V93, P7749, DOI 10.1073/pnas.93.15.7749; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Courties C, 1998, J PHYCOL, V34, P844, DOI 10.1046/j.1529-8817.1998.340844.x; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/10635150118513; Derelle E, 2002, J PHYCOL, V38, P1150, DOI 10.1046/j.1529-8817.2002.02021.x; Dyall SD, 2000, CURR OPIN MICROBIOL, V3, P404, DOI 10.1016/S1369-5274(00)00112-0; Embley TM, 1998, CURR OPIN GENET DEV, V8, P624, DOI 10.1016/S0959-437X(98)80029-4; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Gribaldo S, 2002, THEOR POPUL BIOL, V61, P391, DOI 10.1006/tpbi.2002.1593; Hausmann K., 1996, PROTOZOOLOGY; Hilario E, 1998, J MOL EVOL, V46, P703, DOI 10.1007/PL00006351; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Keeling PJ, 1996, EMBO J, V15, P2285, DOI 10.1002/j.1460-2075.1996.tb00581.x; Klobutcher LA, 2002, CELL, V111, P763, DOI 10.1016/S0092-8674(02)01138-8; LEE JJ, 2000, ILLUTRATED GUIDE PRO; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lopez-Garcia P, 2002, MOL BIOL EVOL, V19, P118, DOI 10.1093/oxfordjournals.molbev.a003976; Massana R, 2002, APPL ENVIRON MICROB, V68, P4554, DOI 10.1128/AEM.68.9.4554-4558.2002; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; PATTERSON DJ, 2000, FLAGELLATES UNITY DI, P269; Prescott DM, 2000, NAT REV GENET, V1, P191, DOI 10.1038/35042057; RIZZO PJ, 1977, SCIENCE, V198, P1258, DOI 10.1126/science.563104; Simpson AGB, 2002, CURR BIOL, V12, pR691, DOI 10.1016/S0960-9822(02)01207-1; SOGIN ML, 1993, NATURE, V362, P795, DOI 10.1038/362795a0; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; YANAI I, 2002, CURR BIOL, V3, P24; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P11724, DOI 10.1073/pnas.172234799	34	572	613	3	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1703	1706		10.1126/science.1085544	http://dx.doi.org/10.1126/science.1085544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805537				2022-12-24	WOS:000183459700038
J	Strang, J; Sheridan, S				Strang, J; Sheridan, S			Effect of national guidelines on prescription of methadone: analysis of NHS prescription data, England 1990-2001	BRITISH MEDICAL JOURNAL			English	Article							DEPENDENCE		Maudsley Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England	University of London; King's College London	Strang, J (corresponding author), Maudsley Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England.		Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725; Sheridan, Janie/0000-0002-0312-3095				Gabbay MB, 2000, BRIT J GEN PRACT, V50, P92; Keen J, 1999, BMJ-BRIT MED J, V318, P1503, DOI 10.1136/bmj.318.7197.1503; Strang J, 1996, BMJ-BRIT MED J, V313, P270, DOI 10.1136/bmj.313.7052.270; Strang J, 1998, BRIT MED J, V317, P1489, DOI 10.1136/bmj.317.7171.1489; Ward J, 1999, LANCET, V353, P221, DOI 10.1016/S0140-6736(98)05356-2	5	14	14	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2003	327	7410					321	322		10.1136/bmj.327.7410.321	http://dx.doi.org/10.1136/bmj.327.7410.321			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	710JE	12907486	Bronze, Green Published			2022-12-24	WOS:000184676400018
J	Harley, HE; Putman, EA; Roitblat, HL				Harley, HE; Putman, EA; Roitblat, HL			Bottlenose dolphins perceive object features through echolocation	NATURE			English	Article							TURSIOPS-TRUNCATUS; RECOGNITION; INFORMATION; INTEGRATION	How organisms (including people) recognize distant objects is a fundamental question(1). The correspondence between object characteristics (distal stimuli), like visual shape, and sensory characteristics (proximal stimuli), like retinal projection, is ambiguous. The view that sensory systems are 'designed' to 'pick up' ecologically useful information is vague about how such mechanisms might work(2). In echolocating dolphins, which are studied as models for object recognition sonar systems, the correspondence between echo characteristics and object characteristics is less clear(3). Many cognitive scientists assume that object characteristics are extracted from proximal stimuli, but evidence for this remains ambiguous. For example, a dolphin may store 'sound templates' in its brain and identify whole objects by listening for a particular sound. Alternatively, a dolphin's brain may contain algorithms, derived through natural endowments or experience or both, which allow it to identify object characteristics based on sounds. The standard method used to address this question in many species(4-7) is indirect and has led to equivocal results with dolphins(8-10). Here we outline an appropriate method and test it to show that dolphins extract object characteristics directly from echoes.	New Coll Florida, Div Social Sci, Sarasota, FL 34243 USA; Walt Disney World Resort, Anim Programs, Epcots Living Seas, Lake Buena Vista, FL 32830 USA; DolphinSearch Inc, Ventura, CA 93001 USA	State University System of Florida; New College Florida; Walt Disney Company	Harley, HE (corresponding author), New Coll Florida, Div Social Sci, 5700 N Tamiami Trail, Sarasota, FL 34243 USA.							Au W. W., 1993, SONAR DOLPHINS; AU WWL, 1980, ANIMAL SONAR SYSTEMS, P859; AU WWL, 1992, J COMP PHYSIOL A, V172, P41; DAVENPORT RK, 1976, ANN NY ACAD SCI, V280, P143, DOI 10.1111/j.1749-6632.1976.tb25482.x; EVANS WE, 1973, J ACOUST SOC AM, V54, P191, DOI 10.1121/1.1913562; GARBIN CP, 1988, J EXP PSYCHOL HUMAN, V14, P547, DOI 10.1037/0096-1523.14.4.547; Gibson J. J, 1979, ECOLOGICAL APPROACH; GOLDSTEIN EB, 2001, BLACKWELL HDB PERCEP; GUNDERSON VM, 1990, DEV PSYCHOL, V26, P576, DOI 10.1037/0012-1649.26.4.576; Harley HE, 1996, J EXP PSYCHOL ANIM B, V22, P164, DOI 10.1037/0097-7403.22.2.164; Herman LM, 1998, J COMP PSYCHOL, V112, P292, DOI 10.1037/0735-7036.112.3.292; Nachtigall PE., 1980, ANIMAL SONAR SYSTEMS, P945, DOI [10.1007/978-1-4684-7254-7_64, DOI 10.1007/978-1-4684-7254-7_64]; PACK AA, 1995, J ACOUST SOC AM, V98, P722, DOI 10.1121/1.413566; ROITBLAT HL, 1990, J EXP PSYCHOL ANIM B, V16, P85, DOI 10.1037/0097-7403.16.1.85; WEISKRANTZ L, 1975, NEUROPSYCHOLOGIA, V13, P257, DOI 10.1016/0028-3932(75)90001-9; Xitco MJ, 1996, ANIM LEARN BEHAV, V24, P355, DOI 10.3758/BF03199007	16	57	58	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					667	669		10.1038/nature01846	http://dx.doi.org/10.1038/nature01846			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	708QE	12904791				2022-12-24	WOS:000184578800043
J	Yamamoto, M; Sato, S; Hemmi, H; Hoshino, K; Kaisho, T; Sanjo, H; Takeuchi, O; Sugiyama, M; Okabe, M; Takeda, K; Akira, S				Yamamoto, M; Sato, S; Hemmi, H; Hoshino, K; Kaisho, T; Sanjo, H; Takeuchi, O; Sugiyama, M; Okabe, M; Takeda, K; Akira, S			Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway	SCIENCE			English	Article								Stimulation of Toll-like receptors (TLRs) triggers activation of a common MyD88-dependent signaling pathway as well as a MyD88-independent pathway that is unique to TLR3 and TLR4 signaling pathways leading to interferon (IFN)-beta production. Here we disrupted the gene encoding a Toll/IL-1 receptor (TIR) domain- containing adaptor, TRIF. TRIF-deficient mice were defective in both TLR3- and TLR4-mediated expression of IFN-beta and activation of IRF-3. Furthermore, inflammatory cytokine production in response to the TLR4 ligand, but not to other TLR ligands, was severely impaired in TRIF-deficient macrophages. Mice deficient in both MyD88 and TRIF showed complete loss of nuclear factor kappa B activation in response to TLR4 stimulation. These findings demonstrate that TRIF is essential for TLR3- and TLR4-mediated signaling pathways facilitating mammalian antiviral host defense.	Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, ERATO, Suita, Osaka 5650871, Japan; Genome Informat Res Ctr, Suita, Osaka 5650871, Japan; RIKEN, Res Ctr Allergy & Immunol, Tsurumi Ku, Kanagawa 2300045, Japan	Osaka University; Japan Science & Technology Agency (JST); RIKEN	Akira, S (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Host Def, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.		Takeuchi, Osamu/AAG-9359-2019; Hoshino, Katsuaki/L-9162-2014; Akira, Shizuo/C-3134-2009; Kaisho, Tsuneyasu/B-4130-2012; Takeuchi, Osamu/D-6007-2011; Takeda, Kiyoshi/C-9331-2009; Hoshino, Katsuaki/AAE-2830-2022; Okabe, Masaru/B-6917-2015	Takeuchi, Osamu/0000-0002-1260-6232; Hoshino, Katsuaki/0000-0003-0493-4815; Hoshino, Katsuaki/0000-0003-0493-4815; Okabe, Masaru/0000-0002-0803-9044; Sato, Shintaro/0000-0001-5156-3354				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Nomura F, 2000, GENES CELLS, V5, P191; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TAKEUCHI O, UNPUB; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	21	2393	2512	4	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					640	643		10.1126/science.1087262	http://dx.doi.org/10.1126/science.1087262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12855817				2022-12-24	WOS:000184473600038
J	Fukami, T; Morin, PJ				Fukami, T; Morin, PJ			Productivity-biodiversity relationships depend on the history of community assembly	NATURE			English	Article							SPECIES-DIVERSITY; GRADIENTS; RICHNESS; PATTERNS	Identification of the causes of productivity-species diversity relationships remains a central topic of ecological research(1,2). Different relations have been attributed to the influence of disturbance(3,4), consumers(5,6), niche specialization 7 and spatial scale(8-14). One unexplored cause is the history of community assembly, the partly stochastic sequential arrival of species from a regional pool of potential community members. The sequence of species arrival can greatly affect community structure(15-19). If assembly sequence interacts with productivity to influence diversity, different sequences can contribute to variation in productivity-diversity relationships. Here we report a test of this hypothesis by assembling aquatic microbial communities at five productivity levels using four assembly sequences. About 30 generations after assembly, productivity-diversity relationships took various forms, including a positive, a hump-shaped, a U-shaped and a non-significant pattern, depending on assembly sequence. This variation resulted from idiosyncratic joint effects of assembly sequence, productivity and species identity on species abundances. We suggest that the history of community assembly should be added to the growing list of factors that influence productivity-biodiversity patterns.	Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA	University of Tennessee System; University of Tennessee Knoxville; Rutgers State University New Brunswick	Fukami, T (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	tfukami@utk.edu	Fukami, Tadashi/A-2934-2010	Fukami, Tadashi/0000-0001-5654-4785				ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; Chase JM, 1999, AM NAT, V154, P559, DOI 10.1086/303260; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; CONNELL JH, 1964, AM NAT, V98, P399, DOI 10.1086/282335; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; DRAKE JA, 1991, AM NAT, V137, P1, DOI 10.1086/285143; GILPIN ME, 1976, NATURE, V261, P40, DOI 10.1038/261040a0; Gross KL, 2000, OIKOS, V89, P417, DOI 10.1034/j.1600-0706.2000.890301.x; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; Huston, 1994, BIOL DIVERSITY COEXI; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Kondoh M, 2001, P ROY SOC B-BIOL SCI, V268, P269, DOI 10.1098/rspb.2000.1384; LAW R, 1993, ECOLOGY, V74, P1347, DOI 10.2307/1940065; Leibold MA, 1997, ANNU REV ECOL SYST, V28, P467, DOI 10.1146/annurev.ecolsys.28.1.467; LEIGH EG, 1965, P NATL ACAD SCI USA, V53, P777, DOI 10.1073/pnas.53.4.777; MITCHELLOLDS T, 1987, EVOLUTION, V41, P1149, DOI 10.1111/j.1558-5646.1987.tb02457.x; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Morin PJ, 2000, NATURE, V406, P463, DOI 10.1038/35020160; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; POST WM, 1983, MATH BIOSCI, V64, P169, DOI 10.1016/0025-5564(83)90002-0; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROSENZWEIG ML, 1992, J MAMMAL, V73, P715, DOI 10.2307/1382191; Scheiner SM, 2000, EVOL ECOL RES, V2, P791; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tilman David, 1993, P13; vandeKoppel J, 1996, ECOLOGY, V77, P736, DOI 10.2307/2265498; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; Wright David H., 1993, P66	30	193	202	8	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					423	426		10.1038/nature01785	http://dx.doi.org/10.1038/nature01785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879069				2022-12-24	WOS:000184318400042
J	Keppler, H; Wiedenbeck, M; Shcheka, SS				Keppler, H; Wiedenbeck, M; Shcheka, SS			Carbon solubility in olivine and the mode of carbon storage in the Earth's mantle	NATURE			English	Article							CO2	The total amount of carbon in the atmosphere, oceans and other near-surface reservoirs is thought to be negligible compared to that stored in the Earth's mantle(1-3). Although the mode of carbon storage in the mantle is largely unknown, observations of microbubbles on dislocations in minerals from mantle xenoliths has led to the suggestion that carbon may be soluble in silicates at high pressure(4,5). Here we report measurements of carbon solubility in olivine, the major constituent of the upper mantle, at pressures up to 3.5 GPa. We have found that, contrary to previous expectations, carbon solubility in olivine is exceedingly low- of the order of 0.1 to 1 parts per million by weight. Together with similar data for pyroxenes, garnet and spinel, we interpret this to imply that most carbon must be present as a separate phase in the deeper parts of the upper mantle, probably as a carbonate phase(6,7). Large-scale volcanic eruptions tapping such a carbonate-bearing mantle reservoir might therefore rapidly transfer large amounts of carbon dioxide into the atmosphere, consistent with models that link global mass extinctions to flood basalt eruptions via a sudden increase in atmospheric carbon dioxide levels(8-11)	Univ Tubingen, Inst Geowissensch, D-72074 Tubingen, Germany; Geoforschungszentrum Potsdam, Projektbereich 4 2, D-14473 Potsdam, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Keppler, H (corresponding author), Univ Tubingen, Inst Geowissensch, Wilhelmstr 56, D-72074 Tubingen, Germany.	Hans.Keppler@uni-tuebingen.de		Shcheka, Svyatoslav/0000-0003-0865-0828				Beerling D, 2002, NATURE, V415, P386, DOI 10.1038/415386a; BELL DR, 1992, SCIENCE, V255, P1391, DOI 10.1126/science.255.5050.1391; FREUND F, 1980, GEOCHIM COSMOCHIM AC, V44, P1319, DOI 10.1016/0016-7037(80)90092-7; GREEN HW, 1972, NATURE-PHYS SCI, V238, P2, DOI 10.1038/physci238002a0; GREEN HW, 1975, GEOL SOC AM BULL, V86, P846, DOI 10.1130/0016-7606(1975)86<846:FPIRFT>2.0.CO;2; HAURI E, 2002, EOS, V83, P383; HAURI EH, 1993, NATURE, V365, P221, DOI 10.1038/365221a0; JAMBON A, 1994, REV MINERAL, V30, P479; JAVOY M, 1982, NATURE, V300, P171, DOI 10.1038/300171a0; Kerrick DM, 2001, REV GEOPHYS, V39, P565, DOI 10.1029/2001RG000105; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; Marzoli A, 1999, SCIENCE, V284, P616, DOI 10.1126/science.284.5414.616; MATHEZ EA, 1987, J GEOPHYS RES-SOLID, V92, P3500, DOI 10.1029/JB092iB05p03500; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; NEWTON RC, 1975, EARTH PLANET SC LETT, V26, P239, DOI 10.1016/0012-821X(75)90091-6; Putnis A., 1992, INTRO MINERAL SCI; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; TINGLE TN, 1988, J GEOPHYS RES-SOLID, V93, P15289, DOI 10.1029/JB093iB12p15289; TSONG IST, 1985, PHYS CHEM MINER, V12, P261, DOI 10.1007/BF00310338; WYLLIE PJ, 1976, CONTRIB MINERAL PETR, V54, P79, DOI 10.1007/BF00372117; ZHANG YX, 1993, EARTH PLANET SC LETT, V117, P331, DOI 10.1016/0012-821X(93)90088-Q	21	125	133	4	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					414	416		10.1038/nature01828	http://dx.doi.org/10.1038/nature01828			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879066				2022-12-24	WOS:000184318400039
J	Neuner, JM; Hamel, MB; Phillips, RS; Bona, K; Aronson, MD				Neuner, JM; Hamel, MB; Phillips, RS; Bona, K; Aronson, MD			Diagnosis and management of adults with pharyngitis - A cost-effectiveness analysis	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	24th Annual Meeting of the Society-of-General-Internal-Medicine	MAY 02-05, 2001	SAN DIEGO, CA	Soc Gen Internal Med			GROUP-A STREPTOCOCCI; ACUTE RHEUMATIC-FEVER; BETA-HEMOLYTIC STREPTOCOCCI; APPROPRIATE ANTIBIOTIC USE; RESPIRATORY-TRACT INFECTIONS; MANAGING SORE THROAT; OPTICAL IMMUNOASSAY; DECISION-ANALYSIS; GENERAL-PRACTICE; RAPID DETECTION	Background: Rheumatic fever has become uncommon in the United States while rapid diagnostic test technology for streptococcal antigens has improved. However, little is known about the effectiveness or cost-effectiveness of various strategies for managing pharyngitis caused by group A beta-hemolytic streptococcus (GAS) in U.S. adults. Objective: To examine the cost-effectiveness of several diagnostic and management strategies for patients with suspected GAS pharyngitis. Design: Cost-effectiveness analysis. Data Sources: Published literature, including systematic reviews where possible. When costs were not available in the literature, we estimated them from our institution and Medicare charges. Target Population: Adults in the general U.S. population. Time Horizon: 1 year. Perspective: Societal. Interventions: Five strategies for the management of adult patients with pharyngitis: 1) observation without testing or treatment, 2) empirical treatment with penicillin, 3) throat culture using a two-plate selective culture technique, 4) optical immunoassay (OIA) followed by culture to confirm negative OIA test results, or 5) OIA alone. Outcome Measures: Cost per lost quality-adjusted life-days (converted to life-years where appropriate) and incremental cost-effectiveness. Results of Base-Case Analysis: Empirical treatment was the least effective strategy at a GAS pharyngitis prevalence of 10% (resulting in 0.41 lost quality-adjusted life-day). Although the other four strategies had similar effectiveness (all resulted in about 0.27 lost quality-adjusted life-day), culture was the least expensive strategy. Results of Sensitivity Analyses: Results were sensitive to the prevalence of GAS pharyngitis: OIA followed by culture was most effective when GAS pharyngitis prevalence was greater than 20%. Observation was least expensive when prevalence was less than 6%, and empirical treatment was least expensive when prevalence was greater than 71%. The effectiveness of strategies was also very sensitive to the probability of anaphylaxis: When the probability of anaphylaxis was about half the baseline probability, OIA/culture was most effective; when the probability was 1.6 times that of baseline, observation was most effective. Only at an OIA cost less than half of baseline did the OIA alone strategy become less expensive than culture. Results were not sensitive to other variations in probabilities or costs of diagnosis or treatment of GAS pharyngitis. Conclusions: Observation, culture, and two rapid antigen test strategies for diagnostic testing and treatment of suspected GAS pharyngitis in adults have very similar effectiveness and costs, although culture is the least expensive and most effective strategy when the GAS pharyngitis prevalence is 10%. Empirical treatment was not the most effective or least expensive strategy at any prevalence of GAS pharyngitis in adults, although it may be reasonable for individual patients at very high risk for GAS pharyngitis as assessed by a clinical decision rule.	Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA	Harvard University; Beth Israel Deaconess Medical Center; Medical College of Wisconsin	Aronson, MD (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Rose Bldg,Room 118, Boston, MA 02215 USA.							ANHALT JP, 1992, J CLIN MICROBIOL, V30, P2135, DOI 10.1128/JCM.30.8.2135-2138.1992; BAKER DM, 1995, DIAGN MICR INFEC DIS, V21, P61, DOI 10.1016/0732-8893(95)00023-4; BELLON J, 1991, J CLIN MICROBIOL, V29, P2084, DOI 10.1128/JCM.29.9.2084-2085.1991; Bisno AL, 1997, CLIN INFECT DIS, V25, P574, DOI 10.1086/513768; BRINK WR, 1951, AM J MED, V10, P300, DOI 10.1016/0002-9343(51)90274-4; BRUMFITT W, 1957, LANCET, V1, P8; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; CATANZARO FJ, 1954, AM J MED, V17, P749, DOI 10.1016/0002-9343(54)90219-3; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; CENTOR RM, 1986, J GEN INTERN MED, V1, P248, DOI 10.1007/BF02596194; CENTOR RM, 1986, ANN INTERN MED, V105, P892, DOI 10.7326/0003-4819-105-6-892; CHAMOVITZ R, 1954, NEW ENGL J MED, V251, P466, DOI 10.1056/NEJM195409162511203; Cooper RJ, 2001, ANN INTERN MED, V134, P509, DOI 10.7326/0003-4819-134-6-200103200-00019; CRAWFORD G, 1979, ANN INTERN MED, V90, P293, DOI 10.7326/0003-4819-90-3-293; Dagnelie CF, 1996, BRIT J GEN PRACT, V46, P589; DAJANI A, 1995, PEDIATRICS, V96, P758; DALY JA, 1994, J CLIN MICROBIOL, V32, P531, DOI 10.1128/JCM.32.2.531-532.1994; DELMAR C, 1992, MED J AUSTRALIA, V156, P644, DOI 10.5694/j.1326-5377.1992.tb121463.x; DELMAR CB, 2002, COCHRANE DATABASE SY, P2; DEMEYERE M, 1992, EUR J CLIN PHARMACOL, V43, P581, DOI 10.1007/BF02284954; DENNY FW, 1950, JAMA-J AM MED ASSOC, V143, P151, DOI 10.1001/jama.1950.02910370001001; DENNY FW, 1953, PEDIATRICS, V11, P7; deShazo RD, 1997, JAMA-J AM MED ASSOC, V278, P1895, DOI 10.1001/jama.278.22.1895; Dobbs F, 1996, BRIT J GEN PRACT, V46, P461; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Ebell MH, 2000, JAMA-J AM MED ASSOC, V284, P2912, DOI 10.1001/jama.284.22.2912; FEINSTEIN AR, 1964, ANN INTERN MED, V60, P87, DOI 10.7326/0003-4819-60-2-87; FINKLER SA, 1982, ANN INTERN MED, V96, P102, DOI 10.7326/0003-4819-96-1-102; FRIES SM, 1995, J PEDIATR-US, V126, P933, DOI 10.1016/S0022-3476(95)70213-X; Gerber MA, 1997, JAMA-J AM MED ASSOC, V277, P899, DOI 10.1001/jama.277.11.899; GERBER MA, 1989, PEDIATR INFECT DIS J, V8, P820, DOI 10.1097/00006454-198911000-00032; Gold MR, 1996, COST EFFECTIVENESS H; Goldman L., 2000, CECIL TXB MED; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; GOSLINGS WR, 1963, NEW ENGL J MED, V268, P687, DOI 10.1056/NEJM196303282681301; GRAHAM L, 1986, J CLIN MICROBIOL, V24, P644, DOI 10.1128/JCM.24.4.644-646.1986; Gunnarsson RK, 1997, SCAND J PRIM HEALTH, V15, P149, DOI 10.3109/02813439709018506; HARBECK RJ, 1993, J CLIN MICROBIOL, V31, P839, DOI 10.1128/JCM.31.4.839-844.1993; HEITER BJ, 1995, J CLIN MICROBIOL, V33, P1408, DOI 10.1128/JCM.33.5.1408-1410.1995; HERMAN JM, 1984, J FAM PRACTICE, V19, P767; HILLNER BE, 1992, JAMA-J AM MED ASSOC, V267, P2055, DOI 10.1001/jama.267.15.2055; HILLNER BE, 1987, J GEN INTERN MED, V2, P244, DOI 10.1007/BF02596449; HOFFMANN S, 1990, DIAGN MICR INFEC DIS, V13, P209, DOI 10.1016/0732-8893(90)90061-Y; Hoffmann Steen, 1992, Scandinavian Journal of Primary Health Care, V10, P295, DOI 10.3109/02813439209014077; HOLMBERG SD, 1983, JAMA-J AM MED ASSOC, V250, P2307, DOI 10.1001/jama.250.17.2307; HORDER J, 1954, Practitioner, V173, P177; HUOVINEN P, 1989, ANN INTERN MED, V110, P612, DOI 10.7326/0003-4819-110-8-612; Kaltwasser G, 1997, PEDIATR INFECT DIS J, V16, P748, DOI 10.1097/00006454-199708000-00004; KAPLAN EL, 1971, J INFECT DIS, V123, P490, DOI 10.1093/infdis/123.5.490; KELLOGG JA, 1986, JAMA-J AM MED ASSOC, V255, P2638, DOI 10.1001/jama.255.19.2638; KELLOGG JA, 1990, J CLIN MICROBIOL, V28, P165, DOI 10.1128/JCM.28.2.165-169.1990; KIRSCHNER CG, 1994, CPT 95; KIRSCHNER CG, 1997, PHYSICIANS CURRENT P; KJAKOVIC M, 1993, NZ MED J, V106, P381; KOMAROFF AL, 1986, J GEN INTERN MED, V1, P1, DOI 10.1007/BF02596317; Kuhn S, 1999, DIAGN MICR INFEC DIS, V34, P275, DOI 10.1016/S0732-8893(99)00027-9; LAUER BA, 1983, J CLIN MICROBIOL, V17, P338, DOI 10.1128/JCM.17.2.338-340.1983; Linder JA, 2001, JAMA-J AM MED ASSOC, V286, P1181, DOI 10.1001/jama.286.10.1181; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Little P, 1999, BRIT MED J, V319, P736, DOI 10.1136/bmj.319.7212.736; MANDELL GL, 1995, GOODMAN GILMANS PHAR, P272; Martin JM, 2002, NEW ENGL J MED, V346, P1200, DOI 10.1056/NEJMoa013169; McIsaac WJ, 1998, CAN MED ASSOC J, V158, P75; *MED EC, 2000, DRUG TOP RED BOOK; MELAND E, 1993, SCAND J INFECT DIS, V25, P177, DOI 10.3109/00365549309008482; MOYER NP, 1990, J CLIN MICROBIOL, V28, P1661, DOI 10.1128/JCM.28.7.1661-1663.1990; Petersen K, 1997, J GEN INTERN MED, V12, P95, DOI 10.1046/j.1525-1497.1997.00013.x; Pitetti RD, 1998, PEDIATR EMERG CARE, V14, P396, DOI 10.1097/00006565-199812000-00004; POSES RM, 1986, ANN INTERN MED, V105, P586, DOI 10.7326/0003-4819-105-4-586; RODDEY OF, 1995, JAMA-J AM MED ASSOC, V274, P1863, DOI 10.1001/jama.274.23.1863; SANFORD JP, 1984, PHARYNGITIS MANAGEME, P251; SAVOIA D, 1994, MICROBIOS, V77, P253; SCHAPPERT SM, 1998, AMBULATORY CARE VISI; Schlager TA, 1996, ARCH PEDIAT ADOL MED, V150, P245, DOI 10.1001/archpedi.1996.02170280015002; SEPPALA H, 1992, NEW ENGL J MED, V326, P292, DOI 10.1056/NEJM199201303260503; SIEGEL AC, 1961, NEW ENGL J MED, V265, P559, DOI 10.1056/NEJM196109212651201; SMITH JM, 1995, LAB MED, V26, P408, DOI 10.1093/labmed/26.6.408; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018; Steinhoff MC, 1997, LANCET, V350, P918, DOI 10.1016/S0140-6736(97)03317-5; STOLLERMAN GH, 1982, ADV INTERNAL MED, V27, P373; Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004; TOMPKINS RK, 1977, ANN INTERN MED, V86, P481, DOI 10.7326/0003-4819-86-4-481; TSEVAT J, 1995, J AM COLL CARDIOL, V26, P914, DOI 10.1016/0735-1097(95)00284-1; TSEVAT J, 1991, J PEDIATR-US, V118, P546, DOI 10.1016/S0022-3476(05)83375-X; Tsevat J, 1999, ARCH PEDIAT ADOL MED, V153, P681, DOI 10.1001/archpedi.153.7.681; VALKENBURG HA, 1971, J INFECT DIS, V124, P348, DOI 10.1093/infdis/124.4.348; VEASY LG, 1994, J PEDIATR-US, V124, P9, DOI 10.1016/S0022-3476(94)70247-0; WALLACE MR, 1989, JAMA-J AM MED ASSOC, V262, P2557, DOI 10.1001/jama.262.18.2557; WALSH BT, 1975, ARCH INTERN MED, V135, P1493, DOI 10.1001/archinte.135.11.1493; WANNAMAKER LW, 1951, AM J MED, V10, P673, DOI 10.1016/0002-9343(51)90336-1; Webb KH, 1998, PEDIATRICS, V101, part. no., DOI 10.1542/peds.101.2.e2; WEGNER DL, 1992, JAMA-J AM MED ASSOC, V267, P695, DOI 10.1001/jama.267.5.695; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WIGTON RS, 1986, ARCH INTERN MED, V146, P81, DOI 10.1001/archinte.146.1.81; Zwart S, 2000, BRIT MED J, V320, P150, DOI 10.1136/bmj.320.7228.150	96	66	69	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2003	139	2					113	122		10.7326/0003-4819-139-2-200307150-00011	http://dx.doi.org/10.7326/0003-4819-139-2-200307150-00011			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	701HX	12859161				2022-12-24	WOS:000184163100005
J	Martin, OY; Hosken, DJ				Martin, OY; Hosken, DJ			The evolution of reproductive isolation through sexual conflict	NATURE			English	Article							FLY SEPSIS-CYNIPSEA; SERIALLY BOTTLENECKED LINES; RAPID EVOLUTION; SPECIATION; SELECTION; BEHAVIOR; COSTS; SIZE	Classical population-genetics theory suggests that reproductive isolation will evolve fastest in small isolated populations(1). In contrast, recent theory suggests that divergence should occur fastest in larger allopatric populations(2). The rationale behind this is that sexual conflict, potentially the strongest driver of speciation, is greater in larger, higher-density populations. This idea is highly controversial(3) and has little experimental support(4,5). Here we show, using replicate fly populations with varying levels of sexual conflict, that larger, more dense populations with more sexual conflict diverged to a greater degree than small populations with relaxed conflict. This result strongly suggests that speciation can occur rapidly in large populations through increased sexual conflict.	Univ Zurich, Museum Zool, CH-8057 Zurich, Switzerland	University of Zurich	Martin, OY (corresponding author), Univ Zurich, Museum Zool, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		MARTIN, OLIVER Y/A-4534-2009	MARTIN, OLIVER Y/0000-0002-8601-7131				Andres JA, 2003, J EVOLUTION BIOL, V16, P219, DOI 10.1046/j.1420-9101.2003.00525.x; Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; Blanckenhorn WU, 2002, BEHAV ECOL, V13, P353, DOI 10.1093/beheco/13.3.353; Blanckenhorn WU, 2000, ETHOLOGY, V106, P577, DOI 10.1046/j.1439-0310.2000.00573.x; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Ding A, 2002, EVOL ECOL RES, V4, P259; Gage MJG, 2002, P ROY SOC B-BIOL SCI, V269, P2309, DOI 10.1098/rspb.2002.2154; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Hosken DJ, 2003, J EVOLUTION BIOL, V16, P485, DOI 10.1046/j.1420-9101.2003.00537.x; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Martin OY, 2003, EVOL ECOL RES, V5, P119; Martin OY, 2002, ANIM BEHAV, V63, P541, DOI 10.1006/anbe.2001.1929; MEFFERT LM, 1992, EVOLUTION, V46, P1399, DOI 10.1111/j.1558-5646.1992.tb01132.x; MEFFERT LM, 1991, EVOLUTION, V45, P293, DOI 10.1111/j.1558-5646.1991.tb04404.x; Muhlhauser C, 2002, BEHAV ECOL, V13, P359, DOI 10.1093/beheco/13.3.359; Parker G.A., 1979, P123; PARKER GA, 1972, BEHAVIOUR, V41, P242, DOI 10.1163/156853972X00031; PARKER GA, 1972, BEHAVIOUR, V41, P172, DOI 10.1163/156853972X00257; Price T, 1998, PHILOS T R SOC B, V353, P251, DOI 10.1098/rstb.1998.0207; Rice WR, 2000, P NATL ACAD SCI USA, V97, P12953, DOI 10.1073/pnas.97.24.12953; Rice WR, 1998, ENDLESS FORMS, P261; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; RICE WR, 1993, EVOLUTION, V47, P1637, DOI 10.1111/j.1558-5646.1993.tb01257.x; Schluter D, 2000, ECOLOGY ADAPTIVE RAD; SHARP PM, 1984, GENETICS, V106, P601; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tregenza T, 2000, NATURE, V407, P149, DOI 10.1038/35025138; WARD PI, 1992, FUNCT ECOL, V6, P649, DOI 10.2307/2389959	28	195	202	0	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					979	982		10.1038/nature01752	http://dx.doi.org/10.1038/nature01752			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827200				2022-12-24	WOS:000183753900048
J	Goldman, DP; Berry, SH; McCabe, MS; Kilgore, ML; Potosky, AL; Schoenbaum, ML; Schonlau, M; Weeks, JC; Kaplan, R; Escarce, JJ				Goldman, DP; Berry, SH; McCabe, MS; Kilgore, ML; Potosky, AL; Schoenbaum, ML; Schonlau, M; Weeks, JC; Kaplan, R; Escarce, JJ			Incremental treatment costs in National Cancer Institute-sponsored clinical trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAST-CANCER; MEDICAL ONCOLOGISTS; BARRIERS; CARE; CHEMOTHERAPY; MULTICENTER; KNOWLEDGE; ATTITUDES	Context Concern about additional costs for direct patient care impedes efforts to enroll patients in clinical trials. But generalizable evidence substantiating these concerns is lacking. Objective To assess the additional cost of treating cancer patients in the National Cancer Institute (NCI)-sponsored clinical trials in the United States across a range of trial phases, treatment modalities, and patient care settings. Design Retrospective cost study using a multistage, stratified, random sample of patients enrolled in 1 of 35 active phase 3 trials or phase 1 or any phase 2 trials between October 1, 1998, and December 31, 1999. Unadjusted and adjusted costs were compared and related to trial phase, institution type, and vital status. Setting and Participants A representative sample of 932 cancer patients enrolled in nonpediatric, NCI-sponsored clinical trials and 696 nonparticipants with a similar stage of disease not enrolled in a research protocol from 83 cancer clinical research institutions across the United States. Main Outcome Measures Direct treatment costs as measured using a combination of medical records, telephone survey, and Medicare claims data. Administrative and other research costs were excluded. Results The incremental costs of direct care in trials were modest. Over approximately a 2.5-year period, adjusted costs were 6.5% higher for trial participants than nonparticipants ($35418 vs $33248; P=.11). Cost differences for phase 3 studies were 3.5% (P=.22), lower than for phase 1 or 2 trials (12.8%; P=.20). Trial participants who died had higher costs than nonparticipants who died (17.9%; $39420 vs $33432, respectively; P=15). Conclusions Treatment costs for nonpediatric clinical trial participants are on average 6.5% higher than what they would be if patients did not enroll. This implies total incremental treatment costs for NCI-sponsored trials of $16 million in 1999. Incremental costs were higher for patients who died and who were in early phase studies although these findings deserve further scrutiny. Overall, the additional treatment costs of an open reimbursement policy for government-sponsored cancer clinical trials appear minimal.	RAND Corp, Hlth, Santa Monica, CA 90407 USA; RAND Corp, Stat, Santa Monica, CA 90407 USA; NCI, Off Educ & Special Initiat, Div Canc Control & Populat Sci, Washington, DC USA; NCI, Clin Invest Branch, Natl Canc Therapy Evaluat Program, Washington, DC USA; Univ Alabama, Dept Hlth Care Org & Policy, Birmingham, AL USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA	RAND Corporation; RAND Corporation; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Alabama System; University of Alabama Birmingham; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Goldman, DP (corresponding author), RAND Corp, Hlth, 1700 Main St, Santa Monica, CA 90407 USA.		Goldman, Dana P/E-7667-2013; Schoenbaum, Michael/GRR-3988-2022	Goldman, Dana P/0000-0001-8498-6396; Kaplan, Richard S./0000-0002-0189-8348				Aaron HJ., 2000, EXTENDING MEDICARE R; BENSON AB, 1991, J CLIN ONCOL, V9, P2067, DOI 10.1200/JCO.1991.9.11.2067; Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; Brown ML, 2002, MED CARE, V40, P104; Brown ML, 1999, J NATL CANCER I, V91, P818, DOI 10.1093/jnci/91.10.818; Chirikos TN, 2001, MED CARE, V39, P373, DOI 10.1097/00005650-200104000-00008; Cochran W. G., 1977, SAMPLING TECHNIQUES; Fireman BH, 2000, J NATL CANCER I, V92, P136, DOI 10.1093/jnci/92.2.136; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; FISHER B, 1989, NEW ENGL J MED, V320, P822, DOI 10.1056/NEJM198903303201302; FLEMING ID, 1994, CANCER, V74, P2662, DOI 10.1002/1097-0142(19941101)74:9+<2662::AID-CNCR2820741813>3.0.CO;2-3; GLICKSMAN AS, 1996, STRATEGIES EVALUATIN; Goldman DP, 2001, J CLIN ONCOL, V19, P105, DOI 10.1200/JCO.2001.19.1.105; GOLDMAN DP, 2000, RAND PUBLICATION; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; HALL WH, 1991, JAMA-J AM MED ASSOC, V265, P391; Lara PN, 2001, J CLIN ONCOL, V19, P1728, DOI 10.1200/JCO.2001.19.6.1728; Manning WG, 1998, J HEALTH ECON, V17, P283, DOI 10.1016/S0167-6296(98)00025-3; MANSOUR EG, 1994, CANCER, V74, P2672, DOI 10.1002/1097-0142(19941101)74:9+<2672::AID-CNCR2820741815>3.0.CO;2-X; Martin Joseph B, 2002, Trans Am Clin Climatol Assoc, V113, P227; Paller MS, 2002, ACAD MED, V77, P1201, DOI 10.1097/00001888-200212000-00008; Perez EA, 1998, J CLIN ONCOL, V16, P754, DOI 10.1200/JCO.1998.16.2.754; POTOSKY AL, 1993, MED CARE, V31, P732; QUIRK J, 2000, ANN M AM SOC CLIN ON; Roche K, 2002, J CLIN ONCOL, V20, P545, DOI 10.1200/JCO.20.2.545; SCHAIN WS, 1994, CANCER, V74, P2666, DOI 10.1002/1097-0142(19941101)74:9+<2666::AID-CNCR2820741814>3.0.CO;2-P; SCHOENBAUM M, 2001, HLTH SERV OUTCOMES R, V2, P67; Siminoff LA, 2000, MED CARE, V38, P696, DOI 10.1097/00005650-200007000-00002; Siminoff LA, 2000, J CLIN ONCOL, V18, P1203, DOI 10.1200/JCO.2000.18.6.1203; Simon MS, 1999, AM J CLIN ONCOL-CANC, V22, P42, DOI 10.1097/00000421-199902000-00011; STINSON TJ, 2000, ANN M AM SOC CLIN ON; US General Accounting Office, 1999, US GEN ACC OFF PUBL; Wagner JL, 1999, JNCI-J NATL CANCER I, V91, P847, DOI 10.1093/jnci/91.10.847; 2002, FED REG          DEC, V76, P236	34	56	56	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2003	289	22					2970	2977		10.1001/jama.289.22.2970	http://dx.doi.org/10.1001/jama.289.22.2970			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687XZ	12799405	Bronze			2022-12-24	WOS:000183403400020
J	Girardin, SE; Boneca, IG; Carneiro, LAM; Antignac, A; Jehanno, M; Viala, J; Tedin, K; Taha, MK; Labigne, A; Zahringer, U; Coyle, AJ; Bertin, J; Sansonetti, PJ; Philpott, DJ				Girardin, SE; Boneca, IG; Carneiro, LAM; Antignac, A; Jehanno, M; Viala, J; Tedin, K; Taha, MK; Labigne, A; Zahringer, U; Coyle, AJ; Bertin, J; Sansonetti, PJ; Philpott, DJ			Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan	SCIENCE			English	Article							NF-KAPPA-B; RECOGNITION PROTEIN; IMMUNE-RESPONSES; ESCHERICHIA-COLI; CROHNS-DISEASE; FAMILY MEMBER; DROSOPHILA; INNATE; TOLL; ACTIVATION	Although the role of Toll-like receptors in extracellular bacterial sensing has been investigated intensively, intracellular detection of bacteria through Nod molecules remains largely uncharacterized. Here, we show that human Nod1 specifically detects a unique diaminopimelate-containing N-acetylglucosamine-N-acetylmuramic acid (GlcNAc-MurNAc) tripeptide motif found in Gram-negative bacterial peptidoglycan, resulting in activation of the transcription factor NF-kappaB pathway. Moreover, we show that in epithelial cells (which represent the first line of defense against invasive pathogens), Nod1 is indispensable for intracellular Gram-negative bacterial sensing.	Inst Pasteur, Unite Neisseria, F-75724 Paris 15, France; Inst Pasteur, INSERM, U389, Unite Pathogenie Microbienne Mol, F-75724 Paris, France; Inst Pasteur, Unite Pathogenie Bacterienne Muqueuses, F-75724 Paris 15, France; Inst Pasteur, Grp Immunite Innee & Signalisat, F-75724 Paris 15, France; Free Univ Berlin, Inst Mikrobiol & Tierseuchen, D-10115 Berlin, Germany; Res Ctr Borstel, Div Immunochem, Ctr Med & Biosci, D-23845 Borstel, Germany; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Free University of Berlin; Forschungszentrum Borstel; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Philpott, DJ (corresponding author), Inst Pasteur, Unite Neisseria, 28 Rue Dr Roux, F-75724 Paris 15, France.		Carneiro, Leticia/T-8978-2019; Boneca, Ivo G/H-1677-2014	Carneiro, Leticia/0000-0001-5870-8288; Boneca, Ivo G/0000-0001-8122-509X; Tedin, Karsten/0000-0003-2109-0730				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Eckmann L, 2000, J BIOL CHEM, V275, P14084, DOI 10.1074/jbc.275.19.14084; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HOLTJE J, 1988, MICROBIOL MOL BIOL R, V62, P181; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Lee HK, 2002, J IMMUNOL, V168, P4012, DOI 10.4049/jimmunol.168.8.4012; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; McLaughlan AM, 1998, MICROBIOL-SGM, V144, P1359, DOI 10.1099/00221287-144-5-1359; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; PEDRON T, UNPUB; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735	30	1156	1214	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1584	1587		10.1126/science.1084677	http://dx.doi.org/10.1126/science.1084677			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791997				2022-12-24	WOS:000183333100059
J	Ling, H; Boudsocq, F; Plosky, BS; Woodgate, R; Yang, W				Ling, H; Boudsocq, F; Plosky, BS; Woodgate, R; Yang, W			Replication of a cis-syn thymine dimer at atomic resolution	NATURE			English	Article							DNA-POLYMERASE-ETA; CRYSTAL-STRUCTURE; SULFOLOBUS-SOLFATARICUS; XERODERMA-PIGMENTOSUM; EXCISION-REPAIR; ERROR-PRONE; DAMAGED DNA; Y-FAMILY; BYPASS; MUTATIONS	Ultraviolet light damages DNA by catalysing covalent bond formation between adjacent pyrimidines, generating cis-syn cyclobutane pyrimidine dimers (CPDs) as the most common lesion(1). CPDs block DNA replication by high-fidelity DNA polymerases, but they can be efficiently bypassed by the Y-family DNA polymerase pol eta(2,3). Mutations in POLH encoding pol h are implicated in nearly 20% of xeroderma pigmentosum, a human disease characterized by extreme sensitivity to sunlight and predisposition to skin cancer(4-6). Here we have determined two crystal structures of Dpo4, an archaeal pol eta homologue, complexed with CPD-containing DNA, where the 3' and 5' thymine of the CPD separately serves as a templating base. The 3' thymine of the CPD forms a Watson-Crick base pair with the incoming dideoxyATP, but the 5' thymine forms a Hoogsteen base pair with the dideoxyATP in syn conformation. Dpo4 retains a similar tertiary structure, but each unusual DNA structure is individually fitted into the active site for catalysis. A model of the pol eta-CPD complex built from the crystal structures of Saccharomyces cerevisiae apo-pol eta and the Dpo4-CPD complex suggests unique features that allow pol eta to efficiently bypass CPDs.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Lab Genom Integr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Yang, W (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.		Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020; Ling, Hong/E-3729-2010	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; Woodgate, Roger/0000-0001-5581-4616	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036119, Z01DK036119] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aishima J, 2002, NUCLEIC ACIDS RES, V30, P5244, DOI 10.1093/nar/gkf661; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bunting KA, 2003, NUCLEIC ACIDS RES, V31, P1633, DOI 10.1093/nar/gkg273; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Glick E, 2001, EMBO J, V20, P7303, DOI 10.1093/emboj/20.24.7303; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lehmann AR, 2002, MUTAT RES-FUND MOL M, V509, P23, DOI 10.1016/S0027-5107(02)00227-0; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; PARK JY, 1995, J BIOCHEM-TOKYO, V118, P989, DOI 10.1093/jb/118.5.989; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Silvian LF, 2001, NAT STRUCT BIOL, V8, P984, DOI 10.1038/nsb1101-984; Szekeres ES, 1996, J BACTERIOL, V178, P2559, DOI 10.1128/jb.178.9.2559-2563.1996; Thoma F, 1999, EMBO J, V18, P6585, DOI 10.1093/emboj/18.23.6585; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; Yang W, 2003, CURR OPIN STRUC BIOL, V13, P23, DOI 10.1016/S0959-440X(02)00003-9; Zhang H, 2002, NUCLEIC ACIDS RES, V30, P1262, DOI 10.1093/nar/30.5.1262; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	30	188	189	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2003	424	6952					1083	1087		10.1038/nature01919	http://dx.doi.org/10.1038/nature01919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12904819				2022-12-24	WOS:000184984200050
J	Palenik, B; Brahamsha, B; Larimer, FW; Land, M; Hauser, L; Chain, P; Lamerdin, J; Regala, W; Allen, EE; McCarren, J; Paulsen, I; Dufresne, A; Partensky, F; Webb, EA; Waterbury, J				Palenik, B; Brahamsha, B; Larimer, FW; Land, M; Hauser, L; Chain, P; Lamerdin, J; Regala, W; Allen, EE; McCarren, J; Paulsen, I; Dufresne, A; Partensky, F; Webb, EA; Waterbury, J			The genome of a motile marine Synechococcus	NATURE			English	Article							CYANOBACTERIUM SYNECHOCOCCUS; SP PCC7942; POLYPEPTIDE; IDENTIFICATION; GENE; PROCHLOROCOCCUS; DEGRADATION; SEQUENCE; STRAINS; ECOLOGY	Marine unicellular cyanobacteria are responsible for an estimated 20-40% of chlorophyll biomass and carbon fixation in the oceans(1). Here we have sequenced and analysed the 2.4-megabase genome of Synechococcus sp. strain WH8102, revealing some of the ways that these organisms have adapted to their largely oligotrophic environment. WH8102 uses organic nitrogen and phosphorus sources and more sodium-dependent transporters than a model freshwater cyanobacterium. Furthermore, it seems to have adopted strategies for conserving limited iron stores by using nickel and cobalt in some enzymes, has reduced its regulatory machinery (consistent with the fact that the open ocean constitutes a far more constant and buffered environment than fresh water), and has evolved a unique type of swimming motility. The genome of WH8102 seems to have been greatly influenced by horizontal gene transfer, partially through phages. The genetic material contributed by horizontal gene transfer includes genes involved in the modification of the cell surface and in swimming motility. On the basis of its genome, WH8102 is more of a generalist than two related marine cyanobacteria(2).	Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Joint Genome Inst, Walnut Creek, CA 94598 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; TIGR, Rockville, MD 20850 USA; CNRS, Biol Stn, UMR 7127, F-29682 Roscoff, France; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; J. Craig Venter Institute; Centre National de la Recherche Scientifique (CNRS); Woods Hole Oceanographic Institution	Palenik, B (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.		Paulsen, Ian T/K-3832-2012; Partensky, Frédéric/B-9194-2018; Palenik, Brian/AAA-1822-2020; Hauser, Loren J/H-3881-2012; chain, patrick/B-9777-2013; Partensky, Frédéric/AAH-1170-2021; Chain, Patrick/O-4140-2019; Land, Miriam L/A-6200-2011	Paulsen, Ian T/0000-0001-9015-9418; Partensky, Frédéric/0000-0003-1274-4050; Palenik, Brian/0000-0002-3717-9046; Partensky, Frédéric/0000-0003-1274-4050; Chain, Patrick/0000-0003-3949-3634; Land, Miriam L/0000-0001-7102-0031; Brahamsha, Bianca/0000-0002-5316-5939				Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Brahamsha B, 1996, P NATL ACAD SCI USA, V93, P6504, DOI 10.1073/pnas.93.13.6504; Brahamsha B, 1996, APPL ENVIRON MICROB, V62, P1747, DOI 10.1128/AEM.62.5.1747-1751.1996; Bushman F, 2002, LATERAL DNA TRANSFER; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DELORIMIER R, 1990, ARCH MICROBIOL, V153, P541, DOI 10.1007/BF00245263; Dolganov N, 1999, J BACTERIOL, V181, P610, DOI 10.1128/JB.181.2.610-617.1999; Ferris MJ, 1998, NATURE, V396, P226, DOI 10.1038/24297; Goto-Seki A, 1999, MOL MICROBIOL, V34, P473, DOI 10.1046/j.1365-2958.1999.01608.x; Harano Y, 1997, J BACTERIOL, V179, P5744, DOI 10.1128/jb.179.18.5744-5750.1997; Long RA, 2001, APPL ENVIRON MICROB, V67, P4975, DOI 10.1128/AEM.67.11.4975-4983.2001; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mann EL, 2002, LIMNOL OCEANOGR, V47, P976, DOI 10.4319/lo.2002.47.4.0976; Monger BC, 1999, LIMNOL OCEANOGR, V44, P1917, DOI 10.4319/lo.1999.44.8.1917; NOMURA M, 1995, PLANT PHYSIOL, V107, P703, DOI 10.1104/pp.107.3.703; Nyyssola A, 2000, J BIOL CHEM, V275, P22196, DOI 10.1074/jbc.M910111199; PALENIK B, 1998, PHOSPHORUS PLANT BIO, P26; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Scanlan DJ, 2002, FEMS MICROBIOL ECOL, V40, P1, DOI 10.1111/j.1574-6941.2002.tb00930.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toledo G, 1999, APPL ENVIRON MICROB, V65, P5247; Volz K., 1995, 2 COMPONENT SIGNAL T, P53; WATERBURY JB, 1986, PHOTOSYNTHETIC PICOP, P71; WILLEY JM, 1989, APPL ENVIRON MICROB, V55, P1888, DOI 10.1128/AEM.55.8.1888-1894.1989; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002	30	516	966	1	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2003	424	6952					1037	1042		10.1038/nature01943	http://dx.doi.org/10.1038/nature01943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12917641	Bronze			2022-12-24	WOS:000184984200039
J	Alonso, JM; Stepanova, AN; Leisse, TJ; Kim, CJ; Chen, HM; Shinn, P; Stevenson, DK; Zimmerman, J; Barajas, P; Cheuk, R; Gadrinab, C; Heller, C; Jeske, A; Koesema, E; Meyers, CC; Parker, H; Prednis, L; Ansari, Y; Choy, N; Deen, H; Geralt, M; Hazari, N; Hom, E; Karnes, M; Mulholland, C; Ndubaku, R; Schmidt, I; Guzman, P; Aguilar-Henonin, L; Schmid, M; Weigel, D; Carter, DE; Marchand, T; Risseeuw, E; Brogden, D; Zeko, A; Crosby, WL; Berry, CC; Ecker, JR				Alonso, JM; Stepanova, AN; Leisse, TJ; Kim, CJ; Chen, HM; Shinn, P; Stevenson, DK; Zimmerman, J; Barajas, P; Cheuk, R; Gadrinab, C; Heller, C; Jeske, A; Koesema, E; Meyers, CC; Parker, H; Prednis, L; Ansari, Y; Choy, N; Deen, H; Geralt, M; Hazari, N; Hom, E; Karnes, M; Mulholland, C; Ndubaku, R; Schmidt, I; Guzman, P; Aguilar-Henonin, L; Schmid, M; Weigel, D; Carter, DE; Marchand, T; Risseeuw, E; Brogden, D; Zeko, A; Crosby, WL; Berry, CC; Ecker, JR			Genome-wide Insertional mutagenesis of Arabidopsis thaliana	SCIENCE			English	Article							T-DNA; TRANSFORMATION; GENES; INTEGRATION; TARGET	Over 225,000 independent Agrobacterium transferred DNA (T-DNA) insertion events in the genome of the reference plant Arabidopsis thaliana have been created that represent near saturation of the gene space. The precise locations were determined for more than 88,000 T-DNA insertions, which resulted in the identification of mutations in more than 21,700 of the similar to29,454 predicted Arabidopsis genes. Genome-wide analysis of the distribution of integration events revealed the existence of a large integration site bias at both the chromosome and gene levels. Insertion mutations were identified in genes that are regulated in response to the plant hormone ethylene.	Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; Natl Res Council Canada, Inst Plant Biotechnol, Saskatoon, SK S7N 0W9, Canada; Univ Calif San Diego, Dept Family Prevent Med, San Diego, CA 92093 USA	Salk Institute; National Research Council Canada; University of California System; University of California San Diego	Ecker, JR (corresponding author), Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ecker@salk.edu	Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008; Schmid, Markus/I-4384-2015; Ecker, Joseph R/B-9144-2008; Alonso, Jose M/K-6826-2014; Stepanova, Anna/P-9575-2019; Weigel, Detlef/AAR-3312-2021; Guzman, Plinio/A-3073-2012	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Schmid, Markus/0000-0002-0068-2967; Ecker, Joseph R/0000-0001-5799-5895; Alonso, Jose M/0000-0001-7087-1571; Stepanova, Anna/0000-0003-1018-4758; Chen, Huaming/0000-0001-5289-7882; Wu, Emily/0000-0001-8160-0654; Koesema, Eric/0000-0002-7743-0127				ALONSO J, UNPUB; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bargmann CI, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews1005; Bechtold N, 2000, GENETICS, V155, P1875; Chen H. M., UNPUB; Desfeux C, 2000, PLANT PHYSIOL, V123, P895, DOI 10.1104/pp.123.3.895; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gong M, 2003, CURR OPIN GENET DEV, V13, P215, DOI 10.1016/S0959-437X(03)00018-2; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Haupt W, 2001, PLANT J, V27, P285, DOI 10.1046/j.1365-313x.2001.01087.x; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; McElver J, 2001, GENETICS, V159, P1751; Parinov S, 2000, CURR OPIN BIOTECH, V11, P157, DOI 10.1016/S0958-1669(00)00075-6; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Tzfira T, 2002, TRENDS CELL BIOL, V12, P121, DOI 10.1016/S0962-8924(01)02229-2; Tzfira T, 2000, MOL PLANT PATHOL, V1, P201, DOI 10.1046/j.1364-3703.2000.00026.x; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	25	4005	4178	13	503	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2003	301	5633					653	657		10.1126/science.1086391	http://dx.doi.org/10.1126/science.1086391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893945				2022-12-24	WOS:000184473600042
J	Bergman, A; Siegal, ML				Bergman, A; Siegal, ML			Evolutionary capacitance as a general feature of complex gene networks	NATURE			English	Article							CANALIZATION; HSP90; ARCHITECTURE	An evolutionary capacitor buffers genotypic variation under normal conditions, thereby promoting the accumulation of hidden polymorphism. But it occasionally fails, thereby revealing this variation phenotypically(1).Theprincipal example of an evolutionary capacitor is Hsp90, a molecular chaperone that targets an important set of signal transduction proteins. Experiments in Drosophila and Arabidopsis have demonstrated three key properties of Hsp90: (1) it suppresses phenotypic variation under normal conditions and releases this variation when functionally compromised; (2) its function is overwhelmed by environmental stress; and (3) it exerts pleiotropic effects on key developmental processes(1,2). But whether these properties necessarily make Hsp90 a significant and unique facilitator of adaptation(1-10) is unclear. Here we use numerical simulations of complex gene networks, as well as genome-scale expression data from yeast single-gene deletion strains, to present a mechanism that extends the scope of evolutionary capacitance beyond the action of Hsp90 alone. We illustrate that most, and perhaps all, genes reveal phenotypic variation when functionally compromised, and that the availability of loss-of-function mutations accelerates adaptation to a new optimum phenotype. However, this effect does not require the mutations to be conditional on the environment. Thus, there might exist a large class of evolutionary capacitors whose effects on phenotypic variation complement the systemic, environment-induced effects of Hsp90.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Ctr Computat Genet & Biol Modeling, Stanford, CA 94305 USA	Stanford University; Stanford University	Siegal, ML (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	mlsiegal@stanford.edu		Siegal, Mark/0000-0001-6930-2988				Cossins A, 1998, NATURE, V396, P309, DOI 10.1038/24483; Dickinson WJ, 1999, NATURE, V399, P30, DOI 10.1038/19894; Edwards RJ, 2003, MOL BIOL EVOL, V20, P30, DOI 10.1093/molbev/msg001; Featherstone DE, 2002, BIOESSAYS, V24, P267, DOI 10.1002/bies.10054; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.3.CO;2-A; Hansen TF, 2001, THEOR POPUL BIOL, V59, P61, DOI 10.1006/tpbi.2000.1508; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; McLaren A, 1999, TRENDS GENET, V15, P169, DOI 10.1016/S0168-9525(99)01732-1; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Mitchell-Olds T, 2002, SCIENCE, V296, P2348, DOI 10.1126/science.1073846; Pigliucci M, 2002, NATURE, V417, P598, DOI 10.1038/417598a; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rice SH, 1998, EVOLUTION, V52, P647, DOI 10.1111/j.1558-5646.1998.tb03690.x; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; SCHARLOO W, 1991, ANNU REV ECOL SYST, V22, P65, DOI 10.1146/annurev.es.22.110191.000433; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; STEARNS SC, 1995, J EVOLUTION BIOL, V8, P539, DOI 10.1046/j.1420-9101.1995.8050539.x; Tautz D, 2000, TRENDS GENET, V16, P475, DOI 10.1016/S0168-9525(00)02118-1; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; Wagner GP, 2000, J THEOR BIOL, V203, P163, DOI 10.1006/jtbi.2000.1074; Wagner GP, 1999, J EXP ZOOL, V285, P116, DOI 10.1002/(SICI)1097-010X(19990815)285:2<116::AID-JEZ3>3.0.CO;2-P; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	27	364	370	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2003	424	6948					549	552		10.1038/nature01765	http://dx.doi.org/10.1038/nature01765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891357				2022-12-24	WOS:000184454700042
J	Agathon, A; Thisse, C; Thisse, B				Agathon, A; Thisse, C; Thisse, B			The molecular nature of the zebrafish tail organizer	NATURE			English	Article								Based on grafting experiments, Mangold and Spemann showed the dorsal blastopore lip of an amphibian gastrula to be able to induce a secondary body axis(1). The equivalent of this organizer region has been identified in different vertebrates including teleosts(2). However, whereas the graft can induce ectopic head and trunk, endogenous and ectopic axes fuse in the posterior part of the body(3,4), raising the question of whether a distinct organizer region is necessary for tail development. Here we reveal, by isochronic and heterochronic transplantation, the existence of a tail organizer deriving from the ventral margin of the zebrafish embryo, which is independent of the dorsal Spemann organizer. Loss-of-function experiments reveal that bone morphogenetic protein (BMP), Nodal and Wnt8 signalling pathways are required for tail development. Moreover, stimulation of naive cells by a combination of BMP, Nodal and Wnt8 mimics the tail-organizing activity of the ventral margin and induces surrounding tissues to become tail. In contrast to induction of the vertebrate head, known to result from the triple inhibition of BMP, Nodal and Wnt(5), here we show that induction of the tail results from the triple stimulation of BMP, Nodal and Wnt8 signalling pathways.	Inst Genet & Biol Mol & Cellulaire, CNRS, UMR 7104, INSERM,ULP, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Thisse, B (corresponding author), Inst Genet & Biol Mol & Cellulaire, CNRS, UMR 7104, INSERM,ULP, 1 Rue Laurent Fries,BP10142,CU Strasbourg, F-67404 Illkirch Graffenstaden, France.	thisse@igbmc.u-strasbg.fr		THISSE, Christine/0000-0002-8684-1681				Connors SA, 1999, DEVELOPMENT, V126, P3119; Furthauer M, 1999, DEV BIOL, V214, P181, DOI 10.1006/dbio.1999.9401; GONT LK, 1993, DEVELOPMENT, V119, P991; JOLY JS, 1993, DEVELOPMENT, V119, P1261; Kanki JP, 1997, DEVELOPMENT, V124, P881; KELLY GM, 1995, DEVELOPMENT, V121, P1787; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; Knezevic V, 1998, DEVELOPMENT, V125, P1791; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Mangold O, 1933, NATURWISSENSCHAFTEN, V21, P761, DOI 10.1007/BF01503740; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Muller F, 2000, DEVELOPMENT, V127, P3889; Mullins MC, 1996, DEVELOPMENT, V123, P81; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Nikaido M, 1999, DEVELOPMENT, V126, P181; Oppenheimer JM, 1936, J EXP ZOOL, V72, P409, DOI 10.1002/jez.1400720304; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; RENUCCI A, 1996, DEVELOPMENT, V122, P735; Saude L, 2000, DEVELOPMENT, V127, P3407; Schier AF, 2001, CURR OPIN GENET DEV, V11, P393, DOI 10.1016/S0959-437X(00)00209-4; Schmid B, 2000, DEVELOPMENT, V127, P957; Shih J, 1996, DEVELOPMENT, V122, P1313; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; TUCKER AS, 1995, CURR BIOL, V5, P807, DOI 10.1016/S0960-9822(95)00158-8; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Woo K, 1997, SCIENCE, V277, P254, DOI 10.1126/science.277.5323.254	28	164	168	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					448	452		10.1038/nature01822	http://dx.doi.org/10.1038/nature01822			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879074				2022-12-24	WOS:000184318400048
J	LaCroix, AZ; Cauley, JA; Pettinger, M; Hsia, J; Bauer, DC; McGowan, J; Chen, Z; Lewis, CE; McNeeley, SG; Passaro, MD; Jackson, RD				LaCroix, AZ; Cauley, JA; Pettinger, M; Hsia, J; Bauer, DC; McGowan, J; Chen, Z; Lewis, CE; McNeeley, SG; Passaro, MD; Jackson, RD			Statin use, clinical fracture, and bone density in postmenopausal women: Results from the women's health initiative observational study	ANNALS OF INTERNAL MEDICINE			English	Article							HMG-COA REDUCTASE; MINERAL DENSITY; RISK; INHIBITORS; PRAVASTATIN; LOVASTATIN; FREQUENCY; MASS	Background: 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have been shown to stimulate bone formation in laboratory studies, both in vitro and in vivo. While early epidemiologic studies showed lower risk for hip fracture among statin users than nonusers, subsequent studies have produced mixed results. Objective: To examine the association of statin use with incidence of hip, lower arm or wrist, and other clinical fractures and with baseline levels of bone density. Design: Prospective study. Setting: women's Health Initiative Observational Study conducted in 40 clinical centers in the United States. Participants: 93 716 postmenopausal women ages 50 to 79 years. Measurements: Rates of hip, lower arm or wrist, and other clinical fractures were compared among 7846 statin users and 85 870 nonusers over a median follow-up of 3.9 years. In 6442 women enrolled at three clinical centers, baseline levels of total hip, posterior-anterior spine, and total-body bone density measured by using dual-energy x-ray absorptiometry were compared according to statin use. Results: Age-adjusted rates of hip, lower arm or wrist, and other clinical fractures were similar between statin users and nonusers regardless of duration of statin use. The multivadate-adjusted hazard ratios for current statin use were 1.22 (95% CI, 0.83 to 1.81) for hip fracture, 1.04 (CI, 0.85 to 1.27) for lower arm or wrist fracture, and 1.11 (CI, 1.00 to 1.22) for other clinical fracture. Bone density levels did not statistically differ between statin users and nonusers at any skeletal site after adjustment for age, ethnicity, body mass index, and other factors. Conclusion: Statin use did not improve fracture risk or bone density in the Women's Health Initiative Observational Study. The cumulative evidence does not warrant use of statins to prevent or treat osteoporosis.	Fred Hutchinson Canc Res Ctr, Womens Hlth Initiat Clin Coordinating Ctr, Seattle, WA 98109 USA; Univ Pittsburgh, Pittsburgh, PA USA; George Washington Univ, Washington, DC USA; Medlant Res Inst, Washington, DC USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Natl Inst Arthrit & Musculoskeletal Dis, NIH, Bethesda, MD USA; Univ Arizona, Tucson, AZ USA; Univ Alabama Birmingham, Birmingham, AL USA; Wayne State Univ, Detroit, MI USA; Ohio State Univ, Columbus, OH 43210 USA	Fred Hutchinson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; George Washington University; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Arizona; University of Alabama System; University of Alabama Birmingham; Wayne State University; University System of Ohio; Ohio State University	LaCroix, AZ (corresponding author), Fred Hutchinson Canc Res Ctr, Womens Hlth Initiat Clin Coordinating Ctr, 1100 Fairview Ave N,MP-1002,POB 19024, Seattle, WA 98109 USA.		Cauley, Jane A/N-4836-2015	Cauley, Jane A/0000-0003-0752-4408				Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Bauer DC, 1999, J BONE MINER RES, V14, pS179; Chan KA, 2000, LANCET, V355, P2185, DOI 10.1016/S0140-6736(00)02400-4; Chung YS, 2000, J CLIN ENDOCR METAB, V85, P1137, DOI 10.1210/jcem.85.3.6476; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Edwards CJ, 2000, LANCET, V355, P2218, DOI 10.1016/S0140-6736(00)02408-9; Garrett IR, 2000, J BONE MINER RES, V15, pS225; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; Kristal AR, 1997, AM J EPIDEMIOL, V146, P856, DOI 10.1093/oxfordjournals.aje.a009203; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Meier CR, 2000, JAMA-J AM MED ASSOC, V283, P3205, DOI 10.1001/jama.283.24.3205; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; MUNDY GR, 2001, IBMS BONE KEY, P1; Pasco JA, 2002, ARCH INTERN MED, V162, P537, DOI 10.1001/archinte.162.5.537; PEDERSEN TR, 1994, LANCET, V344, P1383; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Reid IR, 2001, LANCET, V357, P509, DOI 10.1016/S0140-6736(00)04042-3; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; van Staa TP, 2001, JAMA-J AM MED ASSOC, V285, P1850, DOI 10.1001/jama.285.14.1850; Wang PS, 2000, JAMA-J AM MED ASSOC, V283, P3211, DOI 10.1001/jama.283.24.3211; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watanabe S, 2000, J BONE MINER RES, V15, pS194	22	133	142	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2003	139	2					97	104		10.7326/0003-4819-139-2-200307150-00009	http://dx.doi.org/10.7326/0003-4819-139-2-200307150-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701HX	12859159				2022-12-24	WOS:000184163100003
J	McGrath, J; Somlo, S; Makova, S; Tian, X; Brueckner, M				McGrath, J; Somlo, S; Makova, S; Tian, X; Brueckner, M			Two populations of node monocilia initiate left-right asymmetry in the mouse	CELL			English	Article							POLYCYSTIC KIDNEY-DISEASE; PRIMARY CILIARY DYSKINESIA; RIGHT AXIS DETERMINATION; SITUS-INVERSUS; PRIMARY CILIUM; KINESIN-II; GENE; MICE; MUTATIONS; EXPRESSION	The vertebrate body plan has conserved handed left-right (LR) asymmetry that is manifested in the heart, lungs, and gut. Leftward flow of extracellular fluid at the node (nodal flow) is critical for normal LR axis determination in the mouse. Nodal flow is generated by motile node cell monocilia and requires the axonemal dynein, left-right dynein (lrd). In the absence of lrd, LR determination becomes random. The cation channel polycystin-2 is also required to establish LR asymmetry. We show that lrd localizes to a centrally located subset of node monocilia, while polycystin-2 is found in all node monocilia. Asymmetric calcium signaling appears at the left margin of the node coincident with nodal flow. These observations suggest that LR asymmetry is established by an entirely ciliary mechanism: motile, lrd-containing monocilia generate nodal flow, and nonmotile polycystin-2 containing cilia sense nodal flow initiating an asymmetric calcium signal at the left border of the node.	Yale Univ, Sch Med, Dept Comparat Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pediat, Cardiol Sect, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Brueckner, M (corresponding author), Yale Univ, Sch Med, Dept Comparat Med, 333 Cedar St, New Haven, CT 06520 USA.	martina.brueckner@yale.edu			NIDDK NIH HHS [DK54053] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054053] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Bellomo D, 1996, DEV DYNAM, V205, P471, DOI 10.1002/(SICI)1097-0177(199604)205:4<471::AID-AJA10>3.0.CO;2-4; BROWN NA, 1990, DEVELOPMENT, V109, P1; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Guichard C, 2001, AM J HUM GENET, V68, P1030, DOI 10.1086/319511; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hummel K. P., 1959, Journal of Heredity, V50, P9; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Kramer KL, 2002, CELL, V111, P981, DOI 10.1016/S0092-8674(02)01200-X; LAYTON WM, 1976, J HERED, V67, P336, DOI 10.1093/oxfordjournals.jhered.a108749; Levin M, 1999, DEVELOPMENT, V126, P4703; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Levin M, 1998, DEV BIOL, V203, P90, DOI 10.1006/dbio.1998.9024; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Lowe LA, 2001, DEVELOPMENT, V128, P1831; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Mochizuki T, 1998, NATURE, V395, P177, DOI 10.1038/26006; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Poole CA, 1997, CELL BIOL INT, V21, P483, DOI 10.1006/cbir.1997.0177; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; SULIK K, 1994, DEV DYNAM, V201, P260, DOI 10.1002/aja.1002010309; Supp DM, 1999, DEVELOPMENT, V126, P5495; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; Wilhelmi H, 1921, ARCH ENTWICKLUNG ORG, V48, P517, DOI 10.1007/BF02554577; Wu GQ, 2000, NAT GENET, V24, P75, DOI 10.1038/71724; Wu GQ, 2002, HUM MOL GENET, V11, P1845, DOI 10.1093/hmg/11.16.1845; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178	50	570	595	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2003	114	1					61	73		10.1016/S0092-8674(03)00511-7	http://dx.doi.org/10.1016/S0092-8674(03)00511-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859898	Bronze			2022-12-24	WOS:000184219900006
J	Hillier, LW; Fulton, RS; Fulton, LA; Graves, TA; Pepin, KH; Wagner-McPherson, C; Layman, D; Maas, J; Jaeger, S; Walker, R; Wylie, K; Sekhon, M; Becker, MC; O'Laughlin, MD; Schaller, ME; Fewell, GA; Delehaunty, KD; Miner, TL; Nash, WE; Cordes, M; Du, H; Sun, H; Edwards, J; Bradshaw-Cordum, H; Ali, J; Andrews, S; Isak, A; VanBrunt, A; Nguyen, C; Du, FY; Lamar, B; Courtney, L; Kalicki, J; Ozersky, P; Bielicki, L; Scott, K; Holmes, A; Harkins, R; Harris, A; Strong, CM; Hou, SF; Tomlinson, C; Dauphin-Kohlberg, S; Kozlowicz-Reilly, A; Leonard, S; Rohlfing, T; Rock, SM; Tin-Wollam, AM; Abbott, A; Minx, P; Maupin, R; Strowmatt, C; Latreille, P; Miller, N; Johnson, D; Murray, J; Woessner, JP; Wendl, MC; Yang, SP; Schultz, BR; Wallis, JW; Spieth, J; Bieri, TA; Nelson, JO; Berkowicz, N; Wohldmann, PE; Cook, LL; Hickenbotham, MT; Eldred, J; Williams, D; Bedell, JA; Mardis, ER; Clifton, SW; Chissoe, SL; Marra, MA; Raymond, C; Haugen, E; Gillett, W; Zhou, Y; James, R; Phelps, K; Iadanoto, S; Bubb, K; Simms, E; Levy, R; Clendenning, J; Kaul, R; Kent, WJ; Furey, TS; Baertsch, RA; Brent, MR; Keibler, E; Flicek, P; Bork, P; Suyama, M; Bailey, JA; Portnoy, ME; Torrents, D; Chinwalla, AT; Gish, WR; Eddy, SR; McPherson, JD; Olson, MV; Eichler, EE; Green, ED; Waterston, RH; Wilson, RK				Hillier, LW; Fulton, RS; Fulton, LA; Graves, TA; Pepin, KH; Wagner-McPherson, C; Layman, D; Maas, J; Jaeger, S; Walker, R; Wylie, K; Sekhon, M; Becker, MC; O'Laughlin, MD; Schaller, ME; Fewell, GA; Delehaunty, KD; Miner, TL; Nash, WE; Cordes, M; Du, H; Sun, H; Edwards, J; Bradshaw-Cordum, H; Ali, J; Andrews, S; Isak, A; VanBrunt, A; Nguyen, C; Du, FY; Lamar, B; Courtney, L; Kalicki, J; Ozersky, P; Bielicki, L; Scott, K; Holmes, A; Harkins, R; Harris, A; Strong, CM; Hou, SF; Tomlinson, C; Dauphin-Kohlberg, S; Kozlowicz-Reilly, A; Leonard, S; Rohlfing, T; Rock, SM; Tin-Wollam, AM; Abbott, A; Minx, P; Maupin, R; Strowmatt, C; Latreille, P; Miller, N; Johnson, D; Murray, J; Woessner, JP; Wendl, MC; Yang, SP; Schultz, BR; Wallis, JW; Spieth, J; Bieri, TA; Nelson, JO; Berkowicz, N; Wohldmann, PE; Cook, LL; Hickenbotham, MT; Eldred, J; Williams, D; Bedell, JA; Mardis, ER; Clifton, SW; Chissoe, SL; Marra, MA; Raymond, C; Haugen, E; Gillett, W; Zhou, Y; James, R; Phelps, K; Iadanoto, S; Bubb, K; Simms, E; Levy, R; Clendenning, J; Kaul, R; Kent, WJ; Furey, TS; Baertsch, RA; Brent, MR; Keibler, E; Flicek, P; Bork, P; Suyama, M; Bailey, JA; Portnoy, ME; Torrents, D; Chinwalla, AT; Gish, WR; Eddy, SR; McPherson, JD; Olson, MV; Eichler, EE; Green, ED; Waterston, RH; Wilson, RK			The DNA sequence of human chromosome 7	NATURE			English	Article							HUMAN-CHROMOSOME 7; HUMAN-GENOME; GENE; MAP; IDENTIFICATION; DUPLICATION; INTEGRATION; ANNOTATION; EVOLUTION	Human chromosome 7 has historically received prominent attention in the human genetics community, primarily related to the search for the cystic fibrosis gene and the frequent cytogenetic changes associated with various forms of cancer. Here we present more than 153 million base pairs representing 99.4% of the euchromatic sequence of chromosome 7, the first metacentric chromosome completed so far. The sequence has excellent concordance with previously established physical and genetic maps, and it exhibits an unusual amount of segmentally duplicated sequence (8.2%), with marked differences between the two arms. Our initial analyses have identified 1,150 protein-coding genes, 605 of which have been confirmed by complementary DNA sequences, and an additional 941 pseudogenes. Of genes confirmed by transcript sequences, some are polymorphic for mutations that disrupt the reading frame.	Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Univ Washington, Genome Ctr, Seattle, WA 98195 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Washington Univ, Dept Comp Sci, St Louis, MO 63130 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany; Case Western Reserve Univ, Sch Med, Ctr Computat Genome, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); University of Washington; University of Washington Seattle; University of California System; University of California Santa Cruz; Washington University (WUSTL); European Molecular Biology Laboratory (EMBL); Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Wilson, RK (corresponding author), Washington Univ, Sch Med, Genome Sequencing Ctr, Campus Box 8501,4444 Forest Pk Ave, St Louis, MO 63108 USA.	rwilson@watson.wustl.edu	McPherson, John D/D-2633-2017; Brent, Michael/AAK-3702-2020; Bork, Peer/F-1813-2013; Marra, Marco A/B-5987-2008; Wendl, Michael C/A-2741-2008; Sekhon, Mandeep/L-4665-2018; Mardis, Elaine/W-2202-2019; Wilson, Richard K./AAF-4139-2019; Torrents, David/G-5785-2015	McPherson, John D/0000-0001-8049-9347; Brent, Michael/0000-0002-8689-0299; Bork, Peer/0000-0002-2627-833X; Marra, Marco A/0000-0001-7146-7175; Sekhon, Mandeep/0000-0002-9993-6938; Wilson, Richard K./0000-0002-1992-1358; Kaul, Rajinder/0000-0002-7895-9284; Eddy, Sean/0000-0001-6676-4706; Furey, Terry/0000-0001-5546-9672; Haugen, Eric/0000-0001-7444-8981; Schultz, Brian/0000-0003-4964-976X; Suyama, Mikita/0000-0001-9526-3193; Flicek, Paul/0000-0002-3897-7955; Torrents, David/0000-0002-6086-9037; Chinwalla, Asif/0000-0001-7831-3996				ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Ashburner M, 2001, GENOME RES, V11, P1425; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Benson DA, 2002, NUCLEIC ACIDS RES, V30, P17, DOI 10.1093/nar/30.1.17; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Collins JE, 2003, GENOME RES, V13, P27, DOI 10.1101/gr.695703; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; DeSilva U, 1999, GENOME RES, V9, P428; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Eddy SR, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-18; Eichler EE, 1999, GENOME RES, V9, P1048, DOI 10.1101/gr.9.11.1048; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Felsenfeld A, 1999, GENOME RES, V9, P1; Flicek P, 2003, GENOME RES, V13, P46, DOI 10.1101/gr.830003; HARDY DM, 1995, J BIOL CHEM, V270, P26025, DOI 10.1074/jbc.270.44.26025; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Heilig R, 2003, NATURE, V421, P601, DOI 10.1038/nature01348; Horvath JE, 2001, HUM MOL GENET, V10, P2215, DOI 10.1093/hmg/10.20.2215; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; *HUM GEN MAPP CONS, 2001, NATURE, V409, P934; Korenberg JR, 2000, J COGNITIVE NEUROSCI, V12, P89, DOI 10.1162/089892900562002; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liang H, 1998, P NATL ACAD SCI USA, V95, P3781, DOI 10.1073/pnas.95.7.3781; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MARAIA RJ, 1994, NUCLEIC ACIDS RES, V22, P3045, DOI 10.1093/nar/22.15.3045; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Nadezhdin EV, 2001, MOL GENET GENOMICS, V265, P820; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Ohta T, 1995, J MOL EVOL, V41, P717, DOI 10.1007/BF00173150; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowen L, 1996, SCIENCE, V272, P1755, DOI 10.1126/science.272.5269.1755; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SOLOVYEV VV, 2001, STAT APPROACHES EUKA; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zenklusen JC, 2001, NAT GENET, V27, P392, DOI 10.1038/86891	49	198	992	1	28	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					157	U2		10.1038/nature01782	http://dx.doi.org/10.1038/nature01782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853948	Bronze			2022-12-24	WOS:000184032700033
J	Christensen, PR; Bandfield, JL; Bell, JF; Gorelick, N; Hamilton, VE; Ivanov, A; Jakosky, BM; Kieffer, HH; Lane, MD; Jakosky, BM; Kieffer, HH; Lane, MD; Malin, MC; McConnochie, T; McEwen, AS; McSween, HY; Mehall, GL; Moersch, JE; Nealson, KH; Rice, JW; Richardson, MI; Ruff, SW; Smith, MD; Titus, TN; Wyatt, MB				Christensen, PR; Bandfield, JL; Bell, JF; Gorelick, N; Hamilton, VE; Ivanov, A; Jakosky, BM; Kieffer, HH; Lane, MD; Jakosky, BM; Kieffer, HH; Lane, MD; Malin, MC; McConnochie, T; McEwen, AS; McSween, HY; Mehall, GL; Moersch, JE; Nealson, KH; Rice, JW; Richardson, MI; Ruff, SW; Smith, MD; Titus, TN; Wyatt, MB			Morphology and composition of the surface of Mars: Mars Odyssey THEMIS results	SCIENCE			English	Article							THERMAL INERTIA; MARTIAN SURFACE; WHITE ROCK; ORIGIN; SOIL	The Thermal Emission Imaging System (THEMIS) on Mars Odyssey has produced infrared to visible wavelength images of the martian surface that show lithologically distinct layers with variable thickness, implying temporal changes in the processes or environments during or after their formation. Kilometer-scale exposures of bedrockare observed; elsewhere airfall dust completely mantles the surface over thousands of square kilometers. Mars has compositional variations at 100-meter scales, for example, an exposure of olivine-rich basalt in the walls of Ganges Chasma. Thermally distinct ejecta facies occur around some craters with variations associated with crater age. Polar observations have identified temporal patches of water frost in the north polar cap. No thermal signatures associated with endogenic heat sources have been identified.	Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Colorado, LASP, Boulder, CO 80309 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Planetary Sci Inst, Phoenix, AZ 85032 USA; Malin Space Sci Syst, San Diego, CA 92191 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Tennessee, Dept Geol Sci, Knoxville, TN 37996 USA; Univ So Calif, Los Angeles, CA 90089 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Arizona State University; Arizona State University-Tempe; Cornell University; University of Hawaii System; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Colorado System; University of Colorado Boulder; United States Department of the Interior; United States Geological Survey; University of Arizona; University of Tennessee System; University of Tennessee Knoxville; University of Southern California; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Christensen, PR (corresponding author), Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA.	phil.christensen@asu.edu	Ivanov, Anton B/C-8944-2014; Smith, Michael/C-8875-2012; Moersch, Jeffrey E/F-7189-2010	Ivanov, Anton B/0000-0001-8376-8581; Moersch, Jeffrey E/0000-0003-3433-9419; Gorelick, Noel/0000-0002-5548-2436; Bandfield, Joshua/0000-0003-3571-3716; Richardson, Mark/0000-0001-9633-4141				ARVIDSON RE, IN PRESS J GEOPHYS R; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bandfield JL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002290; Bell JF, 2000, J GEOPHYS RES-PLANET, V105, P1721, DOI 10.1029/1999JE001060; Burr DM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013345; CARR MH, 1977, J GEOPHYS RES, V91, P3533; Christensen, 1992, MARS, P686; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9609, DOI 10.1029/1999JE001127; CHRISTENSEN PR, 1986, ICARUS, V68, P217, DOI 10.1016/0019-1035(86)90020-5; CHRISTENSEN PR, IN PRESS SPACE SCI R; GILLESPIE AR, 1986, REMOTE SENS ENVIRON, V20, P209, DOI 10.1016/0034-4257(86)90044-1; Jakosky BM, 2000, J GEOPHYS RES-PLANET, V105, P9643, DOI 10.1029/1999JE001088; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; KIEFFER HH, 1976, SCIENCE, V194, P1344, DOI 10.1126/science.194.4271.1344; Lane MD, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001832; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; McSween HY, 1999, J GEOPHYS RES-PLANET, V104, P8679, DOI 10.1029/98JE02551; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; MOUGINISMARK P, 1979, J GEOPHYS RES, V84, P8011, DOI 10.1029/JB084iB14p08011; PALLUCONI FD, 1981, ICARUS, V45, P415, DOI 10.1016/0019-1035(81)90044-0; Presley MA, 1997, J GEOPHYS RES-PLANET, V102, P6551, DOI 10.1029/96JE03303; Ruff SW, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001580; Ruff SW, 2001, J GEOPHYS RES-PLANET, V106, P23921, DOI 10.1029/2000JE001329; Shorthill R. W., 1973, Moon, V7, P22, DOI 10.1007/BF00578805; Sullivan R, 2001, J GEOPHYS RES-PLANET, V106, P23607, DOI 10.1029/2000JE001296; Titus TN, 2003, SCIENCE, V299, P1048, DOI 10.1126/science.1080497; Treiman AH, 1997, J GEOPHYS RES-PLANET, V102, P9153, DOI 10.1029/96JE03884; WILLIAMS SH, 1994, GEOLOGY, V22, P107, DOI 10.1130/0091-7613(1994)022<0107:WRAEML>2.3.CO;2	30	285	288	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2003	300	5628					2056	2061		10.1126/science.1080885	http://dx.doi.org/10.1126/science.1080885			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12791998				2022-12-24	WOS:000183774900036
J	Fulton, JE; Delany, ME				Fulton, JE; Delany, ME			Poultry genetic resources - Operation rescue needed	SCIENCE			English	Editorial Material							FUTURE		Hy Line Int, Dallas Ctr, Dallas Ctr, IA 50063 USA; Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Fulton, JE (corresponding author), Hy Line Int, Dallas Ctr, Dallas Ctr, IA 50063 USA.	medelany@ucdavis.edu						ABPLANALP H, 1990, IMMUNOGENETICS, V31, P291, DOI 10.1007/BF02115002; AUSTIN LM, 1995, AM J PATHOL, V146, P1529; Bacon LD, 2000, POULTRY SCI, V79, P1082, DOI 10.1093/ps/79.8.1082; Beck MM, 1998, POULTRY SCI, V77, P226, DOI 10.1093/ps/77.2.226; BRILLARD JP, COMMUNICATION; Chalah T, 1999, CRYOBIOLOGY, V39, P185, DOI 10.1006/cryo.1999.2201; Chang Il-Kuk, 1998, Japanese Poultry Science, V35, P321; Cheng K. S., COMMUNICATION; CHENG KM, 2003, STRATEGIC OPERATIONA; COEHLO CND, 1991, DEVELOPMENT, V113, P1487; Delany ME, 1998, POULT AVIAN BIOL REV, V9, P25; DELANY ME, 2003, POULTRY GENETICS BRE; ERF GF, 2002, MODERN CONCEPTS IMMU, P316; *FAO UN, WORLD WATCH LIST DOM; FITE KV, 1989, CURR EYE RES, V8, P1039, DOI 10.3109/02713688908997396; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Li ZD, 2002, POULTRY SCI, V81, P1360, DOI 10.1093/ps/81.9.1360; PETITTE JN, 2003, POULTRY GENETICS BRE; PISENTI JM, 1999, AVIAN GENETIC RESOUR; Punnett R. C, 1923, HEREDITY POULTRY HEREDITY POULTRY; SOMES RG, 1988, B STORRS AGR EXPT ST, V476; Weigend S, 2002, WORLD POULTRY SCI J, V58, P411, DOI 10.1079/WPS20020031; Wentworth AL, 2000, AVIAN POULT BIOL REV, V11, P173	23	48	50	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1667	1668		10.1126/science.1085407	http://dx.doi.org/10.1126/science.1085407			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805523				2022-12-24	WOS:000183459700024
J	Simpson, GG; Dijkwel, PP; Quesada, V; Henderson, I; Dean, C				Simpson, GG; Dijkwel, PP; Quesada, V; Henderson, I; Dean, C			FY is an RNA 3 ' end-processing factor that interacts with FCA to control the Arabidopsis floral transition	CELL			English	Article							LATE-FLOWERING MUTANTS; DROSOPHILA-MELANOGASTER; REPEAT PROTEIN; DOMAIN; GENE; RECOGNITION; COMPLEX; TIME; MECHANISM; THALIANA	The nuclear RNA binding protein, FCA, promotes Arabidopsis reproductive development. FCA contains a WW protein interaction domain that is essential for FCA function. We have identified FY as a protein partner for this domain. FY belongs to a highly conserved group of eukaryotic proteins represented in Saccharomyces cerevisiae by the RNA 3' end-processing factor, Pfs2p. FY regulates RNA 3' end processing in Arabidopsis as evidenced through its role in FCA regulation. FCA expression is autoregulated through the use of different polyadenylation sites within the FCA pre-mRNA, and the FCA/FY interaction is required for efficient selection of the promoter-proximal polyadenylation site. The FCA/FY interaction is also required for the downregulation of the floral repressor FLC. We propose that FCA controls 3' end formation of specific transcripts and that in higher eukaryotes, proteins homologous to FY may have evolved as sites of association for regulators of RNA 3' end processing.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dean, C (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.		Dijkwel, P/J-5515-2013	Dijkwel, P/0000-0002-1432-2209; quesada, victor/0000-0002-0965-8680; Henderson, Ian/0000-0001-5066-1489				Barabino SML, 1999, CELL, V99, P9, DOI 10.1016/S0092-8674(00)80057-4; Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501; Bedford MT, 2000, J BIOL CHEM, V275, P10359, DOI 10.1074/jbc.275.14.10359; Braun DM, 1997, PLANT J, V12, P83, DOI 10.1046/j.1365-313X.1997.12010083.x; Brogna S, 1997, EMBO J, V16, P2023, DOI 10.1093/emboj/16.8.2023; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Harlow E, 1988, ANTIBODIES LAB MANUA; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Ito S, 2001, BIOCHEM BIOPH RES CO, V280, P656, DOI 10.1006/bbrc.2000.4163; Jones Jonathan D. G., 1992, Transgenic Research, V1, P285, DOI 10.1007/BF02525170; Juge F, 2000, RNA, V6, P1529, DOI 10.1017/S1355838200001266; Koepf EK, 1999, BIOCHEMISTRY-US, V38, P14338, DOI 10.1021/bi991105l; KOORNNEEF M, 1994, PLANT J, V6, P911, DOI 10.1046/j.1365-313X.1994.6060911.x; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, GENETICS, V148, P885; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEE I, 1994, PLANT CELL, V6, P75, DOI 10.1105/tpc.6.1.75; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; MITCHELSON A, 1993, GENE DEV, V7, P241, DOI 10.1101/gad.7.2.241; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Mylne J, 1998, PLANT MOL BIOL REP, V16, P257, DOI 10.1023/A:1007520410190; Ohnacker M, 2000, EMBO J, V19, P37, DOI 10.1093/emboj/19.1.37; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; STONE JM, 1994, SCIENCE, V266, P793, DOI 10.1126/science.7973632; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; TAKAGAKI Y, 1992, J BIOL CHEM, V267, P23471; Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	39	308	343	3	51	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 13	2003	113	6					777	787		10.1016/S0092-8674(03)00425-2	http://dx.doi.org/10.1016/S0092-8674(03)00425-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809608	Bronze			2022-12-24	WOS:000183514400012
J	Rieseberg, LH; Raymond, O; Rosenthal, DM; Lai, Z; Livingstone, K; Nakazato, T; Durphy, JL; Schwarzbach, AE; Donovan, LA; Lexer, C				Rieseberg, LH; Raymond, O; Rosenthal, DM; Lai, Z; Livingstone, K; Nakazato, T; Durphy, JL; Schwarzbach, AE; Donovan, LA; Lexer, C			Major ecological transitions in wild sunflowers facilitated by hybridization	SCIENCE			English	Article							HYBRID SPECIATION; TRANSGRESSIVE SEGREGATION; HELIANTHUS-PARADOXUS; EVOLUTION; ANCIENT; ASTERACEAE; ORIGINS	Hybridization is frequent in many organismal groups, but its role in adaptation is poorly understood. In sunflowers, species found in the most extreme habitats are ancient hybrids, and new gene combinations generated by hybridization are speculated to have contributed to ecological divergence. This possibility was tested through phenotypic and genomic comparisons of ancient and synthetic hybrids. Most trait differences in ancient hybrids could be recreated by complementary gene action in synthetic hybrids and were favored by selection. The same combinations of parental chromosomal segments required to generate extreme phenotypes in synthetic hybrids also occurred in ancient hybrids. Thus, hybridization facilitated ecological divergence in sunflowers.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ Lyon 1, Lab Biol Mol & Phytochim, F-69622 Villeurbanne, France; Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	Indiana University System; Indiana University Bloomington; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University System of Georgia; University of Georgia; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Rieseberg, LH (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	lriesebe@indiana.edu	Raymond, Olivier/AAO-5868-2020; Rosenthal, David/C-9559-2012; Donovan, Lisa A/H-4754-2016; Lexer, Christian/N-3702-2013; Rieseberg, Loren H/B-3591-2013	Raymond, Olivier/0000-0002-9664-5377; Rosenthal, David/0000-0002-4822-5861; Donovan, Lisa A/0000-0001-9814-0666; Rieseberg, Loren H/0000-0002-2712-2417; Lexer, Christian/0000-0002-7221-7482	PHS HHS [R01 G59065] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABBOTT RJ, 1992, TRENDS ECOL EVOL, V7, P401, DOI 10.1016/0169-5347(92)90020-C; Anderson E., 1949, INTROGRESSIVE HYBRID; Arnold ML, 1997, NATURAL HYBRIDIZATIO; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; DANIN A, 1991, J ARID ENVIRON, V21, P193, DOI 10.1016/S0140-1963(18)30682-7; DEVICENTE MC, 1993, GENETICS, V134, P585; Ellstrand NC, 1996, P NATL ACAD SCI USA, V93, P5090, DOI 10.1073/pnas.93.10.5090; Gibson AC, 1998, BIOSCIENCE, V48, P911, DOI 10.2307/1313295; GOULD SJ, 1979, P ROY SOC LOND B BIO, V205, P581, DOI DOI 10.1098/RSPB.1979.0086; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Grant V., 1981, PLANT SPECIATION; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; GROSS BL, IN PRESS AM J BOT; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Lexer C, 2003, MOL ECOL, V12, P1225, DOI 10.1046/j.1365-294X.2003.01803.x; MAYR E, 1992, AM J BOT, V79, P222, DOI 10.2307/2445111; MCCARTHY EM, 1995, HEREDITY, V74, P502, DOI 10.1038/hdy.1995.71; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; RIESEBERG LH, 1991, AM J BOT, V78, P1218, DOI 10.2307/2444926; Rieseberg LH, 2000, EVOLUTION, V54, P859, DOI 10.1111/j.0014-3820.2000.tb00086.x; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rosenthal DM, 2002, INT J PLANT SCI, V163, P387, DOI 10.1086/339237; Schemske D.W., 2000, EVOLUTION, V54, P1069, DOI [DOI 10.1111/J.0014-3820.2000.TB00111.X, DOI 10.1554/0014-3820(2000)054[1069:UTOOS]2.3.CO;2]; Schwarzbach AE, 2002, MOL ECOL, V11, P1703, DOI 10.1046/j.1365-294X.2002.01557.x; Sokal RR., 1995, BIOMETRY, V3; Ungerer MC, 1998, P NATL ACAD SCI USA, V95, P11757, DOI 10.1073/pnas.95.20.11757; Wagner W. H. Jun., 1970, Taxon, P146; Welch ME, 2002, EVOLUTION, V56, P2126, DOI 10.1111/j.0014-3820.2002.tb00138.x; Welch ME, 2002, AM J BOT, V89, P472, DOI 10.3732/ajb.89.3.472; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, VII, P265, DOI DOI 10.1007/978-1-4615-5419-6_10	33	857	894	2	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2003	301	5637					1211	1216		10.1126/science.1086949	http://dx.doi.org/10.1126/science.1086949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZC	12907807				2022-12-24	WOS:000185003500033
J	Keenan, HT; Runyan, DK; Marshall, SW; Nocera, MA; Merten, DF; Sinal, SH				Keenan, HT; Runyan, DK; Marshall, SW; Nocera, MA; Merten, DF; Sinal, SH			A population-based study of inflicted traumatic brain injury in young children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SHAKEN IMPACT SYNDROME; ABUSIVE HEAD TRAUMA; BABY SYNDROME; INFANTS; RISK	Context Physical abuse is a leading cause of serious head injury and death in children aged 2 years or younger. The incidence of inflicted traumatic brain injury (TBI) in US children is unknown. Objective To determine the incidence of serious or fatal inflicted TBI in a defined US population of approximately 230000 children aged 2 years or younger. Design, Setting, and Subjects All North Carolina children aged 2 years or younger who were admitted to a pediatric intensive care unit or who died with a TBI in 2000 and 2001 were identified prospectively. Injuries were considered inflicted if accompanied by a confession or a medical and social service agency determination of abuse. Main Outcome Measure Incidence of inflicted TBI. Multivariate logistic regression models were used to compare children with inflicted injuries with those with non-inflicted injuries and with the general state population aged 2 years or younger. Results A total of 152 cases of serious or fatal TBI were identified, with 80 (53%) incurring inflicted TBI. The incidence of inflicted traumatic brain injury in the first 2 years of life was 17.0 (95% confidence interval [CI], 13.3-20.7) per 100000 person-years. Infants had a higher incidence than children in the second year of life (29.7 [95% CI, 22.9-36.7] vs 3.8 [95% CI, 1.3-6.4] per 100000 person-years). Boys had a higher incidence than girls (21.0 [95% CI, 15.1-26.6] vs 13.0 [95% CI, 8.4-17.7] per 100000 person-years). Relative to the general population, children who incurred an increased risk of inflicted injury were born to young mothers (less than or equal to21 years), non-European American, or products of multiple births. Conclusions In this population of North Carolina children, the incidence of inflicted TBI varied by characteristics of the injured children and their mothers. These data may be helpful for informing preventive interventions.	Univ N Carolina, Sch Med, Dept Social Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Orthoped, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Radiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; Wake Forest Univ, Bowman Gray Sch Med, Brenner Childrens Hosp, Dept Pediat, Winston Salem, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Wake Forest Baptist Medical Center	Keenan, HT (corresponding author), Univ N Carolina, Sch Med, Dept Social Med, Wing D,CB7240, Chapel Hill, NC 27599 USA.		Runyan, Desmond/S-3974-2016	Runyan, Desmond/0000-0001-5571-9029; Marshall, Stephen/0000-0002-2664-9233	ODCDC CDC HHS [R49/CCR402444] Funding Source: Medline	ODCDC CDC HHS		Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; GESSNER RR, 1995, ARCH PEDIAT ADOL MED, V149, P467; GROOTHUIS JR, 1982, PEDIATRICS, V70, P769; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; LUDWIG S, 1990, AJDC, V144, P724; *NC CTR HLTH STAT, HLTH STAT STAT CTR; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Sinal SH, 2000, CHILD ABUSE NEGLECT, V24, P1241, DOI 10.1016/S0145-2134(00)00177-0; STARLING SP, 1995, PEDIATRICS, V95, P259; STIER DM, 1993, PEDIATRICS, V91, P642; *US DEP HHS, 1988, INT CLASS DIS 9 REV	20	401	409	2	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2003	290	5					621	626		10.1001/jama.290.5.621	http://dx.doi.org/10.1001/jama.290.5.621			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708GH	12902365	Bronze			2022-12-24	WOS:000184558500016
J	Alavi, A; Hood, JD; Frausto, R; Stupack, DG; Cheresh, DA				Alavi, A; Hood, JD; Frausto, R; Stupack, DG; Cheresh, DA			Role of Raf in vascular protection from distinct apoptotic stimuli	SCIENCE			English	Article							KINASE-ACTIVITY; B-RAF; PROTEIN; SRC; PHOSPHORYLATION; REQUIREMENT; PATHWAYS; SERINE	Raf kinases have been linked to endothelial cell survival. Here, we show that basic fibroblast growth factor ( bFGF) and vascular endothelial growth factor ( VEGF) differentially activate Raf, resulting in protection from distinct pathways of apoptosis in human endothelial cells and chick embryo vasculature. bFGF activated Raf-1 via p21-activated protein kinase-1 (PAK-1) phosphorylation of serines 338 and 339, resulting in Raf-1 mitochondrial translocation and endothelial cell protection from the intrinsic pathway of apoptosis, independent of the mitogen-activated protein kinase kinase-1 (MEK1). In contrast, VEGF activated Raf-1 via Src kinase, leading to phosphorylation of tyrosines 340 and 341 and MEK1-dependent protection from extrinsic-mediated apoptosis. These findings implicate Raf-1 as a pivotal regulator of endothelial cell survival during angiogenesis.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Cheresh, DA (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cheresh@scripps.edu	; Frausto, Ricardo/AAE-3146-2021	Alavi, Alireza/0000-0002-5502-2616; Frausto, Ricardo/0000-0003-3064-6745	NCI NIH HHS [CA75924, CA50286, P01 CA78045, CA45726] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA078045, R37CA050286, R01CA050286, R01CA045726, T32CA075924] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Hood J, 1998, J BIOL CHEM, V273, P23504, DOI 10.1074/jbc.273.36.23504; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; von Gise A, 2001, MOL CELL BIOL, V21, P2324, DOI 10.1128/MCB.21.7.2324-2336.2001; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	22	275	299	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2003	301	5629					94	96		10.1126/science.1082015	http://dx.doi.org/10.1126/science.1082015			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843393				2022-12-24	WOS:000183914700040
J	Hoffmann, AA; Hallas, RJ; Dean, JA; Schiffer, M				Hoffmann, AA; Hallas, RJ; Dean, JA; Schiffer, M			Low potential for climatic stress adaptation in a rainforest Drosophila species	SCIENCE			English	Article							OPPOSITE LATITUDINAL CLINES; DESICCATION RESISTANCE; CORRELATED RESPONSES; LABORATORY CULTURE; GENETIC-VARIATION; LIFE-HISTORY; MELANOGASTER; TOLERANCE; SELECTION; POPULATIONS	The ability of sensitive rainforest species to evolve in response to climate change is largely unknown. We show that the Australian tropical rainforest fly Drosophila birchii exhibits clinal variation in desiccation resistance, but the most resistant population lacks the ability to evolve further resistance even after intense selection for over 30 generations. Parent-offspring comparisons indicate low heritable variation for this trait but high levels of genetic variation for morphology. D. birchii also exhibits abundant genetic variation at microsatellite loci. The low potential for resistance evolution highlights the importance of assessing evolutionary potential in targeted ecological traits and species from threatened habitats.	La Trobe Univ, Ctr Environm Stress & Adaptat Res, Bundoora, Vic 3086, Australia	La Trobe University	Hoffmann, AA (corresponding author), La Trobe Univ, Ctr Environm Stress & Adaptat Res, Bundoora, Vic 3086, Australia.		Hoffmann, Ary/C-2961-2011; Hoffmann, Ary/R-2972-2019; Schiffer, Michele/AAN-1478-2020	Hoffmann, Ary/0000-0001-9497-7645; Schiffer, Michele/0000-0002-5203-2480				Addo-Bediako A, 2001, J INSECT PHYSIOL, V47, P1377, DOI 10.1016/S0022-1910(01)00128-7; AYALA FJ, 1965, EVOLUTION, V19, P538, DOI 10.1111/j.1558-5646.1965.tb03329.x; Baer CF, 2000, EVOLUTION, V54, P238, DOI 10.1111/j.0014-3820.2000.tb00024.x; BLOWS MW, 1993, EVOLUTION, V47, P1255, DOI 10.1111/j.1558-5646.1993.tb02151.x; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Frankham R, 2010, INTRO CONSERVATION G; Gibbs AG, 1997, J EXP BIOL, V200, P1821; Harshman LG, 2000, TRENDS ECOL EVOL, V15, P32, DOI 10.1016/S0169-5347(99)01756-5; Hercus MJ, 1999, GENETICS, V151, P1493; HOFFMANN AA, 1993, J EVOLUTION BIOL, V6, P643, DOI 10.1046/j.1420-9101.1993.6050643.x; Hoffmann AA, 2001, EVOLUTION, V55, P436, DOI 10.1111/j.0014-3820.2001.tb01305.x; HOFFMANN AA, 1989, BIOL J LINN SOC, V37, P117, DOI 10.1111/j.1095-8312.1989.tb02098.x; Hoffmann AA, 2000, ADAPTIVE GENETIC VARIATION IN THE WILD, P200; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Jenkins NL, 2001, AUST J ENTOMOL, V40, P41, DOI 10.1046/j.1440-6055.2001.00197.x; Karan D, 1998, ECOL ENTOMOL, V23, P391, DOI 10.1046/j.1365-2311.1998.00157.x; Karan D, 1998, EVOLUTION, V52, P825, DOI [10.1111/j.1558-5646.1998.tb03706.x, 10.2307/2411276]; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Lovejoy T.E., 1986, P257; PARSONS PA, 1982, EVOL BIOL, V14, P297; Partridge L, 1999, P ROY SOC B-BIOL SCI, V266, P255, DOI 10.1098/rspb.1999.0630; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Sgro CM, 2000, AM NAT, V156, P341, DOI 10.1086/303394; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054	26	267	271	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2003	301	5629					100	102		10.1126/science.1084296	http://dx.doi.org/10.1126/science.1084296			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843394				2022-12-24	WOS:000183914700042
J	Mou, Z; Fan, WH; Dong, XN				Mou, Z; Fan, WH; Dong, XN			Inducers of plant systemic acquired resistance regulate NPR1 function through redox changes	CELL			English	Article							SALICYLIC-ACID; GLUTATHIONE HOMEOSTASIS; TRANSCRIPTION FACTORS; NUCLEAR-LOCALIZATION; DISEASE-RESISTANCE; NITRIC-OXIDE; ARABIDOPSIS; GENE; INDUCTION; ACTIVATION	NPR1 is an essential regulator of plant systemic acquired resistance (SAR), which confers immunity to a broad-spectrum of pathogens. SAR induction results in accumulation of the signal molecule salicylic acid (SA), which induces defense gene expression via activation of NPR1. We found that in an uninduced state, NPR1 is present as an oligomer formed through intermolecular disulfide bonds. Upon SAR induction, a biphasic change in cellular reduction potential occurs, resulting in reduction of NPR1 to a monomeric form. Monomeric NPR1 accumulates in the nucleus and activates gene expression. Inhibition of NPR1 reduction prevents defense gene expression, whereas mutation of Cys82 or Cys216 in NPR1 leads to constitutive monomerization, nuclear localization of the mutant proteins, and defense gene expression. These data provide a missing link between accumulation of SA and activation of NPR1 in the SAR signaling pathway.	Duke Univ, Dept Biol, Dev Cell & Mol Biol Grp, Durham, NC 27708 USA	Duke University	Dong, XN (corresponding author), Duke Univ, Dept Biol, Dev Cell & Mol Biol Grp, POB 91000, Durham, NC 27708 USA.	xdong@duke.edu						Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; Bent AF, 2000, PLANT PHYSIOL, V124, P1540, DOI 10.1104/pp.124.4.1540; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chamnongpol S, 1998, P NATL ACAD SCI USA, V95, P5818, DOI 10.1073/pnas.95.10.5818; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Chern MS, 2001, PLANT J, V27, P101, DOI 10.1046/j.1365-313x.2001.01070.x; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Despres C, 2000, PLANT CELL, V12, P279, DOI 10.1105/tpc.12.2.279; DURNER J, 1995, P NATL ACAD SCI USA, V92, P11312, DOI 10.1073/pnas.92.24.11312; Garlick AP, 2002, PLANTA, V216, P265, DOI 10.1007/s00425-002-0842-1; Glazebrook J, 1996, GENETICS, V143, P973; Gupte SA, 2002, J PHARMACOL EXP THER, V301, P299, DOI 10.1124/jpet.301.1.299; Hothersall JS, 1998, FEBS LETT, V434, P97, DOI 10.1016/S0014-5793(98)00959-4; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Kuge S, 1998, GENES CELLS, V3, P521, DOI 10.1046/j.1365-2443.1998.00209.x; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Kvaratskhelia M, 1997, J BIOL CHEM, V272, P20998, DOI 10.1074/jbc.272.34.20998; Lebel E, 1998, PLANT J, V16, P223, DOI 10.1046/j.1365-313x.1998.00288.x; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; May MJ, 1998, J EXP BOT, V49, P649, DOI 10.1093/jexbot/49.321.649; Murphy DM, 2002, J BIOL CHEM, V277, P6162, DOI 10.1074/jbc.M110105200; Noctor G, 2002, J EXP BOT, V53, P1283, DOI 10.1093/jexbot/53.372.1283; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; RAO MV, 1995, PHOTOCHEM PHOTOBIOL, V61, P71, DOI 10.1111/j.1751-1097.1995.tb09245.x; Rao MV, 1999, PLANT J, V17, P603, DOI 10.1046/j.1365-313X.1999.00400.x; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Shah J, 1997, MOL PLANT MICROBE IN, V10, P69, DOI 10.1094/MPMI.1997.10.1.69; Sticher L, 1997, ANNU REV PHYTOPATHOL, V35, P235, DOI 10.1146/annurev.phyto.35.1.235; Vanacker H, 2000, PLANT PHYSIOL, V123, P1289, DOI 10.1104/pp.123.4.1289; WINGATE VPM, 1988, PLANT PHYSIOL, V87, P206, DOI 10.1104/pp.87.1.206; Wu GS, 1997, PLANT PHYSIOL, V115, P427, DOI 10.1104/pp.115.2.427; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191	44	1006	1088	11	184	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2003	113	7					935	944		10.1016/S0092-8674(03)00429-X	http://dx.doi.org/10.1016/S0092-8674(03)00429-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	695EJ	12837250	Bronze			2022-12-24	WOS:000183817900016
J	Yildiz, A; Forkey, JN; McKinney, SA; Ha, T; Goldman, YE; Selvin, PR				Yildiz, A; Forkey, JN; McKinney, SA; Ha, T; Goldman, YE; Selvin, PR			Myosin V walks hand-over-hand: Single fluorophore imaging with 1.5-nm localization	SCIENCE			English	Article							FLUORESCENT-PROBES; MOLECULES; MOTOR; ROTATION; MOVEMENT; TRACKING; ACTIN; RESOLUTION; MODEL	Myosin V is a dimeric molecular motor that moves processively on actin, with the center of mass moving similar to37 nanometers for each adenosine triphosphate hydrolyzed. We have labeled myosin V with a single fluorophore at different positions in the light-chain domain and measured the step size with a standard deviation of <1.5 nanometers, with 0.5-second temporal resolution, and observation times of minutes. The step size alternates between 37 + 2x nm and 37 - 2x, where x is the distance along the direction of motion between the dye and the midpoint between the two heads. These results strongly support a hand-over-hand model of motility, not an inchworm model.	Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Pennsylvania	Selvin, PR (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	selvin@uiuc.edu	Ha, Taekjip/B-9506-2009; Yildiz, Ahmet/E-6167-2015	Ha, Taekjip/0000-0003-2195-6258; Yildiz, Ahmet/0000-0003-4792-174X; McKinney, Sean/0000-0002-9740-6247	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR026846, R37AR026846, R29AR044420, R01AR044420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR44420, AR26846] Funding Source: Medline; NIGMS NIH HHS [R01 GM065367, GM65367] Funding Source: Medline; PHPPO CDC HHS [PHS 5 T32 GM08276] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHPPO CDC HHS		Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; Ali MY, 2002, NAT STRUCT BIOL, V9, P464, DOI 10.1038/nsb803; AXELROD D, 1989, METHOD CELL BIOL, V30, P245; Bartko AP, 1999, J PHYS CHEM B, V103, P3053, DOI 10.1021/jp9846330; BOBROFF N, 1986, REV SCI INSTRUM, V57, P1152, DOI 10.1063/1.1138619; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Kubitscheck U, 2000, BIOPHYS J, V78, P2170, DOI 10.1016/S0006-3495(00)76764-6; Lacoste TD, 2000, P NATL ACAD SCI USA, V97, P9461, DOI 10.1073/pnas.170286097; Mehta A, 2001, J CELL SCI, V114, P1981; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Schmidt T, 1996, P NATL ACAD SCI USA, V93, P2926, DOI 10.1073/pnas.93.7.2926; Spudich JA, 2001, NAT REV MOL CELL BIO, V2, P387, DOI 10.1038/35073086; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592	30	1426	1487	14	377	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2003	300	5628					2061	2065		10.1126/science.1084398	http://dx.doi.org/10.1126/science.1084398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12791999				2022-12-24	WOS:000183774900037
J	Schotte, F; Lim, MH; Jackson, TA; Smirnov, AV; Soman, J; Olson, JS; Phillips, GN; Wulff, M; Anfinrud, PA				Schotte, F; Lim, MH; Jackson, TA; Smirnov, AV; Soman, J; Olson, JS; Phillips, GN; Wulff, M; Anfinrud, PA			Watching a protein as it functions with 150-ps time-resolved X-ray crystallography	SCIENCE			English	Article							LIGAND-BINDING; CARBONMONOXY-MYOGLOBIN; CONFORMATIONAL RELAXATION; CRYSTAL-STRUCTURE; PHOTODISSOCIATION; DYNAMICS; CO; INTERMEDIATE; CAVITIES; MOTIONS	We report picosecond time-resolved x-ray diffraction from the myoglobin (Mb) mutant in which Leu(29) is replaced by Phe (L29F mutant). The frame-by-frame structural evolution, resolved to 1.8 angstroms, allows one to literally "watch" the protein as it executes its function. Time-resolved mid-infrared spectroscopy of flash-photolyzed L29F MbCO revealed a short-lived CO intermediate whose 140-ps lifetime is shorter than that found in wild-type protein by a factor of 1000. The electron density maps of the protein unveil transient conformational changes far more dramatic than the structural differences between the carboxy and deoxy states and depict the correlated side-chain motion responsible for rapidly sweeping CO away from its primary docking site.	NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; Pusan Natl Univ, Dept Chem, Pusan 609735, South Korea; Harvard Univ, Sch Med, Boston, MA 02115 USA; Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; European Synchrotron Radiat Facil, F-38043 Grenoble, France	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pusan National University; Harvard University; Harvard Medical School; Rice University; University of Wisconsin System; University of Wisconsin Madison; European Synchrotron Radiation Facility (ESRF)	Schotte, F (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA.		Smirnov, Alexey/AAB-2521-2020	Smirnov, Alexey/0000-0001-5361-8232; Olson, John/0000-0002-0760-5403	NHLBI NIH HHS [HL47020] Funding Source: Medline; NIAMS NIH HHS [AR40252] Funding Source: Medline; NIGMS NIH HHS [GM35649] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK029031, ZIADK029031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANSARI A, 1994, BIOCHEMISTRY-US, V33, P5128, DOI 10.1021/bi00183a017; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunori M, 2000, P NATL ACAD SCI USA, V97, P2058, DOI 10.1073/pnas.040459697; CARVER TE, 1992, J BIOL CHEM, V267, P14443; Cho A, 2002, SCIENCE, V296, P1008, DOI 10.1126/science.296.5570.1008; Chu K, 2000, NATURE, V403, P921, DOI 10.1038/35002641; FRAUENFELDER H, 1991, BER BUNSEN PHYS CHEM, V95, P272, DOI 10.1002/bbpc.19910950310; Goodno GD, 1999, J PHYS CHEM A, V103, P10630, DOI 10.1021/jp993559y; JACKSON TA, 1994, CHEM PHYS, V180, P131, DOI 10.1016/0301-0104(93)E0414-Q; Kachalova GS, 1999, SCIENCE, V284, P473, DOI 10.1126/science.284.5413.473; LIM MH, 1995, J CHEM PHYS, V102, P4355, DOI 10.1063/1.469484; LIM MH, 1993, P NATL ACAD SCI USA, V90, P5801, DOI 10.1073/pnas.90.12.5801; Ostermann A, 2000, NATURE, V404, P205, DOI 10.1038/35004622; SCHLICHTING I, 1994, NATURE, V371, P808, DOI 10.1038/371808a0; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; Srajer V, 2001, BIOCHEMISTRY-US, V40, P13802, DOI 10.1021/bi010715u; TENG TY, 1994, NAT STRUCT BIOL, V1, P701, DOI 10.1038/nsb1094-701; TILTON RF, 1984, BIOCHEMISTRY-US, V23, P2849, DOI 10.1021/bi00308a002; Vitkup D, 1997, NAT STRUCT BIOL, V4, P202, DOI 10.1038/nsb0397-202; Vojtechovsky J, 1999, BIOPHYS J, V77, P2153, DOI 10.1016/S0006-3495(99)77056-6; Ye X, 2002, J AM CHEM SOC, V124, P5914, DOI 10.1021/ja017359n	22	649	658	3	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2003	300	5627					1944	1947		10.1126/science.1078797	http://dx.doi.org/10.1126/science.1078797			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12817148				2022-12-24	WOS:000183619400046
J	Skaletsky, H; Kuroda-Kawaguchi, T; Minx, PJ; Cordum, HS; Hillier, L; Brown, LG; Repping, S; Pyntikova, T; Ali, J; Bieri, T; Chinwalla, A; Delehaunty, A; Delehaunty, K; Du, H; Fewell, G; Fulton, L; Fulton, R; Graves, T; Hou, SF; Latrielle, P; Leonard, S; Mardis, E; Maupin, R; McPherson, J; Miner, T; Nash, W; Nguyen, C; Ozersky, P; Pepin, K; Rock, S; Rohlfing, T; Scott, K; Schultz, B; Strong, C; Tin-Wollam, A; Yang, SP; Waterston, RH; Wilson, RK; Rozen, S; Page, DC				Skaletsky, H; Kuroda-Kawaguchi, T; Minx, PJ; Cordum, HS; Hillier, L; Brown, LG; Repping, S; Pyntikova, T; Ali, J; Bieri, T; Chinwalla, A; Delehaunty, A; Delehaunty, K; Du, H; Fewell, G; Fulton, L; Fulton, R; Graves, T; Hou, SF; Latrielle, P; Leonard, S; Mardis, E; Maupin, R; McPherson, J; Miner, T; Nash, W; Nguyen, C; Ozersky, P; Pepin, K; Rock, S; Rohlfing, T; Scott, K; Schultz, B; Strong, C; Tin-Wollam, A; Yang, SP; Waterston, RH; Wilson, RK; Rozen, S; Page, DC			The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes	NATURE			English	Article							HUMAN X-CHROMOSOME; HUMAN GENOME; SEX-CHROMOSOME; INTRACHROMOSOMAL RECOMBINATION; DROSOPHILA-MELANOGASTER; HUMAN CENTROMERE; GENE CONVERSION; TURNER SYNDROME; SHORT ARM; MAP	The male-specific region of the Y chromosome, the MSY, differentiates the sexes and comprises 95% of the chromosome's length. Here, we report that the MSY is a mosaic of heterochromatic sequences and three classes of euchromatic sequences: X-transposed, X-degenerate and ampliconic. These classes contain all 156 known transcription units, which include 78 protein-coding genes that collectively encode 27 distinct proteins. The X-transposed sequences exhibit 99% identity to the X chromosome. The X-degenerate sequences are remnants of ancient autosomes from which the modern X and Y chromosomes evolved. The ampliconic class includes large regions (about 30% of the MSY euchromatin) where sequence pairs show greater than 99.9% identity, which is maintained by frequent gene conversion (non-reciprocal transfer). The most prominent features here are eight massive palindromes, at least six of which contain testis genes.	MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); University of Amsterdam; Academic Medical Center Amsterdam	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	page_admin@wi.mit.edu	Mardis, Elaine/W-2202-2019; McPherson, John D/D-2633-2017; Wilson, Richard K./AAF-4139-2019; Rozen, Steven G./J-5939-2013	McPherson, John D/0000-0001-8049-9347; Wilson, Richard K./0000-0002-1992-1358; Repping, Sjoerd/0000-0002-6959-149X; Chinwalla, Asif/0000-0001-7831-3996; Schultz, Brian/0000-0003-4964-976X; Rozen, Steven G./0000-0002-4288-0056				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; Carvalho AB, 2001, P NATL ACAD SCI USA, V98, P13225, DOI 10.1073/pnas.231484998; Delbridge ML, 1999, NAT GENET, V22, P223, DOI 10.1038/10279; FERGUSON-SMITH M A, 1965, J Med Genet, V2, P142, DOI 10.1136/jmg.2.2.142; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; FORD CE, 1959, LANCET, V1, P711; Graves JAM, 1992, CURR OPIN GENET DEV, V2, P890, DOI 10.1016/S0959-437X(05)80112-1; JACKSON JA, 1981, NATURE, V292, P306, DOI 10.1038/292306a0; JACOBS PA, 1959, NATURE, V183, P302, DOI 10.1038/183302a0; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Kamp C, 2000, HUM MOL GENET, V9, P2563, DOI 10.1093/hmg/9.17.2563; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 1999, NAT GENET, V21, P429, DOI 10.1038/7771; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mazeyrat S, 1999, NAT GENET, V22, P224, DOI 10.1038/10282; Mumm S, 1997, GENOME RES, V7, P307, DOI 10.1101/gr.7.4.307; Ohno S., 1967, SEX CHROMOSOMES SEX; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; Painter TS, 1921, SCIENCE, V53, P503, DOI 10.1126/science.53.1378.503; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Schweitzer F., 1998, ADV COMPLEX SYST, V1, P11, DOI DOI 10.1142/S021952599800003X; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; STERN C, 1957, AM J HUM GENET, V9, P147; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; TYLERSMITH C, 1988, J MOL BIOL, V203, P837, DOI 10.1016/0022-2836(88)90110-6; TYLERSMITH C, 1993, NAT GENET, V5, P368, DOI 10.1038/ng1293-368; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vogt PH, 1997, CYTOGENET CELL GENET, V79, P2; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WATSON JM, 1991, P NATL ACAD SCI USA, V88, P11256, DOI 10.1073/pnas.88.24.11256; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Zhao S, 2000, GENOMICS, V63, P321, DOI 10.1006/geno.1999.6082; ZINN AR, 1993, TRENDS GENET, V9, P90, DOI 10.1016/0168-9525(93)90230-F	50	1436	1572	2	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2003	423	6942					825	U2		10.1038/nature01722	http://dx.doi.org/10.1038/nature01722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815422	Bronze			2022-12-24	WOS:000183585300035
J	Tsubuki, S; Takaki, Y; Saido, TC				Tsubuki, S; Takaki, Y; Saido, TC			Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of A beta to physiologically relevant proteolytic degradation	LANCET			English	Article							PROTEIN; DISEASE	The Dutch, Flemish, Italian, and Arctic mutations in the amyloid precursor protein (APP) gene encode changes within the sequence of the amyloid beta peptide (Abeta) and cause presenile cerebral amyloid angiopathy, cerebral parenchymal amyloidosis, or both. These disorders are caused by accumulation of Abeta, with no evidence of increased Abeta production. Our results showed that these mutations in Abeta make it resistant to proteolytic degradation by neprilysin, the peptidase with the most important role in catabolism of Abeta in the brain. These mutations in Abeta could thus be pathogenic not only by facilitating fibrillogenesis but also by extending the half-life of Abeta in the brain.	RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan	RIKEN	Saido, TC (corresponding author), RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Saido, Takaomi C/N-5472-2015; Sado, Takaomi/AAN-2759-2021	Saido, Takaomi C/0000-0003-1970-6903; Sado, Takaomi/0000-0003-1970-6903				Kumar-Singh S, 2000, NEUROBIOL DIS, V7, P9, DOI 10.1006/nbdi.1999.0272; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; Perez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160; SAITO T, 2003, SCI SAAGE KE    0122; Walsh DM, 2001, BIOCHEM J, V355, P869, DOI 10.1042/bj3550869	5	115	126	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 7	2003	361	9373					1957	1958		10.1016/S0140-6736(03)13555-6	http://dx.doi.org/10.1016/S0140-6736(03)13555-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687DB	12801742				2022-12-24	WOS:000183359700014
J	Wang, HY; Malbon, CC				Wang, HY; Malbon, CC			Wnt signaling, Ca2+, and cyclic GMP: Visualizing frizzled functions	SCIENCE			English	Editorial Material							BETA-CATENIN; G-PROTEINS; XENOPUS; PATHWAY; KINASE; RECEPTOR; HOMOLOGS; FAMILY; CELLS	Wnts control the specification of cell fate, cell adhesion, migration, polarity, and proliferation. Their roles in development have been probed in fruit flies, nematodes, zebrafish, frogs, and mice. Some Wnts inhibit the degradation of beta-catenin, which can regulate transcription of specific genes. Other Wnts exert their influences in other ways, such as increasing intracellular concentrations of Ca2+ and decreasing intracellular concentrations of cyclic guanosine monophosphate (cGMP). Heterotrimeric guanine nucleotide-binding proteins (G proteins) and RGS proteins have been implicated in Wnt signaling. Wnt regulation of intracellular Ca2+ and cGMP levels requires the G protein transducin and a cGMP-specific phosphodiesterase, which are major elements in signaling of the visual pathway.	SUNY Stony Brook, Hlth Sci Ctr, Dept Pharmacol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Hlth Sci Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Malbon, CC (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Pharmacol, Stony Brook, NY 11794 USA.		malbon, craig/ABF-3604-2020					Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; IRVINE RF, 2002, SCI STKE; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Kume S, 2000, DEV BIOL, V226, P88, DOI 10.1006/dbio.2000.9849; Li H, 2002, BIOCHEM PHARMACOL, V64, P1325, DOI 10.1016/S0006-2952(02)01345-X; Li H, 2002, CANCER BIOL THER, V1, P621, DOI 10.4161/cbt.309; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Liu XX, 1999, P NATL ACAD SCI USA, V96, P14383, DOI 10.1073/pnas.96.25.14383; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; WANG HY, 2003, SCI STKE; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu CL, 2000, DEVELOPMENT, V127, P2773	22	115	119	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1529	1530		10.1126/science.1085259	http://dx.doi.org/10.1126/science.1085259			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791979				2022-12-24	WOS:000183333100039
J	Jansen, VAA; Stollenwerk, N; Jensen, HJ; Ramsay, ME; Edmunds, WJ; Rhodes, CJ				Jansen, VAA; Stollenwerk, N; Jensen, HJ; Ramsay, ME; Edmunds, WJ; Rhodes, CJ			Measles outbreaks in a population with declining vaccine uptake	SCIENCE			English	Article									Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2BZ, England; Hlth Protect Agcy, CDSC, London NW9 5EQ, England	University of London; Royal Holloway University London; Imperial College London; Health Protection Agency	Jansen, VAA (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	vincent.jansen@rhul.ac.uk	Jansen, Vincent A A/C-8353-2009; Ramsay, Mary Elizabeth/S-8281-2016	Jansen, Vincent A.A./0000-0002-6518-2090; Stollenwerk, Nico/0000-0001-9315-5586; Ramsay, Mary Elizabeth/0000-0002-7156-7640				ANDERSON R M, 1991; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; GAY NJ, 1995, EPIDEMIOL INFECT, V115, P139, DOI 10.1017/S0950268800058209; Rhodes CJ, 1996, NATURE, V381, P600, DOI 10.1038/381600a0	4	248	258	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					804	804		10.1126/science.1086726	http://dx.doi.org/10.1126/science.1086726			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907792				2022-12-24	WOS:000184615700035
J	Snow, A				Snow, A			Unnatural selection	NATURE			English	Editorial Material									Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA	Ohio State University	Snow, A (corresponding author), Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA.							Lassner M, 2001, CURR OPIN PLANT BIOL, V4, P152, DOI 10.1016/S1369-5266(00)00152-7; Nam YK, 2001, TRANSGENIC RES, V10, P353, DOI 10.1023/A:1016696104185; Nielsen KM, 2003, NAT BIOTECHNOL, V21, P227, DOI 10.1038/nbt0303-227; United States National Research Council, 2002, ENV EFF TRANSG PLANT	4	14	14	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					619	619		10.1038/424619a	http://dx.doi.org/10.1038/424619a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904767	Bronze			2022-12-24	WOS:000184578800021
J	Garry, DJ; Mammen, PPA				Garry, DJ; Mammen, PPA			Neuroprotection and the role of neuroglobin	LANCET			English	Editorial Material							MYOGLOBIN; MICE; BRAIN; MECHANISMS; PROTECTS; MEMBER		Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Garry, DJ (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA.							Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Couture M, 2001, J BIOL CHEM, V276, P36377, DOI 10.1074/jbc.M103907200; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Garry DJ, 2003, TRENDS CARDIOVAS MED, V13, P111, DOI 10.1016/S1050-1738(02)00256-6; Garry DJ, 1998, NATURE, V395, P905, DOI 10.1038/27681; Godecke A, 1999, P NATL ACAD SCI USA, V96, P10495, DOI 10.1073/pnas.96.18.10495; Grange RW, 2001, AM J PHYSIOL-CELL PH, V281, pC1487, DOI 10.1152/ajpcell.2001.281.5.C1487; Mammen PPA, 2002, J HISTOCHEM CYTOCHEM, V50, P1591, DOI 10.1177/002215540205001203; Meeson AP, 2001, CIRC RES, V88, P713, DOI 10.1161/hh0701.089753; Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Zhang CG, 2002, BIOCHEM BIOPH RES CO, V290, P1411, DOI 10.1006/bbrc.2002.6360	14	38	44	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					342	343		10.1016/S0140-6736(03)14055-X	http://dx.doi.org/10.1016/S0140-6736(03)14055-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907003				2022-12-24	WOS:000184498700004
J	Seo, DW; Li, HM; Guedez, L; Wingfield, PT; Diaz, T; Salloum, R; Wei, BY; Stetler-Stevenson, WG				Seo, DW; Li, HM; Guedez, L; Wingfield, PT; Diaz, T; Salloum, R; Wei, BY; Stetler-Stevenson, WG			TIMP-2 mediated inhibition of angiogenesis: An MMP-independent mechanism	CELL			English	Article							ENDOTHELIAL-CELL PROLIFERATION; PROTEIN-TYROSINE-PHOSPHATASE; TISSUE INHIBITOR; METALLOPROTEINASE INHIBITORS; TUMOR-GROWTH; ACTIVATION; CANCER; GENE; ALPHA-3-BETA-1; INVASION	Tissue inhibitors of metalloproteinases (TIMPs) suppress matrix metalloproteinase (MMP) activity critical for extracellular matrix turnover associated with both physiologic and pathologic tissue remodeling. We demonstrate here that TIMP-2 abrogates angiogenic factor-induced endothelial cell proliferation in vitro and angiogenesis in vivo independent of MMP inhibition. These effects require alpha3beta1 integrin-mediated binding of TIMP-2 to endothelial cells. Further,TIMP-2 induces a decrease in total protein tyrosine phosphatase (PTP) activity associated with beta1 integrin subunits as well as dissociation of the phosphatase SHP-1 from beta1. TIMP-2 treatment also results in a concomitant increase in PTP activity associated with tyrosine kinase receptors FGFR-1 and KDR. Our findings establish an unexpected, MMP-independent mechanism for TIMP-2 inhibition of endothelial cell proliferation in vitro and reveal an important component of the antiangiogenic effect of TIMP2 in vivo.	NCI, Canc Res Ctr, Vasc Biol Fac, Extracellular Matrix Pathol Sect, Bethesda, MD 20892 USA; NCI, Canc Res Ctr, Pathol Lab, Extracellular Matrix Pathol Sect, Bethesda, MD 20892 USA; NIAMSD, Prot Express Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Stetler-Stevenson, WG (corresponding author), NCI, Canc Res Ctr, Vasc Biol Fac, Extracellular Matrix Pathol Sect, Bethesda, MD 20892 USA.		Guedez, Liliana/H-4951-2012; Stetler-Stevenson, William G/H-6956-2012; Stetler-Stevenson, William/AAE-3501-2020	Stetler-Stevenson, William G/0000-0002-5500-5808; Stetler-Stevenson, William/0000-0002-5500-5808; Seo, Dong-Wan/0000-0003-4971-834X; Wingfield, Paul/0000-0002-9515-4752	NATIONAL CANCER INSTITUTE [Z01SC009179, ZIASC009179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041115, Z01AR041115] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Baker AH, 1999, BRIT J CANCER, V79, P1347, DOI 10.1038/sj.bjc.6690217; Barazi HO, 2002, CANCER RES, V62, P1541; Bousquet C, 1998, J BIOL CHEM, V273, P7099, DOI 10.1074/jbc.273.12.7099; BRAUTIGAN DL, 1988, METHOD ENZYMOL, V159, P339; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; EMMERTBUCK MR, 1995, FEBS LETT, V364, P28, DOI 10.1016/0014-5793(95)00345-A; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Guedez L, 2003, AM J PATHOL, V162, P1431, DOI 10.1016/S0002-9440(10)64276-9; Guedez L, 2001, BLOOD, V97, P1796, DOI 10.1182/blood.V97.6.1796; Guedez L, 1998, J CLIN INVEST, V102, P2002, DOI 10.1172/JCI2881; Guedez L, 2001, AM J PATHOL, V158, P1207, DOI 10.1016/S0002-9440(10)64070-9; Guo DQ, 2000, J BIOL CHEM, V275, P11216, DOI 10.1074/jbc.275.15.11216; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hoegy SE, 2001, J BIOL CHEM, V276, P3203, DOI 10.1074/jbc.M008157200; Imren S, 1996, CANCER RES, V56, P2891; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Jiang YF, 2001, CANCER RES, V61, P2365; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; LAU KHW, 1989, BIOCHEM J, V257, P23, DOI 10.1042/bj2570023; Maeshima Y, 2002, SCIENCE, V295, P140, DOI 10.1126/science.1065298; MURPHY AN, 1993, J CELL PHYSIOL, V157, P351, DOI 10.1002/jcp.1041570219; Nakagami H, 2002, ARTERIOSCL THROM VAS, V22, P238, DOI 10.1161/hq0202.104001; Perollet C, 1998, BLOOD, V91, P3289, DOI 10.1182/blood.V91.9.3289.3289_3289_3299; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; STUPACK DG, 2002, ECM REMODELING REGUL; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Tartaglia M, 2001, DNA CELL BIOL, V20, P367, DOI 10.1089/10445490152122488; Tarui T, 2001, J BIOL CHEM, V276, P39562, DOI 10.1074/jbc.M101815200; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wennerberg K, 2000, MOL CELL BIOL, V20, P5758, DOI 10.1128/MCB.20.15.5758-5765.2000; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791	39	407	435	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					171	180		10.1016/S0092-8674(03)00551-8	http://dx.doi.org/10.1016/S0092-8674(03)00551-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887919	Bronze			2022-12-24	WOS:000184378700007
J	Zheng, L; Roeder, RG; Luo, Y				Zheng, L; Roeder, RG; Luo, Y			S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component	CELL			English	Article							OCT-1 POU DOMAIN; CELL-CYCLE; GENE-TRANSCRIPTION; DNA-BINDING; PROTEINS; REPLICATION; PHOSPHORYLATION; DEHYDROGENASE; CHAPERONES; EXPRESSION	We have isolated and functionally characterized a multicomponent Oct-1 coactivator, OCA-S which is essential for S phase-dependent histone H2B transcription. The p38 component of OCA-S binds directly to Oct-1, exhibits potent transactivation potential, is selectively recruited to the H2B promoter in S phase, and is essential for S phase-specific H2B transcription in vivo and in vitro. Surprisingly, p38 represents a nuclear form of glyceraldehyde-3-phosphate dehydrogenase, and binding to Oct-1, as well as OCA-S function, is stimulated by NAD(+) but inhibited by NADH. OCA-S also interacts with NPAT, a cyclin E/cdk2 substrate that is broadly involved in histone gene transcription. These studies thus link the H2B transcriptional machinery to cell cycle regulators, and possibly to cellular metabolic state (redox status), and set the stage for studies of the underlying mechanisms and the basis for coordinated histone gene expression and coupling to DNA replication.	Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Rockefeller University	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.	roeder@mail.rockefeller.edu; luoy@mail.rockefeller.edu						Babb R, 1997, MOL CELL BIOL, V17, P7295, DOI 10.1128/MCB.17.12.7295; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ewen ME, 2000, GENE DEV, V14, P2265, DOI 10.1101/gad.842100; Fan WH, 2002, J BIOL CHEM, V277, P8061, DOI 10.1074/jbc.M110225200; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Ford E, 1998, GENE DEV, V12, P3528, DOI 10.1101/gad.12.22.3528; Freije JMP, 1998, BIOCHEM SOC SYMP, P261; Frydman J, 1997, TRENDS BIOCHEM SCI, V22, P87, DOI 10.1016/S0968-0004(97)01005-0; Ge H, 1996, METHOD ENZYMOL, V274, P57; HAN M, 1987, CELL, V48, P589, DOI 10.1016/0092-8674(87)90237-6; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kimmins S, 2000, CELL STRESS CHAPERON, V5, P76, DOI 10.1379/1466-1268(2000)005<0076:MOSRAE>2.0.CO;2; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; LABELLA F, 1988, GENE DEV, V2, P32, DOI 10.1101/gad.2.1.32; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; LUO Y, 1995, MOL CELL BIOL, V15, P4115; Luo Y, 1999, COLD SPRING HARB SYM, V64, P119, DOI 10.1101/sqb.1999.64.119; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; RONAI Z, 1993, INT J BIOCHEM, V25, P1073, DOI 10.1016/0020-711X(93)90123-V; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Takahashi Y, 2000, GENE DEV, V14, P804; Zhang QH, 2002, SCIENCE, V295, P1895; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zhao JY, 1998, GENE DEV, V12, P456, DOI 10.1101/gad.12.4.456	33	415	448	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2003	114	2					255	266		10.1016/S0092-8674(03)00552-X	http://dx.doi.org/10.1016/S0092-8674(03)00552-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887926	Bronze			2022-12-24	WOS:000184378700014
J	Brook, BW; Sodhi, NS; Ng, PKL				Brook, BW; Sodhi, NS; Ng, PKL			Catastrophic extinctions follow deforestation in Singapore	NATURE			English	Article							CONSERVATION; FOREST; LESSONS; BIRD	The looming mass extinction of biodiversity in the humid tropics is a major concern for the future(1), yet most reports of extinctions in these regions are anecdotal or conjectural, with a scarcity of robust, broad-based empirical data(2-4). Here we report on local extinctions among a wide range of terrestrial and freshwater taxa from Singapore (540 km(2)) in relation to habitat loss exceeding 95% over 183 years(5,6). Substantial rates of documented and inferred extinctions were found, especially for forest specialists, with the greatest proportion of extinct taxa (34-87%) in butterflies, fish, birds and mammals. Observed extinctions were generally fewer, but inferred losses often higher, in vascular plants, phasmids, decapods, amphibians and reptiles (5-80%). Forest reserves comprising only 0.25% of Singapore's area now harbour over 50% of the residual native biodiversity. Extrapolations of the observed and inferred local extinction data, using a calibrated species-area model(7-9), imply that the current unprecedented rate of habitat destruction in Southeast Asia(10) will result in the loss of 13-42% of regional populations over the next century, at least half of which will represent global species extinctions.	Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; No Terr Univ, Key Ctr Trop Wildlife Management, Darwin, NT 0909, Australia; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Kyoto University; Charles Darwin University; National University of Singapore	Brook, BW (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan.	barry.brook@ntu.edu.au; dbsns@nus.edu.sg	Brook, Barry W./G-2686-2011; Ng, Peter/J-7393-2012	Brook, Barry W./0000-0002-2491-1517; 				Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Araujo MB, 2000, BIOL CONSERV, V96, P331, DOI 10.1016/S0006-3207(00)00074-4; BIERREGAARD RO, 1992, BIOSCIENCE, V42, P859, DOI 10.2307/1312085; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Brooks TM, 1997, CONSERV BIOL, V11, P382, DOI 10.1046/j.1523-1739.1997.95493.x; Castelletta M, 2000, CONSERV BIOL, V14, P1870, DOI 10.1111/j.1523-1739.2000.99285.x; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Corlett R.T., 2000, P333; CORLETT RT, 1992, J BIOGEOGR, V19, P411, DOI 10.2307/2845569; DIAMOND J M, 1987, Conservation Biology, V1, P77, DOI 10.1111/j.1523-1739.1987.tb00012.x; Droege S, 1998, CONSERV BIOL, V12, P1134, DOI 10.1046/j.1523-1739.1998.96402.x; HEYWOOD VH, 1992, TROPICAL DEFORESTATION AND SPECIES EXTINCTION, P91; HEYWOOD VH, 1994, NATURE, V368, P105, DOI 10.1038/368105a0; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Lim KS, 1997, BIRDS ILLUSTRATED FI; May RM, 2000, SCIENCE, V290, P2084, DOI 10.1126/science.290.5499.2084; Milner-Gulland EJ, 2001, TRENDS ECOL EVOL, V16, P686, DOI 10.1016/S0169-5347(01)02278-9; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ng P. K., 1994, SINGAPORE RED DATA B; NG PKL, 1992, AQUAT CONSERV, V2, P255, DOI 10.1002/aqc.3270020305; Novacek MJ, 2001, P NATL ACAD SCI USA, V98, P5466, DOI 10.1073/pnas.091093698; Pitman NCA, 2002, SCIENCE, V298, P989, DOI 10.1126/science.298.5595.989; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Ridley H.N., 1900, J STRAITS BRANCH ROY, V33, P27; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Sodhi NS, 2000, CONSERV BIOL, V14, P1211, DOI 10.1046/j.1523-1739.2000.99416.x; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Turner IM, 1996, TRENDS ECOL EVOL, V11, P330, DOI 10.1016/0169-5347(96)10046-X; TURNER IM, 1994, CONSERV BIOL, V8, P705, DOI 10.1046/j.1523-1739.1994.08030705.x; WILLIAMSON M, 1989, PHILOS T ROY SOC B, V325, P457, DOI 10.1098/rstb.1989.0099	30	463	491	0	228	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					420	423		10.1038/nature01795	http://dx.doi.org/10.1038/nature01795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879068				2022-12-24	WOS:000184318400041
J	Travis, LB; Hill, DA; Dores, GM; Gospodarowicz, M; van Leeuwen, FE; Holowaty, E; Glimelius, B; Andersson, M; Wiklund, T; Lynch, CF; Van't Veer, MB; Glimelius, I; Storm, H; Pukkala, E; Stovall, M; Curtis, R; Boice, JD; Gilbert, E				Travis, LB; Hill, DA; Dores, GM; Gospodarowicz, M; van Leeuwen, FE; Holowaty, E; Glimelius, B; Andersson, M; Wiklund, T; Lynch, CF; Van't Veer, MB; Glimelius, I; Storm, H; Pukkala, E; Stovall, M; Curtis, R; Boice, JD; Gilbert, E			Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE REPLACEMENT THERAPY; 2ND MALIGNANT NEOPLASMS; MANTLE IRRADIATION; RADIATION-THERAPY; OVARIAN-FUNCTION; RISK; SURVIVORS; MORTALITY; ESTROGEN; COHORT	Context Second cancer is the leading cause of death in long-term survivors of Hodgkin disease (HD), with exceptionally high risks of breast cancer among women treated at a young age. Quantitative associations between radiotherapy dose delivered to the breast and administered chemotherapy have not been reported to date in large series, nor has the influence of ovarian exposures on subsequent risk. Objective To quantify the long-term risk of breast cancer associated with use of radiotherapy and chemotherapy to treat young women with HD. Design, Setting, and Subjects Matched case-control study of breast cancer within a cohort of 3817 female 1-year survivors of HD diagnosed at age 30 years or younger, between January 1, 1965, and December 31, 1994, and within 6 population-based cancer registries. The study was conducted March 1, 1996, through September 30, 1998. Main Outcome Measures Relative risk (RR) of breast cancer associated with radiation dose delivered to site of breast cancer or to ovaries and with cumulative dose of alkylating agents. Results Breast cancer occurred in 105 patients with HD who were matched to 266 patients with HD but without breast cancer. A radiation dose of 4 Gy or more delivered to the breast was associated with a 3.2-fold (95% confidence interval [CI], 1.4-8.2) increased risk, compared with the risk in patients who received lower doses and no alkylating agents. Risk increased to 9-fold (95% CI, 2.6-26.4) with a dose of more than 40 Gy (P<.001 for trend). Radiation risk did not vary appreciably by age at exposure or reproductive history. increased risks persisted for 25 or more years following radiotherapy (RR, 2.3; 95% CI, 0.5-16.5; P=.03 for trend with dose). Treatment with alkylating agents alone resulted in a reduced risk (RR, 0.6; 95% CI, 0.2-2.0) of breast cancer, and combined alkylating agents and radiotherapy in a 1.4-fold (95% CI, 0.6-3.5) increased risk. Risk of breast cancer decreased with increasing number of alkylating agent cycles (P=.003 for trend). Risk also was low (RR, 0.4; 95% CI, 0.1-1.1) among women who received 5 Gy or more delivered to ovaries compared with those who received lower doses. Conclusions Hormonal stimulation appears important for the development of radiation-induced breast cancer, as evidenced by the reduced risk associated with ovarian damage from alkylating agents or radiation. The high radiation-related risk, which did not diminish at the highest doses or the longest follow-up, however, suggests the need for lifetime surveillance and programs of patient and public awareness.	NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada; Netherlands Canc Inst, Amsterdam, Netherlands; Canc Care Ontario, Toronto, ON, Canada; Uppsala Univ, Uppsala, Sweden; Danish Canc Soc, Copenhagen, Denmark; Univ Helsinki, Cent Hosp, Helsinki, Finland; Univ Iowa, Iowa City, IA USA; Dr Daniel den Hoed Canc Ctr, NL-3008 AE Rotterdam, Netherlands; Finnish Canc Registry, FIN-00170 Helsinki, Finland; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Int Epidemiol Inst, Rockville, MD USA; Vanderbilt Univ, Med Ctr, Nashville, TN USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Netherlands Cancer Institute; Cancer Care Ontario; Uppsala University; Danish Cancer Society; University of Helsinki; Helsinki University Central Hospital; University of Iowa; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Finnish Cancer Registry; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University	Travis, LB (corresponding author), NCI, Div Canc Epidemiol & Stat, NIH, Dept Hlth & Human Serv,EPS 7086,MSC 7238, Bethesda, MD 20892 USA.		Glimelius, Ingrid Cecilia/Q-1325-2015; Glimelius, Ingrid/AAJ-4986-2020	Glimelius, Ingrid Cecilia/0000-0001-6158-3041; Glimelius, Ingrid/0000-0001-6158-3041; Storm, Hans/0000-0001-7223-8198; Dores, Graca/0000-0002-3985-2935; Wiklund, Tom/0000-0002-9384-9614	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP091024, N01CP061120, N01CP061122, N01CP061121, N01CP061119] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CP-61122, N01-CP-61121, N01-CP-91024, N01-CP-61120, N02-CP-81005, N01-CP-61119, CP-33013-18] Funding Source: Medline	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aisenberg AC, 1997, CANCER, V79, P1203, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1203::AID-CNCR20>3.0.CO;2-2; Aisenberg AC, 1999, BLOOD, V93, P761, DOI 10.1182/blood.V93.3.761.403a27_761_779; [Anonymous], 2002, SEER CANC STAT REV 1; ARSENEAU JC, 1972, NEW ENGL J MED, V287, P1119, DOI 10.1056/NEJM197211302872204; Bhatia S, 1996, NEW ENGL J MED, V334, P745, DOI 10.1056/NEJM199603213341201; BOICE JD, 1989, INT J CANCER, V44, P7, DOI 10.1002/ijc.2910440103; Boice JD, 2001, MED PEDIATR ONCOL, V36, P508, DOI 10.1002/mpo.1122; BOICE JD, 1993, J NATL CANCER I, V85, P4, DOI 10.1093/jnci/85.1.4; BOKEMEYER C, 1994, ANN HEMATOL, V68, P105, DOI 10.1007/BF01727413; Breslow NE., 1980, IARC SCI PUBL, V32, P5; Brusamolino E, 2000, HAEMATOLOGICA, V85, P1032; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; Canellos GP, 2002, ANN ONCOL, V13, P153, DOI 10.1093/annonc/mdf653; Chen CL, 2002, JAMA-J AM MED ASSOC, V287, P734, DOI 10.1001/jama.287.6.734; Christie DRH, 1998, INT J RADIAT ONCOL, V41, P223, DOI 10.1016/S0360-3016(97)00902-4; Clemons M, 2000, CANCER TREAT REV, V26, P291, DOI 10.1053/ctrv.2000.0174; Connors J M, 2001, Hematology Am Soc Hematol Educ Program, P178; DARBY SC, 1994, INT J CANCER, V56, P793, DOI 10.1002/ijc.2910560606; DEVITA VT, 1970, ANN INTERN MED, V73, P881, DOI 10.7326/0003-4819-73-6-881; Diller L, 2002, J CLIN ONCOL, V20, P2085, DOI 10.1200/JCO.2002.08.031; Dores GM, 2002, J CLIN ONCOL, V20, P3484, DOI 10.1200/JCO.2002.09.038; HANCOCK SL, 1993, J NATL CANCER I, V85, P25, DOI 10.1093/jnci/85.1.25; Henry-Amar M, 1992, Ann Oncol, V3 Suppl 4, P117; Hoppe RT, 1997, ANN ONCOL, V8, P115, DOI 10.1023/A:1008238908676; HORNING SJ, 1981, NEW ENGL J MED, V304, P1377, DOI 10.1056/NEJM198106043042301; Jolleys JV, 1996, MATURITAS, V23, P47, DOI 10.1016/0378-5122(95)00952-3; Lucraft HH, 2000, CLIN ONCOL-UK, V12, P276, DOI 10.1053/clon.2000.9173; MASHCHAK CA, 1982, AM J OBSTET GYNECOL, V144, P511, DOI 10.1016/0002-9378(82)90218-6; Mauch P, 1999, HODGKINS DIS; Mauch P M, 1995, Cancer J Sci Am, V1, P33; Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Ng AK, 1999, SEMIN HEMATOL, V36, P290; Parkin DM, 1997, CANC INCIDENCE 5 CON, VVII; PERSSON I, 1983, ACTA OBSTET GYN SCAN, V62, P289, DOI 10.3109/00016348309156224; PETERS MH, 1995, AM SURGEON, V61, P763; PETERS MV, 1950, AM J ROENTGENOL, V63, P299; *PHIL MED SYST, RAD ONC SYST PINN; Preston DL, 2002, RADIAT RES, V158, P220, DOI 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2; PRESTON DL, 1991, EPICURE USERS GUIDE; Prosnitz LR, 2002, J CLIN ONCOL, V20, P2225, DOI 10.1200/JCO.2002.20.9.2225; RAY GR, 1970, RADIOLOGY, V96, P175, DOI 10.1148/96.1.175; Schairer C, 1997, INT J CANCER, V70, P150, DOI 10.1002/(SICI)1097-0215(19970117)70:2<150::AID-IJC2>3.0.CO;2-W; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; SHORE RE, 1980, PREV MED, V9, P815, DOI 10.1016/0091-7435(80)90024-9; STOVALL M, 1995, MED PHYS, V22, P63, DOI 10.1118/1.597525; STOVALL M, 1989, MED PHYS, V16, P726, DOI 10.1118/1.596331; Swerdlow AJ, 2000, J CLIN ONCOL, V18, P498, DOI 10.1200/JCO.2000.18.3.498; Titus-Ernstoff L, 1998, CANCER EPIDEM BIOMAR, V7, P783; Travis LB, 1999, NEW ENGL J MED, V340, P351, DOI 10.1056/NEJM199902043400504; Travis LB, 2002, JNCI-J NATL CANCER I, V94, P182, DOI 10.1093/jnci/94.3.182; TRAVIS LB, 2003, NEW ENGL J MED, V95, P971; TRICHOPOULOS D, 1972, JNCI-J NATL CANCER I, V48, P605; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2000, SOURC EFF LON RAD; van Leeuwen FE, 2000, J CLIN ONCOL, V18, P487, DOI 10.1200/JCO.2000.18.3.487; VANLEEUWEN FE, IN PRESS J NATL CANC; Williams RS, 1999, CANCER, V86, P2138, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2138::AID-CNCR36>3.3.CO;2-M; Wolden SL, 2000, J CLIN ONCOL, V18, P765, DOI 10.1200/JCO.2000.18.4.765; YAHALOM J, 1992, J CLIN ONCOL, V10, P1674, DOI 10.1200/JCO.1992.10.11.1674; ZELLMER DL, 1991, INT J RADIAT ONCOL, V21, P1343, DOI 10.1016/0360-3016(91)90296-G; 1983, BR J RADIOL S, V17, P1	61	447	454	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2003	290	4					465	475		10.1001/jama.290.4.465	http://dx.doi.org/10.1001/jama.290.4.465			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703JB	12876089	Bronze			2022-12-24	WOS:000184275300018
J	Diebold, SS; Montoya, M; Unger, H; Alexopoulou, L; Roy, P; Haswell, LE; Al-Shamkhani, A; Flavell, R; Borrow, P; Sousa, CRE				Diebold, SS; Montoya, M; Unger, H; Alexopoulou, L; Roy, P; Haswell, LE; Al-Shamkhani, A; Flavell, R; Borrow, P; Sousa, CRE			Viral infection switches non-plasmacytoid dendritic cells into high interferon producers	NATURE			English	Article								Type I interferons (IFN-I) are important cytokines linking innate and adaptive immunity(1). Plasmacytoid dendritic cells make high levels of IFN-I in response to viral infection and are thought to be the major source of the cytokines in vivo(2). Here, we show that conventional non-plasmacytoid dendritic cells taken from mice infected with a dendritic-cell-tropic strain of lymphocytic choriomeningitis virus make similarly high levels of IFN-I on subsequent culture. Similarly, non-plasmacytoid dendritic cells secrete high levels of IFN-I in response to double-stranded RNA (dsRNA), a major viral signature(3), when the latter is introduced into the cytoplasm to mimic direct viral infection. This response is partially dependent on the cytosolic dsRNA-binding enzyme protein kinase R-4 and does not require signalling through toll-like receptor (TLR) 3, a surface receptor for dsRNA(5). Furthermore, we show that sequestration of dsRNA by viral NS1 (refs 6,7) explains the inability of conventional dendritic cells to produce IFN-I on infection with influenza. Our results suggest that multiple dendritic cell types, not just plasmacytoid cells, can act as specialized interferon-producing cells in certain viral infections, and reveal the existence of a TLR-independent pathway for dendritic cell activation that can be the target of viral interference.	Canc Res UK, London Res Inst, Immunobiol Lab, London WC2A 3PX, England; Edward Jenner Inst Vaccine Res, Compton RG20 7NN, Berks, England; Univ Vet Med, Inst Virol, A-1210 Vienna, Austria; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA; London Sch Hyg & Trop Med, London WC1A 7HT, England; Southampton Gen Hosp, Sch Med, Canc Sci Div, Tenovus Res Lab, Southampton SO16 6YD, Hants, England	Cancer Research UK; University of Veterinary Medicine Vienna; Yale University; Howard Hughes Medical Institute; University of London; London School of Hygiene & Tropical Medicine; University of Southampton	Sousa, CRE (corresponding author), Canc Res UK, London Res Inst, Immunobiol Lab, London WC2A 3PX, England.		Reis e Sousa, Caetano/ABD-7322-2021; Montoya, Maria/G-3430-2015; Reis e Sousa, Caetano/O-1657-2014; Alexopoulou, Lena/A-5041-2017	Reis e Sousa, Caetano/0000-0001-7392-2119; Montoya, Maria/0000-0002-5703-7360; Reis e Sousa, Caetano/0000-0001-7392-2119; Alexopoulou, Lena/0000-0003-4619-697X; Roy, Polly/0000-0001-6535-6911; Borrow, Persephone/0000-0002-3877-9780; Haswell, Linsey/0000-0002-5663-8834				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; BORROW P, 1995, J VIROL, V69, P1059, DOI 10.1128/JVI.69.2.1059-1070.1995; Bruno L, 2001, EUR J IMMUNOL, V31, P3403, DOI 10.1002/1521-4141(200111)31:11<3403::AID-IMMU3403>3.0.CO;2-T; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Colonna M, 2002, CURR OPIN IMMUNOL, V14, P373, DOI 10.1016/S0952-7915(02)00349-7; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Edwards AD, 2002, J IMMUNOL, V169, P3652, DOI 10.4049/jimmunol.169.7.3652; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; MARCUS PI, 1988, J GEN VIROL, V69, P1637, DOI 10.1099/0022-1317-69-7-1637; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; ZINN K, 1988, SCIENCE, V240, P210, DOI 10.1126/science.3281258	30	472	501	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					324	328		10.1038/nature01783	http://dx.doi.org/10.1038/nature01783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12819664				2022-12-24	WOS:000184183900045
J	Atkinson, RC; Beachy, RN; Conway, G; Cordova, FA; Fox, MA; Holbrook, KA; Klessig, DF; McCormick, RL; McPherson, PM; Rawlings, HR; Rapson, R; Vanderhoef, LN; Wiley, JD; Young, CE				Atkinson, RC; Beachy, RN; Conway, G; Cordova, FA; Fox, MA; Holbrook, KA; Klessig, DF; McCormick, RL; McPherson, PM; Rawlings, HR; Rapson, R; Vanderhoef, LN; Wiley, JD; Young, CE			Public sector collaboration for agricultural IP management	SCIENCE			English	Editorial Material									Univ Calif, Oakland, CA 94607 USA; Donald Danforth Plant Sci Ctr, St Louis, MO USA; Rockefeller Fdn, New York, NY 10018 USA; Univ Calif Riverside, Riverside, CA 92521 USA; N Carolina State Univ, Raleigh, NC 27695 USA; Ohio State Univ, Columbus, OH 43210 USA; Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; Rutgers State Univ, New Brunswick, NJ 08901 USA; Michigan State Univ, E Lansing, MI 48824 USA; Cornell Univ, Ithaca, NY 14853 USA; McKnight Fdn, Minneapolis, MN 55401 USA; Univ Calif Davis, Davis, CA 95616 USA; Univ Wisconsin, Madison, WI 53706 USA	University of California System; University of California Berkeley; Donald Danforth Plant Science Center; University of California System; University of California Riverside; University of North Carolina; North Carolina State University; Ohio State University; Cornell University; Boyce Thompson Institute for Plant Research; Rutgers State University New Brunswick; Michigan State University; Cornell University; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison	Atkinson, RC (corresponding author), Univ Calif, Oakland, CA 94607 USA.							Beachy RN, 2003, SCIENCE, V299, P473, DOI 10.1126/science.299.5606.473; Conway G, 1999, NATURE, V402, pC55, DOI [10.1038/35011545, 10.1038/990141]; GRAFF G, UNPUB; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; KRYDER RD, 2000, 20 ISAAA; Mowery DC, 2001, RES POLICY, V30, P99, DOI 10.1016/S0048-7333(99)00100-6; PAULSON L, COMMUNICATION; Phipps RH, 2002, J ANIM FEED SCI, V11, P1; RUFF M, COMMUNICATION; Wright B. D., 1998, California Agriculture, V52, P8, DOI 10.3733/ca.v052n06p8	11	72	74	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2003	301	5630					174	175		10.1126/science.1085553	http://dx.doi.org/10.1126/science.1085553			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	699KN	12855794	Green Submitted			2022-12-24	WOS:000184056200026
J	Mariani, R; Chen, D; Schrofelbauer, B; Navarro, F; Konig, R; Bollman, B; Munk, C; Nymark-McMahon, H; Landau, NR				Mariani, R; Chen, D; Schrofelbauer, B; Navarro, F; Konig, R; Bollman, B; Munk, C; Nymark-McMahon, H; Landau, NR			Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; B MESSENGER-RNA; TYPE-1 VIF; EDITING ENZYME; DNA; HYPERMUTATION; PROTEIN; REPLICATION; EXPRESSION; GENE	The HIV-1 accessory protein Vif (virion infectivity factor) is required for the production of infectious virions by CD4(+) lymphocytes. Vif facilitates particle infectivity by blocking the inhibitory activity of APOBEC3G (CEM15), a virion-encapsidated cellular protein that deaminates minus-strand reverse transcript cytosines to uracils. We report that HIV-1 Vif forms a complex with human APOBEC3G that prevents its virion encapsidation. HIV-1 Vif did not efficiently form a complex with mouse APOBEC3G. Vif dramatically reduced the amount of human APOBEC3G encapsidated in HIV-1 virions but did not prevent encapsidation of mouse or AGM APOBEC3G. As a result, these enzymes are potent inhibitors of wild-type HIV-1 replication. The species-specificity of this interaction may play a role in restricting HIV-1 infection to humans. Together these findings suggest that therapeutic intervention that either induced APOBEC3G or blocked its interaction with Vif could be clinically beneficial.	Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA	Salk Institute	Landau, NR (corresponding author), Salk Inst Biol Studies, Infect Dis Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	landau@salk.edu	König, Renate/AAB-8918-2019	König, Renate/0000-0003-4882-9179	NIDA NIH HHS [DA014494] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014494] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ANANT S, 1995, J BIOL CHEM, V270, P14762, DOI 10.1074/jbc.270.24.14762; BORMAN AM, 1995, VIROLOGY, V208, P601, DOI 10.1006/viro.1995.1191; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Camaur D, 1996, J VIROL, V70, P6106, DOI 10.1128/JVI.70.9.6106-6111.1996; Chowdhury IH, 1996, J VIROL, V70, P5336, DOI 10.1128/JVI.70.8.5336-5345.1996; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Desrosiers RC, 1998, J VIROL, V72, P1431, DOI 10.1128/JVI.72.2.1431-1437.1998; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; Emerman M, 1998, SCIENCE, V280, P1880, DOI 10.1126/science.280.5371.1880; FOLEY GE, 1965, CANCER RES, V25, P1254; Fouchier RAM, 1996, J VIROL, V70, P8263, DOI 10.1128/JVI.70.12.8263-8269.1996; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Gaddis NC, 2003, J VIROL, V77, P5810, DOI 10.1128/JVI.77.10.5810-5820.2003; Goncalves J, 1996, J VIROL, V70, P8701, DOI 10.1128/JVI.70.12.8701-8709.1996; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; JUTILA MA, 1994, J IMMUNOL, V153, P3917; Keppler OT, 2002, J EXP MED, V195, P719, DOI 10.1084/jem.20011549; Keppler OT, 2001, J VIROL, V75, P8063, DOI 10.1128/JVI.75.17.8063-8073.2001; Khan MA, 2001, J VIROL, V75, P7252, DOI 10.1128/JVI.75.16.7252-7265.2001; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Lau PP, 2001, J BIOL CHEM, V276, P46445, DOI 10.1074/jbc.M109215200; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; LENBURG ME, 1993, J VIROL, V67, P7238, DOI 10.1128/JVI.67.12.7238-7245.1993; LIU HM, 1995, J VIROL, V69, P7630, DOI 10.1128/JVI.69.12.7630-7638.1995; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; MANGEAT B, 2003, IN PRESS NATURE; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268; NARA PL, 1988, NATURE, V332, P469, DOI 10.1038/332469a0; OBERSTE MS, 1992, VIRUS GENES, V6, P95, DOI 10.1007/BF01703760; Onishi M, 1996, EXP HEMATOL, V24, P324; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; RALPH P, 1973, J NATL CANCER I, V51, P883, DOI 10.1093/jnci/51.3.883; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; SIMON JHM, 1995, J VIROL, V69, P4166, DOI 10.1128/JVI.69.7.4166-4172.1995; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; Soares MA, 1997, VIROLOGY, V228, P394, DOI 10.1006/viro.1996.8387; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; TRONO D, 1995, CELL, V82, P189, DOI 10.1016/0092-8674(95)90306-2; VARTANIAN JP, 1994, P NATL ACAD SCI USA, V91, P3092, DOI 10.1073/pnas.91.8.3092; VARTANIAN JP, 1991, J VIROL, V65, P1779, DOI 10.1128/JVI.65.4.1779-1788.1991; Vartanian JP, 2002, J GEN VIROL, V83, P801, DOI 10.1099/0022-1317-83-4-801; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Yang Y, 2000, J BIOL CHEM, V275, P22663, DOI 10.1074/jbc.M910406199; ZHANG H, 2003, IN PRESS NATURE	52	748	797	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2003	114	1					21	31		10.1016/S0092-8674(03)00515-4	http://dx.doi.org/10.1016/S0092-8674(03)00515-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859895	Bronze			2022-12-24	WOS:000184219900003
J	Papp, B; Pal, C; Hurst, LD				Papp, B; Pal, C; Hurst, LD			Dosage sensitivity and the evolution of gene families in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN; GENOME; ORGANIZATION; DATABASE; DOMINANCE; CELLS	According to what we term the balance hypothesis, an imbalance in the concentration of the subcomponents of a protein - protein complex can be deleterious(1). If so, there are two consequences: first, both underexpression and overexpression of protein complex subunits should lower fitness, and second, the accuracy of transcriptional co-regulation of subunits should reflect the deleterious consequences of imbalance. Here we show that all these predictions are upheld in yeast ( Saccharomyces cerevisiae). This supports the hypothesis(2,3) that dominance is a by-product of physiology and metabolism rather than the result of selection to mask the deleterious effects of mutations. Beyond this, single-gene duplication of protein subunits is expected to be harmful, as this, too, leads to imbalance. As then expected, we find that members of large gene families are rarely involved in complexes. The balance hypothesis therefore provides a single theoretical framework for understanding components both of dominance and of gene family size.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Eotvos Lorand Univ, Dept Plant Taxon & Ecol, H-1117 Budapest, Hungary	University of Bath; Eotvos Lorand University	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssldh@bath.ac.uk	; Hurst, Laurence/F-9215-2010	Papp, Balazs/0000-0003-3093-8852; Hurst, Laurence/0000-0002-1002-1054				Abruzzi KC, 2002, MOL CELL BIOL, V22, P138, DOI 10.1128/MCB.22.1.138-147.2002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bray D, 1997, P NATL ACAD SCI USA, V94, P13493, DOI 10.1073/pnas.94.25.13493; Carroll S.B., 2001, DNA DIVERSITY; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fisher R. A., 1930, GENETICAL THEORY NAT, DOI 10.5962/bhl.title.27468; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; HODGKIN J, 1993, TRENDS GENET, V9, P1, DOI 10.1016/0168-9525(93)90050-R; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Johnston M, 1999, TRENDS GENET, V15, P29, DOI 10.1016/S0168-9525(98)01637-0; KACSER H, 1981, GENETICS, V97, P639; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kratz E, 2002, TRENDS GENET, V18, P29, DOI 10.1016/S0168-9525(01)02579-3; Li BJ, 1996, P NATL ACAD SCI USA, V93, P1596, DOI 10.1073/pnas.93.4.1596; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Rottensteiner H, 1997, EUR J BIOCHEM, V247, P776, DOI 10.1111/j.1432-1033.1997.00776.x; Sokal RR., 1995, BIOMETRY, V3; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Stevens RC, 1998, J CELL BIOL, V142, P711, DOI 10.1083/jcb.142.3.711; VANHOLDE KE, 1998, PRINCIPLES PHYSICAL; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; WRIGHT S, 1934, AM NAT, V68, P25; Wu X, 2001, MOL GENET GENOMICS, V265, P622, DOI 10.1007/s004380100455; YUAN J, 1995, BLOOD, V86, P3945, DOI 10.1182/blood.V86.10.3945.bloodjournal86103945	30	617	623	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					194	197		10.1038/nature01771	http://dx.doi.org/10.1038/nature01771			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853957				2022-12-24	WOS:000184032700042
J	Mocroft, A; Ledergerber, B; Katlama, C; Kirk, O; Reiss, P; Monforte, AD; Knsyz, B; Dietrich, M; Phillips, AN; Lundgren, JD				Mocroft, A; Ledergerber, B; Katlama, C; Kirk, O; Reiss, P; Monforte, AD; Knsyz, B; Dietrich, M; Phillips, AN; Lundgren, JD		EuroSIDA Study Grp	Decline in the AIDS and death rates in the EuroSIDA study: an observational study	LANCET			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; VIRUS-INFECTED PATIENTS; CLINICAL PROGRESSION; VIROLOGICAL FAILURE; HIV-INFECTION; CELL COUNTS; EUROPE; RECOMMENDATIONS; INDIVIDUALS; PREDICTORS	Background Since the introduction of highly active antiretroviral therapy (HAART), little is known about whether changes in HIV-1-mortality and morbidity rates have been sustained. We aimed to assess possible changes in these rates across Europe. Methods We analysed data for 9803 patients in 70 European HIV centres including ones in Israel and Argentina. Incidence rates of AIDS or death were calculated for overall and most recent CD4 count in 6-monthly periods and in three treatment eras (pre-HAART, 1994-1995; early-HAART, 1996-1997; and late-HAART, 1998-2002). Findings The incidence of AIDS or death fell after September, 1998, by 8% per 6-month period (rate ratio 0.92, 95% CI 0.88-0.95, p<0.0001). When AIDS and death were analysed separately, the incidence of all deaths during the late-HAART era was significantly lower than that during the early-HAART era in patients whose latest CD4 count was 20 cells/mu L or less (0.43, 0.35-0.53, p<0.0001), but at higher CD4 counts, did not differ between early-HAART and late-HAART. Incidence of AIDS was about 50% lower in late-HAART than in early-HAART, irrespective of latest CD4 count (p<0.0001). In multivariate Cox's models, with early-HAART as the reference, there was an increased risk of AIDS (relative hazard 1.39; 95% CI 1.16-1.67, p=0.0004) and all deaths (1.29; 1.08-1.56, p=0.0065) in the pre-HAART era, and a reduced risk of AIDS (0.62; 0.50-0.77, p<0.0001) and all deaths (0.66; 0.53-0.82, p=0.0002) in the late-HAART era. Interpretation The initial drop in mortality and morbidity after the introduction of HAART has been sustained. Potential long-term adverse effects associated with HAART have not altered its effectiveness in treating AIDS.	UCL Royal Free & UCL Med Sch, Royal Free Ctr HIV Med, London NW3 2PF, England; UCL Royal Free & UCL Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; Univ Hosp, Zurich, Switzerland; Hop La Pitie Salpetriere, Paris, France; Univ Copenhagen, Hvidovre Hosp, DK-2650 Hvidovre, Denmark; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Osped L Sacco, Milan, Italy; Univ Wroclaw, Dept Infect Dis, PL-50138 Wroclaw, Poland; Bernhard Nocht Inst Trop Med, Hamburg, Germany	University of London; University College London; University of London; University College London; University of Zurich; University Zurich Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Copenhagen; University of Amsterdam; Academic Medical Center Amsterdam; University of Milan; Luigi Sacco Hospital; University of Wroclaw; Bernhard Nocht Institut fur Tropenmedizin	Mocroft, A (corresponding author), UCL Royal Free & UCL Med Sch, Royal Free Ctr HIV Med, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	a.mocroft@pcps.ucl.ac.uk	Mocroft, Amanda/C-1527-2008; VALLET, Yannick/F-9979-2011; Ledergerber, Bruno/B-5656-2009; Phillips, Andrew N/B-4427-2008; kirk, ole/ABB-4746-2021; Lundgren, Jens/AAE-6876-2019; Mocroft, Amanda/G-8748-2011	Ledergerber, Bruno/0000-0002-6881-4401; Phillips, Andrew N/0000-0003-2384-4807; Mocroft, Amanda/0000-0001-8316-1122; Lundgren, Jens/0000-0001-8901-7850; Johnson, Anne/0000-0003-1330-7100				[Anonymous], 1992, MMWR Recomm Rep, V41, P1; Benson CA, 2002, J INFECT DIS, V185, P599, DOI 10.1086/339014; *BHIVA, 2001, HIV MED, V2, P276; Coakley EPG, 2000, AIDS, V14, P1147, DOI 10.1097/00002030-200006160-00011; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Flandre P, 2002, AIDS, V16, P561, DOI 10.1097/00002030-200203080-00007; Grulich AE, 2002, AIDS, V16, P1155, DOI 10.1097/00002030-200205240-00009; Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Kirk O, 1998, AIDS, V12, P2031, DOI 10.1097/00002030-199815000-00015; Le Moing V, 2002, J INFECT DIS, V185, P471, DOI 10.1086/338929; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Lundgren JD, 1997, J ACQ IMMUN DEF SYND, V16, P153, DOI 10.1097/00042560-199711010-00003; Lundgren JD, 2002, J INFECT DIS, V185, P178, DOI 10.1086/338267; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; Miller V, 2002, J INFECT DIS, V186, P189, DOI 10.1086/341466; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Mocroft A, 2000, LANCET, V356, P291, DOI 10.1016/S0140-6736(00)02504-6; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paredes R, 2000, ARCH INTERN MED, V160, P1123, DOI 10.1001/archinte.160.8.1123; Piketty C, 2001, J INFECT DIS, V183, P1328, DOI 10.1086/319861; Selik RM, 2002, J ACQ IMMUN DEF SYND, V29, P378, DOI 10.1097/00126334-200204010-00009; Sterling TR, 2001, AIDS, V15, P2251, DOI 10.1097/00002030-200111230-00006; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222	29	980	1011	1	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2003	362	9377					22	29		10.1016/S0140-6736(03)13802-0	http://dx.doi.org/10.1016/S0140-6736(03)13802-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699KW	12853195				2022-12-24	WOS:000184056900009
J	Mora, JR; Bono, MR; Manjunath, N; Weninger, W; Cavanagh, LL; Rosemblatt, M; von Andrian, UH				Mora, JR; Bono, MR; Manjunath, N; Weninger, W; Cavanagh, LL; Rosemblatt, M; von Andrian, UH			Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells	NATURE			English	Article							CHEMOKINE RECEPTOR; IN-VIVO; LYMPHOCYTE; TISSUE; DIFFERENTIATION; LOCALIZATION; MIGRATION; INTEGRINS; EFFECTOR; ACQUISITION	Whereas naive T cells migrate only to secondary lymphoid organs(1,2), activation by antigen confers to T cells the ability to home to non-lymphoid sites(3,4). Activated effector/memory T cells migrate preferentially to tissues that are connected to the secondary lymphoid organs where antigen was first encountered(5-7). Thus, oral antigens induce effector/memory cells that express essential receptors for intestinal homing, namely the integrin alpha4beta7 and CCR9, the receptor for the gut-associated chemokine TECK/CCL25 (refs 6, 8, 9). Here we show that this imprinting of gut tropism is mediated by dendritic cells from Peyer's patches. Stimulation of CD8-expressing T cells by dendritic cells from Peyer's patches, peripheral lymph nodes and spleen induced equivalent activation markers and effector activity in T cells, but only Peyer's patch dendritic cells induced high levels of alpha4beta7, responsiveness to TECK and the ability to home to the small intestine. These findings establish that Peyer's patch dendritic cells imprint gut-homing specificity on T cells, and thus license effector/memory cells to access anatomical sites most likely to contain their cognate antigen.	Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Chile, Fdn Ciencias Vida, Fac Ciencias, Lab Inmunol, Santiago 6842301, Chile; Millennium Inst Fundamental & Appl Biol, Santiago 6842301, Chile	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Universidad de Chile	von Andrian, UH (corresponding author), Ctr Blood Res, 800 Huntington Ave, Boston, MA 02115 USA.	uva@cbr.med.harvard.edu	Bono, Maria/G-7461-2014; von Andrian, Ulrich H/A-5775-2008	Weninger, Wolfgang/0000-0003-3133-8699				ANDREW DP, 1994, J IMMUNOL, V153, P3847; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Carramolino L, 2001, BLOOD, V97, P850, DOI 10.1182/blood.V97.4.850; Davenport MP, 2000, IMMUNOL TODAY, V21, P315, DOI 10.1016/S0167-5699(00)01644-3; GUYGRAND D, 1978, J EXP MED, V148, P1661, DOI 10.1084/jem.148.6.1661; HAMANN A, 1994, J IMMUNOL, V152, P3282; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Kantele A, 1999, J IMMUNOL, V162, P5173; Kelsall BL, 2002, NAT IMMUNOL, V3, P699, DOI 10.1038/ni0802-699; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Manjunath N, 1999, P NATL ACAD SCI USA, V96, P13932, DOI 10.1073/pnas.96.24.13932; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Maurice MM, 2001, P NATL ACAD SCI USA, V98, P7437, DOI 10.1073/pnas.141143298; NAKACHE M, 1989, NATURE, V337, P179, DOI 10.1038/337179a0; Schott E, 2002, EUR J IMMUNOL, V32, P3425, DOI 10.1002/1521-4141(2002012)32:12<3425::AID-IMMU3425>3.0.CO;2-Q; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Svensson M, 2002, J CLIN INVEST, V110, P1113, DOI 10.1172/JCI200215988; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Weninger W, 2002, IMMUNOL REV, V186, P221, DOI 10.1034/j.1600-065X.2002.18618.x; Xie HJ, 1999, J EXP MED, V189, P1765, DOI 10.1084/jem.189.11.1765; Zaballos A, 1999, J IMMUNOL, V162, P5671; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241	30	839	870	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2003	424	6944					88	93		10.1038/nature01726	http://dx.doi.org/10.1038/nature01726			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840763				2022-12-24	WOS:000183912800046
J	Pham, P; Bransteitter, R; Petruska, J; Goodman, MF				Pham, P; Bransteitter, R; Petruska, J; Goodman, MF			Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation	NATURE			English	Article							IMMUNOGLOBULIN GENES; POLYMERASE-ETA; RECOMBINATION; MECHANISMS; MUTATIONS; FIDELITY; SEQUENCE; REGION; REPAIR	Activation-induced cytidine deaminase (AID) is a protein required for B cells to undergo class switch recombination and somatic hypermutation (SHM)-two processes essential for producing high-affinity antibodies(1). Purified AID catalyses the deamination of C to U on single-stranded (ss) DNA(2-4). Here, we show in vitro that AID-catalysed C deaminations occur preferentially on 5' WRC sequences in accord with SHM spectra observed in vivo. Although about 98% of DNA clones suffer no mutations, most of the remaining mutated clones have 10-70 C to T transitions per clone. Therefore, AID carries out multiple C deaminations on individual DNA strands, rather than jumping from one strand to another. The avid binding of AID to ssDNA could result from its large net positive charge (+11) at pH 7.0, owing to a basic amino-terminal domain enriched in arginine and lysine. Furthermore, AID exhibits a 15-fold preference for C deamination on the non-transcribed DNA strand exposed by RNA polymerase than the transcribed strand protected as a RNA-DNA hybrid. These deamination results on ssDNA bear relevance to three characteristic features of SHM: preferential mutation at C sites within WRC hotspot sequences, the broad clonal mutagenic heterogeneity of antibody variable regions targeted for mutation(5,6), and the requirement for active transcription to obtain mutagenesis(7),(8).	Univ So Calif, Dept Biol Sci, Hedco Mol Biol Labs, Los Angeles, CA 90089 USA; Univ So Calif, Dept Chem, Hedco Mol Biol Labs, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Hedco Mol Biol Labs, Univ Pk, Los Angeles, CA 90089 USA.	mgoodman@usc.edu						Bebenek K, 1995, METHOD ENZYMOL, V262, P217; BEREK C, 1988, IMMUNOL REV, V105, P5, DOI 10.1111/j.1600-065X.1988.tb00763.x; BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Dorner T, 1998, IMMUNOL REV, V162, P161, DOI 10.1111/j.1600-065X.1998.tb01439.x; GEARHART PJ, 1983, P NATL ACAD SCI-BIOL, V80, P3439, DOI 10.1073/pnas.80.11.3439; Gerber AP, 2001, TRENDS BIOCHEM SCI, V26, P376, DOI 10.1016/S0968-0004(01)01827-8; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Kinoshita K, 2000, CURR OPIN IMMUNOL, V12, P195, DOI 10.1016/S0952-7915(99)00072-2; Kunkel TA, 2003, DNA REPAIR, V2, P135, DOI 10.1016/S1568-7864(02)00224-0; Liu YJ, 1996, IMMUNITY, V4, P603, DOI 10.1016/S1074-7613(00)80486-0; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858; Michael N, 2002, IMMUNITY, V16, P123, DOI 10.1016/S1074-7613(02)00261-3; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Shapiro GS, 2002, J IMMUNOL, V168, P2302, DOI 10.4049/jimmunol.168.5.2302	27	508	525	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2003	424	6944					103	107		10.1038/nature01760	http://dx.doi.org/10.1038/nature01760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12819663				2022-12-24	WOS:000183912800049
J	Sharp, D				Sharp, D			Anyone for GM decaff?	LANCET			English	Editorial Material							COFFEE; CAFFEINE		The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Ashihara H, 2001, TRENDS PLANT SCI, V6, P407, DOI 10.1016/S1360-1385(01)02055-6; GROBBEE DE, 1990, NEW ENGL J MED, V323, P1026, DOI 10.1056/NEJM199010113231504; Michaud DS, 2001, CANCER EPIDEM BIOMAR, V10, P429; Ogita S, 2003, NATURE, V423, P823, DOI 10.1038/423823a; Shlonsky AK, 2003, ANN EPIDEMIOL, V13, P273, DOI 10.1016/S1047-2797(02)00414-3	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2003	361	9376					2172	2172		10.1016/S0140-6736(03)13786-5	http://dx.doi.org/10.1016/S0140-6736(03)13786-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	695DJ	12842367				2022-12-24	WOS:000183815600006
J	Ghattas, H; Fulford, T; Prentice, A				Ghattas, H; Fulford, T; Prentice, A			Effect of moderate anaemia on later mortality in rural African children	LANCET			English	Article							ANEMIA	Severe anaemia in childhood is associated with increased mortality, although evidence relating moderate anaemia to child survival is scarce. We aimed to investigate this association. We did a case-control study of children with moderate anaemia, and compared haemoglobin concentrations measured up to a year before death for 403 children (age range 28 days to 15 years) with those from children who survived (matched for age and sex). Data were obtained from long-term health records (1950-97) of a rural Gambian research centre. Excluding an acute effect In this last week of life, no evidence was recorded of lower haemoglobin concentrations in the children who died than in survivors, or of any general or disease-specific effects of non-severe anaemia (70-110 g/L) on mortality.	St George Hosp, Sch Med, Dept Infect Dis, London SW17 0RE, England; MRC Labs, Banjul, Gambia; London Sch Hyg & Trop Med, MRC, Int Nutr Grp, Publ Hlth Nutr Unit, London WC1B 3DP, England	St Georges University London; MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine	Ghattas, H (corresponding author), St George Hosp, Sch Med, Dept Infect Dis, Cranmer Terrace, London SW17 0RE, England.		Prentice, Andrew/AAG-1961-2019; Ghattas, Hala/K-5661-2016					BATES CJ, 1994, EUR J CLIN NUTR, V48, P660; Brabin BJ, 2001, J NUTR, V131, p636S, DOI 10.1093/jn/131.2.636S; Gonzalez MA, 2000, B WORLD HEALTH ORGAN, V78, P97; SMITH AW, 1989, ANN TROP PAEDIATR, V2, P6; Stoltzfus RJ, 2001, J NUTR, V131, p697S, DOI 10.1093/jn/131.2.697S	5	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 14	2003	361	9374					2048	2050		10.1016/S0140-6736(03)13617-3	http://dx.doi.org/10.1016/S0140-6736(03)13617-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814719				2022-12-24	WOS:000183488900015
J	Salmeen, A; Andersen, JN; Myers, MP; Meng, TC; Hinks, JA; Tonks, NK; Barford, D				Salmeen, A; Andersen, JN; Myers, MP; Meng, TC; Hinks, JA; Tonks, NK; Barford, D			Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate	NATURE			English	Article							HYDROGEN-PEROXIDE; REVERSIBLE INACTIVATION; INSULIN SENSITIVITY; GENERATION; MECHANISM; KINASES	The second messenger hydrogen peroxide is required for optimal activation of numerous signal transduction pathways, particularly those mediated by protein tyrosine kinases(1-6). One mechanism by which hydrogen peroxide regulates cellular processes is the transient inhibition of protein tyrosine phosphatases through the reversible oxidization of their catalytic cysteine, which suppresses protein dephosphorylation(7-9). Here we describe a structural analysis of the redox-dependent regulation of protein tyrosine phosphatase 1B (PTP1B), which is reversibly inhibited by oxidation after cells are stimulated with insulin(8) and epidermal growth factor(9). The sulphenic acid intermediate produced in response to PTP1B oxidation is rapidly converted into a previously unknown sulphenyl-amide species, in which the sulphur atom of the catalytic cysteine is covalently linked to the main chain nitrogen of an adjacent residue. Oxidation of PTP1B to the sulphenyl-amide form is accompanied by large conformational changes in the catalytic site that inhibit substrate binding. We propose that this unusual protein modification both protects the active-site cysteine residue of PTP1B from irreversible oxidation to sulphonic acid and permits redox regulation of the enzyme by promoting its reversible reduction by thiols.	Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cold Spring Harbor Laboratory	Barford, D (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	david.barford@icr.ac.uk	Meng, Tzu-Ching/G-5426-2019	Meng, Tzu-Ching/0000-0001-7693-2021; Andersen, Jannik/0000-0003-4528-2120	NATIONAL CANCER INSTITUTE [R37CA053840] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Blanchetot C, 2002, EMBO J, V21, P493, DOI 10.1093/emboj/21.4.493; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Knebel A, 1996, EMBO J, V15, P5314, DOI 10.1002/j.1460-2075.1996.tb00916.x; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Rao GN, 1996, ONCOGENE, V13, P713; Rhee S. G., 2000, SCI STKE, V53; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Xu D, 2002, DEV CELL, V2, P251, DOI 10.1016/S1534-5807(02)00132-6	26	725	752	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2003	423	6941					769	773		10.1038/nature01680	http://dx.doi.org/10.1038/nature01680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802338				2022-12-24	WOS:000183443400047
J	Moens, V; Baruch, G; Fearon, P				Moens, V; Baruch, G; Fearon, P			Opportunistic screening for Chlamydia at a community based contraceptive service for young people	BRITISH MEDICAL JOURNAL			English	Article								Problem The suspected high prevalence of Chlamydia infection that is undiagnosed and untreated among high risk women who attend a contraceptive service for young people. Design Cross sectional study from a community screening service. Background and setting An inner city contraceptive and psychotherapy service for young people aged 12-21 years. Key measure for improvement Prevalence of infection commensurate with or above findings from the national screening pilot (13.8% for > 16 year olds, 10.5% for 16-19 year olds, and 7.2% for 20 to 24 year olds). Strategies for change Offering testing (of a first catch urine sample) for Chlamydia to all young people using the contraceptive service who were not previously screened; launching a publicity campaign about the new service; training medical staff and reception staff to deliver the service to maximise take up of screening and of treatment by infected cases; and surveying results from testing to monitor significant patterns of infection requiring further action. Effects of change Percentage of clients with infection exceeded targets for each age group, 76% with a positive or equivocal result returned for treatment, 87% of those treated returned for a test of cure, and 99% of tests of cure were negative. Prevention work was initiated in a school with a particularly heavy concentration of infected clients. Lessons learnt A contraceptive service for young women is a highly acceptable location for effective Chlamydia screening.	Brandon Ctr Counselling & Psychotherapy Young Peo, London NW5 3LG, England; UCL, Subdept Clin Hlth Psychol, London WC1E 6BT, England	University of London; University College London	Baruch, G (corresponding author), Brandon Ctr Counselling & Psychotherapy Young Peo, London NW5 3LG, England.	G.Baruch@compuserve.com						BARUCH G., 2001, COMMUNITY BASED PSYC; *CAMD ISL HLTH AUT, 2001, PUBL HLTH REP HLTH I; *DEP HLTH, 2002, PIL STUD OPP SCREEN; Department of Health, 2001, NAT STRAT SEX HLTH H; DiClemente RJ, 2001, LANCET, V358, P1828, DOI 10.1016/S0140-6736(01)06878-7; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6	6	15	15	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 7	2003	326	7401					1252	1255		10.1136/bmj.326.7401.1252	http://dx.doi.org/10.1136/bmj.326.7401.1252			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689FJ	12791743	Green Published			2022-12-24	WOS:000183480700020
J	Petit, RJ; Aguinagalde, I; de Beaulieu, JL; Bittkau, C; Brewer, S; Cheddadi, R; Ennos, R; Fineschi, S; Grivet, D; Lascoux, M; Mohanty, A; Muller-Starck, GM; Demesure-Musch, B; Palme, A; Martin, JP; Rendell, S; Vendramin, GG				Petit, RJ; Aguinagalde, I; de Beaulieu, JL; Bittkau, C; Brewer, S; Cheddadi, R; Ennos, R; Fineschi, S; Grivet, D; Lascoux, M; Mohanty, A; Muller-Starck, GM; Demesure-Musch, B; Palme, A; Martin, JP; Rendell, S; Vendramin, GG			Glacial refugia: Hotspots but not melting pots of genetic diversity	SCIENCE			English	Article							POSTGLACIAL COLONIZATION ROUTES; SOUTHEASTERN EUROPE; CHLOROPLAST DNA; ICE AGES; DIFFERENTIATION; PHYLOGEOGRAPHY; CONSEQUENCES; POPULATIONS; FORESTS; PLANTS	Glacial refuge areas are expected to harbor a large fraction of the intraspecific biodiversity of the temperate biota. To test this hypothesis, we studied chloroplast DNA variation in 22 widespread European trees and shrubs sampled in the same forests. Most species had genetically divergent populations in Mediterranean regions, especially those with low seed dispersal abilities. However, the genetically most diverse populations were not located in the south but at intermediate latitudes, a likely consequence of the admixture of divergent lineages colonizing the continent from separate refugia.	INRA, UMR Biodivers Genes & Ecosyst, F-33612 Cestas, France; Univ Politecn Madrid, Escuela Tecn Super Ingn Agron, E-28040 Madrid, Spain; Fac Sci & Tech St Jerome, Inst Mediterraneen Ecol & Paleoecol, F-13397 Marseille, France; Tech Univ Munich, Fachgebiet Forstgenet, D-85354 Freising Weihenstephan, Germany; Univ Edinburgh, Inst Ecol & Resource Management, Edinburgh EH9 3JU, Midlothian, Scotland; CNR, Ist Biol Agroambientale & Forestale, I-05010 Porano, TR, Italy; Uppsala Univ, Dept Conservat Biol & Genet, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; Off Natl Forets, Dept Rech Tech Conservatoire Genet Arbres Foresti, F-45160 Ardon, France; CNR, Ist Genet Vegetale, Sez Firenze, I-50134 Florence, Italy	INRAE; Universidad Politecnica de Madrid; UDICE-French Research Universities; Aix-Marseille Universite; Technical University of Munich; University of Edinburgh; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Agroambientale e Forestale (IBAF-CNR); Uppsala University; Consiglio Nazionale delle Ricerche (CNR)	Petit, RJ (corresponding author), INRA, UMR Biodivers Genes & Ecosyst, F-33612 Cestas, France.	petit@pierroton.inra.fr	Petit, Remy/AAD-9078-2019; Grivet, Delphine/G-9708-2012; Vendramin, Giovanni G/K-9731-2014; Clemente, Juan Pedro Martín/F-3218-2016; Petit, Rémy/A-8842-2008; Fineschi, Silvia/ABF-9775-2020	Grivet, Delphine/0000-0001-8168-4456; Vendramin, Giovanni G/0000-0001-9921-7872; Clemente, Juan Pedro Martín/0000-0002-8180-5489; Petit, Rémy/0000-0002-4809-1453; FINESCHI, SILVIA/0000-0002-3583-6073; Lascoux, Martin/0000-0003-1699-9042; Brewer, Simon/0000-0002-6810-1911				Austerlitz F, 2000, GENETICS, V154, P1309; Bennett, 1997, EVOLUTION ECOLOGY PA; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Carcaillet C, 2001, QUATERNARY RES, V55, P385, DOI 10.1006/qres.2001.2226; Comps B, 2001, GENETICS, V157, P389; CWYNAR LC, 1987, AM NAT, V129, P463, DOI 10.1086/284651; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Grivet D, 2003, CONSERV GENET, V4, P47, DOI 10.1023/A:1021804009832; Grivet D, 2002, MOL ECOL, V11, P1351, DOI 10.1046/j.1365-294X.2002.01522.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Palme AE, 2003, MOL ECOL, V12, P201, DOI 10.1046/j.1365-294X.2003.01724.x; PALME AE, IN PRESS HEREDITY; PETIT RJ, 1993, HEREDITY, V71, P630, DOI 10.1038/hdy.1993.188; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Petit RJ, 2001, INTEGRATING ECOLOGY, P295; Pons O, 1996, GENETICS, V144, P1237; Rendell S, 2002, MOL ECOL, V11, P69, DOI 10.1046/j.0962-1083.2001.01413.x; Sanchezgoni MF, 2002, CLIM DYNAM, V19, P95, DOI 10.1007/s00382-001-0212-x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Willis KJ, 2000, QUATERNARY RES, V53, P203, DOI 10.1006/qres.1999.2119	25	1351	1407	5	305	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2003	300	5625					1563	1565		10.1126/science.1083264	http://dx.doi.org/10.1126/science.1083264			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791991				2022-12-24	WOS:000183333100053
J	Gandhi, SP; Stevens, CF				Gandhi, SP; Stevens, CF			Three modes of synaptic vesicular recycling revealed by single-vesicle imaging	NATURE			English	Article							RETINAL BIPOLAR CELLS; HIPPOCAMPAL SYNAPSES; NERVE-TERMINALS; MEMBRANE RETRIEVAL; CHROMAFFIN CELLS; ENDOCYTOSIS; EXOCYTOSIS; CALCIUM; FUSION; PH	Synapses recycle their spent vesicles in order to keep up with on-going neurotransmitter release. To investigate vesicle recycling in the small synapses of hippocampal neurons, we have used an optical recording method that permits us to resolve single-vesicle events. Here we show that an exocytic event can terminate with three modes of vesicle retrieval: a fast (400-860 ms) 'kiss-and-run' mode that has a selective fusion pore; a slow (8-21 s) 'compensatory' mode; and a 'stranded' mode of recycling, in which a vesicle is left on the cell surface until a nerve impulse triggers its retrieval. We have also observed that, in response to a nerve impulse, synapses with low release probability primarily use the kiss-and-run mode, whereas high release probability terminals predominantly use the compensatory mode of vesicle retrieval.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Neurosci Program, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; University of California System; University of California San Diego	Stevens, CF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.							Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Cousin MA, 2000, J NEUROCHEM, V75, P1645, DOI 10.1046/j.1471-4159.2000.0751645.x; Engisch KL, 1998, J PHYSIOL-LONDON, V506, P591, DOI 10.1111/j.1469-7793.1998.591bv.x; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P2509, DOI 10.1152/jn.00267.2002; Heidelberger R, 2001, J NEUROSCI, V21, P6467, DOI 10.1523/JNEUROSCI.21-17-06467.2001; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; Huang EP, 1997, J NEUROPHYSIOL, V78, P2870, DOI 10.1152/jn.1997.78.6.2870; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	37	346	356	3	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					607	613		10.1038/nature01677	http://dx.doi.org/10.1038/nature01677			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789331				2022-12-24	WOS:000183301200032
J	Zhao, YD; Dai, XH; Blackwell, HE; Schreiber, SL; Chory, J				Zhao, YD; Dai, XH; Blackwell, HE; Schreiber, SL; Chory, J			SIR1, an upstream component in auxin signaling identified by chemical genetics	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; AUX/IAA PROTEINS; RAPID INDUCTION; TRANSPORT; ROOT; GRAVITROPISM; DEGRADATION; REGULATOR; MECHANISM; MUTATION	Auxin is a plant hormone that regulates many aspects of plant growth and development. We used a chemical genetics approach to identify SIR1, a regulator of many auxin-inducible genes. The sir1 mutant was resistant to sirtinol, a small molecule that activates many auxin-inducible genes and promotes auxin-related developmental phenotypes. SIR1 is predicted to encode a protein composed of a ubiquitin-activating enzyme E1-like domain and a Rhodanese-like domain homologous to that of prolyl isomerase. We suggest a molecular context for how the auxin signal is propagated to exert its biological effects.	Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Harvard Univ, Howard Hughes Med Inst, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; HHMI, Plant Biol Lab, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Harvard University; Howard Hughes Medical Institute; Salk Institute; Howard Hughes Medical Institute	Zhao, YD (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.				NIGMS NIH HHS [1R01GM68631-01, 2R01GM52413] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068631, R01GM052413] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Friml J, 2002, PLANT MOL BIOL, V49, P273, DOI 10.1023/A:1015248926412; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; HAGEN G, 1985, MOL CELL BIOL, V5, P1197, DOI 10.1128/MCB.5.6.1197; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; HOBBIE L, 1994, PLANT CELL ENVIRON, V17, P525, DOI 10.1111/j.1365-3040.1994.tb00147.x; King JJ, 1995, PLANT CELL, V7, P2023, DOI 10.1105/tpc.7.12.2023; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Nieder Joerg, 1997, P275; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Schroeder DF, 2002, CURR BIOL, V12, P1462, DOI 10.1016/S0960-9822(02)01106-5; THEOLOGIS A, 1985, J MOL BIOL, V183, P53, DOI 10.1016/0022-2836(85)90280-3; TIMPTE C, 1994, GENETICS, V138, P1239; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306	27	134	140	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2003	301	5636					1107	1110		10.1126/science.1084161	http://dx.doi.org/10.1126/science.1084161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713RP	12893885				2022-12-24	WOS:000184872400044
J	Hamuy, M; Phillips, MM; Suntzeff, NB; Maza, J; Gonzalez, LE; Roth, M; Krisciunas, K; Morrell, N; Green, EM; Persson, SE; McCarthy, PJ				Hamuy, M; Phillips, MM; Suntzeff, NB; Maza, J; Gonzalez, LE; Roth, M; Krisciunas, K; Morrell, N; Green, EM; Persson, SE; McCarthy, PJ			An asymptotic-giant-branch star in the progenitor system of a type Ia supernova	NATURE			English	Article							DENSE WINDS; 1999EE; 1988Z	Stars that explode as supernovae come in two main classes. A type Ia supernova is recognized by the absence of hydrogen and the presence of elements such as silicon and sulphur in its spectrum; this class of supernova is thought to produce the majority of iron-peak elements in the Universe. They are also used as precise 'standard candles' to measure the distances to galaxies. While there is general agreement that a type Ia supernova is produced by an exploding white dwarf star(1), no progenitor system has ever been directly observed. Significant effort has gone into searching for circumstellar material to help discriminate between the possible kinds of progenitor systems(2), but no such material has hitherto been found associated with a type Ia supernova(3). Here we report the presence of strong hydrogen emission associated with the type Ia supernova SN2002ic, indicating the presence of large amounts of circumstellar material. We infer from this that the progenitor system contained a massive asymptotic-giant-branch star that lost several solar masses of hydrogen-rich gas before the supernova explosion.	Carnegie Inst Washington Observ, Pasadena, CA 91101 USA; Carnegie Observ, Las Campanas Observ, La Serena, Chile; Cerro Tololo Interamer Observ, Natl Opt Astron Observ, La Serena, Chile; Univ Chile, Dept Astron, Santiago, Chile; Univ Arizona, Steward Observ, Tucson, AZ 85721 USA	Carnegie Institution for Science; Carnegie Institution for Science; National Optical Astronomy Observatory; Universidad de Chile; University of Arizona	Hamuy, M (corresponding author), Carnegie Inst Washington Observ, 813 Santa Barbara St, Pasadena, CA 91101 USA.		Hamuy, Mario/G-7541-2016; Maza, José/I-5722-2016	Maza, José/0000-0003-2068-1328; Suntzeff, Nicholas/0000-0002-8102-181X; Phillips, Mark/0000-0003-2734-0796				Aretxaga I, 1999, MON NOT R ASTRON SOC, V309, P343, DOI 10.1046/j.1365-8711.1999.02830.x; Arnett D., 1996, SUPERNOVAE NUCLEOSYN; Chugai NN, 1997, ASTRON REP+, V41, P672; Chugai NN, 1997, ASTROPHYS SPACE SCI, V252, P225, DOI 10.1023/A:1000847125928; Cumming RJ, 1996, MON NOT R ASTRON SOC, V283, P1355, DOI 10.1093/mnras/283.4.1355; Germany LM, 2000, ASTROPHYS J, V533, P320, DOI 10.1086/308639; HAMUY M, 1993, PUBL ASTRON SOC PAC, V105, P787, DOI 10.1086/133231; Hamuy M, 2002, ASTRON J, V124, P417, DOI 10.1086/340968; Hamuy M, 1996, ASTRON J, V112, P2438, DOI 10.1086/118193; Hamuy M., 2003, PREPRINT; HAMUY M, IN PRESS CORE COLLAP; Henry RBC, 1999, PUBL ASTRON SOC PAC, V111, P919, DOI 10.1086/316403; IBEN I, 1983, ANNU REV ASTRON ASTR, V21, P271, DOI 10.1146/annurev.aa.21.090183.001415; Lentz EJ, 2002, ASTROPHYS J, V580, P374, DOI 10.1086/343073; Li WD, 2001, ASTROPHYS J, V546, P734, DOI 10.1086/318299; Livio M, 2001, SPACE TEL S, V13, P334; Phillips MM, 1999, ASTRON J, V118, P1766, DOI 10.1086/301032; PHILLIPS MM, 1992, ASTRON J, V103, P1632, DOI 10.1086/116177; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; SCHLEGEL EM, 1990, MON NOT R ASTRON SOC, V244, P269; Stritzinger M, 2002, ASTRON J, V124, P2100, DOI 10.1086/342544; Strolger LG, 2002, ASTRON J, V124, P2905, DOI 10.1086/343058; SUNTZEFF NB, 1996, IAU COLLOQ, V145, P41; Turatto M, 2000, ASTROPHYS J, V534, pL57, DOI 10.1086/312653; TURATTO M, 1993, MON NOT R ASTRON SOC, V262, P128, DOI 10.1093/mnras/262.1.128; Weidemann V, 2000, ASTRON ASTROPHYS, V363, P647; WOODVASEY WM, 2002, 8019 IAU	27	318	321	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					651	654		10.1038/nature01854	http://dx.doi.org/10.1038/nature01854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904786	Green Submitted			2022-12-24	WOS:000184578800038
J	Bilukha, OO; Brennan, M; Woodruff, BA				Bilukha, OO; Brennan, M; Woodruff, BA			Death and injury from landmines and unexploded ordnance in Afghanistan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LAND MINES; MOZAMBIQUE	Context Afghanistan is one of the countries most affected by injuries due to landmines and unexploded ordnance. Objective To understand the epidemiological patterns and risk factors for injury due to landmines and unexploded ordnance. Design and Setting Analysis of surveillance data on landmine and unexploded ordnance injuries in Afghanistan collected by the International Committee of the Red Cross in 390 health facilities in Afghanistan. Surveillance data were used to describe injury trends, injury types, demographics, and risk behaviors of those injured and explosive types related to landmine and unexploded ordnance incidents. Participants A total of 1636 individuals injured by landmines and unexploded ordnance, March 2001 through June 2002. Results Eighty-one percent of those injured were civilians, 91.6% were men and boys, and 45.9% were younger than 16 years. Children were more likely to be injured by unexploded ordnance (which includes grenades, bombs, mortar shells, and cluster munitions), whereas adults were injured mostly by landmines. The most common risk behaviors for children were playing and tending animals; for adults, these risk behaviors were military activity and activities of economic necessity (eg, farming, traveling). The case-fatality rate of 9.4% is probably underestimated because surveillance predominantly detects those who survive long enough to receive medical care. Conclusions Landmine risk education should focus on hazards due to unexploded ordnance for children and on landmine hazards for adults and should address age-specific risk behaviors. Expanding community-based and clinic-based reporting will improve the sensitivity and representativeness of surveillance.	CDCP, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Serv, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA; CDP, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Bilukha, OO (corresponding author), CDCP, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Serv, Natl Ctr Environm Hlth, 4770 Buford Hwy,Mailstop F-48, Atlanta, GA 30341 USA.		Bilukha, Oleg/ABC-5095-2020					ANDERSSON N, 1995, BRIT MED J, V311, P718, DOI 10.1136/bmj.311.7007.718; ASCHERIO A, 1995, LANCET, V346, P721, DOI 10.1016/S0140-6736(95)91501-X; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P724; Coupland RM, 1999, BRIT MED J, V319, P410, DOI 10.1136/bmj.319.7207.410; Gall C, 2002, NY TIMES, pA15; Giannou C, 1997, BRIT MED J, V315, P1453, DOI 10.1136/bmj.315.7120.1453; Hanevik K, 2000, BRIT MED J, V321, P1189, DOI 10.1136/bmj.321.7270.1189; *INT CAMP BAN LAND, 2002, LANDM MON REP 2002; *INT COMM RED CROS, 2002, SEM ANN REP JAN JUN; Jeffrey SJ, 1996, J ACCID EMERG MED, V13, P343; Kakar F, 1996, Prehosp Disaster Med, V11, P2; *OFF HUM DEM PROGR, 1998, HIDD KILL GLOB LANDM; *TRANS ISL GOV AFG, 2002, AFGH NAT HLTH RES AS	13	49	50	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2003	290	5					650	653		10.1001/jama.290.5.650	http://dx.doi.org/10.1001/jama.290.5.650			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708GH	12902369				2022-12-24	WOS:000184558500020
J	Vasudevan, AR; Kabinoff, GS; Keltz, TN; Gitler, B				Vasudevan, AR; Kabinoff, GS; Keltz, TN; Gitler, B			Blunt chest trauma producing acute myocardial infarction in a rugby player	LANCET			English	Editorial Material							DISSECTION; INJURY		New York Med Coll, Sound Shore Med Ctr Westchester, Dept Cardiol, Westchester, NY 10802 USA; New York Med Coll, Sound Shore Med Ctr Westchester, Dept Med, Westchester, NY 10802 USA	New York Medical College; New York Medical College	Gitler, B (corresponding author), New York Med Coll, Sound Shore Med Ctr Westchester, Dept Cardiol, Westchester, NY 10802 USA.							FOUSSAS SG, 1989, ANGIOLOGY, V40, P313, DOI 10.1177/000331978904000412; Fu M, 1999, J FORMOS MED ASSOC, V98, P136; Ginzburg E, 1998, J TRAUMA, V45, P157, DOI 10.1097/00005373-199807000-00034; MARIK PE, 1990, S AFR MED J, V77, P586; SUTHERLAND GR, 1983, AM J CARDIOL, V52, P1099, DOI 10.1016/0002-9149(83)90540-4	5	26	30	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					370	370		10.1016/S0140-6736(03)14024-X	http://dx.doi.org/10.1016/S0140-6736(03)14024-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907010				2022-12-24	WOS:000184498700010
J	Matsumoto, A; Comatas, KE; Liu, LM; Stamler, JS				Matsumoto, A; Comatas, KE; Liu, LM; Stamler, JS			Screening for nitric oxide-dependent protein-protein interactions	SCIENCE			English	Article								Because nitric oxide (NO) may be a ubiquitous regulator of cellular signaling, we have modified the yeast two-hybrid system to explore the possibility of NO-dependent protein-protein interactions. We screened for binding partners of procaspase-3, a protein implicated in apoptotic signaling pathways, and identified multiple NO-dependent interactions. Two such interactions, with acid sphingomyelinase and NO synthase, were shown to occur in mammalian cells dependent on endogenous NO. Nitrosylation may thus provide a broad-based mechanism for regulating interactions between proteins. If so, systematic proteomic analyses in which redox state and NO bioavailability are carefully controlled will reveal a large array of novel interactions.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Stamler, JS (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.			Matsumoto, Akio/0000-0002-3402-6992; Stamler, Jonathan/0000-0002-6866-1572				BREDT DS, 1992, J BIOL CHEM, V267, P10976; Bulotta S, 2001, J BIOL CHEM, V276, P6529, DOI 10.1074/jbc.M006535200; De Nadai C, 2000, P NATL ACAD SCI USA, V97, P5480, DOI 10.1073/pnas.070062397; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Haneline LS, 1998, BLOOD, V91, P4092; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; HURWITZ R, 1994, J BIOL CHEM, V269, P5440; Huwiler A, 1999, J BIOL CHEM, V274, P7190, DOI 10.1074/jbc.274.11.7190; Igarashi J, 1999, P NATL ACAD SCI USA, V96, P12583, DOI 10.1073/pnas.96.22.12583; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kumar A, 2002, NATURE, V415, P123, DOI 10.1038/415123a; Lipton SA, 2002, CELL, V111, P147, DOI 10.1016/S0092-8674(02)01046-2; Liu LM, 2000, P NATL ACAD SCI USA, V97, P4672, DOI 10.1073/pnas.090083597; Liu LM, 1999, CELL DEATH DIFFER, V6, P937, DOI 10.1038/sj.cdd.4400578; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; MANNICK JB, 1994, CELL, V79, P1137, DOI 10.1016/0092-8674(94)90005-1; Matsumoto A., UNPUB; Nedvetsky PI, 2002, P NATL ACAD SCI USA, V99, P16510, DOI 10.1073/pnas.262701999; Schwandner R, 1998, J BIOL CHEM, V273, P5916, DOI 10.1074/jbc.273.10.5916; SESSA WC, 1995, J BIOL CHEM, V270, P17641, DOI 10.1074/jbc.270.30.17641; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Takeda Y, 1999, J BIOL CHEM, V274, P10654, DOI 10.1074/jbc.274.15.10654; Zech B, 1999, J BIOL CHEM, V274, P20931, DOI 10.1074/jbc.274.30.20931	28	115	118	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					657	661		10.1126/science.1079319	http://dx.doi.org/10.1126/science.1079319			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893946				2022-12-24	WOS:000184473600043
J	Kasthuri, N; Lichtman, JW				Kasthuri, N; Lichtman, JW			The role of neuronal identity in synaptic competition	NATURE			English	Article							SKELETAL-MUSCLE; ELIMINATION; REORGANIZATION; INNERVATION	In developing mammalian muscle, axon branches of several motor neurons co-innervate the same muscle fibre. Competition among them results in the strengthening of one and the withdrawal of the rest(1,2). It is not known why one particular axon branch survives or why some competitions resolve sooner than others(3). Here we show that the fate of axonal branches is strictly related to the identity of the axons with which they compete. When two neurons co-innervate multiple target cells, the losing axon branches in each contest belong to the same neuron and are at nearly the same stage of withdrawal. The axonal arbor of one neuron engages in multiple sets of competitions simultaneously. Each set proceeds at a different rate and heads towards a common outcome based on the identity of the competitor. Competitive vigour at each of these sets of local competitions depends on a globally distributed resource: neurons with larger arborizations are at a competitive disadvantage when confronting neurons with smaller arborizations. An accompanying paper tests the idea that the amount of neurotransmitter released is this global resource(4).	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Lichtman, JW (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	jeff@pcg.wustl.edu						BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; Barber MJ, 1999, J NEUROSCI, V19, P9975; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; Buffelli M, 2002, P NATL ACAD SCI USA, V99, P13200, DOI 10.1073/pnas.202471199; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; JANSEN JKS, 1990, PROG NEUROBIOL, V34, P39, DOI 10.1016/0301-0082(90)90025-C; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; LICHTMAN JW, 1977, J PHYSIOL-LONDON, V273, P155, DOI 10.1113/jphysiol.1977.sp012087; Personius KE, 2000, BRAIN RES BULL, V53, P513, DOI 10.1016/S0361-9230(00)00384-1; Personius KE, 2001, NEURON, V31, P395, DOI 10.1016/S0896-6273(01)00369-5; Press WH., 1992, NUMERICAL RECIPES C; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Wong ROL, 2003, FUNDAMENTAL NEUROSCI, P533	18	98	101	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					426	430		10.1038/nature01836	http://dx.doi.org/10.1038/nature01836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879070				2022-12-24	WOS:000184318400043
J	Lee, K; Jessop, H; Suswillo, R; Zaman, G; Lanyon, L				Lee, K; Jessop, H; Suswillo, R; Zaman, G; Lanyon, L			Endocrinology - Bone adaptation requires oestrogen receptor-alpha	NATURE			English	Article									Univ London Royal Vet Coll, Dept Vet Basic Sci, London NW1 0TU, England	University of London; University of London Royal Veterinary College	Lee, K (corresponding author), Univ London Royal Vet Coll, Dept Vet Basic Sci, 32 Belgrave Sq, London NW1 0TU, England.	llanyon@rvc.ac.uk						Ankrom MA, 1998, BIOCHEM J, V333, P787, DOI 10.1042/bj3330787; Hoyland JA, 1999, J PATHOL, V188, P294; Lee KCL, 2002, BONE, V31, P407, DOI 10.1016/S8756-3282(02)00842-6; Lim SK, 1999, J BONE MINER RES, V14, P1189, DOI 10.1359/jbmr.1999.14.7.1189; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Sutherland MK, 1996, BONE, V18, P361, DOI 10.1016/8756-3282(96)00016-6; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; Zaman G, 2000, BONE, V27, P233, DOI 10.1016/S8756-3282(00)00324-0	9	242	264	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					389	389		10.1038/424389a	http://dx.doi.org/10.1038/424389a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879058	Green Submitted, Bronze			2022-12-24	WOS:000184318400031
J	Pullman, D; Latus, A				Pullman, D; Latus, A			Clinical trials, genetic add-ons, and the question of benefit-sharing	LANCET			English	Editorial Material							ETHICS	Discussion of benefit-sharing has become common in the sphere of human genetic research. Roughly, this term means that individuals or organisations who could reap financial rewards from research into human genetics have some obligation to share the benefits of this research, perhaps with the people who made the research possible in the first place, or with humankind more broadly. This idea has met with some acceptance, finding its way into policy recommendations and statements of several prominent groups. However, the issue of benefit-sharing is generally raised in the context of large-scale population-based genetic studies. Other sources of human DNA are often ignored. In particular, little attention has been paid to the increasingly common practice of collecting genetic samples as addons to clinical drug trials. Generally such trials do not specify a use for these samples, which are collected for purposes of potential future research. We argue that if a case for benefit-sharing can be made for genetic studies in general, it can be made for add-on studies as well. We suggest some ways in which benefit-sharing might be implemented for genetic add-on studies.	Mem Univ Newfoundland, Fac Med, St Johns, NF A1B 3V6, Canada; Mem Univ Newfoundland, Dept Philosophy, St Johns, NF A1B 3V6, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Pullman, D (corresponding author), Mem Univ Newfoundland, Fac Med, St Johns, NF A1B 3V6, Canada.							Berg K, 2001, CLIN GENET, V59, P240, DOI 10.1034/j.1399-0004.2001.590404.x; El Setouhy M, 2002, SCIENCE, V298, P2133; FELDBAUM CB, 2003, BIO 2002 C TOR ONT J; Frank L, 1999, SCIENCE, V286, P1262, DOI 10.1126/science.286.5443.1262; Greely HT, 2001, PERSPECT BIOL MED, V44, P221, DOI 10.1353/pbm.2001.0026; *HUM GEN ORG ETH C, 2003, STAT BEN SHAR; LITMAN MM, 1997, HUMAN DNA LAW POLICY, P17; Merz JF, 2002, AM J HUM GENET, V70, P965, DOI 10.1086/339767; Rose H., 2003, COMMODIFICATION BIOI; *STANF WASH PROGR, 2003, WORLD SURV FUND GEN; *WHO, 2003, GEN WORLD HLTH REP A; *WHO HUM GEN PROGR, 2003, WHO M APR 2	12	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					242	244		10.1016/S0140-6736(03)13916-5	http://dx.doi.org/10.1016/S0140-6736(03)13916-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885490				2022-12-24	WOS:000184232000028
J	Gomez-Gutierrez, J; Peterson, WT; De Robertis, A; Brodeur, RD				Gomez-Gutierrez, J; Peterson, WT; De Robertis, A; Brodeur, RD			Mass mortality of krill caused by parasitoid ciliates	SCIENCE			English	Article							EUPHAUSIID THYSANOESSA-INERMIS		Ctr Interdisciplinario Ciencias Marinas, La Paz 23096, BCS, Mexico; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm, NW Fisheries Sci Ctr, Newport, OR 97365 USA	Oregon State University; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Gomez-Gutierrez, J (corresponding author), Ctr Interdisciplinario Ciencias Marinas, La Paz 23096, BCS, Mexico.		Riley, Eleanor M/C-8960-2013	Riley, Eleanor M/0000-0003-3447-3570; Brodeur, Richard/0000-0002-6629-5564				ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; BRADBURY PC, 1994, PARASITIC PROTOZOA, V8, P139; CAPRIULO GM, 1991, MAR ECOL PROG SER, V72, P203, DOI 10.3354/meps072203; CAPRIULO GM, 1986, DIS AQUAT ORGAN, V1, P141; SIEGEL V, 2000, KRILL BIOL ECOLOGY F, P00103, DOI DOI 10.1002/9780470999493.CH5	5	63	69	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					339	339		10.1126/science.1085164	http://dx.doi.org/10.1126/science.1085164			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869754				2022-12-24	WOS:000184207300034
J	Oyama, N; Chan, I; Neill, SM; Hamada, T; South, AP; Wessagowit, V; Wojnarowska, F; D'Cruz, D; Hughes, GJ; Black, MM; McGrath, JA				Oyama, N; Chan, I; Neill, SM; Hamada, T; South, AP; Wessagowit, V; Wojnarowska, F; D'Cruz, D; Hughes, GJ; Black, MM; McGrath, JA			Autoantibodies to extracellular matrix protein 1 in lichen sclerosus	LANCET			English	Article							BENIGN EPIDERMOLYSIS-BULLOSA; HUMAN KERATINOCYTES; LIPOID PROTEINOSIS; PEMPHIGOID ANTIGEN; SKIN DISEASES; GENE ECM1; MUTATIONS; EXPRESSION; ATROPHICUS; HEMIDESMOSOMES	Background Lichen sclerosus is a common acquired inflammatory disorder of skin and mucous membranes. The aetiology is unknown, although HLA-subtype susceptibility and high rates of other autoimmune disorders suggest that autoantibodies to specific mucocutaneous antigens are involved. The clinicopathological similarities between lichen sclerosus and lipoid proteinosis, which results from mutations in extracellular matrix protein 1 (ECM1), suggest this protein as an autoantigen. Methods We analysed serum autoantibody profiles in 171 individuals (86 with lichen sclerosus, 85 healthy controls) by immunoblotting of extracts from normal human skin and lipoid proteinosis skin (lacking ECM1). We generated a full-length glutathione-S-transferase fusion protein for ECM1 to confirm specific immunoreactivity. We affinity-purified serum from patients with lichen sclerosus and did indirect immunofluorescence microscopy on normal skin with or without preabsorption with recombinant ECM1. Findings By immunoblotting, IgG autoantibodies were found in 20 (67% [95% Cl 45-84]) of 30 lichen sclerosus serum samples. The highest titre was 1 in 20. The bands were not detected in ECM1-deficient substrate. These samples, and those from 56 other patients with lichen sclerosus, showed immunoreactivity to the recombinant ECM1 protein (64 of 86 positive; 74% [65-84]). Only six (7% [2-13]) of 85 control serum samples were positive. Affinity-purified IgG from serum of patients with lichen sclerosus labelled skin similarly to a polyclonal antibody to ECM1. The positive staining was blocked by preabsorption with excess recombinant ECM1 protein. Interpretation These findings provide evidence for a specific humoral immune response to ECM1 in lichen sclerosus and offer insight into disease diagnosis, monitoring, and approaches to treatment.	St Thomas Hosp, St Johns Inst Dermatol, Div Skin Sci,Genet Skin Dis Grp, Guys Kings & St Thomas Sch Med, London SE1 7EH, England; St Thomas Hosp, St Johns Inst Dermatol, Div Skin Sci,Dept Immunofluorescence, Guys Kings & St Thomas Sch Med, London SE1 7EH, England; Churchill Hosp, Dept Dermatol, Oxford, England; St Thomas Hosp, Rayne Inst, Dept Immunol, Lupus Res Unit, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	McGrath, JA (corresponding author), St Thomas Hosp, St Johns Inst Dermatol, Div Skin Sci,Genet Skin Dis Grp, Guys Kings & St Thomas Sch Med, London SE1 7EH, England.	john.mcgrath@kcl.ac.uk	McGrath, John/N-3529-2019; McGrath, John/D-6824-2012	Oyama, Noritaka/0000-0003-4934-5205; McGrath, John/0000-0002-3708-9964				Azurdia RM, 1999, BRIT J DERMATOL, V140, P79; BERNARD P, 1992, J INVEST DERMATOL, V99, P174, DOI 10.1111/1523-1747.ep12616797; Bhogal BS., 1990, MANAGEMENT BLISTERIN, P15; BUSHKELL LL, 1981, ACTA DERM-VENEREOL, V61, P157; Chan LS, 2002, ARCH DERMATOL, V138, P370, DOI 10.1001/archderm.138.3.370; DOMLOGEHULTSCH N, 1994, ARCH DERMATOL, V130, P1521, DOI 10.1001/archderm.130.12.1521; Hamada T, 2003, J INVEST DERMATOL, V120, P345, DOI 10.1046/j.1523-1747.2003.12073.x; Hamada T, 2002, HUM MOL GENET, V11, P833, DOI 10.1093/hmg/11.7.833; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; HARRINGTON CI, 1981, BRIT J DERMATOL, V104, P563, DOI 10.1111/j.1365-2133.1981.tb08172.x; IRVINE HG, 1913, JAMA-J AM MED ASSOC, V61, P396; Jonkman MF, 1999, J DERMATOL SCI, V20, P103, DOI 10.1016/S0923-1811(99)00017-1; MACFARLANE AW, 1989, CLIN EXP DERMATOL, V14, P245, DOI 10.1111/j.1365-2230.1989.tb00944.x; MCGRATH JA, 1995, J INVEST DERMATOL, V104, P467, DOI 10.1111/1523-1747.ep12605904; MCGRATH JA, 1995, NAT GENET, V11, P83, DOI 10.1038/ng0995-83; MEFFERT JJ, 1995, J AM ACAD DERMATOL, V32, P393, DOI 10.1016/0190-9622(95)90060-8; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Ohata Y, 1995, CLIN EXP DERMATOL, V20, P454, DOI 10.1111/j.1365-2230.1995.tb01376.x; Oyama N, 1999, J INVEST DERMATOL, V113, P600, DOI 10.1046/j.1523-1747.1999.00734.x; Powell J, 2000, BRIT J DERMATOL, V142, P481, DOI 10.1046/j.1365-2133.2000.03360.x; Powell JJ, 1999, LANCET, V353, P1777, DOI 10.1016/S0140-6736(98)08228-2; SAHN EE, 1994, PEDIATR DERMATOL, V11, P160, DOI 10.1111/j.1525-1470.1994.tb00572.x; Smits P, 1997, GENOMICS, V45, P487, DOI 10.1006/geno.1997.4918; Smits P, 2000, J INVEST DERMATOL, V114, P718, DOI 10.1046/j.1523-1747.2000.00916.x; Tasker GL, 2003, CLIN EXP DERMATOL, V28, P128, DOI 10.1046/j.1365-2230.2003.01211.x; THOMAS RHM, 1986, BRIT J DERMATOL, V114, P377, DOI 10.1111/j.1365-2133.1986.tb02831.x; THOMAS RHM, 1998, BRIT J DERMATOL, V118, P41; Wallace H J, 1971, Trans St Johns Hosp Dermatol Soc, V57, P9; Yancey KB, 2000, JAMA-J AM MED ASSOC, V284, P350, DOI 10.1001/jama.284.3.350; Zillikens D, 1999, J DERMATOL SCI, V20, P134, DOI 10.1016/S0923-1811(99)00019-5	30	191	208	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2003	362	9378					118	123		10.1016/S0140-6736(03)13863-9	http://dx.doi.org/10.1016/S0140-6736(03)13863-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699ZY	12867112				2022-12-24	WOS:000184089200011
J	Ohbayashi, M; Ohki, K; Miyashita, Y				Ohbayashi, M; Ohki, K; Miyashita, Y			Conversion of working memory to motor sequence in the monkey premotor cortex	SCIENCE			English	Article							PREFRONTAL CORTEX; FRONTAL-CORTEX; DECISIONS; SELECTION; MOVEMENT; PRIMATE; AREAS	To plan a serial order behavior, we hold serial sensory information in our minds and convert it to a movement program. We trained monkeys to memorize a sequence of positional cues and to reproduce it by making saccades in either the original or reverse order. The order was determined in the middle of a trial on the basis of an instruction stimulus. Triggered by the instruction stimulus, single neurons in the dorsal premotor cortex became transiently active only when the order needed to be determined. These transient neurons, together with nearby sustained neurons that hold information on cue or movement sequences, appear to mediate the generation of a motor program from the maintained information.	Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Ohbayashi, M (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ohbayashi-tky@umin.ac.jp; yasushi_miyashita@m.u-tokyo.ac.jp	Miyashita, Yasushi/B-7171-2019; Ohbayashi, Machiko/A-6910-2018	Miyashita, Yasushi/0000-0003-3496-8637; Ohbayashi, Machiko/0000-0003-2563-9049				BARONE P, 1989, EXP BRAIN RES, V78, P447; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Boussaoud D, 1996, BEHAV BRAIN RES, V72, P1; DIPELLEGRINO G, 1993, J NEUROSCI, V13, P1227; Georgopoulos AP, 2000, CURR OPIN NEUROBIOL, V10, P238, DOI 10.1016/S0959-4388(00)00072-6; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Grafton ST, 1998, J NEUROPHYSIOL, V79, P1092, DOI 10.1152/jn.1998.79.2.1092; HALSBAND U, 1985, BEHAV BRAIN RES, V18, P269, DOI 10.1016/0166-4328(85)90035-X; Hoshi E, 2000, NATURE, V408, P466, DOI 10.1038/35044075; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Leon MI, 1998, NEURON, V21, P669, DOI 10.1016/S0896-6273(00)80584-X; LU MT, 1994, J COMP NEUROL, V341, P375, DOI 10.1002/cne.903410308; LUPPINO G, 1990, EXP BRAIN RES, V82, P214; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Miller GA, 1960, PLANS STRUCTURE BEHA; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; Owen AM, 1998, P NATL ACAD SCI USA, V95, P7721, DOI 10.1073/pnas.95.13.7721; Passingham RE., 1993, FRONTAL LOBES VOLUNT; PETRIDES M, 1986, J NEUROSCI, V6, P2054; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Simon SR, 2002, J NEUROPHYSIOL, V88, P2047, DOI 10.1152/jn.2002.88.4.2047; Stern CE, 2000, NEUROIMAGE, V11, P392, DOI 10.1006/nimg.2000.0569; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; WISE SP, 1985, ANNU REV NEUROSCI, V8, P1, DOI 10.1146/annurev.ne.08.030185.000245	27	111	113	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2003	301	5630					233	236		10.1126/science.1084884	http://dx.doi.org/10.1126/science.1084884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855814				2022-12-24	WOS:000184056200049
J	Sidi, S; Friedrich, RW; Nicolson, T				Sidi, S; Friedrich, RW; Nicolson, T			NompC TRP channel required for vertebrate sensory hair cell mechanotransduction	SCIENCE			English	Article							MECHANOSENSORY TRANSDUCTION; DROSOPHILA; MUTANTS	The senses of hearing and balance in vertebrates rely on the sensory hair cells (HCs) of the inner ear. The central element of the HC's transduction apparatus is a mechanically gated ion channel of unknown identity. Here we report that the zebrafish ortholog of Drosophila no mechanoreceptor potential C (nompC), which encodes a transient receptor potential (TRP) channel, is critical for HC mechanotransduction. In zebrafish larvae, nompC is selectively expressed in sensory HCs. Morpholino-mediated removal of nompC function eliminated transduction-dependent endocytosis and electrical responses in HCs, resulting in larval deafness and imbalance. These observations indicate that nompC encodes a vertebrate HC mechanotransduction channel.	Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany; Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Max Planck Society; Max Planck Society	Nicolson, T (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.			Friedrich, Rainer/0000-0001-9107-0482				ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Colbert HA, 1997, J NEUROSCI, V17, P8259; COREY DP, 1983, J NEUROSCI, V3, P962; COREY DP, 1983, J NEUROSCI, V3, P942; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; MONELL C, 2003, SCI STKE 2003; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Seiler C, 1999, J NEUROBIOL, V41, P424, DOI 10.1002/(SICI)1097-4695(19991115)41:3<424::AID-NEU10>3.0.CO;2-G; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Strassmaier M, 2002, CURR OPIN NEUROBIOL, V12, P380, DOI 10.1016/S0959-4388(02)00344-6; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229	19	228	249	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2003	301	5629					96	99		10.1126/science.1084370	http://dx.doi.org/10.1126/science.1084370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12805553				2022-12-24	WOS:000183914700041
J	Yandulov, DV; Schrock, RR				Yandulov, DV; Schrock, RR			Catalytic reduction of dinitrogen to ammonia at a single molybdenum center	SCIENCE			English	Article							NITROGEN-FIXATION; IRON PROTEIN; MOFE-PROTEIN; COMPLEXES; CHEMISTRY; TUNGSTEN; MECHANISM; MODELS	Dinitrogen (N-2) was reduced to ammonia at room temperature and 1 atmosphere with molybdenum catalysts that contain tetradentate [HIPTN3N](3-) triamidoamine ligands {such as [HIPTN3N]Mo(N-2), where [HIPTN3N](3-) is[{3,5-(2,4,6-i-Pr3C6H2)(2)C6H3NCH2CH2}(3)N](3-)} in heptane. Slow addition of the proton source [{2,6-lutidinium}{BAr'(4)}, where Ar' is 3,5-(CF3)(2)C6H3] and reductant (decamethyl chromocene) was critical for achieving high efficiency (similar to66% in four turnovers). Numerous x-ray studies, along with isolation and characterization of six proposed intermediates in the catalytic reaction under noncatalytic conditions, suggest that N-2 was reduced at a sterically protected, single molybdenum center that cycled from Mo(III) through Mo(VI) states.	MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Schrock, RR (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	rrs@mit.edu	Yandulov, Dmitry/GXG-1415-2022	Yandulov, Dmitry/0000-0003-2272-9030	NIGMS NIH HHS [GM 31978] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031978] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN AD, 1965, CHEM COMMUN, P621, DOI 10.1039/c19650000621; Barriere F, 2003, COORDIN CHEM REV, V236, P71, DOI 10.1016/S0010-8545(02)00183-2; BAZHENOVA TA, 1995, COORDIN CHEM REV, V144, P69, DOI 10.1016/0010-8545(95)01139-G; BOLIN JT, 1993, P NATL ACAD SCI USA, V90, P1078, DOI 10.1073/pnas.90.3.1078; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; BURGESS BK, 1990, CHEM REV, V90, P1377, DOI 10.1021/cr00106a002; CHANEY AL, 1962, CLIN CHEM, V8, P130; CHATT J, 1978, CHEM REV, V78, P589, DOI 10.1021/cr60316a001; CHEN J, 1993, ANGEW CHEM INT EDIT, V32, P1592; Connelly NG, 1996, CHEM REV, V96, P877, DOI 10.1021/cr940053x; Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337; DICKSON CR, 1978, J AM CHEM SOC, V100, P8007, DOI 10.1021/ja00493a039; DZIEGIELEWSKI JO, 1990, POLYHEDRON, V9, P645, DOI 10.1016/S0277-5387(00)80270-3; Eady RR, 1996, CHEM REV, V96, P3013, DOI 10.1021/cr950057h; Eady RR, 2001, J INORG BIOCHEM, V86, P42; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Fryzuk MD, 2000, COORDIN CHEM REV, V200, P379, DOI 10.1016/S0010-8545(00)00264-2; Greco GE, 2001, INORG CHEM, V40, P3861, DOI 10.1021/ic001123n; Greco GE, 2001, INORG CHEM, V40, P3850, DOI 10.1021/ic001122v; HENDERSON RA, 1983, ADV INORG CHEM RAD, V27, P197, DOI 10.1016/S0898-8838(08)60108-7; HIDAI M, 1995, CHEM REV, V95, P1115, DOI 10.1021/cr00036a008; Hidai M, 1999, COORDIN CHEM REV, V185-6, P99, DOI 10.1016/S0010-8545(98)00250-1; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; KIM J, 1993, BIOCHEMISTRY-US, V32, P7104, DOI 10.1021/bi00079a006; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; KOMORI K, 1989, J AM CHEM SOC, V111, P1939, DOI 10.1021/ja00187a092; Pickett CJ, 1996, J BIOL INORG CHEM, V1, P601, DOI 10.1007/s007750050099; PICKETT CJ, 1985, NATURE, V317, P652, DOI 10.1038/317652a0; Rees DC, 2000, CURR OPIN CHEM BIOL, V4, P559, DOI 10.1016/S1367-5931(00)00132-0; Rees DC, 1993, ADV INORG CHEM, V40, P89; Richards RL, 1996, COORDIN CHEM REV, V154, P83, DOI 10.1016/0010-8545(96)01186-1; ROBBINS JL, 1982, J AM CHEM SOC, V104, P1882, DOI 10.1021/ja00371a017; Schrock RR, 1997, PURE APPL CHEM, V69, P2197, DOI 10.1351/pac199769102197; SHILOV AE, 1987, J MOL CATAL, V41, P221, DOI 10.1016/0304-5102(87)80030-5; TANAKA K, 1982, CHEM LETT, P1203, DOI 10.1246/cl.1982.1203; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Yandulov DV, 2002, J AM CHEM SOC, V124, P6252, DOI 10.1021/ja020186x; Yandulov DV, 2003, INORG CHEM, V42, P796, DOI 10.1021/ic020505l; YANDULOV DV, UNPUB	39	1026	1039	22	582	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2003	301	5629					76	78		10.1126/science.1085326	http://dx.doi.org/10.1126/science.1085326			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	696YG	12843387				2022-12-24	WOS:000183914700034
J	Anderson, P; Doyle, LW				Anderson, P; Doyle, LW		Victorian Infant Collaborative Stu	Neurobehavioral outcomes of school-age children born extremely low birth weight or very preterm in the 1990s	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COGNITIVE-ABILITIES; PARENTING STRESS; GESTATIONAL-AGE; INFANTS; BRAIN; IMPACT; LESS; ADOLESCENTS; ATTAINMENT; DISORDERS	Context The outcome into school age of regional cohorts of children born in the 1990s with birth weights less than 1000 g (extremely low birth weight, ELBW) or earlier than 28 weeks' gestation (very preterm) is not known. Objective To determine the cognitive, educational, and behavioral outcome of ELBW or very preterm infants born in the 1990s compared with normal birth weight (NBW) controls. Design Regional cohort study. Setting Victoria, Australia. Participants The ELBW or very preterm cohort was composed of 298 consecutive survivors born during 1991-1992. The NBW cohort was composed of 262 randomly selected children with birth weights of more than 2499 g. Main Outcome Measures Cognitive ability, educational progress, and behavioral problems. Results The follow-up rates from birth to 8 years of age for survivors were 92.3% (275/298) for the ELBW or very preterm cohort and 85.1% (223/262) for the NBW cohort. The ELBW or very preterm children scored significantly below NBW controls on full-scale IQ (mean difference, -9.4; 95% confidence interval [CI], -12.1 to -6.7; P<.001) and indices of verbal comprehension (mean difference, -6.8; 95% Cl, -9.5 to -4.2; P<001), perceptual organization (mean difference, -9.9; 95% Cl, -12.7 to -7.2; P<001), freedom from distractibility (mean difference, -8.1; 95% Cl, -10.8 to -5.5; P<001), and processing speed (mean difference, -6.7; 95% Cl, -9.4 to -4.0; P<001). The ELBW or very preterm children performed significantly worse than the NBW cohort on tests of reading (mean difference, -6.7; 95% Cl, -9.5 to -3.9; P<001), spelling (mean difference, -5.6; 95% Cl, -8.0 to -3.3; P<.001), and arithmetic (mean difference, -8.8; 95% Cl, -11.3 to -6.2; P<.001). Attentional difficulties, internalizing behavior problems, and immature adaptive skills were more prevalent in the ELBW or very preterm cohort. Conclusion School-aged ELBW or very preterm children born in the 1990s continue to display cognitive, educational, and behavioral impairments.	Royal Womens Hosp, Dept Obstet & Gynaecol, Carlton, Vic 3053, Australia; Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Univ Melbourne, Melbourne, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne	Doyle, LW (corresponding author), Royal Womens Hosp, Dept Obstet & Gynaecol, 132 Grattan St, Carlton, Vic 3053, Australia.	lwd@unimelb.edu.au	Anderson, Peter J/B-6839-2015; Doyle, Lex/AAJ-5205-2021; Anderson, Peter John/O-5302-2019	Anderson, Peter J/0000-0001-7430-868X; Doyle, Lex/0000-0002-7667-7312; Anderson, Peter John/0000-0001-7430-868X				[Anonymous], 1997, Arch Dis Child Fetal Neonatal Ed, V77, pF91; AYLWARD GP, 1992, J DEV BEHAV PEDIATR, V13, P222; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Botting N, 1998, DEV MED CHILD NEUROL, V40, P652; Botting N, 1997, J CHILD PSYCHOL PSYC, V38, P931, DOI 10.1111/j.1469-7610.1997.tb01612.x; Breslau N, 1996, BIOL PSYCHIAT, V40, P389, DOI 10.1016/0006-3223(95)00399-1; Doyle LW, 1997, J PAEDIATR CHILD H, V33, P161; Doyle LW, 2001, PEDIATRICS, V108, P134, DOI 10.1542/peds.108.1.134; Emsley HCA, 1998, ARCH DIS CHILD-FETAL, V78, pF99, DOI 10.1136/fn.78.2.F99; FERRARA TB, 1994, J PEDIATR-US, V124, P119, DOI 10.1016/S0022-3476(94)70266-7; Grantham-McGregor SM, 1998, J PEDIATR-US, V132, P661, DOI 10.1016/S0022-3476(98)70357-9; Gross SJ, 2001, J PEDIATR-US, V138, P169, DOI 10.1067/mpd.2001.111945; Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8; Hack M, 1996, PEDIATRICS, V98, P931; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; Hall A, 1995, DEV MED CHILD NEUROL, V37, P1037; HAMMILL DD, 1994, COMPREHENSIVE SCALE; Hille ETM, 2001, LANCET, V357, P1641, DOI 10.1016/S0140-6736(00)04818-2; Horbar JD, 2002, PEDIATRICS, V110, P143, DOI 10.1542/peds.110.1.143; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Isaacs EB, 2000, PEDIATR RES, V47, P713, DOI 10.1203/00006450-200006000-00006; LEVYSHIFF R, 1994, J PEDIATR PSYCHOL, V19, P63, DOI 10.1093/jpepsy/19.1.63; Maalouf EF, 1999, J PEDIATR-US, V135, P351, DOI 10.1016/S0022-3476(99)70133-2; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Prifitera A., 1998, WISC 3 CLIN USE INTE, P1, DOI DOI 10.1016/B978-012564930-8/50002-4; Resnick MB, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e74; Reynolds C. R., 1992, BEHAV ASSESSMENT SYS; Rickards AL, 2001, J DEV BEHAV PEDIATR, V22, P11, DOI 10.1097/00004703-200102000-00002; Robson AL, 1997, J PEDIATR PSYCHOL, V22, P297, DOI 10.1093/jpepsy/22.3.297; Rose SA, 1996, CHILD DEV, V67, P2005, DOI 10.1111/j.1467-8624.1996.tb01840.x; Saigal S, 2000, J PEDIATR-US, V137, P701, DOI 10.1067/mpd.2000.109001; SAIGAL S, 1991, J PEDIATR-US, V118, P751, DOI 10.1016/S0022-3476(05)80043-5; Saigal S, 2000, PEDIATRICS, V105, P325, DOI 10.1542/peds.105.2.325; Singer LT, 1999, JAMA-J AM MED ASSOC, V281, P799, DOI 10.1001/jama.281.9.799; Skranes JS, 1998, PEDIATR RADIOL, V28, P471, DOI 10.1007/s002470050387; SOMMERFELT K, 1993, ACTA PAEDIATR, V82, P723, DOI 10.1111/j.1651-2227.1993.tb12546.x; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; SZATMARI P, 1990, DEV MED CHILD NEUROL, V32, P954; Taylor HG, 2000, CHILD DEV, V71, P1495, DOI 10.1111/1467-8624.00242; Taylor HG, 2000, CHILD NEUROPSYCHOL, V6, P49, DOI 10.1076/0929-7049(200003)6:1;1-B;FT049; Taylor HG, 1998, CHILD NEUROPSYCHOL, V4, P21, DOI 10.1076/chin.4.1.21.3188; TAYLOR HG, 1995, J PEDIATR PSYCHOL, V20, P703, DOI 10.1093/jpepsy/20.6.703; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME; Wolke D, 1999, DEV MED CHILD NEUROL, V41, P94, DOI 10.1017/S0012162299000201	46	661	674	1	55	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2003	289	24					3264	3272		10.1001/jama.289.24.3264	http://dx.doi.org/10.1001/jama.289.24.3264			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	693EX	12824207	Bronze			2022-12-24	WOS:000183704600019
J	Hu, C; Ahmed, M; Melia, TJ; Sollner, TH; Mayer, T; Rothman, JE				Hu, C; Ahmed, M; Melia, TJ; Sollner, TH; Mayer, T; Rothman, JE			Fusion of cells by flipped SNAREs	SCIENCE			English	Article							DEPENDENT MEMBRANE-FUSION; COMPLEX-FORMATION; 3-DIMENSIONAL STRUCTURE; EXOCYTOSIS; VESICLE; SPECIFICITY; REQUIRES; PROTEINS; SNAP-25; PATHWAY	The SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) hypothesis suggests that pairs of proteins known as vesicle (v-) SNAREs and target membrane (t-) SNAREs interact specifically to control and mediate intracellular membrane fusion events. Here, cells expressing the interacting domains of v- and t- SNAREs on the cell surface were found to fuse spontaneously, demonstrating that SNAREs are sufficient to fuse biological membranes.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Rothman, JE (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave,Box 251, New York, NY 10021 USA.	j-rothman@ski.mskcc.org		Mayer, Thomas/0000-0001-6954-2287				Banerjee A, 1996, J BIOL CHEM, V271, P20227, DOI 10.1074/jbc.271.34.20227; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; ELBEIN AD, 1984, CRC CR REV BIOCH MOL, V16, P21, DOI 10.3109/10409238409102805; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; HU CY, UNPUB; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Parlati F, 2000, NATURE, V407, P194, DOI 10.1038/35025076; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Paumet F, 2001, J CELL BIOL, V155, P961, DOI 10.1083/jcb.200104092; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241; Witze E, 2002, CURR BIOL, V12, pR467, DOI 10.1016/S0960-9822(02)00948-X	28	172	179	3	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2003	300	5626					1745	1749		10.1126/science.1084909	http://dx.doi.org/10.1126/science.1084909			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805548				2022-12-24	WOS:000183459700051
J	Chauhan, AJ; Inskip, HM; Linaker, CH; Smith, S; Schreiber, J; Johnston, SL; Holgate, ST				Chauhan, AJ; Inskip, HM; Linaker, CH; Smith, S; Schreiber, J; Johnston, SL; Holgate, ST			Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children	LANCET			English	Article							RESPIRATORY SYMPTOMS; AIR-POLLUTION; RISK-FACTORS; IN-VITRO; ASSOCIATION; INFECTION; COOKING; ADULTS; CELLS; GAS	Background A link between exposure to the air pollutant nitrogen dioxide (NO2) and respiratory disease has been suggested. Viral infections are the major cause of asthma exacerbations. We aimed to assess whether there is a relation between NO2 exposure and the severity of asthma exacerbations caused by proven respiratory viral infections in children. Methods A cohort of 114 asthmatic children aged between 8 and 11 years recorded daily upper and lower respiratory-tract symptoms, peak expiratory flow (PEF), and measured personal NO2 exposures every week for up to 13 months. We took nasal aspirates during reported episodes of upper respiratory-tract illness and tested for infection by common respiratory viruses and atypical bacteria with RT-PCR assays. We used generalised estimating equations to assess the relation between low (<7.5 &mu;g/m(3) medium (7.5-14 &mu;g/m(3)), and high (>14 mug/m(3)) tertiles of NO2 exposure in the week before or after upper respiratory-tract infection and the severity of asthma exacerbation in the week after the start of an infection. Findings One or more viruses were detected in 78% of reported infection episodes, and the medians of NO2 exposure were 5 (IQR 3.6-6.3), 10 (8.7-12.0), and 21 mug/m(3) (16.8-42.9) for low, medium, and high tertiles, respectively. There were significant increases in the severity of lower respiratory-tract symptom scores across the three tertiles (0.6 for all viruses [p=0.05] and >2 for respiratory syncytial virus [p=0.01]) and a reduction in PEF of more than 12 L/min for picornavirus (p=0.04) for high compared with low NO2 exposure before the start of the virus-induced exacerbation. Interpretation High exposure to NO2 in the week before the start of a respiratory viral infection, and at levels within current air quality standards, is associated with an increase in the severity of a resulting asthma exacerbation.	Univ Southampton, Resp Cell & Mol Biol Res Div, Southampton, Hants, England; Univ Southampton, MRC, Environm Epidemiol Unit, Southampton, Hants, England; Natl Heart & Lung Inst, London, England; Univ London Imperial Coll Sci Technol & Med, Wright Fleming Inst Infect & Immun, London, England	University of Southampton; University of Southampton; Imperial College London; Imperial College London	Chauhan, AJ (corresponding author), St Marys Hosp, Portsmouth PO3 6AD, Hants, England.		Johnston, Sebastian Lennox/I-2423-2012; Inskip, Hazel/L-5467-2018	Johnston, Sebastian Lennox/0000-0003-3009-9200; Inskip, Hazel/0000-0001-8897-1749				*ADV GROUP MED ASP, 1993, 3 DEP HLTH ADV GROUP, P29; Ando M, 2001, ARCH ENVIRON HEALTH, V56, P227, DOI 10.1080/00039890109604446; Boezen HM, 1999, LANCET, V353, P874, DOI 10.1016/S0140-6736(98)06311-9; BRUNEKREEF B, 1982, INT ARCH OCC ENV HEA, V50, P299, DOI 10.1007/BF00378091; CARSON JL, 1993, AM J RESP CELL MOL, V9, P264, DOI 10.1165/ajrcmb/9.3.264; Chauhan A. J., 1998, Reviews on Environmental Health, V13, P73; CLAUSING P, 1986, Environment International, V12, P413, DOI 10.1016/0160-4120(86)90056-5; Dennekamp M, 2001, OCCUP ENVIRON MED, V58, P511, DOI 10.1136/oem.58.8.511; DEVALIA JL, 1993, AM J RESP CELL MOL, V9, P271, DOI 10.1165/ajrcmb/9.3.271; DEVALIA JL, 1993, EUR RESPIR J, V6, P1308; EHRLICH R, 1966, BACTERIOL REV, V30, P604, DOI 10.1128/MMBR.30.3.604-614.1966; FRAMPTON MW, 1989, ENVIRON RES, V48, P179, DOI 10.1016/S0013-9351(89)80033-7; Frampton MW, 2002, AM J PHYSIOL-LUNG C, V282, pL155, DOI 10.1152/ajplung.2002.282.1.L155; GOINGS SAJ, 1989, AM REV RESPIR DIS, V139, P1075, DOI 10.1164/ajrccm/139.5.1075; HASSELBLAD V, 1992, J AIR WASTE MANAGE, V42, P662, DOI 10.1080/10473289.1992.10467018; INFANTERIVARD C, 1993, AM J EPIDEMIOL, V137, P834, DOI 10.1093/oxfordjournals.aje.a116745; JAKAB GJ, 1987, ENVIRON RES, V42, P215, DOI 10.1016/S0013-9351(87)80023-3; Jarvis D, 1996, LANCET, V347, P426, DOI 10.1016/S0140-6736(96)90009-4; JOHNSTON SL, 1993, J CLIN MICROBIOL, V31, P111, DOI 10.1128/JCM.31.1.111-117.1993; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; KAWAMOTO T, 1993, ARCH ENVIRON CON TOX, V25, P534; Linaker CH, 2000, OCCUP ENVIRON MED, V57, P472, DOI 10.1136/oem.57.7.472; Linaker CH, 1996, OCCUP ENVIRON MED, V53, P200, DOI 10.1136/oem.53.3.200; NEAS LM, 1991, AM J EPIDEMIOL, V134, P204, DOI 10.1093/oxfordjournals.aje.a116073; NOY D, 1990, ATMOS ENVIRON A-GEN, V24, P2903, DOI 10.1016/0960-1686(90)90470-8; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; SAMET JM, 1993, AM REV RESPIR DIS, V148, P1258, DOI 10.1164/ajrccm/148.5.1258; SANDSTROM T, 1992, EUR RESPIR J, V5, P1092; SCHENKER MB, 1983, AM REV RESPIR DIS, V128, P1038; Siegel PD, 1997, TOXICOL APPL PHARM, V144, P356, DOI 10.1006/taap.1997.8148; Spannhake EW, 2002, ENVIRON HEALTH PERSP, V110, P665, DOI 10.1289/ehp.02110665; TUNNICLIFFE WS, 1994, LANCET, V344, P1733, DOI 10.1016/S0140-6736(94)92886-X; WHO, 2000, EUR SER, Vsecond; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	35	215	223	0	35	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 7	2003	361	9373					1939	1944		10.1016/S0140-6736(03)13582-9	http://dx.doi.org/10.1016/S0140-6736(03)13582-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687DB	12801737	Green Published, Bronze			2022-12-24	WOS:000183359700009
J	Thibert, C; Teillet, MA; Lapointe, F; Mazelin, L; Le Douarin, NM; Mehlen, P				Thibert, C; Teillet, MA; Lapointe, F; Mazelin, L; Le Douarin, NM; Mehlen, P			Inhibition of neuroepithelial patched-induced apoptosis by Sonic hedgehog	SCIENCE			English	Article							RECEPTORS UNC5H; NEURAL-TUBE; MECHANISM; SURVIVAL; DCC; SPECIFICATION; DEPENDENCE; DEFINES; CHICK; ACTS	During early development in vertebrates, Sonic hedgehog (Shh) is produced by the notochord and the floor plate. A ventrodorsal gradient of Shh directs ventrodorsal patterning of the neural tube. However, Shh is also required for the survival of neuroepithelial cells. We show that Patched (Ptc) induces apoptotic cell death unless its ligand Shh is present to block the signal. Moreover, the blockade of Ptc-induced cell death partly rescues the chick spinal cord defect provoked by Shh deprivation. Thus, the proapoptotic activity of unbound Ptc and the positive effect of Shh-bound Ptc on cell differentiation probably cooperate to achieve the appropriate spinal cord development.	Univ Lyon 1, CNRS, UMR 5534,Mol & Cellular Genet Ctr, Apoptosis Differentiat Lab, F-69622 Villeurbanne, France; CNRS, UMR 7128, Lab Embryol Cellulaire & Mol, F-94736 Nogent Sur Marne, France; Int Agcy Res Canc, F-69008 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); World Health Organization; International Agency for Research on Cancer (IARC)	Mehlen, P (corresponding author), Univ Lyon 1, CNRS, UMR 5534,Mol & Cellular Genet Ctr, Apoptosis Differentiat Lab, F-69622 Villeurbanne, France.	mehlen@univ-lyon1.fr	Mazelin, Laetitia/AAD-9319-2020; THIBERT, Chantal/N-1828-2013; Thibert, Chantal/D-4367-2019	Mazelin, Laetitia/0000-0002-4001-2132; Thibert, Chantal/0000-0002-1516-5671				Aoto K, 2002, DEV BIOL, V251, P320, DOI 10.1006/dbio.2002.0811; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; Bordeaux MC, 2000, EMBO J, V19, P4056, DOI 10.1093/emboj/19.15.4056; Bredesen DE, 1998, CELL DEATH DIFFER, V5, P365, DOI 10.1038/sj.cdd.4400378; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Charrier JB, 1999, DEVELOPMENT, V126, P4771; Charrier JB, 2001, DEVELOPMENT, V128, P4011; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Koike C, 2002, ONCOGENE, V21, P2670, DOI 10.1038/sj.onc.1205370; Le Douarin NM, 2000, CURR OPIN NEUROBIOL, V10, P23, DOI 10.1016/S0959-4388(99)00062-8; Le Douarin NM, 1998, INT J DEV BIOL, V42, P909; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Miao NN, 1997, J NEUROSCI, V17, P5891; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Wicking C, 2001, CANCER LETT, V173, P1, DOI 10.1016/S0304-3835(01)00676-0; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916	29	250	260	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					843	846		10.1126/science.1085405	http://dx.doi.org/10.1126/science.1085405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907805				2022-12-24	WOS:000184615700048
J	Kuiken, T; Fouchier, RAM; Schutten, M; Rimmelzwaan, GF; van Amerongen, G; van Riel, D; Laman, JD; de Jong, T; van Doornum, G; Lim, W; Ling, AE; Chan, PKS; Tam, JS; Zambon, MC; Gopal, R; Drosten, C; van der Werf, S; Escriou, N; Manuguerra, JC; Stohr, K; Peiris, JSM; Osterhaus, ADME				Kuiken, T; Fouchier, RAM; Schutten, M; Rimmelzwaan, GF; van Amerongen, G; van Riel, D; Laman, JD; de Jong, T; van Doornum, G; Lim, W; Ling, AE; Chan, PKS; Tam, JS; Zambon, MC; Gopal, R; Drosten, C; van der Werf, S; Escriou, N; Manuguerra, JC; Stohr, K; Peiris, JSM; Osterhaus, ADME			Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome	LANCET			English	Article							POLYMERASE-CHAIN-REACTION; HONG-KONG; EXPERIMENTAL-INFECTION; IDENTIFICATION; PATHOGENICITY; CHILDREN; OUTBREAK; DISEASE; GENE; PCR	Background The worldwide outbreak. of severe acute respiratory syndrome (SARS) is associated with a newly discovered coronavirus, SARS-associated coronavirus (SARS-CoV). We did clinical and experimental studies to assess the role of this virus in the cause of SARS. Methods We tested clinical and postmortem samples from 436 SARS patients in six countries for infection with SARS-CoV, human metapneumovirus, and other respiratory pathogens. We infected four cynomolgus macaques (Macaca fascicularis) with SARS-CoV in an attempt to replicate SARS and did necropsies on day 6 after infection. Findings SARS-CoV infection was diagnosed in 329 (75%) of 436 patients fitting the case definition of SARS; human metapneumovirus was diagnosed in 41 (12%) of 335, and other respiratory pathogens were diagnosed only sporadically. SARS-CoV was, therefore, the most likely causal agent of SARS. The four SARS-CoV-infected macaques excreted SARS-CoV from nose, mouth, and pharynx from 2 days after infection. Three of four macaques developed diffuse alveolar damage, similar to that in SARS patients, and characterised by epithelial necrosis, serosanguineous exudate, formation of hyaline membranes, type 2 pneumocyte hyperplasia, and the presence of syncytia. SARS-CoV was detected in pneumonic areas by virus isolation and RT-PCR, and was localised to alveolar epithelial cells and syncytia by immunohistochemistry and transmission electron microscopy. Interpretation Replication in SARS-CoV-infected macaques of pneumonia similar to that in human beings with SARS, combined with the high prevalence of SARS-CoV infection in SARS patients, fulfill the criteria required to prove that SARS-CoV is the primary cause of SARS.	Erasmus Med Ctr, Dept Virol, NL-3000 DR Rotterdam, Netherlands; Erasmus Med Ctr, Dept Immunol, NL-3000 DR Rotterdam, Netherlands; Erasmus Med Ctr, Dept Pathol, NL-3000 DR Rotterdam, Netherlands; Publ Hlth Lab Ctr, Govt Virus Unit, Kowloon, Hong Kong, Peoples R China; Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Hlth Protect Agcy, Enter Resp & Neurol Virus Lab, London, England; Bernhard Nocht Inst Trop Med, Dept Virol, Hamburg, Germany; Inst Pasteur, Unite Genet Mol Virus Resp, Paris, France; WHO, SARS Aetiol Study Grp, CH-1211 Geneva, Switzerland; Univ Hong Kong, Queen Mary Hosp, Dept Microbiol & Med, Hong Kong, Hong Kong, Peoples R China	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Singapore General Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Health Protection Agency; Bernhard Nocht Institut fur Tropenmedizin; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; World Health Organization; University of Hong Kong	Kuiken, T (corresponding author), Erasmus Med Ctr, Dept Virol, POB 1738, NL-3000 DR Rotterdam, Netherlands.	t.kuiken@erasmusmc.nl	Chan, Paul KS/J-9360-2013; Fouchier, Ron A/A-1911-2014; Escriou, Nicolas/A-2392-2016	Chan, Paul KS/0000-0002-6360-4608; Fouchier, Ron A/0000-0001-8095-2869; Escriou, Nicolas/0000-0002-1224-6839; Osterhaus, Albert/0000-0002-6074-1172; van der WERF, Sylvie/0000-0002-1148-4456; van Riel, Debby/0000-0001-9753-3564				BHATT PN, 1977, ARCH VIROL, V54, P345, DOI 10.1007/BF01314779; CHAN PKS, IN PRESS EMERG INFEC; CLAAS HC, 1990, EUR J CLIN MICROBIOL, V9, P864, DOI 10.1007/BF01967500; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; DUNGWORTH DL, 1993, PATHOLOGY DOMESTIC A, V2, P539; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; JABRANE A, 1994, CAN VET J, V35, P86; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; LAI MMC, 1999, FIELDS VIROLOGY, P1163; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; MAHY BWJ, 1997, DICT VIROLOGY; Myers J.L., 1993, PULMONARY PATHOLOGY, P57; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; OTOOLE D, 1989, RES VET SCI, V47, P23, DOI 10.1016/S0034-5288(18)31226-8; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; Peret TCT, 2002, J INFECT DIS, V185, P1660, DOI 10.1086/340518; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Reischl U, 2003, EUR J CLIN MICROBIOL, V22, P54, DOI 10.1007/s10096-002-0858-2; SCHNEIDERSCHAUL.S, 2002, EXPERT REV MOL MED; Stephensen CB, 1999, VIRUS RES, V60, P181, DOI 10.1016/S0168-1702(99)00017-9; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; *WHO, 2003, WKLY EPIDEMIOL REC, V78, P81; PCR PRIMERS SARS DEV; CUMULATIVE NUMBER RE; PNEUMONIA CHINA GUAN	29	755	818	8	122	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					263	270		10.1016/S0140-6736(03)13967-0	http://dx.doi.org/10.1016/S0140-6736(03)13967-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892955	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000184413400007
J	Bergthorsson, U; Adams, KL; Thomason, B; Palmer, JD				Bergthorsson, U; Adams, KL; Thomason, B; Palmer, JD			Widespread horizontal transfer of mitochondrial genes in flowering plants	NATURE			English	Article							PHYLOGENETIC ANALYSES; LATERAL TRANSFER; EVOLUTION; NUCLEUS; PROKARYOTES; ANGIOSPERMS; INVASION; DIVERSE; RATES	Horizontal gene transfer - the exchange of genes across mating barriers - is recognized as a major force in bacterial evolution(1,2). However, in eukaryotes it is prevalent only in certain phagotrophic protists and limited largely to the ancient acquisition of bacterial genes(3-5). Although the human genome was initially reported(6) to contain over 100 genes acquired during vertebrate evolution from bacteria, this claim was immediately and repeatedly rebutted(7,8). Moreover, horizontal transfer is unknown within the evolution of animals, plants and fungi except in the special context of mobile genetic elements(9-12). Here we show, however, that standard mitochondrial genes, encoding ribosomal and respiratory proteins, are subject to evolutionarily frequent horizontal transfer between distantly related flowering plants. These transfers have created a variety of genomic outcomes, including gene duplication, recapture of genes lost through transfer to the nucleus, and chimaeric, half-monocot, half-dicot genes. These results imply the existence of mechanisms for the delivery of DNA between unrelated plants, indicate that horizontal transfer is also a force in plant nuclear genomes, and are discussed in the contexts of plant molecular phylogeny and genetically modified plants.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Iowa State Univ, Dept Bot, Ames, IA 50011 USA; Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Indiana University System; Indiana University Bloomington; Iowa State University; University of Michigan System; University of Michigan	Palmer, JD (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	jpalmer@bio.indiana.edu	Palmer, Jeffrey/P-6747-2014	Palmer, Jeffrey/0000-0002-4626-2220				Adams J L, 1999, Curr Opin Drug Discov Devel, V2, P96; Adams KL, 2000, NATURE, V408, P354, DOI 10.1038/35042567; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Andersson JO, 2003, CURR BIOL, V13, P94, DOI 10.1016/S0960-9822(03)00003-4; Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Barkman TJ, 2000, P NATL ACAD SCI USA, V97, P13166, DOI 10.1073/pnas.220427497; BLANCHARD JL, 1995, J MOL EVOL, V41, P397, DOI 10.1007/BF00160310; Cho Y, 1998, P NATL ACAD SCI USA, V95, P14244, DOI 10.1073/pnas.95.24.14244; Eickbush T.H., 2002, MOBILE DNA-UK, V2, P1111, DOI [10.1128/9781555817954.ch49, DOI 10.1128/9781555817954.CH49]; Feschotte C, 2002, P NATL ACAD SCI USA, V99, P280, DOI 10.1073/pnas.022626699; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Intrieri MC, 2001, MOL PHYLOGENET EVOL, V20, P100, DOI 10.1006/mpev.2001.0927; Kadowaki KI, 1996, EMBO J, V15, P6652, DOI 10.1002/j.1460-2075.1996.tb01055.x; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laroche J, 1997, P NATL ACAD SCI USA, V94, P5722, DOI 10.1073/pnas.94.11.5722; Nixon JEJ, 2002, EUKARYOT CELL, V1, P181, DOI 10.1128/EC.1.2.181-190.2002; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Robertson Hugh M., 2002, P1093; Salzberg SL, 2001, SCIENCE, V292, P1903, DOI 10.1126/science.1061036; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SMITH JM, 1992, J MOL EVOL, V34, P126; Stanhope MJ, 2001, NATURE, V411, P940, DOI 10.1038/35082058; Stupar RM, 2001, P NATL ACAD SCI USA, V98, P5099, DOI 10.1073/pnas.091110398; SWOFFORD D.L., 2003, PAUP PHYLOGENETIC AN; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Zardoya R, 2002, P NATL ACAD SCI USA, V99, P14893, DOI 10.1073/pnas.192573799	30	322	344	4	93	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					197	201		10.1038/nature01743	http://dx.doi.org/10.1038/nature01743			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853958	Green Published			2022-12-24	WOS:000184032700043
J	Raymond, PA; Cole, JJ				Raymond, PA; Cole, JJ			Increase in the export of alkalinity from North America's largest river	SCIENCE			English	Article							WEATHERING RATES; CARBON; CHEMISTRY; EROSION; STREAMFLOW; NITROGEN; TRENDS; IMPACT; FLUX	Chemical weathering and the subsequent export of carbonate alkalinity (HCO3- + CO3-2) from soils to rivers account for significant amounts of terrestrially sequestered atmospheric CO2. We show here that during the past half-century, the export of this alkalinity has increased dramatically from North America's largest river, the Mississippi. This increased export is in part the result of increased flow resulting from higher rainfall in the Mississippi basin. Subcatchment data from the Mississippi suggest that the increase in the export of alkalinity is also linked to amount and type of land cover. These observations have important implications for the potential management of carbon sequestration in the United States.	Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; Inst Ecosyst Studies, Millbrook, NY 12545 USA	Yale University; Cary Institute of Ecosystem Studies	Raymond, PA (corresponding author), Yale Univ, Sch Forestry & Environm Studies, 205 Prospect St, New Haven, CT 06511 USA.	peter.raymond@yale.edu	Raymond, Peter A/C-4087-2009; Cole, Jonathan Jay/G-4566-2011	Raymond, Peter A/0000-0002-8564-7860; Cole, Jonathan Jay/0000-0003-4633-7402				Baldwin CK, 1999, WATER RESOUR RES, V35, P1143, DOI 10.1029/1998WR900070; Banfield JF, 1999, P NATL ACAD SCI USA, V96, P3404, DOI 10.1073/pnas.96.7.3404; BERNER RA, 1984, AM J SCI, V284, P1183, DOI 10.2475/ajs.284.10.1183; Cochran MF, 1996, CHEM GEOL, V132, P71; Dai A, 1997, J CLIMATE, V10, P2943, DOI 10.1175/1520-0442(1997)010<2943:SOGLPV>2.0.CO;2; Dijkstra FA, 2003, BIOGEOCHEMISTRY, V62, P253, DOI 10.1023/A:1021132132199; Frankignoulle M, 1998, SCIENCE, V282, P434, DOI 10.1126/science.282.5388.434; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Goolsby DA, 2001, HYDROL PROCESS, V15, P1209, DOI 10.1002/hyp.210; Hicke JA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013578; HODELL DA, 1991, GEOLOGY, V19, P24, DOI 10.1130/0091-7613(1991)019<0024:VITSIC>2.3.CO;2; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; HOWARTH RW, 1991, ECOL APPL, V1, P27, DOI 10.2307/1941845; Johnson LB, 1997, FRESHWATER BIOL, V37, P193, DOI 10.1046/j.1365-2427.1997.d01-539.x; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Jongmans AG, 1997, NATURE, V389, P682, DOI 10.1038/39493; LASAGA AC, 1994, GEOCHIM COSMOCHIM AC, V58, P2361, DOI 10.1016/0016-7037(94)90016-7; Lins HF, 1999, GEOPHYS RES LETT, V26, P227, DOI 10.1029/1998GL900291; Liu Z, 2000, ENVIRON GEOL, V39, P1053, DOI 10.1007/s002549900072; LYNCH JA, 1995, ATMOS ENVIRON, V29, P1231, DOI 10.1016/1352-2310(94)00371-Q; Markewitz D, 2001, NATURE, V410, P802, DOI 10.1038/35071052; MEYBECK M, 1987, AM J SCI, V287, P401, DOI 10.2475/ajs.287.5.401; Millot R, 2002, EARTH PLANET SC LETT, V196, P83, DOI 10.1016/S0012-821X(01)00599-4; Morgan J.J., 1996, AQUATIC CHEM, V3; Moulton KL, 2000, AM J SCI, V300, P539, DOI 10.2475/ajs.300.7.539; Nemani R, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014867; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; Rothman DH, 2002, P NATL ACAD SCI USA, V99, P4167, DOI 10.1073/pnas.022055499; Rothman DH, 2001, P NATL ACAD SCI USA, V98, P4305, DOI 10.1073/pnas.071047798; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; SCHWARTZMAN DW, 1989, NATURE, V340, P457, DOI 10.1038/340457a0; Semhi K, 2000, APPL GEOCHEM, V15, P865, DOI 10.1016/S0883-2927(99)00076-1; SKIBA U, 1992, ATMOS ENVIRON A-GEN, V26, P2477, DOI 10.1016/0960-1686(92)90100-Y; Smith SV, 2001, GLOBAL BIOGEOCHEM CY, V15, P697, DOI 10.1029/2000GB001341; Strakhov N.M., 1967, PRINCIPLES LITHOGENE, V1; SUNDQUIST ET, 1993, SCIENCE, V259, P934, DOI 10.1126/science.259.5097.934; SUNDQUIST ET, 1991, QUATERNARY SCI REV, V10, P283, DOI 10.1016/0277-3791(91)90026-Q; TURNER RE, 1994, NATURE, V368, P619, DOI 10.1038/368619a0; WHITE AF, 1995, GEOCHIM COSMOCHIM AC, V59, P1729, DOI 10.1016/0016-7037(95)00078-E; White AF, 1999, GEOCHIM COSMOCHIM AC, V63, P3277, DOI 10.1016/S0016-7037(99)00250-1	42	256	272	4	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2003	301	5629					88	91		10.1126/science.1083788	http://dx.doi.org/10.1126/science.1083788			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843391				2022-12-24	WOS:000183914700038
J	Mangeat, B; Turelli, P; Caron, G; Friedli, M; Perrin, L; Trono, D				Mangeat, B; Turelli, P; Caron, G; Friedli, M; Perrin, L; Trono, D			Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ARTHRITIS-ENCEPHALITIS VIRUS; G->A HYPERMUTATION; IN-VIVO; LENTIVIRAL VECTOR; DNA-SYNTHESIS; VIF PROTEIN; GENE; REPLICATION; SUBSTITUTIONS	Viral replication usually requires that innate intracellular lines of defence be overcome, a task usually accomplished by specialized viral gene products. The virion infectivity factor (Vif) protein of human immunodeficiency virus (HIV) is required during the late stages of viral production to counter the antiviral activity of APOBEC3G (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G; also known as CEM15), a protein expressed notably in human T lymphocytes(1-4). When produced in the presence of APOBEC3G, vif-defective virus is non-infectious. APOBEC3G is closely related to APOBEC1, the central component of an RNA-editing complex that deaminates a cytosine residue in apoB messenger RNA(5-7). APOBEC family members also have potent DNA mutator activity through dC deamination(8); however, whether the editing potential of APOBEC3G has any relevance to HIV inhibition is unknown. Here, we demonstrate that it does, as APOBEC3G exerts its antiviral effect during reverse transcription to trigger G-to-A hypermutation in the nascent retroviral DNA. We also find that APOBEC3G can act on a broad range of retroviruses in addition to HIV, suggesting that hypermutation by editing is a general innate defence mechanism against this important group of pathogens.	Univ Geneva, Dept Genet & Microbiol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Med, CH-1211 Geneva, Switzerland; Univ Geneva, Frontiers Genet Res Program, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of Geneva	Trono, D (corresponding author), Univ Geneva, Dept Genet & Microbiol, CH-1211 Geneva 4, Switzerland.			Mangeat, Bastien/0000-0003-2592-0236				BORMAN AM, 1995, VIROLOGY, V208, P601, DOI 10.1006/viro.1995.1191; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; CHARNIAUX-COTTON HELENE, 1962, GEN AND COMP ENDOCRINOL SUPPL, V1, P241, DOI 10.1016/0016-6480(62)90095-3; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Gunther S, 1997, VIROLOGY, V235, P104, DOI 10.1006/viro.1997.8676; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; JAYANTA C, 2003, NATURE, V422, P726; JOHNSON PR, 1991, VIROLOGY, V185, P217, DOI 10.1016/0042-6822(91)90769-8; Klarmann GJ, 2003, J BIOL CHEM, V278, P7902, DOI 10.1074/jbc.M207223200; Kotsopoulou E, 2000, J VIROL, V74, P4839, DOI 10.1128/JVI.74.10.4839-4852.2000; MACGINNITIE AJ, 1995, J BIOL CHEM, V270, P14768, DOI 10.1074/jbc.270.24.14768; Mansky LM, 2000, J VIROL, V74, P9525, DOI 10.1128/JVI.74.20.9525-9531.2000; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6019, DOI 10.1073/pnas.87.16.6019; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Turelli P, 1997, J VIROL, V71, P4522, DOI 10.1128/JVI.71.6.4522-4530.1997; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; VARTANIAN JP, 1991, J VIROL, V65, P1779, DOI 10.1128/JVI.65.4.1779-1788.1991; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; WAINHOBSON S, 1995, VIROLOGY, V209, P297, DOI 10.1006/viro.1995.1261; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	28	1184	1232	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					99	103		10.1038/nature01709	http://dx.doi.org/10.1038/nature01709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12808466				2022-12-24	WOS:000183912800048
J	Zhang, H; Yang, B; Pomerantz, RJ; Zhang, CM; Arunachalam, SC; Gao, L				Zhang, H; Yang, B; Pomerantz, RJ; Zhang, CM; Arunachalam, SC; Gao, L			The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; B MESSENGER-RNA; TYPE-1 VIF PROTEIN; REVERSE TRANSCRIPTION; G->A HYPERMUTATION; NONPERMISSIVE CELLS; EDITING ENZYME; SOR GENE; INFECTION; REPLICATION	High mutation frequency during reverse transcription has a principal role in the genetic variation of primate lentiviral populations. It is the main driving force for the generation of drug resistance and the escape from immune surveillance. G to A hypermutation is one of the characteristics of primate lentiviruses, as well as other retroviruses, during replication in vivo and in cell culture(1-6). The molecular mechanisms of this process, however, remain to be clarified. Here, we demonstrate that CEM15 (also known as apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G; APOBEC3G)(7,8), an endogenous inhibitor of human immunodeficiency virus type 1 (HIV-1) replication, is a cytidine deaminase and is able to induce G to A hypermutation in newly synthesized viral DNA. This effect can be counteracted by the HIV-1 virion infectivity factor (Vif). It seems that this viral DNA mutator is a viral defence mechanism in host cells that may induce either lethal hypermutation or instability of the incoming nascent viral reverse transcripts, which could account for the Vif-defective phenotype. Importantly, the accumulation of CEM15-mediated non-lethal hypermutation in the replicating viral genome could potently contribute to the genetic variation of primate lentiviral populations.	Thomas Jefferson Univ, Dept Med, Div Infect Dis & Environm Med, Ctr Human Virol & Biodef,Dorrance H Hamilton Labs, Philadelphia, PA 19107 USA	Jefferson University	Zhang, H (corresponding author), Thomas Jefferson Univ, Dept Med, Div Infect Dis & Environm Med, Ctr Human Virol & Biodef,Dorrance H Hamilton Labs, Philadelphia, PA 19107 USA.		Yang, Bin/J-4044-2015; Yang, Bin/W-7014-2019	Yang, Bin/0000-0003-4110-1513; Yang, Bin/0000-0003-1180-6184	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047720] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI047720] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; Chester A, 2000, BBA-GENE STRUCT EXPR, V1494, P1, DOI 10.1016/S0167-4781(00)00219-0; Dettenhofer M, 2000, J VIROL, V74, P8938, DOI 10.1128/JVI.74.19.8938-8945.2000; Dornadula G, 2000, J VIROL, V74, P2594, DOI 10.1128/JVI.74.6.2594-2602.2000; FISHER AG, 1987, SCIENCE, V237, P888, DOI 10.1126/science.3497453; FITZGIBBON JE, 1993, AIDS RES HUM RETROV, V9, P833, DOI 10.1089/aid.1993.9.833; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Janini M, 2001, J VIROL, V75, P7973, DOI 10.1128/JVI.75.17.7973-7986.2001; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kao S, 2003, J VIROL, V77, P1131, DOI 10.1128/JVI.77.2.1131-1140.2003; Khan MA, 2001, J VIROL, V75, P7252, DOI 10.1128/JVI.75.16.7252-7265.2001; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; MACGINNITIE AJ, 1995, J BIOL CHEM, V270, P14768, DOI 10.1074/jbc.270.24.14768; MARTINEZ MA, 1994, P NATL ACAD SCI USA, V91, P11787, DOI 10.1073/pnas.91.25.11787; Mehta A, 1996, J BIOL CHEM, V271, P28294, DOI 10.1074/jbc.271.45.28294; PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6019, DOI 10.1073/pnas.87.16.6019; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; SOVA P, 1993, J VIROL, V67, P6322, DOI 10.1128/JVI.67.10.6322-6326.1993; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; VARTANIAN JP, 1994, P NATL ACAD SCI USA, V91, P3092, DOI 10.1073/pnas.91.8.3092; VARTANIAN JP, 1991, J VIROL, V65, P1779, DOI 10.1128/JVI.65.4.1779-1788.1991; Vartanian JP, 1997, J MOL BIOL, V270, P139, DOI 10.1006/jmbi.1997.1104; Vartanian JP, 2002, J GEN VIROL, V83, P801, DOI 10.1099/0022-1317-83-4-801; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Zhang H, 2000, J VIROL, V74, P8252, DOI 10.1128/JVI.74.18.8252-8261.2000; ZHANG L, 1996, TERRA NOVA ABSTR S, V1, P70	30	879	905	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					94	98		10.1038/nature01707	http://dx.doi.org/10.1038/nature01707			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12808465	Green Accepted			2022-12-24	WOS:000183912800047
J	Maiato, H; Fairley, EAL; Rieder, CL; Swedlow, JR; Sunkel, CE; Earnshaw, WC				Maiato, H; Fairley, EAL; Rieder, CL; Swedlow, JR; Sunkel, CE; Earnshaw, WC			Human CLASP1 is an outer kinetochore component that regulates spindle microtubule dynamics	CELL			English	Article							KINESIN-RELATED PROTEIN; NEWT LUNG-CELLS; MITOTIC SPINDLE; CENP-E; IN-VITRO; CHROMOSOME ALIGNMENT; INSTABILITY; ATTACHMENT; MITOSIS; INVITRO	One of the most intriguing aspects of mitosis is the ability of kinetochores to hold onto plus ends of microtubules that are actively gaining or losing tubulin subunits. Here, we show that CLASP1, a microtubule-associated protein, localizes preferentially near the plus ends of growing spindle microtubules and is also a component of a kinetochore region that we term the outer corona. A truncated form of CLASP1 lacking the kinetochore binding domain behaves as a dominant negative, leading to the formation of radial arrays of microtubule bundles that are highly resistant to depolymerization. Microinjection of CLASP1-specific antibodies suppresses microtubule dynamics at kinetochores and throughout the spindle, resulting in the formation of monopolar asters with chromosomes buried in the interior. Incubation with microtubule-stabilizing drugs rescues the kinetochore association with microtubule plus ends at the periphery of the asters. Our data suggest that CLASP1 is required at kinetochores for attached microtubules to exhibit normal dynamic behavior.	Univ Edinburgh, Inst Cell & Mol Biol, Chromosome Struct Grp, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Porto, Inst Biol Mol & Celular, Genet Mol Lab, P-4150180 Oporto, Portugal; Wadsworth Ctr, Lab Cell Regulat, Div Mol Med, Albany, NY 12201 USA; Univ Dundee, Div Gene Regulat & Express, MSI, WTB Complex, Dundee DD1 5EH, Scotland; Univ Porto, Inst Ciencias Biomed Abel Alazar, P-4099003 Oporto, Portugal	University of Edinburgh; Universidade do Porto; Wadsworth Center; University of Dundee; Universidade do Porto	Earnshaw, WC (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Chromosome Struct Grp, Wellcome Trust Ctr Cell Biol, Swann Bldg,Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.		Maiato, Helder/J-9466-2013; Earnshaw, William/AAY-7438-2020; Sunkel, Claudio E/J-3352-2013	Maiato, Helder/0000-0002-6200-9997; Sunkel, Claudio E/0000-0002-2963-9380; Swedlow, Jason/0000-0002-2198-1958; Earnshaw, William/0000-0002-7191-0621	NIGMS NIH HHS [GM 40198, R37 GM040198, R37 GM040198-20] Funding Source: Medline; Wellcome Trust [073915] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM040198, R01GM040198] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrieu A, 2000, CELL, V102, P817, DOI 10.1016/S0092-8674(00)00070-2; AIZAWA H, 1991, J BIOL CHEM, V266, P9841; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Arnal I, 2000, J CELL BIOL, V149, P767, DOI 10.1083/jcb.149.4.767; BRINKLEY BR, 1966, CHROMOSOMA, V19, P28, DOI 10.1007/BF00332792; CARPENTER ATC, 1991, CELL, V64, P885, DOI 10.1016/0092-8674(91)90313-N; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; COOKE CA, 1990, J CELL BIOL, V110, P1475, DOI 10.1083/jcb.110.5.1475; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; COUE M, 1991, J CELL BIOL, V112, P1165, DOI 10.1083/jcb.112.6.1165; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Dujardin D, 1998, J CELL BIOL, V141, P849, DOI 10.1083/jcb.141.4.849; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; HYMAN AA, 1990, J CELL BIOL, V110, P1607, DOI 10.1083/jcb.110.5.1607; HYMAN AA, 1991, NATURE, V351, P206, DOI 10.1038/351206a0; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Inoue YH, 2000, J CELL BIOL, V149, P153, DOI 10.1083/jcb.149.1.153; Ishikawa K, 1998, DNA Res, V5, P169, DOI 10.1093/dnares/5.3.169; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; JOKELAINEN PT, 1967, J ULTRA MOL STRUCT R, V19, P19, DOI 10.1016/S0022-5320(67)80058-3; Jordan MA, 1999, METHOD CELL BIOL, V61, P267; JORDAN MA, 1992, J CELL SCI, V102, P401; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; LaFountain JR, 2001, MOL BIOL CELL, V12, P4054, DOI 10.1091/mbc.12.12.4054; Lemos CL, 2000, EMBO J, V19, P3668, DOI 10.1093/emboj/19.14.3668; Lin HJ, 2001, J CELL BIOL, V155, P1173, DOI 10.1083/jcb.200108119; LOMBILLO VA, 1995, J CELL BIOL, V128, P107, DOI 10.1083/jcb.128.1.107; Maiato H, 2002, J CELL BIOL, V157, P749, DOI 10.1083/jcb.200201101; Mastronarde D. N., 1997, Molecular Biology of the Cell, V8, p171A; McEwen BF, 1998, CHROMOSOMA, V107, P366, DOI 10.1007/s004120050320; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; MITCHISON T, 1986, CELL, V45, P515, DOI 10.1016/0092-8674(86)90283-7; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON TJ, 1985, J CELL BIOL, V101, P766, DOI 10.1083/jcb.101.3.766; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; PASQUALONE D, 1994, J CELL BIOL, V127, P849; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rieder CL, 1999, METHOD CELL BIOL, V61, P297; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; RIEDER CL, 1986, J CELL BIOL, V103, P581, DOI 10.1083/jcb.103.2.581; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Tirnauer JS, 2002, MOL BIOL CELL, V13, P4308, DOI 10.1091/mbc.e02-04-0236; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yin HW, 2002, MOL BIOL CELL, V13, P1881, DOI 10.1091/mbc.01-09-0458	56	164	169	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 27	2003	113	7					891	904		10.1016/S0092-8674(03)00465-3	http://dx.doi.org/10.1016/S0092-8674(03)00465-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	695EJ	12837247	Bronze, Green Submitted			2022-12-24	WOS:000183817900013
J	Morris, MC; Kaiser, P; Rudyak, S; Baskerville, C; Watson, MH; Reed, SI				Morris, MC; Kaiser, P; Rudyak, S; Baskerville, C; Watson, MH; Reed, SI			Cks1-dependent proteasome recruitment and activation of CDC20 transcription in budding yeast	NATURE			English	Article							CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; DEPENDENT PROTEOLYSIS; PROTEIN-KINASE; M-PHASE; GENE; ELONGATION; COMPLEX; PDS1; CLB2	Cks proteins are small evolutionarily conserved proteins that interact genetically and physically with cyclin-dependent kinases. However, in spite of a large body of genetic, biochemical and structural research, no compelling unifying model of their functions has emerged(1,2). Here we show, by investigating the essential role of Cks1 in Saccharomyces cerevisiae, that the protein is primarily involved in promoting mitosis by modulating the transcriptional activation of the APC/C protein-ubiquitin ligase activator Cdc20. Cks1 is required for both the periodic dissociation of Cdc28 kinase from the CDC20 promoter and the periodic association of the proteasome with the promoter. We propose that the essential role of Cks1 is to recruit the proteasome to, and/or dissociate the Cdc28 kinase from, the CDC20 promoter, thus facilitating transcription by remodelling transcriptional complexes or chromatin associated with the CDC20 gene.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Reed, SI (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		MORRIS, May C/J-5940-2016; Rudyak, Stanislav/U-1781-2017; MORRIS, May/ABB-2629-2021	MORRIS, May C/0000-0001-8106-9728; MORRIS, May/0000-0001-8106-9728				AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Bourne Y, 1996, CELL, V84, P863, DOI 10.1016/S0092-8674(00)81065-X; COLLART MA, 1993, CURRENT PROTOCOLS MO, V2; ENDICOTT JA, 1995, STRUCTURE, V3, P321, DOI 10.1016/S0969-2126(01)00162-9; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; GHIARA JB, 1991, CELL, V65, P163, DOI 10.1016/0092-8674(91)90417-W; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; HILT W, 1993, J BIOL CHEM, V268, P3479; Jensen S, 2001, J CELL BIOL, V152, P27, DOI 10.1083/jcb.152.1.27; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kaiser P, 1999, GENE DEV, V13, P1190, DOI 10.1101/gad.13.9.1190; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Lim HH, 1998, CURR BIOL, V8, P231, DOI 10.1016/S0960-9822(98)70088-0; MAHER M, 1995, MOL CELL BIOL, V15, P3129; Nasmyth K, 1993, CURR OPIN CELL BIOL, V5, P166, DOI 10.1016/0955-0674(93)90099-C; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; Pines J, 1996, CURR BIOL, V6, P1399, DOI 10.1016/S0960-9822(96)00741-5; REED SI, 1985, P NATL ACAD SCI USA, V82, P4055, DOI 10.1073/pnas.82.12.4055; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; TANG Y, 1993, GENE DEV, V7, P822, DOI 10.1101/gad.7.5.822; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	23	103	107	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					1009	1013		10.1038/nature01720	http://dx.doi.org/10.1038/nature01720			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827207				2022-12-24	WOS:000183753900055
J	Siddall, M; Rohling, EJ; Almogi-Labin, A; Hemleben, C; Meischner, D; Schmelzer, I; Smeed, DA				Siddall, M; Rohling, EJ; Almogi-Labin, A; Hemleben, C; Meischner, D; Schmelzer, I; Smeed, DA			Sea-level fluctuations during the last glacial cycle	NATURE			English	Article							BAH AL MANDAB; RED-SEA; CLIMATE-CHANGE; GREENLAND; ISOTOPE; RECORDS; CORALS; AGES; FORAMINIFERA; TEMPERATURE	The last glacial cycle was characterized by substantial millennial-scale climate fluctuations(1-5), but the extent of any associated changes in global sea level (or, equivalently, ice volume) remains elusive. Highstands of sea level can be reconstructed from dated fossil coral reef terraces(6,7), and these data are complemented by a compilation of global sea-level estimates based on deep-sea oxygen isotope ratios at millennial-scale resolution(8) or higher(1). Records based on oxygen isotopes, however, contain uncertainties in the range of +/-30 m, or +/-1degreesC in deep sea temperature(9,10). Here we analyse oxygen isotope records from Red Sea sediment cores to reconstruct the history of water residence times in the Red Sea. We then use a hydraulic model of the water exchange between the Red Sea and the world ocean to derive the sill depth and hence global sea level-over the past 470,000 years (470 kyr). Our reconstruction is accurate to within +/-12 m, and gives a centennial-scale resolution from 70 to 25 kyr before present. We find that sea-level changes of up to 35 m, at rates of up to 2 cm yr(-1), occurred, coincident with abrupt changes in climate.	Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Geol Survey Israel, IL-95501 Jerusalem, Israel; Univ Tubingen, Dept Geol & Paleontol, D-7400 Tubingen, Germany; Univ Gottingen, Inst Geol & Palaeontol, Dept Sedimentary Geol, D-37073 Gottingen, Germany	NERC National Oceanography Centre; University of Southampton; Geological Survey Israel; Eberhard Karls University of Tubingen; University of Gottingen	Siddall, M (corresponding author), Southampton Oceanog Ctr, European Way, Southampton SO14 3ZH, Hants, England.		Rohling, Eelco J/B-9736-2008; Smeed, David/B-4726-2012	Rohling, Eelco J/0000-0001-5349-2158; Smeed, David/0000-0003-1740-1778; Almogi-Labin, Ahuva/0000-0002-4082-7120				Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; Almogi-Labina A, 2000, MAR MICROPALEONTOL, V40, P295, DOI 10.1016/S0377-8398(00)00043-8; BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0; Bard E, 1996, NATURE, V382, P241, DOI 10.1038/382241a0; Blunier T, 1998, NATURE, V394, P739, DOI 10.1038/29447; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Chappell J, 2002, QUATERNARY SCI REV, V21, P1229, DOI 10.1016/S0277-3791(01)00141-X; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Edwards F.J., 1987, KEY ENV RED SEA, P45; EDWARDS RL, 1993, SCIENCE, V260, P962, DOI 10.1126/science.260.5110.962; Fairbanks RG, 1990, PALEOCEANOGRAPHY, V5, P937, DOI 10.1029/PA005i006p00937; Fenton M, 2000, MAR MICROPALEONTOL, V40, P277, DOI 10.1016/S0377-8398(00)00042-6; GALLUP CD, 1994, SCIENCE, V263, P796, DOI 10.1126/science.263.5148.796; GRIFFITHS RW, 1984, DEEP-SEA RES, V31, P245, DOI 10.1016/0198-0149(84)90104-3; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Hemleben C, 1996, PALEOCEANOGRAPHY, V11, P147, DOI 10.1029/95PA03838; PIRAZZOLI PA, 1993, MAR GEOL, V109, P221, DOI 10.1016/0025-3227(93)90062-Z; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Rohling EJ, 1999, PALEOCEANOGRAPHY, V14, P706, DOI 10.1029/1999PA900042; SCHMELZER I, 1998, HIGH FREQUENCY EVENT; SHACKLETON NJ, 1987, QUATERNARY SCI REV, V6, P183, DOI 10.1016/0277-3791(87)90003-5; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Siddall M, 2002, DEEP-SEA RES PT I, V49, P1551, DOI 10.1016/S0967-0637(02)00043-2; Smeed D, 1997, OCEANOL ACTA, V20, P773; Smeed DA, 2000, J PHYS OCEANOGR, V30, P2574, DOI 10.1175/1520-0485(2000)030<2574:HCOTLE>2.0.CO;2; Sofianos SS, 2002, DEEP-SEA RES PT II, V49, P1323, DOI 10.1016/S0967-0645(01)00164-3; Voelker AHL, 1998, RADIOCARBON, V40, P517; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9	29	1158	1203	6	324	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					853	858		10.1038/nature01690	http://dx.doi.org/10.1038/nature01690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815427				2022-12-24	WOS:000183585300041
J	Presgraves, DC; Balagopalan, L; Abmayr, SM; Orr, HA				Presgraves, DC; Balagopalan, L; Abmayr, SM; Orr, HA			Adaptive evolution drives divergence of a hybrid inviability gene between two species of Drosophila	NATURE			English	Article							NUCLEAR-PORE COMPLEX; POPULATION-GENETICS; NUCLEOPORIN; PROTEIN; NUP98; MELANOGASTER; HITCHHIKING; SITE; ARCHITECTURE; SPECIATION	Speciation-the splitting of one species into two-occurs by the evolution of any of several forms of reproductive isolation between taxa, including the intrinsic sterility and inviability of hybrids. Abundant evidence shows that these hybrid fitness problems are caused by incompatible interactions between loci: new alleles that become established in one species are sometimes functionally incompatible with alleles at interacting loci from another species. However, almost nothing is known about the genes involved in such hybrid incompatibilities or the evolutionary forces that drive their divergence. Here we identify a gene that causes epistatic inviability in hybrids between two fruitfly species, Drosophila melanogaster and D. simulans. Our population genetic analysis reveals that this gene-which encodes a nuclear pore protein-evolved by positive natural selection in both species' lineages. These results show that a lethal hybrid incompatibility has evolved as a by-product of adaptive protein evolution.	Univ Rochester, Dept Biol, Rochester, NY 14627 USA; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Presgraves, DC (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	dvnp@mail.rochester.edu						Andolfatto P, 2001, MOL BIOL EVOL, V18, P279, DOI 10.1093/oxfordjournals.molbev.a003804; Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Davis AW, 1996, NATURE, V380, P157, DOI 10.1038/380157a0; Dobzhansky T., 1937, GENETICS ORIGIN SPEC; Emtage JLT, 1997, J CELL SCI, V110, P911; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Fay JC, 2000, GENETICS, V155, P1405; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Fontoura BMA, 2001, P NATL ACAD SCI USA, V98, P3208, DOI 10.1073/pnas.061014698; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; HEY J, 1993, MOL BIOL EVOL, V10, P804; KAPLAN NL, 1989, GENETICS, V123, P887; Keller CA, 1998, DEV BIOL, V202, P157, DOI 10.1006/dbio.1998.9009; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; LACHAISE D, 1986, EVOLUTION, V40, P262, DOI 10.1111/j.1558-5646.1986.tb00468.x; Lynch M, 2000, AM NAT, V156, P590, DOI 10.1086/316992; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MULLER H. J., 1942, GENETICS, V27, P157; Naveira HF, 1998, ENDLESS FORMS, P330; Orr HA, 2000, BIOESSAYS, V22, P1085, DOI 10.1002/1521-1878(200012)22:12&lt;1085::AID-BIES6&gt;3.0.CO;2-G; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; Presgraves DC, 2003, GENETICS, V163, P955; ROSE MR, 1983, SCIENCE, V220, P157, DOI 10.1126/science.220.4593.157; Rosenblum JS, 1999, P NATL ACAD SCI USA, V96, P11370, DOI 10.1073/pnas.96.20.11370; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0; Sawamura K, 2000, P NATL ACAD SCI USA, V97, P2652, DOI 10.1073/pnas.050558597; Sturtevant AH, 1920, GENETICS, V5, P488; STURTEVANT AH, 1929, PUBL CARNEG I WASH, V399, P1; TAJIMA F, 1989, GENETICS, V123, P585; Teixeira MT, 1999, J BIOL CHEM, V274, P32439, DOI 10.1074/jbc.274.45.32439; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Turelli M, 2000, GENETICS, V154, P1663; Vasu SK, 2001, CURR OPIN CELL BIOL, V13, P363, DOI 10.1016/S0955-0674(00)00221-0; Wall JD, 2002, GENETICS, V162, P203; WATANABE TK, 1979, JPN J GENET, V54, P325, DOI 10.1266/jjg.54.325; Wilson A.S., 1976, MOL EVOLUTION, P225; WITTBRODT J, 1989, NATURE, V341, P415, DOI 10.1038/341415a0; Wu CI, 1998, ENDLESS FORMS, P339; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4	48	312	315	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2003	423	6941					715	719		10.1038/nature01679	http://dx.doi.org/10.1038/nature01679			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802326				2022-12-24	WOS:000183443400034
J	Reynolds, EH				Reynolds, EH			Brain and mind: a challenge for WHO	LANCET			English	Editorial Material							ILLNESS		Kings Coll London, Inst Epileptol, London SE5 9PJ, England	University of London; King's College London	Reynolds, EH (corresponding author), Kings Coll London, Inst Epileptol, Denmark Hill Campus, London SE5 9PJ, England.	reynolds@buckles.u-net.com						Baker M, 2001, BRIT MED J, V322, P937, DOI 10.1136/bmj.322.7291.937; Bogousslavsky J, 2003, LANCET NEUROL, V2, P212, DOI 10.1016/S1474-4422(03)00347-8; Crisp AH, 2000, BRIT J PSYCHIAT, V177, P4, DOI 10.1192/bjp.177.1.4; EISENBERG L, 1995, AM J PSYCHIAT, V152, P1563, DOI 10.1176/ajp.152.11.1563; Kendell RE, 2001, BRIT J PSYCHIAT, V178, P490, DOI 10.1192/bjp.178.6.490; Ramachandran VS, 2003, REITH LECT, V3; Reynolds E. H., 1989, BRIDGE NEUROLOGY PSY; REYNOLDS EH, 1990, BRIT J PSYCHIAT, V157, P481, DOI 10.1192/bjp.157.4.481; World Health Organisation, 2001, MENT DIS AFF ON 4 PE; 2002, ICD10 INT STAT CLASS	10	44	45	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 7	2003	361	9373					1924	1925		10.1016/S0140-6736(03)13600-8	http://dx.doi.org/10.1016/S0140-6736(03)13600-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687DB	12801732				2022-12-24	WOS:000183359700004
J	Coursol, S; Fan, LM; Le Stunff, H; Spiegel, S; Gilroy, S; Assmann, SM				Coursol, S; Fan, LM; Le Stunff, H; Spiegel, S; Gilroy, S; Assmann, SM			Sphingolipid signalling in Arabidopsis guard cells involves heterotrimeric G proteins	NATURE			English	Article							SPHINGOSINE 1-PHOSPHATE; COUPLED RECEPTOR; KINASE; SPHINGOSINE-1-PHOSPHATE; PLANTS; THALIANA; CHANNELS; LYSOPHOSPHOLIPIDS; PROLIFERATION; ACTIVATION	In animals, the sphingolipid metabolite sphingosine-1-phosphate (S1P) functions as both an intracellular messenger and an extracellular ligand for G-protein-coupled receptors of the S1P receptor family, regulating diverse biological processes ranging from cell proliferation to apoptosis(1-3). Recently, it was discovered in plants that S1P is a signalling molecule involved in abscisic acid (ABA) regulation of guard cell turgor(4). Here we report that the enzyme responsible for S1P production, sphingosine kinase (SphK), is activated by ABA in Arabidopsis thaliana, and is involved in both ABA inhibition of stomatal opening and promotion of stomatal closure. Consistent with this observation, inhibition of SphK attenuates ABA regulation of guard cell inward K+ channels and slow anion channels, which are involved in the regulation of stomatal pore size. Surprisingly, S1P regulates stomatal apertures and guard cell ion channel activities in wild-type plants, but not in knockout lines of the sole prototypical heterotrimeric G-protein alpha-subunit gene, GPA1 (refs 5-8). Our results implicate heterotrimeric G proteins as downstream elements in the S1P signalling pathway that mediates ABA regulation of stomatal function, and suggest that the interplay between S1P and heterotrimeric G proteins represents an evolutionarily conserved signalling mechanism.	Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem, Richmond, VA 23298 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Virginia Commonwealth University	Assmann, SM (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.		LE STUNFF, Hervé/AAA-6882-2019	Gilroy, Simon/0000-0001-9597-6839				Assmann SM, 2001, CURR OPIN PLANT BIOL, V4, P421, DOI 10.1016/S1369-5266(00)00195-3; Assmann SM, 2002, PLANT CELL, V14, pS355, DOI 10.1105/tpc.001792; Blatt MR, 2000, ANNU REV CELL DEV BI, V16, P221, DOI 10.1146/annurev.cellbio.16.1.221; Brownlee C, 2001, CURR BIOL, V11, pR535, DOI 10.1016/S0960-9822(01)00313-X; Cismowski MJ, 2001, LIFE SCI, V68, P2301, DOI 10.1016/S0024-3205(01)01019-0; Colucci G, 2002, P NATL ACAD SCI USA, V99, P4736, DOI 10.1073/pnas.072087699; Crowther GJ, 1997, ARCH BIOCHEM BIOPHYS, V337, P284, DOI 10.1006/abbi.1996.9799; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Heringdorf DMZ, 1998, EMBO J, V17, P2830, DOI 10.1093/emboj/17.10.2830; Himmel HM, 2000, MOL PHARMACOL, V58, P449, DOI 10.1124/mol.58.2.449; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Jones AM, 2002, CURR OPIN PLANT BIOL, V5, P402, DOI 10.1016/S1369-5266(02)00288-1; Josefsson LG, 1997, EUR J BIOCHEM, V249, P415, DOI 10.1111/j.1432-1033.1997.t01-1-00415.x; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Ng CKY, 2001, ANN BOT-LONDON, V88, P957, DOI 10.1006/anbo.2001.1543; Ng CKY, 2001, NATURE, V410, P596, DOI 10.1038/35069092; Nishiura H, 2000, BIOCHEM SOC T, V28, P747, DOI 10.1042/BST0280747; Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576; Pandey S, 2002, NEW PHYTOL, V153, P517, DOI 10.1046/j.0028-646X.2001.00329.x; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Pyne S, 2002, BBA-MOL CELL BIOL L, V1582, P121, DOI 10.1016/S1388-1981(02)00146-4; Schilling T, 2002, NEUROSCIENCE, V109, P827, DOI 10.1016/S0306-4522(01)00534-6; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Sperling P, 1998, J BIOL CHEM, V273, P28590, DOI 10.1074/jbc.273.44.28590; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046	29	264	288	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					651	654		10.1038/nature01643	http://dx.doi.org/10.1038/nature01643			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789341	Bronze			2022-12-24	WOS:000183301200043
